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Preface 
The essential role of epidemiology is to improve the health of populations. Advances
in epidemiology research  are expected to play a central role in medicine and public 
health in the 21st century by providing  information for disease prediction and
prevention. 
This book represents an overview on the diverse threads of epidemiological research
in that captures the new and exciting themes that have been emerging over recent 
years. Diverse topics are  discussed and the book provides an overview of the current
state of epidemiological knowledge and research as a reference to reveal new avenues
of work, while the power of the epidemiological method runs throughout the book.
The first part addresses  the  epidemiology of dermatomycoses and Candida spp.
infections. The second part  addresses the epidemiology molecular of methicillin-
resistant Staphylococcus aureus (MRSA) isolated from humans and animals. The third 
part provides an overview of the epidemiology of varied  manifestations  neuro-
psychiatric. The fourth part covers virology and epidemiology, the fifth part 
addresses epidemiology  of wildlife tuberculosis and the sixth part  epidemiologic
approaches to the study of microbial quality of milk and milk products.  Cox
proportional hazards model (Part 7), epidemiology of lymphoid malignancy (Part 8), 
epidemiology of primary immunodeficiency diseases (Part 9) and genetic 
epidemiology  family-based (Part 10)  are also presented.
All the chapters,  having gathered together a talented and internationally respected
group of contributors, researchers well reputed in the field and have been carefully 
reviewed. The book provides an excellent overview in the different applicative fields 
of epidemiology, for clinicians, researchers and students, who intend to address these
issues.
Maria de Lourdes Ribeiro de Souza da Cunha 
Department of Microbiology and Immunology 
Bioscience Institute 
UNESP - Univ Estadual Paulista, Botucatu-SP 
Brazil 
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Epidemiology of Dermatomycoses  
and Candida spp. Infections 
 
Section 1 
Epidemiology of Dermatomycoses  
and Candida spp. Infections 
 1 
Microsatellite Typing of  
Catheter-Associated Candida albicans Strains  
Astrid Helga Paulitsch-Fuchs1,2, Bettina Heiling1,  
Birgit Willinger3 and Walter Buzina1 
1Institute of Hygiene, Microbiology and Environmental Medicine 
Medical University of Graz, Graz 
2Wetsus Centre of Excellence for Sustainable Water Technology, Leeuwarden 
3Division of Hygiene and Medical Microbiology, Medical University of Vienna, Vienna 
1,3Austria 
2The Netherlands 
1. Introduction  
Candida albicans is the most common pathogenic fungus and occurs frequently in the 
digestive tract (Bernhardt, 1998; Doskey, 2004). Vaginal candidiasis (Mohanty et al. 2007; 
Paulitsch et al., 2006; Sobel, 2007) is also a wide spread problem. This species can become 
invasive, causing infections on many different sites in patients with severe underlying 
diseases (Marol & Yükesoy, 2008; Odds et al., 2007). 
Catheter or shunt related infections caused by C. albicans (Pierce 2005) were reported e.g. by 
Sánchez-Portocarrero et al. (1994), David et al. (2005) and Tumbarello et al. (2007). 
The classical picture of yeast cells as unicellular life forms is based on the pure-culture 
model of growth. In their natural habitat microorganisms including yeasts are mostly 
organized in biofilm ecosystems which are often ´multicultural´, made not only of yeasts but 
also of bacteria (El-Aziz et al., 2004; López-Ribot, 2005; Ramage et al., 2005; Nobile et al., 
2006). The possibility to adhere to a surface is a very important factor for the development of 
fungal (Hogan, 2006; Verstrepen & Klis, 2006) and bacterial biofilms (Dolan, 2001).  
Microsatellites, which are also known as short tandem repeats, are repeated nucleotide 
sequences with a length from 2 up to 7 base pairs. These polymorphic DNA loci are variable 
within a population and in this way multiple alleles are created for a single microsatellite 
locus. These different multilocus genotypes are used to distinguish strains within a single 
species (Applied Biosystems [AB], 2005). Microsatellite markers provide the possibility to 
discriminate strains of the same species and to trace their epidemiological pathways 
(Botterel et al., 2001; Sampaio et al., 2005).  
For this study, pairs for three loci (CDC3, EF3, and HIS3) on three different chromosomes 
developed by Botterel et al. (2001) were used to compare the C. albicans strains which  
were found to produce a biofilm, with those strains which did not produce a biofilm on  
the investigated catheter material. The differentiation of biofilm and non-biofilm forming 
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strains was based on scanning electron microscopical findings (Paulitsch et al., 2009). 
Different primer pairs and also different combinations of primer pairs for the subtyping of 
C. albicans were reported elsewhere, see e.g. the works of Sampaio et al. (2005) or Fan  
et al. (2007). 
For each marker and for a given isolate one or two bands were observed, and each observed 
band was assigned to an allele. Because C. albicans is diploid each strain can be characterized 
by six alleles with the method used.  
The discriminatory power (DP) is a numerical index to describe the probability that two 
unrelated samples of a test group are placed in two different typing groups. The DP of EF3 
is 0.86, the DP of CDC3 is 0.77, and the DP of HIS3 is 0.91 (Botterel et al., 2001). The 
combined DP of all three markers was 0.97. In order to get reliable results, this index has to 
be greater than 0.90 (Botterel et al., 2001). 
2. Microsatellite typing 
2.1 Material and methods 
The 123 C. albicans (64 [52%] of them biofilm positive) strains for this study were collected 
during a study in biofilm forming abilities of yeast on indwelling devices (Paulitsch et al., 
2009). The strains were stored at -70°C until examination. 
Strains were subcultured on Sabouraud agar plates for 24 h at 35°C. For DNA extraction  
the PrepManTM Ultra Kit (Applied Biosystems [AB], Foster City, California) was used. For 
the microsatellite typing three different primer pairs were used (Botterel et al., 2001). The 
unmarked primers were HIS3R, CDC3R, and EF3 (Invitrogen, Lofer, Austria). The 
fluorescence labeling of the primers HIS3 (NEDTM, yellow), CDC3 (VICTM, green), and 
EF3R (6-FAMTM, blue) (all AB) was fitted to the DyeSet DS-33 (AB) which is recommended 
for 5-dye custom primer analyses. PCR was performed using the 96 well GeneAmp  
PCR System 9700 or the 96 well 2700 Thermal Cycler (both AB). PCR reactions were  
carried out as singleplex reactions for each primer pair. The samples were initially incubated 
for 2 minutes at 94°C to activate the Taq Polymerase (Eppendorf, Hamburg, Germany)  
and to denature the DNA. After thermal cycling (30 cycles; 94°C for 45 s, 48°C for 45 s,  
68°C for 90 s) samples were kept at 68°C for another 5 minutes to complete partial 
polymerization. 
Sample preparation for the injection in the 3100 Automatic Sequencer (AB) was done 
following the instructions. For analysis 1 µL of PCR product, 0.3 µL of size standard 
(GeneScanTM 500-LIZ®, AB) and 10 µL Hi-DiTM Formamide (AB) were mixed and 
transferred into a 96 well plate. The samples were denatured for 4 minutes at 94°C in a 
thermal cycler and immediately placed on ice. In every run three samples were used as 
internal control. The plate was transferred in the sequencer and processed using the 
Foundation Data Collection 3.0 software of the sequencer. 
Data analysis was done with the GeneMapper® v3.7 software. Therefore it was necessary to 
set up the microsatellite analyses following the instructions of the manual (AB, 2005). The 
peaks were automatically detected (Auto Binning) with the created bin set, low quality data 
were checked manually and corrected. The results were exported in a Microsoft Excel sheet 
for documentation. 
 




Typing of 123 C. albicans strains was done with the above mentioned three primer pairs. 
Only from strain number 85 (sample W60) no data from the EF3 locus was producible. 
Although the DNA was isolated a second time and several PCR reactions were done for this 
locus, no peaks could be generated. In table 1 detailed information of all three loci for each 
strain is listed.  
 
   CDC3/CDC3R  EF3/EF3R  HIS3/HIS3R 
 sample  allele 1 allele 2  allele 1 allele 2  allele 1 allele 2 
1 K7  117 129  130 139  154 154 
2 K10  125 125  133 133  174 186 
3 K11  117 129  130 139  154 154 
4 K13  125 125  126 133  166 182 
5 K14  117 129  130 139  154 154 
6 K15  125 125  123 123  174 182 
7 K16  125 125  126 126  174 182 
8 K17  117 129  130 139  154 154 
9 K18  117 129  129 139  154 154 
10 K19  117 125  120 129  162 218 
11 K21  117 117  120 126  162 186 
12 K22  117 125  120 129  162 162 
13 K23  125 125  126 126  214 234 
14 K24  117 125  120 129  162 214 
15 K25  121 129  130 139  154 154 
16 K26  117 129  130 139  154 154 
17 K27  117 117  123 129  150 162 
18 K28  125 129  123 123  154 166 
19 K29  117 129  130 139  154 154 
20 K30  117 117  130 139  154 154 
21 K31  117 125  120 129  162 202 
22 K32  117 121  126 129  162 182 
23 K35  117 125  120 129  162 214 
24 K36  117 125  120 129  162 166 
25 K37  113 117  123 130  150 162 
26 K38  121 125  123 137  154 166 
27 K39  117 117  123 129  174 178 
28 K40  125 125  123 137  158 158 
29 K41  121 129  129 139  154 154 
30 K45  125 125  123 137  154 166 
31 K49  117 125  120 129  162 198 
32 K50  117 125  120 129  162 198 
33 K51  117 129  129 139  154 154 
34 K53  117 129  129 139  146 154 
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1 K7  117 129  130 139  154 154 
2 K10  125 125  133 133  174 186 
3 K11  117 129  130 139  154 154 
4 K13  125 125  126 133  166 182 
5 K14  117 129  130 139  154 154 
6 K15  125 125  123 123  174 182 
7 K16  125 125  126 126  174 182 
8 K17  117 129  130 139  154 154 
9 K18  117 129  129 139  154 154 
10 K19  117 125  120 129  162 218 
11 K21  117 117  120 126  162 186 
12 K22  117 125  120 129  162 162 
13 K23  125 125  126 126  214 234 
14 K24  117 125  120 129  162 214 
15 K25  121 129  130 139  154 154 
16 K26  117 129  130 139  154 154 
17 K27  117 117  123 129  150 162 
18 K28  125 129  123 123  154 166 
19 K29  117 129  130 139  154 154 
20 K30  117 117  130 139  154 154 
21 K31  117 125  120 129  162 202 
22 K32  117 121  126 129  162 182 
23 K35  117 125  120 129  162 214 
24 K36  117 125  120 129  162 166 
25 K37  113 117  123 130  150 162 
26 K38  121 125  123 137  154 166 
27 K39  117 117  123 129  174 178 
28 K40  125 125  123 137  158 158 
29 K41  121 129  129 139  154 154 
30 K45  125 125  123 137  154 166 
31 K49  117 125  120 129  162 198 
32 K50  117 125  120 129  162 198 
33 K51  117 129  129 139  154 154 
34 K53  117 129  129 139  146 154 





   CDC3/CDC3R  EF3/EF3R  HIS3/HIS3R 
 sample  allele 1 allele 2  allele 1 allele 2  allele 1 allele 2 
36 K57  117 117  126 137  154 182 
37 K58  117 117  129 133  150 170 
38 K59  117 129  129 137  154 154 
39 K60  117 129  130 139  154 154 
40 K62  121 125  123 137  154 166 
41 K63  117 129  129 139  143 154 
42 K64  117 125  120 129  166 230 
43 K65  111 117  123 130  154 198 
44 K66  125 125  123 133  166 182 
45 K67  117 117  130 139  154 158 
46 K68  117 125  120 120  162 198 
47 K69  117 129  130 139  154 158 
48 K71  121 125  123 123  166 166 
49 W2  113 117  123 129  150 162 
50 W3  117 125  129 129  162 162 
51 W4  117 117  126 139  154 186 
52 W5  117 125  120 129  162 198 
53 W6  117 129  130 139  154 154 
54 W8  117 125  120 129  162 162 
55 W9  117 125  120 120  162 206 
56 W11  117 125  120 120  154 162 
57 W13  117 121  129 129  150 150 
58 W14  117 125  126 126  162 162 
59 W15  125 125  126 133  166 182 
60 W16  125 125  123 133  166 182 
61 W17  117 125  129 133  186 206 
62 W18  117 125  126 126  178 178 
63 W19  117 125  120 129  162 198 
64 W20  117 125  129 129  190 202 
65 W21  125 125  126 126  186 222 
66 W22  125 125  123 139  166 166 
67 W25  117 125  120 129  206 210 
68 W26  117 117  126 139  142 154 
69 W27  109 117  129 139  154 154 
70 W34  117 117  126 139  154 158 
71 W37  117 125  126 126  162 186 
72 W38  113 117  123 129  150 162 
73 W39  117 125  126 126  162 186 
74 W44  117 129  130 139  154 154 
75 W45  117 129  130 139  154 154 
76 W47  109 117  126 131  154 154 
77 W48  117 125  130 133  154 162 
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   CDC3/CDC3R  EF3/EF3R  HIS3/HIS3R 
 sample  allele 1 allele 2  allele 1 allele 2  allele 1 allele 2 
78 W51  117 125  126 133  166 166 
79 W52  117 125  120 129  162 194 
80 W53  125 129  130 139  166 166 
81 W54  125 125  126 133  182 194 
82 W55  117 125  120 120  162 214 
83 W56  113 117  123 129  150 162 
84 W58  121 129  139 139  154 154 
85 W60  117 125     162 210 
86 W61  117 129  130 141  154 154 
87 W62  117 121  126 126  162 190 
88 W63  125 125  133 133  194 198 
89 W64  117 129  129 139  154 154 
90 W65  109 117  126 137  154 214 
91 W67  117 125  120 129  170 206 
92 W68  121 121  120 129  162 202 
93 W69  117 125  129 139  162 202 
94 W70  117 129  129 139  154 154 
95 W71  113 117  126 139  150 162 
96 W73  117 117  126 137  154 186 
97 W74  117 125  120 129  166 226 
98 W75  109 117  126 129  162 186 
99 W76  117 117  126 139  154 182 
100 W77  117 129  130 130  154 186 
101 W78  117 129  129 129  154 162 
102 W79  121 129  130 141  154 154 
103 W80  117 129  120 129  194 206 
104 W82  117 117  123 129  150 150 
105 W83  117 125  120 120  162 198 
106 W84  113 117  129 129  162 162 
107 W85  117 125  120 129  162 206 
108 W87  117 117  120 129  162 178 
109 W91  117 129  129 139  142 142 
110 W92  117 125  123 133  166 186 
111 W94  117 129  129 139  154 154 
112 W96  113 117  129 129  150 150 
113 W97  117 117  123 130  178 182 
114 W98  121 129  130 139  154 154 
115 W101  117 117  126 137  154 154 
116 W102  125 125  123 133  166 182 
117 W103  125 125  126 133  182 186 
118 W104  117 129  130 139  154 154 





   CDC3/CDC3R  EF3/EF3R  HIS3/HIS3R 
 sample  allele 1 allele 2  allele 1 allele 2  allele 1 allele 2 
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50 W3  117 125  129 129  162 162 
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52 W5  117 125  120 129  162 198 
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57 W13  117 121  129 129  150 150 
58 W14  117 125  126 126  162 162 
59 W15  125 125  126 133  166 182 
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64 W20  117 125  129 129  190 202 
65 W21  125 125  126 126  186 222 
66 W22  125 125  123 139  166 166 
67 W25  117 125  120 129  206 210 
68 W26  117 117  126 139  142 154 
69 W27  109 117  129 139  154 154 
70 W34  117 117  126 139  154 158 
71 W37  117 125  126 126  162 186 
72 W38  113 117  123 129  150 162 
73 W39  117 125  126 126  162 186 
74 W44  117 129  130 139  154 154 
75 W45  117 129  130 139  154 154 
76 W47  109 117  126 131  154 154 
77 W48  117 125  130 133  154 162 
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   CDC3/CDC3R  EF3/EF3R  HIS3/HIS3R 
 sample  allele 1 allele 2  allele 1 allele 2  allele 1 allele 2 
78 W51  117 125  126 133  166 166 
79 W52  117 125  120 129  162 194 
80 W53  125 129  130 139  166 166 
81 W54  125 125  126 133  182 194 
82 W55  117 125  120 120  162 214 
83 W56  113 117  123 129  150 162 
84 W58  121 129  139 139  154 154 
85 W60  117 125     162 210 
86 W61  117 129  130 141  154 154 
87 W62  117 121  126 126  162 190 
88 W63  125 125  133 133  194 198 
89 W64  117 129  129 139  154 154 
90 W65  109 117  126 137  154 214 
91 W67  117 125  120 129  170 206 
92 W68  121 121  120 129  162 202 
93 W69  117 125  129 139  162 202 
94 W70  117 129  129 139  154 154 
95 W71  113 117  126 139  150 162 
96 W73  117 117  126 137  154 186 
97 W74  117 125  120 129  166 226 
98 W75  109 117  126 129  162 186 
99 W76  117 117  126 139  154 182 
100 W77  117 129  130 130  154 186 
101 W78  117 129  129 129  154 162 
102 W79  121 129  130 141  154 154 
103 W80  117 129  120 129  194 206 
104 W82  117 117  123 129  150 150 
105 W83  117 125  120 120  162 198 
106 W84  113 117  129 129  162 162 
107 W85  117 125  120 129  162 206 
108 W87  117 117  120 129  162 178 
109 W91  117 129  129 139  142 142 
110 W92  117 125  123 133  166 186 
111 W94  117 129  129 139  154 154 
112 W96  113 117  129 129  150 150 
113 W97  117 117  123 130  178 182 
114 W98  121 129  130 139  154 154 
115 W101  117 117  126 137  154 154 
116 W102  125 125  123 133  166 182 
117 W103  125 125  126 133  182 186 
118 W104  117 129  130 139  154 154 





   CDC3/CDC3R  EF3/EF3R  HIS3/HIS3R 
 sample  allele 1 allele 2  allele 1 allele 2  allele 1 allele 2 
120 W107  117 129  129 139  154 158 
121 W108  117 129  123 133  162 202 
122 W110  121 125  123 137  154 166 
123 W113  117 125  129 133  178 178 
(samples in italic letters: biofilm positive) 
Table 1. Microsatellite data for 123 C. albicans strains. 
A comparison of the results did not reveal information of typical microsatellite models for C. 
albicans strains which produced biofilms in this study.  Only 41 of the investigated strains 
showed a similarity with one or up to six other strains (Table 2). 
 
CDC3/CDC3R  EF3/EF3R  HIS3/HIS3R  n 
allele 1 allele 2  allele 1 allele 2  allele 1 allele 2  + - total 
113 117  123 129  150 162  2  2 
117 129  129 139  154 154  1 4 5 
117 129  130 139  154 154  7 4 11 
121 129  130 139  154 154  2  2 
121 125  123 137  154 166  1 3 4 
117 125  120 129  162 162  2  2 
117 125  126 126  162 186  1 1 2 
117 125  120 120  162 198  2  2 
117 125  120 129  162 198  2 2 4 
117 125  120 129  162 214  2  2 
125 125  123 133  166 182   3 3 
125 125  126 133  166 182  1 1 2 
         23 18 41 
(+: biofilm positive; -: biofilm negative) 
Table 2. Microsatellite models. 
The most convergent data were generated with the CDC3 primer pair, only 12 different 
allele pairs were; found, with the EF3 primer pair 25 different pairs were located, and HIS3 
primers provided 50 different pairs of alleles. 
From six patients two strains were available, each of them originated from different  
samples and showed C. albicans infections in routine diagnostics. Both samples from one 
patient were biofilm positive, from another patient both samples were negative. The 
microsatellite data of these catheters are listed in table 3. When only HIS3 and CDC3  
alleles were compared, five out of the six patients showed the same strain two times, when 
they were also compared with EF3 primer alleles, only one patient had the same strain two 
times. 
The comparison of the genotyping of biofilm forming C. albicans strains (e.g. see figure 1) with 
non-biofilm forming C. albicans species shows also a consistent distribution of genotypes.  
 







Fig. 1. (a) Biofilm of C. albicans (W65) in catheter lumen. (b) Biofilm detail of C. albicans 
(W91). : yeast cells; +: bud scars; m: matrix material; arrow: hyphae. SEM micrographs 
were taken with a Philips XL30 ESEM scanning electron microscope using the high vacuum 







   CDC3/CDC3R  EF3/EF3R  HIS3/HIS3R 
 sample  allele 1 allele 2  allele 1 allele 2  allele 1 allele 2 
120 W107  117 129  129 139  154 158 
121 W108  117 129  123 133  162 202 
122 W110  121 125  123 137  154 166 
123 W113  117 125  129 133  178 178 
(samples in italic letters: biofilm positive) 
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showed a similarity with one or up to six other strains (Table 2). 
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117 125  126 126  162 186  1 1 2 
117 125  120 120  162 198  2  2 
117 125  120 129  162 198  2 2 4 
117 125  120 129  162 214  2  2 
125 125  123 133  166 182   3 3 
125 125  126 133  166 182  1 1 2 
         23 18 41 
(+: biofilm positive; -: biofilm negative) 
Table 2. Microsatellite models. 
The most convergent data were generated with the CDC3 primer pair, only 12 different 
allele pairs were; found, with the EF3 primer pair 25 different pairs were located, and HIS3 
primers provided 50 different pairs of alleles. 
From six patients two strains were available, each of them originated from different  
samples and showed C. albicans infections in routine diagnostics. Both samples from one 
patient were biofilm positive, from another patient both samples were negative. The 
microsatellite data of these catheters are listed in table 3. When only HIS3 and CDC3  
alleles were compared, five out of the six patients showed the same strain two times, when 
they were also compared with EF3 primer alleles, only one patient had the same strain two 
times. 
The comparison of the genotyping of biofilm forming C. albicans strains (e.g. see figure 1) with 
non-biofilm forming C. albicans species shows also a consistent distribution of genotypes.  
 







Fig. 1. (a) Biofilm of C. albicans (W65) in catheter lumen. (b) Biofilm detail of C. albicans 
(W91). : yeast cells; +: bud scars; m: matrix material; arrow: hyphae. SEM micrographs 
were taken with a Philips XL30 ESEM scanning electron microscope using the high vacuum 







    CDC3/CDC3R  EF3/EF3R  HIS3/HIS3R 
Patient sample biofilm  allele 1 allele 2  allele 1 allele 2  allele 1 allele 2 
1 
K15 -  125   126 133  166 182 
K16 +  125   123 133  166 182 
2 
K17 +  117 129  130 139  154  
K18 -  117 129  129 139  154  
3 
K49 -  117 125  120 129  162 198 
K50 +  117 125  120 129  162 198 
4 
K59 +  117 129  129 137  154  
K60 -  117 129  130 139  154  
5 
K67 +  117   130 139  154 158 
K69 +  117 129  130 139  154 158 
6 
W15 -  125   126 133  166 182 
W16 -  125   123 133  166 182 
(+: biofilm positive; -: biofilm negative) 
Table 3. Microsatellite models of 12 strains from six patients (two strains each). 
3. Discussion 
The catheters which were investigated in this study originated from many different stations 
of mainly two hospitals. The analyses of the genotypes of 123 C. albicans strains collected 
from these samples give many interesting points to think about. The comparison of the 
CDC3, EF3, and HIS3 genotyping results from the two hospitals (data not shown) did not 
provide suitable data for distinguishing the epidemiological distribution of C. albicans. The 
contribution of the genotypes was consistent within the University Hospital of Graz 
compared with the AKH Vienna hospital. This was also true for the aggregation of the data, 
no significantly dominant genotype was detected, only a group of 11 (8.9%) strains (Table 2) 
was found to be the most frequent genotype with the multilocus genotype characterised by 
CDC3: 117-129, EF3: 130-139, and HIS3 154-154. All other groups within this study consist of 
at most 5 strains. These results are comparable to those of Eloy et al. (2006) who studied the 
genotypes of C. albicans in two different hospitals using the CDC3, EF3, and HIS3 typing 
system. An overall number of 67 isolates were tested and 50 different genotypes were found. 
Eight patients shared the same genotype in one hospital; the same genotype was also present 
in 3 strains in the second hospital. Botterel et al. (2001) tested 100 isolates for their 
microsatellite profile. They detected 5, 12, and 18 alleles in the CDC3, EF3, and HIS3 system, 
respectively. The different associations of this alleles led to 10 CDC3, 22 EF3, and 25 HIS3 allele 
associations within this system. A group of 17 isolates was found to share the genotype. 
This genotype was the same as reported by Eloy et al. (2006) in the group of 11 genotype 
identical strains. Both authors reported the multilocus genotype characterised by CDC3: 
117-125, EF3: 126-135, and HIS3 162-162 for their most common strains.  
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Totally different data were provided from Shi et al. (2007) who collected isolates by female 
and male patients with genital infection, rectal and oral samples. The authors reported 
54.9% of the strains investigated to show the same multilocus genotype, these results were 
clearly different from all other studies. 
The CDC3 locus showed 12 different allele pairs, the EF3 locus 25 allele pairs, and the 
HIS3 locus 50 allele pairs. This is convergent with the data within the three loci and leads 
to 94 multilocus genotypes. When compared with the results of Botterel et al. (2001)  
who reported 65 different multilocus genotypes with different allele associations of 10  
for CDC3, 22 for EF3, and 25 for HIS3, it is obvious that the HIS3 locus was clearly  
more divergent within the current study. However, it remains unclear whether this 
variation is typical for C. albicans strains collected from BSI, or if the discriminatory power 
(DP) of the HIS3 locus (0.91) is not strong enough. The calculated overall DP for the 
CDC3, EF3, and HIS3 multilocus genotyping was 0.97. It is worth noting that the DP of 
HIS3 alone was the highest of the three loci (CDC3: 0.77, EF3: 0.86) (Botterel et al., 2001). 
Nevertheless, a comparison of the typing information without the HIS3 locus showed that 
the groups of strains sharing the same genotype do not increase significantly (data  
not shown).  
The comparison of the genotyping of biofilm forming C. albicans strains with non-biofilm 
forming C. albicans species shows also a consistent distribution of genotypes. There is no 
literature to compare these specific results with, but as aforementioned, a consistent 
contribution of genotype data collected with the CDC3, EF3, and HIS3 multilocus 
genotyping system seems to be normal for C. albicans strains. 
The collected information about strains from the same patients are worth a closer look: Only 
one patient out of six showed 2 strains sharing the multilocus genotype. Using the same 
typing system, Beretta et al. (2006) investigated 14 isolates of eight patients and reported 4 
strains with the same genotype for one patient out of three. Another patient had 2 of 3 
strains sharing the genotypes (Beretta et al., 2006). When only HIS3 and CDC3 alleles were 
compared, five out of the six patients in the current study show the same strain twice. 
Because of these findings, the typing was done without EF3 locus information, and as it is 
mentioned above for the typing without HIS3 allele information, no significant increase in 
the numbers of strains sharing the same multilocus genotype could be seen (data not 
shown). 
Recapitulating the multilocus genotyping with the CDC3, EF3, and HIS3 system during  
this study, the data presented here is in good agreement with the authors mentioned  
above. 
4. Conclusion 
The multilocus genotyping with the CDC3, EF3, and HIS3 system during this study did 
work well and provided data comparable to former studies. Therefore it is strongly 
indicated that the genotyping of C. albicans strains should be continued in future studies. 
Aditionally the results give possible evidence that genotypes do not matter in the 
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2 
K17 +  117 129  130 139  154  
K18 -  117 129  129 139  154  
3 
K49 -  117 125  120 129  162 198 
K50 +  117 125  120 129  162 198 
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K69 +  117 129  130 139  154 158 
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W15 -  125   126 133  166 182 
W16 -  125   123 133  166 182 
(+: biofilm positive; -: biofilm negative) 
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system. An overall number of 67 isolates were tested and 50 different genotypes were found. 
Eight patients shared the same genotype in one hospital; the same genotype was also present 
in 3 strains in the second hospital. Botterel et al. (2001) tested 100 isolates for their 
microsatellite profile. They detected 5, 12, and 18 alleles in the CDC3, EF3, and HIS3 system, 
respectively. The different associations of this alleles led to 10 CDC3, 22 EF3, and 25 HIS3 allele 
associations within this system. A group of 17 isolates was found to share the genotype. 
This genotype was the same as reported by Eloy et al. (2006) in the group of 11 genotype 
identical strains. Both authors reported the multilocus genotype characterised by CDC3: 
117-125, EF3: 126-135, and HIS3 162-162 for their most common strains.  
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Totally different data were provided from Shi et al. (2007) who collected isolates by female 
and male patients with genital infection, rectal and oral samples. The authors reported 
54.9% of the strains investigated to show the same multilocus genotype, these results were 
clearly different from all other studies. 
The CDC3 locus showed 12 different allele pairs, the EF3 locus 25 allele pairs, and the 
HIS3 locus 50 allele pairs. This is convergent with the data within the three loci and leads 
to 94 multilocus genotypes. When compared with the results of Botterel et al. (2001)  
who reported 65 different multilocus genotypes with different allele associations of 10  
for CDC3, 22 for EF3, and 25 for HIS3, it is obvious that the HIS3 locus was clearly  
more divergent within the current study. However, it remains unclear whether this 
variation is typical for C. albicans strains collected from BSI, or if the discriminatory power 
(DP) of the HIS3 locus (0.91) is not strong enough. The calculated overall DP for the 
CDC3, EF3, and HIS3 multilocus genotyping was 0.97. It is worth noting that the DP of 
HIS3 alone was the highest of the three loci (CDC3: 0.77, EF3: 0.86) (Botterel et al., 2001). 
Nevertheless, a comparison of the typing information without the HIS3 locus showed that 
the groups of strains sharing the same genotype do not increase significantly (data  
not shown).  
The comparison of the genotyping of biofilm forming C. albicans strains with non-biofilm 
forming C. albicans species shows also a consistent distribution of genotypes. There is no 
literature to compare these specific results with, but as aforementioned, a consistent 
contribution of genotype data collected with the CDC3, EF3, and HIS3 multilocus 
genotyping system seems to be normal for C. albicans strains. 
The collected information about strains from the same patients are worth a closer look: Only 
one patient out of six showed 2 strains sharing the multilocus genotype. Using the same 
typing system, Beretta et al. (2006) investigated 14 isolates of eight patients and reported 4 
strains with the same genotype for one patient out of three. Another patient had 2 of 3 
strains sharing the genotypes (Beretta et al., 2006). When only HIS3 and CDC3 alleles were 
compared, five out of the six patients in the current study show the same strain twice. 
Because of these findings, the typing was done without EF3 locus information, and as it is 
mentioned above for the typing without HIS3 allele information, no significant increase in 
the numbers of strains sharing the same multilocus genotype could be seen (data not 
shown). 
Recapitulating the multilocus genotyping with the CDC3, EF3, and HIS3 system during  
this study, the data presented here is in good agreement with the authors mentioned  
above. 
4. Conclusion 
The multilocus genotyping with the CDC3, EF3, and HIS3 system during this study did 
work well and provided data comparable to former studies. Therefore it is strongly 
indicated that the genotyping of C. albicans strains should be continued in future studies. 
Aditionally the results give possible evidence that genotypes do not matter in the 





form such ecosystems. In that case, studies like the recent one can only give evidence of 
epidemiological behavior of the species investigated. 
Another set of microsatellite markers is likely to give more information about those strains 
which are able to form biofilms on indwelling devices or about the epidemiological behavior 
of clinically important strains.  
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1. Introduction 
Candida bloodstream infections (BSI) have become a major healthcare problem, specially in 
tertiary- care hospitals worldwide (Al-Jasser & Elkhizzi, 2004, Almirante et al., 2005, Alonso-
Valle et al., 2003, Atunes et al., 2004 Asmundsdottir et al., 2002, Costa et al., 2000, Fraser et 
al., 1992, Garbino et al., 2002, Luzzati et al. 2000, Marchetti et al., 2004, Pappas et al., 2003, 
Viudes et al., 2002). Several risk factor identified among patients hospitalized for long 
periods such as the exposition to broad spectrum antimicrobial and/or immunosuppressive 
chemotherapy, parenteral nutrition, and invasive medical procedures have contributed to 
this fact (Blumberg et al., 2001, Fraser et al., 1992). Despite some improvements in fungal BSI 
diagnosis during last years, candidemia diagnosis remains difficult. Besides, following the 
data appeared in the classical study from Berenguer and colleagues, only 50% of patients 
with disseminated candidiasis will have positive blood cultures and even fewer will have an 
antemortem diagnosis (15% to 40%) (Berenguer et al., 1993). Therefore, invasive candidemia 
is not easy to diagnose, has an expensive treatment and finally is a serious, often life- 
threatening infection (Girmenia et al., 1996, Messer et al., 2009). 
Although the incidence of candidemia has increased steadily among hospitalized patients 
during the eighties and nineties, recent series suggest that This increase has stabilized, but 
with great variations between different geographical locations with similar socio-economical 
development even in the same continent. For instance, in The Netherlands an increasing 
incidence of candidemia has been reported during the period between eighties and nineties 
(Voss et al., 1996) but on the other hand, in a neighbouring country such as Switzerland the 
incidence of Candida BSI infections remained unchanged during the same period (Marchetti 
et al., 2004). Therefore, it seems that there are some differences in the epidemiology of 
candidemia between different countries. 
Besides, in recent years, a trend towards increasing resistance to both traditional and more 
recently introduced antifungal agents has been observed amongst invasive Candida 
infections, underscoring the need for continuous surveillance to monitor trends in incidence, 
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The epidemiology of candidemia has been extensively studied in many countries and there 
are some large series published in this field (Alonso-Valle et al., 2003, Atunes et al., 2004, 
Banerjee et al., 1991, Colombo et al., 2006, Diekema et al., 2002, Kao et al., 1999, Messer et al., 
2009, San Miguel et al., 2005, Silva et al., 2004, Tortorano et al., 2004, Trick et al., 2002). But, 
most of the data on candidemia in Spain until recent days are limited to retrospective 
reviews of medical records or observational studies conducted in a limited geographical 
area (Almirante et al., 2005, Alonso-Valle et al., 2003, Pemán et al., 2002, Pemán et al., 2011). 
Regarding the Spanish data available on antifungal resistance is often assessed by occasional 
surveys or reported in summaries of sporadically occurring cases of treatment failures. The 
purpose of such investigations is to monitor levels of susceptibility to different agents. 
However, long-term prospective studies of antifungal susceptibility have the advantage of 
eliminating a number of variable factors which may affect these assessments. Some of these 
factors include temporary changes in patterns of Invasive Candida infections (as stated 
before) and transient alterations in antifungal resistance due to special conditions (e.g. 
candidemia outbreaks in ICUs). Consequently, the epidemiological data about candidemia 
and its impact in the healthcare system is unknown, and no reliable nationwide data are 
available. In order to make a realistic global perspective of invasive Candida BSI, we 
designed a prospective laboratory-based surveillance study comprising 40 tertiary care 
hospitals across the country, to assess the incidence, species distribution, frequency of 
antifungal resistance, and risk factors for candidemia. 
2. Materials and methods 
Study design 
A prospective laboratory-based surveillance was established to monitor the predominant 
Candida species and antifungal resistance patterns of nosocomial and community-acquired 
invasive Candida infections via a network of sentinel hospitals distributed by geographic 
location across the country.  
The participating institutions include 40 medical centers which provide medical care either 
to adults and children in several medical specialties. Each participant hospital contributed 
prospectively clinical and epidemiological results (organism identification, date of isolation, 
hospital location, intrinsic and extrinsic risk factors for candidemia) on clinically significant 
consecutive blood culture isolates of Candida spp. (one isolate per patient) detected during 
the 12-month period from June, 2008 through June, 2009. All isolates were saved on agar 
slants and were sent on a trimestral basis to the Mycology Laboratory at Basurto Hospital 
for storage, further characterization and reference susceptibility testing. 
Clinical definitions 
Clinical and case definitions were according the NHSN (formerly NNISS) methodology. 
Statements defining a case and other clinical conditions are summarized in Table 1.  
Quality control measures of clinical data 
The clinical case report list of each hospital was compared with the isolates received at 
Basurto Hospital to perform the antifungal susceptibility in order to verify that neither cases 
nor isolates were missed. Audits of medical records to verify accuracy of data and 
completeness were performed on 25% of cases. 
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Incident  case of candidemia: The incident isolation of Candida spp. from a blood culture. 
New incident case of candidemia: An episode of candidemia occurring more than 30 days 
 after the initial incident isolation. 
Breakthrough candidemia: The incident isolation of Candida spp. from a blood culture 
 from a patient receiving systemic antifungal therapy for 
 any reason. 
Fever:  Peripheral body temperature equal or higher than 37.8°C 
Neutropenia: An absolute neutrophil count of less than 500 cells / mm3.  
Adult patients: All patients whose  age was over 14 years old. 
Table 1. Definitions according to NHSN (formerly NISS) used in this study 
In vitro susceptibility testing 
Antifungal susceptibility tests were performed by using the broth microdilution assay 
according to the methodology recommended by the CLSI (formerly known as NCCLS), 
document M27-A2 (NCCLS, 2002) using a microtiter plate. Each isolate was tested against 
different antifungal drugs at the indicated concentration range suggested in the CLSI 
document. Quality control (QC) was ensured by testing the CLSI recommended QC strains, 
C. krusei ATCC 6258, and C. parapsilosis ATCC 22019.The MIC endpoint for amphotericin B, 
azoles and echinocandins and interpretative MIC breakpoints for azoles and echinocandins 
were those suggested by the CLSI document M27-A2, but for the definition of the 
amphotericin B MIC breakpoints we used the values suggested from a previous study 
published by Nguyen et al. (Nguyen et al., 1998). 
Statistical analysis 
The numbers of admissions and patient-days were collected to calculate incidence rates. The 
incidence rate for each hospital was calculated as the number of candidemias per 1,000 
admissions, whereas the overall incidence was determined using summed denominators of 
patient-days and admissions to calculate pooled mean rates. The data generated during the 
year of the surveillance on the different risk factors, underlying diseases, morbidity and 
mortality were recorded in a Microsoft Access 2003 (Microsoft Corporation, Redmond, WA) 
based case report database. Categorical data were analyzed using Chi-square or Fisher’s 
exact tests as appropriate, and continuous variables were compared using the t-test or 
Wilcoxon test according to the significance of the normality test. Spearman rank-order 
correlation was used to measure the relationship between the MICs of fluconazole and 
voriconazole. We performed univariate and multivariate analysis of factors associated with 
candidemia caused by isolates with decreased susceptibility to fluconazole. Variables 
significant at p-values of less than 0.05 by univariate analysis were included in a 
multivariate model using a repeated measures logistic regression model (backward and 
forward). Data were analyzed using the SPSS 11.0.1 software (SPSS, Inc. Chicago, IL) and 
Stata 8.0 (Stata Corporation, Lenexa, TX). 
3. Distribution of Candida blodostream infections  
During the 12-month study period a total of 984 Candida BSIs were reported. The calculated 
overall incidence was 1.09 cases per 1,000 admissions, however the incidence rate changed a 
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published by Nguyen et al. (Nguyen et al., 1998). 
Statistical analysis 
The numbers of admissions and patient-days were collected to calculate incidence rates. The 
incidence rate for each hospital was calculated as the number of candidemias per 1,000 
admissions, whereas the overall incidence was determined using summed denominators of 
patient-days and admissions to calculate pooled mean rates. The data generated during the 
year of the surveillance on the different risk factors, underlying diseases, morbidity and 
mortality were recorded in a Microsoft Access 2003 (Microsoft Corporation, Redmond, WA) 
based case report database. Categorical data were analyzed using Chi-square or Fisher’s 
exact tests as appropriate, and continuous variables were compared using the t-test or 
Wilcoxon test according to the significance of the normality test. Spearman rank-order 
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3. Distribution of Candida blodostream infections  
During the 12-month study period a total of 984 Candida BSIs were reported. The calculated 
overall incidence was 1.09 cases per 1,000 admissions, however the incidence rate changed a 






Among the invasive Candida BSIs, 45.3 % occurred in patients in an medical service, 23.5% 
in patients hospitalized in an intensive care unit, 17.6% in patients in a surgical ward, 7.41% 
in a pediatric ward and finally 4.06% in other services. Most of the patients (98.7%) were 
hospitalized and only nine of them were outpatients at the time of diagnosis. 
Candidemia incidence was slightly higher in males (64.02% of the case patients) and the 
global average age at the onset of the episode was 41 years with a median age was 53 years 
among adult patients and 7 months among children. 
The frequency of BSIs due to the most frequently isolated species of Candida in the study 
sites are presented in Table 2.  
 
Species No. (%) of cases Range (in %) between clinical settings 
C. albicans 483 (49.08%) 27 – 54 
C. parapsilosis 204 (20.73%) 7 – 40 
C. glabrata 134 (13.61%) 2 – 14 
C. tropicalis 106 (10.77%) 16 – 29 
C. krusei 21 (2.13%) 0 – 9 
Other species a 36 (3.65 %) 0 – 4 
a Species with less than 10 isolates are included in this category. This category includes C. famata, C. 
lusitaniae, C. pelliculosa and Candida spp. 
Table 2. Species distribution and incidence among 984 cases of candidemia detected during 
prospective sentinel surveillance in Spain from June 2008 to June 2009 
Overall, the 49.08% of the cases were attributable to C. albicans, 20.73% were attributable to 
C. parapsilosis, 13.61% were attributable to C. glabrata, 10.77% were attributable to  
C. tropicalis, 2,13% to C. krusei and  the rest of the cases (3.65%) were attributable to other 
species. The distribution of Candida species among adult population was similar to the one 
found in pediatric cases, however, the distribution of species varied considerably when 
analyzed between centers as it has been reflected in the ranges specified in Table 2. The 
species distribution among our study isolates is similar to that described by Pfaller et al. 
(Pfaller et al., 1998) in Latin America with data collected by the Sentry Antimicrobial 
Surveillance Program. As Pfaller and colleagues described previously, the proportion of 
species isolated varies considerably among medical centers beign unclear the reasons for 
such differences and they could be attributed to many different influences. 
Table 3 summarizes the overall clinical characteristics and outcome of the 984 candidemia 
cases identified.  
At the time of candidemia diagnosis, neoplasia was documented for 195 (19.84%) patients, 
35 of which (17.94%) were affected with hematologic malignancies Prior surgery was 
recorded from 311 (31.6%) patients (311 of a total of 984), being most of them abdominal 
surgeries (64% of total surgical patients). Two third of the patients (66.97%) had a central 
venous catheter and one quarter (26.93%) of them were under mechanical ventilation. 
Neutropenia and dialysis were rare conditions which was only documented in only 35 case 
patients (3.55%) and 12 patients (1.21%) respectively. Invasive Candida spp. infection 
complications such as endocarditis or endophalmitis were infrequent and with 17 cases 
documented for the former complication (2%) and 3 patients for the later.  
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Variable Value for all total cases 









Average age (range) 41 (0–96) 46 (0–92) 48 (0–96) 33 (0–89) 52 (0–88) 
No. of males 577 (58.64) 273 (56.52) 182 (89.21) 51 (48.11) 
62 
(46.27) 
No. of outpatients 7 (0.71) 3 (0.62) 1 (0.49) 3 (2.83) 0 (0.00) 
Median no. of days (range)  until 
candidemia 20 (0–385) 
20 (0–
114) 19 (0–385) 19 (0–47) 
19 (0–
115) 
No. of cases of underlying diseases      
Cancer 311 (31.61) 127 (26.29) 86 (42.16) 34 (32.07) 
26 
(19.40) 
Hematological malignancy 20 (2.03) 5 (1.04) 6 (2.94) 1 (0.94) 1 (0.75) 
Coronary artery disease 82 (8.33) 33 (6.83) 23 (11.27) 5 (4.72) 8 (5.97) 
Chronic Obstructive Pulmonary disease 
(COPD) 71 (7.21) 40 (8.28) 11 (5.39) 5 (4.72) 9 (6.71) 
Neurological disease 35 (3.55) 14 (2.80) 12 (5.88) 2 (1.89) 2 (1.49) 
Diabetes 120 (12.20) 53 (10.97) 22 (10.78) 8 (7.55) 20 (14.93) 
Organ transplantation 45 (4.57) 14 (2.90) 21 (10.29) 2 (1.89) 3 (2.23) 
HIV infection 33 (3.35) 18 (3.73) 3 (1.47) 3 (2.83) 3 (2.24) 
Parenteral drug abusers 22 (2.23) 10 (2.07) 4 (1.96) 2 (1.89) 1 (0.75) 
No. of patients with characteristic      
Previous or actual corticosteroid 
therapy 180 (18.29) 80 (16.56) 50 (24.50) 13 (12.26) 
21 
(15.67) 
Immunosuppressive therapy and/or 
neutropenia 265 (26.93) 
102 
(21.12) 75 (36.76) 28 (26.41) 
28 
(20.90) 
In the ICU at diagnosis 252 (25.61) 120 (24.84) 68 (33.33) 21 (19.81) 
25 
(18.66) 
Mechanical ventilation 265 (26.93) 133 (27.54) 71 (34.80) 15 (14.15) 
26 
(19.40) 
Hemodialysis at diagnosis 12 (1.22) 2 (0.41) 4 (1.96) 1 (0.94) 3 (2.24) 
Previous surgery 311 (31.61) 148 (30.64) 82 (40.20) 19 (17.92) 
36 
(26.87) 
Central venous catheter 659 (66.79) 295 (61.07) 187 (91.66) 52 (49.06) 
61 
(45.52) 
Urinary catheter 450 (45.73) 207 (42.86) 112 (54.90) 31 (29.25) 
52 
(38.81) 
Prior antibiotic therapy 747 (75.91) 337 (69.77) 106 (51.96) 60 (56.60) 
71 
(52.98) 
Prior fluconazole use 78 (7.93) 29 (6.00) 10 (4.90) 12 (11.32) 9 (6.71) 
Death attributed to candidemia 134 (13.62) 60 (12.42) 20 (9.80) 13 (12.26) 15 (11.19) 
Mortality due to other conditions 103 (10.47) 48 (9.94) 36 (17.65) 7 (6.60) 14 (10.45) 




Table 3. Demographics, clinical characteristics, and mortality for Candida spp. BSI episodes 
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Table 3. Demographics, clinical characteristics, and mortality for Candida spp. BSI episodes 






There were no statistically significant differences when the risk mentioned above were 
analyzed for the pediatric population of patients. 
4. Antifungal susceptibility 
In vitro susceptibility testing of the 984 BSI isolates of Candida species against amphotericin 
B, fluconazole, voriconazole, caspofungin and anidulafungin revealed that when globally 
analyzed Candida strains causing BSI are rarely resistant to a wide number of antifungal 
agents. However, the resistance rates among the different species vary a lot as it can be 
shown on Table 4.  
 
Species Antifungal agent 
 MIC 
(ug/ml) 
 No. of  resistant or SDD 
isolates 
Range 50% 90% 
C. albicans (483) Amphotericin B 0.125–1.0 0.5 1.0 0 (0.00) 
 Fluconazole 0.125–64 0.5 2.0 10 (2.07) 
 Voriconazole < 0.03–4 0.03 0.03 5 (1.04) 
 Caspofungin <0.03–4 0.25 2.0 3 (0.62) 
 Anidulafungin <0.03–2 0.03 0.03 0 (0.00) 
C. parapsilosis 
(204) Amphotericin B 0.25–1.0 1.0 1.0 0 (0.00) 
 Fluconazole 0.125–64 0.5 4.0 11 (5.39) a 
 Voriconazole 0.03–2 0.03 0.125 3 (1.47) b 
 Caspofungin 0.125–64 1.0 2.0 12 (5.88) 
 Anidulafungin 0.03–64 1.0 2.0 7 (3.43) 
C. glabrata (134) Amphotericin B 0.25–1.0 0.5 1.0 0 (0.00) 
 Fluconazole 1.0–64 4.0 32 25 (18.67) 
 Voriconazole 0.03–4.0 0.125 0.5 3 (2.24) 
 Caspofungin 0.03–0.5 0.06 0.125 0 (0.00) 
 Anidulafungin 0.06–0.5 0.06 0.125 0 (0.00) 
C. tropicalis (106) Amphotericin B 0.125–1.0 0.5 1.0 0 (0.00) 
 Fluconazole 0.25– 
128 
1 2 2 (1.89) 
 Voriconazole 0.03–8 0.06 0.125 2 (1.89) 
 Caspofungin 0.03–0.5 0.06 0.125 0 (0.00) 
 Anidulafungin 0.03–0.5 0.03 0.125 0 (0.00) 
C. krusei (21) Amphotericin B 
0.125–
2.0 0.25 0.75 0 (0.00) 
 Fluconazole 16–128 4.0 8.0 21 (100.00) 
 Voriconazole 0.03–4.0 0.25 1.0 2 (9.52) 
 Caspofungin 0.125–8 0.125 1.0 1 (4.76) 
 Anidulafungin 0.03–8 0.06 0.25 1 (4.76) 
a All the isolates except one exhibit decreased susceptibility (SDD) to fluconazole. b All the isolates are 
SDD to voriconazole. 
Table 4. Antifungal susceptibility test results for selected species of Candida isolated during 
prospective, sentinel surveillance in Spain from June 2008 to June 2009 
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When  we considered the C. glabrata isolates obtained during the study only the 81.33% of 
them were were susceptible to fluconazole and 97.76% were susceptible to voriconazole, but 
on the contrary, 97.93% and 98.96% of the isolates of C. albicans were susceptible to 
fluconazole and voriconazole respectively. The proportion of isolates that was resistant to 
the studied azole drugs was comparable with that observed in the other recently published 
studies. (Messer et al., 2009, Pemán et al., 2011). 
The antifungal activities of voriconazole, fluconazole, amphotericin B, caspofungin and 
anidulafungin against the 984 Candida spp isolated during the study period are summarized 
in Table 4. Among the azole compounds, voriconazole was the most active drug overall 
with an MIC90 of 0.25 µg/ml. Against C. albicans, C. parapsilosis and C. tropicalis isolates, 
voriconazole (MIC90 range 0.03-0.25 µg/ml) was much more active than fluconazole 
(MIC90, 2-4). Although these differences in the drug activity, both azole compounds showed 
lower MICs for fluconazole and voriconazole for the species mentioned before when 
compared to C. glabrata and C. krusei isolates. Despite this good susceptibility profile, we 
found five Candida albicans isolates with a MIC greater than 4 µg/ml to voriconazole and 
two C. krusei isolates that had a voriconazole MIC of 2 ug/ ml. All these isolates were also 
resistant to fluconazole. 
We found that there was a statistically significant moderate linear correlation between 
fluconazole and voriconazole MICs (r = 0.574; P ≤ 0.01). having higher voriconazole MICs 
those isolates from patients who received fluconazole before the candidemia episode when 
compared to those without previous exposure to fluconazole (MIC90s of 0.25 µg/ml and 
0.06 µg/ml, respectively; P ≤ 0.05 
Table 5 summarize the risk factors we identified during the study with a candidemia 
episode due to an isolate with decreased susceptibility (SDD or resistant) to fluconazole 
using univariate statistical techniques.  
 
 No of isolates (%) 
susceptible to 
fluconazole 
No. of isolates (%) with decreased 
susceptibility or resistant to 
fluconazole 
P - value 
Neoplasia 27 (2.95) 6 (8.70) ≤ 0.01 
Neutropenia 37 (4.04) 11(15.94) ≤ 0.01 
Prior fluconazole use 27 (2.95) 10 (14.49) ≤ 0.01 
a Only statistically significant variables are summarized in the table 
Table 5. Summary of univariate statistical analysis between fluconazole susceptible isolates 
vs. resistant or SDD ones  
We found that this condition was associated with neoplasia (9% versus 3%; P ≤ 0.01), current 
neutropenia (16% versus 4%; P ≤ 0.01), and prior fluconazole use (14% versus 3%; P ≤ 0.001). 
These independent factors identified using the univariate statistical approach, were 
analyzed more deeply using a repeated measures logistic regression model. We obtained 
significant results for neoplasia (odds ratio, 2.9; 95% confidence interval, 1.4 to 5.9; P ≤ 0.05) 






There were no statistically significant differences when the risk mentioned above were 
analyzed for the pediatric population of patients. 
4. Antifungal susceptibility 
In vitro susceptibility testing of the 984 BSI isolates of Candida species against amphotericin 
B, fluconazole, voriconazole, caspofungin and anidulafungin revealed that when globally 
analyzed Candida strains causing BSI are rarely resistant to a wide number of antifungal 
agents. However, the resistance rates among the different species vary a lot as it can be 
shown on Table 4.  
 
Species Antifungal agent 
 MIC 
(ug/ml) 
 No. of  resistant or SDD 
isolates 
Range 50% 90% 
C. albicans (483) Amphotericin B 0.125–1.0 0.5 1.0 0 (0.00) 
 Fluconazole 0.125–64 0.5 2.0 10 (2.07) 
 Voriconazole < 0.03–4 0.03 0.03 5 (1.04) 
 Caspofungin <0.03–4 0.25 2.0 3 (0.62) 
 Anidulafungin <0.03–2 0.03 0.03 0 (0.00) 
C. parapsilosis 
(204) Amphotericin B 0.25–1.0 1.0 1.0 0 (0.00) 
 Fluconazole 0.125–64 0.5 4.0 11 (5.39) a 
 Voriconazole 0.03–2 0.03 0.125 3 (1.47) b 
 Caspofungin 0.125–64 1.0 2.0 12 (5.88) 
 Anidulafungin 0.03–64 1.0 2.0 7 (3.43) 
C. glabrata (134) Amphotericin B 0.25–1.0 0.5 1.0 0 (0.00) 
 Fluconazole 1.0–64 4.0 32 25 (18.67) 
 Voriconazole 0.03–4.0 0.125 0.5 3 (2.24) 
 Caspofungin 0.03–0.5 0.06 0.125 0 (0.00) 
 Anidulafungin 0.06–0.5 0.06 0.125 0 (0.00) 
C. tropicalis (106) Amphotericin B 0.125–1.0 0.5 1.0 0 (0.00) 
 Fluconazole 0.25– 
128 
1 2 2 (1.89) 
 Voriconazole 0.03–8 0.06 0.125 2 (1.89) 
 Caspofungin 0.03–0.5 0.06 0.125 0 (0.00) 
 Anidulafungin 0.03–0.5 0.03 0.125 0 (0.00) 
C. krusei (21) Amphotericin B 
0.125–
2.0 0.25 0.75 0 (0.00) 
 Fluconazole 16–128 4.0 8.0 21 (100.00) 
 Voriconazole 0.03–4.0 0.25 1.0 2 (9.52) 
 Caspofungin 0.125–8 0.125 1.0 1 (4.76) 
 Anidulafungin 0.03–8 0.06 0.25 1 (4.76) 
a All the isolates except one exhibit decreased susceptibility (SDD) to fluconazole. b All the isolates are 
SDD to voriconazole. 
Table 4. Antifungal susceptibility test results for selected species of Candida isolated during 
prospective, sentinel surveillance in Spain from June 2008 to June 2009 
Epidemiology of Bloodstream Candida spp. Infections  
Observed During a Surveillance Study Conducted in Spain 
 
21 
When  we considered the C. glabrata isolates obtained during the study only the 81.33% of 
them were were susceptible to fluconazole and 97.76% were susceptible to voriconazole, but 
on the contrary, 97.93% and 98.96% of the isolates of C. albicans were susceptible to 
fluconazole and voriconazole respectively. The proportion of isolates that was resistant to 
the studied azole drugs was comparable with that observed in the other recently published 
studies. (Messer et al., 2009, Pemán et al., 2011). 
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voriconazole (MIC90 range 0.03-0.25 µg/ml) was much more active than fluconazole 
(MIC90, 2-4). Although these differences in the drug activity, both azole compounds showed 
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found five Candida albicans isolates with a MIC greater than 4 µg/ml to voriconazole and 
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We found that there was a statistically significant moderate linear correlation between 
fluconazole and voriconazole MICs (r = 0.574; P ≤ 0.01). having higher voriconazole MICs 
those isolates from patients who received fluconazole before the candidemia episode when 
compared to those without previous exposure to fluconazole (MIC90s of 0.25 µg/ml and 
0.06 µg/ml, respectively; P ≤ 0.05 
Table 5 summarize the risk factors we identified during the study with a candidemia 
episode due to an isolate with decreased susceptibility (SDD or resistant) to fluconazole 
using univariate statistical techniques.  
 
 No of isolates (%) 
susceptible to 
fluconazole 
No. of isolates (%) with decreased 
susceptibility or resistant to 
fluconazole 
P - value 
Neoplasia 27 (2.95) 6 (8.70) ≤ 0.01 
Neutropenia 37 (4.04) 11(15.94) ≤ 0.01 
Prior fluconazole use 27 (2.95) 10 (14.49) ≤ 0.01 
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Table 5. Summary of univariate statistical analysis between fluconazole susceptible isolates 
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We found that this condition was associated with neoplasia (9% versus 3%; P ≤ 0.01), current 
neutropenia (16% versus 4%; P ≤ 0.01), and prior fluconazole use (14% versus 3%; P ≤ 0.001). 
These independent factors identified using the univariate statistical approach, were 
analyzed more deeply using a repeated measures logistic regression model. We obtained 
significant results for neoplasia (odds ratio, 2.9; 95% confidence interval, 1.4 to 5.9; P ≤ 0.05) 






 Odds ratio 95 percent confidence Limits P - value 
Neoplasia 2.9 1.4 – 5.9 ≤ 0.05 
Prior fluconazole use 3.8 1.7 – 8.2 ≤ 0.01 
a Only statistically significant variables are summarized in the table. 
Table 6. Summary of multivariate statistical analysis of risk factors for candidemia caused 
by fluconazole susceptible isolates vs. resistant or SDD ones a 
Caspofungin and anidulafungin resistance was low (16 cases for caspofungin and 8 cases  
for anidulafungin) (Table 4). Despite this low rate of in vitro resistance to echinocandins  
of the isolates studied MICs from C. parapsilosis and C. guilliermondi were higher  
compared to the MIC obtained from other Candida spp. as it has been described in others 
studies. 
5. Antifungal treatment 
At the time of diagnosis and inclusion in this study, 122 case patients (12.3%) were receiving 
a systemic antifungal agent and were considered breakthrough infections (fluconazole, 78 
patients, amphotericin B, 31 patients, itraconazole and voriconazole, 3 patient each; and 
echinocandins, 5 patients). Although the reason for this high rate of breakthrough infections 
is not clear, it is possible that other factors besides the antifungal resistance have got a role in 
the explanation of this phenomenon. A deep analysis of these 122 cases showed that either 
the antifungal therapy duration or the election of the antifungal drug was inadequate. A 
total of 536 case patients (54.5%) received antifungal therapy, started at a median of 3 days 
from the Candida isolation or onset of candidemia. 
6. Mortality 
The crude mortality rate was 24.10%, but the mortality rate among children was 
significantly lower. (see Table 3) As it has been described in different studies published in 
the medical literature candidemia due to C. parapsilosis had a lower mortality rate than the 
rate due other Candida species (Morgan et al., 2005, Pappas et al., 2004, Pemán et al., 2002), 
but no statistically significant result when analyzing the death rate of patients infected by a 
susceptible isolate (54%) or a less-susceptible isolate (SDD or resistant) (64%) among 
patients who received fluconazole as treatment. (P ≤ 0.44). 
7. Discussion and remarks 
This prospective candidemia surveillance study represents one of the largest multicenter 
studies conducted in Spain and provide one of the most representative data on the 
epidemiology of candidemia to date. The first remarkable finding of our study was the 
higher incidence of candidemia than those reported from centers located in the Northern 
Hemisphere which ranged between 0.28 to 0.96 per 1,000 admissions (Banerjee et al., 1991, 
Doczi et al., 2002, Marchetti et al., 2002, Pfaller et al., 1998, Pfaller et al., 2004, Richet et al., 
2002, Sandven et al., 1998, Tortorano et al., 2002, Tortorano et al., 2004) and including those 
published before in Spain (0.76 to 0.81 per 1,000 admissions) (Almirante et al., 2005, Alonso-
Valle et al., 2003, Pemán et al., 2002, Pemán et al., 2011, San Miguel et al., 2005). Although 
the reasons for this high rate are not entirely clear, it is possible that this may be related to a 
Epidemiology of Bloodstream Candida spp. Infections  
Observed During a Surveillance Study Conducted in Spain 
 
23 
combination of multiple factors, including differences in medical care resources, 
transplantation programs, implementation of infection control measures in hospitals, 
empirical antifungal therapy and prophylaxis for high-risk patients. Another possibility is 
that our series may not reflect the current trends, but the data from a prospective study held in 
Spain and recently published by Peman et al. support our data (Pemán et al., 2011, Pfaller & 
Diekema, 2007) (see Table 7). 
 















USA 1992-1993 837 52 21 10 12 4 
USA 1993-1995 79 56 15 10 15 - 
USA 1995-1997 1593 46 14 12 20 2 
USA 1995-1998 934 53 10 12 20 3 
USA 1998-2000 935 45 13 12 24 2 
USA 2001-2004 2773 51 14 7 22 2 
USA 2008-2009 1354 48 17 10 18 2 
Canada 1992-94 415 69 10 7 8 1 
Latin America 1995-1996 145 37 25 24 4 1 
Latin America 2001-2004 1565 50 16 20 7 2 
Asia-Pacific 2001-2004 1344 56 16 14 10 2 
Taiwan 1994-2000 1095 50 14 21 12 <1 
Europe 1992-94 249 49 11 11 10 9 
Europe 1997-99 2089 56 13 7 14 2 
Europe 2001-2004 2515 60 12 9 10 5 
Norway 1991-2003 1415 70 6 7 13 2 
Denmark 2003-2004 307 63 4 4 20 3 
Spain 2002-2003 351 51 23 10 9 4 
Spain 2001-2006 1997 47 19 10 12 5 
Spain 2008-2009 984 49 21 13 11 2 
Spain 2009-2010 1377 45 29 12 8 2 
Table 7. Summary of geographical differences in species distribution in Candida BSI isolates. 
(Adapted and modified from Pemán et al., 2001 and Pfaller & Diekema, 2007). 
Despite this fact, it seems that probably a combination of factors may have affected the 
overall rates of fungemia cases in Spain. The differences appeared in the average age of our 
patients when compared to other surveillance series from the United States (Ostrosky-
Zeichner et al., 2003, Pappas et al., 2003), are probably due to the high proportion of children 
in our study, especially in the Spanish hospitals located in the Southern part of the country 
(32% of children in the Spanish hospitals from the Southern part of the country compared to 
9% described in the study from the United States) (data not shown). Therefore, this 
condition reflects that there are great differences among patients of different geographical 
locations as it was mentioned in the introduction and the demographical composition and 
lastly the risk factors, could be very different from one population to another. (Table 7). In 
fact, the number of cases of invasive candidemia was not homogeneous across the country., 
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geographical areas in Spain,. (North, Center, East and South). C. albicans covers almost half 
(49.08%) of the global cases, remaining as the most frequently isolated specie, but the rates 
between the four different areas were not homogenous., for instance,  in the Southern part of 
the country the rate of isolates of C. albicans (39.2%) was similar to the one of C. parapsilosis 
(37.4%). 
Some studies have reported a shift in the etiology of candidemia reporting an increase of 
candidemia cases caused by non-albicans Candida species during the last decade (Colombo et 
al., 2006, Richet et al., 2002, Tortorano et al., 2004) (Table 7). Although C. albicans remain the 
most frequently isolated specie, reasons for the emergence of non-albicans species remain 
unclear, but some medical conditions may explain increasing incidence of candidemia due 
to non-albicans species. It has been noted in previous reports that infections due to C. 
tropicalis candidemia is associated with neoplasia and neutropenia (Komshian et al., 1989) 
and those attributable to C. parapsilosis are often associated with the presence of 
intravascular catheters and are not influenced by exposure to fluconazole or other 
antifungal agents (Clark et al., 2004, Girmenia et al., 1996, Levy et al., 1998, Sandven et al., 
1998).  The last situation, may us to consider C. parapsilosis as an exogenous pathogen and 
breaches of catheter care and of infection control practice should be investigated and revised 
within institutions where this species has become a common blood culture isolate. 
The increasing incidence some of non-albicans Candida species with reduced susceptibility to 
azoles, such as C. glabrata, creates new therapeutic challenges and leads to another 
important question such as the influence of previous antifungal therapy in the development 
of non-albicans species candidemia. Recent studies, such as those published by Marr et al. 
and Tortorano et al. had addressed this question and showed interesting results about the 
association with previous exposure to azoles and the risk of development of fungemias due 
to C. krusei and / or C. glabrata (Marr et al., 2000, Tortorano et al., 2004). In fact, the 
differences in antifungal susceptibilities among isolates between different regions in Spain 
was almost entirely attributable to high-level resistance to azoles observed among C. glabrata 
and C. krusei isolates (Table 4). 
We are not aware of these epidemiological changes mentioned in the paragraph above and 
our findings from our study are supportive of them. C. parapsilosis fungemia account for the 
large majority of non-albicans species (in the same manner that that been described for other 
European countries) and candidemia due to C. krusei is rare in Spain as it has been described 
in other series (Almirante et al., 2005, Alonso-Valle et al., 2003, Ostrosky-Zeichner et al., 
2003, Pemán et al., 2002, Pemán et al., 2011, Tortorano et al., 2004). The explanation for this 
species distribution in Spain which is more or less similar to other Latin American countries 
is not clear and perhaps many factors are involved. However, this species distribution has 
got a great importance in the developing of therapeutic schemes and in the prevention of 
antifungal resistance. 
While most non-albicans Candida species are associated with high fluconazole minimum 
inhibitory concentrations (MIC), C. parapsilosis is typically susceptible to most antifungals, 
although is associated with higher echinocandin MIC that vary between different agents. 
Moreover, the rate of persistently positive fungemia in patients treated with caspofungin 
was reported as almost double for C. parapsilosis versus other Candida species. Even more, if 
we consider clinical patients at risk of suffering a candidemia episode, such as 
Epidemiology of Bloodstream Candida spp. Infections  
Observed During a Surveillance Study Conducted in Spain 
 
25 
immunocompromised patients, where clinical responses are poorer the picture is not good. 
Summarizing, we are concerned about the use of echinocandins alone based on the 
identification of non-albicans Candida specie. Grouping these agents into one treatment 
scheme is difficult due to the variability not only in the susceptibility of the isolates, as well 
as the microbiological responses seen between different echinocandins.  
Regarding the susceptibility of the studied isolates, antifungal resistance was an infrequent 
finding in our study and was restricted to a few isolates, and none of them were resistant to 
amphotericin B. This condition is similar to the findings published in three recent studies 
(Almirante et al., 2005, Messer et al., 2009, Pemán et al., 2011). Our proportion of 
fluconazole-resistant isolates (6.32%) was low, similarly to the rate observed with Spanish 
(Almirante et al., 2005,  Pemán et al., 2011) European (5.2%) and North American isolates 
(6.6%) (Messer et al., 2009, Richardson & Lass-Flörl et al., 2008) (see Table 7). Mixing the 
ideas exposed above we can argue that the differences in the activity and susceptibility of 
the antifungal compounds studied suggest that azole drugs and echinocandins have got a 
complementary susceptibility profile. While azoles has got excellent in vitro activity to C. 
albicans, C. parapsilosis and C. tropicalis bloodstream isolates, echinocandins showed excellent 
activity against C. glabrata and C. krusei which are are associated with higher azole MICs. On 
the contrary, species with high MICs to echinocandins such as C. parapsilosis and C. 
guilliermondii showed excellent activity to azole agents. (Table 8).  
 
Specie of Candida Susceptibility to antifungal agent Amphotericin B Fluconazole Voriconazole Caspofungin Anidulafungin 
C. albicans S S S S S 
C. parapsilosis S S S S - I S – I 
C. glabrata S – NS S – SDD – R S – NS S S 
C. tropicalis S S S – NS S S 
C. krusei S R S S S 
a S, susceptible; NS, non-susceptible (intermediate for CLSI M27-A2 clinical breakpoints); SDD, sensitive 
dose-dependent; R, resistant. 
b The clinical breakpoints adopted in this table are those reflected in the CLSI M27-A2 methodology. No 
new clinical breakpoints or epidemiological cut-offs were used, in order to make the data comparable to 
the one reflected in our work. 
Table 8. Summary of commonly associated in-vitro susceptibility profiles for Candida spp. 
BSI isolates. (Adapted and modified from Richardson & Lass-Flörl, 2008) a, b 
These ideas are of great importance because previous exposure to fluconazole was a strong 
and independent factor associated with candidemia caused by fluconazole non-susceptible 
isolates as it had been reported previously by Marr et al. and Lin and colleagues and higher 
voriconazole MICs tended to be associated with prior exposure to fluconazole. Although 
these obtained results are statistically significant, they must be taken with some caution 
because the low resistant proportion of isolates in our study. However, they depict a 
situation of concern and illustrate the potential problem of cross-resistance between azoles 
with a direct impact in treatment failure and the outcome of the patient. Moreover, the 
potential for voriconazole resistant C. glabrata to emerge as a threat in people receiving 
voriconazole therapy and or prophylaxis has been raised in reports of breakthrough 
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and independent factor associated with candidemia caused by fluconazole non-susceptible 
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voriconazole MICs tended to be associated with prior exposure to fluconazole. Although 
these obtained results are statistically significant, they must be taken with some caution 
because the low resistant proportion of isolates in our study. However, they depict a 
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with a direct impact in treatment failure and the outcome of the patient. Moreover, the 
potential for voriconazole resistant C. glabrata to emerge as a threat in people receiving 
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Despite these concerning matters exposed above, voriconazole was the azole which 
exhibited the best in vitro antifungal activity in our study, and only one of six fluconazole-
resistant isolates was cross-resistant to voriconazole. The combination of a third generation 
azole such as voriconazole or posaconazole with an echinocandin could be of benefit for 
some patients, especially in those with persistent candidemia. 
The crude mortality rate observed in our study was similar to that reported in other series 
(Almirante et al., 2005, Colombo et al., 2006, Gudlaugsson et al., 2003, Pappas et al., 2003, 
Pfaller et al., 2004). Adults had higher mortality rates than pediatric patients (24.10% to 
16%). Similar to other reports, patients with C. parapsilosis candidemia had the lowest death 
rates (Nucci et al., 1998, Pappas et al., 2003).  
Summarizing, the epidemiological and susceptible data described along the text, document 
important differences and similarities in the epidemiology of candidemia in Spain compared 
to updated reports from other countries. This report shows that candidemia is a source of 
significant morbidity and mortality with high associated healthcare costs. Although our 
high rates of candidemia may be related to many factors, reasons for them are not clear and 
further study is necessary. Determining them may lead to identify potential measures that 
can help in disease prevention. In addition, our data support that fluconazole non-
susceptibility could be associated with prior fluconazole exposure and suggest that such 
exposure could lead to other new azoles cross-resistance and complicate the clinical 
outcome of some patients. 
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Despite these concerning matters exposed above, voriconazole was the azole which 
exhibited the best in vitro antifungal activity in our study, and only one of six fluconazole-
resistant isolates was cross-resistant to voriconazole. The combination of a third generation 
azole such as voriconazole or posaconazole with an echinocandin could be of benefit for 
some patients, especially in those with persistent candidemia. 
The crude mortality rate observed in our study was similar to that reported in other series 
(Almirante et al., 2005, Colombo et al., 2006, Gudlaugsson et al., 2003, Pappas et al., 2003, 
Pfaller et al., 2004). Adults had higher mortality rates than pediatric patients (24.10% to 
16%). Similar to other reports, patients with C. parapsilosis candidemia had the lowest death 
rates (Nucci et al., 1998, Pappas et al., 2003).  
Summarizing, the epidemiological and susceptible data described along the text, document 
important differences and similarities in the epidemiology of candidemia in Spain compared 
to updated reports from other countries. This report shows that candidemia is a source of 
significant morbidity and mortality with high associated healthcare costs. Although our 
high rates of candidemia may be related to many factors, reasons for them are not clear and 
further study is necessary. Determining them may lead to identify potential measures that 
can help in disease prevention. In addition, our data support that fluconazole non-
susceptibility could be associated with prior fluconazole exposure and suggest that such 
exposure could lead to other new azoles cross-resistance and complicate the clinical 
outcome of some patients. 
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In Poland, there are only few Trichophyton species, which are common, including: 
 Trichophyton rubrum – antropophilic dermatophyte, distributed worldwide, usually 
specific to human, but infections in animals also have been reported. It may be the 
cause of practically all infections of body surface areas (with exception of fungal 
infections of the scalp). Most commonly it causes onychomycosis and athlete`s foot 
(tinea pedis). It may also cause infections of glabrous skin (tinea corporis, tinea faciei), 
groin (tinea cruris), hands (tinea manuum) or nails (tinea ungiuim). This fungus causes 
persistent, chronic infections.  
 Trichophyton mentagrophytes – zoophilic dermatophyte, cosmopolitan fungus, 
distributed worldwide. It causes infections in animals (cats, dogs, rabbits, guinea pigs, 
rodents, hedgehogs) as well as in human. Most commonly it causes infections of 
glabrous skin (tinea corporis, tinea faciei) and scalp infections (tinea capitis). Lesions often 
proceed with a large inflammatory reactions. 
 Trichophyton tonsurans – antropophilic species, usually specific to human, practically 
cosmopolitan. Most commonly it causes infections of the scalp (tinea capitis) and it may 
also cause infections of glabrous skin (tinea corporis), especially in the “shower area” - 
on neck, shoulder, back, buttocks, and feet, when inoculum is washed off from head on 
the other parts of the body, while taking shower. Infections usually proceed with mild 
inflammatory reaction, but cases with severe inflammatory responses also have been 
reported. This fungus often causes family and school outbreaks. It is also responsible 
for infections among wrestlers and judo competitors (tinea corporis gladiatorum). This 
dermatophyte is resistant to the adverse impact of external conditions and it is 
transferred by asymptomatic carriers. 
 Trichophyton interdigitale – antropophilic species, distributed worldwide. It causes 
infections of feet (aspecially in the interdigital spaces) and hands (tinea manuum), 
sometimes it can also infect nails (tinea unguium). 
 Trichophyton verrucosum – zoophilic species, the mostly isolated from cattle, it infects 
people, who work with these animals (farmers). Cosmopolitan fungus, it causes 
diseases of exposed parts of the body (tinea corporis) and face (tinea faciei), beard (tinea 
barbae) or head (tinea capitis). 
 Trichophyton violaceum – antropophilic species, mostly it causes infections of the scalp 
(tinea capitis) and glabrous skin (tinea corporis), aspecially in the “shower area”. It can 
also cause onychomycosis. It is specific to human, but it also can be pathogenic for 
animals. It is the cause of family and institutional outbreaks. 
 Trichophyton schoenleinii – antropophilic species, it causes favus. Nowadays is practically 
unique.  
Among Microsporum genera, only few species are common in lab-practice: 
 Microsporum canis – zoophilic species, cosmopolitan, distributed worldwide. It is very 
contagious aspecially for young cats and dogs. In human it causes infections of the 
scalp (tinea capitis) and beard (tinea barbae) or infections of glabrous skin or face (tinea 
corporis, tinea faciei). 
 Microsporum audouinii – antropophilic species, cosmopolitian, however, the incidence of 
fungal infections caused by this pathogen in Poland is very small. It causes infections of 
the scalp (tinea capitis), glabrous skin (tinea corporis), face (tinea faciei), affecting mostly 
school-age children (boys:girls=4:1), however cases of dermatomycoses in adults, 
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caused by Microsporum audouinii also were described. Although it is human pathogen, it 
was isolated from fur of guinea pigs and rarely, from dog`s fur. 
 Microsporum gypseum – geophilic species, ubiquitous, isolated from soils worldwide. 
Most exposed to infections are people, who cultivate the soil (farmers, gardeners), 
percentage of males prevails over females. Sometimes infection could be transmitted 
from animals . In human it causes infections of the scalp (tinea capitis) and glabrous skin 
(tinea corporis). 
 Microsporum nanuum – zoophilic species, isolated also from soil. It causes infections 
among breeding cattle, mostly in pigs. In human it causes infections of the glabrous 
skin (tinea corporis) and the scalp (tinea capitis) proceeding with or without severe 
inflammation. 
 Microsporum persicolor – zoophilic species, cosmopolitan. In human it causes infections 
of the scalp (tinea capitis), glabrous skin (tinea corporis) and feet (tinea pedis). Infections 
proceed with significant inflammatory reaction. 
The genera Epidermophyton has only one representative, quite often isolated form lesions: 
 Epidemophyton floccosum – antropophilic species, cosmopolitan. In human it causes 
mostly infections of the groin (tinea cruris), rarely of glabrous skin (tinea corporis), feet 
(tinea pedis) and very rarely of toenais (onychomycosis). 
2.1 Methods of pathogen transmission – a short description 
Dermatophytes are keratinophilic fungi, which parasitize on corneous structures, such as 
stratum corneum, hair or nails (Kobierzycka et al., 2005). Dermatophyte species are equipped 
with numerous enzymes, enabling them to survive on the skin and its appendages, because 
they have a proteolytic, keratinolytic and lipolytic activity. Furthermore the skin environment 
is conducive to dermatophytes because the corneal layer lacks blood vessels making it difficult 
to contact with immunologically competent cells and activate the defense mechanisms. On the 
surface of the epidermis are proteins, carbohydrates and micronutrients (including iron ions), 
which may provide substrates for the metabolism of fungi and help them to survive. Of great 
importance may also be some specific anatomic regions of the skin, greatly facilitating the 
colonization by fungi. Scalp hair can therefore arrest arthrospores spreaded by air. Similarly, 
spores are arrested in the hyponychium under or in the interdigital spaces, or in the folds of 
the skin where additionally oclusion helps them to develop (Dworacka-Kaszak, 2004). The 
spores are particularly resistant to environmental conditions, such as variable temperature and 
drying (Hryncewicz-Gwozdz et al., 2005; Kobierzycka et al., 2005). It is known that they can 
survive outside the host organism and colonize the skin and its appendages under favorable 
conditions, for example, in warm and humid environment, with increased amounts of CO2, 
which prevails in the poorly sheered shoes, it can lead to growth of the fungi and invasion of 
the skin structures. 
To narrowly understand epidemiology of dermatomycoses, methods of pathogen 
transmission, are described below. 
The sources of dermatophyte fungi infection are: human, animals and soil.   
Infection with antropophilic dermatophytes may happen through direct contact with 
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appendixes without causing the disease (asymptomatic carrier) (Adamski & Batura- 
Gabryel, 2007). 
Infection may occur also through some objects on which infectious material can be found 
(stratum corneum or hair with spores of fungi). The source of trunk, groin or extremities  
infections may be clothes, underwear or towels and sponges. Scalp diseases may happen 
through using the same brushes or combs. Shoes, socks, accessories for feet care or cosmetic 
pedicure are often the source of infections of feet and toenails.  
Nails diseases are often connected with cosmetic manicure, infection may be a result of 
unsuitable disinfection of nails care accessories in cosmetic salons. 
Also some public places could be potential source of antropophilic dermatomycoses – for 
example swimming-pools, toilets, showers, hotels, schools and similar (Bolinski et al., 2003, 
Szepietowski & Baran, 2005). 
Recently some cases of tinea corporis gladiatorum were described in literature. This type of 
dermatomycosis is common among wrestlers and judo competitors. The source of infection 
are athletes and wrestling mats (Hryncewicz-Gwozdz et al., 2011). 
Similarly with zoophilic species – transmission of pathogen may happen through direct 
contact with an infected animal or animal being carrier of fungus. Zoophilic dermatophytes 
can be also transmited from human to human. The source of infection in children and adults 
are mostly domestic animals – cats, dogs, hamsters, guinea pigs, rabbits or even some birds. 
Farmers also often suffer from dermatomycoses transmitted from breeding cattle (pigs, 
cows, sheep, horses, goats) (Adamski Z & Batura-Gabryel H., 2007). 
Infection with geophilic dermatophytes usually happens as a result of contact with soil and 
it is common among people, who cultivate the soil (gardeners, farmers). The disease more 
often affect males than females. Working without protective gloves and unsuitable hygiene 
is conductive for transmission of pathogen. In literature were also described cases of 
transmission of geophilic dermatophytes through some animals (for example monkeys, 
mouses, leopards, rats, tigers) and insects (flies). Infection through direct contact with ill 
peoples occurs rather rarely (Kalinowska et al., 2009b)  
2.2 Clinical picture of dermatomycosis 
Fungi are present both in the natural environment and in the immediate surroundings of 
man. The host organism reaction to the infection with these pathogens is different and it 
depends greatly on what kind of dermatophyte causes it. 
The main factor favourable to the development of fungal infection is a disorder of right 
microclimate of the skin, which is often caused by occlusion (poorly sheered clothes, shoes 
made of synthetic fabric) and microinjuries. Some diseases like diabetes and circulation 
disorders are of great importance in the development of mycoses (Macura & Pawlik, 1998).  
Clinical pictures of superficial mycoses are diverse, types of fungi infections are: 
 Tinea capitis – infection of the scalp. When it is caused by antropophilic and zoophilic 
species ringworm of the scalp reveals the presence of foci of alopecia and scaling. The 
changes develop on erythematous base, but the severity of the inflammation is very 
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diverse and in some individuals may it be a slight erythema. In extreme cases, the 
changes are soft with the presence of pustules and inflammatory tumors with pus or 
yellow crusts. This condition is called deep mycosis (kerion) and is the result of an 
inflammatory response to the presence of the fungus. Apart from very severe forms of 
deep fungal infection of the scalp, hair loss is usually transient. Even in the worst cases, 
regrowth occurs at a surprisingly high proportion. Exception is infection with 
antropophilic Trichophyton schoenleinii, which leads to scarring and permanent alopecia 
foci formation. Lesions very often are accompanied with itching. 
 Tinea corporis – infection of the trunk and also extremities. Caused by antropophilic, 
zoophilic and geophilic species. Fungi, after infection of the skin form colonies and 
grow centrifugally. Lesions caused by antropophilic species form round or oval 
patches, which are spreading peripherally, and resolving and disappearing in the 
middle. In the part of the peripheral states moderate inflammation, redness and slight 
swelling, and even the production of pustules is seen. Lesions caused by zoophilic 
species characterize with significant inflammation, are well separated from the healthy 
skin, with exfoliation on the whole surface. Lesions are very often accompanied with 
itching. 
 Tinea barbae – infection of the bearded area of men. Mostly it is caused by zoophilic 
species. Generally, the infection occurs as a follicular inflammation, or as a cutaneous 
granulomatous lesion, i.e. a chronic inflammatory reaction. It is one of the causes of 
folliculitis. Lesions are accompanied with itching. This infection is most common in  
farmers.  
 Tinea faciei – infection of the glabrous skin of the face. It is caused by antropophilic and 
zoophilic species. Itchy lesions appearing on the face may be erythematous with 
exfoliation in the peripheral part or they may proceed with significant inflammation 
with the exfoliation on the entire surface.  
 Tinea pedis – infection of feet and the interdigital spaces. Mostly it is caused by 
antropohilic species. In the interdigital variety, lesion appear in the folds between 3rd 
and 4th toes. The lateral surfaces of the toes and the bottom of folds are covered with 
layers and scales of keratinized epidermis. In the depth of the fold may appear cracks of 
the skin.  Lesions may proceed on the dorsal and the basal surface of toes. There is a 
slight redness and exfoliation of the skin, and sometimes tiny vesicles and pustules may 
appear. The course is usually chronic, but it may be subject to intensify. On the plantar 
surface of feet occur eruptions similar to eczema. There are itchy follicles of various 
sizes. The course is chronic and recurrent, sometimes severe, however,complicated by 
purulent secondary infection and secondary prone to allergization.  
 Tinea manuum – fungal infections of hands, it is caused by antropophilic species. Fungal 
infection of hands is almost always secondary to athlete's foot. Very rare primary form 
may develop in the case of occupational exposure to dermatophytes. 
Dermatophyte infections of hands can take several different clinical forms. The most 
commonly occurring is hiperkeratotic form, which is characterized by excessive 
keratosis of hands skin, with the presence of small and very adherent scales on 
erythematous base. Infectious process is typically subject to the fingertips. Also often 
coexists nail fungal infection. Less common is intertrigous form. 
 Tinea cruris - dermatophyte infection of the groin, caused mostly by antropophilic species. 
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feet. It is revealed by the appearance of a typical erythematous lesions associated with 
exfoliation and itching, which spread on the upper surface of the thighs and crotch.  
 Tinea unguium, Onychomycosis – dermatophyte infection of the nail plates. Mostly 
caused by antropophilic and very rarely by geophilic species. Changes within nail 
plates begin on free edge of nail and can cause excessive callus and fragility, appearance 
of grooves and fractures on surface of nail, the most often nail plates are turning yellow. 
Infected, untreated nails undergo gradually diminishing. Toenails are more often 
infected than fingernails. Fungal infection of toenails is often a result of athlete`s foot.  
2.3 Treatment of dermatomycosis 
There are many antifungal drugs, allowing for treatment dermatomycoses effectively.  
These drugs can be divided to several groups : 
 Antifungal antiseptics: 
1. Iodine compounds 
2. Phenol derrivates 
3. Sulphur and its derrivates 
4. Alcohol 
5. Inorganic acids 
6. Organic acids and their derrivates 
7. Derrivates of unsaturated fatty acids 
8. Aniline dyes 
9. Heavy metals compounds 
10. Quaternary ammonium hydroxides 
11. Quinoline derrivates 
12. Benzimidazole derrivates 
 Antifungal antibiotics:  
1. Polyene antibiotics (Natamycin) 
2. Non-polyene antibiotcs (Gryzeofulvin) 
 Antifungal chemioterapeutics : 
1. Fluorpirimidine derrivates - flucytosine 
2. Imidazole derrivates:  
a. Azole drugs of the 1st generation - Chlormidazole, Clotrimazole, Miconazole, Econazole, 
Izoconazole, Tioconazole, Bifonazole 
b. Azole drugs of the 2nd generation - Ketoconazole 
c. Azole drugs of the 3rd generation – Itraconazole, Fluconazole, Voriconazole, Posaconazole 
3. Allyloamin derrivates - Naftifine, Terbinafine 
4. Morpholine derrivates - Amorpholine 
5. Pyridone derrivates - Cyclopirox 
The mechanism of action of antifungal drugs is based on disruption of a fungal cell 
membrane or inhibition or disruption of DNA or RNA synthesis or inhibition of egrosterole 
synthesis in fungal cells.  
Antifungal therapy should be selected to the type of dermatomycosis, some of them can be 
treated topically, others require systemic treatment. Sometimes, when fungal infection is 
difficult to treat, both of these therapies should be involved.  
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Topical antifungal therapy is often the only procedure in the superficial mycoses of skin, it is 
decisive for the effectiveness of therapy. In cases of extensive and chronic superficial fungal 
infections of the scalp and nails, topical treatment is usually an essential element of 
combined therapy, shortening its duration and improves the treatment results. 
The main indications for oral antifungal agents include the following infections :  
 Fungal infections of nails and scalp 
 Fungal infections involving large areas of skin 
 Fungal infections in patients with immune disorders 
 In a situation where there is a poor penetration of topical drug to the foci of fungal 
infection 
 Persistent focus of fungal infection  
To effectively treat fungal infections following conditions should be also applied: 
 The correct mycological diagnosis before starting treatment. 
 Removal of the factors predisposing to the development of fungal infection. 
 Appropriate selection of  drug. 
 Knowledge of the principles of conducting antifungal treatment. 
 Good cooperation with the patient. 
 Control after treatment (clinical and mycological).  
After complete cure of fungal infection, the physician should inform the patient about  the  
the principles of prevention. This is especially important for onychomycosis, because these 
infections are often recurrent and chronic. For this purpose, patient should frequently 
disinfect shoes, wear cotton socks and avoid places with high humidity such as saunas, 
steam baths or swimming pools (Adamski & Batura-Gabryel, 2007). 
3. Epidemiology of dermatomycoses in Poland over the past decades 
Within the past decades changes in percentage of fungal infections and spectrum of 
dermatophytes were observed – in given geographical regions appear new species, 
replacing the existing ones. Migration of population, industrialization, economic and 
cultural development, ageing of society, increased percentage of diseases like diabetes, 
circulation disorders, antibiotic therapy or taking of immunosuppressive medicines - these 
are the factors that are conductive to this phenomenon. There is a close relation between 
mycological biota isolated from skin and its appendages and changing spectrum of 
dematophyte fungi in environment (Wronski & Nowicki, 2005). 
3.1 Geographical distribution of dermatophytes in Poland 
Studies on epidemiology of dermatomycoses in different parts of the world show how large 
changes can occur in the fungal biota in just a few decades. This phenomenon concerns also 
Poland and it is affected by changing environmental factors, including the formation of ever 
larger urban agglomerations, permanently changing  profiles of the economy, and also 
clearly present in the last 15 - 20 years the changes in climatic conditions (Kobierzycka et al., 
2005; Macura & Pawlik, 1998; Szepietowski & Baran, 2005). Of great importance is also easy 
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for economic reasons. Thereby, various species of fungi appear far beyond the borders of the 
endemic areas.  
The accumulated epidemiological data indicate how much the fungal biota of the given 
area, including Poland, changes over time. In the first half of the twentieth century in 
Central and Western Europe dominated zoophilic dermatophyte Trichophyton 
mentagrophytes, and today the predominant species is Trichophyton rubrum, antropophilic 
dermatophyte originating from Asia (Bajcar & Ratka, 2002; Glinski et al., 2002, Szepietowski 
et al., 2001). Currently it is the most common etiological agent of fungal infections of toenails 
in Poland. 
The increasing dominance of infections caused by Trichophyton rubrum appears to be a 
negative phenomenon, because these types of diseases are particularly chronic and often 
recurrent. As fungal infections of the skin and its appendages in different regions of the 
world are caused by different species of fungi, mycological biota present in the skin lesions 
is associated with changes in the natural environment and man's artificial environment. It is 
known that Trichophyton rubrum came to Poland during the mass migration after World War 
II (Macura&Pawlik, 1998). This species was rare then, but over the years it has achieved a 
dominant position, while causing a permanent reduction in the participation of other 
dermatophyte infections of the skin and its appendages. Similarly, the major change relates 
to the presence on Polish territory The fungus Trichophyton schoenleinii. Today infections 
caused by this species are not found in Poland, but they occurred very often throughout the 
country in the first half of the twentieth century. Between 50`s and 60`s it caused only 5.7% 
of fungal infections, and in the late 90`s its isolation has already belonged to the casuistic 
rarity (Macura & Pawlik, 1998; Szepietowski & Baran, 2005). Increasing number of infections 
caused by other antropophilic dermatophyte was observed instead. Although 
Epidermophyton floccosum was only 0.7% of all isolated dermatophytes in the 70`s, then after 
20 years the percentage of fungal infections increased 3-fold, up to 2.23%. Moreover, in place 
of Microsporum gypseum, which was only sporadically isolated in the 70`s of the twentieth 
century, occured an unprecedented then species Microsporum canis, taking the 3rd position 
among the dermatophytes (2.64%) (Macura&Pawlik, 1998). 
Mass migrations are particularly important and confirmed by epidemiological importance. 
It contributes to a large extent with spreading of fungal pathogens, especially antropophilic 
dermatophytes. The example is the African species (Trichophyton soudanense), and in the 
recent decades continuously isolated in Europe from immigrants  coming from endemic 
areas. Similarly, in the U.S. athlete's foot cases caused by Trichophyton violaceum in 
immigrant from Asia, where this fungus is found endemic, were reported (Kobierzycka et 
al., 2005). 
Interestingly, some species of dermatophytes found throughout the world, such as 
Microsporum audouinii and Trichophyton schoenleinii, are now very rare in the U.S. and 
Western Europe, although they are common in the other areas, particularly in Africa 
(Kobierzycka et al, 2005). Epidemiological data indicate that the changes that constantly 
occur in the distribution of pathogenic fungal biota are dependent on many factors. In 
addition to the progressive migration and climate change, social and economic conditions 
that affect skin exposure to fungal pathogens, and therapeutic methods are also important 
Szepietowski & Baran, 2005). These factors significantly affect the changes in the proportion 
of different species of fungi at the time in a given area. Extremely rare occurrence of tinea 
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capitis caused by Trichophyton schoenleinii in Poland now is mainly associated with 
progressive, improved sanitation in the second half of the twentieth century (Szepietowski 
& Baran, 2005).  
Given the fact that people are constantly exposed to the possibility of contact with 
dermatophytes, since infectious material is commonly present in the environment, in the 
case of infection with widespread antropophilic species it is difficult to identify the source 
and route of infection. Conversely, if the fungal infection is caused by zoophilic 
dermatophyte with a relatively narrow specificity of the species (Microsporum canis, 
Trichophyton verrucosum), and the number of actual cases is not large, the epidemiological 
investigation may allow to trace the spread of infection and determine its source 
(Kobierzycka et al., 2005).    
Many years of studies of mycological biota indicate that one of its characteristics are 
constant changes in time, related to the presence of particular species of fungi in the natural 
environment and their involvement in causing infections of the skin and its appendages in 
human. Changing mycological biota varies in different geographical regions. Moreover, it 
was found that the clinical forms of fungal infections in different parts of the world are 
caused by different species of fungi (Chong & Sinclair, 2000; Cribier & Paul, 2001; Gupta, 
2001). Tracing this variability is essential for epidemiological research, as it allows to prove 
the existence of variation ranges of the different species of dermatophytes. It also has no less 
important from the standpoint of public health, makes it possible to forecast the 
development of fungal infections in the population. Although Poland is a relatively small 
territory, epidemiological studies conducted in different parts of the country consistently 
show the changes in the fungal biota during the last 50 years.  
Baran and Szepietowski analyzed results of mycological examinations from years 1988 – 
1992, conducted across the country, updating epidemiological map of Poland (Baran & 
Szepietowski, 1994). These researchers have demonstrated a definite advantage in the 
incidence of anthropophilic dermatophytes (64.3% of all dermatophytes) over zoophilic 
dermatophytes (35%). In addition, they found that infections with geophilic dermatophytes 
occured occasionally (0.7% of all isolated pathogens)  (Figure 1). 
 
Fig. 1. Dermatophytes in Poland in years 1988-1992. 
Anthropophilic dermatophytes dominance was observed in almost all regions of the 
country, but particularly clearly in the centraleastern region (75.9%),  midwestern region 
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region of the country, this advantage was small, anthropophilic fungi accounted for only 
54.6% of the total number of dermatophytes (Szepietowski & Baran, 2005; Baran & 
Szepietowski, 1994).  
Quite different results were obtained in the province of Bialystok. Only in this region 
anthropophilic dermatophytes formed a minority, accounting for just 45.1% of all 
dermatophytes isolated in the area. It also appeared that the zoophilic fungi were the most 
common dermatophytes (54.9%) in Bialystok province (northeastern Poland) (Szepietowski 
& Baran, 2005; Baran & Szepietowski, 1994). Authors found a clear upward trend in a 
southerly direction for the anthropophilic dermatophytes, closely associated with the 
occurrence of an inverse trend for zoophilic fungi (Szepietowski & Baran, 2005). It turned 
out that zoophilic dermatophytes are the most commonly reported in the northern region 
(45.4%) and least often in the middleeastern region (24.1%). Baran and Szepietowski thus 
agreed that the distribution of zoophilic dermatophytes is the reverse of the map of 
anthropophilic dermatophytes distribution (Szepietowski & Baran, 2005; Baran & 
Szepietowski, 1994). 
Among the anthropophilic fungi Trichophyton rubrum was isolated most frequently, it  
accounted for 45.5% off all dermatophytes and for anthropophilic dermatophytes – 70.8%. 
This species occurred most frequently in the southwestern region (59.1% of all 
dermatophytes), midwestern region (55.8%) and southeastern region (53.4%). Least often it 
was isolated in the northern region (7.7% of all dermatophytes ascertained in this area). The 
second in the order, Trichophyton interdigitale usually occurred in the northern region (34.0% 
of all dermatophytes), slightly less often (24.5%) in the central-eastern parts of the country, 
but only occasionally - in the West (0.6%). Epidermophyton floccosum was found the most 
frequently in the northeastern region (19.5%) and the midwestern region (15.6%), with a 
clear decrease in the incidence in the southern direction. Other species of anthropophilic 
dermatophytes were very rare, they were isolated only sporadically. In the group of 
zoophilic fungi Trichophyton mentagrophytes was mostly isolated. It accounted for 22.4% of all 
dermatophytes and among zoophilic dermatophytes it accounted for 64.4%, and most 
occurred in the northeastern region (31.5% of all dermatophytes), and the least in the region 
of central-western and south-western regions. Isolated somewhat less Microsporum canis 
constituted 9.7% of all dermatophytes and 27.6% of zoophilic dermatophytes. This fungus 
was typically found mostly in the northern region (21.5% of dermatophytes in this area), in 
the central region (12.1%) and least often in the centraleastern region and northeastern 
regions (3.8 % and 0.5%, respectively) (Baran & Szepietowski, 1994). 
Among the geophilic fungi, Microsporum gypseum was isolated most often. It represented 
only 0.6% of all dermatophytes and among geophilic dermatophytes - 82.8%, and most 
frequntly occurred in the central region (Szepietowski & Baran, 2005; Baran & Szepietowski, 
1994).  
The authors analyzed the results of mycological examinations from the years 1988-1992 
conducted across the country. The most often isolated fungus was antropophilic 
Trichophyton rubrum. Only in the northeastern region, in the province of Bialystok 
Trichophyton mentagrophytes was the most frequently observed species (40.7% of all 
dermatophytes in the province). In the northern part of the Poland dominated 
Trichophyton interdigitale (34% of all dermatophytes), although in the Gdansk region 
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dominated infections caused by Microsporum canis (30.5% of isolated dermatophytes) 
(Baran & Szepietowski, 1994).  
The results of this analysis showed how great epidemiological changes took place in relation 
to the occurrence of fungal pathogens, at a relatively small area of Poland in about 30 years. 
In the earlier years (1952-1967) a distinct advantage of zoophilic dermatopytes, representing 
69.6% of the total dermatophytes over antropophilic (30.3%) and geophilic dermatophytes 
(0.1%) was observed (Figure 2). At that time, the dominance of zoophilic fungi did not 
concern only the region of Bialystok, where antropophilic dermatophytes accounted for 
58.2% (Wronski & Nowicki, 2000). 
 
Fig. 2. Dermatophytes in Poland in years 1952-1967. 
In the following years (1974-1979) more pronounced changes were observed in Poland, and 
the incidence of infections due to zoophilic and antropophilic dermatophytes became 
similar and amounted to 50.9% and 48.1%, respectively (Lange et al., 2002). Geophilic 
dermatophytes constituted then only 1% (Hryncewicz-Gwozdz et al, 2005).  
In the region of Olsztyn (northeastern Poland) incidence of zoophilic dermatophytes 
decreased from 51.7% in 1978-1981 to 48.8% in 1982-1986 (Nowicki & Bykowska, 2006).  
Increased frequency of isolation of anthropophilic fungi in relation to the zoophilic species, 
is confirmed by other studies – Ratka (1977-1988) and Baran et al in Lower Silesia 
(southwestern Poland) region (1977-1991) (Baran et al, 1993; Ratka, 1990). Over the years 
steadily increased the frequency of isolation of anthropophilic fungi among the 
dermatophytes. Previous studies showed that more than 40 years ago, most often isolated 
fungus in Poland was zoophilic Trichophyton mentagrophytes and Baran and Szepietowski 
showed that nowadays the most common species in Poland is Trichophyton rubrum (Baran & 
Szepietowski, 1994; Wronski & Nowicki, 2005) .  
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dominated infections caused by Microsporum canis (30.5% of isolated dermatophytes) 
(Baran & Szepietowski, 1994).  
The results of this analysis showed how great epidemiological changes took place in relation 
to the occurrence of fungal pathogens, at a relatively small area of Poland in about 30 years. 
In the earlier years (1952-1967) a distinct advantage of zoophilic dermatopytes, representing 
69.6% of the total dermatophytes over antropophilic (30.3%) and geophilic dermatophytes 
(0.1%) was observed (Figure 2). At that time, the dominance of zoophilic fungi did not 
concern only the region of Bialystok, where antropophilic dermatophytes accounted for 
58.2% (Wronski & Nowicki, 2000). 
 
Fig. 2. Dermatophytes in Poland in years 1952-1967. 
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has been found a decrease of the incidence of Trichophyton mentagrophytes from over 50% to 
33%, while the number of isolation of Trichophyton rubrum has increased from 25% to 34% 
which places this species in the first place among diagnosed dermatophytes (Kaszuba et al., 
1997). 
Between 1995-1999 survey of fungal infections in the Wroclaw (Lower Silesia) region 
conducted Sikora et al (Sikora et al., 2000). A large variety of mycological biota was found. 
Among the dermatophytes, most often because 62.7% of infections concerned Trichophyton 
mentagrophytes, Trichophyton rubrum was isolated less frequently (27.8%), Epidermophyton 
floccosum (6.2%) and least often Microsporum canis (3%). An important observation was  
a significant decrease in the number of infections caused by Trichophyton rubrum (32.9%)  
and Epidermophyton floccosum (25.6%). Moreover, the frequency of isolation of Trichophyton 
mentagrophytes grew by 61.5%. In the case of Microsporum canis infections with this  
species increased to 1997, with subsequent later decrease of the number of infections (Sikora 
et al., 2000). 
Between years 1996-2000 in region of Bydgoszcz (Central Poland) antropophilic Trichophyton 
rubrum was isolated in 41.6% of cases, followed by antropophilic Trichophyton interdigitale 
(26.9%).  Zoophilic Microsporum canis was isolated in 8.2% of cases (Mrotek et al., 2001). 
In the years 1996-2001 further studies concerned analysis of mycological biota and 
assessment of the incidence of  fungal infections in patients from the urban environment of  
Bialystok. Anthropophilic dermatophytes were found in 40.1% of all isolates and among 
them most often were: Trichophyton rubrum, Trichophyton interdigitale, and Epidermophyton 
floccosum. Zoophilic dermatophytes represented 34.4% of fungi and most often occurred 
Trichophyton mentagrophytes. The results of studies conducted in region of Bialystok 
indicated the anthropophilic dermatophytes as the main etiological agents of fungal 
infections of the skin and its appendages (Bolinski et al., 2003). 
Multiannual mycological research (1984-2001) were conducted in the Subcarpathian region 
(southeastern Poland) by Bajcar and Ratka. They compared in terms of epidemiology two 
periods: the years 1984-1993 and 1994-2001. Among isolated dermatophytes prevailed 
Trichophyton rubrum (68.9% of all infections), and Trichophyton interdigitale was found in 
11.3% of cases, Epidermophyton floccosum in 9.1% of cases, and Trichophyton tonsurans in 6.2% 
of cases. Zoophilic fungi were isolated rarely, in 4.1% of cases Trichophyton mentagrophytes 
was isolated. Comparing the results of research conducted in the years 1994-2001 with data 
obtained in the previous decade, Bajcar and Ratka observed in the Subcarpathian region 
continuing dominance of antropophilic fungi infections. Among the antropophilic 
dermatophytes was observed a decrease  in the number of infections caused by Trichophyton 
rubrum (9.5%) and an increased participation of Trichophyton interdigitale (9.4%). An 
important observation of the authors was the emergence in the region of Subcarpathian an 
unprecedented Trichophyton violaceum species (0.4% of isolates) – species frequent in Eastern 
Europe. Comparing the two periods also a slight increase of fungal infections with zoophilic 
fungi was observed: Trichophyton mentagrophytes (from 4.1% to 5.5%) and Trichophyton 
verrucosum (from 0.2% to 1.1%) (Bajcar & Ratka, 2002). 
In the region of Gdansk Szarmach and Nowicki in years 1994-1998 found large share of 
dermatophytes as etiological  agents of onychomycosis. They accounted for 44.8% of all 
fungal pathogens and most often isolated species were: Trichophyton rubrum and 
Trichophyton interdigitale (Szarmach & Nowicki, 2001).  
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Further studies conducted in Gdansk (midsouthern region of Poland) in years 2003-2005 
showed an increase in the number of infections and variability of pathogenic fungi species. 
Among dermatophytes Trichophyton rubrum and Trichophyton mentagrophytes were 
recognized  the most often (43.9% and 35.6%, respectively). These fungi were isolated 
mainly from toenails. Microsporum canis was isolated from 8.4% of patients, mostly from 
children it caused infections of the scalp (65.7%) and glabrous skin (34.3%) (Nowicki & 
Bykowska, 2006). Moreover, this dermatophyte is the most common fungal pathogen among 
children in Gdansk region since 1984 (Wilkowska & Nowicki, 1991). 
Kalinowska et al studied dermatomycoses in Lower Silesia in years 2004 – 2008. The author  
found, that pathogen isolated most fequently (59.27%) was antropophilic Trichophyton 
rubrum, sencond most frequently isolated fungus was Trichophyton mentagrophytes (22.09%). 
Interestingly,   the incidence of dermatomycoses caused by Trichophyton tonsurans increased, 
and this dermatophyte was placed on the third position (10.45%), followed by Microsporum 
canis (4.74%) (Kalinowska et al., 2010). 
Previous mycological research carried out in different regions of Poland indicate the need 
for constant observation and epidemiological analyses, to monitor ongoing changes of the 
fungal biota and its contribution to infections in human.  
International Studies (Achilles project) conducted in 1989-1999 showed that Poland takes 4th 
place after Russia, Hungary and the Czech Republic in the incidence of fungal infections in 
European countries (Glinski et al, 2002).  
Among the 40,000 surveyed Poles 42% of them were diagnosed with athlete's foot and 21% 
with onychomycosis. The results of these studies additonally support the view that the 
epidemiological data of fungal infections must be constantly updated to confirmed 
variations of fungal biota in the natural environment.   
From the 50`s of the past centrury, mycoses caused by zoophilic species represented up to 
almost 70% of diagnosed mycoses, whereas infections caused by antropophilic 
dermatophytes represented 30% and infections caused by geophilic dermatophytes 
represented  0.1% of all dermatomycoses. This situation has changed entirely in next 
decades, so different data are shown in literature from 1980s and 1990s – the most common 
were antropophilic dermatophytes (64.3%), less common zoophilic dermatophytes (35.0%) 
and infections caused by geophilic dermatophytes represented 0.7%. Among antropophilic 
dermatophytes, Trichophyton rubrum is in the lead over past fifty years, this species is 
commonly responsible for onychomycosis. Among zoophilic dermatophytes, most 
frequently Trichophyton mentagrophytes was isolated. Among geophilic dermatophytes 
Microsporum gypseum was isolated most frequently. 
Nowadays, depending on geographical region of Poland, antropophilic species represent 
about 45 – 75 % of all dermatophytes and zoophilic species represent about 30 – 55%. 
3.2 Epidemiology of different types of dermatomycoses in Poland 
Fungal infections are now a major epidemiological and social problem worldwide. 
According to various data relating to different geographical regions, they concern from 10 to 
40% ofthe world's population (Bolinski et al., 2003; Foster et al., 2004; Kaszuba et al., 1997; 
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zones showed chronic fungal infections among 10-20% of the population (Bolinski et al., 
2003; Glinski et al., 2002). Fungi pathogenic for human usually cause infections of the skin 
and its appendages, although in recent years also increasing recognition of fungal infections 
of internal organs is seen. 
Among the more than 200 000 species of fungi about 200 are pathogenic to human 
(Szepietowski & Baran, 2005). Their high morphological diversity allows them to survive in 
different ecosystems. Polymorphism of fungi is also a result of their diverse needs for 
growth substances in certain ecological niches, because they have a high potential to adapt 
to the changing resources of their environment (Dworacka-Kaszak, 2004). Among potential 
fungal skin pathogens are fungi not only highly adapted for parasite on the skin – 
dermatophytes, but also yeasts and molds.  
Observed in recent decades, the increasing incidence of fungal infections of the skin is 
mainly associated with the constant presence, and even an increase in risk factors for fungal 
infections. It was established a number of factors predisposing to the development of fungal 
infections, some of which relate to the host, and other to biological characteristics of the 
fungal pathogens. One of the main factors is prolongation of the average life span, age 
proved to be a physiological risk factor for fungal infection. Particularly predisposed group 
are not only people over 65 years, but also premature newborns and infants. It was found 
that the presence of multifocal skin infections increases with age and is 2-fold more frequent 
in men than in women (Kobierzycka et al., 2005). 
One of the most important factors influencing the increasing number of fungal infections is 
the progress in medical science, it now allows the survival of patients with an impaired 
immune response in the course of chronic, severe illnesses such as cancer, metabolic and  
endocrine diseases, renal failure, HIV infection and other (Hryncewicz, Gwozdz et al., 2006; 
Miroszewska-Sobanska & Adamski, 2000). This is related to the development of intensive 
medical care, dialysis, parenteral nutrition and artificial ventilation, conducting invasive 
diagnostics, catheterization of vascular and body cavities, and also with the use of modern 
cardiac transplantation techniques (Glisnki et al., 2002). Very important is also antibiotic 
therapy, treatment with cytostatics, immunosuppressants and corticosteroids (Krajewska-
Kulak et al., 2000). 
Superficial mycoses of skin and its appendages are diagnosed in Poland very often. Among 
the clinical forms of mycoses of skin and its appendages special place because of the 
prevalence takes athlete's foot and onychomycosis. Athlete's foot occurs mostly in adults, 
rarely in children and often is acquired early in adolescence. 
For example, studies of Kalinowska et al on lowersilesian population in years 2004-2008 
indicated, that tinea pedis and onychomycosis were very often in adults, whereas in children 
and adolescents tinea capitis and tinea corporis were predominated (Kalinowska et al., 2010). 
It is believed that in developed countries athlete`s foot may affect up to 10% of the total 
population. In recent years, it was found that for most cases of athlete's foot are responsible  
three anthropophilic species of dermatophytes: Trichophyton rubrum, Trichophyton 
interdigitale  and Epidermophyton floccosum (Kobierzycka et al., 2005). 
Studies of Szepietowski et al indicate that the athlete's foot was 28% of all fungal infections 
of skin and nails in Poland and it is the second most common after onychomycosis. Other 
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authors estimate the incidence of fungal infection rates similar of 25-30% in the general 
population, although this is difficult to determine it because in the special risk groups 
(athletes, miners), it can grow up to 60-70%. In studies of Szepietowski et al most common 
type of tinea pedis was a athlete's foot (45.5%), and the most common pathogens causing it 
were dermatophytes, which were isolated in 88.8% of all patients with fungal infections. 
Among the most commonly cultured dermatophytes were  Trichophyton rubrum (51%), 
followed by Trichophyton mentagrophytes (33.1%) (Szepietowski et al., 2001). 
The authors found that athlete's foot in 75.2% of patients occurred together with the other 
forms of fungal infection of the skin, the most common was onychomycosis found in 69.2% 
of patients. Described in the literature the simultaneous occurrence of fungal infection of the 
both  feet with one hand forming the so-called two feet and one hand syndrome and was 
rarely observed, because only in 2.5% of patients (Szepietowski et al., 2001). It is believed 
that the probability of developing athlete's foot is lower in women than in men. The 
differences are likely to result from increased exposure to pathogenic fungi associated with 
wearing heavy occlusive footwear by men (Kobierzynska et al., 2005). 
Onychomycosis is often concomitant with athlete`s foot, it is developed by the occurrence of 
the same favorable environmental conditions for fungi (Elewski, 2000a; Hryncewicz-
Gwozdz et al., 2005; Wronski & Nowicki, 2005). Infections concerns mostly the elderly, after 
65 years. Its occurence is much rarer in children, it is associated with rapid growth of the 
nails in young people which hinders the development of infection because the fungus is 
removed together with the growing plate (Hryncewicz-Gwozdz et al., 2006; Lange & 
Bykowska, 2004). Epidemiological data from recent years show significant dominance of 
dermatophyte fungi  as a etiological agents of onychomycosis. It is assumed that currently 
about 80% of fungal infections of nails are caused by Trichophyton rubrum (Wronski & 
Nowicki, 2000).  
Fungal infection of hands is most common as a secondary infection in patients with athlete`s 
foot. It can then concern the dominant hand and form the aforementioned two feet and one 
hand sydrome (Szepietowski et al., 2001). In most cases the etiological factors for mycosis of 
hands are anthropophilic species of dermatophytes that also cause athlete's foot also: 
Trichophyton rubrum, rarely Epidermophyton floccosum and Trichophyton interdigitale. Much 
less fequently hand`s skin can be infected by  antropohilic species Trichophyton violaceum and 
some zoophilic species such as Trichophyton mentagrophytes (Kobierzycka et al., 2005; 
Hryncewicz-Gwozdz et al., 2005) .  
The development of fungal infection of the hands may facilitate various factors causing 
maceration of the skin, such as wearing rings, watches, anatomical deformities, and 
environmental factors associated with the professional activities (Kobierzycka et al., 2005). 
Species of dermatophytes that cause athlete's foot can also cause fungal infection of the 
groin. The most common pathogen is Trichophyton rubrum, while Trichophyton  interdigitale 
and Epidermophyton floccosum more rarely cause infections of this area. This infection is a 
common disease, occurring more often in men than in women, but it is rarely observed in 
children. Tinea cruris is a very widespread in the tropics, particularly among immigrants 
from countries with temperate climates, especially when factors that makes them 
predisposed to the formation of intertrigos and development of fungal infections are 
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authors estimate the incidence of fungal infection rates similar of 25-30% in the general 
population, although this is difficult to determine it because in the special risk groups 
(athletes, miners), it can grow up to 60-70%. In studies of Szepietowski et al most common 
type of tinea pedis was a athlete's foot (45.5%), and the most common pathogens causing it 
were dermatophytes, which were isolated in 88.8% of all patients with fungal infections. 
Among the most commonly cultured dermatophytes were  Trichophyton rubrum (51%), 
followed by Trichophyton mentagrophytes (33.1%) (Szepietowski et al., 2001). 
The authors found that athlete's foot in 75.2% of patients occurred together with the other 
forms of fungal infection of the skin, the most common was onychomycosis found in 69.2% 
of patients. Described in the literature the simultaneous occurrence of fungal infection of the 
both  feet with one hand forming the so-called two feet and one hand syndrome and was 
rarely observed, because only in 2.5% of patients (Szepietowski et al., 2001). It is believed 
that the probability of developing athlete's foot is lower in women than in men. The 
differences are likely to result from increased exposure to pathogenic fungi associated with 
wearing heavy occlusive footwear by men (Kobierzynska et al., 2005). 
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the same favorable environmental conditions for fungi (Elewski, 2000a; Hryncewicz-
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65 years. Its occurence is much rarer in children, it is associated with rapid growth of the 
nails in young people which hinders the development of infection because the fungus is 
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foot. It can then concern the dominant hand and form the aforementioned two feet and one 
hand sydrome (Szepietowski et al., 2001). In most cases the etiological factors for mycosis of 
hands are anthropophilic species of dermatophytes that also cause athlete's foot also: 
Trichophyton rubrum, rarely Epidermophyton floccosum and Trichophyton interdigitale. Much 
less fequently hand`s skin can be infected by  antropohilic species Trichophyton violaceum and 
some zoophilic species such as Trichophyton mentagrophytes (Kobierzycka et al., 2005; 
Hryncewicz-Gwozdz et al., 2005) .  
The development of fungal infection of the hands may facilitate various factors causing 
maceration of the skin, such as wearing rings, watches, anatomical deformities, and 
environmental factors associated with the professional activities (Kobierzycka et al., 2005). 
Species of dermatophytes that cause athlete's foot can also cause fungal infection of the 
groin. The most common pathogen is Trichophyton rubrum, while Trichophyton  interdigitale 
and Epidermophyton floccosum more rarely cause infections of this area. This infection is a 
common disease, occurring more often in men than in women, but it is rarely observed in 
children. Tinea cruris is a very widespread in the tropics, particularly among immigrants 
from countries with temperate climates, especially when factors that makes them 
predisposed to the formation of intertrigos and development of fungal infections are 





Most dermatophytes can infect hair, the exceptions are, however, some species such as 
Epidermophyton floccosum, Trichophyton rubrum, Trichophyton interdigitale. 
Conversely, some dermatophytes (Microsporum audouinii, Trichophyton schoenleinii, 
Trichophyton violaceum) have a strong affinity for hair structures. It was found that all the 
dermatophytes, which cause fungal infections of the scalp can also infect glabrous skin 
(Kobierzycka et al., 2005). Pathogens that cause tinea capitis differs between countries and 
geographic regions. In recent years, it has been observed in most European countries, an 
increase in the frequency of infections caused by Microsporum canis, whereas in the U.S. 
urban environments - a larger share Trichophyton tonsurans was seen (Elewski, 2000b). 
Mycosis of the scalp concerns mainly children. Peak incidence falls on 4 – 6 years of age, and 
the infection is spreading especially in boys. Higher incidence of fungal infections in 
children is associated with the difference of biological characteristics of the skin, including 
the different composition of sebum in children and adults (Szepietowski & Baran, 2005). 
In a study of Lange et al, of the pediatric population in the region of Gdansk (midsouthern 
Poland), fungal infections of skin were usually caused by dermatophytes, which accounted  
for 60% of all infections. The highest incidence of skin fungal infections was observed  
in children aged 4-7 years. In this age group, the lesions caused by Microsporum canis 
affected the scalp. In slightly older children, aged 8-12 years, the number of infections of  
the scalp decreased rapidly, and over 13 years of age lesions in this location rarely have been 
observed. Most common form of fungal infection, that was seen in the pediatric population 
studies, was fungal infection of the glabrous skin (30%), mostly caused by Microsporum  
canis, rarely by Trichophyton mentagrophytes and by  Trichophyton rubrum, occurring most 
often in children aged 8 - 15 years. It is interesting that in children above 12 years of age 
athlete's foot was also observed (11%), in most cases caused by Trichophyton rubrum and 
Trichophyton mentagrophytes, and also fungal infections of the toenails (8%) caused by 
Trichophyton rubrum were seen (Lange et al., 2002). Similar results were obtained in the 
studies of pediatric patients in the region of Poznan (Central-West Poland) (Zaba & 
Danczak-Pazdrowska, 2001). 
Many authors underline the rarity of these forms of mycoses in children before puberty, in 
contrast to the fungal infections of glabrous skin and scalp, considered to be typical for the 
childhood. Accepted view is that the athlete's foot and onychomycosis are very common 
skin and nails diseases in adults, and their incidence increases with age. However, 
epidemiological studies on the population of children of different ages and in different 
regions of the world indicate that the athlete's foot may relate to 2.2-8.2% of the pediatric 
population (Lange & Bykowska, 2004) In addition, there are also cases of athlete's foot in 
pediatric patients like tinea incognito, proceeding without symptoms or mistakenly 
acknowledged as bacterial lesions or allergic changes and treated with antibiotics or topical 
cortycosteroids (O`Grady & Sahn, 1999). 
Studies of Lange and Bykowska on recognition of fungal infections in pediatric patients in 
years 1993-2002 showed an increase in the prevalence rates of onychomycosis in children 
(Lange & Bykowska, 2004). In the literature, individual national studies of mycoses of the 
feet and toenails in children and adolescents refers to the area of Wroclaw (Lower Silesia, 
southwestern Poland), where there has been considerable percentage of fungal infection of 
the feet and toenails in children under 15 years of age (16.3% and 21%, respectively) 
(Szepietowski, 1997).  
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Also, Zaba and Danczak-Pazdrowska examining children and adolescents to 18 years of age, 
living in the area of Greater Poland, found fungal infections of toenails in 34.5% patients and 
mycoses of hands and feet in 26.1% of cases (Zaba & Danczak-Pazdrowska, 2001). It seems 
that a particular risk factor in children is a participation in sport activities. It turned out  
that in this group superficial mycosis of the feet occurs several times more often than in 
children not involved in sport, which is related to use of occlusive footwear, as well as 
frequent, repetitive injuries of fingers and toenails. Thus, the results of the Polish authors 
suggest that fungal infection of the feet and toenails in children and adolescents currently 
are not that uncommon. Moreover, as in adults, athlete's foot in children can coexist with 
other clinical forms of fungal infection, especially fungal infection of the toenails (Lange & 
Bykowska, 2004). 
The analysis of few described so far cases in the world of dermatomycosis in newborns 
showed that it could even occur on the second day of life and can be caused both by 
anthropophilic dermatophytes (Trichophyton rubrum) and as well as zoophilic dermatophytes 
(Microsporum canis). The source of infection in case of antropophilic dermatophytes was 
immediate family and in case of zoophilic dermatophytes – pets, especially cats. Descriptions 
analyzed by Szepietowski of dermatomycosis in newborns come mostly from India and 
Japan, which is probably related both to climatic conditions, as well as significantly to local 
practices for baby care (Szepietowski, 1997). 
4. Conclusion 
Fungal infections are a serious problem - not only clinical, but also therapeutic and social. 
Fungi are widespread in the environment of human life, are ubiquitous, so the disorders 
caused by them could be classified as a lifestyle diseases, affecting people independtly of 
age, sex, race or social status. Fortunately, our knowledge about these parasites of the skin 
and its appendages is growing, new therapies and new methods of treatment of fungal 
diseases are developed, which allows us to effective protection against these pathogens.  
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1. Introduction 
The emergence of community-acquired methicillin resistant Staphylococcus aureus  
(CA-MRSA) strains in individuals without traditional risk factors, has caused a drastic 
change in MRSA epidemiology since community acquired infections are etiologically caused 
by MSSA (methicillin sensitive S. aureus). Initially the most affected social groups were 
soldiers, men who have sex with men, prisoners, illicit injection drug users, and athletes; 
people with compromised skin and mucosa, poor hygiene habits and postpartum mastitis; 
Native Americans of the United States, and children due to their close contact with 
contaminated nasal secretions.  
This change in epidemiology lead to molecular studies aimed at determining pathogenicity, 
virulence, resistance to different antimicrobial classes and the behavior of these strains 
against selective pressure of the human immunological system. Associating risk factors with 
the molecular studies gave rise to Molecular Epidemiology. 
Humans are the main source of Staphylococcus spp., which can be found in the skin, throat, 
intestine and nose without causing damage to the host. In hospitals, the asymptomatic host 
can disseminate S. aureus to immunocompromised patients. Since they are ubiquitous, these 
bacteria can cause several types of infections such as: necrotizing pneumonia, skin and soft 
tissue infections, bacteremia, as well as food poisoning through enterotoxin production. 
Individuals affected by CA-MRSA strains can develop from mild to metastatic and lethal 
infections, which are directly related to the synthesis of certain toxins, antimicrobial 
resistance and individual health conditions. One of the most discussed virulence factors is 
PVL (Panton-Valentine Leukocidine). Since its first association with skin and soft tissue 
infections, PVL is now believed to contribute to the elevated virulence potential attributed to 
CA-MRSA.  
Methicillin resistance is conferred by mecA gene inserted in a mobile genomic island, the 
Staphylococcal cassette chromosomal (SCCmec). Some different SCCmec regions are 
responsible for mobility and regulation, and others for resistance to several antimicrobial 
classes. According to the presence, lack or genomic variations in these regions, the cassettes 
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can be classified in a range from type I to XI largely used to discriminate hospital and 
community types. 
Community strains are usually more sensitive to other antimicrobial classes compared to 
multiresistant health care associated strains. In fact, CA-MRSA can be resistant to other 
antimicrobials besides beta-lactams, thus decreasing the options of drug choices. Another 
subject of concern is resistance to the drug of choice for treating MRSA, vancomycin. There 
are few antimicrobials to control the infections caused by MRSA and vancomycin is one of 
them. Reports of resistance and low level of sensitivity to this drug in health care 
environments have been reported worldwide. 
All of the issues mentioned above, underscore the importance of further research on the 
behavior of CA-MRSA at the epidemiological and molecular levels enabling establishment 
and application of preventive measures and treatment in view of infections. The present 
chapter will outline the main features of CA-MRSA and epidemiological principles involved 
in the outcome briefly described above. 
2. Resistance evolution background  
Staphylococcus spp. are gram-positive cocci, catalase positive, belonging to the family 
Staphylococcaceae and the genus Staphylococcus, which currently comprises 45 species 
(Euzéby, 2011), from which 17 species can be isolated from samples from humans. 
Staphylococcus aureus is the most important species and can be found in both healthy and 
immunocompromised individuals (Santos et al., 2007). 
The Staphylococcus genus is classified according to the synthesis of the enzyme coagulase, 
and those that synthesize are classified as coagulase-positive, represented by the species 
Staphylococcus aureus, S. intermedius, S. hyicus, S. schleiferi subspecie coagulans, S. delphine and 
S. lutrae, and in the absence of the synthesis, are represented by other coagulase-negative 
species (Baba et al., 2002). Both groups can cause infections in humans and, among them, the 
main species are: S. aureus, S. epidermidis, S. saprophyticus, S. haemolyticus, S. hominis, S. 
warneri, S. capitis, S. saccarolyticus, S. lugdunensis, S. cohnii, S. xylosus, S. simulans, S. 
auricularis, S. caprae and S. schleiferi (Layer et al., 2006). 
Humans are the main reservoir of Staphylococcus aureus, which can colonize the skin, throat, 
intestine and nasal passages without causing damage to the host. Asymptomatic carriers in 
hospitals can spread S. aureus increasing risk to immunocompromised patients (Santos et al., 
2007). This ubiquity favors the installation of various types of infections such as necrotizing 
pneumonia, skin and soft tissue infections, food poisoning bacteremia through the synthesis 
of enterotoxin (Santos et al., 2007; Cunha et al., 2006; Jarraud et al., 2002; Gandhinagar & 
Silva, 2004). 
In 1940, staphylococcal infections were treated with penicillin; however, only two years after 
its introduction, nosocomial penicillinase producing strains grew resistant to penicillin by 
the inactivation of the penicillin molecules (Mimica & Mendes, 2007). Shortly thereafter, the 
same occurred with the strains of community origin necessitating the use of alternative 
antibiotics to treat infections caused by S. aureus (Ricardo, 2004). 
In the late 1950s, in Europe, resistant nosocomial and community Staphylococcus spp. had 
penicillin resistance rates of 90% and 70%, respectively (Ricardo, 2004). This finding led to a 
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search for alternatives, and in 1959, adding the acid 6-aminopenicilanic in the penicillin 
molecule allowed for protecting the precursor of penicillin beta-lactam ring. This semi-
synthetic penicillin (Named methicillin (and the analog oxacillin, used in Brazil) proved to 
be resistant to the action of beta-lactamase. However, both were effective for a short period 
of time, and in 1961, strains resistant to semisynthetic penicillins emerged. These emerging 
new strains were named MRSA (Methicillin-Resistant Staphylococcus aureus), so far unique to 
hospital settings (Ricardo, 2004; Salgado et al., 2003). 
In the 1980s the first reports emerged of infections caused by S. aureus in patients without 
risk factors for acquisition of nosocomial MRSA (HA-MRSA), resulting in the designation of 
CA-MRSA (Community-Acquired Methicillin-Resistant S. aureus) in the 1990s when reports 
of CA-MRSA increased (Ricardo, 2004). The community-acquired infections are usually 
distinct from hospitals in terms of susceptibility and the carriage of the gene that codifies for 
the synthesis of Panton-Valentine Leukocidin (PVL) responsible for tissue invasion 
preceding the skin infections (Klevens et al., 2007). 
According to criteria, it is considered that individuals affected by CA-MRSA should not 
report previous MRSA infections; the patient must have a positive culture for MRSA 
within 48 hours after hospital admission, and must not be hospitalized in the last 12 
months, or admitted to nursing homes or homecare, and did not report undergoing 
dialysis, surgery, catheters or any prior or invasive treatment at the time of MRSA 
isolation (Salgado et al. 2003). 
The transmission of the bacteria occurs through direct contact of susceptible individuals 
with asymptomatic carriers. There are frequent reports of the spread of CA-MRSA among 
men who have sex with men, soldiers, athletes, intravenous illicit drug users, prisoners, 
people with compromised skin and mucous membranes, poor hygiene, postpartum mastitis 
(Reddy et al., 2007), Native Americans from the U.S. (Klevens et al., 2007; Stemper et al., 
2006) and among children due to the contact with contaminated nasal discharge (Klevens et 
al., 2007). 
The transmission of MRSA among family members was reported in a study with 10 families. 
Strains with PFGE ST8 (USA 300), ST59 (USA 1000), and ST80 PVL-positive were found in 
this investigation (Huijsdens et al., 2006). Lung infections caused by these strains can be 
serious because the symptoms are similar to pneumonia in children; therefore, it is 
important to consider infection by MRSA especially if there were previous reported. 
(Huijsdens et al., 2006). 
Among pathogens that can cause pulmonary infections, CA-MRSA is associated with 
pneumonia and is frequently associated with pulmonary viral coinfection. Studies indicate 
that CA-MRSA agents are commonly found in pneumonia during the influenza season, and 
about 85% of S. aureus strains isolated contained the PVL gene. In three cases of severe 
necrotizing pneumonia, strategies were carried out to prevent the synthesis of Leukocidin, 
including the administration of antibiotics such as rifampicin, linezolid and clindamycin, 
and/or applying intravenous immunoglobulin to block the lytic effect of PVL under 
polymorphonuclear cells (Rouzic et al., 2010). During the influenza season of 2006 and 2007, 
there were 51 reported cases of pneumonia in health centers caused by S. aureus, and 79% 
were MRSA. Most cases of pneumonia due to MRSA occurred during or after viral infection 
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The treatment of MRSA infections is variable. Within a hospital environment, there are 
several options such as linezolid, daptomycin, quinupristin/dalfopristin, but vancomycin is 
one of the most commonly used to treat several types of infections, but the emergence of 
strains resistant to this antimicrobial agent limits its use. Historically the emergence of 
vancomycin resistance occurred primarily in isolates of Enterococcus spp. in 1986 and 
reported only in 1988 in a European hospital. In 1989, in the United States, Vancomycin-
Resistant Enterococci (VRE) were detected in clinical isolates and in 1993 accounted for 7.9% 
of the enterococci samples in nosocomial environments reported by the CDC. The most 
important reservoir is the gastrointestinal tract and transmission occurs mainly through 
contact with healthcare workers, and indirectly by contaminated hands in contact with the 
hospital objects where at least one of the patients had diarrhea (Mayall, 2002). 
Vancomycin resistance in VRE is due to the presence of van genes (A to G) that encode for 
the synthesis of peptidoglycan by an alternative pathway that produces precursors ending 
in D-Ala-D-Lac or D-Ala-D-Ser instead of D-Ala-D-Ala. In S. aureus, however the main 
mechanism involved in vancomycin resistance relies on a thickened cell wall, production of 
abundant extracellular material that remains not well characterized and it ends up 
compromising the ability of division. These characteristics result in the synthesis of an 
altered peptidoglycan with an increased number of terminal D-Ala-Ala-D capable of 
binding free vancomycin in the outer cell wall, thus leading to a lower availability of the 
antimicrobial target molecule in the intracellular region. Strains of S. aureus with 
intermediate resistance to vancomycin (VISA) may contain 2 to 4 times more layers of D-
Ala-D-Ala than susceptible strains, being capable of binding to three to six times more 
vancomycin molecules. Some chromosomal changes are necessary to maintain this 
resistance , and in addition require a larger amount of precursors than normal strains, thus 
compromising their fitness in an environment free of this antimicrobial. This may explain 
the reason for the loss of the vancomycin resistance of VISA strains when they are in 
environments without antibiotics, giving rise to heteroresistant strains called hetero-VISA 
(Van Bambeke et al., 2004). 
3. MRSA colonization and decolonization 
Studies on colonization intend to elucidate the mechanism by which certain individuals are 
persistently or intermittently colonized while others are non-carriers. MRSA colonization is 
an important predisposing factor, since colonized individuals are at increased risk of 
acquiring infections (van Belkun et al., 2009). Colonization is well studied in inpatients due 
to the risk of dissemination and the fact that it can facilitate severe infections. 
Nasal colonization is the main form, and colonization can occur in other extra-nasal sites as 
in the skin, pharynx and perineum, but some sites are considered unusual such as the 
vagina, axilla and gastrointestinal tract. Studies may help to define carriers as in most cross-
sectional studies only a culture classifies individuals as carriers or not, while longitudinal 
studies usually classify three categories of carriers: intermittent, persistent or non-carriers. 
Often cultures are harvested in three different time periods to define the carriers (Werthein 
et al., 2005). A study concluded that a "culture rule" which combines qualitative and 
quantitative results of two nasal cultures with an interval of one week could accurately 
classify nasal carriage (Nouwen et al., 2004). 
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Persistent carriers are usually colonized by a single strain of S. aureus over a long period of 
time, whereas intermittent carriers may carry different strains over time (Werthein et al., 
2005). MRSA colonization in individuals in the community remains a low burden as 
demonstrated in a study of high school boys where no individuals were found colonized 
with MRSA. The fact that there were no carriers among this population may be a reflection 
of improvement in hygiene practices among these individuals due to previous reports of 
outbreaks in team sports (Lear et al., 2011). Although they did not found MRSA in the 
population, other studies have found colonization rates in individuals in the community 
ranging from 0.8 to 3% (Keuhnert et al., 2006; Salgado et al., 2003; Ellis et al., 2004). 
MRSA colonization in a hospital environment is a matter of utmost importance since it is 
characterized as a predisposing factor to infection. Nasal decolonization is usually 
performed with the application of mupirocin and is useful for reducing symptoms and its 
spread in hospital environments. However, the practice of decolonization with 
antimicrobials remains controversial because of the risk of acquiring drug resistance, which 
limits its use. Despite this risk, it is advised to perform decolonization in healthcare settings 
because of the risk of developing infections especially in individuals who are under invasive 
treatments and are immunocompromised (Coates et al., 2009). 
But how should we manage individuals living in the community who are characterized as 
persistent carriers of CA-MRSA, but show no clinical manifestations and are healthy? This is 
a controversial subject because a previous study showed that individuals might be co-
colonized with MSSA and MRSA, where the strains of MSSA have better fitness than MRSA, 
most likely due to the additional mechanism of resistance, which requires a cost in the 
feasibility and competitiveness of these strains. Thus, when decolonization is performed 
with mupirocin, both are eliminated and there will be competition, thus increasing the 
chances of colonization by resistant strains if both were competing for the same ecological 
niche (Dall'Antonia et al., 2005). Studies are needed to evaluate the cost-effectiveness of 
nasal colonization among residents in the community as a predisposition to infections, but 
there are chances of acquisition of resistant strains. 
The nasal vestibule is composed of highly keratinized cells including apocrine and 
sebaceous glands and hair follicles. These factors are poorly studied compared to the 
mucosa and its linkage to mucins. Some of the pathogen virulence factors contribute to 
successful colonization; for example, the clumping factor B is highly associated with nasal 
colonization (Wertheim et al., 2007). Studies have reported the binding of S. aureus surface 
protein G (SasG) to a ligand in nasal epithelial cells. Other factors such as: Teichoic acid and 
cell wall components recognizing microbial surface adhesive matrix molecules 
(MSCRAMMS) responsible for the adherence protein in fibronectin, fibrinogen and collagen, 
may play an important role in colonization (Wertheim et al., 2005). 
4. Case reports 
Case reports of CA-MRSA emerged worldwide revealing the severity, spread, which has 
helped to chart the epidemiologic distribution in the various communities and provide a 
better understanding of the behavior of virulence and resistance profile of these strains 
involved. Such isolates are associated with diseases of skin and soft tissue (Ribeiro et al., 
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Persistent carriers are usually colonized by a single strain of S. aureus over a long period of 
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disrupting natural barriers (Santos et al., 2007). The characteristics of the infection have to be 
similar to those caused by MSSA (methicillin-sensitive S. aureus) (Baba et al., 2002). 
Outbreaks of infections caused by CA-MRSA are increasing worldwide among all age 
groups. Several countries reported their presence as an emerging pathogen, including  the 
United States, Australia, New Zealand, Samoa, several EU countries (Ribeiro et al., 2005) 
and South America (Brazil, Uruguay and Colombia) (Alvarez et al., 2006). In Brazil there are 
several case reports confirming the presence of this pathogen in the community involving 
cases of furunculosis (Razera et al., 2009), metastatic infections with major complications 
(Strong et al., 2008) and pneumonia (d'Azevedo et al. 2009; Gelatti et al., 2009). 
There is transmission of CA-MRSA between humans and animals, and these strains may 
carry genes codifying for Panton-Valentine Leukocidin (PVL) (Rutland et al., 2009; Van 
Duijkeren et al., 2005). A diabetic patient first diagnosed with cellulitis in the bicep region in 
December 2007 was positive for S. aureus in February 2008 from ankle biopsies and of nasal 
swab cultures; both isolates had the same profile of resistance to trimethoprim/ 
sulfamethoxazole, clindamycin, erythromycin, tetracycline and ciprofloxacin, and were, 
therefore, treated both times with vancomycin . In February 2008, his eight-year-old female 
Labrador dog had widespread cellulitis in the neck, which did not respond to treatment 
with cephalexin. Tissue, blood, and secretion cultures were carried out identifying the same 
MRSA resistance profile as the dog’s owner. Typing performed by pulsed-field isolates of 
the man and animal was inconsistent with the USA epidemic clones. A spa typing 
(staphylococcal protein A) was performed and identified as spa3, the samples were negative 
for the presence of PVL. Due to the resistance profile of isolates of the patient and his close 
relationship with the hospital, it is likely that the source of these isolates was the hospital. 
This study demonstrated that humans could be a source of multiresistant pathogenic 
microorganisms for their animals (Rutland et al., 2009). 
A case study revealed that a woman with successive complications with MRSA transmitted 
the strain to her relatives as well as her dog. Samples collected from the nose and throat of 
other asymptomatic relatives were positive for MRSA. Everyone was treated with 
rifampicin and ciprofloxacin. After six months of treatment, no new samples were recovered 
in the tests for detection of CA-MRSA among the family members and the dog (Van 
Duijkeren et al., 2005). 
CA-MRSA pneumonia can be hotbeds for metastatic infections leading to vital organ 
failure. In Sao Paulo, a previously healthy of 17-year-old patient was admitted to the 
hospital with upper respiratory infection that progressed with worsening of 
bronchopneumonia, septic shock and respiratory failure in just three days. The course of 
the infection followed with pulmonary cavitations, empyema and bronchopleural fistula 
requiring pleural drainage and tracheostomy. On the 16th day of hospitalization, the 
patient required total colectomy with ileostomy for ischemic colitis. In less than 48 hours, 
the patient had two blood cultures positive for Gram-positive cocci. Laboratory tests 
revealed MRSA with resistance to erythromycin and cefoxitin, with MIC for oxacillin of 
3µg/ml and vancomycin sensitive (2µg/mL) and teicoplamin (2mg/mL). The strain was 
sensitive to trimethoprim/ sulfamethoxazole and clindamycin. PCR analysis confirmed 
the presence of the mecA gene, SCCmec type IVa in the presence of genes for γ hemolysin, 
enterotoxin A (sea) and was negative for PVL. The treatment was maintained with 
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teicoplamin for 36 days, and from day 7 with meropenem for 14 days, showing 
progressive improvement and was discharged after 72 days from the hospital. No family 
member was colonized by CA-MRSA (d'Azevedo et al., 2009). 
The presence of CA-MRSA infections involved in high morbidity has been reported. After 
infection of traumatic injury, a 27-year-old patient, healthy and without history of 
hospitalization in the previous 12 months, was admitted to the University Hospital 
Clementino Fraga Filho (Rio de Janeiro, RJ - Brazil) and treated with ceftriaxone and 
vancomycin. The examination by transtoraxic echocardiography revealed a commitment of 
the anterior mitral valve and multiple blood cultures positive for MRSA, and molecular 
analysis detected the PVL toxin and the presence of cassette type IV. The vancomycin MIC 
performed by E-test was 2µg/mL. Removal of the spleen due to an abscess was carried out, 
and the patient had a syncope and cerebral mycotic aneurysm. The patient was discharged 
after 3 months of the treatment (Strong et al., 2008). 
Pneumonia and sepsis caused by a localized source of infection caused by CA-MRSA 
occurred in one patient in Porto Alegre, Brazil, treated at the Pediatric Emergency Room 
diagnosed with cellulitis and pneumonia. The X-ray of the lesion revealed bone 
involvement, liver and aneurysm of the pulmonary vessel. Blood culture revealed the 
presence of S. aureus resistant only to oxacillin and cefoxitin. Testing by PCR revealed the 
presence of mecA, the PVL and the cassette type IVc. The clonal profile analyzed by  
PFGE found that the strain was similar to clone OSPC. The patient remained hospitalized 
for 50 days and was discharged after treatment with clindamycin and gentamicin (Gelatti 
et al., 2009). 
Reinert et al. (2008), analyzed a culture collection grown between 1995 and 1999 and 
characterized them by PFGE (electrophoresis in pulsed-field gel). The results showed that 
the predominant profile (80%) corresponded to the Brazilian Epidemic Clone (BEC). Three 
of the 50 selected samples, harbored the cassette type IVc, and MLST (Multi Locus Sequence 
Typing) differed from each other: ST3, ST5 and ST88. These data showed that the presence 
of CA-MRSA in Brazil is longstanding and well established and must have passed 
unnoticed in clinical laboratories. It is necessary to detect and monitor these strains in the 
community and in hospitals for a better understanding of its epidemiology, as well as to 
inform public health strategies to control its spread (Reinert et al., 2008). 
Risk factors for acquisition of CA-MRSA should be evaluated due to widespread character. 
In areas of close proximity among individuals, there is a greater risk of infection by S. 
aureus. Studies with people who maintain close contacts show that poor hygiene is an 
important factor in the acquisition of Staphylococcus aureus. In addition, younger individuals 
and the obese are more prone to colonization by MRSA. The objects of common use (soap 
and towels) and the environment are related to containing outbreaks of infections with this 
pathogen (Turabelidze et al., 2006). 
Antimicrobial agents have different levels of concentration in certain sites of infection and, 
therefore, can reach subinhibitory levels during the treatment. Studies indicate that these 
levels may contribute to an increased expression of fibronectin binding proteins in samples 
having mutant genes for DNA gyrase and topoisomerase IV (grlA and gyrA, respectively) in 
MRSA strains. Bisognano et al. (1997) noted that the mutation sites that confer resistance to 
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FNB expression of genes that encode the fibronectin binding protein, but the mechanisms 
have not yet been defined. This may explain why patients who had prior use of 
ciprofloxacin have a higher likelihood of MRSA colonization. 
The colonization by CA-MRSA in adults and children differs in the profiles of resistance to 
beta-lactam antibiotics, in which it is more typical that multi-sensitive strains colonize and 
affect children. This is mainly due to different environments they attend and hygienic 
practices follow. In addition, the antibiotics used in children may differ from those 
administered to adults, thus providing a different selective pressure in the community. 
Among adults CA-MRSA strains are more frequently resistant to gentamicin, tetracycline, 
ciprofloxacin, clindamycin and erythromycin than those observed in isolates from children 
(David et al., 2006). 
One study evaluated S. aureus strains isolated from blood cultures as the type of SCCmec, 
the presence of PVL and analyzed the clonal profile by PFGE. In this study, they mainly 
included cases of HA-MRSA defined by the following isolation criterion for MRSA: must be 
isolated for 48 hours after hospital admission, previous isolation of MRSA colonized or 
infected patient during hospitalization or surgical procedures in the 12 months preceding 
the isolation, patients who  underwent installation of a catheter or invasive devices. Of all 
the samples analyzed, 65% had the cassette type IV and that PVL was present in 92% of 
these samples. The clonal profile of 92% of samples with SCCmec type IV was USA300-ST8 
(Gonzalez et al., 2006). The isolation of S. aureus resistant to methicillin with the cassette 
type IV suggests that these strains, particularly the USA300, presents an adaptation that 
expands beyond the community environment which may cause a change in the 
epidemiology of CA-MRSA. 
5. Genetic characteristics of CA-MRSA 
As a result of these observations genetic studies began focusing on molecular mechanisms 
responsible for the resistance to antibiotics and identification of MRSA strains. These strains 
had acquired and integrated into their genome harboring resistance genes, called 
Staphylococcal cassette chromosome mec (SCCmec). SCCmec present the gene responsible for 
methicillin and other beta-lactamic antibiotic resistance (mecA), and can carry genes that 
determine resistance to other classes of antibiotics. Strains related to community-acquired 
infections contain the smaller and lighter mobile element, the types and subtypes of SCCmec 
IV or V (21 to 25 kb) (Zhang et al., 2005). 
Strains of HA-MRSA carry heavier mobile elements (SCCmec I to III) because they have 
genes that encode for resistance to several antimicrobial classes (Okuma et al., 2002). The 
mobile element SCCmec is characterized by the presence of essential genetic elements: the 
mec complex (classes A to E), the ccr complex (Hanssen & Sollid, 2007), junkyard regions (J) 
(Zhang et al., 2009) and end 3' is connected to the open reading frame (ORF), orfX. The 
SCCmec is integrated into the chromosome of Staphylococcus called attBscc a specific site 
located downstream of orfX (Zhang et al., 2008). There are several types of SCCmec (I to XI) 
(IWG-SCCmec, 2011) in addition to subtypes IIA to E and the IVg to IVa (Hanssen & Sollid, 
2007). The ccr complex has five different allotypes for the ccrA and the ccrB: ccrA1 to ccrA5, 
the ccrB1 to ccrB4 and ccrB6 and ccrC1 (IWG-SCCmec, 2011). The allotypes of the SCCmec 
complexes are characterized by the presence of certain ccr genes (Ito et al., 2004). The ccrA 
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and ccrB genes encode for recombinases of the family "invertase/resolvases." These 
enzymes mediate the integration within and outside of the SCCmec thus giving mobility to 
the chromosome cassette (Zhang et al., 2005). 
The J regions encode several pseudogenes apparently with functions related to the bacterial 
metabolism (Zhang et al., 2005), and also contain genes for resistance mediated by plasmids 
or transposons to non beta-lactam antibiotics and heavy metals (Zhang et al., 2009). They are 
divided into three segments: J1, which is the region between the ccr complex the right 
chromosomal junction and the ccr gene complex; J2, between the ccr and mec regions, and J3 
which is located between orfX and mec. Variations in the J regions within the same mec-ccr 
gene complex are used for defining SCCmec subtypes. 
The SCCmec can be found in several species of Staphylococcus spp., such as S. aureus, S. 
epidermidis, S. haemolyticus, S. hominis and S. warneri (Hanssen & Sollid, 2007). The origin of 
SCCmec is unknown, and there have been no reports that any other genus than 
Staphylococcus carries the Staphylococal cassette chromosome. The presence of SCCmec type 
IV in S. epidermidis in healthy people suggests that this can be responsible for the conversion 
of CA-MSSA for CA-MRSA (Hanssen et al., 2004) where the transmission of the mobile 
element occurs mainly by transduction mediated by bacteriophages (Ito et al., 1999). 
The mecA gene codifies a penicillin binding protein PBP 2 'or 2A (Menegoto & Picoli, 2007) 
present on the outer surface of the cytoplasmic membrane (Ricardo, 2004). In susceptible 
strains, conventional PBPs have a high affinity with the beta-lactam antibiotics which 
prevents the proper formation of cell walls. However, the second PBP has low affinity to this 
class of antimicrobials, which explains resistance to antimicrobials of the group of 
methicillin (Menegoto & Picoli, 2007; Ito et al., 2001).  
The mecA gene is regulated by two genes mecI and mecR1 that have similar functions of the 
blaR1 and blaI  mechanism that regulates the production of beta-lactamase (Chambers, 1997). 
The mecA gene is regulated by a repressor mecI, a signal transducer and trans-membrane 
sensitive to the beta-lactam mecRI; both are divergently transcribed. In the absence of beta-
lactam antimicrobial, mecI represses the expression of mecA and mecRI-mecI. However in the 
presence of beta-lactam antibiotics, the mecI is cleaved autocatalytically, and a 
metalloprotease domain, located in the cytoplasmic portion mecRI, becomes active. What 
allows the mecA gene transcription and subsequent synthesis of PBP2a is the cleavage of the 
mecI by the metalloprotease and its connection on the operative region of the mecA gene 
(Berger-Bachi & Rohrer, 2002). The presence of insertion sequences IS431 and IS1272 results 
in the induction of the mecA gene (Katayama et al., 2001). 
Other resistance mechanisms have been identified in strains that lack the mecA gene, for 
example, the overproduction of beta-lactamase responsible for the inactivation of oxacillin 
or modified resistance (MOD-SA) mediated by different types of PBPs with changed 
affinities to this antibiotic. Strains with this profile are called borderline resistant (Wey et al., 
1990). 
CA-MRSA can express resistance inducible clindamycin resistance, an option for treating 
both MSSA and MRSA in particular in cases of toxic shock syndrome. In MLSBi positive 
strains (macrolide-lincosamides-streptogramin B resistance), an inducer promotes methylase 
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and ccrB genes encode for recombinases of the family "invertase/resolvases." These 
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presence of beta-lactam antibiotics, the mecI is cleaved autocatalytically, and a 
metalloprotease domain, located in the cytoplasmic portion mecRI, becomes active. What 
allows the mecA gene transcription and subsequent synthesis of PBP2a is the cleavage of the 
mecI by the metalloprotease and its connection on the operative region of the mecA gene 
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in the induction of the mecA gene (Katayama et al., 2001). 
Other resistance mechanisms have been identified in strains that lack the mecA gene, for 
example, the overproduction of beta-lactamase responsible for the inactivation of oxacillin 
or modified resistance (MOD-SA) mediated by different types of PBPs with changed 
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CA-MRSA can express resistance inducible clindamycin resistance, an option for treating 
both MSSA and MRSA in particular in cases of toxic shock syndrome. In MLSBi positive 
strains (macrolide-lincosamides-streptogramin B resistance), an inducer promotes methylase 





ribosome unit causing an expression of the resistance to lincosamides (e.g. clindamycin). 
Phenotypically the strains are resistant to erythromycin and clindamycin sensitive, but 
when the disk of erythromycin is set at 15mm from the clindamycin disk, the clindamycin-
induced resistant strain expressed the resistance forming a D zone near clindamycin. The 
presence of the mecA gene in CA-MRSA does not fulfill the identification criteria in itself for 
the expression of the inducible clindamycin resistance (Patel et al., 2006). 
Boyle-Vavra et al. (2005) conducted a study with patients who had skin and soft tissue 
infections and another with colonized individuals with CA-MRSA, in order to test the 
resistance to various antibiotics and isolate those carrying the mecA gene. The results 
showed that 94% of the strains recovered from these infections and 85.3% of the strains that 
colonized healthy individuals showed resistance to three or more non-beta-lactam 
antibiotics. The SCCmec IV was present in 34% of the samples from individuals who had at 
least one risk factor for acquisition of MRSA and 14.7% of the isolates showed a different 
SCCmec called SCCmec VT (Boyle-Vavra et al., 2005). 
6. Detection of phenotypic resistance to oxacillin 
There are several tests that detect phenotypic resistance to oxacillin, such as the E-test with 
oxacillin agar screening test, or Kirb-Bauer disk diffusion test, cefoxitin disk diffusion, 
determining the minimum inhibitory concentration (MIC) (Felten et al., 2002), latex 
agglutination test to detect PBP2a (Bressler et al., 2005; Martins et al. 2010). 
CHROMagar is used for the cultivation of S. aureus resulting in pink-colored colonies. 
Carricajo et al. (2001) tested the sensitivity and specificity of this medium compared with 
conventional (Columbia agar with 5% horse blood and chocolate agar). The CHROMagar 
allowed 22 strains of S. aureus grown from polymicrobial samples unlike conventional 
methods. Despite the high cost, this method had a sensitivity of 98% and specificity of 100% 
(Carricajo et al., 2001). 
The latex agglutination test detects the PBP2a protein in the cell wall of staphylococci. To 
assess the effectiveness of this test, Bressler et al. (2005) compared it with PCR for mecA and 
determined the MIC of the MicroScan PC20 samples tested. The latex agglutination test had 
a 99% agreement with MicroScan; three strains that were false positive in the mecA 
agglutination had two strains that were resistant, and one presented sensitivity. The latter 
had a different aminoacid in PBP2a, the M483I that conferred susceptibile to oxacillin. This 
amino acid can increase the affinity for this antibiotic or eliminate the transpeptidase 
activity of PBP2a (Bressler et al., 2005). 
The disk diffusion test in mannitol salt agar also showed favorable results in the detection of 
oxacillin resistance and a method almost as effective as the method of disk diffusion in 
Mueller-Hinton agar (Kampf et al., 1998). 
The presence of heteroresistant strains can complicate the detection of the resistance by 
these methods due to the false-negative results. The disk diffusion test with cefoxitin is 
widely used due to the induction of mecA gene expression with the production of PBP2a, 
which promotes antibiotics in strains apparently sensitive to oxacillin (Feltenet al., 2002). 
Factors such as lower incubation temperature (30 to 35 º C), osmolarity of the medium (2-4% 
NaCl), extended incubation period and inoculum density favor the detection of 
heteroresistant strains (Camarena & Sanchez, 2009). 
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The use of cefoxitin disk diffusion to detect strains carrying the mecA gene is widely 
applied, but there are laboratories that use only the broth dilution test to determine the 
MIC of a sample. One study showed correlation of the MIC of cefoxitin in the presence of 
the mecA gene for both Staphylococcus aureus and coagulase-negative Staphylococcus testing 
three brands of Mueller-Hinton broth. After testing, the strains were sent to the CDC for 
molecular detection of the mecA gene by PCR. For mecA negative S. aureus strains the MIC 
of cefoxitin was <4ug/ml and for mecA positive the MIC was >6 or 8 µg/ml when read in 
18 hours of incubation, the result was highly sensitive and specific (99.7 and 100%). 
However, for coagulase-negative levels of cefoxitin were sensitive (at 24 hours, 94 to 99% 
for S. epidermidis and 91 to 100% non S. epidermidis), but not specific (24 hours, 85 to 91 % 
for S. epidermidis and 54 to 69% non S. epidermidis) to detect the presence of mecA 
(Swenson et al., 2009). 
Screening with oxacillin agar supplemented with 4% NaCl proposed by CLSI, as well as the 
oxacillin agar dilution and broth microdilution with 2% NaCl is used with results close to 
100% sensitivity for the detection of the mecA gene. However, when it comes to very diverse 
strains, detection of oxacillin resistance and the mecA gene are compromised, especially in 
disk diffusion testing, decreasing its specificity (classifying mecA negative strains as 
resistant) and agar screening, where low sensitivity values are obtained when more 
heterogenenous strains were tested (Swenson, 2002). 
Experiments aimed at improving identification and detection MRSA strains, particularly 
heterogeneous strains, which are more difficult to detect by conventional methods. The 
sensitivity of disk diffusion testing using 1g oxacillin disk increased from 83.5% at 35 ° C to 
91.7% when incubated at 30° C. Similarly, the sensitivity and specificity of the cefoxitin disk 
diffusion of 30 µg were 100% at a temperature of 30°C. Tests with cefoxitin are effective, 
because this antibiotic is able to detect strains inducing heterogeneous subpopulations 
expressing the mecA gene better than oxacillin. The sensitivity of the test screening at 6 µl 
oxacillin on Mueller-Hinton agar supplemented with 4% NaCl was 91.7% and specificity of 
100% in 24 hours of incubation at 35°C. The latex agglutination test for detection of PBP2a 
can reach a sensitivity of 100%, being able to identify strains with low levels of PBP2a 
(Cauwelier et al. 2004). 
Pereira et al. (2009) analyzed the sensitivity of the method of disk diffusion with oxacillin 
and cefoxitin disks, incubated for 24 h at 35°C in 100 samples of S. aureus isolated from 
pediatric and neonatal ICUs. They reported oxacillin disk sensitivity of 94.4% and specificity 
of 98%, while the cefoxitin disk presented 98% sensitivity and 100% specificity. The same 
authors also tested the screening method on Mueller Hinton agar with 6µg/ml of oxacillin 
and 4% NaCl and found a sensitivity of 98% and specificity of 100%. 
Martins et al. (2010) compared the screening methods of disk diffusion and E-test for 
detection of oxacillin resistance. They found that approximately 45% of samples were 
positive for the mecA gene, and the disk diffusion method with oxacillin disk showed a 
sensitivity of 86.9% and specificity 91.1%, respectively. The screening method showed the 
same sensitivity and specificity of 91.3%, while the E-test showed the same specificity of 
other methods and a sensitivity of 97.8% (Martin et al., 2010). 
The results found in several studies to determine the accuracy of these methods show that 
the results can vary depending on a number of factors especially the origin of the samples 
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7. Characterization of strains of CA-MRSA 
New typing multiplex PCR protocols have been proposed, which are fast, practical and 
economical for the differentiation of clones of CA-MRSA. Some techniques are able to 
differentiate the clone of the USA 300 from the USA 400, and detects the presence of the 
gene determining resistance to oxacillin the mecA gene target of the 16S rRNA that 
distinguish Staphylococcus spp. from other bacteria, the specific nuc gene of S. aureus, the 
PVL genes and other specific genes (Zhang et al., 2008). The multiplex PCR also allows the 
detection of genes encoding toxins and chromosomal cassettes responsible for 
antimicrobial resistance in a rapid and reliable manner compared to other methods 
(Oliveira & Lencastre, 2002). 
The technique of Multilocus Sequence Typing (MLST) is widely used for typing of 
microorganisms and is based on amplification and sequencing of genes encoding proteins 
essential defining each strain based on the sequences of fragments of the seven loci of 
essential genes. As there are many allelic combinations for each of these genes, there are no 
identical profiles, and those that have, are considered members of a clone. This technique 
can be used to study evolutionary and population biology of bacteria (Enright et al., 2000). 
Strains isolated in the United States were classified as pulsed-field types (PFT's) USA300, 
USA400, USA500, USA600, USA700, USA100 and USA800, USA900, USA1000, and USA1100 
(Han et al., 2007). It is estimated that most CA-MRSA present the genetic profile of USA300, 
USA400, USA1000, and USA1100, which the predominant profile is USA300. Strains 
USA100, USA200 and USA500 are frequently associated with nosocomial infections, and 
mostly have chromosomal cassette multidrug resistance in type II (Klevens et al., 2007). 
For MRSA typing techniques based on PCR, PFGE, ribotyping and plasmid typing, are 
widely used with successful results. The considerable genetic similarity between these 
microorganisms requires the use of more than one method for identifying more accurately 
(Oliveira et al., 2001). 
spa typing involves sequencing the polymorphic region X of the gene of protein A (spa) that 
contains a variable number of repeated regions of 24 bp flanked by conserved regions as 
well. In addition to this grouping, based on the sequence of a locus, it is practical, 
inexpensive, fast, and has a lower probability of errors compared to PFGE and MLST 
techniques, and can be used in local and global epidemiological studies due to micro-and 
macro-variations that occur simultaneously in region X. The following types of protein A 
were characterized in CA-MRSA: t008, t019, t021, t044, T131, t216 (Hallin et al., 2007). 
8. The role of the Panton-Valentine Leukocidin (PVL) 
One of the most important common virulence mechanisms in CA-MRSA is PVL (Panton-
Valentine Leukocidin) production. Strains that harbor the SCCmec element may 
simultaneously carry the lukS and lukF genes wich encode for PVL (Boyle-Vavra & Daum, 
2007). Deep infections of skin and soft tissues such as skin boils and abscesses, and 
necrotizing pneumonia are attributed to the presence of PVL toxin in strains of S. aureus 
(Lina et al., 1999, Melles et al., 2006). The presence in the lungs causes hemorrhage, extensive 
necrosis of alveolar septa, destruction of the epithelium covering the bronchi and 
bronchioles (Zhang et al., 2005), and histological sections show necrotic lesions in the 
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mucosa of the trachea (Lina et al., 1999). Due to these facts, studies have proposed that the 
propensity of CA-MRSA infections cause severe skin and soft tissue lesions, and possibly 
necrotizing pneumonia, is due to the presence of the gene encoding the production of PVL 
(Saïd-Salim et al. 2005). 
PVL was first described as a "substance leukocidin" by Van deVelde in 1894 but was first 
associated with skin and soft tissue infections by Panton and Valentine in 1932. The 
acquisition of genes encoding PVL is made by transduction of a specific type of 
bacteriophage, phiSLT, which causes cytolysis in carrier gene cells and transport this gene to 
another cell. From its transcription two exoproteins , the Luks-PV and LukF-PV are 
produced, acting through the synergistic action of both subunits (Melles et al., 2006, Saïd-
Salim et al., 2005). When secreted, LukS-PV initiates a connection to the membrane of the 
polymorphonuclear leukocyte (PMN) and is dimerized with LukF-PV, alternating one and 
another until the complete formation of a heptamer. Calcium channels are formed by 
inducing the production of interleukins and inflammatory mediators. Because of this 
evidence, probably the PVL is not directly associated with tissue necrosis, but related to 
lysosomal granules released by cytotoxic lysis of PMN, the release of granulocyte reactive 
oxygen or even the inflammatory cascade (Boyle-Vavra & Daum, 2007). 
The main target of PVL is human and rabbit neutrophils, having little or no effect on non-
human primates and mice (Löffler et al., 2010). The reason for differences in sensitivities to 
PVL is not yet fully known but may be related to receptor/signal transducers that are 
species-specific (Löffler et al., 2010). Its action is directly related to the concentration: at high 
concentrations, it causes cell lysis; at low concentrations, it mediates caspase dependent 
apoptosis by forming pores in the membrane of mitochondria (Boyle-Vavra & Daum, 2007; 
Lo & Wang 2011). Sub-lytic concentrations induce apoptosis of human neutrophils within 6 
hours, and at high concentrations leads to cell death in only 1 hour (Lo & Wang, 2011). 
9. Other virulence factors of MRSA 
The pathogenicity of S. aureus depends on several determinants, among them, the 
production of toxins and extracellular membrane components (Jarraud et al., 2002; 
Gandhinagar & Silva, 2004). The molecular basis of pathogenicity of S. aureus depends on 
the expression of broad classes of accessory genes producing components of the cell wall 
and extracellular proteins. The expression of these virulence factors is regulated by genes in 
the operon agr (accessory gene regulator), which regulates the expression of genes for toxins 
and adhesins (Purcell & Fergie, 2005). Enzymes such as coagulase and catalase are 
responsible for its evasion of the immune system (Gandhinagar & Silva, 2004). 
The toxins are related to staphylococcal toxic shock syndrome (TSS), staphylococcal scarlet 
fever (both due to the toxin of toxic shock syndrome 1 [TSST-1] and staphylococcal 
enterotoxins), scalded skin syndrome (SSS due to exfoliatins) and food poisoning (SE’s, 
staphylococcal enterotoxins) (Santos et al., 2007; Jarraud et al., 2002; Johnson et al., 1991). 
Genetic sequencing of a strain called MW2, CA-MRSA, revealed the presence of genes 
responsible for specific virulence factors such as the PVL toxin, staphylococcal enterotoxin H 
(seh) and staphylococcal enterotoxin C (sec) (Saïd-Salim et al., 2005). 
Toxic shock syndrome was related primarily to the use of a particular brand of tampons in 
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fever, rash, and toxicity, which often progresses to hypotension with a prior history of 
watery diarrhea, sore throat, nausea, vomiting and myalgia. A number of other symptoms 
involving dehydration and its effects are often related to the syndrome. Blood cultures may 
be negative for the pathogen. The strain that carries TSST-1 reacts with phage group I and is 
likely to produce toxins, including other enterotoxins, and exoproteins. It may also exhibit 
resistance to heavy metals, and proteolytic characteristics are not often haemolytic and 
usually tend to be pigmented. It is interesting that strains produce TSST-1 positive alpha-
hemolysin in low quantities even if they have the gene, suggesting that certain genetic 
events leading to repression of some genes (e.g., hemolysin) at the same time the expression 
of other genes (i.e. TSST -1) is increased (Todd, 1988). 
Scalded skin syndrome (SSS), better known as Ritter's disease was first described by 
German physician Baron Gotfried Ritter von Rittershain who observed the widespread 
phenomenon in 297 children calling it neonatal exfoliative dermatitis. This disease usually 
appears in children with clinical features ranging from localized to disseminated bullous 
impetigo, known for easily rupturing on the skin surface, releasing a fluid with features 
ranging from thin to thick, being opaque purulent yellowish, whitish or opaque. In neonates 
lesions are mainly located in the perineum, or both in the periumbilical region, and in older 
children the lesions are located near the umbilicus. This is the mildest form of the disease, in 
which the skin around the preserved area remains without systemic signs and symptoms. 
The generalized form of the disease is mainly spread across the surface of the skin and 
mucous membranes are usually spared. In infants, onset of symptoms begins between 3 to 
16 days. Patients with systemic SSS present fever, malaise, lethargy, irritability, loss of 
appetite, followed by the appearance of erythematous papules that usually start in the head 
and neck and spread to the rest of the body in a few days (Ladhani et al., 1999). 
Another mechanism of virulence that has often been identified  in samples of CA-MRSA is 
phenol-soluble Moduline . PSM was first detected in cultures of S. epidermidis. Antimicrobial 
activity against Group A Streptococcus (Cogen et al., 2010) and activities that stimulate the 
immune system of NFkB nuclear factor kB in THP-1 cells and cytokines in THP-1 monocytes 
and its role in the infection still need to be clarified (Mehlin et al., 1999). In PVL-positive CA-
MRSA samples, the PSM effect is to intensify the effects of the toxin in the presence of both 
units (LukS-and LukF-PV) (Hongo et al., 2009). 
The detection of PSM in CA-MRSA strains was higher than in HA-MRSA strains showing 
that S. aureus PSM activate human neutrophils triggering an inflammatory response and 
thereby contributes to staphylococcal virulence. CA-MRSA PSM has an important role in 
leukocyte cytolysis by CA-MRSA primarily participating in evasion of the host defense 
system (Wang et al., 2007). 
PVL, alpha-toxin and protein A, represent the virulence factors involved in pneumonia 
caused by S. aureus. Alpha-toxins and PVL form pores in the polymorphonuclear cells and 
thus causes an exaggerated response by the release of cytokines and reactive oxygen 
specimens and contributing to damage in lung tissue (Hayashida et al., 2009). 
Studies in the United States report that the USA400 strain responsible for lethal pneumonia 
in three children, had cytotoxins, such as virulence factors alpha and gamma, PVL, phenol-
soluble Moduline (PSMs), staphylococcal enterotoxin (SE) B or C. The profile of toxigenic 
strains of USA300 is similar, except for staphylococcal-like enterotoxin (SE-l) Q present in 
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these strains. CA-MRSA USA 100 and 200 clones have emerged with alpha +/- and gamma-
toxin +/-, PVL +/- PSM+ and TSST-1+ profiles. Probably the production of several 
cytotoxins combined with superantigen action culminates in a devastating disease 
(Schlievert, 2009). 
Beta hemolysin was also related to lung injury as demonstrated by Hayashida et al. (2009). 
In this study, the hemolysin was attributed to the ability to increase the influx of neutrophils 
in the lung and alveolar spaces, causing leakage of serum proteins into the lung parenchyma 
and exudation of protein rich fluid into the air. The neutrophil migration is indirectly 
modulated by beta-hemolysin through the stimulation of other host factors. Thus, the 
virulence of hemolysin increases the regulation of various pro-inflammatory cytokines and 
generates an exaggerated response in the host (Hayashida et al., 2009) 
10. Current antimicrobial drug choice 
Given the great potential of CA-MRSA infections to develop into serious and/or systemic 
infections, there is an interest in reintroducing drugs such as trimethoprim/ 
sulfamethoxazole, tetracycline and clindamycin for treatment of CA-MRSA. In severe cases 
where there is need for hospitalization and intravenous therapy, antibiotics such as 
vancomycin, linezolid and daptomycin are reliable options (LaPlante et al., 2008). 
The combination of trimethoprim/sulfamethoxazole (cotrimoxazole) has been considered a 
good therapeutic option for the treatment of patients affected by CA-MRSA. In vitro tests 
show that it has excellent bactericidal activity, but its activity can be reduced in the presence 
of rifampicin. Several antimicrobial combinations were tested, such as linezolid and 
cotrimoxazole, rifampicin,. Cotrimoxazole, minocycline, linezolid, clindamycin  
or moxifloxacin, cotrimoxazole alone proved to be more effective in in vitro tests (Kaka  
et al., 2006). 
However, in another study with patients affected by CA-MRSA treated with 
trimethoprim/sulfamethoxazole, clindamycin and cephalexin resulted in a treatment failure 
rate of 26%, 25% and 33%, respectively. In addition, patients who received the drainage of 
abscesses in addition to antibiotic therapy had lower rates of treatment failure (25%) than 
patients who received only incision and drainage (60%) (Frei et al., 2010). 
One of the main strains in the community, the USA300 had plasmid-mediated resistance to 
tetracycline, clindamycin, and mupirocin (Han et al., 2007). In addition, there is the 
possibility of clindamycin inducible resistant strains resulting in treatment failure. In places 
where there is high frequency of isolation of strains with this characteristic, it is necessary to 
choose alternative treatments. It is estimated that this phenomenon occurs in approximately 
13% of CA-MRSA strains (LaPlante et al., 2007) and from 36% to 56% of HA-MRSA (Siberry 
et al., 2003). The treatment of clindamycin-sensitive strains was assessed showing that the 
best options were daptomycin, clindamycin, doxycycline, vancomycin, linezolid and 
trimethoprim/sulfamethoxazole, respectively, with the latter three being equally effective. 
Treatment with daptomycin was better than vancomycin and linezolid, the latter two 
having equal effect, but all three overcame the effects of clindamycin since these strains can 
show induced resistance and the treatment with clindamycin also induces the emergence of 
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Choosing the best option for treating infections caused by CA-MRSA has risks and benefits 
of each antimicrobial agent that must be considered before prescribing. The ideal 
antimicrobial agent would be one of low toxicity to the individual, the rapid bactericidal 
activity, excellent tissue penetration, consistent pharmacokinetics and pharmacodynamics 
that would allow a predetermined dose, low potential for development of resistance during 
therapy and a proven clinical efficacy and microbiological (Nguyen & Graber, 2010). 
Finding a single antimicrobial agent with these characteristics may be complex, whereas a 
combination of agents can be a successful alternative. 
It is not enough to choose antimicrobials with these characteristics; it is also essential to 
observe antimicrobial participation in the various mechanisms of virulence of the 
microorganism. In several reports of infections caused by CA-MRSA, PVL appears 
simultaneously as a virulence factor. The use of antimicrobials may act in the synthesis of 
Leukocidin improving the patient's condition in cases of pneumonia caused by CA-MRSA 
PVL positive strains treated with linezolid and clindamycin which suggests that this is a 
good choice, acting on the protein production mechanism, these antibiotics prevent PVL 
production compared with vancomycin and nafcillin (Stevens et al., 2007).  
11. Vancomycin resistance 
Another concern is the emergence of resistance to the antibiotic of choice for treating MRSA, 
vancomycin. Few drugs are available to control MRSA, and vancomycin is one of them. 
Reports of resistance and low sensitivity to this antibiotic are present in nosocomial 
environments worldwide (Martins & Cunha et al., 2007). 
The first case of reduced susceptibility to vancomycin was reported by Hiramatsu (1997) in a 
pediatric patient with positive culture for MRSA who was treated with glycopeptide. 
Phenotypic analysis showed that the MIC for this strain was 8 µg/mL in the microdilution 
test, and molecular analysis did not detect the presence of vanA or vanB genes. Strain Mu50, 
recovered from this patient, represents the first strain of S. aureus to demonstrate this level 
of resistance to vancomycin (Hiramatsu, 1997). 
The first report of vancomycin resistance in the U.S. was described by Sievert et al. (2002). 
The patient was treated with several courses of antibiotics including vancomycin and 
subsequently developed MRSA bacteremia due to a hemodialysis catheter. He received 
vancomycin, rifampin and required removal of this catheter. The cultures of the catheter 
revealed the presence of S. aureus resistant to oxacillin and vancomycin. After one week, 
VRSA and vancomycin-resistant Enterococcus (VRE) were isolated. Cultures did not 
recovered VRSA from the patient being treated with trimethoprim/sulfamethoxazole, 
successfully. Molecular analysis revealed the presence of the vanA gene from enterococci, 
which explains the resistance to glycopeptides, and mecA (Sievert et al., 2002). 
Cases of S. aureus with intermediate resistance to vancomycin (VISA) in addition to 
presenting heteroresistance are increasingly common in health centers where MRSA 
infections are treated with vancomycin (Trakulsomboon et al., 2001; Van Duijkeren et al., 
2005; Kim et al., 2000). 
Kim et al. (2000) observed that the vancomycin-resistant strains showed changes in the cell 
wall due to selective pressure caused by prolonged use of vancomycin in the treatment of 
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infections caused by MRSA. On the other hand, in vitro gene transfer of vanA resistance was 
observed from vancomycin-resistant Enterococcus strains to S. aureus (Sievert et al., 2002). 
The detection of resistance is a matter of controversy. Some authors Defend the idea that the 
disk diffusion method may not be effective in detecting resistance to glycopeptides, 
particularly vancomycin (Kim et al., 2000; Walsh et al., 2001). 
In San Francisco, USA, a patient with subsequent complications was initially diagnosed with 
MRSA susceptible to trimethoprim-sulfamethoxazole. A more accurate survey was 
conducted showing that the strain belonged to the PFGE USA 300-0114 of community origin 
and had intermediate resistance to vancomycin. This strain is closely related to infections of 
skin and soft tissues as well as lung disease. Surveillance in the United States in San 
Francisco shows an explosive increase of infections by USA300 CA-MRSA, can also replace 
other strains (Graber et al., 2007). 
12. Resistance in Staphylococcus spp. 
Coagulase-negative staphylococci (CoNS) are part of the microbiota of the skin, most often 
presenting a benign relationship with the host. However, they are the major opportunistic 
pathogens of immunocompromised patients in hospitals (Bisno & Stevens, 1996; Cunha et 
al., 2004). Important infectious processes related to CoNS have been reported in recent 
decades. They are commonly isolated from blood cultures of patients undergoing invasive 
procedures such as prostheses, catheters, organ transplants, as well as from premature 
infants (Cunha et al., 2004). 
The main species of CoNS that are involved in infections in humans are S. epidermidis (may 
cause bacteremia, osteomyelitis, peritonitis, surgical site infections, infections due to the 
installation of catheters and prostheses, endophthalmitis, etc.), S. haemolyticus (urinary tract 
infection, peritonitis, injuries, etc.) and S. saprophyticus (urinary tract infection and 
septicemia) (Cunha et al., 2004). Specifically regarded to the occurrence of bacteremia in 
hospitals, the species S. epidermidis was found to be the etiologic agent in 80% of cases 
(Gongora-Rubio et al., 1997). 
Resistance to methicillin in species of CoNS (MRSCoN) colonizing healthy individuals can 
overcome MRSA in the same population as demonstrated by a Japanese study (Hisato et 
al., 2005). Analysis of 818 children revealed that 35 (4.3%) carried MRSA, while 231 
(28.2%) MRSCoN. The fact that MRSCoN strains are prevalent in the community suggests 
that they are important reservoirs of SCCmec that can be carried to strains of S. aureus 
(Hisato et al., 2005). 
Strains of vancomycin-resistant CoNS are common in hospitals due to this antibiotics’ 
selective pressure in this environment, but few studies have been published on this 
community. A surveillance study assessed the cultures of saliva collected from employees of 
a private school and 37 hospital staff. The identification of specimens recovered from 
samples revealed that 98.5% were carriers of Staphylococcus spp. and 76.5% were carriers of 
more than one Staphylococcus spp. species. Four strains were resistant to vancomycin 
according to phenotypic tests isolated from two school officials and two hospital employees, 
and two identified as S. capitis and the other two as S. haemolyticus and S. epidermidis. All 
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vanA, vanB and vanC. The samples relating to employees of the hospital were also resistant 
to other classes of antimicrobials (Palazzo et al., 2005). 
MRSCoN may be involved in severe infections and present different resistances, as well as 
virulence factors able to offer health risks of individuals with impaired immune systems or 
in development as in the case of neonates. Despite its great importance in critically ill 
patients, its presence in healthy individuals deserves special attention mainly because they 
are both sources of genes for virulence and resistance. 
13. Future prospects 
The emergence of S. aureus resistant to methicillin in the community as the main agent of 
serious infections of skin and soft tissue is disturbing since oxacillin would be the drug of 
choice to treat infections caused by strains resistant to other antibiotics. Several techniques 
can be used to detect resistance to oxacillin, but PCR is the safest and most effective. In 
addition to PCR, other techniques allow genetic characterization of CA-MRSA detailing an 
arsenal of toxins and differentiation of clones involved in outbreaks. These techniques help 
epidemiologist determine correct measures in controlling the spread of this pathogen. 
Studies in Epidemiology associated with molecular studies represent good tools for 
understand the distribution and inform treatment success. The detection of antimicrobial 
resistance in strains from patients living in the community reveals that the alternatives 
available to the medical community for successful treatment are decreasing gradually, thus, 
presenting an opportunity to research new drugs, and antimicrobial agents considered older 
and well established such as trimethoprim/sulfamethoxazole, which is re-emerging as an 
option for treating infections caused by CA-MRSA. 
The presence of CA-MRSA strains involved in nosocomial infection implies the need for 
greater control of its spread among hospitalized patients, since the reports of strains of 
community origin suggest they are also more virulent compared to strains of nosocomial 
origin, and may lead to serious complications of rapid evolution. Treatment strategies that 
may delay or prevent the expression of these factors will need to be established, as well as 
administering the correct treatment quickly and effectively. 
14. Conclusion 
The presence of resistant strains in the community, especially S. aureus, poses a risk to public 
health since the treatment may fail, delaying the elimination of pathogens involved in these 
infections. This delay can result in serious complications leading to early death of the 
patient. New treatment alternatives and the rediscovery of antimicrobials that are no longer 
being used provide to the medical community a new opportunity for successful treatment. 
In addition to antimicrobial resistance, community strains have become more virulent, 
which provides another challenge to the attending physician to choose the best treatment 
strategy possible. Attention should also be directed to CoNS strains resistant to methicillin, 
which can serve as reservoirs of resistance genes S. aureus that are more virulent. The 
detections of virulence factors and antimicrobial additional resistance can be truly 
challenging and lead to treatment failure if it is not detected quickly. Fortunately there are 
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far as the patient is attended. But to reach the 100% of the treatment success it will need 
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1. Introduction 
Until the 1990s, methicillin-resistant Staphylococcus aureus (MRSA) was traditionally 
considered a pathogen causing nosocomial infections, being the so-called HA-MRSA 
(healthcare-associated methicillin-resistant Staphylococcus aureus). However, over time, cases 
of MRSA-positive individuals were observed who never had contact with hospital services, 
and strains from these individuals were identified and named CA-MRSA (community-
associated methicillin-resistant Staphylococcus aureus). In 2003 in the Netherlands, a new 
MRSA strain arose in patients that could not be typed through PFGE (pulsed field gel 
electrophoresis) with SmaI, with resistance to digestion by this enzyme (Bens et al., 2006), 
being called since then NT-MRSA (non typeable methicillin-resistant Staphylococcus aureus). 
Investigations of this NT-MRSA intensified, and it was observed that these patients carrying 
this strain had previous contact with pigs and the geographic distribution of cases showed 
clusters near pig farms (van Loo et al., 2007). With more advanced studies, it was possible to 
determine strains strictly related to animals, such as those found in pigs, which were named 
LA-MRSA (livestock-associated methicillin-resistant Staphylococcus aureus) in 2010 
(Vanderhaeghen et al., 2010). 
The resistance to methicillin in staphylococci is mediated by the mecA gene that encodes a 
modified penicillin-binding protein (PBP), the PBP2a or 2’, which shows reduced affinity 
to the resistant penicillins to penicillinase, such as methicillin and oxacillin and for all 
other beta-lactam antibiotics (van Duijkeren et al., 2004). Due to the need for better 
characterizing these isolates, they have been classified in a more detailed manner, 
beginning with the SCCmec types and patterns identified by PFGE, and are currently 
based on sequence type and spa typing. With the use of techniques such as MLST (multi 
locus sequence typing) and spa typing, characteristic clones from animals have been 
observed, and it is suspected that some have tropism by determined host species. An 
example of this is ST398, which in addition to being strictly linked to pigs, has carried 
novel types of SCCmec. Li et al. (2011) analyzed the SCCmec element structure carried by 
31 CC398 MRSA strains isolated from participants of a conference. The strains were 
classified into novel types, IX and X, type V (5C2&5) subtype c and type IVa, all carriers of 
genes conferring resistance to metals. The SCCmec structures from CC398 strains were 
distinct from those usually found in humans, complementing evidence that humans are 
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genes conferring resistance to metals. The SCCmec structures from CC398 strains were 
distinct from those usually found in humans, complementing evidence that humans are 





for carrying this strain as much in animals as in humans, Graveland et al. (2010) carried 
out the first study that showed direct association between animal and human carriage of 
ST398. This association, in addition to the association between MRSA and the 
antimicrobial use in calves, highlights the need for prudent use of antibiotics in farm 
animals. 
One clone of special interest in ruminants is the CC133. The great majority of isolates from 
small ruminants is represented by this clonal complex of S. aureus, but its evolutionary 
origin and molecular basis for its host tropism remain unknown. Guinane et al. (2010), 
attempting to determine whether the CC133 developed as result of a transmission from 
human host to ruminant followed by an adaptative diversification of the genome, carried 
out a comparative sequencing of the complete genome. Several novel mobile genetic 
elements were observed in the CC133 isolates encoding virulence proteins with attenuated 
or enhanced activity and they were widely distributed, suggesting a key role in their host-
specific interaction. These data provide broad and new insights into the origin and basis 
molecular of S. aureus ruminant host specificity. The MRSA evolution and epidemiology in 
animals are discussed in this chapter. 
2. History of MRSA in animals 
The first report of MRSA in animals was in milk from Belgium cows with mastitis (Morgan, 
2008). Until 2000, MRSA had been isolated sporadically from animals, in particular cows, 
small companion animals, and horses. With exception of some equine isolates, the nature of 
these cases suggested a human origin and no epidemics have been reported. In this respect, 
until the end of 20th century, both the scientific community and policy makers were 
convinced that animal husbandry was of little relevance for MRSA causing diseases in 
humans, but was particularly a problem based on antimicrobial use in human medicine. The 
situation has changed with a growing number of reports of MRSA in livestock, especially 
pigs and veal calves. MRSA has also been reported in companion animals and horses, as 
well as transmission between humans and animals (Catry et al., 2010). Calling attention to 
this dramatic increase of MRSA in animals, van Duijkeren et al. (2010) at the Veterinary 
Microbiological Diagnostic Center, in the Netherlands, reported 0% MRSA in isolates from 
equine clinical samples in 2002 and then 37% in 2008. 
3. The importance of the different animal species 
Various species have been identified as host and carriers of MRSA in different countries and 
settings, including dogs, cats, sheep, chickens, horses, pigs, rabbits, seals, psittacine birds, 
and one turtle, bat, guinea pig and chinchilla (Morgan, 2008). With differences between 
strains isolated from pets, wild animals and cattle, it is important to evaluate each species 
individually, because they present peculiar characteristics, including the series of resistance 
genes. Thus, the concern for MRSA types in animals has grown considering their role as a 
potential reservoir or vector for human infection by MRSA in the community. However the 
data available on MRSA transmission between humans and companion animals are limited, 
and further epidemiological studies are needed on this transmission and its impact on 
public health (Loeffler & Lloyd, 2010). 
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3.1 Companion animals 
Pets have been shown to act as reservoirs of bacteria resistant to antimicrobials, and MRSA 
transmission between humans and animals has been described. For strains of MRSA with a 
low specificity to the host, the transference is likely to occur in both directions between 
humans and pets living at the same household (Nienhoff et al., 2009). The infections by 
MRSA in companion animals are predominantly of skin and soft tissues, especially during 
post-surgical (Morgan, 2008).  
Nienhoff et al. (2009) reported two cases of transmission of MRSA strains between humans 
and dogs. Three positive dogs to MRSA were identified in a survey carried out in 803 dogs 
and 117 cats admitted to the Small Animal Clinic of the University of Veterinary Medicine 
Hannover, Germany. The first case was a 6-month-old female admitted to the clinic for teeth 
extraction. The owner, MRSA-positive, was a specialist veterinarian in swine diseases, 
working in pig barns 4-5 days per week and having access to MRSA ST398-positive farms. 
The dog and owner strains were identical through molecular typing, belonging to ST398 and 
spa type t034. The second case was an 11-year-old male admitted to the clinic because of a 
cardiac problem. The likely origin of the strain was the mother-in-law of the dog’s owner, 
who is diabetic, having received nursing care at home and presenting an infected wound on 
the foot and an ulcer in the right eye. The MRSA isolates found in these lesions and in the 
dog belonged to ST225, which is frequently found in humans. 
3.2 Cattle 
Cows with mastitis have been the most likely to harbor MRSA, and they may be related to 
horizontal transfer via wet hands of colonized or infected dairy farm workers, and selection 
by the use of antibiotics to treat mastitis (Morgan, 2008). The first known case of MRSA 
transmission between cows and a person was reported by Juhász-Kaszanyitzky et al. (2007). 
MRSA strains isolated from cows with subclinical mastitis were phenotypically and 
genotypically indistinguishable from the strain from the person who worked with these 
animals. These strains were determined as ST1, spa type t127, SCCmecIVa. The authors 
considered these strains epidemiologically related, indicating transmission from cow to 
human or from human to cow. 
Feβler et al. (2010) studied 25 MRSA ST398 isolates from cases of bovine clinical mastitis and 
two isolates from farm workers originating from 17 dairy farms in Germany, evaluating the 
genetic relatedness, antimicrobial resistance and virulence properties. Nine major ApaI 
PFGE patterns were found, three spa types (t011, t034 and t2576) and two types of SCCmec 
(IV and V) were identified. As described previously for ST398 from pigs, isolates from this 
sequence type originating in cases of bovine mastitis have also shown a high degree of 
variability when the ApaI PFGE profile and other genotypic and phenotypic characteristics 
were compared. A uniform pattern of virulence genes appeared to be conserved between 
ST398 isolated from both animal species. 
Türkyιlmaz et al. (2010) detected 14 of 16 strains from bovine milk of the lineage MRSA ST-
239-III in which one was related to hospital-associated clones, and two strains were ST8/IV, 
which correspond to USA300, which causes severe community-acquired infections. The 
presence of MRSA ST239-III lineage can indicate a transmission from humans to animals, 
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3.1 Companion animals 
Pets have been shown to act as reservoirs of bacteria resistant to antimicrobials, and MRSA 
transmission between humans and animals has been described. For strains of MRSA with a 
low specificity to the host, the transference is likely to occur in both directions between 
humans and pets living at the same household (Nienhoff et al., 2009). The infections by 
MRSA in companion animals are predominantly of skin and soft tissues, especially during 
post-surgical (Morgan, 2008).  
Nienhoff et al. (2009) reported two cases of transmission of MRSA strains between humans 
and dogs. Three positive dogs to MRSA were identified in a survey carried out in 803 dogs 
and 117 cats admitted to the Small Animal Clinic of the University of Veterinary Medicine 
Hannover, Germany. The first case was a 6-month-old female admitted to the clinic for teeth 
extraction. The owner, MRSA-positive, was a specialist veterinarian in swine diseases, 
working in pig barns 4-5 days per week and having access to MRSA ST398-positive farms. 
The dog and owner strains were identical through molecular typing, belonging to ST398 and 
spa type t034. The second case was an 11-year-old male admitted to the clinic because of a 
cardiac problem. The likely origin of the strain was the mother-in-law of the dog’s owner, 
who is diabetic, having received nursing care at home and presenting an infected wound on 
the foot and an ulcer in the right eye. The MRSA isolates found in these lesions and in the 
dog belonged to ST225, which is frequently found in humans. 
3.2 Cattle 
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by the use of antibiotics to treat mastitis (Morgan, 2008). The first known case of MRSA 
transmission between cows and a person was reported by Juhász-Kaszanyitzky et al. (2007). 
MRSA strains isolated from cows with subclinical mastitis were phenotypically and 
genotypically indistinguishable from the strain from the person who worked with these 
animals. These strains were determined as ST1, spa type t127, SCCmecIVa. The authors 
considered these strains epidemiologically related, indicating transmission from cow to 
human or from human to cow. 
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two isolates from farm workers originating from 17 dairy farms in Germany, evaluating the 
genetic relatedness, antimicrobial resistance and virulence properties. Nine major ApaI 
PFGE patterns were found, three spa types (t011, t034 and t2576) and two types of SCCmec 
(IV and V) were identified. As described previously for ST398 from pigs, isolates from this 
sequence type originating in cases of bovine mastitis have also shown a high degree of 
variability when the ApaI PFGE profile and other genotypic and phenotypic characteristics 
were compared. A uniform pattern of virulence genes appeared to be conserved between 
ST398 isolated from both animal species. 
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239-III in which one was related to hospital-associated clones, and two strains were ST8/IV, 
which correspond to USA300, which causes severe community-acquired infections. The 
presence of MRSA ST239-III lineage can indicate a transmission from humans to animals, 





region in Turkey. This study underscores the necessity to take measures to avoid MRSA 
transmission between humans and animals. 
3.3 Horses 
In horses, MRSA have been reported in infections of skin and soft tissues, bacteraemia, 
septic arthritis, osteomyelitis, implant-related infections, metritis, omphalitis, catheter-
related infections and pneumonia. The first MRSA outbreak in horses was observed in 1993, 
with 11 infected horses in the post-surgical in a veterinary teaching hospital in Michigan. 
Subsequent outbreaks have occurred on Japan, Austria, the UK, Ireland, Canada, and other 
areas of the USA (Morgan, 2008). 
In 2009, Loeffler et al. reported the first isolation of MRSA ST398 spa type t011 in animals 
from the UK. They were two horses in southeastern England, with isolates with identical 
phenotypic and genotypic characteristics as reported in horses in Belgium, Austria and 
Germany, which also carried the SCCmec type IVa. They vary from those commonly found 
in pigs (spa type t108, t034 or t571) and frequently carry SCCmec V, possibly indicating host-
specific variation within this lineage or independent evolution. One interesting fact is that 
isolates from pigs and horses commonly show resistance to tetracycline and/or gentamicin, 
both agents frequently used in pigs and horses, respectively. These findings demonstrate the 
introduction of ST398 in England and provide more evidence of successful dissemination of 
this zoonotic pathogen in the animal reservoir. The authors recommended vigilance for 
MRSA ST398 in both animals and humans. 
Outbreaks of MRSA were observed in horses and horse personnel in the Netherlands in the 
period of 2006-2008. The isolates belonged to ST8, spa type t064, and to ST398, spa types t011 
and t2123, predominantly. During the outbreak of post-surgical infections by MRSA in horses 
in a veterinary teaching hospital, isolates from spa type t2123 were isolated from 7 horses, and 
4 of 61 personnel indicating a zoonotic transmission; after intervention, the outbreak stopped. 
In another outbreak that occurred in 2008, 17 horses with MRSA were detected, with 12 spa 
type t011, 4 spa type t2123 and 1 spa type t064. From 170 personnel, 16 were positive for MRSA, 
with 11 spa type t011 and 5 spa type t2123. From 106 personnel who maintained close contact 
with horses, 15 were MRSA-positive compared with 1 MRSA-positive of 64 personnel who 
had no close contact with the animals. Furthermore, screening carried out on the horses on 
admission showed that 9.3% were MRSA-positive, predominantly spa-type t011. Weekly cross-
sectional sampling from all horses hospitalized for 5 weeks demonstrated that 42% were 
MRSA-positive at least once, again predominantly with spa type t011, which suggests that a 
nosocomial transmission appeared. The research of environmental samples from veterinary 
hospital revealed the presence of 53% of MRSA, including samples from students and staff 
member rooms, all spa type t011, indicating that humans contribute to the microorganism 
dissemination. The samples cultured employing pre-enrichment with high-salt concentration 
presented better results than the method without pre-enrichment. These results demonstrate 
that the nosocomial transmission in equine clinics occurs and suggest that personnel play a 
role in the transmission (van Duijkeren et al., 2010). 
3.4 Poultry 
The first reports of MRSA in chicken meat occurred in Korea in 2003 (Lee, 2003) and Japan 
in 2005 (Kitai et al., 2005), but it was not determined as livestock-associated, raising the 
hypothesis of meat contamination with human strains through handlers. 
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LA-MRSA was reported primarily in health poultry in 2008 in Belgium, with ten recent 
isolates classified as ST398 spa types t011 and t567. In this study, strains isolated in 1970s 
and strains isolated recently in 2006 were evaluated. It was observed that from 12 
antimicrobial agents tested, eight presented percentage of resistance significantly higher in 
the recent isolates (Nemati et al., 2008). 
Persoons et al. (2009) evaluated samples from 50 laying hens and 75 broiler chickens in 
Belgium. MRSA was found in 8 broiler chickens from 2 of 14 farms sampled, belonging to 
ST398 spa type t1456. According to the author, it still remains unclear as to whether this 
strain is associated with poultry. 
3.5 Pigs 
Mounting evidence suggests that livestock, particularly pigs, can represent an important 
reservoir of CA-MRSA (community-associated – CA) strains that can colonize and infect 
humans in close contact with them. ST398 is the most commonly reported MRSA sequence 
type among large livestock in Europe. These strains frequently carry genes encoding for 
non-beta-lactam antimicrobial resistance, including a plasmid-borne gene with resistance to 
trimetoprim, dfrK, identified in an isolate from a pig from Germany. Furthermore, these 
isolates are referred to often as nontypeable by PFGE because their genome is not digested 
by SmaI enzymes, several common spa types have been associated with them, carrying 
SCCmec types IV and V and they typically lack PVL genes (David & Daum, 2010). 
In 2008, with the aim of evaluating whether other professionals in contact with pigs, in 
addition to farmers and veterinarians, have a higher risk of carrying MRSA than the 
population in general, a study was carried out with 272 participants of a conference on 
swine health in Denmark. In total, 34 (12.5%) participants from 9 countries carried MRSA, 
being that 31 isolates were not typeable by PFGE with SmaI. They belonged to ST398, spa 
types t011, t034, t108, t571, t567 and t899. The MRSA transmission from pigs to staff 
demonstrated to be an international problem, creating a new reservoir for a strain that was 
still considered CA-MRSA (Wulf et al., 2008). 
Horgan et al. (2010) evaluated the prevalence of MRSA in the swine population in Ireland. A 
total of 440 pigs were evaluated from 41 geographically distributed farms and 100 
individuals involved in the pig industry. No MRSA isolate was recovered from pigs  but 
two humans tested were identified as MRSA carriers. These individuals were working in the 
wider pig industry. These isolates belonged to ST22 and ST1307, indicating that during the 
period of study the porcine colonization by MRSA, in particular the animal-related strain 
ST398, was not common in Ireland. 
Wagenaar et al. (2009) published the first report of MRSA on pig farms in China, and it was 
the first time that MRSA ST9 in 4 pig farms and one single locus variant of MLST ST9 
(ST1376) were detected in a pig farm. This study shows that LA-MRSA is not restricted to 
the clonal lineage ST398 found in Europe and North America in commercial pigs, but that 
other MRSA lineages are able to spread in the livestock in the same manner, also confirming 
that livestock can act as a reservoir of MRSA. 
Despite that LA-MRSA appears be the predominant MRSA strain in pigs, some studies 
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human strains to the animals. In Singapore, ST22-MRSA-IV was isolated from pigs and this 
strain was previously found increasingly important in the hospital population there. 
Notably the ST22-MRSA-IV is also a major hospital clone, as is the UK-EMRSA-15 found in 
the UK, with both strains indicating a contamination of human origin. In Canada, 14% of 
MRSA isolated from pigs appeared to belong to the human epidemic clone CMRSA-2 
(Canadian epidemic MRSA-2, known as USA100), while 74.4% of isolates were LA-MRSA. 
The remaining strains belonged to rare clones, not related to LA-MRSA or CMRSA-2. Most 
reports on LA-MRSA in pigs originate from the Netherlands. In Europe, LA-MRSA has also 
been found in pigs in Germany, Denmark and Belgium, and beyond Europe, in Canada, 
Singapore and the USA (Vanderhaeghen et al., 2010). 
3.6 Products of animal origin 
Besides the importance of living animals as a source of MRSA, animal origin products also 
play a role in disseminating these strains to the humans. Lozano et al. (2009) detected MRSA 
ST398 in food samples in Spain. A total of 318 samples of raw food were evaluated from 
food-producing animals (148 from chicken, 55 from pork, 46 from veal, 19 from lamb, 10 
from turkey, 8 from rabbit and 12 minced-meat samples) and of wild animals (8 game birds, 4 
wild boar, 4 deer and 4 hare samples). MRSA was detected in 5 of 318 (1.6%) food samples 
(pork, chicken, rabbit, veal and wild boar). The two strains from pork and veal 
corresponded to ST398-SCCmecV clone (spa types t011 and t1197, respectively), the two 
strains from chicken and rabbit were typed as ST125-SCCmecIVa-t067, and the strain from 
one wild boar was ST217-SCCmecIVa-t032, with all the MRSA being PVL negative. The 
characteristics of these strains suggest that they can be of both animal and human origin, 
and although the presence of MRSA in food is low, it must be monitored, because it can 
contribute to its dissemination. 
Recently, Weese et al. (2011) evaluated the presence of MRSA in feedlot cattle, close to the 
time of slaughter, in nasal and rectal fecal samples. It was not possible to detect MRSA in 
these animals, in contrast to recent studies on retail beef (Weese et al., 2010), demonstrating 
the need for more studies of livestock, as well as farms, processing and retail environments 
to elucidate the epidemiology of contamination with MRSA in meat. 
4. MRSA as zoonosis or humanosis 
Several studies have been done to determine the degree to which MRSA plays a role in 
zoonosis or humanosis. It has been observed that usually the strains originating from 
companion animals are originally human strains, and that the infection with this MRSA type 
is considered humanosis. On the other hand, the strains orginating from livestock (livestock-
associated - LA) are often divergent from human strains and the infection with this type of 
LA-MRSA could be considered zoonosis, and in this case MRSA would be an emergent 
zoonotic agent. Within this context, veterinarians, cattle farmers and pet owners are 
considered risk groups for acquiring MRSA (Morgan, 2008). 
In 2011, a case of empyema was reported in a 79-year-old man in Spain with isolation of 
MRSA ST398 in purulent exudates from the thorax and trachea and nasal swabs. The  
ineffective initial therapy with levofloxacin was modified to intravenous linezolid, but the 
clinical situation of the patient rapidly deteriorated, and he died of multiorgan failure. The 
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three MRSA strains were typed as ST398, spa-type t011, SCCmec V and agrI and presented 
the same phenotypic resistance, including β-lactam, tetracycline, clindamycin (but not 
erythromycin), ciprofloxacin and levofloxacin. It is important to point out that the patient 
lived with his wife and two sons near a pig farm. Both sons worked on the farm. The 
patient, but not his wife, sporadically helped on the farm. Nasal samples from three family 
members indicated MRSA carriage in one son. The characteristics of this isolate were 
identical to the isolate from the patient. Furthermore, nasal swabs of 18 pigs from the farm 
were randomly collected, and MRSA isolates were detected in 9 (50%) pigs. One MRSA 
isolated in each animal was minutely characterized. Eight isolates were typed as ST 
398/t011/SCCmec V/agrI and one remaining isolate as ST398/t1451/SCCmec V/agrI. All 
MRSA isolated from the animals had the same phenotypic and genotypic resistance 
comparing MRSA isolated from the patient and son. These findings indicate potential pig-
human zoonosis transmission of MRSA ST398 and that this clone can be associated with 
severe respiratory pathology in immunocompromised patients, and this microorganism can 
also be resistant to other first-line antimicrobial agents, such as fluoroquinolones, used to 
treat these infections. Furthermore, the unusual clindamycin-resistance/erythromycin-
susceptibility phenotype can be a key marker (in addition to tetracycline resistance) of the 
possible presence of livestock-associated MRSA (Lozano et al., 2011). 
As seen in the reports, animal reservoirs for MRSA are becoming recognized worldwide 
with increasing awareness of MRSA ST398 colonizing pig and veal farmers, and attending 
veterinarians, at high rates. In The Netherlands, these groups are now considered high risk, 
and if admitted to a hospital, they are immediately conducted to isolation, screening for 
MRSA and decolonization (Loeffler et al., 2009). 
MRSA isolates originating from animals have been shown to hold important genes  
of resistance which could be transferred to less pathogenic human strains, but well adapted, 
in a nasal co-colonization and resulting in new human lineages, for example (Springer et  
al., 2009). The gene czrC, which confers resistance to cadmium and zinc, was determined  
in isolates of MRSA CC398 of SCCmec type V originating from 23 (74%) pigs and 24  
(48%) humans from Denmark. It is suggested that resistance to heavy metals can play a  
role in coselection of MRSA, because it was strongly related to the clone CC398 (Cavaco et 
al., 2010). 
In lineages MRSA ST398 and MSSA ST9 isolated from pigs in Germany, the major reservoir 
of these lineages, the gene cfr was found, a gene of multi-resistance to the drugs 
phenicol/lincosamine/oxazolidinone/pleuromutilin/streptogramin A. The risk of its 
transference to humans with exposure to pig farms is of concern since these lineages can 
colonize and cause infections in humans (Kehrenberg et al., 2009). 
Genes encoding virulence factors can also be carried by animal strains. An example is the 
PVL gene, encoding an important virulence factor related to MRSA, rarely reported in 
animals, but can be found in companion animals. PVL-positive CA-MRSA has been 
reported in cats, dogs, rabbits, birds, bats, turtles, pigs and cattle. The strains associated with 
pigs that have been rapidly disseminating are currently PVL-negative (Morgan, 2008). 
As for animal origin food, meats of several animal species have been evaluated for detection 
of MRSA. The contamination has been reported in meats of turkey, chicken, veal, pork, beef 
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number of non typeable MRSA in patients, the role of food products in disseminating MRSA 
seems to have been overlooked (Morgan, 2008). 
5. MRSA detection in animals 
Animal studies of MRSA are limited by certain research bottlenecks compared to human 
studies, including a lack of standardization regarding culture methodology, susceptibility 
testing, definition of genetic profile and sampling methods, which ultimately renders 
comparison difficult. A mass animal screening is logistically difficult, expensive, and 
impractical in many situations. Moreover, physical challenges exist: for example, carrying 
out a nasal swab in cats is only possible with appropriate animal restraints (Morgan, 2008). 
Despite these drawbacks, several studies have been carried out, as more detailed studies of 
epidemiological aspects of animal MRSA are indispensable, primarily in food-producing 
animals of particular concern. These animals are not only reported as the primary source of 
a recently emergent new type of MRSA, LA-MRSA, but studies also suggest that they are 
involved in transmission of other strains of MRSA between animals and humans 
(Vanderhaeghen et al., 2010). MRSA screening must be performed in all diagnostic 
laboratories, even if done through disk diffusion with oxacillin, which is better than 
methicillin related to the resistance to degradation and the detection of heteroresistant 
strains (Weese et al., 2004). 
MRSA detection in animals has been performed, generally, with isolation from samples 
from nasal and oral mucosae and perineum in small animals (Loeffler et al., 2005; Nienhoff 
et al., 2009), samples from milk in cows (Kwon et al., 2005), samples from nasal, oral and/or 
perineal swab, in pigs and horses (Baptiste et al., 2005; Voss et al., 2005; Huijsdens et al., 
2006), samples from nose and cloacae in poultries (Nemati et al., 2008) and samples from 
meats (Lozano et al., 2009). 
The samples were pre-enriched in different selective mediums with the aim of increasing the 
sensitivity of the culture technique. Lozano et al. (2009), to detect MRSA in meat, pre-enriched 
the samples in BHI broth (brain heart infusion) containing 6.5% of sodium chloride at 35°C for 
24 h. An aliquot of each growth was seeded on ORSAB plates (oxacillin resistance screening 
agar base) with oxacillin (2mg/L) and incubated at 35°C for 36 h. Van Duijkeren et al. (2010) 
compared two methods of culture technique; the first was Müeller Hinton Broth containing 
6.5% sodium chloride, which after overnight incubation at 37°C, was transferred to phenol red 
mannitol broth with 5µg/ml of ceftizoxime and 75µg/ml of aztreonam and after overnight 
incubation at 37°C was plated onto sheep blood agar and brilliance MRSA agar. In the second 
method, Tryptone Soy Broth was used containing 4% sodium chloride, 1% mannitol, 16µg/ml 
of phenol red, 50µg/ml of aztreonam and 5µg/ml ceftizoxime, plating onto sheep blood agar 
and MRSA brilliance agar after 48 hours of incubation at 37°C. The first method, with the pre-
enrichment containing higher salt concentration, presented better results. Weese et al. (2011) 
used as pre-enrichment a broth containing tryptone, sodium chloride, mannitol, yeast extract 
and incubated at 35°C for 24 h to evaluate MRSA presence in feedlot cattle, as well the nose 
samples as feces. An aliquot of the growth was inoculated onto MRSA Chromogenic agar and 
incubated at 35°C for 48 hours. 
Many methodologies have been employed to identify and characterize strains, ranging from 
phenotypic to genotypic. Both present advantages and disadvantages and must be 
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performed in accordance with the need of the study and the material and personnel 
available in each laboratory. Relative speed and the reliability are the desirable 
characteristics in both methods, because the choice of treatment and infection control 
measures are determined by the results of such testing (Kaya et al., 2009). Phenotypic 
methods at first are more accessible and nearly always cheaper; however they depend on 
the characteristic expression and visualization that cannot occur or be reduced, as for 
example, by environmental influences and/or regulatory genes (Berger-Bächi, 2002; 
Mohanasoundaram & Lalitha, 2008). 
Methicillin-resistant S. aureus can be identified through different genotypic methods, such as 
species-specific primers for detection of DNA fragment of S. aureus-specific (van Duijkeren 
et al., 2010, as cited in Martineau et al., 1998) and with gene mecA (Murakami et al., 1991) by 
PCR (polymerase chain reaction), or the detection of DNA fragment of S. aureus-specific and 
gene mecA by multiplex PCR (Huijsdens et al., 2006), for example. 
To determine the MRSA clones involved, in the beginning of 1990s the pulsed-field gel 
electrophoresis (PFGE) of genomic SmaI macrorestriction fragments were introduced and 
still represents the gold standard with respect to discriminatory power. The clonal groups 
determined by cluster analysis through PFGE are largely congruent with those defined by 
MLST. However, with the presence of some lineages of special interest (for example ST398) 
that are non typeable by the standard restriction enzyme SmaI, other methods have been 
used (Cuny et al., 2010). 
As observed in the majority of studies discussed in this chapter, from genotypic methods for 
classification of predominant strains and determination of evolutionary pathways, MLST 
and spa typing have been the most widely employed: the first because it is an unambiguous 
discriminatory method for studying MRSA epidemiology and evolution, with results that 
can be truly portable between laboratories (Enright, 2003) and the second method to indicate 
genetic microvariation permitting investigation of outbreaks or accomplishment of 
phylogenetic analysis (Koreen et al., 2004). MLST characterize bacteria isolates 
unambiguously using the sequences of internal fragments of seven “housekeeping” genes, 
being a discriminatory method which permits that related strains recovered from different 
countries be quickly identified (Enright et al., 2002). The spa type identified by DNA 
sequence analysis of the X region of the protein A gene (spa) is less expensive, time-
consuming, and error prone than multilocus techniques, such as MLST (Shopsin et al., 1999; 
Koreen et al., 2004). 
The classification by MLST permits that the genomes of strains deposited in the GenBank 
database to be compared to establish their evolution and characteristic features. Comparing 
the genome of CA-MRSA and HA-MRSA from the same clonal lineage as well as their most 
probable MSSA ancestor, about 78% of the genes are conserved, and the remaining 22% 
comprise an “accessory genome” including genomic islands, pathogenicity islands, 
prophages, integrated plasmids, and transposons. However, comparing the S. aureus 
genome from cattle mastitis (ST151) with human S. aureus, it has been demonstrated that 
this bovine clone probably evolved from a common ancestor by acquiring foreign DNA. 
Subsequent microarray studies on recent epidemic strains of bovine origin (such as ST97) 
also revealed the presence of mobile genetic elements absent from S. aureus of human origin. 
Even with these impressive insights into the evolution of S. aureus, research has not yet 
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are available (Cuny et al., 2010). In this respect, further research is needed to address these 
gaps, as well as to better understand the evolution of these strains in humans and animals. 
6. MRSA prevention and control in animals 
All studies on animal MRSA have helped establish critical measures for its control. 
Numerous reports on MRSA control in humans have been published and many of the 
principles may also be applied to control in animals. However, caution is necessary for 
extrapolating these human guidelines to animals, as disease epidemiology can differ 
significantly (Leonard & Markey, 2008). 
It has been observed that exposure to antimicrobials is a risk factor for the acquisition and 
dissemination of MRSA in humans and also most probably in animals. In this respect, 
strategies for prevention and management of MRSA in animals should be, as much as 
possible, related to the use of antimicrobials. If the antimicrobial treatment is necessary in 
individual cases for the sake of animal welfare, the risk of the emergence of wider resistance 
in MRSA strains colonizing animals needs to be managed, especially considering zoonotic 
aspects. Options to manage this risk include the non-use of antimicrobials except as a last 
resort strategy, decolonization in humans, isolation of animals during treatment, and 
monitoring the effects of treatment in strain resistance through selective culture and 
susceptibility tests (CATRY et al., 2010). 
6.1 General preventive and control measures 
Good hygiene is an important general preventive and control measure, both in homes and 
human and animal healthcare environments, because environmental contamination with 
MRSA acts as a reservoir for infection. Known MRSA-positive animals should be nursed 
apart from other animals, with strict washing of the hands, gloves and gowns if in close 
contact. Recording the history of contact with human or animal MRSA, as well as an early 
culture of a wound non-responsive to first-line therapy allows for earlier recognition of 
MRSA and its appropriate management. Furthermore, when faced with repeated and 
inexplicable failure of human decolonization, clinicians can investigate nearby exposure to 
animals and birds that could be the reservoirs (Morgan, 2008). 
Below, are some precolonized specific measures cited from (Catry et al., 2010). 
6.1.1 Specific measures for livestock animals 
 Reduction of antimicrobial selective pressure in livestock by avoiding routine mass 
medication 
 Prevention of transmission of MRSA between and within the farms with sanitary 
measures of control between herds and during transportation 
 Identification and isolation of animals to minimize the risk for zoonotic infection 
 Use of contact precautions such as protective outerwear, overalls, aprons or coats and 
boots or overshoes that are not worn elsewhere 
 Protective outerwear and all the items handled during the treatment of MRSA-positive 
animals should be considered potentially contaminated 
 Hands can be hygienically cleaned with alcohol gel pouches, which are essential but 
need to be used correctly 
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 Proper cleaning and disinfection of contaminated environments, including transport 
vehicles.  Special attention should be paid to dust in stables 
 Animal owners should be informed about the risks and necessary precautions. 
6.1.1.1 Reducing carriers on MRSA-positive livestock farms 
Control and/or treatment of colonized and infected animals with or without antimicrobials 
is necessary for the reduction of carriers. 
Th1e affected animals need to be immediately separated from healthy animals. In extreme 
cases culling of infected animals is a further option. Milk of animals with mastitis by MRSA 
must be destroyed, and in some cases the infected quarter must be prematurely dried-off. 
If the antimicrobial treatment is chosen, it is necessary to evaluate its risk-benefit compared 
with other alternatives. The choice of antimicrobials should always be based on a 
susceptibility test, and all precautions should be taken that the drug reaches the infected site 
with appropriate concentrations. 
6.1.2 Specific measures for horses 
The options of control for colonized horses, as well as livestock animals, include the non-
antimicrobial management and the antimicrobial treatment of colonized or infected horses. 
In a Canadian study, two farms with horses colonized by MRSA drastically reduced the 
number of affected animals with active screening and strict implementation of control 
protocols of infection, without the use of antimicrobial therapy. Antimicrobial treatment 
must be applied only if the colonization is persistent or in cases in which control measures 
are impossible. 
Preventive measures for the infected animals are the same for the previously mentioned 
livestock animals. In equine hospitals, MRSA management for veterinary practices, 
guidelines stipulated by the British Small Animal Veterinary Association (BSAVA), for 
example, can also be applicable. In the confirmed or suspected cases of infection by MRSA, 
horses must be isolated and treated as if disseminating a nosocomial and zoonotic agent. It 
is necessary to take precautions with staff hygiene as well, using protective barriers, such as 
gloves, aprons, and boots. Moreover, the entire animal must be evaluated before being 
admitted to the hospital to ensure prevention of MRSA dissemination. 
6.1.3 Specific measures for companion animals 
In colonized animals, it not recommended to decolonize animals having mucosae 
colonization with MRSA. And it is observed that apparently some pets eliminate the 
carriage of MRSA spontaneously if the re-colonization is prevented. Antimicrobial therapy 
is only indicated in exceptionally persistent cases or when control measures are impossible., 
If the infection is local in infected animals, meticulous management of the wound can avoid 
the necessity of antimicrobial use. The risk of resistance development, the susceptibility 
profile of the isolate, the severity of the infection and the presence of systemic disease (fever, 
leukocytosis), and the patient’s underlying disease or any comorbidity must be taken into 
account when choosing the antimicrobial treatment. In deciding to treat or eventually 
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profile of the isolate, the severity of the infection and the presence of systemic disease (fever, 
leukocytosis), and the patient’s underlying disease or any comorbidity must be taken into 
account when choosing the antimicrobial treatment. In deciding to treat or eventually 





Preventive measures include the strict control practices of the infection in homes, 
particularly frequent hand washing hygiene, avoiding high-risk contact to minimize the 
chance of becoming colonized and isolating the animal and other pets. Gloves, masks and 
eye protection must be used to attend patients, as well as planning surgeries to avoid risk 
for infection, removing permanent urinary catheters as soon as possible and preventing 
complications from intravenosous and urinary catheters with appropriate asepsis. 
7. Conclusion 
This paper summarizes a wide range of information and findings from the literature on 
MRSA in animals and humans in contact with them. Notwithstanding, there is enormous 
potential for new research aiming to conclusively address certain unknown questions such 
as, at which point does an infection play the role of a zoonosis or humanosis? This question 
has yet to be answered because several animal species are involved, with distinct 
characteristics of transmission and isolated clones, raising appropriate concern for MRSA in 
animals. 
Steadfast vigilance of MRSA in samples of animal origin in laboratory diagnoses is essential 
for: consistent and thorough monitoring of the evolution and dissemination of these strains; 
elucidating characteristics that determine a predilection for a determined host; determing 
transmission routes; identifying resistance and virulence genes received by these new 
lineages; and distinguishing molecular markers that allow for discriminating between CA-
MRSA, HA-MRSA and LA-MRSA. 
Appropriate and effective measures of control and prevention must be better determined 
and applied to each situation and country, according to previously reported guidelines, 
aiming to minimize risks to humans, since these strains have housed new virulence and 
resistance genes which can be transferred to human strains. Veterinarians play an important 
role in public health, in controlling this pathogen through measures appropriately applied 
in veterinary medicine, namely, the rational use of antimicrobials and appropriate 
management of infected animals, together with other health professionals, for prevention of 
MRSA dissemination. 
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Preventive measures include the strict control practices of the infection in homes, 
particularly frequent hand washing hygiene, avoiding high-risk contact to minimize the 
chance of becoming colonized and isolating the animal and other pets. Gloves, masks and 
eye protection must be used to attend patients, as well as planning surgeries to avoid risk 
for infection, removing permanent urinary catheters as soon as possible and preventing 
complications from intravenosous and urinary catheters with appropriate asepsis. 
7. Conclusion 
This paper summarizes a wide range of information and findings from the literature on 
MRSA in animals and humans in contact with them. Notwithstanding, there is enormous 
potential for new research aiming to conclusively address certain unknown questions such 
as, at which point does an infection play the role of a zoonosis or humanosis? This question 
has yet to be answered because several animal species are involved, with distinct 
characteristics of transmission and isolated clones, raising appropriate concern for MRSA in 
animals. 
Steadfast vigilance of MRSA in samples of animal origin in laboratory diagnoses is essential 
for: consistent and thorough monitoring of the evolution and dissemination of these strains; 
elucidating characteristics that determine a predilection for a determined host; determing 
transmission routes; identifying resistance and virulence genes received by these new 
lineages; and distinguishing molecular markers that allow for discriminating between CA-
MRSA, HA-MRSA and LA-MRSA. 
Appropriate and effective measures of control and prevention must be better determined 
and applied to each situation and country, according to previously reported guidelines, 
aiming to minimize risks to humans, since these strains have housed new virulence and 
resistance genes which can be transferred to human strains. Veterinarians play an important 
role in public health, in controlling this pathogen through measures appropriately applied 
in veterinary medicine, namely, the rational use of antimicrobials and appropriate 
management of infected animals, together with other health professionals, for prevention of 
MRSA dissemination. 
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time after its use was implemented (Hiramatsu et al, 2001). In Brazil, it is estimated that the 
frequency of oxacillin resistance is high among S. aureus samples, particularly in large and in 
university hospitals. Gales (2009) described an oxacillin resistance rate of 31% in a multi-
center study involving four Brazilian hospitals. As regards CoNS, 78.7% of the samples were 
resistant. At the Botucatu School of Medicine University Hospital – SP, approximately 45% 
of the S. aureus samples from hemocultures were positive for the mecA gene (Martins et al., 
2010). In a study conducted at the neonatal intensive care unit of the same hospital, a total of 
18% of MRSA samples was found (Pereira et al., 2009).  According to a study by Sader et al. 
(2004) in Latin America and Brazil, respectively, 80.4% and 84.6% of the CoNS samples from 
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anti-staphylococcal therapy. The first report on methicillin resistance was in 1961, a short 
time after its use was implemented (Hiramatsu et al, 2001). In Brazil, it is estimated that the 
frequency of oxacillin resistance is high among S. aureus samples, particularly in large and in 
university hospitals. Gales (2009) described an oxacillin resistance rate of 31% in a multi-
center study involving four Brazilian hospitals. As regards CoNS, 78.7% of the samples were 
resistant. At the Botucatu School of Medicine University Hospital – SP, approximately 45% 
of the S. aureus samples from hemocultures were positive for the mecA gene (Martins et al., 
2010). In a study conducted at the neonatal intensive care unit of the same hospital, a total of 
18% of MRSA samples was found (Pereira et al., 2009).  According to a study by Sader et al. 
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Although S. epidermidis is the most frequently found species (Vuong & Otto, 2002),  
others are also associated with human infection, such as S. haemolyticus, which can be multi-
resistant and present intermediate resistance to vancomycin (Secchi et al., 2008). The  
main resistance mechanism is the presence of the mecA gene, inserted in the chromosomal 
cassette, known as staphylococcal chromosomal cassette mec (SCCmec). The detection of  
this gene and the typing of the chromosomal cassette by means of various molecular 
methods are important tools for the diagnosis and epidemiology of oxacillin-resistant 
Staphylococcus spp. 
There are eleven SCCmec types, with subtypes, which are characterized by molecular tools, 
such as Multilocus Sequence Typing (MLST), pulsed-field gel electrophoresis (PFGE), spa 
typing and Multiplex PCR for SCCmec detection. They are useful in the characterization and 
detection of alterations in molecular structure.  By using these methods, it was possible to 
identify pandemic clones as well as to characterize strains causing outbreaks in hospitals. 
Among these methods, the MLST is noteworthy due to its high reproducibility and capacity 
of detecting pandemic clones. Given the fact that vancomycin is a therapeutic option for 
oxacillin-resistant samples, with the emergence of vancomycin-resistant Staphylococcus spp., 
the characterization of circulating strains and clones is highly important. This chapter aimed 
at addressing aspects related to the molecular epidemiology in Staphylococcus spp. since 
these microorganisms have been increasingly frequent as agents of nosocomial and 
community infection. 
2. Epidemiological aspects 
Oxacillin resistance in CoNS is a problem in hospitals around the world, and there are reports 
of oxacillin-resistant samples in all continents (Witte, 1999).  The use of methicillin, a semi-
synthetic penicillin, commenced in 1959, and only two years after its first use, the first report of 
a methicillin-resistant Staphylococcus spp. sample was published (Hiramatsu et al., 2001). 
Oxacillin resistance rates vary among various studies, but they are usually high, above 50%. 
Chaudhury & Kumar (2007) reported that, in a study conducted in a tertiary Indian hospital, 
64.6% of the CoNS samples were oxacillin resistant. The most prevalent species was S. 
haemolyticus, isolated from urine samples. Another study also performed in India, described 
resistance levels of approximately 63% (Jain et al., 2008).  
In the European continent, several reports described high oxacillin resistance levels in 
hospital wards. In a study analyzing samples collected from various hospitals in Eastern 
Europe in 2005, Sader et al. (2007) reported oxacillin resistance levels in CoNS which varied 
from 54.8% in Sweden to 83.3% in Greece. A study conducted at a university hospital in 
Turkey found 54.4% of resistant samples from a total of 158 isolated samples (Ercis et al., 
2008). The rates found by a multi-center study conducted in the USA in 2007 and 2008 were 
of 74% of CoNS oxacillin-resistant samples (Sader & Jones, 2009).  
Nevertheless, in the last few years, resistance levels have stabilized. In Spain, a multi-center 
study on 146 hospitals detected oxacillin resistance in 61.3% of the samples in 2002 and 
66.7% in 2006 (Cuevas et al., 2008). In Brazil, recent studies showed resistance rates of 69% 
(Caierão et al., 2004), 78.4% (Perez & d'Azevedo 2007) and even 88.1% (Antunes et al., 2007). 
In the case of non-epidermidis CNS, Secchi et al. (2008) reported 71% of resistant samples. 
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Based on the described reports, it is clear that oxacillin resistance is prevalent in hospital in 
all continents, a fact that reinforces the importance of good antibiotic therapy practices and 
of infection control measures in hospitals.  
3. Oxacillin resistance 
Oxacillin resistance is associated with the drug’s reduced capacity to adhere to the 
penicillin-binding protein (PBP), thus also losing its capacity to lyse the bacterial cell. There 
are three mechanisms of resistance to semi-synthetic penicillinases, a group of drugs in 
which oxacillin is included. The first is related to the hyperproduction of β-lactamases, 
enzymes that cleave the drug’s β-lactam ring, thus inactivating it (McDougal & Thornsberry, 
1986). The second mechanism, known as MOD-SA, occurs when normal PBPs have reduced 
affinity with oxacillin (Tomasz et al., 1989). The third and most important mechanism is the 
presence of the mecA gene. This gene codifies a changed PBP, known as PBP 2a, thus 
preventing its binding to oxacillin (Zhang et al., 2009).  
Although resistance mediated by the mecA gene is present in all cells of the population with 
intrinsic resistance, it can only be expressed by a small percentage of such cells, thus leading 
to the so-called heterogeneous resistance.  Resistance expression in lineages with intrinsic 
resistance has been categorized into four phenotypic classes; classes 1 to 4, in which class 1 is 
the most heterogeneous and class 4 is the homogeneous one (Tomacz et al., 1991). The 
majority of cells (99.9 or 99.99%) in the culture of lineages with class-1 heterogeneous 
resistance show minimum inhibitory concentration (MIC) of 1.5 to 3 g/ml, but such culture 
also contains a small number of bacteria (10-7 to 10-8) that could form colonies even in the 
presence of 25 g/ml or more of oxacillin. In class-2 lineage cultures, the majority of cells ( 
99.9%) show MIC of 6 to 12 g/ml, and in these cultures, the frequency of highly resistant 
cells (capable of growing in the presence of 25 g/ml) is higher (10-5) than in class-1 lineages 
(Tomacz et al. , 1991). Class-3 lineage cultures consist of bacteria (99 to 99,9%) that show 
high levels of oxacillin resistance (MIC = 50 to 200 g/ml), but they usually have a 
subpopulation (10-3) of highly resistant cells that are capable of forming colonies even in the 
presence of 300 to 400 g de oxacillin/ml. Class-4 cultures comprise cells with homogeneous 
resistance, with all cells showing high resistance levels and MIC of 400 to 1,000 g/ml 
(Tomacz et al., 1991).  
The phenotypic expression codified by the mecA gene is affected by various factors, 
including pH, temperature and osmolarity (Swenson, 2002). When proper conditions are 
used for laboratory MRSA detection, including Mueller-Hinton agar supplementation with 
NaCl and adequate temperature and time, as recommended by CLSI (Clinical and 
Laboratory Standards Institute), detection is achieved without much difficulty. However, for 
more heterogeneous lineages, detection can be more difficult, even with reference methods 
(Swenson, 2002). 
Adequate detection of oxacillin resistance mediated by the mecA gene is important for 
clinical laboratories. Although the recommended methods detect most of the oxacillin-
resistant lineages, there are two situations that require additional phases to confirm 
sensitivity or resistance. The first is the occurrence of extremely heterogeneous lineages that 
are found to be sensitive by reference methods. The second is the occurrence of borderline 
resistance (MIC close to the sensitivity breakpoint), which must be differentiated from 
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resistance mediated by the mecA gene as long as the clinical significance of the resistance 
determined by the mecA gene is greater.  
The mecA gene is inserted in a transposable genetic element known as Staphylococcal 
Chromosomal Cassette mec (SCCmec). This element varies in its constitution and is divided 
into eleven types. The typing of SCCmec types is useful as an epidemiological tool 
(Mombach Pinheiro Machado et al., 2007) given that the different types are more prevalent 
in hospital and community environments. The SCCmec types (IWG-SCC, 2009) differ from 
one another in relation to the number of genes that they carry in their gene architecture 
(Hiramatsu et al., 2001). Some of these types are carriers of resistance genes that are 
determinant for multiple antibacterial drugs. In addition to beta-lactam antibiotics, 
macrolides, lincosamides, streptogramins, aminoglycosides and tetracycline are noteworthy. 
Hence, when a bacterial cell acquires such SCCmec, it at once acquires a multiple-resistance 
phenotype (Ito et al., 2003). 
The SCCmec types have been defined by the combination of two parts: the ccr complex and 
the mec complex, with three phylogenetically distinct ccr genes classified as: ccrA, ccrB and 
ccrC.  Additionally, there are five classes of mec gene complexes (classes A, B, C1, C2 and 
class D) (Ito et al., 2004; IWG-SCC, 2009). The different SCCmec types are classified as: type-I 
SCCmec (class B and ccrA1B1 mec gene complex), type-II SCCmec (class A and ccrA2B2 mec 
gene complex), type-III SCCmec (class A and ccrA3B3 mec gene complex), type-IV SCCmec 
(class B and ccrA2B2 mec gene complex), type-V SCCmec (class C2 and ccrC mec gene 
complex), type-VI SCCmec (class B and ccrA4B4 mec gene complex), type-VII SCCmec (class 
C1 and ccrC mec gene complex) and type-VIII SCCmec (class A and ccrA4B4 mec gene 
complex). The remaining region of SCCmec is called the J region (Joining region), which 
constitutes non-essential components of the cassette that can carry additional antimicrobial 
resistance determinants (Hanssen & Sollid, 2006; IWG-SCC, 2009). Recently, types IX (class 
C2, ccr1 mec gene complex), X (class C1, ccr7 mec gene complex) and XI (class E, ccr8 mec 
gene complex) have been described (IWG-SCC, 2011) (Table 1).  
 


































Source: http://www.sccmec.org/Pages/SCC_TypesEN.html. Accessed on 06/20/2011 
Table 1. SCCmec types identified in S.aureus 
The first three types were detailed by Ito et al. in 2001, and the same author also reported 
and described type V in 2004. Ma et al. (2002) described type IV, which is mainly found in 
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community samples. Types I, II and III are mainly responsible for nosocomial infections, 
and they are significantly larger than the last types IV and V. Type-I cassette was described 
with a size of 34.364 bp, and it is the largest of the three. This cassette does not feature any 
inserted transposons or plasmids that provide resistance to other drugs besides methicillin 
or to heavy metals. It has a sub-type known as IA, which differs from type I for having an 
integrated plasmid, pUB110 (Shore et al., 2005). 
The second cassette, referred to as II, has 53.017 bp, and in addition to the mecA and mecRI 
genes, which cause methicillin resistance, it contains transposon Tn 554. The latter is 
responsible for the resistance of this sample type to erythromycin and streptomycin. This 
cassette has a sub-type that is referred to as IIA, with a size of 40 Kb, thus being a little 
smaller than type II (Shore et al., 2005). 
Type-III cassette, the largest of the five types, has a size of 66.896 bp and contains genes 
mecA, mecRI, transposons Tn 554 and Tn 554 and plasmid pt 181. Transposon Tn 554 
induces cadmium resistance, and plasmid pt 181 is responsible for tetracycline and mercury 
resistance. In addition to the information described above, the authors also mentioned 
differences between the ccr gene types, by describing, in type-III SCCmec, a gene that is not 
present in the other types and is referred to as ccr. They also suggested that some of the 
resistance characteristics in type III can be used as selective markers. This cassette type 
presents two sub-types: IIIA, which does not have plasmid pt 181 and flanks with element IS 
431, and IIIB, where there are no copies of plasmids pt 181 or tn 554 (Shore et al., 2005). 
Type-IV SCCmec is mainly responsible for community infections. It is a small element that 
does not carry other resistance genes, except for mecA. It is also divided into multiple sub-
types, which suggests that type-IV SCCmec is highly transmittable (Ito et al., 2004). The four 
sub-types of type-IV, -IVA, -IVB, -IVC and -IVD cassettes differ for presenting different 
sequences on the left extremity of the ccr complex, which is known as L – C Region (Shore et 
al., 2005). 
Type-V SCCmec was identified by Ito et al. (2004) in an Australian isolate. It has the size of 
27.624 bp, and it is a little larger than SCCmec IV although smaller than the other existing 
types. Similarly to type IV, it has only genes that codify methicillin resistance; however, 
differently from the other elements in this family, type V has a new ccr gene type that is 
characterized as type c and is individually found, contrarily to other elements, which have a 
pair of such genes. Another new element found only in type V is a restriction and 
modification system codified by genes V22 and V23. Recent studies associate the presence of 
this mec cassette type with community infections (O’Brien et al., 2005; Ho et al., 2007). 
Oliveira et al. (2006) characterized type-VI SCCmec, which is found in samples belonging to 
the pediatric clone of MRSA (Methicillin Resistant S.aureus) samples and previously typed 
as SCCmec IV. The authors described differences in the ccrAB complex, identified as type 4, 
and the presence of the type-B mec complex, which does not have the mecl gene. 
Type-VII SCCmec was identified by Higuchi et al. (2008) through a detailed analysis of 
community S.aureus samples isolated in Taiwan. It has a size of 41.347 bp, and its mec 
complex is homologous to that found in type V, but presents substitutions, insertions and 
rearrangements that differentiate it. The main characteristics of this cassette type are the 
presence of the ccrC complex, of transposon ΨIS431 and of a unique sequence on the right 
side of the cassette which is referred to as orf35. 
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Source: http://www.sccmec.org/Pages/SCC_TypesEN.html. Accessed on 06/20/2011 
Table 1. SCCmec types identified in S.aureus 
The first three types were detailed by Ito et al. in 2001, and the same author also reported 
and described type V in 2004. Ma et al. (2002) described type IV, which is mainly found in 
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community samples. Types I, II and III are mainly responsible for nosocomial infections, 
and they are significantly larger than the last types IV and V. Type-I cassette was described 
with a size of 34.364 bp, and it is the largest of the three. This cassette does not feature any 
inserted transposons or plasmids that provide resistance to other drugs besides methicillin 
or to heavy metals. It has a sub-type known as IA, which differs from type I for having an 
integrated plasmid, pUB110 (Shore et al., 2005). 
The second cassette, referred to as II, has 53.017 bp, and in addition to the mecA and mecRI 
genes, which cause methicillin resistance, it contains transposon Tn 554. The latter is 
responsible for the resistance of this sample type to erythromycin and streptomycin. This 
cassette has a sub-type that is referred to as IIA, with a size of 40 Kb, thus being a little 
smaller than type II (Shore et al., 2005). 
Type-III cassette, the largest of the five types, has a size of 66.896 bp and contains genes 
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complex is homologous to that found in type V, but presents substitutions, insertions and 
rearrangements that differentiate it. The main characteristics of this cassette type are the 
presence of the ccrC complex, of transposon ΨIS431 and of a unique sequence on the right 
side of the cassette which is referred to as orf35. 
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Recently, Zhang et al. (2009) have described a new SCCmec type which has been 
denominated as SCCmec VIII and was found in an MRSA sample from a hospital. This new 
cassette has a size of 32.168 base pairs, and genes mecA mecR1 mecI of the mec complex and 
ccrA4 ccrB4 of the ccr complex are present in addition to transposon Tn554, which is also 
present in type II. 
4. Molecular epidemiology  
In addition to the characterization of SCCmec types as an epidemiological tool, other 
methods are available for molecular epidemiology studies, such as Pulsed Field Gel 
Electrophoresis (PFGE), Multilocus Sequence Typing (MLST) and spa typing, which allow 
for the identification of circulating bacterial clones in hospitals and in the community.  
PFGE is a method that uses restriction enzymes to cleave the extracted DNA, and in the case 
of the Staphylococcus genus, the enzyme used is SmaI. The fragments are separated in 
agarose gel. The direction of the electrical field is periodically changed, forming a 120º angle. 
This allows for fragments of up to 12mb to be separated, contrarily to conventional 
electrophoresis, which is not capable of separating fragments that are larger than 50kb 
(Herschleb et al., 2007). This method is generally used in local studies, such as in hospital 
outbreaks, which allows for identifying the circulating type.  
The sequencing of constitutive bacterial genes can also be used as an important 
epidemiological tool. The method known as spa typing investigates polymorphisms on a 
single locus. It can discriminate between PFGE and MLST and is also applied in local studies 
and for detecting pandemic clones (Malachowa et al., 2005). 
Another methodology that uses the sequencing and analysis of genetic polymorphisms is 
MLST. It analyzes the sequence of seven constitutive genes (gmk, pta, dfp, gtr, mutS, pyrR, 
and xpt) and compares them with the sequences of each allele in the locus, which are 
previously numbered. The combination of the alleles identified in each gene determines the 
profile of the sample. (Aanensen & Spratt, 2005). It is the most adequate methodology for 
detecting pandemic clones given that the investigated genes are constitutive, with low 
mutation rates when compared to the analysis of the whole chromosome, in the case of 
PFGE (Miragaia et al., 2007). 
5. Pandemic clones of MRSA samples 
Currently, Staphylococcus spp. samples have been typed in numerous epidemiological studies 
by means of the methods described above. By using these tools, 05 large pandemic clones 
have been described. These are the Brazilian clone, characterized by SCCmec IIIA, MLST 2-3-
1-4-4-3 (ST 239); the Iberian clone with type-IA SCCmec, and MLST 3-3-1-1/12-4-4-16 (ST 
247); the clone known as New York / Japan, with type-III SCCmec, pattern MLST 1-4-1-4-12-
1-10 (ST 05); the Hungarian clone, with SCCmec III, MLST 2-3-1-1-4-4-3 (ST 239); the 
pediatric clone, with type-IV SCCmec, MLST 1-4-1-4-12-1-10 (ST 05) and the last large clone 
known as EMRSA-16, SCCmec II MLST 15-12-16-02-16-02-25-17-24-24-24 (ST 36) (Oliveira et 
al., 2002; Melter et al., 2003; Velásquez-Meza et al. 2004; Aires de Souza & De Lencastre, 
2004, Aires Ribeiro et al., 2005). 
In our scenario, the predominant MRSA samples belong to the Brazilian clone (Oliveira et 
al., 2001). The first report on the emergence of this clone dates to 1992-93 in various hospitals 
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in Brazil. The samples were characterized as belonging to the same clone by methods such 
as PFGE and by showing patterns of transposon Tn554 and the polymorphism of the mecA 
gene (Teixeira et al., 1995). In other countries, the Brazilian clone is also disseminated, as is 
the case of the Czech Republic, where the isolation of this clone represented 80% of the 
MRSA samples found in 1996-1997 (Melter et al., 2003).  The Brazilian clone was also 
described in India, in two hospitals in the region of Bengalore, conjointly with the 
Hungarian clone (SCCmec III) (Arakere et al., 2005)  
Other clones are distributed in several parts of the world. The Iberian clone was firstly 
described in samples from hospitals in Barcelona and Madrid, Spain, and in Lisbon, 
Portugal. These samples were typed by the PFGE method and probe hybridization, 
producing a pattern that characterized them as belonging to the same clone. This clone is 
also described in other countries, such as the Czech Republic (Melter et al., 2003). The clone 
known as New York – Japan, firstly isolated in the USA in 1994-98 and in Japan in 1997-98 
(Oliveira et al., 2002), was also predominant in Mexico during a study on 98 MRSA samples, 
thus replacing the local clone, known as Mexican (PFGE M, type-IV SCCmec), in nosocomial 
infections (Velasquez-Meza et al., 2004).  
The Hungarian clone, firstly identified in Hungary in 1993-94, was characterized by the 
same methods used for the clones described above in studies on MRSA samples from 
hospitals in 06 provinces in that country (De Lencastre, 1997). The pediatric clone was 
isolated in large numbers in 1996-98 in Colombia, and it is also found in Argentina and 
Poland in 1994-98 and 1990-98 (Oliveira et al., 2002).  
The last of the large pandemic clones, referred to as EMRSA-16, is prevalent in hospitals in 
the United Kingdom, Mexico and Greece, in addition to being responsible for an outbreak in 
Sweden from 1997 to 2000 (Aires de Souza & De Lencastre, 2004). 
6. Epidemiology and MLST 
The MLST method was developed by Maiden et al. (1998) by the sequencing and analysis of 
the loci of eleven constitutive genes of Neisseria meningitidis, and it is presently applied in 
molecular epidemiology studies on various pathogens, among which are S. aureus and S. 
epidermidis. 
This methodology has been used in numerous studies on molecular epidemiology with 
good results due its good reproducibility, thus allowing for the detection of pandemic 
clones from circulating S. aureus and S. epidermidis samples. 
Geng et al. (2010) reported the presence of clone ST59-MRSA-IV in China in community 
samples isolated from 47 children with impetigo and abscesses. In Malaysia, a study on 36 
samples isolated from a hospital in Klang Valley for a five-month period reported a rate of 
83.3% of samples belonging to clone ST 239 SCCmec III (Neela et al., 2010). 
MLST has been used for studies in which circulating clones are identified in replacement of 
another already established clone. Sola et al. (2006) reported the emergence of a new clone 
identified as ST5 in hospitals in Cordoba, Argentina, in replacement of the Brazilian clone 
(ST239), which circulates in that region. In that study, 103 MRSA samples isolated from 
April to June 2001 and 31 MSSA samples isolated from 1999 to 2002 were used. 
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Previous studies have used MLST for comparison between samples and the prevalence 
between different pandemic clones. Campanille et al. (2009) analyzed 301 MRSA samples 
isolated from 19 Italian hospitals from 1990 to 2001. An increase of clone ST228, known as 
Italian clone, was observed from 2000 to 2007, conjointly with the decrease of clone ST247 
(Iberian clone) when compared to the 1990-1999 period.  
Clone ST228 is also associated with patients with cystic fibrosis. A study conducted on 93 
MRSA samples isolated from patients with that disease at a treatment center in Madrid, 
Spain, identified 15 different PFGE patterns.  A sample of each of these patterns was typed 
by MLST, with clone ST228 showing higher prevalence, with eight pulsetypes, followed by 
ST5, with two pulsetypes, and ST247, ST72 and ST255 with one pulsetype each (Molina et 
al., 2008).  
In addition to epidemiological studies in hospitals and the detection of these pandemic 
clones from MRSA samples, the MLST method has been used to detect the transmission of 
oxacillin-resistant samples from animal reservoirs to humans, including its detection in 
hospitals. Some studied have detected the presence of MRSA clones in swines, thus 
emphasizing the importance of such animals as reservoirs. Smith et al. (2009) reported the 
presence of ST398 samples in swines and farmers in the mid-western region of the United 
States, which suggests transmission between animals and their breeders. In Germany, 1,600 
swabs from swines from 40 farms were analyzed in a study where samples typed as ST398 
were also identified (Köck et al., 2009). 
MLST is usually used for detecting pandemic clones with good results. But this method can 
also be utilized for characterizing samples involved in hospital outbreaks.  
Peacock et al. (2002) compared the MLST and PFGE methods in a study conducted on 104 S. 
aureus samples isolated from nasal swabs from patients under renal therapy. The isolated 
samples were typed by the MLST and PFGE methods with a similar discriminatory power 
between the two techniques for identification of circulating samples in hospitals. 
Vindel et al. (2009) analyzed 463 S.aureus samples isolated from 145 Spanish hospitals in 
2006. In addition to MLST, several methodologies such as PFGE, spa typing, SCCmec 
characterization and agr typing were used. MLST showed good correlation with the 
methodologies used for detecting circulating samples, with applicability in localized 
nosocomial studies. 
The combination of the two molecular epidemiology techniques can increase discriminatory 
power for analysis of different clones. Cookson et al. (2007) reported that the combination of 
the MLST and SCCmec methods are more appropriate for multi-center studies. The authors 
analyzed MRSA samples from various European countries by means of PFGE, MLST, 
SCCmec analysis and spa typing.  
7. Vancomycin-resistant S. aureus (VRSA) 
Detection of oxacillin resistant staphylococci is important to guide therapies and also to 
avoid use of vancomycin, which is an antimicrobial agent with therapeutic complications, 
and can lead to selection of resistant strains. Acquired microbial resistance to vancomycin is 
a growing problem, in particular, within healthcare facilities such as hospitals.  The 
widespread use of vancomycin makes resistance to the drug a significant worry, especially 
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for individual patients if resistant infections are not quickly identified and the patient 
continues the ineffective treatment. Vancomycin-resistant Enterococcus (VRE) emerged in 
1987 and the transfer potential of such resistance to other bacteria, vancomycin resistance 
surveillance has been an object of great scientific interest worldwide.  Vancomycin 
resistance emerged in more common pathogenic organisms during the 1990s and 2000s, 
including vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant 
Staphylococcus aureus (VRSA). 
In 1996, the first clinical S. aureus isolate with reduced vancomycin sensitivity, with MIC 
value in the intermediate range (MIC = 8 g/ml) and referred to as VISA was reported in 
Japan (Hiramatsu et al. 1997). Additionally, in June 2002 [44], eight patients with infections 
caused by S. aureus with reduced vancomycin sensitivity were confirmed in the United 
States. One month later, the Centers for Disease Control and Prevention (CDC) published 
the first reported on vancomycin-resistant S. aureus (VRSA, with MIC = or  32 g/ml) in a 
patient in Michigan, United States. The sample isolated from the patient contained the vanA 
gene as well as the mecA gene for oxacillin resistance. The presence of the vanA gene in this 
VRSA suggests that resistance may have been acquired through the passage of genetic 
material from vancomycin-resistant enterococci to S. aureus. In October of the same  
year [44], the second clinical isolate of VRSA was reported in a patient in Pennsylvania. The 
VRSA isolate also contained the vanA and the mecA genes. The presence of the vanA  
gene suggests that the resistance determinant was acquired from vancomycin-resistant 
Enterococcus isolated from the same patient. April 2004, the third VRSA isolated from a 
patient in New York was reported. The isolate also contained the oxacillin- and vancomycin-
resistance mecA and vanA genes, respectively. According to CDC, the three VRSA isolated 
did not seem to be epidemiologically related (CDC 2002; CDC 2004). The CDC (2010)  
has recently confirmed the 11th case of vancomycin resistant Staphylococcus aureus  
(VRSA) infection since 2002 in the United States (Table 2).  This serves as a reminder about the  
 
Case State Year Age Source 
1 Michigan 2002 40 Plantar ulcers & 
Catheter tip 
2 Pennsylvania 2002 70 Plantar ulcer 
3 New York 2004 63 Urine from a 
nephrostomy tube 
4 Michigan 2005 78 Toe wound 
5 Michigan 2005 58 Surgical site wound 
after panniculectomy 
6 Michigan 2005 48 Plantar ulcer 
7 Michigan 2006 43 Triceps wound 
8 Michigan 2007 48 Toe wound 
9 Michigan 2007 54 Surgical site wound 
after foot amputation 
10 Michigan 2009 53 Plantar foot wound 
11 Delaware 2010 64 Wound drainage 
Source: CDC (2010) 
Table 2. Vancomycin resistant Staphylococcus aureus (VRSA) infection in the United States 
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caused by S. aureus with reduced vancomycin sensitivity were confirmed in the United 
States. One month later, the Centers for Disease Control and Prevention (CDC) published 
the first reported on vancomycin-resistant S. aureus (VRSA, with MIC = or  32 g/ml) in a 
patient in Michigan, United States. The sample isolated from the patient contained the vanA 
gene as well as the mecA gene for oxacillin resistance. The presence of the vanA gene in this 
VRSA suggests that resistance may have been acquired through the passage of genetic 
material from vancomycin-resistant enterococci to S. aureus. In October of the same  
year [44], the second clinical isolate of VRSA was reported in a patient in Pennsylvania. The 
VRSA isolate also contained the vanA and the mecA genes. The presence of the vanA  
gene suggests that the resistance determinant was acquired from vancomycin-resistant 
Enterococcus isolated from the same patient. April 2004, the third VRSA isolated from a 
patient in New York was reported. The isolate also contained the oxacillin- and vancomycin-
resistance mecA and vanA genes, respectively. According to CDC, the three VRSA isolated 
did not seem to be epidemiologically related (CDC 2002; CDC 2004). The CDC (2010)  
has recently confirmed the 11th case of vancomycin resistant Staphylococcus aureus  
(VRSA) infection since 2002 in the United States (Table 2).  This serves as a reminder about the  
 
Case State Year Age Source 
1 Michigan 2002 40 Plantar ulcers & 
Catheter tip 
2 Pennsylvania 2002 70 Plantar ulcer 
3 New York 2004 63 Urine from a 
nephrostomy tube 
4 Michigan 2005 78 Toe wound 
5 Michigan 2005 58 Surgical site wound 
after panniculectomy 
6 Michigan 2005 48 Plantar ulcer 
7 Michigan 2006 43 Triceps wound 
8 Michigan 2007 48 Toe wound 
9 Michigan 2007 54 Surgical site wound 
after foot amputation 
10 Michigan 2009 53 Plantar foot wound 
11 Delaware 2010 64 Wound drainage 
Source: CDC (2010) 
Table 2. Vancomycin resistant Staphylococcus aureus (VRSA) infection in the United States 
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important role of clinical laboratories in the diagnosis of VRSA cases to ensure prompt 
recognition, isolation, and management by infection control personnel. Appropriate 
antimicrobial prescribing by healthcare providers, adherence to recommended infection 
control guidelines, and, ultimately, the control of both MRSA and VRE are necessary to 
prevent further emergence of VRSA strains. 
8. Conclusions and perspectives 
Given the high rates of oxacillin resistance reported in various countries and the 
emergence of vancomycin-resistant MRSA samples, further detailed studies on the 
characteristics of circulating strains in hospitals and the characterization of clones 
prevailing in larger regions are necessary since the different MRSA clones vary in 
virulence and antimicrobial resistance. The molecular epidemiology methods are useful 
tools in these types of study, and the MLST technique is especially useful due to its 
versatility, easy performance and high reproducibility, with applications in localized 
studies, such as in the characterization of outbreaks and in the detection of circulating 
clones in large regions. 
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‘To grasp the full meaning of the obvious is a better basis for the  
understanding than the confused knowledge of the obscure.’  
(Engels) 
1. Introduction 
Schizophrenia is a common deleterious psychosis that begins typically in late adolescence or 
early adulthood (Gottesman, 1991; Jablensky, 1995). Although it has a strong genetic 
component in its etiology, no susceptibility genes conferring a large proportion of heritability 
have been identified (Allen et al., 2008; Need et al, 2009). Results of association studies 
including genome-wide scans have been inconsistent, and schizophrenia-associated genes 
including copy number variations differ across populations or even across individuals of a 
same ethnicity (Allen et al., 2008; Xu et al., 2008; Need et al, 2009). Thus, situation of molecular 
genetics of schizophrenia has become rather perplexing just contrary to our expectation. 
In this chapter, we describe the consistent major epidemiological findings of schizophrenia, and 
show how these evident macroscopic aspects shed light to the confused microscopic aspects of 
schizophrenia genetics today, proposing a new hypothesis for this puzzling disorder. 
2. Devil’s triangle of human genetics – Epidemiological facts of 
schizophrenia 
We describe here three epidemiological facts of schizophrenia – high prevalence, high 
heritability and low reproductive fitness. These properties form a Devil’s triangle; any 
combination of the two tends to exclude the third, and in this triangle most diseases vanish 
except for schizophrenia, suggesting that schizophrenia has a unique etiological basis 
among the many human diseases. 
2.1 Schizophrenia as a common disease 
Substantial evidence of epidemiology shows that schizophrenia crosses all cultures and 
tribes in different continents at a relatively high prevalence (approximately 0.7%; 95% 
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Confidence Interval 0.3% - 2.7%) (Saha et al., 2005); the prevalence of schizophrenia, at the 
macro-level, varies within narrow limits (Jablensky, 1995), and appears to be stable across 
generations in several countries (Harrison et al., 1991; Osby et al., 2001). This 
epidemiological fact suggests that schizophrenia has an ancient origin. 
2.2 Schizophrenia as a heritable disease 
It has long been known that schizophrenia runs in families (McGue & Gottesman, 1991). 
Adoption studies demonstrate an increased risk of schizophrenia in biological relatives  
of adoptees with schizophrenia, suggesting that genetic components play an important 
role in the etiology of schizophrenia (Kendler & Dichl, 1993). Now it has been established 
by twin studies that heritability of schizophrenia is ~0.85 (Cannon et al., 1998; Cardno  
et al., 1999). 
Although the mode of transmission of schizophrenia is still unknown, several reports 
suggest a higher maternal transmission of schizophrenia (Shimizu et al., 1987; Goldstein et 
al., 1990; Valero et al., 1998; Li et al., 2007). 
2.3 Schizophrenia as a low fitness disease 
It has been well documented that the fertility of patients with schizophrenia, particularly 
of males, is remarkably reduced compared to healthy individuals (Böök, 1953; Larson & 
Nyman, 1973; Ødegård, 1980; Nanko & Moridaira, 1993; Fãnanás & Bertranpetit, 1995; 
Nimgaonkar, 1998; McGrath et al., 1999; Haukka et al., 2003; Svensson et al., 2007).  
The latest meta-analysis (Bundy et al., 2011) shows that fertility ratio (patients/controls)  
is ~0.39 and that the reduction of fertility is more pronounced in males (male/female ratio 
is ~0.54). 
Because schizophrenia is an early onset disease (late adolescence ~ early adulthood), 
psychotic symptoms of the disease such as autistic way of life and abnormal behaviors may 
make mating unsuccessful. This tendency may be more pronounced in males because the 
age at onset is significantly lower in males than in females (Jablensky, 1995; Kulkarni & 
Fink, 2000). Thus, unsuccessful mating, coupled with an increased mortality (McGrath et al., 
2008), may remarkably reduce the fertility of patients with schizophrenia. 
2.4 Schizophrenia and the Devil’s triangle of human genetics 
The three epidemiological characteristics of schizophrenia - high prevalence, high 
heritability and low fitness - form a Devil’s triangle; any combination of the two tends to 
exclude the third, and in this triangle most diseases vanish except for schizophrenia (Fig. 1). 
Diseases with high prevalence and high heritability such as type 2 diabetes and adult 
cancers are late-onset diseases and exhibit almost normal reproductive fitness. Diseases with 
high heritability and low reproductive fitness such as most harmful Mendelian diseases in 
childhood are rare. Diseases with low reproductive fitness and high prevalence such as poor 
nutrition, severe injuries and infections in childhood or early adulthood are mainly due to 
the environmental factors. 
This may lead us to strongly suspect that schizophrenia has a unique etiological basis 
among the many human diseases. 
 




Fig. 1. Devil’s triangle of human genetics (Doi et al., 2009) 
3. Persistence problem and mutation-selection balance in schizophrenia 
The three epidemiological characteristics of schizophrenia mentioned above give a paradox. 
How has a highly heritable disease associated with a remarkable biological disadvantage 
never been extinct in the long human history? And how can it persist at a relatively high 
prevalence? This ‘persistence problem of schizophrenia’ (or ‘schizophrenia paradox’) has 
puzzled scientists for long years (Huxley et al., 1964; Crow, 1995; Brüne, 2004; Keller & 
Miller, 2006). 
In this section, we discuss that the only plausible mechanism for the persistence is mutation-
selection balance with or without heterozygote advantage. Based on the consistent 
epidemiological findings on the fertility of patients with schizophrenia and their family 
members, we show that heterozygote advantage works in the mitochondrial genome model 
but not in the nuclear genome model. 
3.1 Mutation-selection balance is the only plausible mechanism for the persistence 
From an evolutionary viewpoint, four explanations are possible for the persistence: (i) 
ancestral neutrality, (ii) negative frequency-dependent selection, (iii) heterozygote 
advantage (balancing selection or pleiotropy), and (iv) mutation-selection balance. 
‘Ancestral neutrality’ assumes that reproductive fitness of affected individuals and/or their 
relatives was higher in ancient environments and that selection coefficients of pathogenic 
alleles were close to zero. Because the effective population size in ancient times might be 
much smaller than now, pathogenic but neutral or almost neutral alleles could be fixed by 
genetic drift. While this hypothesis explains that schizophrenia has not been extinct in the 
long human history, ancestral neutrality itself provides no explanation for the apparently 
stable prevalence of the disease across generations today; although ‘ancestral neutrality’ 
might be plausible, it needs another mechanism to account for the persistence in modern 
environments, where the effective population size has been expanded and the influence of 
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the environmental factors. 
This may lead us to strongly suspect that schizophrenia has a unique etiological basis 
among the many human diseases. 
 




Fig. 1. Devil’s triangle of human genetics (Doi et al., 2009) 
3. Persistence problem and mutation-selection balance in schizophrenia 
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never been extinct in the long human history? And how can it persist at a relatively high 
prevalence? This ‘persistence problem of schizophrenia’ (or ‘schizophrenia paradox’) has 
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Miller, 2006). 
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selection balance with or without heterozygote advantage. Based on the consistent 
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members, we show that heterozygote advantage works in the mitochondrial genome model 
but not in the nuclear genome model. 
3.1 Mutation-selection balance is the only plausible mechanism for the persistence 
From an evolutionary viewpoint, four explanations are possible for the persistence: (i) 
ancestral neutrality, (ii) negative frequency-dependent selection, (iii) heterozygote 
advantage (balancing selection or pleiotropy), and (iv) mutation-selection balance. 
‘Ancestral neutrality’ assumes that reproductive fitness of affected individuals and/or their 
relatives was higher in ancient environments and that selection coefficients of pathogenic 
alleles were close to zero. Because the effective population size in ancient times might be 
much smaller than now, pathogenic but neutral or almost neutral alleles could be fixed by 
genetic drift. While this hypothesis explains that schizophrenia has not been extinct in the 
long human history, ancestral neutrality itself provides no explanation for the apparently 
stable prevalence of the disease across generations today; although ‘ancestral neutrality’ 
might be plausible, it needs another mechanism to account for the persistence in modern 
environments, where the effective population size has been expanded and the influence of 





‘Negative frequency-dependent selection’ explains the persistence only when the fitness of 
the affected individuals increases as the prevalence in the general population decreases, 
which seems not to be the case with schizophrenia. 
Thus, the remaining possibility for persistence mechanism is mutation-selection balance 
with or without heterozygote advantage. 
3.2 Heterozygote advantage works in the mitochondrial genome model but not in the 
nuclear genome model for schizophrenia 
‘Heterozygote advantage’ assumes that the susceptibility alleles increase the fitness of the 
unaffected gene carriers, thereby sustaining the gene frequencies. This line of explanations 
may include: (i) physiological advantage (resistance to shock, infections, and poor nutrition 
etc.), (ii) a higher sexual activity and/or attractiveness, and (iii) creative intelligence or a 
higher trait creativity including ‘everyday creativity’. 
This hypothesis needs two lines of confirmation: (a) that unaffected gene carriers have such 
advantages, and (b) that such advantages really contribute to sufficiently increase their 
reproductive fitness. 
It seems to gain the confirmation (a). For example, Erlenmeyer-Kimling (1968) reported an 
increased survival rate of female children of parents with schizophrenia, proposing a 
possible physiological advantage associated with schizophrenia. Kinney et al. (2001), in a 
well-designed and methodologically sophisticated study, showed that an advantage of 
everyday creativity was linked to a subtle clinical picture (schizotypal signs) in a non-
psychotic sample of schizophrenia offspring. 
However, it lacks the confirmation (b) in the nuclear genome model. This hypothesis, 
although theoretically plausible and fascinating, has not been supported by most 
epidemiological studies, which show a decreased reproductive fitness of unaffected siblings 
of patients with schizophrenia. Although recent large-sampled epidemiological studies 
(Bassett et al., 1996; McGrath et al., 1999; Haukka et al., 2003; Svensson et al., 2007) have 
consistently shown that the reproductive fitness of unaffected female siblings of patients with 
schizophrenia is slightly but significantly increased (1.02-1.08), it is not large enough to 
compensate for the gene loss due to the decreased reproductive fitness of patients (0.2-0.3 in 
males and 0.4-0.5 in females) and their unaffected male siblings (0.9-1.0) in the nuclear 
genome model. On the other hand, the latest meta-analysis (Bundy et al., 2011) shows no 
significant difference between the fertility of parents of patients with schizophrenia and 
healthy controls, although there is a trend towards parents having more offspring. 
Therefore, heterozygote advantage seems not to work in the nuclear genome model. 
On the other hand, it works in the mitochondrial genome model because mitochondrial 
DNA (mtDNA) is transmitted to the next generation only through females. Indeed, we can 
see that this slightly elevated reproductive fitness of the unaffected female siblings, coupled 
with the less pronounced decreased reproductive fitness of female patients, is sufficient to 
compensate for the gene loss; when we calculate  , the cross-generational reduction of the 
frequency of females with a putative pathogenic mtDNA in the general population, using 
the data in the largest-sampled cohort study to date (Haukka et al., 2003), we have 
35.06 10   (Note). This figure implies that the gene loss can be balanced by de novo 
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mutation in the mtDNA which occurs at a rate of 4 28.8 10 ~ 1.3 10    per locus per 
generation ( 34.3 10 on average) (Sigurđardóttir et al., 2000). 
4. Persistence criterion for nuclear susceptibility genes for schizophrenia 
As is shown in the previous section, putative pathogenic genes, if located in the mtDNA, are 
sustained by mutation-selection balance with heterozygote advantage. On the other hand, if 
located in the ncDNA, they should be sustained by mutation-selection balance without 
heterozygote advantage. In this section, we introduce our previous work (Doi et al., 2009), in 
which we carefully re-examined the necessary conditions for putative nuclear susceptibility 
genes for schizophrenia and deduced a criterion (persistence criterion, or ‘P-criterion’) that 
every nuclear susceptibility gene should fulfill for persistence of the disease, and present its 
applications to association studies for schizophrenia. 
4.1 Three basic assumptions 
At first we describe our three basic assumptions. 
4.1.1 An ideal human population 
We assume here a random-mating human population with a sufficiently large effective 
population size at equilibrium, where negative selection pressures on the susceptibility 
alleles for schizophrenia are predominant and the effect of genetic drift is negligibly small. 
The prevalence p of schizophrenia in this ideal human population is assumed to be stable 
across generations by mutation-selection balance. Therefore, the gene frequency in the 
general population (mG) is given in terms of the gene frequencies in the affected population 
(mA) and in the unaffected population (mU): 
 (1 )G A Um pm p m   , or (1 )A Gm m p d   .  A Ud m m  ) (1) 
4.1.2 Mutation-selection balance in each risk locus 
We assume here that the total of the population frequencies of the pathogenic alleles at each 
risk locus is preserved by mutation-selection balance. Therefore, Gm ,the cross-generational 
reduction of the frequency of a pathogenic allele should not be more than the rate of 
mutations that produce pathogenic variants at the locus. On the other hand, since mutations 
at the locus include mutations of two directions that produce pathogenic or non-pathogenic 
variants, the mutation rate at the locus (  ) should be greater than the rate of mutations that 
produce pathogenic variants at the locus. 
Thus we have: 
 Gm   . (2) 
4.1.3 Multifactorial threshold model 
We assume the multifactorial threshold model, in which quantitative traits such as liability 
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stochastic and/or an epigenetic effect. Under this assumption, the relative fitness as a 
quantitative trait in the affected population is determined by multiple factors and 
approximately follows a gamma distribution with a mean (1 )s . (s is the selection coefficient 












Fig. 2. Distribution curve of the reproductive fitness in the affected population 
Distribution curve of the reproductive fitness in the affected subpopulation with a 
schizophrenia-associated allele M never shifts to the right unless M has a strong protective 
effect (i.e. an effect of elevating carrier’s reproductive fitness by reducing severity of and 
liability to the disease). Therefore, we can assume that Ms , the selection coefficient in the 
affected subpopulation with a schizophrenia-associated allele M, is not smaller than s 
( 1Ms s  ) for a susceptibility allele (Fig. 2). The inequality Ms s  implies that M is a 
resistance gene that reduces severity and risk of the disease. 
No special assumptions else are required on the allelic structure in each locus, penetrance of 
each susceptibility gene, and possible interactions among the loci. 
4.2 Deduction of the P-criterion 
Now we proceed to deduce the P-criterion. From the assumptions, Gm' , the population 
frequency of the schizophrenia-associated allele M in the next generation, is given by: 
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On the other hand, the principle of association studies demands: d0 . 
Thus we have the criterion for a susceptibility gene:  











From the observation (5), we can see that d  implies Mss   for any schizophrenia-
associated variant M which is sustained by mutation-selection balance. 
4.3 Parameter estimate for schizophrenia 
Mutation rates on autosomes and the X chromosome almost always fall within the range 
between 610  and 410  per locus per generation (usually < 510 ; one generation = 20 years) 
(Nachman & Crowell, 2000) and can be approximated by a linear function of the parental 
age at least under 30 years for maternal age and under 40 years for paternal age (Risch et al., 
1987). Large-sampled cohort studies in Israel, Sweden and Denmark show that the mean age 
of parents in the general population is ~ 28 years for mothers and ~31 years for fathers; the 
mean age of both parents is < 29.6 years (Malaspina et al., 2001; El-Saadi et al., 2004).  
Therefore we assume here:  
6 4 429.610 10 1.48 10
20
       . 
According to the epidemiological data by Haukka et al. (2003), the estimated values for p 
and s are 21.29 10p    and 16.54 10s   . Therefore, we have 31.76 10   for the average 
mutation rate ( 51.48 10 ), 21.76 10   for the highest mutation rate ( 41.48 10 ), and 
41.76 10    for a relatively low mutation rate (
61.48 10 ). 
4.4 Implications for association studies of schizophrenia 
We present here some applications of the P-criterion to association studies of schizophrenia. 
The results suggest that common disease/common variant hypothesis is unlikely to fit 
schizophrenia and that an enormous sample size is required to detect a nuclear 
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4.4.1 Calculation of an upper bound of the effect size of a putative susceptibility gene 
of a given frequency 
Using the P-criterion, we can calculate an upper bound of the effect size of a putative 
susceptibility gene of a given frequency. 
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And since the criterion demands A Um m  , we have 
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for 1 1Um   . 
Thus, we have an upper bound of the effect size for a given frequency. 
From the above we can easily see that the common disease/ common variant hypothesis, 
which proposes that common alleles at a handful of loci interact to cause a common disease, 
is unlikely to fit schizophrenia. No common alleles with population frequency between 0.05 
and 0.95 can have large effects for schizophrenia: the odds ratio of every common risk allele 
is less than 1.04 for the average mutation rate, less than 1.58 for the highest mutation rate, 
and less than 1.004 for a relatively low mutation rate (Table 1). 
4.4.2 Calculation of range of the frequency of a putative susceptibility gene of a  
given effect size 
By solving the inequality (7) or (8), we can estimate the range of gene frequency for a given 
effect size. Thus, we can see that susceptibility genes of the average mutation rate and a 
moderate effect that meet the criterion are limited to ‘very rare variants’ or ‘very common 
variants’. For example, suppose 51.48 10   and OR=5.0, then we have: 21.76 10    and 
4




  .  
Solving this inequality, we get either 0 0.00044Um   (that is, 
0 0.00176 0.0022A Um m    ) or 0.9977Um  . 
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Um  61048.1   51048.1   41048.1   
0.01 < 1.02 < 1.18 < 2.81 
0.02 < 1.009 < 1.09 < 1.92 
0.05 < 1.004 < 1.04 < 1.38 
0.1 < 1.002 < 1.02 < 1.20 
0.3 < 1.0009 < 1.009 < 1.09 
0.5 < 1.0008 < 1.008 < 1.08 
0.7 < 1.0009 < 1.009 < 1.09 
0.9 < 1.002 < 1.02 < 1.24 
0.95 < 1.004 < 1.04 < 1.58 
0.98 < 1.009 < 1.10 < 8.49 
Table 1. Upper bounds of odds ratio for given allele frequencies in the unaffected 
population 
4.4.3 Calculation of the required sample size and the power of an association study 
Using the P-criterion we can calculate a lower bound of sample size required in an 
association study of a given power as well as an upper bound of the power of an association 
study of a given sample size. 
Concerning the required sample size 2N (N case-control pairs) and the power 1   of an 
association study, we have the well-established formulae (Ohashi & Tokunaga, 2002): 
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Here,  , *z  , and z  denote the cumulative distribution function of the standard normal 
curve, the two sided α point (α: a significant level) and the upper β point of the standard 
normal curve, and x (population frequency of the allele) and 2 are defined as follows. 
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For the average mutation rate 51.48 10   , we have 31.76 10   . Suppose 
0.0005 0.9995x  , then we have 32 (1 ) 0.9995 10x x    . From the P-criterion, we have: 
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for 5.0x . Therefore, more than 3.7 million case-control pairs are required in a genome-
wide association study with a power 0.95 to detect a susceptibility variant of the average 
mutation rate and a population frequency between 0.0005 and 0.9995. 
Similarly we can see that more than 37,000 case-control pairs are required in a genome-wide 
association study with a power 0.95 to detect a susceptibility variant of the highest mutation 
rate ( 41.48 10   ) and a population frequency between 0.005 and 0.995. 
Finally, let us consider the case with a relatively low mutation rate 61.48 10   , which 
corresponds to 41.76 10   . In this case, more than 370 million case-control pairs are 
required in a genome-wide association study with a power 0.95 to detect a susceptibility 
variant of a population frequency between 0.000005 and 0.999995. Therefore it would take 
more than several hundred years to gather the required number of samples even if all of the 
affected individuals in the world were to be recruited to the study. 
5. Mitochondrial DNA (mtDNA) hypothesis of schizophrenia 
In this final section, we discuss on the nature of those schizophrenia-associated genes that 
do not meet the P-criterion, suggesting that these genes should be resistance genes that 
reduce the morbid risk and severity of the disease. We show that the results of association 
studies to date is compatible with the mitochondrial genome model but not with the nuclear 
genome model and propose a new hypothesis which assumes that the risk loci are in the 
mtDNA. We present eight major predictions of this hypothesis, and discuss that these 
predictions seem to accord with the other epidemiological findings and the results of the 
genetic and the pathophysiological studies to date. 
5.1 Nature of schizophrenia-associated genes that do not meet the P-criterion 
Now, let us consider the nature of those schizophrenia-associated genes that do not meet the 
persistence criterion. The inequality d   implies Ms s , where sM and s denote the selection 
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coefficient in the affected subpopulation with an allele M and in the affected population 
respectively. Therefore, such genes, if sustained by mutation-selection balance, cannot be 
susceptibility genes but resistance genes that reduce severity and risk of the disease (see 4.2). 
If they were not resistance genes, their frequencies in the affected population must have 
been reduced to the same level in the unaffected population. 
5.2 The results of association studies to date accord with the mitochondrial genome 
model but not with the nuclear genome model 
Since a resistance gene in the nuclear genome model cannot be associated with the disease 
unless it is linked with a susceptibility gene, resistance genes in the nuclear model should be 
located in the vicinity of susceptibility genes, which disagrees with the results of association 
studies to date.  
For example, on the chromosome 1, all of the schizophrenia-associated genes that could 
meet the criterion (RGS4, PLXNA2, DISC1) are located on 1q, while four resistance genes 
(MHTFR, GRIK3, PDE4B, GSTM1) are on 1p (Table 2). Fifteen resistance genes are located 
on 2q, 5q, 7q, 10q, 11p, 12p, 12q, 13p, 13q, 16p, 17p, and 19q, where no schizophrenia-
associated variants that could meet the criterion are located (data: not shown). Therefore, the 
results of association studies to date argue against the nuclear genome model. 
A possible interpretation which accords with the nuclear genome model might be that many 
nuclear susceptibility genes of less than the highest mutation rates have not been detected 
by association studies to date due to lack of power. In this case, however, an enormous 
sample size (more than 3.7~370 million case-control pairs) would be required to identify 
them as was mentioned above. In other words, such an enormous sample size is required to 
prove the nuclear genome model. 
On the other hand, every resistance gene on any chromosome can be associated with 
schizophrenia in the mitochondrial genome model; since mtDNA is transmitted only via 
females and there is no link between the nuclear genome and the mitochondrial genome, 
every nuclear genome which interacts with a pathogenic mitochondrial genome to alter 
severity and risk of the disease is subject to natural selections in the predisposed maternal 
lineage that succeeds to a same pathogenic mitochondrial genome. Therefore, every 
resistance gene for schizophrenia in the mitochondrial genome model is to be subject to a 
positive selection in the predisposed maternal lineage, thereby associating with 
schizophrenia. 
Thus, the mitochondrial genome model is compatible with the results of the association 
studies to date. 
It should be noted that in the mitochondrial genome model every facilitating gene (a gene 
that increases the severity and morbid risk in the predisposed population) on any 
chromosome may diminish in the predisposed matrilineal pedigrees by negative selection, 
thereby negatively associating with the disease. 
Schizophrenia-associated variants listed in the top 45 in the SZGene Database (the version of 
10th December, 2010) were selected. Based on the genotype distributions in meta-analyses, 
allele frequencies and the case-control differences were calculated. 4 variants at the 3 loci 
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coefficient in the affected subpopulation with an allele M and in the affected population 
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model but not with the nuclear genome model 
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A possible interpretation which accords with the nuclear genome model might be that many 
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by association studies to date due to lack of power. In this case, however, an enormous 
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them as was mentioned above. In other words, such an enormous sample size is required to 
prove the nuclear genome model. 
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rates at those loci are near the upper limit in the autosomes. All of them are located on 1q, 
while 4 resistance genes (MHTFR, GRIK3, PDE4B, GSTM1) are on 1p. * schizophrenia-





(minor/major) mA mU OR d 
MHTFR 1p36.22      
rs1801133  T*/C 0.3532 0.3211 1.15 0.032 
GRIK3 1p34.3      
rs6691840  G*/T 0.2600 0.2226 1.25 0.037 
PDE4B 1p31.3      
rs910694  C/T* 0.5780 0.5477 1.30 0.030 
GSTM1 1p13.3      
GSTM1*0  ins-allele/del-allele* 0.7546 0.7140 1.35 0.041 
RGS4 1q23.3      
rs2661319  A/G* 0.4920 0.4744 1.08 0.0176 
IL10 1q32.1      
rs1800896  G*/A 0.3056 0.2657 1.42 0.040 
PLXNA2 1q32.2 A/G     
rs841865  A/G* 0.8434 0.8001 1.32 0.043 
rs1327175  G/C* 0.92840 0.91243 1.32 0.016 
DISC1 1q42.3      
rs3737597  A*/G 0.03069 0.01735 1.80 0.013 
rs999710  A*/G 0.3989 0.3819 1.07 0.0170 
Table 2. Schizophrenia-associated genes on the chromosome 1 that could meet the criterion 
5.3 The mtDNA hypothesis for schizophrenia and its predictions 
Thus we propose here a new hypothesis which insists that the risk loci for schizophrenia are 
in the mtDNA.  
Mitochondria are involved in a variety of major cellular events such as oxidative 
phosphorylation, free radical production and Ca2+ buffering, and play an active role in 
apoptosis. They possess two classes of antioxidant defense system (non-enzymatic and 
enzymatic), and structurally and functionally intact mitochondria serve as a net sink rather 
than a net source of reactive oxygen species (ROS) (Andreyev et al., 2005). ROS-defenses are 
severely undermined in structurally compromised mitochondria (Andreyev et al., 2005). 
Thus, mitochondrial dysfunction, presumably through imbalance of ROS production and 
removal (Andreyev et al., 2005), raises ROS emission (Esposito et al., 1999; Senoo-Matsuda 
et al., 2001) and causes intracellular oxidative stress. 
Because abnormal mtDNA may cause mitochondrial dysfunction, the hypothesis predicts: 
(1) enhanced oxidative stress and disturbed energy metabolism in predisposed individuals, 
which may cause various pathogenic alterations such as genomic instability, aberrations in 
neurodevelopment, and the brain dysfunction. Furthermore, because mtDNA can be 
transmitted only through females and there is no link between the nuclear genome and the 
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mitochondrial genome, the mtDNA hypothesis predicts: (2) a higher maternal transmission 
of schizophrenia, and (3) positive associations between resistance genes and schizophrenia 
as well as negative associations between facilitating genes and schizophrenia (see 5.2). These 
predictions seem to be consistent with other major epidemiological findings and the results 
of the genetic and the pathophysiological studies to date. 
5.3.1 Mitochondrial dysfunction and enhanced oxidative stress in affected individuals 
The hypothesis predicts that patients with schizophrenia show mitochondrial dysfunction 
and enhanced oxidative stress. 
Indeed, in the past decade, mitochondrial dysfunction and oxidative stress in schizophrenia 
has been suggested by several independent lines of evidence (for review, see Marchbanks et 
al., 1995; Ben-Shaffer, 2002; Wood et al., 2009); those include mitochondrial hypoplasia, 
disturbed oxidative phosphorylation, and altered mitochondrial-related gene expression in 
several cell lines. 
The pioneering works in this field may be noteworthy (Utena & Niwa, 1992). As early as 
1950, Hayashi, in a longitudinal study on glucose metabolites in blood sampled from the 
superior bulb of the internal jugular vein of schizophrenics, observed a decreased 
carbonic dioxide production in the brain and a higher level of lactate and glutathione, the 
brain’s dominant free radical scavenger, in patients in an acute exacerbation of the illness. 
Utena and Ezoe (1951) reported a decreased glucose consumption in vitro in cortical brain 
tissues sampled from patients with schizophrenia who underwent prefrontal leukotomy. 
Takahashi (1953) confirmed this finding and emphasized the necessity of further 
investigations on oxidative phosphorylation in the brain tissue of schizophrenics. In line 
with those findings was the report by Stabenau et al. (1969), who observed, in a 
biochemical study of discordant monozygotic twin pairs, that lactate production and the 
lactate-pyruvate ratio were higher in the affected twins than the unaffected cotwins. More 
recently, Prabakaran et al. (2004), in a large-scale functional genomics study, suggested a 
state of intermittent or chronic hypoxic stress and mitochondrial dysfunction in the brain 
of patients with schizophrenia. 
5.3.2 The mode of transmission 
The hypothesis predicts a higher maternal transmission of schizophrenia. Although there 
has been no convincing evidence for maternal transmission of schizophrenia, several reports 
suggest a higher maternal transmission of schizophrenia (Shimizu et al., 1987; Goldstein et 
al., 1990; Valero et al., 1998; Li et al., 2007). 
Some researchers have proposed the hypothesis that schizophrenia is associated with de 
novo mutations arising in paternal germ cells (Malaspina et al., 2001; Zammit et al., 2003; 
Byrne et al., 2003; El-Saadi et al., 2004; Sipos et al., 2004). It is based on the observation 
(‘paternal age effect’) that the risk of schizophrenia in the offspring seems to increase as the 
paternal age advances from 20 years to over 50 years. 
However, the difference in the mean ages of fathers between affected and unaffected 
individuals are not very large (< 1.7 years) (Malaspina et al., 2001; El-Saadi et al., 2004). 
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(< 21 years) (Malaspina et al., 2001; El-Saadi et al., 2004; Sipos et al., 2004) as well as in the 
offspring of younger women (< 20 years) (El-Saadi et al., 2004). Therefore, major roles of 
paternally derived mutations in schizophrenia seem to remain unsubstantiated. 
Indeed, no available data can exclude the possibility that the ‘paternal age effect’ has a 
‘maternal origin’; while women in many countries today may be usually supposed to bear 
children after the age of 20 years and not to marry much older men or too young men unless 
the men have special socio-economic benefits, a certain proportion of predisposed women 
might behave differently. 
It should be noted that in the famous twin study by Gottesman and Bertelsen (1989) which 
included almost equal number of male and female monozygotic twins, most schizophrenic 
twins whose offspring are affected are females (12 out of 14), implying that the transmission 
was mainly via females ( 14 14 1414 12 14 13 14 140.5 0.5 0.5 0.007p C C C       ). While this 
gender effect might be due to non-genetic factors such as stronger psychological interactions 
between mother and child, we must also consider the possibility that it is due to the closer 
genetic relationship between mother and child, i.e. the mtDNA. 
5.3.3 Sex difference and a protective effect of estrogen in schizophrenia 
The hypothesis predicts that endogenous antioxidants exhibit a protective effect against 
schizophrenia, and may give a plausible explanation for sex difference of the disease. 
A consistent and specific finding for schizophrenia is that the age at onset is significantly 
lower in males than in females (Jablensky, 1995; Kulkarni & Fink, 2000); schizophrenia starts 
earlier on average in males and reaches its peak between 15 and 25 years of age, whereas in 
females it occurs almost between 20 and 30 years of age and shows a less steep curve after 
that age. It also appears that women are vulnerable to relapses or first episode of 
schizophrenia in the perimenoposal period (the second peak of onset for females) (Kulkarni 
& Fink, 2000), when estrogen production diminishes. A close association between 
premenstrual or menstruation phase and exacerbation of the illness in females has been well 
documented (Kulkarni & Fink, 2000). In addition, less negative symptoms, less brain 
morphological changes, and better response to neuroleptic medication are relatively 
consistent finding in female patients with schizophrenia (Jablensky, 1995; Goldstein & 
Lewine, 2000). 
These observations lead to the concept that estrogen protects predisposed females (Kulkarni 
& Fink, 2000), which seems to accord with the hypothesis; estrogen has been shown to have 
antioxidant activity due to its intrinsic antioxidant structure that lies in the phenolic moiety 
of the steroidal compound (Behl, 2002), to increase antioxidant enzyme activities (Strehlow 
et al., 2003; Pajović et al., 2003), and to have neuroprotective effect against oxidative stress 
(Behl, 2002; Brann et al., 2007). Furthermore, mitochondrion has estrogen binding sites 
(Monje & Boland, 2001; Chen et al., 2004) and estrogen increases mitochondrial efficiency 
and reduces intracellular oxidative stress (Stirone et al, 2005). 
5.3.4 Low comorbidity between schizophrenia and rheumatoid arthritis 
The hypothesis predicts that diseases predisposed by facilitating genes, if present, would be 
negatively associated with schizophrenia. Rheumatoid arthritis could be one of such 
candidates. 
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A role of oxidative stress in the pathogenesis of rheumatoid arthritis has been suggested by 
several lines of evidence (for review, see Hitchon et al, 2004). In addition, it has been shown 
that chronic oxidative stress in the synovial T lymphocytes is not secondary to exposure to 
environmental free radicals but originates from intracellularly produced reactive oxygen 
species (Remans et al, 2005). Therefore, a presumptive susceptibility gene for rheumatoid 
arthritis, which may cause intracellular oxidative stress in several cell lines, could be a 
facilitating gene for schizophrenia in this model and is likely to be subject to a negative 
selection in the predisposed matrilineal pedigrees. 
Indeed, robust evidence shows a negative association between schizophrenia and 
rheumatoid arthritis while the exact mechanism is still unknown (Vinogradov et al., 1991; 
Jablensky, 1995; Rubinstein, 1997; Oken 1999). According to the nuclear genome model, 
several hypotheses have been proposed such that pathogenic genes for schizophrenia may 
be protective genes for rheumatoid arthritis and vice versa. 
Thus the mitochondrial genome model may offer a new explanation for the low comorbidity 
between schizophrenia and rheumatoid arthritis and the additional prediction: most of 
patients with both of the diseases would be females because the survival rate of males in 
early life stage must be remarkably reduced due to lack of the antioxidant defense by 
estrogen, and show more negative symptoms, poorer response to neuroleptic medication, 
and/or more morphological changes in the brain. 
5.3.5 Prenatal risk factors for schizophrenia 
The hypothesis predicts that early-life exposure to environments which induce strong 
oxidative stress can increase the risk of later development of schizophrenia in the 
predisposed population. 
Indeed, prenatal environmental factors such as severe nutritional deficiency (Susser, et al., 
1996), exposure to increased homocysteine (Brown et al., 2007) or lead (Opler & Susser, 
2005), and infection of influenza virus (Limosin et al., 2003; Brown et al., 2004; Opler & 
Susser, 2005) and Toxoplasma gondii (Brown et al., 2005) have been suggested to increase 
the risk for schizophrenia. More recently, it has been suggested that central nervous system 
infections of cytomegalovirus or mumps virus in childhood may also increase the risk for 
schizophrenia (Dalman et al., 2008). All of these factors have been shown to affect 
mitochondria, inducing strong intracellular oxidative stress and/or apoptosis (Akaike et al., 
1990; Edlund et al., 1994; Speir et al., 1998; He et al., 2003; Berger et al., 2004; Zaki et al., 2005; 
Gupta et al., 2004; Kruman et al., 2006; Wang et al., 2006; Poncet et al., 2006; Chang et al., 
2007; Nishikawa et al., 2007). 
5.3.6 Increased obstetric complications in the birth of patients with schizophrenia 
It has been suggested that mitochondrial dysfunction may be involved in the etiology of 
preeclampsia (Shanklin et al., 1990; Barton et al., 1991; Furui et al., 1994). In addition, a high 
incidence of preeclampsia, eclampsia, and stillborn infants has been observed in a family 
with a known mitochondrial disorder (Torbergsen et al. 1989). Folgero et al. (1996) 
demonstrated two separate mtDNA point mutations in two families having a high incidence 
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Therefore, the hypothesis predicts that the risk of preeclampsia, eclampsia, or stillbirth may 
be increased in the birth of patients with schizophrenia as well as in the pregnancies of 
women with schizophrenia. Indeed, an excess of stillbirths and neonatal deaths among 
women with schizophrenia has been reported by several investigators (Sobel, 1961; Rieder et 
al., 1975; Modrzewska, 1980; Webb et al., 2005). 
Furthermore, there has been a body of evidence for an increased risk of obstetric 
complications in the birth of patients with schizophrenia (Dalman et al., 1999; Cannon et al., 
2002). A meta-analysis of population-based data (Cannon et al., 2002) found significant 
estimates for three main categories of obstetric complications: (1) complications of 
pregnancies, (2) abnormal fetal growth and development, and (3) complications in delivery. 
Among all, preeclampsia was the strongest individual risk factor detected in the largest 
single population-based cohort study to date (Dalman et al., 1999). 
Although obstetrical events in schizophrenia are often considered as having a direct 
causative effect, none of the available data can refute the hypothesis that they are merely 
markers of some other causal process (Rapoport et al., 2005), such as mitochondrial 
dysfunction which is implicated in this hypothesis. 
5.3.7 An apparent signature of positive selection in schizophrenia-associated  
genes 
Since the positive selection of the schizophrenia-associated alleles mentioned above occurs 
only in the predisposed matrilineal pedigrees, a ubiquitous subpopulation in humans, 
frequencies of those alleles may not be so high in the general population as if the selection 
had occurred recently in the general population.  
Thus, the hypothesis predicts that every schizophrenia-associated nuclear gene shows an 
apparent signature as if it had been subject to a positive selection in the recent evolutionary 
history of humans. Recent two reports (Lo et al, 2007; Crespi et al., 2007) seem to be in line 
with this prediction. 
On the other hand, the nuclear genome model predicts that every schizophrenia-associated 
nuclear gene shows an apparent signature of negative selection due to the strong negative 
selection pressure. 
5.3.8 Genomic instability 
It is generally thought that a major cause of DNA damage that leads to mutations is reactive 
oxygen species, which are generated as a normal part of oxygen metabolism but are also 
produced by ionising radiation, metabolism of exogenous compounds (Hussain et al., 2003; 
Finkel, 2003). It has been shown that endogenous mitochondrial oxidative stress can induce 
many types of DNA damage including double strand breaks, end-to-end fusions, base and 
sugar modifications, DNA-protein cross-links, and gross chromosomal rearrangements 
(Ragu et al., 2007; Samper et al., 2003). 
Therefore, the hypothesis predicts that the enhanced oxidative stress may cause genomic 
instability during meiosis and/or early phase of ontogeny, producing increased rates of 
random point mutations and/or structural variants of the nuclear genome in the 
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predisposed population. In addition, genomic instability may be more pronounced in males 
due to lack of antioxidant protection by estrogen. 
There have been numerous reports of associations between schizophrenia and chromosomal 
abnormalities including fragile sites, reciprocal translocations, inversions, insertions, 
deletions, disomy and trisomy in many autosomes, and sex chromosome aneuploidies 
(Macintyre et al, 2003). However, with an exception of 22q11 deletion, none of these have 
been consistently replicated, and with another exception of (1,11) (q42;q14.3) balanced 
translocation, none provides convincing evidence for the location of a ‘susceptibility’ gene 
(Kirov et al., 2005). 
A popular explanation in the nuclear genome model may be that most of these  
structural variants are coincidental findings of no clinical significance. Alternatively, those 
alterations may indicate genomic instability in schizophrenia. An increased risk of 
schizophrenia in individuals with 22q11 deletion (Pulver et al., 1994; Murphy et al.,  
1999) might be due to haplodeficiency of presumptive resistance genes of gain-of- 
function type and/or presumptive facilitating genes of loss-of-function type aggregated on 
22q11. 
More recently, it has been reported that rare structural variants such as microdeletions or 
microduplications of sizes ranging from 100kb to 15MB throughout the genome are more 
frequent among individuals with schizophrenia than unaffected individuals (Walsh et al., 
2008). While many of those structural variants duplicate or delete genes in 
neurodevelopmental pathways, one third of those do not disrupt genes, leaving their role in 
causation of the disease unwarranted. Another recent report (Xu et al., 2008) has shown that 
de novo copy number mutations are increased in sporadic schizophrenia. However, the 
cytobands of those copy number mutations are diverse among the affected individuals and 
their roles in the pathogenesis still remain unclear. Therefore, no available data can refute 
the possibility that those structural variants and copy number mutations are not the causes 
of schizophrenia but the results of the genomic instability in schizophrenia predicted by our 
hypothesis. 
Indeed, direct measure of the de novo mutation rates shows an increased mutation rate in 
schizophrenia (Awadalla et al., 2010), and genomic and epigenomic instability has been 
suggested in schizophrenia (Smith et al., 2010). Furthermore, it has been shown that blood 
cells from patients with schizophrenia present a higher rate of folate-sensitive fragile sites, 
and that male patients exhibit twice as many fragile sites as females while there are no age 
effects (Demirhan et al., 2006). This sex difference may indicate that increased fragile sites 
expression (genomic instability) is the results of enhanced oxidative stress in patients with 
schizophrenia. 
6. Conclusion 
Genetic research of schizophrenia based on the nuclear genome model has been one of the 
most active areas in psychiatry for the past two decades. Although this effort is ongoing, 
results of association studies have been inconsistent and the situation of molecular genetics 
of schizophrenia today has become much confused just contrary to our expectation. The 
consistent major epidemiological findings of schizophrenia, coupled with the results of 
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Rather, they seem to argue in favor of the mitochondrial genome model, suggesting a 
necessity of paradigm shift from the nuclear genome model to the mitochondrial genome 
model in genetic research of schizophrenia in the coming years. 
Note: Cross-generational reduction of females with pathogenic genes in the 
mitochondrial genome model 
At first we define several notations. N1: the number of normal females in the first generation; 
N2: number of female offspring of normal females; S1: the number of unaffected female 
siblings of patients in the first generation; S2: the number of female offspring of unaffected 
female siblings of patients; P1: the number of female patients; P2: the number of female 
offspring of female patients; r (0 < r < 1): the proportion of gene carriers in normal females in 
the first generation. Then the number of female gene carriers in the first generation is 
( 111 PSrN  ) and the frequency of female gene carriers in the first generation is given by: 
1 1 1 1 1
1
1 1 1 1 1 1
(1 )rN S P S Pf r r
N S P N S P
  
    
   
.  
And the frequency of female gene carriers in the second generation is given by: 
2 2 2 2 2
2
2 2 2 2 2 2
(1 )rN S P S Pf r r
N S P N S P
  
    
   
. 
Thus we have (Table 3): 
31 1 2 2
1 2
1 1 1 2 2 2
(1 ) 5.06 10S P S Pf f r
N S P N S P
           
    
. 
 
 N S P Total (S+P) / Total 
# of females 410,093 11,873 4,784 426,750 0.03903 
# of female 
children 366,460 10,969 1,917 379,346 0.03397 
      31006.5)1(00506.0  r  
Table 3. Epidemiological data by Haukka et al. (2003) 
In this largest-sampled cohort study to date, Haukka et al. comprised all births in Finland 
during 1950-1959 (N=870,093) and followed up through the National Hospital Discharge 
Register for Hospitalizations between 1969 and 1992. N: normal females; S: unaffected 
female siblings of patients; P: female patients with schizophrenia 
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 N S P Total (S+P) / Total 
# of females 410,093 11,873 4,784 426,750 0.03903 
# of female 
children 366,460 10,969 1,917 379,346 0.03397 
      31006.5)1(00506.0  r  
Table 3. Epidemiological data by Haukka et al. (2003) 
In this largest-sampled cohort study to date, Haukka et al. comprised all births in Finland 
during 1950-1959 (N=870,093) and followed up through the National Hospital Discharge 
Register for Hospitalizations between 1969 and 1992. N: normal females; S: unaffected 
female siblings of patients; P: female patients with schizophrenia 
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1. Introduction 
Epidemiological information is needed for developing public policies to improve children’s 
mental health. In particular, epidemiological research could provide answers to questions 
such as 1) How many children in the community have mental health problems; 2) What is 
the distribution of mental health problems across age, sex, levels of socio-economic status, 
and neighbourhood disadvantage; 3) What is the information about mental health problems 
from different informants (parents, teachers, and the child); and 4) What is the 
developmental course of mental health problems in childhood (Costello & Angold, 2006)? 
Answers to such questions may assist policy-makers and clinicians in designing strategies 
for improving mental health in children.  
After briefly explaining epidemiological concepts and strategies, a selective review of 
epidemiological research relevant to child mental health policies is given. The purpose of 
the second part of this chapter is to report on results of two studies. The studies were 
performed in order to assess the prevalence of emotional and behavioural problems from 
different informants, to investigate factors which may be associated with prevalence, and to 
determine the prevalence and incidence rates of ADHD and ODD from preschool to 
primary school. Of additional concern was the developmental course of externalizing 
behaviour problems. Finally, the implication of the epidemiological outcomes for future 
research and mental health services are discussed. 
2. Aims of epidemiological research 
The epidemiology of childhood psychopathology includes the following aims (Costello & 
Angold, 1995):  
- to identify the onset, frequency and distribution of mental disorders and the occurrence 
of psychological symptoms in different population groups and regions, 
- the risk-increasing factors that determine the onset and course of disorder, to determine 
in different population groups, 
- to determine the risk mitigation factors that protect individuals at increased risk of 
interference from mental disorders, 
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After briefly explaining epidemiological concepts and strategies, a selective review of 
epidemiological research relevant to child mental health policies is given. The purpose of 
the second part of this chapter is to report on results of two studies. The studies were 
performed in order to assess the prevalence of emotional and behavioural problems from 
different informants, to investigate factors which may be associated with prevalence, and to 
determine the prevalence and incidence rates of ADHD and ODD from preschool to 
primary school. Of additional concern was the developmental course of externalizing 
behaviour problems. Finally, the implication of the epidemiological outcomes for future 
research and mental health services are discussed. 
2. Aims of epidemiological research 
The epidemiology of childhood psychopathology includes the following aims (Costello & 
Angold, 1995):  
- to identify the onset, frequency and distribution of mental disorders and the occurrence 
of psychological symptoms in different population groups and regions, 
- the risk-increasing factors that determine the onset and course of disorder, to determine 
in different population groups, 
- to determine the risk mitigation factors that protect individuals at increased risk of 
interference from mental disorders, 






- to determine the need for psychosocial support facilities and possible costs that burdens 
the healthcare system due to mental disorders and their consequences. 
Epidemiology does not refer to a single scientific discipline or the use of one specific 
methodology. Instead, epidemiology derives and integrates concepts and methods from 
other areas such as biology, statistics, and sociology. In epidemiology, the combination of 
measurement principles and statistics is used for the development and testing of diagnostic 
assessment procedures. When applied to psychological concepts, the combination of 
measurement and statistics is called psychometrics. In epidemiology of child 
psychopathology, psychometric principles play an important role. A number of specialized 
areas that are derived from classical epidemiology are relevant to child psychopathology, 
including clinical epidemiology, genetic epidemiology, and pharmaco-epidemiology. 
Clinical epidemiological studies concern the development and application of diagnostic and 
screening tests, the prognosis of disorders, the effects of treatment and clinical decision-
making.  
3. Epidemiological concepts and strategies 
Epidemiology is concerned with the study of the distribution and determinants of disease 
frequency in human populations. The quantification of the occurrence of psychopathology 
in populations, can be regarded the central task of epidemiology. Well-known measures of 
frequency are prevalence (see 4.1) or incidence. Incidence quantifies the number of new cases 
with a disorder that develop in a population during a specified period of time. Cumulative 
incidence is the proportion of individuals who become disordered during a specified period 
of time (Verhulst, 1995). The distribution of disorders, involves comparisons between 
different populations or subpopulations. The examination of factors that are associated with 
variations in the distribution of psychopathology is essential for testing etiological 
hypotheses. Measures of association and risk are quantifications of the influence of certain 
factors on the occurrence of disorder. In follow-up studies measures of risk for developing a 
disorder using categorical data are relative risk, and attributable risk. In case-control studies 
the measure often used is the odds ratio which reflects the likelihood for developing a 
disorder in the group with a possible aetiological factor versus the group without this factor 
(Verhulst, 1995). For a more detailed discussion, see Verhulst and Koot (1992). 
Epidemiological studies can be divided into prospective and retrospective studies, 
depending respectively on whether the measurement of exposure to a risk factor was done 
before or after the disorder occurred. A study, in which the presence or absence of a 
disorder and the presence or absence of associated factors are assessed at the same time, is 
called a cross-sectional study. If the aim of the cross-sectional study is limited to the 
determination of the prevalence, the study is called prevalence study.  
4. Prevalence studies 
4.1 Basics 
Prevalence can be defined as the proportion of a population that has mental health problems 
at a specific point in time; it is often defined as point prevalence. Prevalence is calculated by 
dividing the number of cases by the total population. It is also possible to quantify the 
number of cases known to have the disorder at any time during a specified period. This so-
 
The Epidemiology of Child Psychopathology: Basic Principles and Research Data 
 
141 
called period prevalence (e.g. 6-month prevalence or lifetime prevalence) is frequently used in 
prevalence studies of child psychiatric conditions. There are two types of studies 
determining the prevalence of child psychopathology: (1) those that produce prevalence 
rates of psychiatric diagnoses, usually based on DSM (Diagnostic and Statistical Manual of 
Mental Disorders) criteria, and (2) those that generate scores on psychiatric symptom rating 
scales. 
Many studies that determined prevalence rates of DSM diagnoses in general population 
samples of children have been conducted. Costello, Egger and Angold (2005), Roberts, 
Attkisson and Rosenblatt (1998), Verhulst (1995), and Waddell et al. (2002) provided 
reviews. Despite huge research efforts and many children involved, comparisons between 
these studies are seriously hampered by large differences in design and methodology 
including differences in sample size, age of children, assessment and sampling procedures, 
and case definition. Even for studies conducted in countries comparable in language, 
culture, and availability of services, differences in prevalence rates were extremely large and 
ranged from 10% to 20% (Waddell et al., 2002). It is more likely that these differences reflect 
variations in methodology than differences in true prevalence. Methodological variations 
and the lack of standardization among studies seriously limit the value of prevalence figures 
of categorical diagnoses. 
The second approach, the use of rating scales for assessing parent- or self-reported 
emotional and behavioural problems of children in representative general population 
samples, is less vulnerable to methodological differences. This approach produces 
problem scores on continuous scales and does not generate prevalence rates for 
categorical diagnoses. Often, statistical criteria are used for distinguishing between cases 
and non-cases. Although dividing lines for caseness may be rather arbitrary, there are 
epidemiological methods for selecting effective cut-off points. However, prevalence 
figures will vary with the statistical criterion and cannot be used as absolute population 
prevalence measures without relating them to similar measures for other populations or 
subpopulations (Verhulst, 1995). In two recent multicultural prevalence studies, parents’ 
reports and youths’ self-reports of problems for children using the Child Behavior 
Checklist (CBCL) in 31 cultures, and the Youth Self-Report (YSR) in 24 cultures, were 
compared (Rescorla et al., 2007a; b). It was found that, when the same standardized 
assessment procedures are used for assessing children from different cultures, cultural 
differences per se do not lead to big differences in reported problems. Instead, individual 
differences within each cultural group are bigger than differences between the average 
scores obtained in different cultures. Assessment procedures with good cross-cultural 
track records and appropriate translations that capture individual differences in reliable 
and valid ways are apt to reflect the mental health needs of children that are robust across 
cultures (Achenbach & Rescorla, 2007).  
4.2 Methodological Issues  
A number of methodological issues of child psychiatric prevalence studies will be 
considered for better understanding the results of these studies. Issues that pertain to 
general epidemiological methodology, such as sampling and data analysis, will not be 
discussed here. The focus will be on issues that are specific to child psychopathology, such 
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A number of methodological issues of child psychiatric prevalence studies will be 
considered for better understanding the results of these studies. Issues that pertain to 
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Assessment: All assessment procedures are subject to error due to variations in the 
phenomena being assessed and in the procedures themselves. To reduce variations in the 
data obtained and to improve precision is the use of standardized assessment procedures. 
Epidemiological researchers in child psychiatry were among the first to use standardized 
assessment procedures (Rutter et al., 1970). Rating scales were developed because they 
could easily be applied in a cost effective way in large-scale epidemiological studies, and 
standardized psychiatric interviews were developed for more in-depth assessments of the 
prevalence of psychiatric diagnoses. Conversely, epidemiological data are indispensable for 
obtaining norms and for testing the validity of these instruments (Shaffer et al., 1999). 
Epidemiological comparisons of normal and disordered children are needed to determine 
how childhood disorders are actually distributed and for identifying optimal cut-offs for 
distinguishing between children who will most likely benefit from particular interventions 
versus those who will not (Fombonne, 2002; Verhulst, 1995). 
There are two main approaches, the empirical and the a priori approach, to determine the 
level of psychopathology in individuals. The empirical approach employs multivariate 
statistical techniques, such as factor analysis and principal components analysis that are 
used to identify sets of problems that tend to occur together. These co-occurring items 
constitute empirical syndromes. This approach starts with empirical data derived from 
informants who describe the behaviour of children, without any assumptions about whether 
these syndromes reflect predetermined diagnostic categories. The empirical-quantitative 
approach forms the basis of the empirical syndromes of rating scales such as the Child 
Behavior Checklist (CBCL; Achenbach, 2009) or the Conners’ Rating Scales (Conners, 1997). 
Prevalence studies using the empirical approach generate quantitative scores reflecting the 
level of problems of a child. Imposing cut points to the quantitative scores can make 
categorical distinctions between disordered and normal individuals. The second approach 
refers to the diagnostic categories employed by of one of the two international nosological 
systems, the fourth edition of the American Psychiatric Association's Diagnostic and 
Statistical Manual of Mental Disorders (DSM-IV) or the World Health Organization's 
International Classification of Diseases (ICD). This approach starts with assumptions about 
which disorders exist and about which symptoms define them. Some prevalence studies 
generating DSM diagnoses for general population samples as discussed above used 
combinations of both approaches with rating scales for screening the total sample and 
psychiatric interviews used for assessing a selected subsample of children scoring in the 
problem range of the rating scales. 
Multiple informants: To obtain a comprehensive picture of a child’s functioning, information 
from different informants is needed. Many prevalence studies used information from 
usually parents, teachers, and the child. The reason for this is because agreement among 
informants is far from perfect, and because no one informant can substitute for all others. 
Different informants having different relations to the child and seeing the child under 
different conditions, often vary in their response to the child's behaviour. In a first meta-
analytic study, Achenbach et al. (1987) computed the average correlation between different 
informants' ratings of problem behaviours in a large number of published samples. The 
mean correlation between pairs of adult informants who played different roles with respect 
to the children was 0.28 (e.g., parents versus teachers). The mean correlation between self-
reports and reports by parents, teachers, and mental health workers was even lower (0.22). 
In contrast, the mean correlation between pairs of similar informants (e.g., father and 
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mother; teacher and teacher aide) was 0.60. These findings were confirmed by more recent 
studies (Duhig et al. 2000; Grietens et al. 2004). There are several possible explanations for 
cross-informant discrepancies in parent and teacher reports of child behaviour problems, 
including issues related to informant bias, the demands of the context in which the child’s 
behaviour is being assessed and poor measurement reliability (De Los Reyes & Kazdin, 
2005). For reasons of comparability, it is recommended that prevalence studies report 
prevalence rates based on specific informants separately, and that procedures for combining 
information from different informants will be well documented in ways that can be easily 
replicated.  
Disagreement among informants can be valuable (Jensen et al., 1999). As example, 
Ferdinand et al. (2003) studied problem behaviour in adolescents from the Dutch general 
population, aged 15 to 18 years, across a 4-year period. Initially, parent information was 
obtained with the CBCL and self-reports with the Youth Self-Report. Signs of poor outcome, 
including police contacts and drug use, were assessed four years later. Discrepancies 
between information from parents and adolescents added significantly to the prediction of 
poor outcome based on information from each informant separately. For instance, scores on 
the Delinquent Behavior syndrome based on parent information or on adolescents´ self-
reports separately did not predict future police contacts. However, if parents reported scores 
in the deviant range on the Delinquent Behavior scale, while adolescents reported scores in 
the normal range on this scale, adolescents were at increased risk for later police or judicial 
contacts (Verhulst & Koot, 1995).  
Morbidity criteria: Most problem behaviours in children can best be regarded as quantitative 
variations rather than present/absent categories. This approach allows for inter-individual 
differences that are normal. Abnormality can be regarded as the quantitative extreme of the 
normal distribution. This quantitative approach makes it possible to assess the degree to 
which an individual child’s problems deviate from those that are typical of the individual’s 
age and sex. In order to make such comparisons, we need data on large, representative 
samples of boys and girls of different ages from the general population. Despite the fact that 
many psychopathological phenomena in children can best be regarded as quantitative 
variations, for identifying individuals in the general population with mental health 
problems, we need to dichotomise quantitative information into categories that are defined 
by cut points for distinguishing between cases and non-cases. There is as yet little basis for 
perfect categorical distinctions between psychopathology and normality. For most problem 
rating scales this is done by comparing the distribution of scores for non-cases with the 
distribution of scores for cases. In the absence of an ultimate criterion for caseness, the most 
frequently used morbidity criterion is whether a child has been referred for specialist mental 
health services. However, caution is needed because this approach is fallible; some children 
who are not referred may have significant problems, while not all children who are referred 
really need professional help.  
DSM diagnostic criteria can also be used for deciding who is disordered and who is not. 
These criteria are the result of negotiations among expert panels and often lack firm 
empirical evidence. Prevalence studies that use DSM diagnostic criteria to define caseness 
run into the problem that DSM criteria are overinclusive, often resulting in extremely high 
prevalence rates. As example, Bird et al. (1988) found that 49.5% of children in Puerto Rico 
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DSM diagnostic criteria with impairment measure, for example the Children’s Global 
Assessment Scale (CGAS; Shaffer et al., 1999). The newest versions of some psychiatric 
interviews such as the Diagnostic Interview Schedule for Children (DISC; Shaffer et al., 
2000) and the Child and Adolescent Psychiatric Assessment (CAPA; Angold & Costello, 
2000) have included impairment criteria. Because many children who meet criteria for DSM 
disorders are not greatly impaired in their everyday functioning, the addition of impairment 
measures results in a decrease of prevalence rates. In a Dutch prevalence study, for example, 
the prevalence of 21.8 % of children who met criteria for any DSM-III-R disorder based on 
parent interview information dropped to 5.9 % when combined with a CGAS score 
indicating definite impairment (Verhulst et al., 1997). Conversely there are also many 
children who can be regarded functionally impaired but do not meet criteria for DSM 
diagnoses. Some 50% of children attending clinics in the Great Smoky Mountains Study do 
not reach DSM or ICD criteria for a diagnosis and yet half of these are significantly impaired 
in their social functioning (Angold et al., 1999).  
4.3 Factors associated with prevalence 
Of many factors that have been tested for association with prevalence in general population 
studies, findings for gender, age, SES, and degree of urbanization will be discussed here, 
because those are factors with findings that have been replicated across studies (Achenbach 
& Rescorla, 2007). 
Gender: Gender differences in prevalence are very robust across cultures, informants and 
across types of studies, in particular those that used rating scales and those that used DSM 
diagnostic criteria. Girls score higher than boys on internalizing psychopathology such as 
anxiety, depression and somatic complaints, and boys score higher than girls on 
externalizing behaviours such as attention and hyperactivity problems and aggressive and 
delinquent behaviours. These gender differences are found for both parent- and self-
reported problems. Despite the range in cultural, economic, political and genetic differences, 
there is consistency in population-based findings that boys have more externalizing and 
girls have more internalizing problems. 
Age of children and adolescents: From a developmental perspective, the effects of age on levels 
of psychopathology in individuals can best be studied through longitudinal studies. For 
public policy purposes, cross-sectional data on prevalence with age can be important for 
service planning. Age interacts with gender as a factor associated with prevalence. Boys 
show more problems than girls when they are younger, whereas girls show more problems 
than boys in adolescence (Achenbach & Rescorla, 2007). In a multicultural study of self-
reported problems across 7 countries, both internalizing and externalizing behaviours 
increased with ages 11 to 18 years. In another multicultural study of parent-reported 
problems of children aged 6 through 11 years across 12 countries, and aged 6 through 17 
years in 9 countries, externalizing problems decreased and internalizing problems increased 
with age (Achenbach & Rescorla, 2007). Although parents and adolescents agreed in 
reporting increases with age of internalizing problems, they disagreed about externalizing 
problems. Apparently parents are increasingly unaware of their child’s externalizing 
behaviours with increasing age. This is probably caused by a developmental shift in type of 
externalizing problems, with overt physically aggressive and oppositional behaviours 
decreasing with age and status violations such as truancy, running away from home, and 
substance abuse increasing with age (Bongers et al., 2003). 
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Socio-economic status: Previous studies have shown that rates of psychopathology are higher 
among individuals with lower socioeconomic status (SES) than those with higher SES (e.g. 
Schonberg & Shaw 2007). Published findings regarding associations between parents’ 
marital status, immigration, and child behaviour problems are rare, and fewer studies still 
have reported on these associations in early childhood (Javo et al., 2004). Achenbach and 
Rescorla (2007) summarize studies from 15 cultures that tested associations between scores 
on empirically based scales and measures of socio-economic status (SES) in large population 
samples. Measures of SES varied across studies, but most used the occupation and/or 
education of the child’s parents and grouped participants into low-, medium-, and high-SES 
groups. A few studies also used measures of family income. Although the studies varied in 
statistical details, they were consistent in reporting higher problem scores for children from 
lower-SES than from higher SES (Verhulst, 1995; Waddell, 2002). Although this finding was 
consistent across studies, the effects were rather small. There are a number of reasons that 
may be responsible for the finding that children from lower SES are somewhat 
disadvantaged.  
Degree of urbanization: Most studies investigating differences in prevalence rates between 
urban and rural populations did not find significant differences (Waddell et al., 2002). 
Achenbach and Rescorla (2007) conducted a detailed comparison of varying degrees of 
urbanization while controlling for sex, age, referral status, SES, region and ethnicity in a US 
national sample. Children from the most urban areas showed a slight tendency to obtain 
higher parent reported problem scores than children from the most rural areas. However, 
unexpectedly, the greatest contrast in problem scores was found between children in the 
intermediate categories versus those in the most rural areas, with highest scores for children 
in the intermediate categories. 
5. Behavioural and emotional problems of kindergarten children 
5.1 Background 
Behavioural and emotional disturbance are very common among children and adolescents. 
Approximately 20 % of children in Western, industrialized countries experience the signs 
and symptoms that constitute internalizing (e.g. anxiety/depression, withdrawal) or 
externalizing (e.g. oppositional defiance, aggression) DSM-IV disorders (Tolan & Dodge, 
2005). Recently, epidemiological research has begun to focus on children younger than six 
and to consider the clinical significance of behavioural and emotional problems of this 
period of the life span (Angold & Egger, 2007). A review on the epidemiology of emotional 
and behavioural disorders in preschool children estimated the overall prevalence of 
‘problematic’ behaviour as lying at somewhere between 7 % and 25 % (Egger & Angold, 
2006). Empirical findings illustrate a first peak in multi modal distribution of mental health 
service utilization in childhood in 6-9-year-old children (e.g. Campbell, 2006). This raises the 
question of whether child psychiatric disturbance pre-exists school attendance, but remains 
undetected.  
In a study in the US, Wadsworth and Achenbach (2005) reported differential incidence by SES 
for elevated scores on internalizing and externalizing disorders. It is not yet clear whether 
these findings can be generalized outside of the US, and to preschool age and other 
informants. From a multicultural perspective, Achenbach and Rescorla (2007) specified in their 
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of the study were 1) to assess the prevalence of emotional and behavioural problems from 
different informants in children aged 3-6 years old, and 2) to investigate factors which may be 
associated with prevalence such as demographic and socio-economic factors. 
5.2 Methods 
5.2.1 Participants 
The study population comprised 474 families and their children attending preschools in the 
city of Braunschweig (Germany), a moderately sized city with 250,000 inhabitants. Families 
were recruited for universal and selective prevention efficacy studies of child behaviour 
problems. Study details for recruitment were described by Hahlweg et al. (2010) and Heinrichs 
(2006). Data reported here were collected at the first (pre) assessment point. The age of the 
parents ranged between 23 and 47 years (mothers: M = 34.5, SD = 5.3; fathers: M = 36.4, SD = 
6.1). The families had between one and four children (M = 2.0, SD = 0.9). The average age of 
the target children was 4.5 years (SD = 1.0), and 53% (n = 253) were boys. Seventy-eight 
percent (n = 219) of the couples were married, and 27 % (n = 127) were single parents. 200 
fathers (91 % participation rate) completed the questionnaire assessment at pre-test. Forty-two 
percent of mothers (51 % of fathers) had a higher-track school school leaving qualification  
(= 13 years of schooling), and 37 % (22 %) had completed medium-track school (= 10 years of 
schooling). The net family income was equivalent to the German average; 35 % of the families 
were receiving social security benefits, and 7 % of mothers (5 % of fathers) were immigrants.  
5.2.2 Measures 
To assess psychopathology in children the German translation of the ASEBA Preschool 
Forms & Profiles (Achenbach & Rescorla, 2000) was used. The CBCL/1½-5 and the C-TRF 
are similarly constructed to cover an empirical range of behavioural, emotional and social 
function problems. Both forms comprise 99 items, and the respondent is requested to rate 
each item, based on the preceding two months, as 0 for not true, 1 for somewhat or sometimes 
true or 2 for very true or often true. The CBCL/1½-5 was completed by the mothers and 
fathers, whereas the kindergarten teachers completed the C-TRF. 
The CBCL/1½-5 consists of three problem scales (Internalizing, Externalizing, and Total 
Problems) and seven syndrome subscales (Emotionally Reactive, Anxious/Depressed, Somatic 
Complaints, Withdrawn, Sleep Problems, Attention Problems, and Aggressive Behavior). The 
C-TRF consists also of three problem scales (Internalizing, Externalizing, and Total Problems) 
and six syndrome subscales (Emotionally Reactive, Anxious/Depressed, Somatic Complaints, 
Withdrawn, Attention Problems, and Aggressive Behavior).  Studies on the German versions 
of the ASEBA Preschool Forms have supported the psychometric properties, showing good 
reliability and validity in both clinical and non-clinical populations (e.g. Plück et al., under 
review). Since there are no German norms available for the ASEBA Preschool Forms & 
Profiles, we used the norms provided by Achenbach and Rescorla (2000).  
5.2.3 Statistical analysis 
Prevalence rates of problem scales and syndrome subscales were calculated for mothers, 
fathers and caregivers based on the norms provided by Achenbach and Rescorla (2000). 
Prevalence rates were calculated as a proportion of children with subclinical behaviour  
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(T = 60 - 63 for problem scales, T = 65 - 69 for syndrome subscales) and clinically relevant 
behaviour (T ≥ 64 for problem scales, T ≥ 70 for syndrome subscales). Associations between 
problem scale prevalence and demographic and socio-economic factors (e.g. child´s age and 
gender, single parenthood, parents’ education, family income, migration status) were 
carried out with Chi square statistics, and the significance level was set at p < .01. To 
determine whether children who had deviant problem scores (T ≥ 60) were at higher risk of 
having a demographic (economic) factor, odds ratios (OR) and 95 % confidence intervals 
were calculated. 
5.3 Results 
Table 1 reports the prevalence rates of problem scales and syndrome subscales for different 
informants. In this sample, the prevalence rate of Internalizing problems varied from 7.3 % 
(fathers) to 12.0 % (mothers) in the borderline range. Across informants, about 12 - 13% of 
the children met the criterion of the clinical range. For internalizing syndrome scales, 5 - 6 % 
prevalence rates were obtained for predominantly clinically relevant somatic complaints, 
anxious depressive behaviour, and withdrawn behaviour. Prevalence rates of Externalizing 
problems ranged from 4.9 % (fathers) to 9.7 % (caregivers) in the borderline range. Across 
informants, 6 - 9% of the children met the criterion of the clinical range. For externalizing 
syndrome scales, marginally higher rates of aggressive behaviour (4 - 5% clinically relevant) 
than attention problems were found. In summary, the results indicate higher prevalence 
rates on internalizing than externalizing problem behaviour across informants. For Total 
Problems, rates varied from 6.9 % (mothers) to 10.8 % (caregivers) in the borderline range. 
For the clinical range, 5.8 % (fathers) to 11.0 % (caregivers) of the children met the criterion. 
Overall, total problems were more frequently indicated by caregivers compared to parents. 
 
Scales Borderline Range Clinical Range 
 Mother Father Caregiver Mother Father Caregiver 
Internalizing 12.0 7.3 8.8 12.4 11.6 12.8 
Emotionally Reactive 8.4 9.2 6.8 4.1 2.4 2.9 
Anxious/Depressed 5.6 6.4 5.3 3.0 0.6 6.4 
Somatic Complaints 10.1 7.3 4.0 4.3 3.1 6.4 
Withdrawn 3.9 3.1 5.3 5.6 5.2 2.2 
Sleep Problems 2.4 0.6 only parents 3.9 2.4 only parents 
Externalizing 8.6 4.9 9.7 7.3 5.5 8.6 
Attention Problems 3.9 2.4 4.2 3.0 2.1 3.1 
Aggressive Behavior 4.5 4.3 5.5 2.8 1.2 2.6 
Total Problems 6.9 7.0 10.8 10.3 5.8 11.0 
Table 1. Prevalence rates in percentage for syndrome scales and broad-band scales, and 
different informants.  
For all informants, there were no significant associations between children’s age and gender 
in terms of prevalence of problem and syndrome subscales. Odds ratios ranged between 
0.99 and 1.28 and were not significant. Chi-square analysis showed that Internalizing 
problems reported by mothers were overrepresented among mothers with lower education 
(< 9 years) compared to those with higher education levels (35.1% vs. 26.4 and 16.9%; χ2 (2) = 
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(T = 60 - 63 for problem scales, T = 65 - 69 for syndrome subscales) and clinically relevant 
behaviour (T ≥ 64 for problem scales, T ≥ 70 for syndrome subscales). Associations between 
problem scale prevalence and demographic and socio-economic factors (e.g. child´s age and 
gender, single parenthood, parents’ education, family income, migration status) were 
carried out with Chi square statistics, and the significance level was set at p < .01. To 
determine whether children who had deviant problem scores (T ≥ 60) were at higher risk of 
having a demographic (economic) factor, odds ratios (OR) and 95 % confidence intervals 
were calculated. 
5.3 Results 
Table 1 reports the prevalence rates of problem scales and syndrome subscales for different 
informants. In this sample, the prevalence rate of Internalizing problems varied from 7.3 % 
(fathers) to 12.0 % (mothers) in the borderline range. Across informants, about 12 - 13% of 
the children met the criterion of the clinical range. For internalizing syndrome scales, 5 - 6 % 
prevalence rates were obtained for predominantly clinically relevant somatic complaints, 
anxious depressive behaviour, and withdrawn behaviour. Prevalence rates of Externalizing 
problems ranged from 4.9 % (fathers) to 9.7 % (caregivers) in the borderline range. Across 
informants, 6 - 9% of the children met the criterion of the clinical range. For externalizing 
syndrome scales, marginally higher rates of aggressive behaviour (4 - 5% clinically relevant) 
than attention problems were found. In summary, the results indicate higher prevalence 
rates on internalizing than externalizing problem behaviour across informants. For Total 
Problems, rates varied from 6.9 % (mothers) to 10.8 % (caregivers) in the borderline range. 
For the clinical range, 5.8 % (fathers) to 11.0 % (caregivers) of the children met the criterion. 
Overall, total problems were more frequently indicated by caregivers compared to parents. 
 
Scales Borderline Range Clinical Range 
 Mother Father Caregiver Mother Father Caregiver 
Internalizing 12.0 7.3 8.8 12.4 11.6 12.8 
Emotionally Reactive 8.4 9.2 6.8 4.1 2.4 2.9 
Anxious/Depressed 5.6 6.4 5.3 3.0 0.6 6.4 
Somatic Complaints 10.1 7.3 4.0 4.3 3.1 6.4 
Withdrawn 3.9 3.1 5.3 5.6 5.2 2.2 
Sleep Problems 2.4 0.6 only parents 3.9 2.4 only parents 
Externalizing 8.6 4.9 9.7 7.3 5.5 8.6 
Attention Problems 3.9 2.4 4.2 3.0 2.1 3.1 
Aggressive Behavior 4.5 4.3 5.5 2.8 1.2 2.6 
Total Problems 6.9 7.0 10.8 10.3 5.8 11.0 
Table 1. Prevalence rates in percentage for syndrome scales and broad-band scales, and 
different informants.  
For all informants, there were no significant associations between children’s age and gender 
in terms of prevalence of problem and syndrome subscales. Odds ratios ranged between 
0.99 and 1.28 and were not significant. Chi-square analysis showed that Internalizing 
problems reported by mothers were overrepresented among mothers with lower education 
(< 9 years) compared to those with higher education levels (35.1% vs. 26.4 and 16.9%; χ2 (2) = 





education compared to higher maternal education (28.3% vs. 6.5 %; χ2 (2) = 15.82, p < .001). 
Rates of total problem behaviour were also significantly more common with lower 
education of fathers (< 9 years) in comparison to fathers with a higher education level 
(24.7% vs. 8.6 %; χ2 (2) = 12.72, p < .01). Caregivers reported no significant associations 
between parents’ education and child behaviour problems. 
The prevalence of Internalizing problems reported by both parents was higher in low-income 
families (mothers: 35.5 %, fathers: 32.7 %) than in the group with an income of over 3,000 € 
per month (10.8 % and 9.2 %; χ2 (2) = 20.71, p < .001; χ2 (2) = 12.14, p < .01). The prevalence of 
Total Problems reported by mothers is comparable in this context: Children from low-income 
households (24.3 %) were overrepresented compared to children from higher-income 
families (3.2 %; χ2 (2) = 18.67, p < .001). In contrast to these findings, caregivers reported 
more Externalizing problems for children from lower-income families. The results narrowly 
failed to reach statistical significance. 
The immigrant children’s adjustment reported by informants was as follows: Non-German 
children (rated by their mothers) had higher prevalence rates on internalizing problems than 
those reported for native-German preschool children (48.5 % vs. 20.3 %; χ2 (2) = 24.23,  
p < .001). The odds ratio was 3.0 (95 %-CI 1.82-4.96). There were no significant associations 
between immigrant status, problem behaviour and other informants. There were also no 
significant discrepancies between parental marital status and prevalence rates of problem 
scales. The odds ratio for Internalizing problems in single-parent families versus dual-parent 
households was 1.96 (95 %-CI 1.07-2.68). The odds ratio for scoring T ≥ 60 on Total Problems 
was 1.80 (95 %-CI 1.08-3.00) for children with single parent versus dual-parent families. 
5.4 Discussion 
This study was designed to determine the prevalence rates of behavioural and emotional 
problems for different informants among 3-6-year-old preschool children and to evaluate 
demographic factors which may be associated with prevalence. 
In conclusion, 5 - 6 % predominantly clinically relevant internalizing problems were found. 
From the total of 447 children, 12 – 13 % met the criterion of the clinical range of 
internalizing mental health problems. Thus, an important finding across informants was 
higher prevalence for internalizing than externalizing problems in preschool children. Other 
studies in this age group have found higher rates of externalizing as opposed to 
internalizing problems (Bongers et al., 2003; Campbell, 2006). Therefore, this result was 
unexpected and might be important in understanding mental health in the preschool years. 
Such discrepancies may result from different assessment measures, procedures, and 
normative data. The use of the CBCL ASEBA preschool forms (Achenbach & Rescorla, 2000) 
is a particular strength of the study, as the CBCL is a well-established measure of mental 
health morbidity. While this advantage is important, the study was limited by the lack of 
representativeness. So far, no comparable studies using ASEBA preschool instruments have 
been published. When interpreting the results, it should be taken into account that the child 
mental health status was assessed by a symptom checklist questionnaire. Given a large 
number of subjects and multiple informants, the questionnaire approach is economical and 
offers useful information, but lacks the specificity and additional depth that structured 
psychiatric interviews might provide. 
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When compared with other studies of older children, many similarities are seen concerning 
the associations between prevalence and demographic factors. In the current study, parental 
education, income, and immigrant status were also significantly associated with mental 
health problems of preschool children. In contrast to earlier studies, we observed effects 
specific to internalizing problem behaviour. In this context, it is essential to underline the 
fundamental longitudinal results of Wadsworth and Achenbach (2005), who found more 
interactions of SES over time, indicating increasing socioeconomic differences for child 
behaviour problems. The results for odds ratios are consistent with those reported by 
Harland et al. (2002) for a larger range of children’s age. 
The results of the present study revealed that the psychopathology of preschool children 
was already as high as has been found in studies of school children and adolescents. An 
increased utilization of child mental health services by older children, who already show 
disturbance in preschool years, has important implications for early preschool recognition of 
child mental health problems and indicates the need for the prevention and development of 
a differentiated delivery of child mental health services for preschool children. Clinicians 
working in primary care, day care, or school systems need to be attentive to opportunities 
for early detection and intervention regarding preschoolers’ emotional and behavioural 
problems, particularly since efficacious prevention and treatment exists for the 
psychopathology of young children (e.g. Weisz et al., 2005). 
6. Continuity and change of externalizing behaviour 
6.1 Background 
Within the last century, considerable changes in the health and illness patterns of young 
children have been observed. One characteristic of this phenomenon, which is referred as 
the “new morbidity’, is the growing importance of mental health concerns (Palfrey et al., 
2005). Externalizing problem behaviours are the most common and persistent forms of 
childhood maladjustment (Campbell, 2006). Kraemer et al. (2000) reported that, at the same 
time, externalizing behaviours change so much in expression and frequency over the course 
of development that studies at any single point in development will provide only limited 
information or misrepresent the phenomenon. Therefore, there is a growing agreement that 
externalizing behaviour must be studied from a developmental perspective (Costello & 
Angold, 2006). The present article aims to describe the development of externalizing 
behaviours from preschool age to primary school.  
Previous studies have investigated the development of externalizing behaviour in the 
general population (e.g. Bongers et al., 2004; Hofstra et al., 2000; Loeber et al., 2000). 
However, these studies used two different diagnostic approaches to describe externalizing 
problem behaviour. The empirical approach utilized multivariate statistical techniques to 
identify sets of problems that tend to occur together. This approach starts with empirical 
data derived from different informants who describe the behaviour of children and forms 
the basis of the empirical syndromes of rating scales such as the Child Behavior Checklist 
(CBCL; Achenbach, 2009) or the Conners’ Rating Scales (Conners, 1997). The diagnostic 
approach is to take the diagnostic categories of one of the international nosological systems, 
the fourth edition of the American Psychiatric Association’s Diagnostic and Statistical 
Manual of Mental Disorders (DSM-IV) or the World Health Organization’s International 
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studies in this age group have found higher rates of externalizing as opposed to 
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unexpected and might be important in understanding mental health in the preschool years. 
Such discrepancies may result from different assessment measures, procedures, and 
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is a particular strength of the study, as the CBCL is a well-established measure of mental 
health morbidity. While this advantage is important, the study was limited by the lack of 
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been published. When interpreting the results, it should be taken into account that the child 
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Verhulst and Koot (1995) hold the view that both approaches are needed, and that 
combining both by adding information from one approach that is not captured by the other 
may increase our knowledge of children’s psychopathology (Ferdinand et al., 2004).  
A classification scheme of externalizing behaviours developed by Frick and colleagues 
(1993) distinguishes four types of externalizing behaviour problems based on a meta-
analysis of 60 studies involving more than 28,000 youth. The four behavioural clusters that 
emerged may be ordered along two independent dimensions (overt vs. covert; destructive 
vs. non-destructive) and were labelled opposition, aggression, property violations, and 
status violations. These behaviour clusters were also confirmed in independent studies of 
adolescents. Most mental health practitioners and researchers distinguish between two 
types of childhood conduct problems based on the age at which children show first 
symptoms and the persistence of the symptoms across development (Moffitt, 2003). The 
differentiation between childhood-onset and adolescent-onset conduct problems is based on 
results from the Dunedin Multidisciplinary Health and Development Study, a 30-year 
longitudinal study of 1,000 New Zealand youths (Moffitt et al., 2001). Moffitt et al. (2001) 
identified two developmental pathways for childhood conduct problems: the life-course 
persistent path and the adolescence-limited path. Children with life-course persistent 
conduct problems first show symptoms in preschool or early primary school. Partly 
consistent with this theory, four developmental trajectories were identified for boys’ 
externalizing problems from ages 2 to 8 and 6 to 15 years in two samples (Nagin & 
Tremblay, 1999): a persistent problem trajectory, a high-level desister trajectory, a moderate-level 
desister trajectory, and a persistent low trajectory. In addition, Campbell et al. (2006) identified 
for physical aggression from 24 months to age 9 the following trajectories: very-low, low-
stable, moderate-decreasing, moderate-stable, and high stable aggression. Schaeffer et al. 
(2003) identified four somewhat different pathways of antisocial behaviour from first to 
seventh grade within an epidemiological sample of boys: chronic high, moderate (and stable), 
and increasing aggression trajectories as well as a nonaggressive trajectory. Early, persistent 
externalizing problems (e.g. aggression), however, predicts a range of negative outcomes 
including poor emotion regulation and impulsive behaviour, school failure and dropout, 
peer problems, and adolescent delinquency (Patterson et al., 1989; Tremblay, 2000). 
Studies, in which researchers employed the empirical approach, have shown that between 
ages 2 and 9 children generally decline on externalizing behaviour measures (NICHD Early 
Child Care Research Network ECCRN; Shaw et al., 2003). Bongers et al. (2003) also found a 
decline in mother-reported externalizing behaviour problems for both boys and girls 
between ages 4 and 18 in a representative sample of over 2,000 Dutch children. The aims of 
the study were 1) to assess the prevalence and incidence of externalizing behavioural 
problems in children from kindergarten to primary school, and 2) to investigate the 
developmental course of externalizing behaviours. 
6.2 Methods 
6.2.1 Sample and design 
In the present study, families with children aged 3 to 6 years were recruited in preschools in 
the city of Braunschweig (Germany), a moderately sized city with 250,000 inhabitants. 
Families were recruited for a universal prevention efficacy study of child behaviour 
problems. Study details for recruitment were described by Hahlweg et al. (2010). We first 
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contacted all potentially eligible preschools (N = 33). Project staff members were present at 
preschool teacher meetings and explained the project. Twenty-three preschools (70 %) 
expressed interest in participating in the project. Seventeen of these preschools were then 
randomly selected to participate in the project, and then preschools were randomly assigned 
to either the intervention or control condition. 
The study population comprised 136 control preschool children. The baseline demographic 
characteristics of the 136 children and their families were follows: The age of the mothers 
ranged between 23 and 57 years (M = 35.0, SD = 5.4). The families had between one and five 
children (M = 2.0, SD = 0.9). The average age of the target children was 4.1 years (SD = 1.1), 
and 51% (n = 69) were girls. 33 % (n = 46) of the children lived with single parents. Fifty-
three percent of mothers had a higher-track school qualification (= 13 years of schooling), 
and 32 % had completed a medium-track school (= 10 years of schooling). The net family 
income was equivalent to the German average; 33 % of the families were receiving social 
security benefits, and 8 % of mothers were immigrants.  
The developmental course of child behaviour problems was established with self-report 
measures from mothers at pre, 1, 2, 3 and 4 years after the first assessment (follow-up 1 - 4). 
Across the four years after pre-test, 2 - 4 % of the families dropped out of the study, leaving 
122 families (retention rate 90 %). The sample size at the 4-year follow-up assessment 
(primary school) consisted of 62 boys (50.8 %) and 60 girls. The mean age of the children 
was 8;8 years (SD = 1;1; range 6;3 – 10;8 years). 
6.2.2 Measures 
At pre-assessment, families provided information regarding their age, nationality, 
relationship to the child, education level, employment, receipt of social welfare assistance, 
and household income. They also provided data on the age and gender of the child of 
interest and any siblings. 
Child mental health was measured during the preschool years by the German version of the 
Child Behavior Checklist (CBCL/1½-5; Achenbach & Rescorla, 2000; see 5.2.2). A recent 
study tested the generalizability of the seven-syndrome model in 23 societies (Ivanova et al., 
2010). Findings from this study indicate that researchers (clinicians) can use the syndromes 
to assess preschool psychopathology. For the 2-year follow-up and after, the Child Behavior 
Checklist 4-18 (Arbeitsgruppe Deutsche Child Behavior Cheklist, 1998) was used. The scores 
from the parent-report were classified according to the manual into age- and sex-dependent 
categories which are based on the percentiles of the normative study. 
The German ADHD Rating scale (FBB-HKS) is part of the comprehensive Diagnostic System 
for Mental Disorders in Childhood and Adolescence (DISYPS-KJ; Döpfner & Lehmkuhl, 
1998) and can be rated by parents and teachers. This ADHD rating scale includes 20 items 
addressing symptom criteria of both ICD-10 and DSM-IV as well as additional criteria 
assessing symptom onset, symptom duration, pervasiveness and functional impairment. 
Internal consistencies were satisfactory to very good in the different representative samples 
(Döpfner et al., 2008). The DSM-IV recognizes three subtypes of the disorder - the 
predominantly inattentive type, the predominantly hyperactive-impulsive type and the 
combined type. Children were diagnosed with any ADHD if parents reported that six or 
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The German Conduct Disorder Rating scale (FBB-SSV) is also part of the comprehensive 
Diagnostic System for Mental Disorders in Childhood and Adolescence (DISYPS-KJ). The 
rating scale includes 23 items using the symptom criteria of both the ICD-10 and DSM-IV, as 
well as additional criteria (e.g. symptom onset). Studies have supported the instrument’s 
psychometric properties, showing good reliability and validity in both clinical and non-
clinical populations (Döpfner et al., 2008). Children were diagnosed with oppositional 
defiant disorder (ODD) if parents reported that four or more symptoms had persisted for at 
least 6 months. All questionnaire assessments were conducted at five assessment points: 
pre-test, and 1, 2, 3 and 4 years after the first assessment (follow-up 1- 4). 
6.2.3 Statistical analysis 
Prevalence rates of the Externalizing problem scale during the preschool years were 
calculated for mothers based on the norms provided by Achenbach and Rescorla (2000). 
Prevalence rates were calculated as a proportion of children with subclinical behaviour  
(T = 60 - 63) and clinically relevant behaviour (T ≥ 64). From the 2-year follow-up, the 
CBCL 4-18 with representative German norms was used. Percentages of ADHD and ODD 
mental health problems were calculated for all assessment points. Incidence rates are 
based on cumulative incidence for time periods as follows: pre-FU1, pre-FU2, pre-FU3, 
and pre-FU4. 
6.3 Results 
Figure 1 reports the prevalence rates of the CBCL-Externalizing problem scale and DSM-
IV ADHD- and DSM-IV ODD-disorders for each assessment point. In this sample,  
the prevalence rate of Externalizing problems in the borderline and clinical range varied 
from 7.5 % (FU1) to 30.8 % (FU2). In primary school, about 22 % of the children were 
identified as having clinically significant externalizing behaviour problems. There was an 
increase over time in prevalence of 11 %. Significantly more children had externalizing 
problems during the primary school years than in the preschool years: 11.3 % vs. 30.8 % 
(FU2; χ2 (1) = 12.3, p < .001), 22.0 % (FU3; χ2 (1) = 16.3, p < .001, and 22.9 % (FU4; χ2 (1) = 
10.4, p < .001). For ADHD disorders, prevalence rates between 6 % and 10 % were obtained. 
Chi-square analysis showed that the gain of prevalence in attention deficit-/hyperactivity 
disorder over time failed to reach statistical significance. Prevalence rates of ODD disorder 
ranged from 7.4 % (FU3) to 10.5 % (FU1). There were no significant increases in 
prevalence rates. 
The incidence rates for the CBCL-Externalizing problems and DSM-IV ADHD- and DSM-IV 
ODD-disorders are shown in Figure 2. This represents the cumulative incidence for the time 
periods from first assessment (pre) to each follow-up (FU1-FU4). Incidence for externalizing 
problems ranged from 4.5 % to 22.5 %. The highest incidence was present in the period two 
years after the pre-assessment. Infants had an incidence of 15-16 %. Lower rates in the DSM-
IV-ODD were found, ranging from 3.5 % to 6.1%. Incidence for oppositional defiant disorder 
decreased from kindergarten to primary school. These findings are comparable to the 
incidence of DSM-IV-ADHD. The lowest incidence was 2.3 % (pre-FU2), the highest 
incidence was 4.8 % (pre-FU4). In summary, the results indicate higher incidence rates on 
externalizing behaviour problems established by the empirical approach than externalizing 
behaviour problems based on diagnostic categories of DSM-IV.  
 




Fig. 1. Prevalence rates of externalizing problems and DSM-IV-disorders 
 
Fig. 2. Incidence rates of externalizing problems and DSM-IV-disorders 
The developmental course of externalizing behaviour problems is presented in Table 2. 
Table 2 includes the developmental patterns of CBCL-Externalizing problems, DSM-IV 
ADHD- and DSM-IV ODD-disorders. Overall, we found three different patterns: the first 
group is stable normal – for each of the five assessments no borderline and clinical scores on 
the Child Behavior Checklist or no diagnoses of ADHD or no diagnoses of ODD were 
obtained. The second group of children is temporary clinical – for at least one assessment 
borderline and clinical scores on the Child Behavior Checklist or a diagnosis of ADHD or a 
diagnosis of ODD was seen. The third group (stable clinical) showed relevant externalizing 
symptoms on the Child Behavior Checklist or ADHD-diagnoses or ODD-diagnoses for at 
least four of five assessments. 
On the CBCL Externalizing scale 61.0 % of the sample was stable normal; from preschool 
to primary school, mother’s report resulted in T-scores < 60. In addition, 31.6 % of the 
children had deviant CBCL scores for at least one assessment point. The stable clinical-
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comparison with rates of ADHD- and ODD-disorders in childhood, the percentage of 
children in the group “temporary clinical” was relatively high. Regarding the ADHD-
disorders and as shown in Figure 3, 83.8 % of our sample was stable normal and showed 
no clinical relevant ADHD-symptoms over the course. Overall, 12 % of children met at 
least at one assessment time the criteria for a disorder of ADHD. For 3.7 % of the sample 
the stable clinical pattern was observed. These children met on at least four occasions the 
criteria for a DSM-IV ADHD disorder. We found similar results in terms of oppositional 
deviant disorder: Stable normal behaviour was seen in 80.1 % of the sample. The 
percentage of the stable clinical pattern (3.7 %) corresponds with that for the rate of 
attention deficit-/hyperactivity. Only in relation to the temporary clinical course was a 
slightly higher rate (16.2 % to 12.5 %) observed. 
 
Developmental pattern CBCL-EXT DSM-IV ADHD DSM-IV ODD 
Stable normal 61.0 83.8 80.1 
Temporary clinical 31.6 12.5 16.2 
Stable clinical 7.4 3.7 3.7 
Table 2. Developmental course of externalizing problem (CBCL EXT) behaviour and DSM-
IV-disorders. Data in percent. 
In summary, the results showed that about 80 % to 84 % of the preschool children were 
stable normal with regard to the development of ADHD- and ODD-disorders. However, 
when only CBCL externalizing scores were taken into consideration the rate decreased 
from 80 % to 60 %. In about one third of the sample temporary clinical CBCL 
Externalizing scores were observed. In contrast to results for the diagnostic categories of 
DSM-IV these rates are two-fold higher. Regarding the stable clinical pattern from 
preschool to primary school, 4 % of the children fulfilled the criteria for an ADHD- or an 
ODD-DSM-IV disorder. 
6.4 Discussion 
In summary, with regard to the empirical approach a considerable variation and a 
significant increase in the prevalence of externalizing problems were found. The results for 
preschool aged children correspond with other German findings reported by Beyer and 
Furniss (2007). Within the BELLA study, a representative national sample of children and 
adolescents was surveyed (Ravens-Sieberer et al., 2008). Parent’s report on externalizing 
problems in children aged 7-10 indicated a slightly lower prevalence than in the current 
sample. In a multicultural study on the CBCL, Externalizing scores generally decreased with 
age (Achenbach & Rescorla, 2007). A review by Rescorla et al. (2007a) included data from 31 
societies. Therefore, our findings were unexpected and might be important in 
understanding mental health in the preschool and primary school years. Discrepancies were 
attributed to different assessment instruments, sample procedures, use of cut-off points, and 
normative data. In this study, prevalence rates of 7 - 10% for the diagnoses of ADHD 
according to DSM-IV symptom criteria were found. When compared with a representative 
German sample (Döpfner, Breuer, et al., 2008), similarities are seen concerning the 
prevalence in the age group 7 -10 years. Our prevalence rates are also in line with results 
found in other countries and cultures and with other assessment instruments. In their 
international review, Polanczyk et al. (2007) found an overall rate of 5.3 % and a rate of 4.6 % 
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for Europe in general. The findings of this study support the assumption that studies 
without a definition of impairment had significantly higher prevalence rates than those with 
a definition of impairment. Besides, the diagnostic approach on oppositional defiant 
disorder in the preschool and primary school years has yielded prevalence rates ranging 
from 7.4 to 10.5 %. These results are consistent with the lifetime prevalence of ODD reported 
by Nock et al. (2007), who found a rate of 10.2 %. Prevalence estimates in previous studies 
have yielded a wide range from 2 - 15% (e.g. Loeber, Burke et al., 2000). Our prevalence is 
concordant with those of another European study on preschool children. Furthermore, 
although considerable research exists on ADHD and conduct disorder, information 
regarding ODD is limited. 
So far, no comparable studies reporting incidence rates on externalizing behaviour have 
been published. In the absence of sufficient comparison studies it is not yet clear whether 
the findings reported here can be generalized. Further research is urgently called for to 
answer this important question. Therefore, incidence rates and the developmental course of 
externalizing problem behaviour are considered together.  
On the CBCL about 7 % of preschool and primary school children showed a stable pattern of 
relevant externalizing problem behaviour. A recent study by van Lier et al. (2007) assessed 
the trajectories of parent-rated symptoms of conduct problems from age 4 to 18 years old 
also in a general population sample. In this broader age group slightly lower rates (4 - 5 %) 
of a high trajectory of ODD- and ADHD-symptoms were found. A thorough statistical 
analysis of trajectories through growth mixture modelling on a large sample size of Dutch 
children yielded these results. The discrepancies in findings from those in the present study 
were attributable to different age groups, data collection and recruitment procedures, and 
CBCL-versions. The results on the stable normal pattern are in line with data from the 
literature (Bongers et al., 2003; Keiley et al., 2000). 
The study had several strengths. First, it is one of the rare studies with preschool children 
conducted in a universal setting with a 4-year follow-up over that time span. Second, the 
time intervals between the assessments were shorter compared with other longitudinal 
studies examining the same topic. Third, we used two different diagnostic approaches to 
describe externalizing problems: one of the best-studied instruments for the evaluation of 
children´s psychopathology (Achenbach, 2009) and DSM-IV ADHD- and ODD-diagnostic 
criteria. In this context, the study met for the most part the methodological criteria 
previously suggested by Robins and Rutter (1990), since it investigated behavioural 
problems in a sample of the population assessed longitudinally through standardized 
procedures. The present study is not without limitations. A main limitation is the 
generalizability of findings. Our sample is relatively advantaged with only 1/3 of all 
potentially eligible families participating. This finding corresponds to the fact that the 
rates of families and children recruited for family-focused preventions are typically very 
low (e.g. Spoth & Redmond, 2000). When interpreting the results, it should be taken into 
account that the child mental health status was assessed by symptom checklist 
questionnaires and disorder rating scales. The use of maternal self-report on child 
behaviour ratings may have been affected by the mother’s experience of stress, depressive 
symptomatology, or marital problems. Given a large number of subjects, the 
questionnaire approach is economical and offers useful information, but lacks the 
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Furthermore, a teacher perspective could add valuable information about problem 
behaviour at school, which might possibly result in reports of more externalizing 
problems. Due to principles of data collection, frequent change of teachers, and the 
transition from kindergarten to primary school it was only possible to obtain the parental 
report. For international comparison of the results, the age at school entry in Germany, 
generally at the age of 6 years, needs to be taken into account. 
To sum up, the study contributes to a more complete understanding of externalizing 
behaviour problems and their continuity from kindergarten to primary school. The results 
point to the need for early child psychiatric research on child mental health beginning in 
infancy and the preschool years. The development of problem behaviour in specific clinical 
or risk groups may differ from the pattern found in the present data. An increased 
utilization of child mental health services by older children, who already show disturbances 
in the preschool years, has important implications for early preschool recognition of child 
mental health problems and indicates the need for the prevention and development of a 
differentiated delivery of child mental health services. Clinicians working in primary care, 
day care, or school systems need to be attentive to opportunities for early detection and 
intervention regarding preschoolers’ externalizing behavioural problems, particularly since 
efficacious prevention and treatment exists for the psychopathology of young children (e.g. 
Weisz et al., 2005). 
7. Conclusion 
Since the first child psychiatric epidemiological studies in the 1950´s and 1960´s, 
epidemiological research has provided a wealth of empirical findings that may aid 
develop strategies for improving the mental health outcomes of children. Descriptive 
epidemiological data on prevalence rates, historical trends, and outcomes of mental health 
problems can help planning mental health services for children and provide evidence for 
setting priorities when resources are limited. Etiologic epidemiological research forms the 
basis for prevention interventions by unravelling the causative mechanisms in the 
development of psychopathology. Clinical epidemiological strategies are important for 
more evidence-based approaches to diagnostic assessment and intervention strategies, 
and outcome research may help improving the quality of mental health services. Finally, 
more efforts should be put into improving partnerships between epidemiological 
researchers and prevention specialists and between epidemiological researchers and 
policy-makers for improving strategies for preventing and treating mental health 
problems in children. 
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develop strategies for improving the mental health outcomes of children. Descriptive 
epidemiological data on prevalence rates, historical trends, and outcomes of mental health 
problems can help planning mental health services for children and provide evidence for 
setting priorities when resources are limited. Etiologic epidemiological research forms the 
basis for prevention interventions by unravelling the causative mechanisms in the 
development of psychopathology. Clinical epidemiological strategies are important for 
more evidence-based approaches to diagnostic assessment and intervention strategies, 
and outcome research may help improving the quality of mental health services. Finally, 
more efforts should be put into improving partnerships between epidemiological 
researchers and prevention specialists and between epidemiological researchers and 
policy-makers for improving strategies for preventing and treating mental health 
problems in children. 
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1. Introduction 
Tics are the most frequent movement disorders during childhood; their highest prevalence 
occurs at scholar and adolescence-ages. Most tics are transient but some of them become 
chronic having educational, familial and social negative implications. 
Moreover, some tics are related to disorders with significant impact, like attention-deficit 
hyperactivity disorder (ADHD), obsessive-compulsive (OCD) and affective disorders. 
Epidemiological studies are the initial approach to diagnose them and properly begin 
treatment. 
In this chapter, we explained the clinical bases of tics, review the more representative 
epidemiological studies that assess the prevalence of tics and make a critical standpoint of 
these studies about epidemiology applicable to clinical practice. 
2. Content 
2.1 Definition of tics and their practical ways to characterize them since clinical view 
As we described elsewhere, tics are defined as “sudden, rapid, recurrent, nonrhythmic, 
stereotyped motor movements or vocalizations”and have clinical concerns1.Tics are likely to 
differ in terms of the body location, number, frequency, complexity, intensity or 
forcefulness, noticeable and resulting social consequences2. Intervals between tics can range 
from seconds, hours or even days. The forcefulness with which a tic is performed can range 
from slight and barely noticeable to intense and obvious. Over time, the frequency and 
intensity of tics may wax and wane and maybe influenced by a variety of internal and 
external stimuli including private events, contextual variables and social reinforcement 
contingencies3. 
Tics can also vary considerably in their complexity. Tics that involve the contraction of a 
single muscle group are typically referred as simple tics and those that involve the 
contraction of multiple muscle groups are typically considered complex. Simple tics are 
typically of very short duration (i.e. 1 second) and include such behaviors as eye blinking; 
jerking of the face, head, torso, or limbs; coughing; sniffing; throat clearing and making 
singles syllable sounds. Complex tics are often sustained for longer durations or occur in 
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meeting the definition of a tic. Common examples include picking, tapping, gesturing, 
mimicking the gestures of others (echopraxia), repeating one’s own speech (palilalia), 
mimicking the speech of others (echolalia) and the production of inappropriate words or 
sentences. 
Tics comprise a group of movement disorders. Thus, transient tics, the most common form 
of the disorder, consists of single or multiple motor and/or vocal tics that occur for at last 
four weeks but no longer than 12 months. GTS has onset before 18 years of age, 
characterized by motor and vocal tics over more than a year, there is never a tic-free period 
of more than 3 consecutive months, not produced by Huntington disease neither viral 
encephalitis and produces a negative personal impact. The disorder is called chronic motor 
tics if the criteria of GTS are present but vocal tics are absent. By contrast, if there are vocal 
tics but no motor tics the disorder is called chronic vocal tics4. 
2.1.1 Differential diagnosis 
Simple motor tics may need to be differentiated from myoclonic jerks, which are not 
typically repetitive in the same body part like tics. Tics are commonly associated with 
premonitory sensations and suppressibility. Complex motor tics need to be distinguished 
from stereotypies that are longer lasting, more stereotyped movements (eg, body rocking, 
head nodding, and hand/wrist flapping) or sounds (eg, moaning, yelling) that occur over 
and over again in a more continuous, less paroxysmal fashion. Stereotypies are typically 
seen in patients with autism, mental retardation, Down syndrome, Rett syndrome, 
psychosis, or congenital blindness and deafness. 
Some tics are slow or twisting in character resembling dystonia and are termed ‘‘dystonic 
tics”. Contrary to dystonic tics, dystonia per se tends to beslower and leads to more 
sustained disturbances in posture of a limb, the neck, or trunk. Compulsions frequently 
occur in association with tics, can sometimes be difficult to distinguish from complex motor 
tics but typically differ by being done in response to an obsession, being performed to avoid 
future problems or being done according to ritualistic rules5 6 With very high comorbidity 
rates of both ADHD and OCD, GTS may represent a multifaceted developmental 
neuropsychiatric brain disorder7.  
2.1.2 Secondary tic disorders 
A secondary cause for tics should be considered if it is accompanied by other movement 
disorders or neurologic abnormalities. Tics often indicate the presence of a global brain 
developmental disorder in conditions like mental retardation, autism and pervasive 
developmental disorder. Similarly, a variety of genetic and neurodegenerative conditions 
can cause tics, including Wilson disease, neuroacanthocytosis8 9, neurodegeneration with 
brain iron accumulation10 11and Huntington disease12.Other potential causes of tics include 
lesions involving frontal-subcortical circuits like trauma13, carbon monoxide poisoning14, 
hypoxic-ischemic encephalopathy and stroke15; central nervous system (CNS) infections 
(neuroborreliosis16, viral encephalitis17) and central nervous system immune disorders (like 
antiphospholipid antibody syndrome18, Sydenham’schorea19). Tics can be a manifestation of 
neuroleptic drug-related tardive dyskinesia20 or withdrawal emergent syndrome21. 
Induction or exacerbation of tics has been reported with antiepileptic drugs22 23, cocaine24, 
caffeine25and stimulants26. 
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3. Biological frame to understand the base of tics and related comorbidities 
3.1 Mechanism and pathways of tics and comorbidities 
Figure 1 is a practical schema explaining the mechanism and pathways of tics and related 
disorders based in experimental models resulting of neuroanatomy and neurobiology 
grounds. 
 
Fig. 1. Cerebral cortex giving glutamatergic excitatory projections to striatum. 
Abbreviations: Glu: glutamate, DR: dopamine receptors, DA: dopamine, GABA: gamma 
aminobutiric acid, enk: encephaline K, SNpc: substantia nigra pars compacta, SNpr: 
substantia nigra pars reticulata, Sust P: susbstantia P, GPe: external globus pallidus, GPi: 
internal globus pallidus, NST: nucleus subthalamic, VA: ventral anterior, VT: ventral nuclei, 
CM-PF: centromedian -parafascicular nuclear complex. 
The cerebral cortex provides excitatory glutamatergic projections to striatum. The striatum 
has a topographic distribution as follows:  somatosensorial dorsolateral, intermediate / 
associative and a centromedial / limbic. 
Five parallel circuits connecting the cortex to the striatum27 28: 
1. Motor circuit: gives origin to motor tics and arises in the supplementary motor area. 
2. Oculomotor circuits: is the potential source for ocular tics and  connects the frontal eye 
field with the caudate nucleus. 
3. Dorsolateral prefrontal circuit: related to difficulties in executive functions, motor 
planning, cognition and attention. It is connected to Brodmann areas 9 and 10 and 
caudate head. 
4. Lateral orbitofrontal circuit: It is associated with OCD, irritability and mania. It 





meeting the definition of a tic. Common examples include picking, tapping, gesturing, 
mimicking the gestures of others (echopraxia), repeating one’s own speech (palilalia), 
mimicking the speech of others (echolalia) and the production of inappropriate words or 
sentences. 
Tics comprise a group of movement disorders. Thus, transient tics, the most common form 
of the disorder, consists of single or multiple motor and/or vocal tics that occur for at last 
four weeks but no longer than 12 months. GTS has onset before 18 years of age, 
characterized by motor and vocal tics over more than a year, there is never a tic-free period 
of more than 3 consecutive months, not produced by Huntington disease neither viral 
encephalitis and produces a negative personal impact. The disorder is called chronic motor 
tics if the criteria of GTS are present but vocal tics are absent. By contrast, if there are vocal 
tics but no motor tics the disorder is called chronic vocal tics4. 
2.1.1 Differential diagnosis 
Simple motor tics may need to be differentiated from myoclonic jerks, which are not 
typically repetitive in the same body part like tics. Tics are commonly associated with 
premonitory sensations and suppressibility. Complex motor tics need to be distinguished 
from stereotypies that are longer lasting, more stereotyped movements (eg, body rocking, 
head nodding, and hand/wrist flapping) or sounds (eg, moaning, yelling) that occur over 
and over again in a more continuous, less paroxysmal fashion. Stereotypies are typically 
seen in patients with autism, mental retardation, Down syndrome, Rett syndrome, 
psychosis, or congenital blindness and deafness. 
Some tics are slow or twisting in character resembling dystonia and are termed ‘‘dystonic 
tics”. Contrary to dystonic tics, dystonia per se tends to beslower and leads to more 
sustained disturbances in posture of a limb, the neck, or trunk. Compulsions frequently 
occur in association with tics, can sometimes be difficult to distinguish from complex motor 
tics but typically differ by being done in response to an obsession, being performed to avoid 
future problems or being done according to ritualistic rules5 6 With very high comorbidity 
rates of both ADHD and OCD, GTS may represent a multifaceted developmental 
neuropsychiatric brain disorder7.  
2.1.2 Secondary tic disorders 
A secondary cause for tics should be considered if it is accompanied by other movement 
disorders or neurologic abnormalities. Tics often indicate the presence of a global brain 
developmental disorder in conditions like mental retardation, autism and pervasive 
developmental disorder. Similarly, a variety of genetic and neurodegenerative conditions 
can cause tics, including Wilson disease, neuroacanthocytosis8 9, neurodegeneration with 
brain iron accumulation10 11and Huntington disease12.Other potential causes of tics include 
lesions involving frontal-subcortical circuits like trauma13, carbon monoxide poisoning14, 
hypoxic-ischemic encephalopathy and stroke15; central nervous system (CNS) infections 
(neuroborreliosis16, viral encephalitis17) and central nervous system immune disorders (like 
antiphospholipid antibody syndrome18, Sydenham’schorea19). Tics can be a manifestation of 
neuroleptic drug-related tardive dyskinesia20 or withdrawal emergent syndrome21. 
Induction or exacerbation of tics has been reported with antiepileptic drugs22 23, cocaine24, 
caffeine25and stimulants26. 
 
Epidemiology of Tics 
 
165 
3. Biological frame to understand the base of tics and related comorbidities 
3.1 Mechanism and pathways of tics and comorbidities 
Figure 1 is a practical schema explaining the mechanism and pathways of tics and related 
disorders based in experimental models resulting of neuroanatomy and neurobiology 
grounds. 
 
Fig. 1. Cerebral cortex giving glutamatergic excitatory projections to striatum. 
Abbreviations: Glu: glutamate, DR: dopamine receptors, DA: dopamine, GABA: gamma 
aminobutiric acid, enk: encephaline K, SNpc: substantia nigra pars compacta, SNpr: 
substantia nigra pars reticulata, Sust P: susbstantia P, GPe: external globus pallidus, GPi: 
internal globus pallidus, NST: nucleus subthalamic, VA: ventral anterior, VT: ventral nuclei, 
CM-PF: centromedian -parafascicular nuclear complex. 
The cerebral cortex provides excitatory glutamatergic projections to striatum. The striatum 
has a topographic distribution as follows:  somatosensorial dorsolateral, intermediate / 
associative and a centromedial / limbic. 
Five parallel circuits connecting the cortex to the striatum27 28: 
1. Motor circuit: gives origin to motor tics and arises in the supplementary motor area. 
2. Oculomotor circuits: is the potential source for ocular tics and  connects the frontal eye 
field with the caudate nucleus. 
3. Dorsolateral prefrontal circuit: related to difficulties in executive functions, motor 
planning, cognition and attention. It is connected to Brodmann areas 9 and 10 and 
caudate head. 
4. Lateral orbitofrontal circuit: It is associated with OCD, irritability and mania. It 





5. Anterior cingulate circuit: is part of limbic system and is associated to silence, apathy 
and tics. This circuit is originated in anterior cingulate gyrus and connects with ventral 
striatum, which is formed by olfactory tubercle, nucleus accumbens, caudate and 
putamen. Moreover, the striatum receives additional inputs of hippocampus, amygdala 
and entorhinal cortex. 
Although the hypothesis of neural circuit was developed for tics and movement disorders, it 
is possible that this fundamental principle works for limbic and cognitive aspects. 
Gangliobasal outputs to frontal lobe via thalamus provide an anatomical substrate for the 
production of simple and complex tics and compulsions. Thus, abnormal activation of the 
motor cortex via thalamocortical circuit can cause motor and vocal tics. Abnormal activation 
of the supplementary area and gyrus cinguli can cause complex tics. Abnormal activation of 
orbitofrontal cortex can cause compulsions. 
3.1.1 Stratium 
Striatum has three anatomical divisions: caudate, putamen and ventral striatum or limbic29. 
It has bony neurons with the inhibitory neurotransmitter GABA and another subgroup 
which uses substance P and dynorphin. Striatum projects to globus pallidus and substantia 
nigra pars reticulata30. By the way, neurons with encephalin projects to external globus 
pallidus and subthalamic nucleus. 
Boneless interneurons are divided into five subgroups: cholinergic and GABAergic neurons 
expressing parvualbumin; those expressing somatostatin; neuropeptide Y; nicotinamide 
adenine dinucleotide phosphatase and nitric oxide31. 
3.1.2 Striatotalamhic and thalamocortical tracts 
There are two different striatal pathways: one is direct and projects to the internal pallidus 
globus and substantia nigra pars reticulata; and the indirect going to the external globus 
pallidus. Both are inhibitory and mediated by GABA and neuroactive peptide. Integration 
of pathways inhibitory direct and indirect excitatory takes place at the internal globus 
pallidus and substantia nigra pars reticulata. Internal globus pallidus projects to thalamus 
through inhibitors GABA fibers. 
The effects of facilitation played by the direct route or suppression maintained by the 
indirect on the outputs of the thalamus to the cortex influences movement and cognitive 
processing. Deinhibition of thalamic neurons results in hyperexcitability of the projections 
from the thalamus to the motor cortex leading to tics. 
4. Initial treatment considerations 
The critical first step in making treatment decisions in patients with tics or GTS is select the 
most appropriate target symptoms, the ones causing the most problemsin a patient’s daily 
functioning. In one patient it maybe the tics themselves, in another it may be comorbid 
ADHD or OCD and in another it may be a combination of targets. Because psychosocial 
stresses can worsen symptoms, it is important to probe for these and consider interventions 
such as individual or family counseling. For patients with mild symptoms, educational and 
psychological interventions may be sufficient to bringing down symptoms to a tolerable 
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level. Clinicians should remember that tics characteristically wax and wane in severity, so 
sometimes just waiting for some period of time can result in a lessening of tics and avoid 
medication use or increases. 
Tics that interfere with school or other daily activities or are disabling because of social 
embarrassment, physical discomfort or self-injury must be treated. Tic-suppressing 
medications should be dosage titrated to identify the lowest one that will produce resolution 
of disability. 
4.1 Tic-suppressing drugs 
Usual medication treatment for tics centers in alpha agonists and antipsychotics. 
However, other types of drugs may be of benefit for patients having an inadequate 
response or problems with tolerability. Clonazepam has had reported modest tic-
suppressing effects in published case series32.This drug may be particularly useful in 
patients with an associated anxiety disorder. The dopamine-depleting drug tetrabenazine 
has possible efficacy. The drug is marketed with restriction in some countries. In an open-
label study the drug showed sustained moderate to marked reduction in tics over an 
average of 2 years’ follow-up33. However, only 22% of subjects were free of side effects. 
The most common side effects are sedation, depression, insomnia, and parkinsonism. 
Children may tolerate higher doses of tetrabenazine than adults34. Tetrabenazine does not 
cause tardive phenomena but dopamine-depleting agents can cause neuroleptic 
malignant syndrome even after years of use35. 
Local injections of botulinum toxin can be considered when one or a few dystonic tics are 
present in patient’s repertoire, such as holding of a sustained neck posture or sustained eye 
closure36, cervical tics associated with myelopathy37 and laryngeal injections for severe vocal 
tics, including copralalia38. 
4.2 Deep brain stimulation surgery 
Deep brain stimulation surgery (DBS) is an approach used to treat other movement 
disorders including tremor and may be effective for selected patients with severe, disabling 
and medication-refractory tics. Have been open-label reports of tic reduction following 
transcranial magnetic stimulation (TMS) of the supplementary motor area39 40. To date, most 
reported cases involve bilateral targeting of the centro-median parafascicular and ventralis 
oralis complex or central nuclei of the thalamus41, the globus pallidus internus42 and nucleus 
accumbens/anterior limb of the internal capsule43. 
Although sustained benefit has been reported to at least 17 months and most patients 
continue to require some medication for tics44, more careful investigation of their efficacy, 
safety, and tolerability of DBS for the treatment of tics is needed. 
4.3 Treatment of tics associated with streptococcal infection 
The ‘‘Pediatric autoimmune neuropsychiatric disorders associated with streptococcal 
infection (PANDAS)’’ hypothesis suggested that chronic, recurrent tics and OCD can arise 
as an autoimmune sequel of infection with group A beta-hemolytic streptococcus45. 
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Deep brain stimulation surgery (DBS) is an approach used to treat other movement 
disorders including tremor and may be effective for selected patients with severe, disabling 
and medication-refractory tics. Have been open-label reports of tic reduction following 
transcranial magnetic stimulation (TMS) of the supplementary motor area39 40. To date, most 
reported cases involve bilateral targeting of the centro-median parafascicular and ventralis 
oralis complex or central nuclei of the thalamus41, the globus pallidus internus42 and nucleus 
accumbens/anterior limb of the internal capsule43. 
Although sustained benefit has been reported to at least 17 months and most patients 
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4.3 Treatment of tics associated with streptococcal infection 
The ‘‘Pediatric autoimmune neuropsychiatric disorders associated with streptococcal 
infection (PANDAS)’’ hypothesis suggested that chronic, recurrent tics and OCD can arise 
as an autoimmune sequel of infection with group A beta-hemolytic streptococcus45. 





etiological role in causing tics. Children with documented streptococcal infections be treated 
with an appropriate course of antibiotics, but that treatment with chronic antibiotics or 
immune-modifying therapies like plasma exchange or intravenous immuneglobulin are not 
justified based on existing evidence. 
4.4 Treatment of secondary tic disorders 
Tic disorders secondary to CNS lesions or infection may improve with antipsychotic drug 
therapy. Tics are not commonly a disabling feature of neurodegenerative diseases such as 
Huntington’s disease and antipsychotics have the potential to worsen overall motor 
function. In tardive phenomena patients including tics, discontinuation of the offending 
agent is suggested as first-line treatment and improvement can be attained with use of 
clonazepam, clozapine, an alpha-2-agonist46 or reintroduction of an antipsychotic47. 
4.5 Behavioral treatment 
Behavioral therapies have not been particularly beneficial for patients with disabling tics. 
Behavioral approaches have included operant conditioning models, rewarding tic 
suppression and discouraging disruptive tics and massed practice, repeated, voluntarily 
performance of a tic until fatigue occurs. Habit reversal therapy (HRT) can be considered if a 
single tic or small subset of tics is unduly disruptive or causing self-injury or pain. HRT 
trains patients to recognize their tics and to perform a volitional movement different from 
the tic each time a problem tic occurs. Open-label assessments have identified sustained 
benefit from HRT for up to 10months48. However, current trials will include raters blinded 
to treatment assignment lacking in previous trials. 
In the school setting, approaches often include preferential classroom seating, extra time for 
tests, an opportunity to take tests in a separate quiet room and assistance with organizing 
schoolwork. An alpha-2-agonist, such as guanfacine, is a good first choice medication for 
patients experiencing problematic tics and ADHD because this type of drug can improve 
both conditions. 
4.6 Treatment of ADHD 
For patients with tics and ADHD without response to behavioral therapies, options of 
treatment including the use of the norepinephrine reuptake inhibitor atomoxetine. This drug 
has documented efficacy for ADHD and has been associated with either no change or a 
slight reduction in tics49. Stimulants remain the most potent and most predictably effective 
medications for treating ADHD in children with tics and they are well tolerated by the 
majority of patients. It does seem that upon initiation of therapy stimulants can worsen tics 
in some patients but this effect is temporary and tic severity usually returns to baseline or 
even declines from baseline within a few weeks50. The efficacy and good tolerability of the 
stimulant methylphenidate in children with tics and ADHD has been well documented in 
placebo-controlled trials51. Methylphenidate may be less likely to exacerbate tics than some 
other stimulant preparations, such as mixed amphetamine salts and dextroamphetamine52. 
Newer extended release preparations of methylphenidate tend to provide good coverage of 
ADHD during the school day and have been very well tolerated by patients with tics. 
Supplemental use of short-acting methylphenidate formulations can be useful, particularly 
for college students who have unpredictable study hours. 
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4.7 Treatment of OCD 
Associated OCD can be more disabling than the tics themselves and may create a state of 
tension and anxiety that heightens tic severity. Cognitive behavioral therapy performed by a 
well-trained and experienced therapist can be a very effective non-pharmacological 
treatment for OCD. Selective serotonin reuptake inhibitors (SSRIs) are considered the first-
line medications for OCD. Combination with an atypical antipsychotic may be helpful for 
cases resistant to an SSRI alone. DBS involving the internal capsule/nucleus accumbens is 
under investigation as a therapy more severe and medication-refractory cases of OCD. 
The Tourette Syndrome Association (TSA) is an informative reference guide to patients, 
parents, and teachers, because it clearly outlines many home and school psychoeducational 
modifications and interventions that may be effective for children with ADHD and tics. 
There are local support groups in many cities that can provide information, guidance, and 
support. 
The optimum management of patients with tics involves a comprehensive approach  
that focuses not only on the tics themselves, but also on neuropsychiatric comorbidities 
(particularly ADHD and OCD) and existing psychosocial stressors. For young patients, 
major goals of treatment include helping the child to develop self-confidence, personal 
resilience, and positive psychosocial skills. A critical goal is to reduce obstacles to successful 
learning and socialization. The ultimate management usually requires a spectrum  
of interventions that may include education, cognitive-behavioral therapies, counseling,  
and medications. DBS might prove to be a useful therapy for patients with severe, disabling 
tics, or OCD. 
4.8 Educating the patient, family and school 
Education of parents, teachers and peers is a critical initial intervention. Patients and their 
parents should be informed that it is appropriate explain to others that they have tics, that 
they cannot control certain movements or sounds, provide patients and parents with current 
information about the causes of tics such as genetic factors, brain neurochemical imbalances, 
emphasize that they are not signs of psychological or emotional illness, a common 
misperception, explain how tics change in type over time and that they naturally fluctuate in 
severity. 
A majority of GTS patients experience improvement of tics in late adolescence or early 
adulthood. So the prognosis of TS could be quite good. 
Education is often needed for school personnel because there are many misperceptions of 
tics as being voluntary, attention-seeking or purposely disruptive behaviors. It is 
recommended that special accommodations be considered in the school setting, like 
excusing the child, at his or her request, to the nurse’s office to release tics or providing 
additional time in a separate room when taking school tests. Such provisions should be 
mandated in the countries under laws protecting individuals with disabilities. 
5. Studies about tics 
As expected in behavior-analytic research, direct observation has been the preferred method 
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broader field of behavior therapy have preferred indirect measures, such as clinical 
impression, self-report inventories and clinician-rated scales. The most commonly cited 
reasons for not using direct observation include concerns about generalization of 
observations made in clinic or research settings to other relevant settings, such as home or 
school53 and disagreement about the best methods for collecting and scoring direct 
observation data54. Although the empirical basis for these concerns is not firmly established, 
acquisition of data supporting the use of direct observation methods may encourage those 
outside behavior analysis to use direct observation as a primary assessment method rather 
than relying on potentially biased verbal self-reports. 
Studies in tics may be divided into three groups: 1) Studies made in clinical grounds, 2) 
Large-scale screenings and 3) Studies involving selectively school population. 
Studies of in-hospital population comprise patients with most severe symptoms, in different 
age groups and different methods of final diagnosis confirmation are used. Procedures used 
in large-scale screening studies make possible the elimination of potential selection bias. 
Large populations are studied using transparent and repetitive confirmation of diagnoses. 
Their validity is additionally checked in parallel validity studies. The highest prevalence of 
tics is obtained in studies involving schoolchildren. Data are gathered from multiple 
sources: from parents, teachers, and children, as well as videos, from classroom observation 
and diagnoses made by experienced clinicians. Epidemiological surveys of school-age 
children have shown tic rates ranging from 4% to 50%55. This instability in reported rates is 
perplexing and is probably more artifact than truth. For example, prevalence of tics 
increases if transient tics are taken into account56, if studies were made just in public awards 
and when children attending special education schools were studied57. Inversely, prevalence 
of tics lowers after direct observation extends for a wide time58. 
5.1 Indirect observations 
Majority of the studies regarding prevalence of tics based in indirect measures employs 
questionnaires for parents, teacher and patient; instruments self-administered for detect and 
draw characteristics of tics, as follows in Table 1. 
 
Tics are abnormal movements with the following characteristics: 
They are sudden, brief, and rapid 
They are repetitive 
They can be controlled voluntarily during short periods of time 
They can change and affect other body parts periodically 
They improve and worsen from time to time 
The most common tics are eye blinking, elevating the eyebrows, twitching the nose and the 
mouth and shoulder shrugging, shaking the head, twitching the neck, touching objects, 
other people, or body parts (hair, nose, etc.), kicking the legs, throat clearing, sniffing, 
barking, and verbalizations. 
According to these characteristics: 
Do you believe that your son/daughter has had tics? (yes or no) 
Do you believe that your son/daughter (or pupil) has tics? (yes or no) 
Table 1. General structure used in questionnaires for tics detection. 
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The indirect measures of tic severity could seem inadequate and, as such, research that has 
relied exclusively on instruments designed for collection of indirect measures should be 
interpreted with caution. 
5.2 Direct observation 
One of the hallmarks of behavior analysis is the use of direct observation to quantify 
behavior. This preference is based on the premise that direct observation is more objective 
than indirect methods such as self-report or clinician ratings of tic severity. Several 
studies, published in behavior-analytic outlets, demonstrate the value of using direct 
observation to quantify changes in tic frequency when evaluating behavioral treatments 
for tics59. Still, many researchers outside behavior analysis have largely preferred indirect 
measures over direct observation60. Among the foremost concerns raised by these 
researchers is that observations conducted within a clinical or research context may not 
generalize to other settings such as school or home. Generalization between settings is an 
important issue in both research and clinical practice. Indeed, it is not uncommon for 
parents to report that a child’s tics are more or less severe while at the clinic compared to 
when the child is at home61 Such reactivity to setting has been attributed to several factors 
including natural fluctuation, reinforcement contingencies, children’s ability to 
volitionally suppress or temporarily withhold tics, reactivity to observation and internal 
states such as anxiety62. 
Regardless of the reason for contextual variation in tics, such fluctuations have important 
implications for the measurement of tics. If the scientific and clinical community is to  
have confidence in the results of behavior-analytic work utilizing direct observation 
methodology, observations conducted within a research setting must be generalizable  
to other settings. Clinic- and homebased observations are highly related, suggesting  
that, in general, clinic observations correspond well with home observations63. However, 
examination of individual data shows that generalization should not necessarily  
be assumed; many children exhibited differential tic frequencies across the two settings, 
suggesting that, whenever possible, observations should be conducted in multiple 
settings. Lack of consensus regarding the most reliable, valid and feasible methods  
for collecting and coding direct observation data has also been cited as a reason for  
the preference of indirect measures over direct observation64. Practitioners and 
researchers in disciplines outside behavior analysis may be more likely to use direct 
observation methods if the effort associated with their use can be reduced, without any 
sacrifice of their validity and capacity to generate representative samples of target 
behaviors. 
Direct observation to longer samples and event-frequency coding to a less arduous time-
sampling method (i.e. partial-interval coding) have been used to evaluate outcomes in tic 
research65, although partial-interval coding is more user-friendly because it does not require 
the observer to record each occurrence of the tic; thus, it might be preferred over the event 
frequency method. However, partial-interval coding cannot be recommended as an 
alternative if it does not yield a reliable measure of the behavior. Because simulation studies 
have suggested that partial-interval coding may underestimate the frequency of high-rate 
short duration responses, especially if they occur in rapid succession or as bouts, as is the 
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5.3 Yale global tic severity scale 
Yale global tic severity scale (YGTSS) is a clinician-completed rating scale used to rate tic 
severity along several dimensions based on parent and child reports and clinician 
observations during the interview64. Each dimension is represented by a subscale designed 
to quantify the number, frequency, duration, intensity and complexity of both motor and 
vocal tics. Each subscale includes several descriptions to help the clinician make his or her 
ratings. Guided by these descriptions, each subscale is issued a rating between 0 and 5, with 
higher scores indicating greater severity. Examples of descriptions included on the number 
subscale are single tic, multiple discrete tics and multiple discrete tics plus several 
orchestrated paroxysms of multiple simultaneous or sequential tics where it is difficult to 
distinguish discrete tics. Examples of items on the frequency subscale are ‘‘rarely—specific 
tic behaviors have been present during the previous week; these behaviors occur 
infrequently, often not on a daily basis; if bouts of tics occur, they are brief and uncommon 
and ‘‘always—specific tic behaviors are present virtually all the time”. Examples of items on 
the intensity subscale include ‘‘minimal intensity—tics not visible or audible (based solely 
on patient’s private experience) or tics are less forceful than comparable voluntary actions 
and are typically not noticed because of their intensity’’ and ‘‘severe intensity— tics are 
extremely forceful and exaggerated in expression; these tics call attention to the individual 
and may result in risk of physical injury because of their forceful expression’’. Examples on 
the complexity subscale include ‘‘borderline—some tics are not clearly ‘simple in character’’ 
and ‘‘severe—some tics involve lengthy bouts of orchestrated behavior or speech that would 
be impossible to camouflage or successfully rationalize as normal because of their duration 
or extremely unusual, inappropriate, bizarre or obscene character’’. Examples of interference 
items include ‘‘minimal—when tics are present, they do not interrupt the flow of behavior 
of speech’’ and ‘‘severe—when tics are present, they frequently disrupt intended action or 
communication’’. Finally, examples of items on the impairment subscale include 
‘‘minimal—tics associated with subtle difficulties in self-esteem, family life, social 
acceptance or school or job functioning’’ and ‘‘severe—tics associated with extreme 
difficulties in self-esteem, family life, social acceptance or school or job functioning’’. The 
five subscales are rated separately for motor and vocal tics. The motor subscales are then 
summed to produce an overall motor tic severity rating and the vocal tic subscales are 
summed to provide an overall vocal tic severity rating; each ranges from 0 to 25. The motor 
and vocal tic severity ratings are then summed to produce an overall tic severity score that 
ranges from 0 to 50. Studies have shown the YGTSS total tic score to have acceptable internal 
consistency, good inter-rater reliability and acceptable convergent and divergent validity in 
samples of adults and children. 
5.4 Gross-site procedural training 
Prior to the beginning of the study, a face-to-face meeting between personnel for tic 
assessment must held to review the standardized observation protocol and to conduct 
training on YGTSS administration and scoring. Sample tapes of children with tics may be 
used to conduct cross site YGTSS training and direct observation coding. Tapes included an 
interview and YGTSS administration conducted by the primary investigators with a child 
and his or her parents, along with a while direct observation segment of the child (at least 10 
minutes). YGTSS training has to continue until the clinicians obtained agreement of at least 
90% on the training. Disagreements during training have to be resolved by discussion 
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between the primary investigators and coders and recoding of videotapes until agreement 
criterion is reached. 
5.5 Not clinical studies of tics 
A key factor in understanding these divergent results of epidemiological studies concerns 
the sample size, randomization, stratification, steps in epidemiological assessment and 
clinical aspects to warrant quality of databases67. Most relevant studies about prevalence are 
showed in Table 2, including their methodological aspect.  
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90% on the training. Disagreements during training have to be resolved by discussion 
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between the primary investigators and coders and recoding of videotapes until agreement 
criterion is reached. 
5.5 Not clinical studies of tics 
A key factor in understanding these divergent results of epidemiological studies concerns 
the sample size, randomization, stratification, steps in epidemiological assessment and 
clinical aspects to warrant quality of databases67. Most relevant studies about prevalence are 
showed in Table 2, including their methodological aspect.  
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5.6 Clinical studies of tics 
Clinic-based studies are believed to underestimate the frequency of tics, as only a small 
fraction of children and adults with tics are brought to a health care provider for 
evaluation73. There is evidence of a reporting bias in community studies with 50% of the 
children with observed tics reported to have tics by their parents. Results of investigations 
also support the previously reported findings that tics wax and wane in severity and 
frequency over time, as individual shad fluctuating symptoms over the observation 
period74. Most relevant clinical studies about prevalence are showed in Table 3. 
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5.7 Clinical characterization of tics 
 








2003 4479 Swedish 
school children 
aged 7 to 15 years.  
Total population and their parents 
were asked to fill in a questionnaire 
covering both motor and vocal tics. A 
three- stage procedure was used: 
screening, interview and clinical 
investigation. SGT were diagnosed 
according to DMS-IV criteria. 
0,8 0,5 0,6 
Himle, M. B., & 
Woods, D. W63. 
2006 43 children, ages 8 
to 17 years 
Patients recruited through print 
advertisement, physician referrals  
and Tic Disorder Clinics. The  
assessment consisted of a structured 
diagnostic interview, including 
intelligence quotient (IQ), videotape  
and patient, parent and clinics-reports. 
Monetary compensation was given to 
children. 





2006 78 Children and 




Retrospective analyses from clinical 
archives of child neurology outpatients 
of Hospital General de Santo Antonio, 
Spain. 






Kaminska A, et 
al70. 






Students were screened by inquiring 
their parents and teachers.  
Children indicated as tic-positive by 
the screening procedure were 
investigated using semi-structured 
questionnaires and the Polish version 
of YGTSS scale. A validity study 
involved random selection and 
investigation of 130 non indicated 
subjects. Screening procedure had high 
sensitivity (92%) and low positive 
predictive value (18%). 
NA NA 0,6 
Ortiz B, David 
M, Sánchez Y, 
Mira J, Sierra 
JM, Cornejo 
JW72. 
2011 346 students of 
public elementary 
school. 
Assessment by structured 
questionnaire, interview and 20 
minutes of clinical examination.  
63,8 12 19 
Table 4. Clinical characteristics of tics. 
6. Related problems in tic disorders along life 
Oftenly, presence of tics are associated with messing conditions that impair the performance 
at work, familiar and social environments. Prevalence studies should consider these entities 
because detection is a first step to diagnose and treat them. We illustrate studies of tic 
disorders and related morbidities in Table 3. 
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2002 Community-based study 
of school children since 
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using interviews to 
determine the prevalence 
of tics and 
psychopathological 
disorders. A standard 
psychiatric interview and 
standardized rating 
scales were utilized to 
diagnose childhood 
behavioral disorders. 
1596 children interviewed, 
21.2% had tics, 38.4% with 
ADHD, 10.9% with OCD, 
29.2% with social phobia, 
9.4% with agoraphobia, 
14.8% with separation 
anxiety, 21.2% with anxiety 
disorder, 1.2% with mania 
and 17.4% oppositional 









Data obtained from the 
CBCL can be influenced 
by which parent or 
teacher completed the 
scale, tic severity and 
psychotropic medication, 
factors that were not 









2002 553 children of 
kindergarten through 
sixth grade, observed 
monthly from November 
1999 to June 2000 by 3 
raters. Problem behaviors 
were rated as absent, 




anxious and distracted. 
One quarter of all children 
exhibited problem behaviors. 
The monthly point 
prevalence was significantly 
higher during winter months 
compared with the spring 
months. Behavior 
comorbidity is associated 
with the more persistent tic 
symptoms versus all tic 
symptoms, as children with 
isolated tics lasting only 1 to 
2 months did not have 
increased rates of problem 
behaviors, whereas those 
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monthly from November 
1999 to June 2000 by 3 
raters. Problem behaviors 
were rated as absent, 




anxious and distracted. 
One quarter of all children 
exhibited problem behaviors. 
The monthly point 
prevalence was significantly 
higher during winter months 
compared with the spring 
months. Behavior 
comorbidity is associated 
with the more persistent tic 
symptoms versus all tic 
symptoms, as children with 
isolated tics lasting only 1 to 
2 months did not have 
increased rates of problem 
behaviors, whereas those 












seasonal prevalence are 
limited because the 
children were not 
observed from July 
through October. It’s 
possible that clinic-based 
studies overestimate the 
frequency of comorbid 
behavior problems, in 
part because the behavior 
problems can be more 
troublesome than the tic 
symptoms and become 
the motivating factor for 
seeking treatment. It is 
also possible that clinic-
based studies estimate 
accurately the prevalence 
of comorbid conditions 
and that the discrepancy 
came from the 
inappropriate 
generalization of clinic 







2006 78 Children and 
teenagers with tics 
diagnosed based by 
DSM-IV criterions. 
Retrospective analyses 
from clinical archives of 
child neurology 
outpatients of Hospital 
General de Santo 
Antonio, Spain. 
ADHD was present in 67.9%, 
learning difficulties in 59%, 
sleep disorders in 23.1%, 
developmental delay in 
21.8%, unspecified mental 
retardation in 16.7%, ODD in 
10.3%, obsessive compulsive 
symptoms (OCS) in 7.7%, 
epilepsy in 6.4%, autism in 
3.8%, migraine/headache in 
3.8% and depression in 2.6% 
Wide clinical 
sample. DSM-
IV criteria were 





Data was extracted from 
clinic archives and 
patients were selected by 









6.2 Adults with tics and comorbidities 
Tics and vocalizations developing in later life in association with neuroacanthocytosis80, 
Sydenham’s chorea and L-dopa–treated postencephalitic parkinsonian syndrome81. There 
are a few reports of isolated and spontaneous adult-onset tics disorders. 
Chouinard and colleagues reported on 7 cases of idiopathic tic disorder that presented after 
the patients were 21 years of age75. Adult-onset tic disorder in the absence of any other 
primary neurological disorder has onset of tic symptoms from 23 to 52 years76. 
Adult-onset cases need to be evaluated using a wide screening, like the National Hospital 
Interview Schedule for the assessment of GTS and related behavior82; this is a standardized, 
semistructured instrument that includes systematic assessment of personal and family 
history of GTS, ADHD, and obsessive compulsive behavior (OCB). The interview is 
conducted with the patient and a family member (usually a parent) who knows the patient 
well enough to give relevant details about childhood. 
Several cases of secondary tourettism have been described in the literature. The causes have 
included postencephalic syndrome and carbon monoxide intoxication, and other causes 
have been degenerative or vascular75. Tourettism has also occurred secondary to trauma83, 
infection84, alcohol withdrawal85, or intake of certain drugs such as stimulants, 
anticholinergics, or antipsychotics86 87. In almost all patients there was a potential trigger 
event, such as drug exposure, viral or bacterial infection, physical trauma, cerebrovascular 
disease, or psychiatric illness prior to the onset of tic symptomatology. These may have 
acted as a trigger to unmask the symptoms in a constitutionally predisposed individual. In 
this regard, it is interesting to note that in 50% of cases there is either a personal or family 
history of GTS-related behavior. However, it is also possible that these represented 
secondary tics. It is now recognized that GTS has a genetic cause, with some studies 
suggesting an autosomal dominant transmission and others a mixed model88. 
Goetz and coworkers in a study of 58 adult GTS patients diagnosed during childhood observed 
that childhood tic severity had no predictive value and that coprolalia did not increase the risk 
for severe tics in adult life89. Features predictive of mild tics in adulthood were mild tics 
during the patients’ worst preadulthood function and mild tics during adolescence. The 
phenomenology of tics encountered in later life may also be somewhat different from those in 
early-onset GTS. For example, it has been reported reduced response to treatment (31%), a 
high degree of social morbidity (89%) and a low frequency of spontaneous complete remission 
in adult-onset cases. It seems that adult-onset tic disorder, whether idiopathic, secondary or a 
recurrence of childhood tics, may be different from younger-onset GTS. 
A majority of patients exhibit OCB in childhood and have a positive family history of tics or 
OCB. It may also be noted that childhood rheumatic chorea may resolve only to return in late 
adult life89. Linazasoro and colleagues described a patient who had presented with only OCD 
since childhood but developed GTS symptoms at the age of 72 years and suggested that the 
expression of the gene may be different in the same patient during the course of his life90.  
7. Conclusions 
Data from tics research prompt significant variations in prevalence. Future research should, 
at minimum, supplement indirect measures with direct methods. Nolan demonstrated that 
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correspondence between direct observation scores and YGTSS ratings may be lower for low-
frequency tics than for high-frequency tics91. 
Whether tic frequency is the most important dimension of tic severity (e.g. best predicts 
psychosocial functioning) is an empirical issue that warrants investigation. Studies should 
evaluate methods capable of quantifying multiple dimensions of tics including overt 
physical dimensions (e.g. frequency, intensity, complexity), social dimensions (e.g. social 
reinforcement and punishment contingencies, functional interference) and the concomitant 
private dimensions commonly reported to accompany tics (e.g. sensory events). The research 
will likely require novel direct observation techniques used in combination with other 
measurement methods (e.g. functional assessment, self-report, clinician ratings, social 
acceptability ratings, physiological measures, neuroimaging techniques, etc.) and research 
strategies (e.g. functional analysis, group research designs, inferential statistical analyses). 
The use of not traditional measurement techniques to complement direct observation is 
likely to increase in popularity within the broader field of clinical behavior analysis. Clinical 
researchers are increasingly concerning themselves with the study of behavior that is 
complex, highly variable and not easily accessible by traditional direct-observation 
techniques (e.g. the private behaviors of individuals who suffer from anxiety and mood 
disorders). If behavior analysts are to continue to be at the forefront for understanding and 
treating clinical problems (including tic disorders), they must systematically determine 
which dimensions of specific target behaviors are socially relevant and must be diligent not 
to restrict themselves by investigating only those aspects that are easily quantifiable with 
traditional direct observation methods92. This will require researchers both to refine their 
current measurement techniques and to incorporate techniques that have not traditionally 
been employed in behavior-analytic research (e.g. clinician ratings, self-report, physiological 
and neuroimaging techniques, etc). This is not to suggest that clinical behavior analysts 
abandon direct observation in favor of other measurement techniques. On the contrary, it is 
a call to behavior analysts to develop, investigate and incorporate new direct and indirect 
measurement techniques that will enhance scientific investigation of the environment– 
behavior relations involved in clinical problems. 
8. References 
 
[1] Cornejo JW. (2008). Tics y síndrome de Gilles de la Tourette. In: Manual de pediatría 
ambulatoria. Marín A; Jaramillo JC; Gómez JF; Gómez LF. Pp. 151-153. Editorial 
Médica Panamericana. ISBN 978-958-4410-19-9. Bogotá. 
[2] Leckman, J. F.; King, R. A. & Cohen, D. J. (1999). Tics and tic disorders. In: Tourette’s 
syndrome—Tics, obsessions, compulsions: Developmental psychopathology and clinical 
care, J. F. Leckman & D. J. Cohen, pp. 23–42, Wiley, ISBN 0-471-16037-7, New York. 
[3] Carr, J. E., Taylor, C. C., Wallander, J. J., & Reiss, M. L. (1996). A functional analytic 
approach to the diagnosis of transient tic disorder. Journal of Behavior Therapy and 
Experimental Psychiatry, 27, 291–297, ISSN 0005-7916. 
[4] Cornejo W, Posada C, Uribe A. (2001). Caracterización clínica de pacientes con trastorno 
de Gilles de la Tourette. Acta Neurológica Colombiana; 17: 97-102, ISSN 0120-8748. 
[5] Kurlan R, Como PG, Miller B, Palumbo D, Deeley C, Andresen EM, Eapen S, McDermott 
MP. (2002). "The behavioral spectrum of tic disorders: a community-based study." 





6.2 Adults with tics and comorbidities 
Tics and vocalizations developing in later life in association with neuroacanthocytosis80, 
Sydenham’s chorea and L-dopa–treated postencephalitic parkinsonian syndrome81. There 
are a few reports of isolated and spontaneous adult-onset tics disorders. 
Chouinard and colleagues reported on 7 cases of idiopathic tic disorder that presented after 
the patients were 21 years of age75. Adult-onset tic disorder in the absence of any other 
primary neurological disorder has onset of tic symptoms from 23 to 52 years76. 
Adult-onset cases need to be evaluated using a wide screening, like the National Hospital 
Interview Schedule for the assessment of GTS and related behavior82; this is a standardized, 
semistructured instrument that includes systematic assessment of personal and family 
history of GTS, ADHD, and obsessive compulsive behavior (OCB). The interview is 
conducted with the patient and a family member (usually a parent) who knows the patient 
well enough to give relevant details about childhood. 
Several cases of secondary tourettism have been described in the literature. The causes have 
included postencephalic syndrome and carbon monoxide intoxication, and other causes 
have been degenerative or vascular75. Tourettism has also occurred secondary to trauma83, 
infection84, alcohol withdrawal85, or intake of certain drugs such as stimulants, 
anticholinergics, or antipsychotics86 87. In almost all patients there was a potential trigger 
event, such as drug exposure, viral or bacterial infection, physical trauma, cerebrovascular 
disease, or psychiatric illness prior to the onset of tic symptomatology. These may have 
acted as a trigger to unmask the symptoms in a constitutionally predisposed individual. In 
this regard, it is interesting to note that in 50% of cases there is either a personal or family 
history of GTS-related behavior. However, it is also possible that these represented 
secondary tics. It is now recognized that GTS has a genetic cause, with some studies 
suggesting an autosomal dominant transmission and others a mixed model88. 
Goetz and coworkers in a study of 58 adult GTS patients diagnosed during childhood observed 
that childhood tic severity had no predictive value and that coprolalia did not increase the risk 
for severe tics in adult life89. Features predictive of mild tics in adulthood were mild tics 
during the patients’ worst preadulthood function and mild tics during adolescence. The 
phenomenology of tics encountered in later life may also be somewhat different from those in 
early-onset GTS. For example, it has been reported reduced response to treatment (31%), a 
high degree of social morbidity (89%) and a low frequency of spontaneous complete remission 
in adult-onset cases. It seems that adult-onset tic disorder, whether idiopathic, secondary or a 
recurrence of childhood tics, may be different from younger-onset GTS. 
A majority of patients exhibit OCB in childhood and have a positive family history of tics or 
OCB. It may also be noted that childhood rheumatic chorea may resolve only to return in late 
adult life89. Linazasoro and colleagues described a patient who had presented with only OCD 
since childhood but developed GTS symptoms at the age of 72 years and suggested that the 
expression of the gene may be different in the same patient during the course of his life90.  
7. Conclusions 
Data from tics research prompt significant variations in prevalence. Future research should, 
at minimum, supplement indirect measures with direct methods. Nolan demonstrated that 
 
Epidemiology of Tics 
 
183 
correspondence between direct observation scores and YGTSS ratings may be lower for low-
frequency tics than for high-frequency tics91. 
Whether tic frequency is the most important dimension of tic severity (e.g. best predicts 
psychosocial functioning) is an empirical issue that warrants investigation. Studies should 
evaluate methods capable of quantifying multiple dimensions of tics including overt 
physical dimensions (e.g. frequency, intensity, complexity), social dimensions (e.g. social 
reinforcement and punishment contingencies, functional interference) and the concomitant 
private dimensions commonly reported to accompany tics (e.g. sensory events). The research 
will likely require novel direct observation techniques used in combination with other 
measurement methods (e.g. functional assessment, self-report, clinician ratings, social 
acceptability ratings, physiological measures, neuroimaging techniques, etc.) and research 
strategies (e.g. functional analysis, group research designs, inferential statistical analyses). 
The use of not traditional measurement techniques to complement direct observation is 
likely to increase in popularity within the broader field of clinical behavior analysis. Clinical 
researchers are increasingly concerning themselves with the study of behavior that is 
complex, highly variable and not easily accessible by traditional direct-observation 
techniques (e.g. the private behaviors of individuals who suffer from anxiety and mood 
disorders). If behavior analysts are to continue to be at the forefront for understanding and 
treating clinical problems (including tic disorders), they must systematically determine 
which dimensions of specific target behaviors are socially relevant and must be diligent not 
to restrict themselves by investigating only those aspects that are easily quantifiable with 
traditional direct observation methods92. This will require researchers both to refine their 
current measurement techniques and to incorporate techniques that have not traditionally 
been employed in behavior-analytic research (e.g. clinician ratings, self-report, physiological 
and neuroimaging techniques, etc). This is not to suggest that clinical behavior analysts 
abandon direct observation in favor of other measurement techniques. On the contrary, it is 
a call to behavior analysts to develop, investigate and incorporate new direct and indirect 
measurement techniques that will enhance scientific investigation of the environment– 
behavior relations involved in clinical problems. 
8. References 
 
[1] Cornejo JW. (2008). Tics y síndrome de Gilles de la Tourette. In: Manual de pediatría 
ambulatoria. Marín A; Jaramillo JC; Gómez JF; Gómez LF. Pp. 151-153. Editorial 
Médica Panamericana. ISBN 978-958-4410-19-9. Bogotá. 
[2] Leckman, J. F.; King, R. A. & Cohen, D. J. (1999). Tics and tic disorders. In: Tourette’s 
syndrome—Tics, obsessions, compulsions: Developmental psychopathology and clinical 
care, J. F. Leckman & D. J. Cohen, pp. 23–42, Wiley, ISBN 0-471-16037-7, New York. 
[3] Carr, J. E., Taylor, C. C., Wallander, J. J., & Reiss, M. L. (1996). A functional analytic 
approach to the diagnosis of transient tic disorder. Journal of Behavior Therapy and 
Experimental Psychiatry, 27, 291–297, ISSN 0005-7916. 
[4] Cornejo W, Posada C, Uribe A. (2001). Caracterización clínica de pacientes con trastorno 
de Gilles de la Tourette. Acta Neurológica Colombiana; 17: 97-102, ISSN 0120-8748. 
[5] Kurlan R, Como PG, Miller B, Palumbo D, Deeley C, Andresen EM, Eapen S, McDermott 
MP. (2002). "The behavioral spectrum of tic disorders: a community-based study." 






[6] Robertson MM. (2000). Tourette syndrome, associated conditions and the complexities of 
treatment. Brain;123(pt 3):425–462. ISSN 1460-2156. 
[7] Palumbo D, Maughan A, Kurlan R. (1997). Hypothesis III. Tourette syndrome is only one 
of several causes of a developmental basal ganglia syndrome. Arch Neurol;54:475–
483, ISSN 1538-3687. 
[8] Ruiz-Sandoval JL, Garcia-Navarro V, Chiquete E, et al. (2007). Choreoacanthocytosis in a 
Mexican family. Arch Neurol;64: 1661–1664, ISSN 1538-3687. 
[9] Hardie RJ, Pullon HW, Harding AE, et al. (1991). Neuroacanthocytosis. A clinical, 
haematological and pathological study of 19 cases. Brain;114 (pt 1A):13–49, ISSN 
1460-2156. 
[10] Scarano V, Pellecchia MT, Filla A, Barone P. (2002). Hallervorden-Spatz syndrome 
resembling a typical Tourette syndrome. Mov Disord;17:618–620, ISSN 0885-3185. 
[11] Pellecchia MT, Valente EM, Cif L, et al. (2005). The diverse phenotype and genotype of 
pantothenate kinase-associated neurodegeneration. Neurology;64:1810–1812, ISSN 
0028-3878. 
[12] Angelini L, Sgro V, Erba A, Merello S, Lanzi G, Nardocci N. (1998). Tourettism as 
clinical presentation of Huntington’s disease with onset in childhood. Ital J Neurol 
Sci;19:383–385, ISSN 0392-0461. 
[13] Krauss JK, Jankovic J. (1997). Tics secondary to craniocerebral trauma. Mov 
Disord;12:776–82, ISSN 0885-3185. 
[14] Pulst SM, Walshe TM, Romero JA. (1983). Carbon monoxide poisoning with features of 
Gilles de la Tourette’s syndrome. Arch Neurol;40:443–444, ISSN 1538-3687. 
[15] Kwak CH, Jankovic J. (2002). Tourettism and dystonia after subcortical stroke. Mov 
Disord;17:821–825, ISSN 0885-3185. 
[16] Riedel M, Straube A, Schwarz MJ, Wilske B, Muller N. (1998). Lyme disease presenting 
as Tourette’s syndrome. Lancet;351: 418–419, ISSN 0140-6736. 
[17] Northam RS, Singer HS. (1991). Postencephalitic acquired Tourette-like syndrome in a 
child. Neurology;41:592–593, ISSN 0028-3878. 
[18] Martino D, Chew NK, Mir P, Edwards MJ, Quinn NP, Bhatia KP. (2006). Atypical 
movement disorders in antiphospholipid syndrome. Mov Disord;21:944–949, ISSN 
0885-3185. 
[19] Moore DP. Neuropsychiatric aspects of Sydenham’s chorea: a comprehensive review. 
(1996). J Clin Psychiatry;57:407–414, ISSN 1555-2101. 
[20] Bharucha KJ, Sethi KD. (1995). Tardive tourettism after exposure to neuroleptic 
therapy. Mov Disord;10:791–793, ISSN 0885-3185. 
[21] Polizos P, Engelhardt DM, Hoffman SP, Waizer J. (1973). Neurological consequences of 
psychotropic drug withdrawal in schizophrenic children. J Autism Child 
Schizophr;3:247–253, ISSN 0021-9185. 
[22] Lombroso CT. (1999). Lamotrigine-induced tourettism. Neurology; 52:1191–1194, ISSN 
028-3878. 
[23] Neglia JP, Glaze DG, Zion TE. (1984). Tics and vocalizations in children treated with 
carbamazepine. Pediatrics;73:841–844, ISSN 1098-4275. 
[24] Cardoso FE, Jankovic J. (1993). Cocaine-related movement disorders. Mov Disord;8:175–
78, ISSN 0885-3185. 
[25] Davis RE, Osorio I. (1998). Childhood caffeine tic syndrome. Pediatrics;101:E4, ISSN 
1098-275. 
 




[26] Lowe TL, Cohen DJ, Detlor J, Kremenitzer MW, Shaywitz BA. (1982). Stimulant 
medications precipitate Tourette’s syndrome. JAMA;247:1729–1731, ISSN 1538-
3598. 
[27] Harris K, Singer HS. (2006). Tic disorders: neural circuits, Neurochemistry, and 
Neuroimmunology. J Child Neurol; 21 (8) :678-89, ISSN 1708-8828. 
[28] Langen M, M JH Kas,. Staal WG, Engeland HV, Durston S. (2011). The neurobiology of 
repetitive behavior: Of mice. Neuroscience and Biobehavioral Reviews; 345-355, ISSN 
0149-7634. 
[29] Y. Kawaguchi. (2003). Local circuit neurons in the frontal Cortico-striatal system. In: 
Excitatory-Inhibitory Balance: Synapses, Circuits, Systems, Hensch T.K.; Fagiolini M, 
pp. 125-148, KluwerAcademic/Plenum Publishers, ISBN 0-306-47962-1, New York. 
[30] Ouyer J.J., Park D.H., Joh T.H., Pickel V.M. (1984). Chemical and structural analysis of 
the relation between tyrosine hydroxyl cortical inputs and terminals in rat-
containing neostriatum. Brain Research; 302 (2), pp. 267-275, ISSN 1872-6240. 
[31] Kalanithi PS, Zheng W, Kataoka Y, DiFiglia M, Grantz H, Saper CB, Schwartz ML, 
Leckman JF, Vaccarino FM. (2005). Altered parvalbumin-positive neuron 
distribution in basal ganglia of individuals with Tourette syndrome. Proc Natl Acad 
Sci U S A; 13;102(37):13307-12, ISSN 1091-6490. 
[32] Steingard RJ, Goldberg M, Lee D, DeMaso DR. (1994). Adjunctive clonazepam 
treatment of tic symptoms in children with comorbid tic disorders and ADHD. J 
Am Acad Child Adolesc Psychiatry;33:394–399, ISSN 0890-8657. 
[33] Kenney C, Jankovic J. (2006). Tetrabenazine in the treatment of hyperkinetic movement 
disorders. Expert Rev Neurother;6:7–17, ISSN 1473-7175. 
[34] Jain S, Greene PE, Frucht SJ. (2006). Tetrabenazine therapy of pediatric hyperkinetic 
movement disorders. Mov Disord;21: 1966–1972, ISSN 0885-3185. 
[35] Petzinger GM, Bressman SB. (1997). A case of tetrabenazine-induced neuroleptic 
malignant syndrome after prolonged treatment. Mov Disord;12:246–248., ISSN 0885-
3185. 
[36] Jankovic J. (1994). Botulinum toxin in the treatment of dystonic tics. Mov Disord;9:347–
349, ISSN 0885-3185. 
[37] Salloway S, Stewart CF, Israeli L, et al. (1996). Botulinum toxin for refractory vocal tics. 
Mov Disord;11:746–748, ISSN 0885-3185. 
[38] Trimble MR, Whurr R, Brookes G, Robertson MM. (1998). Vocal tics in Gilles de la 
Tourette syndrome treated with botulinum toxin injections. Mov Disord;13:617–619., 
ISSN 0885-3185. 
[39] Mantovani A, Lisanby SH, Pieraccini F, Ulivelli M, Castrogiovanni P, Rossi S. (2006). 
Repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive-
compulsive disorder (OCD) and Tourette’s syndrome (TS). Int J 
Neuropsychopharmacol;9:95–100, ISSN 1461-1457. 
[40] Mantovani A, Leckman JF, Grantz H, King RA, Sporn AL, Lisanby SH. (2007). 
Repetitive transcranial magnetic stimulation of the supplementary motor area in 
the treatment of Tourette syndrome: report of two cases. Clin 
Neurophysiol;118:2314–2315, ISSN 1388-2457. 
[41] Servello D, Porta M, Sassi M, Brambilla A, Robertson MM. (2008). Deep brain 
stimulation in 18 patients with severe Gilles de la Tourette syndrome refractory to 







[6] Robertson MM. (2000). Tourette syndrome, associated conditions and the complexities of 
treatment. Brain;123(pt 3):425–462. ISSN 1460-2156. 
[7] Palumbo D, Maughan A, Kurlan R. (1997). Hypothesis III. Tourette syndrome is only one 
of several causes of a developmental basal ganglia syndrome. Arch Neurol;54:475–
483, ISSN 1538-3687. 
[8] Ruiz-Sandoval JL, Garcia-Navarro V, Chiquete E, et al. (2007). Choreoacanthocytosis in a 
Mexican family. Arch Neurol;64: 1661–1664, ISSN 1538-3687. 
[9] Hardie RJ, Pullon HW, Harding AE, et al. (1991). Neuroacanthocytosis. A clinical, 
haematological and pathological study of 19 cases. Brain;114 (pt 1A):13–49, ISSN 
1460-2156. 
[10] Scarano V, Pellecchia MT, Filla A, Barone P. (2002). Hallervorden-Spatz syndrome 
resembling a typical Tourette syndrome. Mov Disord;17:618–620, ISSN 0885-3185. 
[11] Pellecchia MT, Valente EM, Cif L, et al. (2005). The diverse phenotype and genotype of 
pantothenate kinase-associated neurodegeneration. Neurology;64:1810–1812, ISSN 
0028-3878. 
[12] Angelini L, Sgro V, Erba A, Merello S, Lanzi G, Nardocci N. (1998). Tourettism as 
clinical presentation of Huntington’s disease with onset in childhood. Ital J Neurol 
Sci;19:383–385, ISSN 0392-0461. 
[13] Krauss JK, Jankovic J. (1997). Tics secondary to craniocerebral trauma. Mov 
Disord;12:776–82, ISSN 0885-3185. 
[14] Pulst SM, Walshe TM, Romero JA. (1983). Carbon monoxide poisoning with features of 
Gilles de la Tourette’s syndrome. Arch Neurol;40:443–444, ISSN 1538-3687. 
[15] Kwak CH, Jankovic J. (2002). Tourettism and dystonia after subcortical stroke. Mov 
Disord;17:821–825, ISSN 0885-3185. 
[16] Riedel M, Straube A, Schwarz MJ, Wilske B, Muller N. (1998). Lyme disease presenting 
as Tourette’s syndrome. Lancet;351: 418–419, ISSN 0140-6736. 
[17] Northam RS, Singer HS. (1991). Postencephalitic acquired Tourette-like syndrome in a 
child. Neurology;41:592–593, ISSN 0028-3878. 
[18] Martino D, Chew NK, Mir P, Edwards MJ, Quinn NP, Bhatia KP. (2006). Atypical 
movement disorders in antiphospholipid syndrome. Mov Disord;21:944–949, ISSN 
0885-3185. 
[19] Moore DP. Neuropsychiatric aspects of Sydenham’s chorea: a comprehensive review. 
(1996). J Clin Psychiatry;57:407–414, ISSN 1555-2101. 
[20] Bharucha KJ, Sethi KD. (1995). Tardive tourettism after exposure to neuroleptic 
therapy. Mov Disord;10:791–793, ISSN 0885-3185. 
[21] Polizos P, Engelhardt DM, Hoffman SP, Waizer J. (1973). Neurological consequences of 
psychotropic drug withdrawal in schizophrenic children. J Autism Child 
Schizophr;3:247–253, ISSN 0021-9185. 
[22] Lombroso CT. (1999). Lamotrigine-induced tourettism. Neurology; 52:1191–1194, ISSN 
028-3878. 
[23] Neglia JP, Glaze DG, Zion TE. (1984). Tics and vocalizations in children treated with 
carbamazepine. Pediatrics;73:841–844, ISSN 1098-4275. 
[24] Cardoso FE, Jankovic J. (1993). Cocaine-related movement disorders. Mov Disord;8:175–
78, ISSN 0885-3185. 
[25] Davis RE, Osorio I. (1998). Childhood caffeine tic syndrome. Pediatrics;101:E4, ISSN 
1098-275. 
 




[26] Lowe TL, Cohen DJ, Detlor J, Kremenitzer MW, Shaywitz BA. (1982). Stimulant 
medications precipitate Tourette’s syndrome. JAMA;247:1729–1731, ISSN 1538-
3598. 
[27] Harris K, Singer HS. (2006). Tic disorders: neural circuits, Neurochemistry, and 
Neuroimmunology. J Child Neurol; 21 (8) :678-89, ISSN 1708-8828. 
[28] Langen M, M JH Kas,. Staal WG, Engeland HV, Durston S. (2011). The neurobiology of 
repetitive behavior: Of mice. Neuroscience and Biobehavioral Reviews; 345-355, ISSN 
0149-7634. 
[29] Y. Kawaguchi. (2003). Local circuit neurons in the frontal Cortico-striatal system. In: 
Excitatory-Inhibitory Balance: Synapses, Circuits, Systems, Hensch T.K.; Fagiolini M, 
pp. 125-148, KluwerAcademic/Plenum Publishers, ISBN 0-306-47962-1, New York. 
[30] Ouyer J.J., Park D.H., Joh T.H., Pickel V.M. (1984). Chemical and structural analysis of 
the relation between tyrosine hydroxyl cortical inputs and terminals in rat-
containing neostriatum. Brain Research; 302 (2), pp. 267-275, ISSN 1872-6240. 
[31] Kalanithi PS, Zheng W, Kataoka Y, DiFiglia M, Grantz H, Saper CB, Schwartz ML, 
Leckman JF, Vaccarino FM. (2005). Altered parvalbumin-positive neuron 
distribution in basal ganglia of individuals with Tourette syndrome. Proc Natl Acad 
Sci U S A; 13;102(37):13307-12, ISSN 1091-6490. 
[32] Steingard RJ, Goldberg M, Lee D, DeMaso DR. (1994). Adjunctive clonazepam 
treatment of tic symptoms in children with comorbid tic disorders and ADHD. J 
Am Acad Child Adolesc Psychiatry;33:394–399, ISSN 0890-8657. 
[33] Kenney C, Jankovic J. (2006). Tetrabenazine in the treatment of hyperkinetic movement 
disorders. Expert Rev Neurother;6:7–17, ISSN 1473-7175. 
[34] Jain S, Greene PE, Frucht SJ. (2006). Tetrabenazine therapy of pediatric hyperkinetic 
movement disorders. Mov Disord;21: 1966–1972, ISSN 0885-3185. 
[35] Petzinger GM, Bressman SB. (1997). A case of tetrabenazine-induced neuroleptic 
malignant syndrome after prolonged treatment. Mov Disord;12:246–248., ISSN 0885-
3185. 
[36] Jankovic J. (1994). Botulinum toxin in the treatment of dystonic tics. Mov Disord;9:347–
349, ISSN 0885-3185. 
[37] Salloway S, Stewart CF, Israeli L, et al. (1996). Botulinum toxin for refractory vocal tics. 
Mov Disord;11:746–748, ISSN 0885-3185. 
[38] Trimble MR, Whurr R, Brookes G, Robertson MM. (1998). Vocal tics in Gilles de la 
Tourette syndrome treated with botulinum toxin injections. Mov Disord;13:617–619., 
ISSN 0885-3185. 
[39] Mantovani A, Lisanby SH, Pieraccini F, Ulivelli M, Castrogiovanni P, Rossi S. (2006). 
Repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive-
compulsive disorder (OCD) and Tourette’s syndrome (TS). Int J 
Neuropsychopharmacol;9:95–100, ISSN 1461-1457. 
[40] Mantovani A, Leckman JF, Grantz H, King RA, Sporn AL, Lisanby SH. (2007). 
Repetitive transcranial magnetic stimulation of the supplementary motor area in 
the treatment of Tourette syndrome: report of two cases. Clin 
Neurophysiol;118:2314–2315, ISSN 1388-2457. 
[41] Servello D, Porta M, Sassi M, Brambilla A, Robertson MM. (2008). Deep brain 
stimulation in 18 patients with severe Gilles de la Tourette syndrome refractory to 







[42] Dehning S, Mehrkens JH, Muller N, Botzel K. (2008). Therapy-refractory Tourette 
syndrome: beneficial outcome with globus pallidus internus deep brain 
stimulation. Mov Disord;23: 1300–1302, ISSN 0885-3185. 
[43] Flaherty AW, Williams ZM, Amirnovin R, et al. (2005). Deep brain stimulation of the 
anterior internal capsule for the treatment of Tourette syndrome: technical case 
report. Neurosurgery; 57:E403; discussion E403, ISSN 0148-396X. 
[44] Servello D, Porta M, Sassi M, Brambilla A, Robertson MM. (2008). Deep brain 
stimulation in 18 patients with severe Gilles de la Tourette syndrome refractory to 
treatment: the surgery and stimulation. J Neurol Neurosurg Psychiatry;79:136–142, 
ISSN 0022-3050. 
[45] Swedo SE, Leonard HL, Garvey M, et al. (1998). Pediatric autoimmune 
neuropsychiatric disorders associated with streptococcal infections: clinical 
description of the first 50 cases. Am J Psychiatry;155:264–271, ISSN 0002-953X. 
[46] Jaffe E, Tremeau F, Sharif Z, Reider R. (1995). Clozapine in tardive Tourette syndrome. 
Biol Psychiatry; 38:196–197, ISSN 0006-3223. 
[47] Reid SD. (2004). Neuroleptic-induced tardive Tourette treated with clonazepam: a case 
report and literature review. Clin Neuropharmacol;27:101–104, ISSN 0362-5664. 
[48] Wilhelm S, Deckersbach T, Coffey BJ, Bohne A, Peterson AL, Baer L. (2003). Habit 
reversal versus supportive psychotherapy for Tourette’s disorder: a randomized 
controlled trial. Am J Psychiatry;160:1175–1177, ISSN 0002-953X. 
[49] Allen AJ, Kurlan RM, Gilbert DL, et al. (2005). Atomoxetine treatment in children and 
adolescents with ADHD and comorbid tic disorders. Neurology;65:1941–1949, ISSN 
0028-3878. 
[50] Tourette’s Syndrome Study Group. (2002). Treatment of ADHD in children with tics: a 
randomized controlled trial. Neurology; 58: 527–536, ISSN 0028-3878. 
[51] Gadow KD, Sverd J, Nolan EE, Sprafkin J, Schneider J. (2007). Immediate- release 
methylphenidate for ADHD in children with comorbid chronic multiple tic 
disorder. J Am Acad Child Adolesc Psychiatry;46:840–848, ISSN 0890-8567. 
[52] Castellanos FX, Giedd JN, Elia J, et al. (1997). Controlled stimulant treatment of ADHD 
and comorbid Tourette’s syndrome: effects of stimulant and dose. J Am Acad Child 
Adolesc Psychiatry;36:589–596, ISSN 0890-8657. 
[53] Goetz, C. G., Leurgans, S., & Chmura, T. A. (2001). Home alone: Methods to maximize 
tic expression for objective videotape assessments in Gilles de la Tourette 
syndrome. Movement Disorders, 16, 693–697, ISSN 0885-3185. 
[54] Chappell, P. B., McSwiggan-Hardin, M. T., Scahill, L., Rubenstein, M., Walker, D. E., 
Cohen, D. J., et al. (1994). Videotape tic counts in the assessment of Tourette’s 
syndrome: Stability, reliability, and validity. Journal of the American Academy of Child 
and Adolescent Psychiatry, 33, 386–393, ISSN 0890-8657. 
[55] Nomoto F, Machiyama Y. (1990). An epidemiological study of tics. Jpn J Psychiatry 
Neurol;44:649–655, ISSN 0912-2036. 
[56] Wang HS, Kuo MF. (2003). Tourette’s syndrome in Taiwan: an epidemiological study 
of tic disorders in an elementary school at Taipei County. Brain Dev;25(Suppl. 
1):S29 –S31, ISSN 0387-7604. 
[57] Saccomani L, Fabiana V, Manuela B, Giambattista R. (2005). Tourette syndrome and 
chronic tics in a sample of children and adolescents. Brain Dev;27:349 –352, ISSN 
0387-7604. 
 




[58] Linazasoro G, Blercom NV, Ortiz C. (2006). Prevalence of tic disorder in two schools in 
the Basque Country: results and methodological caveats. Movement disorders; 21: 
2106-2109, ISSN 0885-3185. 
[59] Peterson, A. L., & Azrin, N. H. (1992). An evaluation of behavioral treatments for 
Tourette syndrome. Behaviour Research and Therapy, 30, 167–174, ISSN 0005-7967. 
[60] Bruun, R. D., & Budman, C. L. (1996). Risperidone as a treatment for Tourette’s 
syndrome. Journal of Clinical Psychiatry, 57, 29–31, ISSN 1555-2101. 
[61] Comings, D. E. (1990). Tourette syndrome and human behavior, Hope Press, ISBN 1-
878267-27-2, Durante, CA:. 
[62] Himle, M. B., & Woods, D. W. (2005). An experimental evaluation of tic suppression and 
the tic rebound effect. Behaviour Research and Therapy, 43, 1443–1451, ISSN 0005-7967. 
[63] Himle MB, Chang S, Woods DW, Pearlman A, Buzzella B, Bunaciu L, Piacentini JC. 
(2006). Establishing the feasibility of direct observation in the assessment of tics in 
children with chronic tic disorders. Journal of applied behavior analysis, 39, 429–440, 
ISSN 0021-8855. 
[64] Leckman, J. F., Riddle, M. A., Hardin, M., Ort, S. I., Swartz, K. L., & Stevenson, J., et al. 
(1989). The Yale global tic severity scale: Initial testing of a clinicianrated scale of tic 
severity. Journal of the American Academy of Child and Adolescent Psychiatry, 28, 566–
573, ISSN 0890-8657. 
[65] Azrin, N. H., & Peterson, A. L. (1988). Behavior therapy for Tourette’s syndrome and 
tic disorders, In: Tourette syndrome and tic disorders: Clinical understanding and 
treatment, D. J. Cohen, J. F. Leckman, & R. D. Bruun (Eds.), pp. 237–255, Wiley, 
ISBN 978-0471629245, New York. 
[66] Harrop, A., & Daniels, M. (1986). Methods of time sampling: A reappraisal of 
momentary time sampling and partial interval recording. Journal of Applied Behavior 
Analysis, 19, 73–77, ISSN 0021-8855. 
[67] Stefanoff P, Mazurek J. (2003). Epidemiological methods used in studies in the 
prevalence of Tourette syndrome. Psychiatr Pol;37: 97–107, ISSN 0033-2674. 
[68] Khalifa N, Knorring ALV. (2003). Prevalence of tic disorders and Tourette syndrome in 
a Swedish school population. Developmental medicine and child neurology; 45 (5): 315-
319, ISSN 0012-1622. 
[69] Lanzi G, Zambrino CA, Termine C, Palestra M, Ferrari O, Orcesi S, et al. (2004). 
Prevalence of tic disorders among primary schools students in the city of pavia, 
Italy. Arch Dis Child; 89: 45-47, ISSN 1468-2044. 
[70] Stefanoff P, Wolanczyk T, Gawrys A, Swirszcz K, Stefanoff E, Kaminska A, et al. 
(2008). Prevalence of tic disorders among schoolchildren in Warsaw, Poland. Eur 
Child Adolesc psychiatry; 17: 171-178, ISSN 1018-8827. 
[71] Schlander M, Schwarz O, Rothenberger A, Roessner V. (2010). Tic disorders: 
administrative prevalence and co-occurrence with attention-definit/hyperactivity 
disorder in a German community sample. European Psychiatry. Eur Psychiatry. 
26(6):370-4, ISSN 0924-9338. 
[72] Ortiz B, David M, Sánchez Y, Mira J, Sierra JM, Cornejo W. (2011). Prevalencia de tics 
en población escolar de 6 a 12 años de edad en el municipio de itagüi - colombia en 
el año 2010. In press. 
[73] Mason A, Banerjee S, Eapen V, Zeitlin H, Robertson MM. (1998). The prevalence of 
Tourette syndrome in a mainstream school population. DevMed Child 






[42] Dehning S, Mehrkens JH, Muller N, Botzel K. (2008). Therapy-refractory Tourette 
syndrome: beneficial outcome with globus pallidus internus deep brain 
stimulation. Mov Disord;23: 1300–1302, ISSN 0885-3185. 
[43] Flaherty AW, Williams ZM, Amirnovin R, et al. (2005). Deep brain stimulation of the 
anterior internal capsule for the treatment of Tourette syndrome: technical case 
report. Neurosurgery; 57:E403; discussion E403, ISSN 0148-396X. 
[44] Servello D, Porta M, Sassi M, Brambilla A, Robertson MM. (2008). Deep brain 
stimulation in 18 patients with severe Gilles de la Tourette syndrome refractory to 
treatment: the surgery and stimulation. J Neurol Neurosurg Psychiatry;79:136–142, 
ISSN 0022-3050. 
[45] Swedo SE, Leonard HL, Garvey M, et al. (1998). Pediatric autoimmune 
neuropsychiatric disorders associated with streptococcal infections: clinical 
description of the first 50 cases. Am J Psychiatry;155:264–271, ISSN 0002-953X. 
[46] Jaffe E, Tremeau F, Sharif Z, Reider R. (1995). Clozapine in tardive Tourette syndrome. 
Biol Psychiatry; 38:196–197, ISSN 0006-3223. 
[47] Reid SD. (2004). Neuroleptic-induced tardive Tourette treated with clonazepam: a case 
report and literature review. Clin Neuropharmacol;27:101–104, ISSN 0362-5664. 
[48] Wilhelm S, Deckersbach T, Coffey BJ, Bohne A, Peterson AL, Baer L. (2003). Habit 
reversal versus supportive psychotherapy for Tourette’s disorder: a randomized 
controlled trial. Am J Psychiatry;160:1175–1177, ISSN 0002-953X. 
[49] Allen AJ, Kurlan RM, Gilbert DL, et al. (2005). Atomoxetine treatment in children and 
adolescents with ADHD and comorbid tic disorders. Neurology;65:1941–1949, ISSN 
0028-3878. 
[50] Tourette’s Syndrome Study Group. (2002). Treatment of ADHD in children with tics: a 
randomized controlled trial. Neurology; 58: 527–536, ISSN 0028-3878. 
[51] Gadow KD, Sverd J, Nolan EE, Sprafkin J, Schneider J. (2007). Immediate- release 
methylphenidate for ADHD in children with comorbid chronic multiple tic 
disorder. J Am Acad Child Adolesc Psychiatry;46:840–848, ISSN 0890-8567. 
[52] Castellanos FX, Giedd JN, Elia J, et al. (1997). Controlled stimulant treatment of ADHD 
and comorbid Tourette’s syndrome: effects of stimulant and dose. J Am Acad Child 
Adolesc Psychiatry;36:589–596, ISSN 0890-8657. 
[53] Goetz, C. G., Leurgans, S., & Chmura, T. A. (2001). Home alone: Methods to maximize 
tic expression for objective videotape assessments in Gilles de la Tourette 
syndrome. Movement Disorders, 16, 693–697, ISSN 0885-3185. 
[54] Chappell, P. B., McSwiggan-Hardin, M. T., Scahill, L., Rubenstein, M., Walker, D. E., 
Cohen, D. J., et al. (1994). Videotape tic counts in the assessment of Tourette’s 
syndrome: Stability, reliability, and validity. Journal of the American Academy of Child 
and Adolescent Psychiatry, 33, 386–393, ISSN 0890-8657. 
[55] Nomoto F, Machiyama Y. (1990). An epidemiological study of tics. Jpn J Psychiatry 
Neurol;44:649–655, ISSN 0912-2036. 
[56] Wang HS, Kuo MF. (2003). Tourette’s syndrome in Taiwan: an epidemiological study 
of tic disorders in an elementary school at Taipei County. Brain Dev;25(Suppl. 
1):S29 –S31, ISSN 0387-7604. 
[57] Saccomani L, Fabiana V, Manuela B, Giambattista R. (2005). Tourette syndrome and 
chronic tics in a sample of children and adolescents. Brain Dev;27:349 –352, ISSN 
0387-7604. 
 




[58] Linazasoro G, Blercom NV, Ortiz C. (2006). Prevalence of tic disorder in two schools in 
the Basque Country: results and methodological caveats. Movement disorders; 21: 
2106-2109, ISSN 0885-3185. 
[59] Peterson, A. L., & Azrin, N. H. (1992). An evaluation of behavioral treatments for 
Tourette syndrome. Behaviour Research and Therapy, 30, 167–174, ISSN 0005-7967. 
[60] Bruun, R. D., & Budman, C. L. (1996). Risperidone as a treatment for Tourette’s 
syndrome. Journal of Clinical Psychiatry, 57, 29–31, ISSN 1555-2101. 
[61] Comings, D. E. (1990). Tourette syndrome and human behavior, Hope Press, ISBN 1-
878267-27-2, Durante, CA:. 
[62] Himle, M. B., & Woods, D. W. (2005). An experimental evaluation of tic suppression and 
the tic rebound effect. Behaviour Research and Therapy, 43, 1443–1451, ISSN 0005-7967. 
[63] Himle MB, Chang S, Woods DW, Pearlman A, Buzzella B, Bunaciu L, Piacentini JC. 
(2006). Establishing the feasibility of direct observation in the assessment of tics in 
children with chronic tic disorders. Journal of applied behavior analysis, 39, 429–440, 
ISSN 0021-8855. 
[64] Leckman, J. F., Riddle, M. A., Hardin, M., Ort, S. I., Swartz, K. L., & Stevenson, J., et al. 
(1989). The Yale global tic severity scale: Initial testing of a clinicianrated scale of tic 
severity. Journal of the American Academy of Child and Adolescent Psychiatry, 28, 566–
573, ISSN 0890-8657. 
[65] Azrin, N. H., & Peterson, A. L. (1988). Behavior therapy for Tourette’s syndrome and 
tic disorders, In: Tourette syndrome and tic disorders: Clinical understanding and 
treatment, D. J. Cohen, J. F. Leckman, & R. D. Bruun (Eds.), pp. 237–255, Wiley, 
ISBN 978-0471629245, New York. 
[66] Harrop, A., & Daniels, M. (1986). Methods of time sampling: A reappraisal of 
momentary time sampling and partial interval recording. Journal of Applied Behavior 
Analysis, 19, 73–77, ISSN 0021-8855. 
[67] Stefanoff P, Mazurek J. (2003). Epidemiological methods used in studies in the 
prevalence of Tourette syndrome. Psychiatr Pol;37: 97–107, ISSN 0033-2674. 
[68] Khalifa N, Knorring ALV. (2003). Prevalence of tic disorders and Tourette syndrome in 
a Swedish school population. Developmental medicine and child neurology; 45 (5): 315-
319, ISSN 0012-1622. 
[69] Lanzi G, Zambrino CA, Termine C, Palestra M, Ferrari O, Orcesi S, et al. (2004). 
Prevalence of tic disorders among primary schools students in the city of pavia, 
Italy. Arch Dis Child; 89: 45-47, ISSN 1468-2044. 
[70] Stefanoff P, Wolanczyk T, Gawrys A, Swirszcz K, Stefanoff E, Kaminska A, et al. 
(2008). Prevalence of tic disorders among schoolchildren in Warsaw, Poland. Eur 
Child Adolesc psychiatry; 17: 171-178, ISSN 1018-8827. 
[71] Schlander M, Schwarz O, Rothenberger A, Roessner V. (2010). Tic disorders: 
administrative prevalence and co-occurrence with attention-definit/hyperactivity 
disorder in a German community sample. European Psychiatry. Eur Psychiatry. 
26(6):370-4, ISSN 0924-9338. 
[72] Ortiz B, David M, Sánchez Y, Mira J, Sierra JM, Cornejo W. (2011). Prevalencia de tics 
en población escolar de 6 a 12 años de edad en el municipio de itagüi - colombia en 
el año 2010. In press. 
[73] Mason A, Banerjee S, Eapen V, Zeitlin H, Robertson MM. (1998). The prevalence of 
Tourette syndrome in a mainstream school population. DevMed Child 






[74] Saunders-Pullman R, Braun I, Bressman S. (1999). Pediatric movement disorders. Child 
Adolesc Psychiatry Clin North Am;8:747–765, ISSN 1056-4993. 
[75] Chouinard S, Ford B. (2000). Adult onset tic disorders. J Neurol Neurosurg Psychiatry; 
68: 738-743, ISSN 0022-3050. 
[76] Eapen V, Lees AJ, Lakke J.P.W.F., Trimble MR, Robertson MM. (2002). Adult-Onset Tic 
Disorders. Movement Disorders Vol. 17, No. 4, pp. 735–740, ISSN 0885-3185. 
[77] Prior AC, Tavares S, Figueiroa S, Temudo T. (2007). Tics in children and adolescents: a 
retrospective analysis of 78 cases. An Pediatr (Barc); 66(2):129-34, ISSN 1695-4033. 
[78] Khalifa N, Knorring ALV. (2003). Prevalence of tic disorders and Tourette syndrome in 
a Swedish school population. Developmental medicine and child neurology; 45 (5): 315-
319. ISSN 1469-8749. 
[79] Snider LA, Seligman LD, Ketchen BR, Levitt SJ, Bates LR, Garvey et al. (2002). Tics and 
problem behaviors in schoolchildren: prevalence, characterization and associations. 
Pediatrics; 110: 331-336, ISSN 0031-4005 
[80] Hardie RJ, Pullon HW, Harding AE, et al. (1990). Neuroacanthocytosis. Brain;114:13–
49, ISSN 1460-2156. 
[81] Sacks OW. (1982). Acquired Tourettism in adult life. In: Advances in neurology: Gilles de 
la Tourette syndrome, Friedhoff AJ, Chase TN, editors, Raven Press, ISBN 0091-3952, 
New York. 
[82] Robertson MM, Eapen V. (1996). The National Hospital Interview Schedule for the 
assessment of Gilles de la Tourette syndrome and related behaviours. Int J Methods 
Psychiat Res;6:203–226, ISSN 1557-0657. 
[83] Goetz CG, Pappert EJ. Trauma and movement disorders. Neurol Clin 1992;10:907–919, 
ISSN 0733-8619. 
[84] Swedo SE, Leonard HL, Garvey M, Mittleman B, Allen AJ, Perlmutters, Longee L, Dow 
S, Zamkoff J, Dubbert BK. (1998). Pediatric autoimmune neuropsychiatric disorders 
associated with streptococcal infections: clinical description of the first 50 cases. Am 
J Psychiatry;155:264–271, ISSN 0002-953X. 
[85] Cardoso F, Vargas AP. (1996). Persistent dyskinesia and obsessive compulsive 
behaviour following alcohol withdrawal. Neurology; 47:844, ISSN 0028-3878. 
[86] Stahl SM. (1980). Tardive Tourette’s syndrome in an autistic patient after long term 
neuroleptic administration. Am J Psychiatry;137: 1267–1269, ISSN 0002-953X. 
[87] Fog R, Pakkenberg H, Regeur L, Pakkenberg B. (1982). “Tardive” Tourette syndrome in 
relation to long term neuroleptic treatment multiple tics. Adv Neurol;35:419–421, 
ISSN 0091-3952. 
[88] Walkup JT, LaBuda MC, Singer HS, Brown J, Riddle MA, Hurko O. (1996). Family 
study of segregation analysis of Tourette syndrome. Am J Hum Genet;59:684–693, 
ISSN 0002-9297. 
[89] Goetz CG, Tanner CM, Stebbins GT, Leipzig G, Carr WC. (1992). Adult tics in Gilles de 
la Tourette syndrome. Neurology;42:784–788, ISSN 0028-3878. 
[90] Linazasoro G, Olsagasti B, Marti Masso JF. (1992). Atypical presentation of Gilles de la 
Tourette syndrome. Br J Psychiatry;160:426, ISSN 1472-1465. 
[91] Nolan EE, Gadow KD, Sverd J. (1994). Observations and ratings of tics in school 
settings. J Abnorm Child Psychol;22(5):579-93, ISSN 1573-2835. 
[92] Baer, D. M., Wolf, M. M., & Risley, T. R. (1987). Some still-current dimensions of 
applied behavior analysis. Journal of Applied Behavior Analysis, 20, 313–327, ISSN 
0021-8855. 
10 
A Review of the Etiology Delirium 
Nese Kocabasoglu1, Gul Karacetin2, Reha Bayar1 and Turkay Demir3 
1Cerrahpasa Medical School, Department of Psychiatry 
2Department of Child and Adolescent Psychiatry 
3Cerrahpasa Medical School, Department of Child and Adolescent Psychiatry 
Turkey 
1. Introduction 
Delirium, also called as organic brain syndrome, acute brain syndrome, acute brain 
failure, acute confusional episode and reversible or masked dementia, as a concept, 
stretches back to the age of Hypocrates (Burns et al., 2004). Delirium is described as a 
condition characterized by a disturbance of consciousness with reduced ability to focus, 
sustain, or shift attention according to the Diagnostic and Statistical Classification of 
Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) criteria (American 
Psychiatric Association, 2000). Also, delirium involves a change in cognition (such as 
memory deficit, disorientation, language disturbance) or the development of a perceptual 
disturbance that is not better accounted for by a preexisting, established, or evolving 
dementia (American Psychiatric Association, 2000). In addition to these, impairment in 
the brain’s ability to integrate perceptions correctly, coupled with memory deficits and 
confusion may result in psychotic symptoms in delirium. Hallucinations (especially visual 
and tactile), delusions, paranoia, illusions, and bizarre behavior are the commonly 
encountered psychotic symptoms in delirium (Leigh, 2008). 
Delirium is associated with longer hospital stay, poorer functional outcome, and cognitive 
decline in addition to an elevated morbidity and mortality. Despite these adverse outcomes, 
delirium recognition rates are low (12–43%) and its management remains inadequate in up 
to 80% of patients (Morrison et al., 2003). These findings suggest lack of preventive and 
screening activities, missed diagnoses, and inappropriate management of diagnosed 
delirium (Michaud et al., 2007). 
2. Epidemiology 
2.1 Prevalence 
The prevalence of delirium varies with the population that is being studied (Fong et al., 
2009). Delirium is a relatively common disorder, especially in older people with physical 
illness (Saxena & Lawley, 2009). Community rates of delirium are reported to vary from 
0.4% to 2% (Saxena & Lawley, 2009, Fong et al., 2009). In general hospital setting prevalence 
of delirium has been reported to range from 11% to 33% on admission (Lindesay et al., 2002) 
and its incidence during hospital stay ranges between 3% and 56% (Inouye, 2006; Michaud L 
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1. Introduction 
Delirium, also called as organic brain syndrome, acute brain syndrome, acute brain 
failure, acute confusional episode and reversible or masked dementia, as a concept, 
stretches back to the age of Hypocrates (Burns et al., 2004). Delirium is described as a 
condition characterized by a disturbance of consciousness with reduced ability to focus, 
sustain, or shift attention according to the Diagnostic and Statistical Classification of 
Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) criteria (American 
Psychiatric Association, 2000). Also, delirium involves a change in cognition (such as 
memory deficit, disorientation, language disturbance) or the development of a perceptual 
disturbance that is not better accounted for by a preexisting, established, or evolving 
dementia (American Psychiatric Association, 2000). In addition to these, impairment in 
the brain’s ability to integrate perceptions correctly, coupled with memory deficits and 
confusion may result in psychotic symptoms in delirium. Hallucinations (especially visual 
and tactile), delusions, paranoia, illusions, and bizarre behavior are the commonly 
encountered psychotic symptoms in delirium (Leigh, 2008). 
Delirium is associated with longer hospital stay, poorer functional outcome, and cognitive 
decline in addition to an elevated morbidity and mortality. Despite these adverse outcomes, 
delirium recognition rates are low (12–43%) and its management remains inadequate in up 
to 80% of patients (Morrison et al., 2003). These findings suggest lack of preventive and 
screening activities, missed diagnoses, and inappropriate management of diagnosed 
delirium (Michaud et al., 2007). 
2. Epidemiology 
2.1 Prevalence 
The prevalence of delirium varies with the population that is being studied (Fong et al., 
2009). Delirium is a relatively common disorder, especially in older people with physical 
illness (Saxena & Lawley, 2009). Community rates of delirium are reported to vary from 
0.4% to 2% (Saxena & Lawley, 2009, Fong et al., 2009). In general hospital setting prevalence 
of delirium has been reported to range from 11% to 33% on admission (Lindesay et al., 2002) 
and its incidence during hospital stay ranges between 3% and 56% (Inouye, 2006; Michaud L 





Delirium rates depend on the setting in which the patient belong; for example, delirium 
prevalence has been reported to be between 7-10% in emergency department, whereas it has 
been reported to be as high as 33% in the orthopedic surgery patients (Samuels & 
Neugroschl, 2005). Postoperative delirium is reported to be in 15% to 62% of elderly patients 
(Saxena & Lawley, 2009, Fong et al., 2009). Higher rates of delirium have been reported in 
elderly patients in intensive care units (ICU), which ranges from 70% to 87% (Saxena & 
Lawley, 2009, Fong et al., 2009).  
Children are also are at risk of delirium. There is a paucity of data on the rates of delirium in 
children, but delirium was reported to be seen in 10 to 40 percent of preschool children 
during emergence from anesthesia. Children with severe burns and fever are at risk for 
delirium (Saxena & Lawley, 2009).  
3. Etiology 
Delirium is divided into subtypes according to the etiological factors. When there is 
evidence from the history, physical examination, or laboratory findings that the disturbance 
is caused by the direct physiological consequences of a general medical condition, it is called 
as Delirium due to a general medical condition.  When the symptoms of delirium are due to 
substance intoxication, it is called as Substance intoxication delirium. When the delirium is due 
to substance withdrawal, it is called as Substance withdrawal delirium. When there is evidence 
from the history, physical examination, or laboratory findings that the delirium has more 
than one etiology, it is called as Delirium due to multiple etiologies. Delirium that is of unclear 
etiology is called as Delirium not otherwise specified (American Psychiatric Association, 2000). 
Delirium usually has a multifactorial etiology. It has been reported that 90% of patients with 
delirium had three to four identifiable etiologic factors, 27% had two factors, and only 16% 
had one identifiable etiologic factor (Camus et al., 2000). The etiology of delirium is complex 
and multifactorial, with the interaction of precipitating factors (acute insults) on a 
vulnerable patient with predisposing conditions (Inouye, 1999).  
3.1 Predisposing factors  
The predisposing factors are those that place patients vulnerable to develop delirium. Older 
age, neurological disorders, male sex, sensory impairment, , depression, functional 
dependence, immobility, hip fracture, dehydration, alcoholism, severity of physical illness, 
stroke, metabolic abnormalities are among the predisposing factors that increase an 
individual’s vulnerability to delirium (Inouye, 1999; Burns et al., 2004; Fong et al., 2009; 
Staus, 2011). The National Clinical Guideline Center (in the UK) has published a data 
synthesis on this topic commissioned by the National Institute for Health and Clinical 
Excellence (NICE). In this analysis, the risk factors for delirium were reported as age 65 
years or older, cognitive impairment (past or present) and/or dementia, hip fracture on 
admission, severe illness (a clinical condition that is deteriorating or is at risk of 
deterioration) (National Clinical Guideline Center). 
3.1.1 Age 
One of the most important predisposing factors is age (Inouye, 1999). Both the geriatric and 
pediatric populations are at risk of developing delirium (Dulcan, 2010).  The elderly are 
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more vulnerable to delirium because of the age-related loss of cholinergic reserve that is 
necessary for memory, learning, attention, and wakefulness (Maclullich et al., 2008).  
Among this age group, one of the most common risk factors for delirium is dementia, with 
two-thirds of elderly cases of delirium having comorbid dementia (Fong et al., 2009). 
Delirium and dementia are both associated with cholinergic deficiency (Hshieh et al., 2008) 
and decreased cerebral blood flow or metabolism (Fong et al., 2006, Yokota et al., 2003); 
these common properties might explain the relationship between these two conditions 
(Eikelenboom and Hoogendijk, 1999; Fong et al., 2009). 
As mentioned above, the main mechanism that predisposes elderly to delirium is 
diminished cholinergic reserve; on the other extremes of age are children who are also prone 
to delirium because of the immature and evolving structural brain development (Williams, 
2007). According to the study of Leentijens et al., 2008, etiological factors differed among 
pediatric, adult and geriatric populations; for children neurological, respiratory and 
circulatory disorders were among the most important causes of delirium (with ratios of 39%, 
%26, %17 in order), whereas for adults the most common factors were medication 
intoxication or withdrawal (24%), brain metastases/CNS neoplasms (24%) and metabolic 
and endocrine causes(20%), for elderly patients metabolic and endocrine causes (26%), 
systemic effects of a neoplasm (19%),medication intoxication or withdrawal (19%) were 
most important factors (Leentijens et al., 2008). 
3.1.2 Neurological disorders 
Dementia is a major predisposing factor for delirium, a meta-analysis suggesting a relative 
risk of 5.2 (Elie et al., 1998). Fick et al. reported that approximately 45% of patients with 
dementia develop delirium during hospitalization (2002). Elderly patients with dementia are 
at higher risk for developing delirium not only because they have the usual age-related 
decrease in acetylcholine described previously, but also have a focal loss of acetylcholine 
due to death of the cholinergic cells in the nucleus basalis of Meynert as a result of the 
disease process (Tune & Egeli, 1999).  
In a study that included patients over the age of 65 years admitted to hospital with a 
fractured neck of femur, cognitive impairment which was measured by the Mini-Mental 
State Examination (MMSE), has been found to be the most significant predisposing factor 
for the development of delirium (Freter et al., 2005).  
Other neurological causes are cerebrovascular diseases (thrombosis, embolism, arteritis, 
hemorrhage, hypertensive encephalopathy), degenerative disorders (multiple sclerosis), 
epilepsy, head trauma, space-occupying lesions (tumor, subdural hematoma, abscess, 
aneurysm) and encephalitis (Michaud et al., 2007; Fong et al., 2009). 
3.1.3 Hip fracture 
Hip fracture patients are at increased risk of delirium because of the trauma associated with 
the injury and the rapid progression to hospitalization and surgery, in addition to the pain 
and loss of function (Schor et al., 1992; Williams et al., 1985). Delirium has been reported to 
be seen in 20%–40% of patients with hip fracture at the time of hospital admission 
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The most common of delirium in hip fracture patients were reported as drugs that have 
central nervous system effects, infections, fluid-electrolyte disturbances, metabolic/ 
endocrine disturbances, intracranial processes, cardiopulmonary compromise and/or drug 
withdrawal and sensory/environmental causes (Brauer et al., 2000). 
3.1.4 Severe, traumatic or systematic illnesses 
Medical comorbidities such as burns (Palmu, 2011), cancer (Bond et al., 2011), cardiovascular 
disease (Branco et al., 2011), and alcoholism (Pompei et al., 1994) are among the 
predisposing factors for delirium. Sensory impairments like visual impairment and 
functional dependence also predispose individuals to delirium (Burns et al., 2004). In a 
study investigating a multifactorial model of delirium etiology, a predictive model was 
formed and 4 predisposing factors were identified for delirium: vision impairment, severe 
illness, cognitive impairment and BUN/creatinine ratio of 18 (Inouye, 1999).  
Having a severe illness and staying in intensive care unit are also predisposing factors for 
delirium. Delirium has been reported in up to 80% of critically ill patients (Ouimet et al., 
2007). Delirium is an independent predictor of adverse intensive care unit outcomes, 
including increased risk of death, longer hospital stay, and higher costs (Ely et al., 2004; 
Milbrandt et al., 2004; Thomason et al., 2005). 
3.1.5 Male gender 
Male gender was found to be a risk factor in some of the studies of delirium (Williams-
Russo et al., 1992; Fisher & Flowerdew, 1995; Kolbeinsson & Jonsson, 1993; Schor et al., 1992; 
Edlund et al., 2001). In the meta-analysis of Elie et al., a statistically significant relative risk 
of 1.9 was found for the male gender (1998). In a study that investigated the differences 
between preoperative and postoperative delirium regarding predisposing, precipitating 
factors and outcome in older patients admitted to hospital with femoral neck fractures, it 
was found that the men with femoral neck fractures were in poorer health than the women, 
except that more female patients had hypertension and were treated with diuretics (Edlund 
et al., 2001). In the same study, male patients were reported to suffer more postoperative 
complications and have higher long-term mortality (Edlund et al., 2001). These factors might 
have contributed to the increased risk of delirium in men. 
Another factor contributing to the increased risk of delirium in men might be reluctance of 
men to consult a doctor. Men with health problems were found to be more likely than 
women to have had no recent contact with a doctor regardless of income or ethnicity 
(Courtenay, 2000). This reluctance means that men often do not seek help until a disease has 
progressed (Banks, 2001). 
3.1.6 Depression 
Depression has been reported to be a predisposing factor for delirium in the elderly (Elie et 
al., 1998) and in non-cardiac surgical patients (Dasgupta and Dumbrell, 2006). The reduced 
functional connectivity in the human brain which is associated with depression (Anand et 
al., 2005) was hypothesized to be one of the mechanisms that predispose depressive patients 
to delirium (Sanders, 2011). On the other hand, the authors of the data synthesis 
commissioned by the National Institute for Health and Clinical Excellence (NICE) reported  
 
A Review of the Etiology Delirium 
 
193 
uncertainty for depression as a precipitating factor for delirium (National Clinical Guideline 
Center; Steiner, 2011). 
3.2. Precipitating factors 
Precipitating factors are the acute insults that trigger the mechanisms resulting in delirium 
(Fong et al., 2009; Inouye, 1999). Factors that have been reported to precipitate delirium are: 
anemia (Joosten et al., 2006), hypoxaemia (Kazmierski et al., 2010), Intensive Care Unit 
admission (Branco et al., 2011), electrolyte abnormalities (Korevaar et al., 2005), sleep 
deprivation (Weinhouse et al., 2009), pain, bladder catheter use, drugs and surgery (Burns et 
al., 2004). Biochemical abnormalities such as hyponatremia and hypokalemia and 
hyperuricemia and low body mass index and sensory impairment reflects the severity of the 
underlying precipitating cause of delirium (Elie et al., 1998; Mussi et al., 1999). 
Inouye and Charpentier performed a study to establish a predictive model for development 
of delirium and identified 5 independent precipitating factors for delirium in the elderly: 
use of physical restraints, malnutrition, more than 3 medications added, use of bladder 
catheter and any iatrogenic event (Inouye & Charpentier, 1996). Among the predisposing 
factors, surgery and drugs will be discussed in this section. 
3.2.1 Surgery 
The incidence of post-operative delirium ranges from 5% to 15%(Deiner& Silverstein, 2009). 
Certain high-risk groups have increased rates of delirium. Delirium has been reported in 
16.3% after cardiac surgery (Kazmierski et al., 2010). Rates as high as 30.2% after hip surgery 
(Lee et al., 2011) and 50% have been reported in elderly patients (Inouye et al., 1993; 
Dasgupta & Dumbrell, 2006). Factors that increase the risk of delirium in surgical patients 
include electrolyte disturbances, increased age, dementia, low cardiac output, perioperative 
hypotension, postoperative hypoxia, and use of anticholinergic drugs. (Michaud et al., 2007; 
Norkiene et al., 2007). Pandharipande et al. found that 70% of the combined surgical and 
trauma ICU patients had at least one episode of delirium (Pandharipande et al., 2007).   
3.2.2 Drugs 
Delirium is characterised by a global cerebral dysfunction resulting in a generalized 
reduction in cerebral oxidative metabolism and an imbalance of several neurotransmitters 
in the brain. Any drug that interferes with these neurotransmitter systems or with the 
supply or use of substrates for metabolism of the central nervous system can cause 
delirium (Gray et al., 1999; Moore & O'Keeffe, 1999; Nayeem & O'Keeffe, 2003). For a drug 
to be clearly implicated as an etiological factor in delirium, the administration of the drug 
should precede the onset of symptoms of delirium within a short time duration and 
withdrawal of the drug should result in a return to baseline cognitive functioning (Moore 
& O’Keeffe, 1999). 
3.2.2.1 Anticholinergic drugs 
The causal association of drugs to delirium is most clear for anticholinergic drugs with 
muscarine receptor affinity (White et al., 2007). Antihistaminics, antipsychotics, tricyclic 
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and captopril are among the mostly used durs that have primary or secondary 
anticholinergic effects contributing to risk of delirium (Burns, 2004,). Many commonly used 
drugs in the elderly, that are the principal treatments of clinical conditions, such as urinary 
incontinence and cardiovascular disease, have anticholinergic properties (Scheife & Takeda, 
2005; Uusvaara et al., 2011). Older patients and those with mental illness are particularly 
vulnerable to the adverse neuropsychiatric effects of anticholinergics as they may already 
have cognitive impairment (Gerretsen & Pollock, 2011).  
3.2.2.2 Opioids 
Delirium has been reported to be associated with opioid use (Gray et al., 1999, Brouquet, 
2010). The association of delirium with opioids is dose-related (Burkhart et al., 2010). 
Persistent delirium has been reported to be associated with use of opioids at doses greater 
than 54mg/day (Pisani et al., 2010). On the other hand, there are studies reporting no 
association between opioid use and delirium (Pandharipande et al., 2006; Pisani et al., 2007). 
In a systemic review which aimed to determine medications to avoid in people at risk of 
delirium, it was concluded that, although use of opioids should be prescribed with caution 
in people at risk of delirium, as untreated severe pain can itself trigger delirium, this caution 
should be tempered (Clegg & Young, 2011).  
3.2.2.3 Antidepressants 
All tricyclic antidepressants have an anticholinergic effect, with amitryptiline having the 
strongest and nortriptyline the weakest (White et al., 2007).   Delirium has been reported to 
develope after abrupt discontinuation of fluoxetine (Blum et al., 2008) and with concominant 
use of fluoxetine and lamotrigine (Chistyakova & Amos, 2008). In addition, concomitant use 
of low-dose bupropion sustained release and fluoxetine has been reported to be associated 
with delirium (Chan et al., 2006). 
3.2.2.4. Other drugs 
Benzodiazepines (Sanders, 2011), antipsychotics with strong anticholinergic effects (e.g. 
clozapine) (Centorrino et al., 2003), antiparkinson medications (i.e. levodopa) (Delmas et al., 
2008) are among the other drugs that were erorted to be associated with delirium. A 
systematic review of prospective studies that investigated the association between 
medications and risk of delirium reported that delirium risk appears to be increased with 
opioids, benzodiazepines, dihydropyridines and possibly antihistamine. The authors 
conluded that there appears to be no increased risk with neuroleptics or digoxin and there is 
uncertainty regarding H(2) antagonists, tricyclic antidepressants, antiparkinson 
medications, steroids, non-steroidal anti-inflammatory drugs and antimuscarinics (Clegg, A. 
& Young, 2011). 
3.3. Pathophysiology 
The pathophysiology of delirium is still poorly understood. The risk factors described above 
may act by similar mechanisms, leading to a common pathway that interferes with 
neurotransmitter function or with the supply or use of substrates to the brain (Maldonado, 
2008). Imbalance in neurotransmitter systems is the leading hypothesized mechanism for 
delirium (Inouye, 2006). Other hypothesized mechanisms are neural injury, inflammation, 
and stress response (Hshieh et al., 2008). 
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3.3.1 Imbalance in neurotransmitter systems    
3.3.1.1 Cholinergic deficiency 
Cholinergic neurons play an important role in cognition and memory (Kopelman, 1986). 
Evidence from electroencephalographic and pharmacologic studies supports the role of 
cholinergic deficiency in genesis of delirium. Electroencephalographic studies have shown 
that delirium is associated with occipital slowing, peak power and alpha decrease, delta and 
theta power increase and slow wave ratio increase during active delirious states (Thomas et 
al., 2008). Cholinergic thalamo-cortical pathways responsible for attention, alertness and 
vigilance regulation modulate the basic EEG alpha rhythm (Nunez et al., 2001). Centrally 
acting anticholinergics result in a pattern very similar to the electroencephalographic 
findings in delirium (Renner et al., 2005; Sloan et al., 1992). 
Pharmacologic studies have shown an association between delirium and administration of 
anticholinergic drugs and serum anticholinergic activity (Inouye, 2006). High serum 
anticholinergic activity is associated with severity of delirium (Mussi et al., 1999; Trzepacz, 
1999).  Also, the importance of cholinergic deficiency in pathophysiology of delirium is 
supported by studies showing that acetylcholine neurotransmission decreases with age, which 
is consistent with the finding that increasing age is a risk factor for delirium (Flacker & Lipsitz, 
1999). Several mechanisms can result in cholinergic deficiency and predispose to delirium, 
including impairment in acetylcholine synthesis and cholinergic synaptic mechanisms, 
ischemia and global stressors and neurotransmitter imbalance (Hshieh et al., 2008).  
3.3.1.2 Monoamine neurotransmitter system  
Another neurotransmitter system supposed to have a role in pathogenesis of delirium is 
monoamine neurotransmitter system (Gaudreau & Gagnon, 2005). Dopamine, 
norepinephrine and serotonin have roles in arousal and sleep-wake cycle, they modulate 
physiological responses to stimuli (Robbins & Arnsten, 2009). This system, which is 
composed of three monoamine neurotransmitters, dopamine, norepinephrine and serotonin, 
has a balancing role for the cholinergic activity. The development of delirium involves 
interaction between these two neurotransmitter systems (Cole, 2004; Trzepacz & van der 
Mast, 2002). But instead of deficiency, dopamine excess has been reported to play a role in 
delirium (Moyer, 2011).  It is suggested that dopamine increase during the stress of surgery 
can cause postoperative agitation and delusions in the patient. In laboratory studies, stress 
has been shown to elevate levels of mesocortical dopamine (Cassem et al., 2004). 
Haloperidol, a dopamine blocking agent has been used successfully to treat delirium for 
years (Moore & O'Keeffe, 1999).  
Depending on the serotonin receptor bound, both serotonin excess and deficiency may be 
associated with cholinergic deficiency and predispose to delirium (Hshieh et al., 2008). 
Selective serotonin reuptake inhibitors like fluoxetine and buproprion have been reported to 
cause delirium (Chan et al., 2006).  Delirium has been reported in a patient taking paroxetine 
preoperatively, the authors have contributed that postoperative delirium was indicating an 
adverse drug interaction involving, paroxetine (Stanford & Stanford, 1999). 
3.3.2 Neural injury, inflammation, and stress response 
Delirium has been hypothesized to result from increased release of proinflammatory 
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2008). Proinflammatory cytokines can affect the synthesis or release of acetylcholine, 
dopamine, noradrenaline and serotonin, and thereby increase the risk of delirium (Dunn, 
2006). Also, these cytokines can stimulate responses from microglia, by this way cause 
inflammation in the brain (Dilger & Johnson, 2008). The effect of these proinflammatory 
cytokines do not appear to affect younger individuals with healthy brains, while the aging 
brain is more susceptible to the memory impairments produced by immune system 
activation (Staus, 2011). 
4. Conclusion  
Delirium is a common condition, especially in the elderly and in patients with severe 
illness. Delirium is associated with longer hospital stay, poorer functional outcome, and 
cognitive decline. Also, it is associated with elevated morbidity and mortality. 
Understanding etiology of delirium is important because treatment of delirium is 
identification and reversal of etiological factors. Etiological factors are of two types: 
predisposing and precipitating factors. The risk of delirium should be kept in mind when 
approaching to a patient with predisposing factors like increased age, cognitive 
impairment, hip fracture on admission and severe illness are among the most common 
ones. The presence of precipitating factors (the acute insults that trigger the mechanisms 
resulting in delirium) like anemia, hypoxaemia, electrolyte abnormalities, sleep 
deprivation, pain, bladder catheter use and drugs should be evaluated and be treated 
promptly if possible. 
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1. Introduction 
The following chapter describes the process and results of a survey conducted in six cities in 
Southern and Eastern Europe to obtain data on (i) the prevalence of HIV and Syphilis 
among Men who have Sex with Men (MSM), (ii) sexual behaviour risk patterns of MSM and 
(iii) the determinants of access to Voluntary Counselling and Testing (VCT) by MSM.  
The chapter describes how the survey was undertaken against a backdrop of evidence 
indicating a rising incidence of HIV infection in Europe and in the context of a gap in 
information on HIV incidence and prevalence amongst the MSM community which has 
been identified as an at risk population for HIV infection.  
In this context, the methodology used for obtaining reliable information and data, 
represents a key factor in the process. The Time-Location Sampling (TLS) method has 
proven to be an effective means for gathering both behavioural and biological data in 
hidden or hard to reach populations, such as MSM.  
The chapter provides a description of the implementation of TLS for epidemiological 
purposes and a summary of the main results of the survey which reveal (i) a high 
unawareness of HIV positive serostatus, (ii) a higher risk among younger people of 
obtaining the HIV infection due to their risk behaviour (e.g. unprotected anal intercourse) 
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and a more limited access to HIV screening services and prevention programmes, (iii) the 
correlation between HIV infection and STIs and Syphilis and (iv) the association between 
HIV risk and alcohol and drug use.  
This chapter also discusses the use of UNGASS indicators and the Second Generation 
Surveillance System (SGSS) approach in the survey and in general as key features to be 
considered as part of a comprehensive surveillance system. 
Finally, a number of conclusions are drawn with regard to the need for repeated 
epidemiological studies focusing on hard to reach populations as well as to the need for 
targeted health promotion and prevention campaigns.  
2. Background  
HIV infection remains a relevant issue in Europe in the field of public health. Moreover, 
scientific literature suggests an increasing HIV transmission in several European countries. 
MSM represent one of the most at risk populations for acquiring HIV. In 2009, 9,023 newly 
diagnosed HIV infections were reported among this population in Europe, which accounts 
for 35% of all HIV diagnoses in that year (European Centre for Disease Prevention and 
Control ECDC/World Health Organisation WHO – Regional Office for Europe, 2010; 
Likatavi ius et al., 2008). Moreover, in this specific population, a high level of risk 
behaviours associated with an increasing incidence of other Sexually Transmitted Infections 
(STI) clearly show the need for specific and targeted prevention campaigns (Dodds et al., 
2005; Van de Laar et al., 2009). 
Due to a lack of risk perception and also to perceived social stigma, MSM tend to refer a low 
level of VCT and active health seeking behaviours (MacKellar et al., 2005). In addition, social 
and cultural obstacles to testing can be perceived by MSM also in health facilities. From a 
methodological point of view, since the introduction of Highly Active Anti-Retroviral 
Therapy (HAART), AIDS has become less indicative of the underlying trends in HIV 
infection, for this population in particular. Data based on the clinical records, at the same 
time, seems to not realistically reflect the HIV trends for two reasons. On the one hand, 
clinical records often do not include information regarding hard-to-reach MSM, who are less 
likely to ask for VCT and regular testing. On the other hand, a low level of knowledge about 
the real serostatus is reported among MSM (Williamson & Hart, 2007; Mirandola et al., 
2009). Therefore, specific surveillance and outreach research targeting MSM who cannot 
attend the clinical facilities, is strongly required in order to obtain a more realistic estimation 
of the HIV epidemic.  
In this context, a need for reliable and comparable data across different countries is also a 
key issue in monitoring the spread of HIV and in providing meaningful prevention. 
Unfortunately, data are often collected across a number of countries or in the same 
country using different sampling methods, or different testing methods, or different 
testing algorithms. In addition, questionnaire items used in various studies are often 
based on different assumptions and they can vary greatly in terms of time frame of the 
questions (last 12 or 3 months, last intercourse), definition of risk sexual practice, etc. 
Finally, specific HIV surveys focusing on MSM are rarely repeated on a regular basis. For 
that reason, a lack of reliable data and trends on HIV epidemic is available for this at risk 
population.  
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In this framework, a specific Declaration of Commitment on HIV/AIDS and a Political 
Declaration on HIV/AIDS were proposed and adopted by the UN General Assembly in 
2001. In these documents, a specific set of epidemiological and surveillance activities are 
suggested, as well as the adoption of the so-called UNGASS indicators. UNGASS indicators 
are a set of measures to be used among different countries in order to effectively monitor the 
HIV epidemic (Joint United Nations Programme on HIV/AIDS UNAIDS & World Health 
Organization WHO, 2009). The Declaration provides a comprehensive framework to achieve 
the Millennium Development Goal in order to reverse the HIV epidemic by 2015. 
In addition, specific indications for developing and implementing a more effective surveillance 
system are provided in UNAIDS and WHO publications (UNAIDS & WHO, 2002, 2005). 
These documents suggest the adoption of the so-called Second Generation Surveillance System 
(SGSS), which foresees a set of detailed managerial and epidemiological procedures, as well as 
standardized processes and actions for managing surveillance studies . The SGSS foresees the 
implementation of surveys repeated on a regular basis according to different indicators, which 
require the collection of both behavioural and biological data. The SGSS provides a meaningful 
tool for developing prevention initiatives according to reliable data on HIV epidemics and 
behavioural patterns, which represent the major challenge for the coming years. 
The “Capacity building in HIV/Syphilis prevalence estimation using non-invasive methods 
among MSM in Southern and Eastern Europe” – SIALON project was developed and 
implemented according to the main procedures and processes foreseen in the UNGASS 
declaration and in the SGSS approach. The SIALON project was funded in the framework of 
the 2003-2008 Public Health Programme (Work Plan 2007) and implemented by a team of 
European Public Institutions under the leadership of the Veneto Region in close collaboration 
with local partners ranging from Universities, teaching hospitals, epidemiological centres and 
Gay NGOs. In particular, the SIALON study was carried out in six cities of Southern and 
Eastern European countries: Barcelona (Spain), Bratislava (Slovakia), Bucharest (Romania), 
Ljubljana (Slovenia), Prague (Czech Republic), Verona (Italy). 
3. Methods  
3.1 Study design 
The study conducted during the SIALON project was a cross-sectional study targeting MSM 
who have had sex with another man during the last 12 months. The data collection was 
conducted according to the Time-Location (or Time-Space) Sampling (TLS) procedure. This 
method was used to recruit men visiting the selected gay settings in each participating city, 
allowing to construe a representative sample with known properties. The cross-sectional 
study was conducted using a self-administered pen-and-paper questionnaire and an oral 
fluid collector to gather both behavioural and biological data for each participant.  
The study design was planned and implemented in line with the Second Generation 
Surveillance System (SGSS) criteria (UNAIDS & WHO, 2002, 2005) and the United Nations 
General Assembly Special Session (UNGASS) Indicators (UNAIDS & WHO, 2009). 
3.1.1 Study population 
According to data and the results of some seroprevalence studies, levels of HIV 
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In this framework, a specific Declaration of Commitment on HIV/AIDS and a Political 
Declaration on HIV/AIDS were proposed and adopted by the UN General Assembly in 
2001. In these documents, a specific set of epidemiological and surveillance activities are 
suggested, as well as the adoption of the so-called UNGASS indicators. UNGASS indicators 
are a set of measures to be used among different countries in order to effectively monitor the 
HIV epidemic (Joint United Nations Programme on HIV/AIDS UNAIDS & World Health 
Organization WHO, 2009). The Declaration provides a comprehensive framework to achieve 
the Millennium Development Goal in order to reverse the HIV epidemic by 2015. 
In addition, specific indications for developing and implementing a more effective surveillance 
system are provided in UNAIDS and WHO publications (UNAIDS & WHO, 2002, 2005). 
These documents suggest the adoption of the so-called Second Generation Surveillance System 
(SGSS), which foresees a set of detailed managerial and epidemiological procedures, as well as 
standardized processes and actions for managing surveillance studies . The SGSS foresees the 
implementation of surveys repeated on a regular basis according to different indicators, which 
require the collection of both behavioural and biological data. The SGSS provides a meaningful 
tool for developing prevention initiatives according to reliable data on HIV epidemics and 
behavioural patterns, which represent the major challenge for the coming years. 
The “Capacity building in HIV/Syphilis prevalence estimation using non-invasive methods 
among MSM in Southern and Eastern Europe” – SIALON project was developed and 
implemented according to the main procedures and processes foreseen in the UNGASS 
declaration and in the SGSS approach. The SIALON project was funded in the framework of 
the 2003-2008 Public Health Programme (Work Plan 2007) and implemented by a team of 
European Public Institutions under the leadership of the Veneto Region in close collaboration 
with local partners ranging from Universities, teaching hospitals, epidemiological centres and 
Gay NGOs. In particular, the SIALON study was carried out in six cities of Southern and 
Eastern European countries: Barcelona (Spain), Bratislava (Slovakia), Bucharest (Romania), 
Ljubljana (Slovenia), Prague (Czech Republic), Verona (Italy). 
3. Methods  
3.1 Study design 
The study conducted during the SIALON project was a cross-sectional study targeting MSM 
who have had sex with another man during the last 12 months. The data collection was 
conducted according to the Time-Location (or Time-Space) Sampling (TLS) procedure. This 
method was used to recruit men visiting the selected gay settings in each participating city, 
allowing to construe a representative sample with known properties. The cross-sectional 
study was conducted using a self-administered pen-and-paper questionnaire and an oral 
fluid collector to gather both behavioural and biological data for each participant.  
The study design was planned and implemented in line with the Second Generation 
Surveillance System (SGSS) criteria (UNAIDS & WHO, 2002, 2005) and the United Nations 
General Assembly Special Session (UNGASS) Indicators (UNAIDS & WHO, 2009). 
3.1.1 Study population 
According to data and the results of some seroprevalence studies, levels of HIV 





sub-population continues to be at high risk of HIV infection, especially in Europe, and 
according to the available data a hidden HIV epidemic seems currently underway (ECDC, 
2010; Likatavi ius et al., 2008). Because of a high level of risk sexual practices, MSM 
become a key population for HIV surveillance. In addition, especially because of stigma, a 
low level of VCT is reported, particularly among hard-to-reach MSM who do not attend 
health services regularly. Moreover, since the introduction of HAART, AIDS has become 
less indicative of the underlying trends in HIV infection, for this population in particular. 
For these reasons, field research and surveillance activities targeting this specific 
population seem to be essential in monitoring the HIV epidemic and in developing 
preventive action in Europe.  
3.1.2 Sampling 
The sample size estimation for a prevalence study was calculated on the basis of previous 
prevalence estimation studies, where available (Folch et al., 2005). According to this 
calculation, a total of 2,800 persons (400 per city) were planned to be included in the data 
collection process.  
Time-Location (or Time-Space) Sampling (TLS) was used to recruit representative samples 
of men visiting the gay scene in each city. This specific approach was used in previous 
studies (Williamson & Hart, 2007; Stueve et al., 2001; MacKellar et al., 2007; Gallagher et 
al., 2007; Muhib et al., 2001), and has proven to be a good and reliable method for 
gathering both behavioural and biological data in hidden or hard to reach populations. 
According to the TLS method, spaces (locations) are venues attended by the target 
population, in this case MSM, while times refer to specific days and time periods when 
the target population attends each identified space or setting. This sampling approach 
allows to construe a sample with known properties, enabling statistical inferences to be 
made to the larger population of venue visitors (ideally, all MSM attending the gay scene 
in each city).  
In order to identify timing and settings, a specific formative research was conducted  
in each city. The first step in the formative research was the identification and selection  
of all gay venues in the given city. Bars, discos, saunas, cruising venues, sex-shops,  
sex-clubs were therefore identified. All venues were mapped and visited when 
information was not sufficient. This process allowed to identify the potential TLS units  
(the attendance time frame, opening days and hours) and to create a specific  
data collection calendar. The spaces and their associated days were divided into 
standardised time segments (four-hour periods). MSM were then enrolled over the entire 
TLS unit time period. During the data collection sessions, information regarding the 
number of refusals per unit was registered. In order to include all possible time and 
location units that did not occur frequently but that may attract members of the target 
population, also settings or special gay events were identified and mapped, creating a 
“special events” category. A list of TLS units was created according to this sampling 
approach, where the TLS units were the “primary sampling units” (PSU). In addition,  
in creating the final list of TLS units, safety and feasibility of data collection in different 
settings and at different times (especially in cruising venues) was taken into account.  
At this stage, the PSU were randomly selected from complete list of eligible TLS list in 
each participating city.  
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3.2 Data collection and analysis 
3.2.1 Questionnaire 
The SIALON questionnaire was specifically designed according to the international 
literature and according both to the study design and the data collection procedures. The 
self-administered pen-and-paper questionnaire was developed to obtain information on a 
range of different aspects and taking into account both UNGASS and ECDC indicators. The 
first part refers to background data. The second part lists items on sexual practices, risk-
reducing strategies, condom use, STI history and self-reported/perceived serostatus.   
Moreover, questions regarding number of both steady and casual partners were foreseen, as 
well as frequency and type of sexual practices in both cases. In construing the different 
questions, specific attention was paid to the social/cultural/environmental and contextual 
variables, as well as to access and barriers to VCT.  
From a structural point of view, the questionnaire contained items referring to different 
time-spans: last 12 months, last 6 months, and last time (last sexual intercourse). This 
structure allowed to include all items needed for the construction of the UNGASS and 
ECDC indicators.  
In terms of the UNGASS and ECDC indicators themselves, according to the WHO-UNAIDS 
documents, questions referring to UNGASS 8 (testing), 9 (prevention campaigns), 19 
(condom use) and 23 (HIV prevalence) were included. 
Finally, specific attention was paid to the time span required to fulfill the questionnaire: a 
maximum of 20 minutes was required for completing the questionnaire. For this purpose, 
specific piloting was conducted.  
3.2.2 Enrolment 
With regard to the enrolment of subjects, a specific easy-to-use and practical manual was 
provided to all data collectors, in order to standardise all procedures and to guarantee the 
safety and reliability of data collected. Following the data collection calendar created 
through the TLS method, trained field workers from gay associations attended the different 
gay venues in specific time-location units. The self-administered pen-and-paper 
questionnaires were distributed, as well as the Oracol devices for oral fluid collection 
(Malvern Medical Developments, Worcester, UK). Both self-completed questionnaires 
(behavioural data) and oral fluid samples (biological data) were collected for each subject. A 
unique barcode for each subject was used to link behavioural and biological information.  
Finally, regarding the enrolment period, this varied between the different participating 
cities, according to the different situations and calendars (from 2 months to 9 months), 
starting in November 2008 and ending in October 2009.  
3.2.3 Statistical analysis 
Mean, median, standard deviation, quartiles and inter-quartiles were calculated and 
proportions with 95% confidence intervals (CI) were adopted for all variables and indicators. 
With regard to the UNGASS indicators calculation, specific reference to the UNGASS-WHO 
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3.3 Laboratory testing  
3.3.1 Oral fluid sampling and testing 
To collect oral fluids, Oracol oral fluid collection kits (Malvern Medical Developments, 
Worcester, UK) were used. The main advantages for replacing serum with oral fluid were 
easy access and non-invasive collection. After collection, oral fluid samples were kept 
refrigerated and sent to the national reference laboratory for HIV/AIDS in the respective 
countries no more than 72 hours after collection. 
3.3.2 HIV testing 
The oral fluid samples were sent for the analysis by each national reference laboratory to the 
Teaching Hospital-University of Verona, Immunology Unit, Verona, Italy. EIA testing 
GENSCREEN HIV 1/2 version 2, BIO-RAD on oral fluid sample was performed according to 
the manufacturer’s instructions. All positive samples were confirmed with a Western Blot test. 
In terms of quality control, for each oral fluid sample, a total IgG antibodies ELISA test was 
performed in order to assess the sample suitability for testing. Samples below 3.5 titre (cut-off) 
were excluded from the study as invalid (see Fig. 1: Survey testing algorithm). A validation  
 
(1) Rapid Immunocromatograpy Determine HIV 1/2 ( Unipath Ltd, Bedford UK) CE marked for serum 
were used 
(2) HIV 1/2 BLOT 2.2 ( MP Biomedical, China) CE marked for serum 
Fig. 1. HIV testing algorithm on oral fluid samples 
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study of Bio-Rad OF testing comparing serological testing involving 37 HIV positive patients 
and 35 controls per country was carried out according to Commission decision of 7 May 2002 
on common technical specifications for in vitro medical devices. EIA on oral fluid samples 
from 259 of the 263 HIV positive subjects were positive, giving a sensitivity of 98.5% (CI 96.2-
99.6). All 233 controls were found negative for HIV in oral fluid and no false positives were 
detected (100% specificity; CI 98.4-100). The positive and negative predictive values of the OF 
test according to HIV prevalence are presented in Table 1. 
 
Prevalence 5 % 15 % 
PPV 100 % 100 % 
NPV 99.9 % 99.7 % 
Table 1. PPV and NPV according to prevalence 
4. Results  
4.1 General description of the sample 
In this section, the description of the sample is provided in terms of number of MSM 
recruited, questionnaires and oral fluid samples collected, and characteristics of the sample. 
4.1.1 Numbers of subjects recruited 
A total of 2,592 subjects were recruited as follows: 408 MSM in Prague, 185 in Athens, 405 in 
Verona, 398 in Bucharest, 394 in Bratislava, 401 in Ljubljana and 401 in Barcelona. This study 
does not include the analysis of data from Athens as the Greek partner did not achieve the 
data collection.  
4.1.2 Questionnaires and oral fluid samples collected 
Table 2 shows the number of questionnaires and the number of oral fluid samples gathered 
during the data collection period for each country. Both the number of valid and invalid 
questionnaires and OF samples are given. From a general point of view, the percentage of 
invalid questionnaires is low, with the highest percentage in Ljubljana (0.7%). In three cases 
the percentage is 0% (Athens, Bucharest and Bratislava). With regards to the OF samples, in  
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two cities the percentage of invalid samples is higher than 10% (Athens 15.7%; Bucharest 
13.3%). In the other cities the percentage is low, ranging from 2.3% (Verona) to 2.5% 
(Ljubljana, Barcelona and Bratislava). 
4.1.3 Venue types 
The proportion of subjects recruited by venue type is shown in Fig. 2. 47.1% of the 
respondents were recruited in a disco (1,128 MSM). With the exception of Verona, discos 
were the main location where questionnaires and oral fluid were collected (36.7% in Prague, 
71.3% in Bratislava, 65.2% in Bucharest, 64.0% in Ljubljana). Bars represented the second 
location in each city, in terms of number of participants (22.6% of the total, 540 subjects). The 
percentage of subjects recruited in this location ranged from 3.0% in Bratislava to 32.2% in 
Verona. With regard to saunas, 39.1% of the sample was recruited in this setting in Verona, 
26.3% in Barcelona, 15.5% in Prague, 15.3% in Ljubljana and 13.7% in Bratislava. In 
Bucharest there is no sauna. Taking into account the total of the sample, the percentage of 
MSM recruited in a sauna was 18.4%. Low percentages of participants were recruited in 
cruising settings. Naked sex party and sex clubs were not present in Bucharest and 
Ljubljana, and the percentages of MSM recruited in this type of venue ranged from 6.4% in 
Verona up to 15.5% in Prague. 
 
Fig. 2. Subjects recruited by venue type 
4.1.4 Age of subjects 
Median age and age distribution by city are presented in Figure 3. Respondents in Barcelona 
and Verona had a similar age distribution and were older (38 and 35 years respectively) than 
those in Eastern European cities.  
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Fig. 3. Age distribution of MSM recruited by city 
4.2 UNGASS indicators  
In this section, the main data referring to the UNGASS indicators are provided. As 
mentioned in section 2, a specific Declaration of Commitment on HIV/AIDS and a Political 
Declaration on HIV/AIDS were proposed and adopted by the UN General Assembly in 
2001. In these documents, a specific set of epidemiological and surveillance activities are 
proposed, as well as the adoption of the so-called UNGASS indicators. UNGASS indicators 
are a set of measures to be used among different countries in order to effectively monitor the 
HIV epidemic (UNAIDS & WHO, 2009). The idea which is behind the UNGASS indicators is 
that all data provided by the different countries can represent a reliable picture of the status 
of the epidemic and on the different prevention activities implemented against the spread of 
HIV in specific and general population.  
The national-level UNGASS indicators are basically divided into three categories. The first 
one refers to the National commitment and action, taking into account topics as policy 
decisions, financial plan and activities for the HIV prevention, testing and treatment, drugs 
and care as well. The second category refers to knowledge and behaviour in different 
population, while the third category refers to the national level programme impact. For all 
these three areas, specific guidelines and procedures on how these indicators have to be 
calculated are provided (for instance, they provide specific numerators and denominators to 
calculate the different percentages and levels of the indicators). 
Despite the relevance and importance of the UNGASS Declaration and the number of 
countries involved in this process, it should be mentioned that to date, a number of 
limitations in the UNGASS reporting have emerged. For instance, in 2008 less than half of 
those countries that stated the indicators and procedures referring to the most-at-risk 
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In this regard, one of the added values of the SIALON project is to provide reliable data on 
behaviours and HIV infection levels based on the UNGASS procedures and indicators. In 
some of the participating countries, the results of the SIALON project represent the first time 
in which UNGASS indicators were put into practice at the National level through a cross-
sectional survey. In designing the SIALON questionnaire, four indicators were taken into 
account, focusing on high risk population, namely MSM. UNGASS indicators have proven 
to be effective measures to be considered in surveillance systems and in a comprehensive 
national monitoring and in an evidence-based evaluation approach.  
4.2.1 UNGASS indicator N°8 
In order to measure the HIV testing level, a specific UNGASS indicator was set, namely the 
UNGASS 8. This indicator refers to the percentage of MSM tested for HIV in the last 12 
months and who know/collected the result, with the purpose of monitoring advancement 
in promoting HIV VCT among most-at-risk populations, in this case MSM. The indicator 
foresees as a numerator the number of most-at-risk population respondents who have been 
tested for HIV during the last 12 months and who know the results and as denominators the 
number of most-at-risk population included in the sample (Fig. 4).  













Prague Bratislava Barcelona Bucharest Ljubljana Verona
Country  
Fig. 4. UNGASS indicator N. 8: MSM who were tested in the last 12 month and knew the 
result 
The Southern European cities had a high percentage of tested people who collected the test 
result (56.3% in Barcelona and 53.0% in Verona). In the other cities, low percentages are 
reported: 31.6% in Bratislava, 42.6% in Bucharest, 38.0% in Ljubljana and 40.2% in Prague. 
4.2.2 UNGASS indicator N°9 
This indicator refers to the percentage of most-at-risk populations reached with HIV 
prevention programmes. With regard to the construction of the indicator, the numerator is 
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the number of respondents who replied that they have been given condoms for free in the 
last 12 months and knew where to go if they wished to be given an HIV test. The 
denominator is the number of MSM involved in the survey (Fig. 5).  
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Fig. 5. UNGASS indicator N. 9: MSM reached by prevention programmes 
The highest percentages of participants reached by prevention programmes are reported in 
Ljubljana (84.7%) and Barcelona (83.5%), while the lowest are in Prague (59.5%) and 
Bratislava (38.3%). In Verona, the percentage is 71.3%, while in Bucharest it is 71.1%. 
According to the UNGASS request of disaggregating the data according to the age group 
(<25/25+), young people (< 25 years old) were less reached by prevention programmes than 
older people (61.4% and 72.0% respectively).  
4.2.3 UNGASS indicator N°19 
This indicator describes the percentage of men reporting the use of a condom during their 
last anal sex intercourse with a male partner. The goal is to monitor the condom use among 
MSM, as it represents the main means for risk reduction. In this case, the numerator is the 
number of respondents who reported that a condom was used the last time they had anal 
sex, while the denominator is the number of respondents who reported having had anal sex 
with a male partner in the last six months (Fig. 6).  
UNGASS 19 with steady and casual partner was calculated. As shown in Fig. 6, the 
percentage of participants who reported the use of a condom the last time they had anal sex 
with a male partner in the last 6 months with their steady partner was highest in Barcelona 
(35.1%) and lowest in Prague (19.1%). The percentage with occasional partner was highest in 
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Fig. 6. UNGASS indicator N. 19: MSM reporting the use of a condom the last time they had 
anal sex with a male partner in the last 6 months: steady and occasional partners.  
4.2.4 UNGASS indicator N°23 
The UNGASS 23 refers to the HIV prevalence in a specific population, representing 
therefore the main indicator. This indicator allows to directly assess improvement in 
containing HIV levels among most-at-risk, namely MSM. In this case, the prevalence was 
calculated from the oral fluid tests performed in the central laboratory (Fig. 7).  
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Fig. 7. UNGASS indicator N. 23 HIV prevalence 
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HIV percentages are 17.0% in Barcelona and 11.8% in Verona. Lower percentages were 
calculated in Bratislava (6.0%), Bucharest (4.6%) and Ljubljana (5.1%). In Prague, HIV level 
was 2.6%. 
4.3 HIV prevalence 
As reported in the UNGASS 23, data regarding HIV prevalence levels were calculated through 
the oral fluid samples tests. As mentioned before, the cities with the highest HIV prevalence 
were Barcelona (17.0%) and Verona (11.8%). Lower percentages were reported in Bratislava 
(6.0%), Bucharest (4.6%) and Ljubljana (5.1%). Prague had the lowest HIV prevalence (2.6%). 
The overall prevalence of HIV positive oral fluid samples was 7.9%. Previous studies carried 
out in some of the participating cities, came to quite different prevalence estimates. For 
instance, in Barcelona HIV prevalence found in previous studies using a convenience sample 
was slightly higher than the prevalence found in the SIALON study. The lower levels reported 
in Ljubljana and Bratislava in previous studies may be partly due to the different sampling 
method adopted and lower number of MSM recruited in the study. 
4.3.1 HIV prevalence by age 
The prevalence according to age group is represented in Table 3. In the overall sample, 
prevalence of HIV among young people (less than 25 years old) was significantly lower than 
among people of over 25 years of age (3.5% vs 9.6%). This difference in prevalence according 
to age group was also significant in Ljubljana where no HIV positive cases were found 
among younger MSM, and in Bratislava where 1.7% of younger MSM were HIV positive 
compared to 7.6% of older ones. 
 
  Negative Positive Total 
Age group No. % 95% Conf. Interval No. % 95% Conf. Interval No. % 
< 25 553 96.5 95.0 98.0 20 3.5 2.0 5.0 573 100.0 
>= 25 1447 90.4 88.9 91.8 154 9.6 8.2 11.1 1601 100.0 
Total 2000 92.0 91.0 93.2 174 8.0 6.8 9.0 2174 100.0 
Table 3. HIV result according to age group 
The mean age of HIV positive MSM was 36, significantly higher than the mean for HIV 
negative people (31.6 years). Table 4 shows the mean age of HIV positive people by country. 
This figure was lowest in Bucharest (27.1 years old) and the highest in Verona (38.9 years old). 
 
Age group Mean 95% Conf. Interval 
Prague 32.3 28.2 36.3 
Bratislava 34.8 30.9 38.8 
Barcelona 37.5 35.1 39.8 
Bucharest 27.1 23.5 30.8 
Ljubljana 35.1 32.2 38.0 
Verona 38.9 36.3 41.5 
Total 36.0 34.7 37.4 
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4.3.2 HIV prevalence by venue type 
As shown in Fig. 8, HIV prevalence, based on oral fluid samples, was higher in subjects 
recruited in sex-focused venues like saunas (14.3%), cruising venues (15.2%) sex shops and 
naked parties (11.5%) than in other venues such as discos and bars (4.6% and 6.7% 
respectively). 
At city level, HIV prevalence by type of venue (sex focused versus non-sex focused) was 
significantly higher in sex focused venues in Verona, Bratislava and Ljubljana. 
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Fig. 8. HIV Prevalence by venue type 
4.3.3 Knowledge of actual HIV status and undiagnosed infection 
56% of HIV positive people were not aware of their HIV serostatus, that is, they declared 
they had never been tested (7.8%), were found to be HIV negative at their last HIV test 
(47.6%) or didn’t collect their result (0.6%). As shown in Fig. 9, the rates of people unaware 
of their HIV positive status were almost 80% in Bucharest and Ljubljana and lower than 50% 
only in Barcelona. 
Moreover, the average age of people unaware of their HIV positive status was 33.9 y/o 
lower than that of subjects that knew their seropositivity that was 37.9 y/o, based on their 
reported last HIV test. Another important fact is that among oral fluid HIV positive 
subjects, nearly one third (30.9%) reported a negative HIV test over the last 12 months. 
This data seems to indicate that quite a number of infections were acquired over the  
last 12 months. At city level this percentage was higher than 50% in Ljubljana while the 
lowest figure was in Bratislava (less than 20%). All other cities had intermediate values 
(nearly 30%). 
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Fig. 9. Percentage of HIV positive MSM unaware of their HIV status 
4.4 Other STI infections 
4.4.1 STI history 
Of the overall sample, 11.7% of respondents declared that they had at least one STI during 
the last 12 months. The highest proportion of people with a declared STI history was in 
Barcelona (15.3%) and the lowest in Bucharest (6.5%). For the details from all participating 
cities, see Fig. 10. 
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4.4 Other STI infections 
4.4.1 STI history 
Of the overall sample, 11.7% of respondents declared that they had at least one STI during 
the last 12 months. The highest proportion of people with a declared STI history was in 
Barcelona (15.3%) and the lowest in Bucharest (6.5%). For the details from all participating 
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4.4.2 Self reported history of Syphilis 
2.5% of the overall sample had had Syphilis during the last year. The highest percentage 
was in Barcelona (5.6%) followed by Verona and Prague (3.7% and 3.4% respectively) while 
Bratislava, Bucharest and Ljubljana had the lowest figures (less than 1%). 
4.4.3 Other STIs 
The most frequent STI was Urethritis (6.2% including Gonorrhoea and Chlamydia), 
followed by anogenital warts (2.5%), Hepatitis B (1.2%) and genital herpes (1.0%). The 
distribution by city is shown in Fig. 11. The Urethritis category, including Gonorrhoea and 
Chlamydia, appears to be the most frequent in all cities. The second most frequent STI was 
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Fig. 11. Other STIs during the last 12 months by city 
4.5 Risk behaviour 
As mentioned in section 3.2.1, when designing the questionnaire, a number of questions 
were included to collect information on risk behaviours, which are proven to be widely 
adopted in the MSM community. This section provides data collected regarding the most at 
risk behaviours, namely unprotected anal intercourse (UAI) and the use of alcohol and 
drugs before or while having sex.  
4.5.1 UAI 
Unprotected anal intercourse during the last 6 months with steady and casual partners was 
calculated. As shown in Fig. 12, the percentage of participants who reported UAI over the 
last 6 months with their steady partner was highest in Prague (74.2%) and Bratislava (72.5%) 
The SIALON Project: Report on HIV Prevalence  
and Risk Behaviour Among MSM in Six European Cities 
 
223 
and lowest in Verona (58.1%). With regard to UAI with an occasional partner, this behaviour 
was reported in Bucharest in almost 60% of respondents, while in Prague the percentage 
reaches 46.5%, in Bratislava 45.7%, and similar percentages in Barcelona, Ljubljana and 
Verona (33.7%, 32.0%, 33.0% in this order). The percentage of MSM reporting UAI was 
significantly higher among young people (<25 years of age, according to the UNGASS 
disaggregation cut-off) with a steady (70.8%) and occasional (51.2%) partner (P<0.05 and 
P<0.001 respectively) compared to older people (64.9% and 37.8% in that order). 
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Fig. 12. UAI in the last 6 months with steady and occasional partner 
4.5.2 Alcohol and drug use 
As the alcohol and recreational drug use seems to be connected to an increase in 
unprotected sexual practices, the use of alcohol and drug before or during sex was included 
in the questionnaire.  
With regard to alcohol use is concerned (Fig. 13), a significant percentage of respondents in 
the overall sample stated that they had used alcohol before or during sex in the last 6 
months. The percentage of subjects reach 82.9% in Bratislava, 54.2% in Verona, 85.0% in 
Prague, 66.0% in Barcelona, 64.3% in Bucharest, while the level is of 72.3% in Ljubljana. With 
regards to the alcohol use before or during their last sexual encounter, percentages are lower 
compared with the last 6 months. The levels of alcohol use are in this case high in Prague 
(56.0%), Bucharest (46.3%), Bratislava (45.2%), Barcelona (43.0%), while rates lower than 40% 
were found only in Ljubljana and Verona (32.2% and 23.2% respectively). 
With regard to drug use (see Fig. 14), drug use before or during sex in the last 6 months 
seems to be widely present in the sample. In Ljubljana the percentage reaches 58.8%, in 
Barcelona 57.1%, in Prague 52.7%. Low percentages are reported in Bucharest (33.2%), 
Verona (34.3%) and Bratislava (44.5%). Here again the proportion of people using drugs 
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and lowest in Verona (58.1%). With regard to UAI with an occasional partner, this behaviour 
was reported in Bucharest in almost 60% of respondents, while in Prague the percentage 
reaches 46.5%, in Bratislava 45.7%, and similar percentages in Barcelona, Ljubljana and 
Verona (33.7%, 32.0%, 33.0% in this order). The percentage of MSM reporting UAI was 
significantly higher among young people (<25 years of age, according to the UNGASS 
disaggregation cut-off) with a steady (70.8%) and occasional (51.2%) partner (P<0.05 and 
P<0.001 respectively) compared to older people (64.9% and 37.8% in that order). 
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Fig. 13. Alcohol use before or while having sex in the last six months and in the last sexual 
intercourse  
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Fig. 14. Drug use before or while having sex in the last six months  
5. Conclusions  
In terms of the methodology, the use of TLS as a sampling method proved to be efficient 
and easily applicable especially in cities where gay scenes are highly developed and, in line 
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with the scientific literature, it increases the possibility of involving a variety of participants 
from the target population.  
In implementing this method, the formative research is a crucial step of the process. The 
initial identification and selection of all gay venues (bars, discos, saunas, cruising venues, 
sex-shops, sex-clubs, special events) is a key factor for including all possible places and 
events and creating a list of all possible time-space units.  
Moreover, it should be pointed out that in this project different ways of recruiting MSM, 
such as internet, chat rooms and so on, were excluded. In actual fact, these virtual settings 
seem to play a very important role in the process of socialising and finding potential sexual 
partners among MSM. Nevertheless, the selection of “real” gay venues allowed to collect 
both behavioural data (questionnaire) and biological data (oral fluid sample). In this way, it 
was possible to triangulate behavioural data, risk factors, and HIV prevalence and to obtain 
reliable information on epidemic patterns. 
With regard to oral fluid sample collection, this procedure has clear advantages in terms of 
simplifying both the data collection and the diagnostic processes in community settings, 
compared to venopuncture. Oral fluid testing proved to be an ideal tool for surveillance and 
epidemiological purposes in outreach settings among high-risk and hard to reach 
populations, namely MSM. The acceptability of this biological data collection procedure in 
gay settings is proven by the number of samples collected in all sites confirmed. 
Furthermore, the SIALON project methodology included several epidemiological 
approaches: first of all, the Second Generation Surveillance System philosophy, which 
strongly suggests the combination of both behavioural and biological data and the regular 
replication of surveillance survey. Secondly, the implementation of UNGASS indicators, 
which proved to be very useful in focusing on specific topics such as access to prevention 
(testing and prevention programmes), high risk behaviours and HIV prevalence. Indicators 
related to HIV testing, prevention programs, condom use, and understanding of how to 
protect against HIV infection, revealed how many MSM are unaware of their HIV status and 
fail to practice behaviour that could protect them from infection.  
This very approach seems to be a crucial activity in order to develop, pilot and validate 
multi-faceted epidemiological approaches in monitoring HIV epidemic. 
In terms of the data collected, the highest rates of HIV seroprevalence were found in 
Southern European cities, namely Barcelona and Verona. This could be partly attributed to 
the older samples and therefore to longer exposure to risk, since HIV prevalence was higher 
among MSM of over 25.  
The highest rates of syphilis prevalence were also found in Barcelona and Verona. In 
general, data confirms that a correlation exists between STI, previous syphilis, IgG anti-
Treponema seroprevalence and HIV infection.  
Alarming findings included undiagnosed HIV infections. Over half the respondents were 
unaware of their HIV positive status. This proportion was slightly lower only in Barcelona, 
but very high (nearly 80%) in Ljubljana and Bucharest. Moreover, nearly one third of MSM 
found to be HIV-positive through oral fluid samples reported a negative HIV test result over 
the last 12 months, so the undiagnosed infections were recent. This figure was highest in 
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with the scientific literature, it increases the possibility of involving a variety of participants 
from the target population.  
In implementing this method, the formative research is a crucial step of the process. The 
initial identification and selection of all gay venues (bars, discos, saunas, cruising venues, 
sex-shops, sex-clubs, special events) is a key factor for including all possible places and 
events and creating a list of all possible time-space units.  
Moreover, it should be pointed out that in this project different ways of recruiting MSM, 
such as internet, chat rooms and so on, were excluded. In actual fact, these virtual settings 
seem to play a very important role in the process of socialising and finding potential sexual 
partners among MSM. Nevertheless, the selection of “real” gay venues allowed to collect 
both behavioural data (questionnaire) and biological data (oral fluid sample). In this way, it 
was possible to triangulate behavioural data, risk factors, and HIV prevalence and to obtain 
reliable information on epidemic patterns. 
With regard to oral fluid sample collection, this procedure has clear advantages in terms of 
simplifying both the data collection and the diagnostic processes in community settings, 
compared to venopuncture. Oral fluid testing proved to be an ideal tool for surveillance and 
epidemiological purposes in outreach settings among high-risk and hard to reach 
populations, namely MSM. The acceptability of this biological data collection procedure in 
gay settings is proven by the number of samples collected in all sites confirmed. 
Furthermore, the SIALON project methodology included several epidemiological 
approaches: first of all, the Second Generation Surveillance System philosophy, which 
strongly suggests the combination of both behavioural and biological data and the regular 
replication of surveillance survey. Secondly, the implementation of UNGASS indicators, 
which proved to be very useful in focusing on specific topics such as access to prevention 
(testing and prevention programmes), high risk behaviours and HIV prevalence. Indicators 
related to HIV testing, prevention programs, condom use, and understanding of how to 
protect against HIV infection, revealed how many MSM are unaware of their HIV status and 
fail to practice behaviour that could protect them from infection.  
This very approach seems to be a crucial activity in order to develop, pilot and validate 
multi-faceted epidemiological approaches in monitoring HIV epidemic. 
In terms of the data collected, the highest rates of HIV seroprevalence were found in 
Southern European cities, namely Barcelona and Verona. This could be partly attributed to 
the older samples and therefore to longer exposure to risk, since HIV prevalence was higher 
among MSM of over 25.  
The highest rates of syphilis prevalence were also found in Barcelona and Verona. In 
general, data confirms that a correlation exists between STI, previous syphilis, IgG anti-
Treponema seroprevalence and HIV infection.  
Alarming findings included undiagnosed HIV infections. Over half the respondents were 
unaware of their HIV positive status. This proportion was slightly lower only in Barcelona, 
but very high (nearly 80%) in Ljubljana and Bucharest. Moreover, nearly one third of MSM 
found to be HIV-positive through oral fluid samples reported a negative HIV test result over 
the last 12 months, so the undiagnosed infections were recent. This figure was highest in 





The risk of HIV infection was assessed with a major focus on unprotected anal intercourse 
(UAI). Two respondents out of ten reported having had UAI with an occasional partner the 
last time they had sex, while four out of ten reported having had UAI in the last 6 months 
with this kind of partner or partners. The percentages of UAI with an occasional partner 
were highest in Bucharest, Prague and Bratislava both for the last sexual encounter and for 
encounters over the previous 6 months. In line with this finding, in these cities MSM 
reported less use of a condom for anal intercourse the last time they had anal sex. Young 
MSM exhibited the riskiest behaviour, as the highest rates of UAI with occasional partners, 
both last time and in the last 6 months, were found amongst young people under 25 years 
old. As expected, UAI with a steady partner was more frequent than with an occasional 
partner, in the overall sample and in all the cities. 
Finally, the association between HIV risk and alcohol and drug use was confirmed. At least 
one third of respondents had used drugs before or during sex over the last six months and 
half the respondents had used alcohol. This proportion was above half in Ljubljana, 
Barcelona and Prague for drugs, and higher than 80% in Prague and Bratislava. 
This data suggests the (i) the need for health promotion and prevention messages 
particularly focused on sexual behaviour and alcohol and drug use (ii) the need for 
prevention and information programmes for STIs given that the presence of an STIs 
increases the risk of HIV infection (iii) the need for policies and strategies promoting VCT 
among hard to reach populations such as MSM, especially young MSM. 
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Throughout human history, infectious diseases have caused debilitation and premature death
to large portions of the human population, leading to serious social-economic concerns. Many
factors have contributed to the persistence and increase in the occurrence of infectious disease
(demographic factors, political, social and economic changes, environmental change, public
health care and infrastructure, microbial adaptation, etc.), which according to the World
Health Organization (WHO), are the second leading cause of death globally (≈ 23 % of deaths)
after cardiovascular diseases (WHO, 2010).
Research on basic and applied aspects of host, pathogen, and environmental factors that
influence disease emergence, transmission and spread have been supported so far, and
the development of diagnostics, vaccines, and therapeutics has been greatly increased. In
recent years, mathematical modeling became an interesting tool for the understanding of
infectious diseases epidemiology and dynamics, leading to great advances in providing
tools for identifying possible approaches to control, including vaccination programs, and for
assessing the potential impact of different intervention measures.
Epidemiological models are a formal framework to convey ideas about the components of a
host-parasite interaction and can act as a tool to predict, understand and develop strategies
to control the spread of infectious diseases by helping to understand the behaviour of the
system under various conditions. They can also aid data collection, data and interpretation
and parameter estimation. The purpose of epidemiological models is to take different aspects
of the disease as inputs and to make predictions about the numbers of infected and susceptible
people over time as output.
In the early 20th century, mathematical models were introduced into infectious
disease epidemiology, and a series of deterministic compartment models such as
SI (susceptible-infected), SIS (susceptible-infected-susceptible), and e.g SIR (susceptible-
infected-recovered) have been proposed based on the flow patterns between compartments
of hosts. In our days, most of the models developed try to incorporate other factors focusing
on several different aspects of the disease, which can imply rich dynamic behaviour even in
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Throughout human history, infectious diseases have caused debilitation and premature death
to large portions of the human population, leading to serious social-economic concerns. Many
factors have contributed to the persistence and increase in the occurrence of infectious disease
(demographic factors, political, social and economic changes, environmental change, public
health care and infrastructure, microbial adaptation, etc.), which according to the World
Health Organization (WHO), are the second leading cause of death globally (≈ 23 % of deaths)
after cardiovascular diseases (WHO, 2010).
Research on basic and applied aspects of host, pathogen, and environmental factors that
influence disease emergence, transmission and spread have been supported so far, and
the development of diagnostics, vaccines, and therapeutics has been greatly increased. In
recent years, mathematical modeling became an interesting tool for the understanding of
infectious diseases epidemiology and dynamics, leading to great advances in providing
tools for identifying possible approaches to control, including vaccination programs, and for
assessing the potential impact of different intervention measures.
Epidemiological models are a formal framework to convey ideas about the components of a
host-parasite interaction and can act as a tool to predict, understand and develop strategies
to control the spread of infectious diseases by helping to understand the behaviour of the
system under various conditions. They can also aid data collection, data and interpretation
and parameter estimation. The purpose of epidemiological models is to take different aspects
of the disease as inputs and to make predictions about the numbers of infected and susceptible
people over time as output.
In the early 20th century, mathematical models were introduced into infectious
disease epidemiology, and a series of deterministic compartment models such as
SI (susceptible-infected), SIS (susceptible-infected-susceptible), and e.g SIR (susceptible-
infected-recovered) have been proposed based on the flow patterns between compartments
of hosts. In our days, most of the models developed try to incorporate other factors focusing
on several different aspects of the disease, which can imply rich dynamic behaviour even in
the most basic dynamical models. Factors that can go into the models include the duration
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of disease, the duration of infectivity, the infection rate, the waning immunity, and so forth.
In such a way, differential equation models are a simplified representation of reality, which
are designed to facilitate prediction and calculation of rates of change as functions of the
conditions or the components of the system.
There are two common approaches in modeling, the deterministic and the stochastic one.
In the first case, the model is one in which the variable states are uniquely determined by
parameters in the model and by sets of previous states of these variables. In mathematics,
a deterministic system is a system in which no randomness is involved in the development
of future states of the system. In a stochastic model, randomness is present, and variable
states are not described by unique values, but rather by probability distributions. Stochastic
epidemic models are appropriate stochastic processes that can be used to model disease
propagation. Disease propagation is an inherently stochastic phenomenon and there are a
number of reasons why one should use stochastic models to capture the transmission process.
Real life epidemics, in the absence of intervention from outside, can either go extinct with
a limited number of individuals getting ultimately infected, or end up with a significant
proportion of the population having contracted the disease in question. It is only stochastic,
as opposed to deterministic, models that can capture this behavior and the probability of each
event taking place.
Only few stochastic processes can be solved explicitly. The simplest and most thoroughly
studied stochastic model of epidemics are based on the assumption of homogeneous mixing,
i.e. individuals interact randomly at a certain rate. The mean field approximation is a good
approximation to be used in order to understand better the behavior of the stochastic systems
in certain parameter regions, where the dynamics of the mean quantities are approximated by
neglecting correlations, giving closed ordinary differential equations (ODE) systems, hence
mathematically deterministic systems which are easier to analyze.
In the following section of this chapter we present the properties of the basic SIR epidemic
model for infectious diseases with a summary of the analysis of the dynamics, identifying the
thresholds and equilibrium points. The goal is to introduce notation, terminology, and results
that will be generalized in later sections on more advanced models motivated by dengue fever
epidemiology as an example of multi-strain systems.
2. The SIR epidemic model
The SIR epidemic model divides the population into three classes: susceptible (S), Infected
(I) and Recovered (R). It can be applied to infectious diseases where waning immunity
can happen, and assuming that the transmission of the disease is contagious from person
to person, the susceptibles become infected and infectious, are cured and become recovered.
After a waning immunity period, the recovered individual can become susceptible again.
This model was for the first time proposed by William Ogilvy Kermack and Anderson Gray
McKendrick in 1927 (Weisstein, 2010). The model was brought back to prominence after
decades of neglect by Anderson and May (Anderson & May, 1979).
In the simple SIR epidemics without strain structure of the pathogens we have the following
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for a host population of N individuals, with contact and infection rate β, recovery rate γ
and waning immunity rate α. The dynamic model in terms of ordinary differential equations
(ODE) reads,
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where we use the time derivative Ṡ = dS/dt with time t for a constant population size of
N = S + I + R individuals. The solution of R(t) is given by R(t) = N − I(t)− S(t) which
can be calculated using the solution of the ODEs. The susceptible individuals become infected
with infection rate β, recover from the infection with recovery rate γ and become susceptible
again after waning immunity rate α.
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Fig. 1. Time dependent solution simulation for the SIR epidemic model. With a population
N = 100, and starting values I = 40, S = 60 and R = 0, we fixed β = 2.5, α = 0.1, and γ = 1.
In green the dynamics for the susceptibles S(t), in pink the dynamics for the infected I(t)
and in blue the dynamics of the recovered R(t). Note that N = 100 allows for the
interpretation for the class abundances in percentages.
The basic SIR model has only fixed points as possible stationary solutions, that can be
calculated setting the rates of change Ṡ and İ to zero. For the disease free equilibrium state,
the solution is given by
I∗1 = 0 (3)
S∗1 = N (4)
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where we use the time derivative Ṡ = dS/dt with time t for a constant population size of
N = S + I + R individuals. The solution of R(t) is given by R(t) = N − I(t)− S(t) which
can be calculated using the solution of the ODEs. The susceptible individuals become infected
with infection rate β, recover from the infection with recovery rate γ and become susceptible
again after waning immunity rate α.
In Fig. 1 we show the dynamical behavior of the susceptible, infected and recovered

















Fig. 1. Time dependent solution simulation for the SIR epidemic model. With a population
N = 100, and starting values I = 40, S = 60 and R = 0, we fixed β = 2.5, α = 0.1, and γ = 1.
In green the dynamics for the susceptibles S(t), in pink the dynamics for the infected I(t)
and in blue the dynamics of the recovered R(t). Note that N = 100 allows for the
interpretation for the class abundances in percentages.
The basic SIR model has only fixed points as possible stationary solutions, that can be
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The epidemic dynamic as a function of the parameter β shows the spread of the epidemic
























Fig. 2. Epidemic dynamics as a function of β. With the same initial values as used in Fig. 1,
we plot time dependent solutions I(t) for several β values. In a)β ∈ [1.5, 2.5], with a
resolution Δβ = 0.1 and in b) β ∈ [0, 0.9] where Δβ = 0.2.
In order to analyze the stability of the equilibrium states, we look at the Jacobian matrix and
its eigenvalues. Let the dynamics for the state x := (S, I) be f (x), hence ddt x = f (x) which
explicitly gives Δx := x(t)− x∗ as a small perturbation around the fixed point x∗. We linearize
the dynamic ddt Δx =
d
dt (x(t)− x∗) applying Taylor’s expansion





· (Δx) +O((Δx)2) (7)
with f (x∗) = 0 for the fixed point and neglecting higher order terms. For our system we have

































where f := ( f , g) and the Jacobian matrix is explicitly given by
⎛
⎜⎝







⎟⎠ =: A (9)
where we have to insert for S∗ and I∗, the respective steady states. In order to decoupled
the linear differential equation system, we diagonalize the matrix A, (9), with the eigenvalue
decomposition A u = λ u, u is an eigenvector of A, and λ is an eigenvalue of A
corresponding to the eigenvector u.
The eigenvalues can be calculated setting the determinant of [A − λ 1] equal zero.
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2.1 The disease free equilibrium state
For the disease free equilibrium state (I∗1 and S∗1), Eq.(3) and Eq. (4), the eigenvalues are given
by
λ1 = β − γ (10)



















Fig. 3. Eigenvalues for the disease free equilibrium state as functions of β when fixing α = 0.1































































































































 eigendirection uλ1  eigendirection uλ2
Fig. 4. eigenvectors for the disease free equilibrium state in function of β. For a population
N = 100, where I = 0.0001, S = 99.99, and R = N − I − S, in a) β = 0.9, in b) β = 0.97, in c)
β = 0.999, in d) β = 1.001, in e) β = 1.1, and in f) β = 1.3.
When looking at Eq. (10) and Eq. (11) we see that for β < γ both eigenvalues are negative, i.e.
the fixed point I∗1 is stable. The eigenvalues λ1 and λ2 are equal at the point β = γ − α and
for β > γ, λ1 is positive and λ2 is negative, therefore the fixed point I∗1 = 0 is unstable. The
stability of the system changes when one of the eigenvalues of the system becomes zero. At
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for β > γ, λ1 is positive and λ2 is negative, therefore the fixed point I∗1 = 0 is unstable. The
stability of the system changes when one of the eigenvalues of the system becomes zero. At
233odeling Infectious Diseases Dynamics: Dengue Fever, a Case Study
6 Will-be-set-by-IN-TECH
this point, βc = γ, when I∗1 becomes unstable and I
∗
2 stable. Fig. 3 shows the eigenvalues for
the disease free equilibrium state as functions of β.




























In Fig. 4 we show the eigenvectors for the disease free equilibrium state as functions of β,
when fixing α = 0.1, and γ = 1. We plot the eigenvectors, u1 (blue line) and u2 (green line) on
top of the trajectory of the infected individuals (red line). Note that λ1 = λ2 at β = (γ − α),
i.e. the eigenvectors u1 = u2 (see Fig. 4a)). By increasing β toward the critical value βc = γ
the trajectory needs longer time to hit the fixed point (see Fig. 4b) and 4c)). For β > γ, the
trajectory goes toward the other fixed point I∗2 (see Fig. 4d) and 4e)).
2.2 The disease endemic equilibrium state
For the disease endemic equilibrium state (I∗2 and S∗2), Eq. (5) and Eq. (6), the eigenvalues are
giving by















− (β − γ)α (12)















− (β − γ)α . (13)










)]2 − (β− γ)α =: b.
If b > 0 the eigenvalues are real numbers, giving the contraction or expansion of the
trajectories near to the considered fixed point, and can be written as
λ1 = a +
√
b (14)
λ2 = a −
√
b . (15)
If b < 0, the eigenvalues
λ1 = a + i
√
|b| (16)
λ2 = a − i
√
|b| (17)
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become complex, where the real part a gives the contraction or expansion, and the imaginary
part i
�|b| gives the frequency of oscillations of the trajectories spiraling into the fixed point
as is shown in Fig. 5. The parabola curve shows the contraction and expansion of the
eigenvalues. For β < γ the fixed I∗2 point is unstable, with one positive eigenvalue.
For β > γ, the fixed point I∗2 becomes stable with both eigenvalues negative. The system

































Fig. 5. Plot of the eigenvalues as functions of β when fixing α = 0.1 and γ = 1.0. In a) the real
part a of the eigenvalues gives the contraction and expansion of the trajectories. For β < γ
the fixed point is unstable (λ1 > 0). The system changes stability when βc = γ and becomes
complex when λ1 = λ2. Here, the straight green line represents only the real parts of the
complex eigenvalues obtained putting
√−b = 0. In b) the imaginary part of the eigenvalues
gives the frequency of the oscillatory behavior on the trajectory toward at the fixed point.
The correspondent eigenvectors of the disease endemic equilibrium state can be calculated for
the eigenvalues in the same manner as it was shown above. For the first eigenvalue λ1, the







































In Fig. 6 we show the eigenvectors for the disease endemic equilibrium state in function of β.




when λ1 �= λ2. By including the respective eigenvalues, Eq. (10) and Eq.(11), we get as a
solution
x(t) = C1e
(β−γ)tu1 + C2e−αtu2 (20)
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Fig. 6. eigenvectors for the disease endemic equilibrium state in function of β. For a
population N = 100, where I = 0.001 and S = 99, we fixed α = 0.1, γ = 1 and vary β. We
plot the eigenvectors, u1 (blue line) and u2 (greenline), on top of the trajectory of the infected
individuals toward the second fixed point I∗2 . In a) β = 1.01, and in b) β = 1.025. In c) we
show the oscillatory trajectory toward the fixed point when β = 2.5
where the eigenvector u1 is the driving force for t → ∞, since λ1 > λ2 (see Fig. 4b) to 4f)).
When λ1 < λ2 the eigenvector u2 is the driving force for t → ∞.
For the special case where λ1 = λ2 =: λ and therefore the eigenvectors u1 = u2 =: u the




where w is the so called generalized eigenvector, satisfying (A − λ1) w = u. In this case, for
t → ∞, the eigenvector u is again the driving force (see Fig. 4a)).
For the complex eigenvalues, where the real part a gives the contraction or expansion, and the
imaginary part i
√|b| gives the frequency of oscillations of the trajectories spiraling into the
























where C1 and C2 depend on the initial conditions and ui, respectively the real and imaginary
parts of the complex eigenvector. This expression shows that the stability of the fixed point
depends on the sign of a. For detailed information on the solution of a linear two dimensional
ODE system, see (Mattheij & Molenaar, 1996).
The stochastic SIR epidemic is modeled as a time-continuous Markov process to capture
population noise. The dynamics of the probability of integer infected and integer susceptibles,
while the recovered follow from this due to constant population size, can be give as a master






(S + 1)(I − 1) p(S + 1, I − 1, t) + γ(I + 1) p(S, I + 1, t) (21)




+ γI + α(N − S − I)
)
p(S, I, t) .
This process can be simulated by the Gillespie algorithm giving stochastic realizations of
infected and susceptibles in time (Gillespie, 1976, 1978).














































   
Fig. 7. Stochastic simulations for the basic SIR epidemic model. Here 10 realizations are
plotted. We fixed α = 0.1, γ = 1 and β = 2.5. The deterministic trajectory is shown (pink
line) top of the stochastic realizations for different population size N a. In a) N = 100, in b)
N = 1000 and in c) N = 100000.
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with �R� = N − �S� − �I�. For more details on the calculations see e.g. (Stollenwerk & Jansen,
2010). These equations for the mean dynamics include now due to the nonlinear transition
rates in the master equation also higher moments �S · I�. The simplest approximation to
obtain a closed ODE system is to neglect cross-correlations �S · I� − �S� · �I� ≈ 0, the so-called
mean field approximation (originally introduced for spatially extended systems in statistical
physics (Stollenwerk et al., 2010)). Hence, the equation system (23) gives with identifying
the higher moment �S · I� = �S� · �I� by a product of simple moments gives again the
ODE system for SIR system, as it was just presented above. For certain parameter regions
the mean field approximation describes the system well in terms of its mean dynamics and
only small fluctuations around it. Then the previously shown analysis of the system is
appropriate. However, noise can stabilize transients, a feature which becomes important
in parameter regions where in the deterministic description a fixed point is reached via
decreasing oscillations, as we have observed them in the SIR system. The noisy system would
show here continued oscillations (Alonso et al., 2006).
In Fig. 7 we compare the deterministic and stochastic dynamics and we see that the magnitude
of stochastic fluctuations decreases when the population size increases. However, the good
approximation (see Fig. 7c)) is only achieved when the population size is large enough (see
Fig. 7a) where most simulations die out very quickly for small population size).
Almost all mathematical models of diseases start from the same basic premise: that the
population can be subdivided into a set of distinct classes. The most commonly used
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framework for epidemiological systems, is still the SIR type model, a good and simple model
for many infectious diseases. However, different extensions of the classical single-strain SIR
model show a rich dynamic behavior, e.g. (Stone et al., 2007) in measles, or in generalized
multi-strain SIR type models to describe the epidemiology of dengue fever (Aguiar et al.,
2008).
3. Dengue fever epidemiology
Dengue is a viral mosquito-borne infection which in recent years has become a major
international public health concern. According to the estimates given by (PDVI, 2011), 3.6
billion (55% of world population) are at risk of acquiring dengue infection (see Fig. 8a)). It
is estimated that every year, there are 70 − 500 million dengue infections, 36 million cases of
dengue fever (DF) and 2.1 million cases of dengue hemorragic fever (DHF), with more than
20.000 deaths per year (CDC, 2011; PDVI, 2011; WHO, 2009). In many countries in Asia and
South America DF and DHF has become a substantial public health concern leading to serious
social-economic costs.
Fig. 8. Worldwide Dengue distribution 2010. In red Countries and areas where dengue has
been reported Data source: World Health Organization (WHO) & Centers for Disease
Control and Prevention (CDC). Adapted from (Gubler, 2002; Mackenzie et al., 2004).
Dengue fever is transmitted by the female domestic mosquito Aedes aegypti, although Ae.
albopictus and Ae. polynesiensis can also act as transmission vector (Favier et al., 2005). Virus
transmission in its simplest form involves the ingestion of viremic blood by mosquitoes and
passage to a second susceptible human host. The mosquito becomes infected when taking a
blood meal from a viremic person. After an extrinsic incubation period, the mosquito becomes
infective and remains so during its entire life span (Rigau-Pérez et al., 1998). As the blood meal
stimulates ovoposition, which undergoes at least one, often more, reproductive cycles there is
an opportunity of vertical transmission to the eggs, passing the virus to the next generation of
mosquitoes (CDC, 2011; Monath, 1994; Rosen et al., 1983).
There are four antigenically distinct dengue viruses, designated DEN-1, DEN-2, DEN-3, and
DEN-4 (Guzmán et al., 2010; Halstead, 1994; SES, 2010; WHO, 2009). Infection by one serotype
confers life-long immunity to only that serotype and a short temporary cross-immunity period
to other serotypes exists. It lasts from three to nine months, when the antibody levels created
during the response to that infection would be enough to protect against infection by a
different but related serotype (Dejnirattisai et al., 2010; Halstead, 1994; Matheus et al., 2005;
SES, 2010; WHO, 2009). Two variants of the disease exist: dengue fever (DF), a non-fatal form
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of illness, and dengue hemorrhagic fever (DHF), which may evolve toward a severe form
known as dengue shock syndrome (DSS).
Epidemiological studies support the association of DHF with secondary dengue infection
(Guzmán et al., 2000; Halstead, 1982, 2003; Nisalak et al., 2003; Vaughn, 2000), and there is
good evidence that sequential infection increases the risk of developing DHF, due to a process
described as antibody-dependent enhancement (ADE), where the pre-existing antibodies to
previous dengue infection cannot neutralize but rather enhance the new infection.
Fig. 9. Scheme of the immunological response on recurrent dengue infections. In (a.) the first
infection with a given dengue virus serotype, in (b.) production of antibodies
(Immunoglobulin M (IgM)), in (c.) inactivation of the virus and in (d.) production of
antibodies (IgG class, the so called memory antibodies). In (e.) the temporary cross immunity
period, that lasts between 3-9 months. After that period, the individual can get infected again
with another dengue virus serotype (f.). In (g.) the IgG from the previous dengue infection
binds to the new virus but do not inactivate them. In (h.) the complex antibody-virus
enhances the new infection (i.). In (j.) the production of antibodies (IgM class) which is then
able to inactivate the new viruses, leading to (l.), an enhanced immune response, such that
hemorrhagic symptoms are observed. In (m.) production of IgG antibodies.
In the first dengue infection virus particles will be captured and processed by so-called antigen
presenting cells. These viruses will be presented to T-cells causing them to become activated.
And likewise B-cells will encounter their antigen free floating and become activated. B-cells
produce antibodies that are used to tag the viruses to encourage their uptake by macrophages
and inactivate them. In a secondary infection the antibodies from the first infection will attach
to the virus particles but will not inactivate them. The antibody-virus complex suppresses
innate immune responses, increasing intracellular infection and generating inflammatory
citokines and chemokines that, collectively, result in enhanced disease (Dejnirattisai et al.,
2010; Guzmán et al., 2010; Halstead, 1982, 1994, 2003; Mackenzie et al., 2004; WHO, 2009).
Fig.9 is an scheme to illustrate the immunological response on recurrent dengue infections.
DF is characterized by headache, retro-orbital pain, myalgia, arthralgia, rash, leukopenia,
and mild thrombocytopenia. The symptoms resolve after 27 days. DHF is a potentially
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framework for epidemiological systems, is still the SIR type model, a good and simple model
for many infectious diseases. However, different extensions of the classical single-strain SIR
model show a rich dynamic behavior, e.g. (Stone et al., 2007) in measles, or in generalized
multi-strain SIR type models to describe the epidemiology of dengue fever (Aguiar et al.,
2008).
3. Dengue fever epidemiology
Dengue is a viral mosquito-borne infection which in recent years has become a major
international public health concern. According to the estimates given by (PDVI, 2011), 3.6
billion (55% of world population) are at risk of acquiring dengue infection (see Fig. 8a)). It
is estimated that every year, there are 70 − 500 million dengue infections, 36 million cases of
dengue fever (DF) and 2.1 million cases of dengue hemorragic fever (DHF), with more than
20.000 deaths per year (CDC, 2011; PDVI, 2011; WHO, 2009). In many countries in Asia and
South America DF and DHF has become a substantial public health concern leading to serious
social-economic costs.
Fig. 8. Worldwide Dengue distribution 2010. In red Countries and areas where dengue has
been reported Data source: World Health Organization (WHO) & Centers for Disease
Control and Prevention (CDC). Adapted from (Gubler, 2002; Mackenzie et al., 2004).
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deadly complication that is characterized by high fever and hemorrhagic phenomenae. DHF
develops rapidly, usually over a period of hours, and resolves within 12 days in patients who
receive appropriate fluid resuscitation. Otherwise, it can quickly progress to shock (CDC,
2011; WHO, 2009).
Treatment of uncomplicated dengue cases is only supportive, and severe dengue cases
requires careful attention to fluid management and proactive treatment of hemorrhagic
symptoms (CDC, 2011; WHO, 2009). A vaccine against dengue is not yet available, since
it would have to simulate a protective immune response to all four serotypes (Stephenson,
2005), although several candidates of tetravalent vaccines are at various stages of development
(WHO, 2011).
Mathematical models describing the transmission of dengue viruses appeared in the literature
early as 1970 (Fischer & Halstead, 1970). More recently, mathematical models describing
the transmission of dengue viruses have focused on the ADE effect and temporary cross
immunity trying to explain the irregular behavior of dengue epidemics. Such models
ultimately aim to be used as a predictive tool with the objective to guide the policies of
prevention and control of the dengue virus transmission, including the implementation
of vaccination programs when the candidate dengue fever vaccines will be accessible. In
the literature the multi-strain interaction leading to deterministic chaos via ADE has been
described previously, e.g. (Billings et al., 2007; Ferguson et al., 1999; Schwartz et al, 2005) but
neglecting temporary cross immunity. Consideration of temporary cross immunity is rather
complicated and up to now not in detail analyzed. Models formulated in (Loureço & Recker,
2010; Nagao & Koelle, 2008; Recker et al., 2009; Wearing & Rohani, 2006), did not investigate
closer the possible dynamical structures. In (Aguiar & Stollenwerk, 2007; Aguiar et al., 2008,
2009, 2011 a) by including temporary cross immunity into dengue models with ADE, a rich
dynamic structure including deterministic chaos was found in wider and more biologically
realistic parameter regions.
4. Multi-strain models motivated by dengue fever epidemiology: a review
Multi-strain dynamics are generally modelled with SIR-type models and have demonstrated
to show critical fluctuations with power law distributions of disease cases, exemplified
in meningitis and dengue epidemiology (Massad et al., 2008; Stollenwerk & Jansen, 2003;
Stollenwerk et al., 2004). Dengue models including multi-strain interactions via ADE but
without temporary cross immunity period e.g. (Billings et al., 2007; Ferguson et al., 1999;
Schwartz et al, 2005) have shown deterministic chaos when strong infectivity on secondary
infection was assumed. The addition of the temporary cross immunity period in such models
shows a new chaotic attractor in an unexpected parameter region of reduced infectivity
on secondary infection (Aguiar & Stollenwerk, 2007; Aguiar et al., 2008, 2009, 2011 a), i.e.
deterministic chaos was found in a wider parameter regions. This indicates that deterministic
chaos is much more important in multi-strain models than previously thought, and opens
new ways to data analysis of existing dengue time series, as will be shown below. It offers a
promising perspective on parameter values inference from dengue cases notifications.
The basic multi-strain model divides the population into ten classes: susceptible to both
strains, 1 and 2 (S), primarily infected with strain one (I1) or strain two (I2), recovered from
the first infection with strain one (R1) or strain two (R2), susceptible with a previous infection
with strain one (S1) or strain two (S2), secondarily infected with strain one when the first
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infection was caused by strain two (I21) or for second time infected with strain two when
the first infection was caused by strain one (I12). Notice that infection by one serotype confers
life-long immunity to that serotype. Then the individuals recover from the secondary infection
(R).
To capture differences in primary infection by one strain and secondary infection by another
strain we consider a basic two-strain SIR-type model for the host population, which is only
slightly refined as opposed to previously suggested models for dengue fever (Billings et al.,
2007; Ferguson et al., 1999; Schwartz et al, 2005).
The stochastic version of the multi-strain dengue model is now in complete analogy to the
previously described SIR model, and the mean field ODE system for the multi-strain dengue
model can be read from the following reaction scheme (24), describing the transitions for first
infection with strain 1 and secondary infection with strain 2, and for the reverse process, where
the first infection is caused by strain 2 and the secondary infection is caused by strain 1, the
same reaction scheme can be used to describe the transitions by just changing labels.
S + I1
β−→ I1 + I1
S + I21






β−→ I12 + I2
S1 + I12
φβ−→ I12 + I12
I12
γ−→ R
The demographic transitions are S, I1, I2, R1, R2, S1, S2, I12, I21, R
μ−→ S defining the system
of two strains completely (for more information on the deterministic ODE system and its
parametrization, see (Aguiar et al., 2011 a)).
The complete system of ordinary differential equations for the two strain epidemiological
system is given by Eq. system (25) and the dynamics are described as follows. Susceptibles to
both strains can get the first infection with strain one or strain two with force of infection βIN
when the infection is acquired via an individual in his first infection or φβIN when the infection
is acquired via an individual in his second infection. They recover from the first infection
with a recovery rate γ, conferring full and life-long immunity against the strain that they
were exposed to, and also a short period of temporary cross-immunity α against the other
strain, becoming susceptible to a second infection with a different strain. The susceptible with
a previous infection gets the secondary infection with force of infection βIN or
φβI
N depending
on whom (individual on his primary or secondary infection) is transmitting the infection.
Then, with recovery rate γ, the individuals recover and become immune against all strains.
We assume no epidemiological asymmetry between strains, i.e. infections with strain one
or strain two contribute in the same way to the force of infection. Here, the only relevant
difference concerning disease transmissibility is that the force of infection varies accordingly
to the number of previous infections the hosts have experienced. The parameter φ in our
model, is the ratio of secondary infection contribution to the force of infection. For more
241odeling Infectious Diseases Dynamics: Dengue Fever, a Case Study
12 Will-be-set-by-IN-TECH
deadly complication that is characterized by high fever and hemorrhagic phenomenae. DHF
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strain we consider a basic two-strain SIR-type model for the host population, which is only
slightly refined as opposed to previously suggested models for dengue fever (Billings et al.,
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model can be read from the following reaction scheme (24), describing the transitions for first
infection with strain 1 and secondary infection with strain 2, and for the reverse process, where
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of two strains completely (for more information on the deterministic ODE system and its
parametrization, see (Aguiar et al., 2011 a)).
The complete system of ordinary differential equations for the two strain epidemiological
system is given by Eq. system (25) and the dynamics are described as follows. Susceptibles to
both strains can get the first infection with strain one or strain two with force of infection βIN
when the infection is acquired via an individual in his first infection or φβIN when the infection
is acquired via an individual in his second infection. They recover from the first infection
with a recovery rate γ, conferring full and life-long immunity against the strain that they
were exposed to, and also a short period of temporary cross-immunity α against the other
strain, becoming susceptible to a second infection with a different strain. The susceptible with
a previous infection gets the secondary infection with force of infection βIN or
φβI
N depending
on whom (individual on his primary or secondary infection) is transmitting the infection.
Then, with recovery rate γ, the individuals recover and become immune against all strains.
We assume no epidemiological asymmetry between strains, i.e. infections with strain one
or strain two contribute in the same way to the force of infection. Here, the only relevant
difference concerning disease transmissibility is that the force of infection varies accordingly
to the number of previous infections the hosts have experienced. The parameter φ in our
model, is the ratio of secondary infection contribution to the force of infection. For more
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information on the parametrization of ADE and secondary dengue infection by φ, see (Aguiar
et al., 2008; Ferguson et al., 1999). The parameter values are given in Table 1, if not otherwise
explicitly stated.
Ṡ = − β
N








S(I2 + φI12)− (γ + μ)I2
Ṙ1 = γI1 − (α + μ)R1
Ṙ2 = γI2 − (α + μ)R2 (25)
Ṡ1 = − βN S1(I2 + φI12) + αR1 − μS1








S2(I1 + φI21)− (γ + μ)I21
Ṙ = γ(I12 + I21)− μR ,
Par. Description Values Ref
N population size 100 —
μ new born susceptible rate 1/65y (UNWPP, 2008)
γ recovery rate 52y−1 (Gubler et al., 1981; WHO, 2009)
β infection rate 2γ (Ferguson et al., 1999)
α temporary cross-immunity rate 2y−1 (Matheus et al., 2005; SES, 2010)
φ ratio of contrib. to force of inf. variable —
Table 1. Parameter set, rates given in units per year, ratio without unit
The stationary states can be calculated analytically by setting the time derivatives in Eq.
system (25) to zero,
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where still the stationary values of I∗1 and I∗2 have to be determined.





























































and the solution of the extinction of one of the strains is as follows
I∗1 =
μN(β − (γ + μ))
(γ + μ)β
(28)
I∗2 = 0 .
Finally, the stationary value of R∗, when hosts have been recovered from both strains, is given
by the balance equation for the total population size N, explicitly
R∗ = N − (S∗ + I∗1 + I∗2 + R∗1 + R∗2 + S∗1 + S∗2 + I∗12 + I∗21) . (29)
The time series for φ < 1 shows that the total number of infected I := I1 + I2 + I12 + I21 stays
quite away from zero, avoiding the chance of extinction in stochastic systems with reasonable
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Ṡ1 = − βN S1(I2 + φI12) + αR1 − μS1








S2(I1 + φI21)− (γ + μ)I21
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system size (see Fig. 10 a)). The parameter region previously considered to model ADE effects
on dengue epidemiology, i.e. φ > 1, leads to rather low troughs for the total number of
infected giving unrealistically low numbers of infected. In Fig. 10 b) the logarithm of total
number of infected goes as low as −70 for φ = 2.7 in the chaotic region of φ > 1. Population














































Fig. 10. Time series of the logarithm of the overall infected (ln(I)) comparison: a) simulation
for φ = 2.7 and b) simulation for φ = 0.6 for the same time interval.
The state space plots in terms of the variables S and the logarithm of the total number of
infected I show a rich dynamical behavior with bifurcations from fixed point to limit cycles,

































































Fig. 11. Attractors for various values of φ < 1: a) fixed point for φ = 0.1, and b) limit cycle for
φ = 0.4, and c) chaotic attractor for φ = 0.6.
Looking for higher values of φ, the chaotic attractor becomes unstable, just leaving simple
limit cycles as attractors for large parameter regions beyond φ = 1 (Aguiar & Stollenwerk,
2007; Aguiar et al., 2008). Only for much higher values of φ >> 1, another chaotic attractor
appears, the classical “ADE chaotic attractor” (Aguiar & Stollenwerk, 2007; Aguiar et al., 2008;
Ferguson et al., 1999).
The bifurcation diagram was obtained plotting the local extrema of ln(I) over the varying
parameter φ (see Fig. 12). Fixed points appear as one dot per parameter value, limit cycles
appear as two dots, double-limit cycles as four dots, more complicated limit cycles as more
dots, and chaotic attractors as continuously distributed dots for a single φ value (Ruelle, 1989).
We observe two chaotic windows, one for φ < 1, where this dynamical behavior has never
been described before, and also another one for φ > 1 (see Fig. 12a)) where the minimal
values go to very low numbers of infected, which already has been described (see Fig. 12b)) in
previous publications (Billings et al., 2007; Ferguson et al., 1999; Schwartz et al, 2005). In Fig.
12b) the dynamical behavior was obtained when neglecting the temporary cross-immunity































Fig. 12. Bifurcation diagram for the local extrema of the overall infected with changing
parameter φ. In a) α = 2 (six month) and in b) α = 52 (one week).
period, i.e. by putting α → ∞. The recovered individuals can be immediately infected
with another strain, whereas consideration of temporary cross-immunity brings a new chaotic
attractor found first by Aguiar et al. (Aguiar & Stollenwerk, 2007; Aguiar et al., 2008).
This finding encourages to look closer to the parameter region of φ < 1, when dengue
patients in a secondary infection evolving to severe disease because of the ADE phenomenon
contribute less to the force of infection, and not more, as previous models suggested. This
assumption is likely to be more realistic for dengue fever since the possible severity of a
secondary infection may hospitalize people, not contributing to the force of infections as much
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Fig. 13. In a) spectrum of the four largest Lyapunov exponents with changing parameter φ
and fixed α = 2. In b) we show the one-parameter bifurcation diagram with temporary
cross-immunity rate α = 2 and varying the ratio of secondary infection contribution to the
force of infection φ. Solid lines denote stable equilibria or limit cycles, and dashed lines
unstable equilibria or limit cycles.
We quantify the attractor structure, fixed point, limit cycle or chaotic attractor etc., by
calculating Lyapunov exponents (Ott, 1993; Ruelle, 1989), which were calculated using an
iterated technique along a trajectory using the QR decomposition algorithm via Householder
matrices (see (Aguiar et al., 2008; Holzfuss & Lauterborn, 1989; Holzfuss & Parlitz, 1991)).
Lyapunov exponents are essentially a generalization of eigenvalues determining stability
versus instability along trajectories. A negative largest Lyapunov exponent indicates a stable
fixed point as attractor, a zero largest Lyapunov exponent indicates a stable limit cycle and
a positive largest Lyapunov exponent indicates a chaotic attractor. Fig. 13a) shows the
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system size (see Fig. 10 a)). The parameter region previously considered to model ADE effects
on dengue epidemiology, i.e. φ > 1, leads to rather low troughs for the total number of
infected giving unrealistically low numbers of infected. In Fig. 10 b) the logarithm of total
number of infected goes as low as −70 for φ = 2.7 in the chaotic region of φ > 1. Population
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for φ = 2.7 and b) simulation for φ = 0.6 for the same time interval.
The state space plots in terms of the variables S and the logarithm of the total number of
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φ = 0.4, and c) chaotic attractor for φ = 0.6.
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Ferguson et al., 1999).
The bifurcation diagram was obtained plotting the local extrema of ln(I) over the varying
parameter φ (see Fig. 12). Fixed points appear as one dot per parameter value, limit cycles
appear as two dots, double-limit cycles as four dots, more complicated limit cycles as more
dots, and chaotic attractors as continuously distributed dots for a single φ value (Ruelle, 1989).
We observe two chaotic windows, one for φ < 1, where this dynamical behavior has never
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assumption is likely to be more realistic for dengue fever since the possible severity of a
secondary infection may hospitalize people, not contributing to the force of infections as much
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Fig. 13. In a) spectrum of the four largest Lyapunov exponents with changing parameter φ
and fixed α = 2. In b) we show the one-parameter bifurcation diagram with temporary
cross-immunity rate α = 2 and varying the ratio of secondary infection contribution to the
force of infection φ. Solid lines denote stable equilibria or limit cycles, and dashed lines
unstable equilibria or limit cycles.
We quantify the attractor structure, fixed point, limit cycle or chaotic attractor etc., by
calculating Lyapunov exponents (Ott, 1993; Ruelle, 1989), which were calculated using an
iterated technique along a trajectory using the QR decomposition algorithm via Householder
matrices (see (Aguiar et al., 2008; Holzfuss & Lauterborn, 1989; Holzfuss & Parlitz, 1991)).
Lyapunov exponents are essentially a generalization of eigenvalues determining stability
versus instability along trajectories. A negative largest Lyapunov exponent indicates a stable
fixed point as attractor, a zero largest Lyapunov exponent indicates a stable limit cycle and
a positive largest Lyapunov exponent indicates a chaotic attractor. Fig. 13a) shows the
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largest four Lyapunov exponents as a function of φ. We observe that for small φ up to 0.1
all four Lyapunov exponents are negative, indicating the stable fixed point solution. Then
follows a region up to φ = 0.5 where the largest Lyapunov exponent is zero, characteristic for
stable limit cycles. Above φ = 0.5 a positive Lyapunov exponent, clearly separated from the
second largest Lyapunov exponent being zero, indicates deterministically chaotic attractors.
In the chaotic window between φ = 0.5 and φ = 1 also periodic windows appear, giving a
zero largest Lyapunov exponent. These findings are in good agreement with the numerical
bifurcation diagram, Fig. 13b).
A further analysis of the bifurcation structure, in the region of interest of φ < 1, was performed
using the numerical software AUTO (AUTO, 2009). Various bifurcations were found: Hopf
bifurcation H(φ = 0.11326), pitchfork bifurcations P(φ = 0.41145, 0.99214), torus bifurcation
TR(φ = 0.55069) and tangent bifurcations T(φ = 0.4.9406, 0.53874, 0.93103, 0.97825, 1.05242).
In addition to this main bifurcation pattern we found two isolas, consisting of isolated limit
cycles existing between two tangent bifurcations (see Fig. 13b), for more information on the
isolas see (Aguiar et al., 2008, 2009). These results agree very well with the simulation results























Fig. 14. Time series of DHF incidence in Thailand.
Dengue fever epidemiology is characterized as a yearly cycle of incidences (see Fig. ??),
therefore in order to be able to reproduce the yearly cycle in dengue incidence seasonal
forcing and a low import of infected have to be included in the models. The first recorded
epidemic of DHF in Thailand (population of approximately 66 million people (Wikipedia,
2011)) was in 1958 (WHO, 2009). The co-circulation of all four dengue serotypes and their
capacity to produce severe dengue disease was demonstrated as early as 1960 in Bangkok,
Thailand (Halstead et al., 1969). DHF occurred first only in Bangkok, but was disseminated
to the whole region during the 1970s (Chareonsook et al., 1999; Gubler, 2002; Halstead et al.,
1969). Physicians in Thailand are trained to recognize and treat dengue fever and practically
all cases of DHF and DSS are hospitalized. A system for reporting communicable diseases
including DHF/DSS was considered fully installed in 1974 and the data bank of DHF and
DSS is available at the Ministry of Public Health, Bangkok (Chareonsook et al., 1999).
We extend the previously studied non-seasonal model by adding seasonal forcing, mimicking
the vectorial dynamics, and a low import of infected individuals, which is realistic in the
dynamics of infectious diseases, in order to get a more realistic pattern of dengue fever
epidemics, with irregular, yearly and smooth outbreaks.
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Fig. 15. The state flow diagram for the seasonal multi-strain model. The transition rate μ
coming out of the class R represents the death rates of all classes,
S, I1, I2, R1, R2, S1, S2, I12, I21, R, getting into the class S as a birth rate.
The seasonal multi-strain model is represented in Fig. 15 by using a state flow diagram where
the boxes represent the disease related stages and the arrows indicate the transition rates. In
the same manner as described for the non-seasonal, the population is divided into ten classes,
with constant size N = S+ I1 + I2 + R1 + R2 + S1 + S2 + I12 + I21 + R. The complete system of
ordinary differential equations for the seasonal multi-strain epidemiological can be written as
shown in system (25), with the difference that now the parameter β takes the seasonal forcing
into account as a cosine function given explicitly by
β(t) = β0 · (1 + η · cos(ω · t)) , (30)
where β0 is the infection rate, and η is the degree of seasonality. In this model, a susceptible
individual can become infected also by meeting an infected individual from an external
population (hence (β/N · S · I) goes to (β/N · S · (I + ρ · N))) contributing to the force of
infection with an import parameter ρ.
The parameters are fixed, temporary cross immunity rate α = 2y−1, recovery rate γ = 52y−1,
infection rate β0 = 2 · γ, seasonality η = 0.35, import factor ρ = 10−10, birth and death rate
μ = 1/65y and the ratio of secondary infection contribution to the force of infection φ = 0.9.
In Fig. 16a) the time series simulation results for the total number of infected (I1 + I2 + I12 +
I21) in the non-seasonal system, previously studied in (Aguiar et al., 2008), is shown. Besides
showing an irregular pattern of outbreaks that happens every 5 years, the non-seasonal system
and its time series are not able to represent dengue fever epidemiology that is characterized
as a yearly cycle of incidences. By adding low seasonality into the system, the epidemic
outbreaks appear every year (see (Aguiar et al., 2011 a)). However, between two large
outbreaks there is a very low number of cases in subsequent years, which is also not data
alike. In Fig. 7c), the time series simulation in the high seasonal system with a low import
of infected contributing to the force of infection is shown. The addition of import into the
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Fig. 16. Time series simulations. In a) time series simulation for the non-seasonal model
(η = 0). In b) time series simulation for the seasonal model with a low import of infected.















Fig. 17. Bifurcation diagram for the seasonal model with import. Here, the degree of
seasonality η = 0.35 and the import factor ρ = 10−10.
seasonal system gives a much more realistic pattern of dengue fever epidemics, with irregular,
yearly and smooth outbreaks. The system has a reasonable size (the number of infected stays
quite away from zero), avoiding the chance of extinction in stochastic systems. For detailed
analysis on the attractors in state space for the seasonal model, see (Aguiar et al., 2011 a). The
bifurcation diagram for the seasonal model with import is shown in Fig. 17.
For the seasonal model with import AUTO predicted a torus bifurcation TR at φ = 0.13, and
at φ = 0.522 which are also predicted very well when comparing with the results given by
the Lyapunov exponent calculation. In the limiting case where the amplitude of the seasonal
forcing is zero, the torus bifurcation TR of the seasonally forced system coincides with the
Hopf bifurcation H of the non-seasonal system, as was shown in (Aguiar et al., 2011 a).

































































Fig. 18. Qualitative insight into the predictability in the monthly time series. In a) the
Lyapunov spectrum and in b) the time series for the non-seasonal model. In c) the Lyapunov
spectrum and in d) the time series for the seasonal model with import.
In Fig. 18 the Lyapunov spectrum for both non-seasonal model and the seasonal model with
import are shown and compared concerning the prediction horizon of the monthly peaks in
the multi-strain dengue model time series. We take as an example the Dominant Lyapunov
Exponent (DLE) for φ = 0.9 in the region where the system is chaotic (positive DLE). For
the non-seasonal system, the DLE = 0.04 giving around 25 years of prediction horizon in the
monthly time series (see Fig. 18b)), whereas for the seasonal system with import,the DLE=
0.118 giving around 8.5 years of prediction horizon in the monthly time series. It is clear that
the addition of seasonal forcing into the system by itself decreases the practical predictability,
however, the addition of a low import into the seasonally forced system helps to get a more
complex dynamics and a better prediction horizon in the monthly time series. In order to get
a qualitative insight into the predictability in the monthly sampled time series, i.e. to show
how the original system behaves under a small perturbation we plot two different trajectories
of the same system (for the non-seasonal model in Fig. 18b), and for the seasonal model with
import of infected in Fig. 18d)), where the perturbed system (black line) is compared with the
original model simulation (red line). To get the trajectory of the perturbed system, we keep
the last point of the transient of the original system and use those values as starting values to
compute the new and perturbed trajectory. The perturbation is given by Sp = S + R · � and
Rp = R · (1.0 − �), where Sp is the susceptibles perturbed and Rp is the recovered perturbed
with � = 0.001. (for details on the perturbed system see (Aguiar et al., 2011 a)).
The inspection of the available DHF incidence data in Thailand shows a smooth behavior with
a well defined maximum each year of irregular hight for the Northern Provinces.
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 Chiang Mai 
Fig. 19. Empirical DHF incidence data matched with the model simulation.
We take the Province of Chiang Mai as a case study where the empirical DHF incidence data
and the time series simulation for the seasonal model with import are compared (see Fig.
19)). The seasonal model with import shows complex dynamics and qualitatively a very good
result when comparing empirical DHF and simulations. However, the extended model needs
to be parametrized on data referring to incidence of severe disease.
5. Discussions
In this chapter we presented the properties of the basic SIR epidemic model for infectious
diseases with a summary of the analysis of the dynamics, identifying the thresholds and
equilibrium points in order to introduce notation, terminology. The results that were
generalized to more advanced models motivated by dengue fever epidemiology.
The epidemiology of dengue fever was described presenting the relevant biological features
that are taken into the modeling process. Then, multi-strain models previously described in
the literature were presented. We focused in a minimal model motivated by dengue fever
epidemiology, formulated first by Aguiar et al. (Aguiar & Stollenwerk, 2007), where the
notion of at least two different strains is needed to describe differences between primary
infections, often asymptomatic, and secondary infection, associated with the severe form of
the disease. We discussed the role of seasonal forcing and the import of infected individuals
in such systems, the biological relevance and its implications for the analysis of the available
dengue data. The extended model (Aguiar et al., 2011 a) shows complex dynamics and
qualitatively a good agreement between empirical DHF monitoring data and the obtained
model simulation. This suggests that the used parameter set can be the starting set for a
more detailed parameter estimation procedure. Such a technical parameter estimation is
notoriously difficult for chaotic time series but temporally local approaches are possible (He
et al., 2010; Ionides et al., 2006). At the moment only such minimalistic models have a chance
to be qualitatively understood well and eventually tested against existing data.
The introduction of stochasticity is needed to explain the fluctuations observed in some of
the available data sets, revealing a scenario where noise and complex deterministic skeleton
strongly interact (Aguiar et al., 2011 b). For large enough population size, the stochastic
system can be well described by the deterministic skeleton gaining insight into the relevant
parameter values purely on topological information of the dynamics, rather than classical
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parameter estimation of which application is in general restricted to fairly simple dynamical
scenarios.
6. Conclusions
Being able to predict future outbreaks of dengue in the absence of human interventions is a
major goal if one wants to understand the effects of control measures. Even after a dengue
virus vaccine has become accessible, this holds true for the implementation of a vaccination
program. For example, to perform a vaccine trial in a year with normally low numbers
of cases would make statistical tests of vaccine efficacy much more difficult than when it
was performed in a year with naturally high numbers of cases. Thus predictability of the
next season’s hight of the dengue peak on the basis of deterministic balance of infected and
susceptible would be of major practical use.
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1. Introduction 
DNA-containing polyomavirus SV40 was isolated in 1961 from poliovaccine prepared on 
kidney cell culture of M.mulatta naturally infected with this virus. Main part of 
poliovaccines (IPV and OPV) was contaminated with SV40. From 1955 till 1963 hundred 
millions of people in USA, Russia (USSR), and in some other countries were immunized 
with contaminated SV40 Salk and Sabin vaccine and a lot of people became carriers of SV40. 
This virus was detected also in some human tumors. Epidemiological researches were not 
carried out in Russia before 2009.  By present time possibility and ways of SV40 excretion 
into environment and possibility of its horizontal spreading is established. From the 
beginning of 60s (in Russia a little bit later) vaccines were free from SV40 contamination. In 
this article the data about SV40 infection of population in Moscow, St. Petersburg, in some 
cities of the Black Sea coast of Caucasus, in Novosibirsk and in one area of Krasnoyarsk 
region are presented., Analysis of the source of SV40 people infection is performed.  
Small size DNA virus was isolated from mice in 1953. The virus was called “polyomavirus” 
SV40 (Gross, 1951; Gross, 1953). because it was able to produce multiple malignant tumors 
in newborn rodents. 
Simian SV40 was the second discovered polyomavirus. It was isolated in 1961 from 
poliovaccine propagated on M.mulatta kidney cell cultures naturally infected with SV40 as 
it was established later (Eddy et al., 1961; Sweet & Hilleman, 1960). 
SV 40 is a small DNA virus which does not have envelope; its capsid consisted of 72 
capsomers. The size of virion is 45 nm; the viral genome is represented by two-stranded 
DNA aprox. 5000 bp long. On character of the changes caused in cell cultures, the virus also 
has received the name “vacuolating virus”(Sweet & Hilleman, 1960; Butel et al., 1999).  
During next years polyomaviruses were isolated from different animals including different 
monkey species and from humans with different pathology as well (Simon,2008; Gjoerup, 
2010; Voevodin, 2009).).  
In 1957 baboon polyomavirus was discovered (Gardner et al., 1989); polyovavirus of African 
green monkeys was discovered in 1979 (zur Hausen & Giosmann, 1979), after that 
polyomaviruses of M.fascicularis and chimpanzee were discovered (but not isolated). Two 
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region are presented., Analysis of the source of SV40 people infection is performed.  
Small size DNA virus was isolated from mice in 1953. The virus was called “polyomavirus” 
SV40 (Gross, 1951; Gross, 1953). because it was able to produce multiple malignant tumors 
in newborn rodents. 
Simian SV40 was the second discovered polyomavirus. It was isolated in 1961 from 
poliovaccine propagated on M.mulatta kidney cell cultures naturally infected with SV40 as 
it was established later (Eddy et al., 1961; Sweet & Hilleman, 1960). 
SV 40 is a small DNA virus which does not have envelope; its capsid consisted of 72 
capsomers. The size of virion is 45 nm; the viral genome is represented by two-stranded 
DNA aprox. 5000 bp long. On character of the changes caused in cell cultures, the virus also 
has received the name “vacuolating virus”(Sweet & Hilleman, 1960; Butel et al., 1999).  
During next years polyomaviruses were isolated from different animals including different 
monkey species and from humans with different pathology as well (Simon,2008; Gjoerup, 
2010; Voevodin, 2009).).  
In 1957 baboon polyomavirus was discovered (Gardner et al., 1989); polyovavirus of African 
green monkeys was discovered in 1979 (zur Hausen & Giosmann, 1979), after that 





human polyomaviruses BKV and JCV were firstly isolated in 1971: JCV from a patient with 
Progressive multifocal leukoencephalopathy (Padgett et al., 1971), BKV from patient with 
nephropathy (Gardner et al., 1971; Padgett et al., 1971). 
Later 3 more polyomaviruses were isolated: KI, Wu from respiratory tract and MCV from 
rare malignant skin tumor – Merkel carcinoma (Feng et al., 2008) 
Among human viruses such ubiquitous viruses as JCV and BKV are widely known and are 
determined from 60 to 90% of cases in humans according to data of different authors 
(Knowles et al., 2006; Maginnis & Atwood, 2009). 
However many publications often contradictory were associated with simian polyomavirus 
SV40. The virus was unintentionally introduced into human populations together with 
poliovaccine contaminated with SV40 as it turned out later (Shah, 2007). 
The middle 50s of the last century was marked by epoch-making event – creating of 2 types 
of poliovaccines: Salk formolvaccine (IPV) and live attenuated Sabin vaccine (OPV). More 
than 100 million people were immunized in USA beginning from 1956 till 1963 using the 
above mentioned 2 types of vaccines; more than 70 million people were immunized in 
Russia (USSR) in 1960 using Sabin vaccine (Fisher, 1999. Rizzo, 1999, Peden, 2008, Drozdov, 
2005, Mironova et al., 2006). Significant amount of predominantly young people were 
immunized in different European countries (Shah & Nathanson, 1976).  
It is necessary to look back to the history of poliovaccine creation by Salk and Sabin. Both 
vaccines (Salk inactivated formolvaccine and Sabin live attenuated vaccine) were poliovirus 
propagated on M. mulatta kidney cell culture. Soon it was shown that in high percent of 
cases M.mulatta had been already infected with SV40 in natural conditions (Sweet 
&Hilleman, 1960; Lapin et al., 1965). That is why many poliovaccine lots were contaminated 
with this virus. As it was found out later Salk method of vaccine preparation did not 
provide full inactivation of the vaccine (Carbone et al., 1997). As to the Sabin vaccine – it was 
initially contaminated with polyomavirus (Peden, 2008). 
Zoonotic SV40 origin perhaps is beyond doubt but some authors advance an opinion in 
their publications about preexisting of this virus in humans (Levine, 1998; Geissler, 1985; 
Paracchini, 2005). This assumption could be supported if SV40 (or DNA sequences of this 
virus or antibodies to it) could be reliably detected in human materials obtained before mass 
poliovaccination. Some publications contain information about detection the antibodies to 
SV40 before beginning the vaccination against poliomyelitis (Geissler, 1985). It can be 
supposed that the virus could be introduced into human population from the countries of 
monkey natural habitat (Southeast Asia and India). Serological investigations revealed SV40 
infection of Zoo workers and in workers of India companies exporting monkeys and 
contacting with animals. SV40 footprints were detected in their blood (Horvath, 1965; Engels 
et al., 2004; Shah, 1966). All this testifies the possibility of contact infection humans from 
animals carriers of the virus.(citation from: Vastad, JAMA, 2002, 288, 1337-1338). However 
the quantity of people infected with SV40 greatly increased particularly after beginning of 
mass poliovaccination which testifies this supposition.   
Thus mass vaccination of millions of people with poliovaccine which made it possible to 
eradicate poliomyelitis as an epidemic disease simultaneously led to infection of people 
with simian polyomavirus SV40. 
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In 1961 as it was mentioned above USA investigators revealed contamination of 
poliovaccine with simian (M.mulatta) virus SV40.   
Serological investigation and PCR revealed antibodies to SV40 and virus DNA sequences in 
polio immunized people. To the researcher’s surprise the antibodies to SV40 were also 
detected in not vaccinated people. In connection with this fact the researchers came out with 
a suggestion that in human populations virus can spread horizontally (Knowles et al., 2006) 
It has been shown that virus can excrete into surrounding with excrements, breast milk, 
sperm, that supports the assumption about the possibility of horizontal spreading of the 
virus (David, 2001; Martini, 1996; Vastag, 2002). 
Some investigators described discovery of polyomaviruses in sewage and in sea and river 
waters which undoubtedly could be the source of horizontal spreading of infection in 
regions with high SV40 prevalence (Vastag, 2002; Bofill-Mas et al., 2009).  
Appearance of people infected with SV40 after immunization with polio vaccine caused 
anxiety of physicians due to virus ability to induce malignant tumors in laboratory rodents. 
However absence of apparent increase of tumors in polio vaccinated people reduced the 
interest to SV40 in people. A new wave of anxiety and long lasting discussions continuing 
up to now was caused by discovery of DNA sequencing of SV40 in some human tumors. As 
a result great many contradictory publications appeared describing infection of people with 
this virus, its origin, ways of spreading and possible connection with human pathology 
(Carbone, 1994, 1997,1999; De Rizzo, 1998, 2001; Arrington, 2000; Tognon, 2001; 
Lednicky,2001; Bergsagel, 1992; Vilchez, 2002; Klein, 2002; Bocchetta, 2001; Lapin & 
Chikobava, 2011; Cutrone et al., 2005; Carter et al., 2003; Hübner R. & Van Marck E.2002; 
Martini et al., 1998; Barbanti-Brodane et al., 2004).   
Some researchers considered discovery of SV40 in human blood and in tumors as artifact 
(Shah, 1976; Lopez-Rios, 2004; Manfredi, 2005; Mayall, 2003, and many others). 
Disagreement was caused mainly by high homology of SV40 with ubiquitous human 
polyomaviruses JCV and BKV and consequently with their immunologic and molecular-
biological reactivity (Testa, 1998; Lopez-Rios, 2004; Heinsohn, 2005; Shah & Nathanson, 
1976; Shah, 2007; Carter et al., 2003). Some researchers denied infection people with SV40 
and believed that discovered antibodies and DNA sequencing belong to human 
polyomaviruses JCV and BKV.  
Because M.mulatta are carriers of polyomavirus SV40 in natural conditions WHO 
recommended to replace in manufacture poliovaccines kidneys of rhesus monkeys with 
kidneys of green monkeys not containing this virus. At the same time methods of vaccine 
decontamination were improved. It is possible to assert that in the period from 1960 till 1962 
poliovaccine produced by USA, Great Britain, and some other European countries was free 
from SV40 contamination. However by that period of time hundred millions of people had 
been already immunized with contaminated SV40 vaccine in USA, Russia (USSR) and many 
other countries. In Russia (USSR) that produced vaccine for own needs and also for export to 
east European countries and countries of southeast Asia clearing vaccine from contamination 
happened some years later Chumakov et al., 1961;Chumarjvet al., 1963; Scovranek, 1961)  
Vaccine produced in east countries was contaminated with SV40 till 1978 according to data 
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samples produced in different time in different countries. Authors of the publication note 
that method of heat inactivation of the vaccine in the presence of MgCl2 inactivated SV40 
not completely (Cutrone et al., 2005). 
Epidemiological investigations carried out in different countries revealed infection of 
population with SV40. K. Leithner et al (2005) in Fig 4 of their article published a schematic 
map demonstrating data on infection of population with SV40 in European countries where 
contaminated SV40 vaccine was used and afterwards SV40 infection of population was 
revealed and also those countries where contaminated vaccine was also used but the 
population was not examined for SV40 infection. Such countries were Russia, Ukraine, 
Byelorussia, and some East European countries in which vaccination was carried out with 
OPV Sabin vaccine perhaps produced in Russia (USSR).  
 
Fig. 1. Red color designates countries where contaminated SV40 vaccine was used and SV40 
carriers were discovered (continuous coloring does not mean degree of prevalence). Shaded 
area designates countries where contaminated vaccine was also used but people were not 
tested for SV40 carriers. (Leithner 2005). See also Table 1. 
Authors of this publication prepared a Table on the basis of literary data which helps to 
understand where the source of SV40 infection was.  
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Contaminated Russian vaccine (OPV) 
used since 1960 (Chumakov et al, 
1961;Chumakov et al, 1963; Shah & 
Nathanson, 1990; Levine et al, 1998). 
 
Mass vaccinations with SV40-free British 
vaccine (OPV) since winter 1961/62 
(Kundratitz, 1962; Friza, 1962) 
 
Contaminated Russian vaccine (OPV) 
used since 1960 (Chumakov et al, 1961; 
Chumakov et al, 1963; Shah & 
Nathanson, 1990; Levine et al, 1998). 
 
Since 1960: limited use of IPV, mass 
vaccinations with OPV, partly with 
contaminated Russian vaccine 
(Chumakov et al, 1961; Chumakov et al, 
1963; Shah & Nathanson, 1990; Levine et 
al, 1998; Skovranek,1961; Chron Wld 
Hlth Org, 1960) 
 
Vaccinations from 1955 with widely 
contaminated Danish vaccine (IPV), 
SV40-free from 1963 (Engels, 2003). A 
combined schedule was introduced in 
1968 (Murdin et al, 1996). 
 
Mass vaccinations since 1957 with SV40-
free Belgium vaccine (IPV) (Hirvonen, 
1999). Finland has never used OPV on a 
routine basis (Murdin et al, 1996) 
 
Contaminated Russian vaccine (OPV) 
used since 1960 (Geissler, 1983; 
Chumakov et al, 1963; Shah & Nathanson 
,1976; Prog Med Virol, 1990; Levine et 
al,1998, Belian & Rademacher, 1961). 
 
Since 1957: limited use of IPV, mass 
vaccinations with vaccines from the US, 
Canada, Hungary and Russia (also OPV) 
(Chumakov et al, 1963; Shah & 
Nathanson, 1976; Geissler, 1990; Levine 
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Vaccinations started 1956 with Danish 
vaccine (IPV); since 1957 potentially 
contaminated U.S.vaccine (IPV) (Thu et 
al, 2006), change to OPV from 1967 to 
1979, then back to IPV from 1979 
onwards (Murdin et al, 1996). 
 
Mass vaccinations (OPV) since 1958 with 
Koprowski strain live vaccine [94]; 
vaccine was claimed to be Russian made 
(Minor et al, 2003), but Russian vaccines 
were derived from Sabin's strain 
(Chumakov et al, 1961) 
 
Mass vaccinations since 1959 with 
contaminated Russian vaccine (OPV). A 
small proportion of persons were 
vaccinated with IPV at the beginning of 
the mass vaccinations (Chumakov et al, 
1961; Chumakov et al, 1963; Shah & 
Nathanson , 1976; Levine et al, 
1998;Chron Wld Hlth Org 1960). 
 
Mass vaccinations since 1963 with British 
vaccine (OPV) [101]; British vaccines 
were SV40-free since 1962 (Sangar et al, 
1999); in contrast some vaccines were 
later claimed to have been contaminated 
(De Sanjose et al, 2003). 
 
In 1957 potentially contaminated U.S. 
vaccine (IPV), from 1958 SV40-free 
Swedish vaccine (IPV). Sweden has 
never used OPV (Murdin et al, 1996) 
 
Vaccination was not started before 1970, 
at a time where polio vaccines were 
required to be SV40-free (De Rienzo et al, 
2002). The type of the vaccine is unclear. 
In a global poliomyelitis eradication 
initiative starting in 1989, OPV was used. 
 
Vaccination started in 1956 with OPV 
(Chron Wld Hlth Org, 1958; Chron Wld 
Hlth Org, 1960). SV40-free since 1962 
(Rev Sanid Hi Publica, 1965) 
 
Table 1. (Leithner, 2005) 
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We were aimed at carrying out epidemiological investigation and determining infection of 
population with polyomavirus SV40 in different regions of Russia and also determine 
intensity and source of infection. Investigation was carried out mainly anonymously. Each 
sample was accompanied with information about the place from where the sample was 
delivered, sex and age of the person.  
To determine SV40 infection of population in Russia we decided to determine virus DNA 
sequences in blood samples of persons of different sex and age delivered to us by different 
medical institutions from different regions of Russia. Investigation of biological samples for 
SV40 is rather difficult because standard PCR and immunological tests (IFA, western 
blotting) do not allow differentiation of SV40 from widely spread ubiquitous human 
polyomaviruses JCV and BKV which have cross-immunological and cross molecular-
biological-reactivity with SV40 (Viscidi, 2003). That is why for SV40 detection we chose the 
recommended method Real Time PCR (RQ-PCR) with TaqMan probe addressed to the area 
with 9-nucleotid deletion distinguishing SV40 from JVC and BKV.  
2. Methods 
For PCR analysis 100 ul of blood was put into a test tube containing EDTA and kept at 4o C 
until it was delivered to the laboratory for DNA extraction. After extraction DNA samples 
were kept at -20o C. 
Genome of SV40 can be present in the cell in 2 forms: episomal or integrated into genome of 
host cell. Because of few SV40 copies in the sample the best method allowing detecting 
episomal forms of SV40 DNA in RQ-PCR are methods based on DNA sorption by SiO2. That 
is why we used modified GuSCN protocol (Boom et al., 1992, Testa et al., 1998) for 
extraction of DNA from whole blood. 
Three hundreds microliters of solution containing 5 M GuSCN,1% Triton X-100(v/v), 20 
mM EDTA, 50 mM Tris-HCl (pH 6,4), 10 ul SiO2 was added to the blood sample (100 ul) and 
incubated 15 min, centrifugated and the sediment was washed once in 5 M GuSCN, 50 mM 
Tris-HCl (pH 6,4) and twice in 10 mM Tris-HCl (pH 7,3), 50 mM NaCl, 50% ethanol. The 
sample was desiccated in thermostat and DNA was eluted by TE-buffer (10 mM Tris-HCl 
(pH 8,0), 1Mm EDTA). For PCR amplification 5 ul were used. Rest was kept at -20o C. 
As it was mentioned above SV40 detection was carried out by RQ-PCR method with 
internal probe directed to SV40 genome region in 4517 position, characterized by deletion of 
9 nucleotides distinguishing SV40 from viruses JCV and BKV. PCR was carried out on 
BioRad Thermocycler according to the following program: 5 min initial denaturation, then 8 
sec at 94oC, 23 sec at 60oC, 30 sec at 72oC, during 50 cycles. DNA extracted from M.mulatta 
blood was used as positive control. Water 5 ul from opened test tube kept together with 
extracted DNA samples was used as negative control.  
3. Results 
In total 768 blood samples obtained from different cities and regions of Russian Federation 
(St. Petersburg - 56, Moscow – 50, Krasnodar region – 352, Novosibirsk – 108, Krasnoyarsk 
region – 202) have been investigated by RQ-PCR. Results of these investigations are 
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Because this investigation revealed a rather high number of SV40 carriers in Krasnodar 
region we decided to check the situation in Sochi and Adler (Table 3). 
 
Region Number of samples 
Number of SV40 positive 
Absolute  number % 
Sochi 102 44 43 
Adler 150 48 32 
Table 3. 
To confirm the results of RQ PCR, and prepare amplicons for sequencing another sets 
(SV5/SV6) of primers directed to conservative region 173-bp length of SV40 T-ag were used. 
These PCR primers amplify a region of SV40 that could be distinguished from BK and JC 
viral DNA. (Testa et al. 1998).  
 
Fig. 2. 
The ethidium bromide-stained 2.5% agarose gel shows the PCR products of 9 blood 
samples, some of which are SV40 positive. N10(-) control (water), 11 (+) control (DNA 
extracted from blood of SV40+ positive M. mulatta). 
The obtained samples were sequenced on a ABI Prism 377 sequenator. Result of sequencing 
confirmed belonging of amplified regions to SV40. 
We believe that the results can be corrected both towards the increase and towards 
reduction on the basis of age, sex and other factor analyzes of representative groups. 
Nevertheless obtained material allows drawing some conclusions. High percent of SV40 
infected children in Sochi and Krasnodar region at the age of 10 years who were immunized 
with poliovaccine reliably free from contamination with this virus definitely testifies 
horizontal way of contamination. 
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Numerous publications are devoted to polyomavirus problem and a great part of them to 
SV40 problem: reliability or unauthenticity of SV40 detection in healthy people, in human 
neoplasm, SV40 role in tumor emergence, SV40 origin and ways of spreading are  discussed. 
In a great degree a lot of publications are connected with scandalous character of the 
problem – SV40 introduction into human population during immunization against 
poliomyelitis.  
Despite the fact that preparing vaccines on rhesus kidney cell cultures was stopped about  
30 years ago SV40 carrying is still determined in high percent of cases in healthy  
persons and also in some malignant human neoplasm (brain tumors, mesotheliomas, 
osteosarcomas etc.). 
Polyomavirus SV40 has been detected practically on all continents (Fig. 2). After 
introduction it into human population it should be considered as human virus – man has 
become its reservoir. The virus circulates among people, spreading horizontally, excretes 
into surrounding, pollutes it and this is perhaps a very important factor of its 
epidemiology.  
 
Fig. 3. SV40 infection of population was discovered on all Continents. Black color designates 
countries where SV40 carriers were discovered. However it does not mean the prevalence of 
SV40 infection. 
4. Сonclusion 
In this article data on analysis of SV40 polyomavirus contamination of population in some 
regions of Russia are presented. Infection was detected by PCR in real time (RQ-PCR) with 
TaqMan probe directed to the site of 9 nucleotide deletion distinguishing SV40 from 
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with Sabin OPV vaccine contaminated with SV40. Virus SV40 was detected in archive 
vaccine samples produced in East European countries before 1978 because heating with 
MgCl2 did not free the vaccine from SV40 contamination. Infection rate was investigated in 5 
Russian regions: Russia (Moscow, St. Petersburg, cities of the Black Sea coast, Novosibirsk 
and Krasnoyarsk region).  
The highest values were detected on the Black Sea and the lowest in St. Petersburg. Presence 
of SV40 in children vaccinated with reliably decontaminated vaccine confirms possibility of 
horizontal spreading of the virus. According to reference data contamination of population 
was revealed on all Continents.    
Despite the fact that preparing polio vaccine on culture of M.mulatta kidney cells was 
stopped 30 years ago SV40 carriage still exists in healthy people in rather high percent and 
also in human malignant neoplasms practically in all countries, on all Continents (Basetse, 
2002; Leithner et al., 2006; Minor et al., 2003; Zekri et al., 2007; Dang-Tan et al., 2004). 
Polyomavirus SV40 was introduced into human population and should be considered as 
human virus. Man has become its reservoir. The virus circulates among people, spreads 
horizontally, excretes into environment and pollutes it and this is an important factor in its 
epidemiology.    
Perhaps true value of SV40 prevalence in different regions can be established at examination 
of randomized groups generated on age, sex, place of residing, conditions of life and 
cultural skills. 
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Mycobacterium bovis is the main etiological agent of bovine tuberculosis, infecting many 
species of wild and domestic mammals and also man. Bovine tuberculosis is a chronic and 
contagious infectious disease that has been reported to infect wild ungulates, carnivores, 
marsupials and primates (de Lisle et al., 2002). Bovine tuberculosis (bTB) also occurs 
worldwide in livestock (Humblet et al., 2009), causing annual economic losses estimated at 3 
billion USD in 1995 (Steele, 1995). It remains a serious risk for animal health, and a threat for 
human health in many developing countries (Etter et al., 2006). Several countries 
successfully eradicated bovine tuberculosis in livestock through test-and-slaughter and/or 
abattoir surveillance programs. Yet other countries, using similar strategies, did not achieve 
eradication and some even face the re-emergence of the disease (Schiller et al., 2010). In 
Europe for instance, the prevalence of bTB in cattle is increasing in several countries 
(Gordejo & Vermeersch, 2006). Moreover current eradication and control programs in 
livestock in Europe are facing a range of challenges as stamping out is becoming a less 
attractive option for economic and environmental reasons and due to animal welfare 
concerns (Whiting, 2003).  
Some of the abovementioned difficulties in eradicating bTB in cattle may relate with the 
occurrence of the disease in wildlife (Schiller et al., 2010). In fact it has been demonstrated 
that the complete elimination of bTB can be extremely complicated by persistent infection 
of wild hosts, such as badgers in the United Kingdom, white tailed deer in the United 
States and brushtail possum in New Zealand (Corner, 2006). The single successful 
example of bTB eradication in a wildlife host is the Australian case, where it was 
accomplished through stamping out, which eliminated introduced water buffalo Bubalus 
arnee, the only maintenance host in that ecosystem, (Corner, 2006). This is not an option 
when autochthonous, protected or economic and socially valuable species are involved 
(Artois et al., 2001). In most cases, an integrated control program is needed (Horan et al., 
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2008), but this is often hampered by the lack of epidemiological data (Artois et al., 2001; 
Corner, 2006). 
Bovine tuberculosis control programs in cattle are in place for several decades in Iberian 
Peninsula and consequently incidence has been decreasing (Allepuz et al., 2011; Cunha et al., 
2011). However in the last few years incidence has stabilized, or even slightly increased in 
both Portugal and Spain (Allepuz et al., 2011; Cunha et al., 2011). The role of wildlife hosts in 
this scenario remains speculative; nevertheless the existence of wildlife reservoirs may 
compromise the goal of eradication in cattle. Besides livestock, attention should be given to 
spill-over from wildlife to other domestic animals (e.g. goats and free-ranging pigs) and 
even to humans, namely hunters and others that handle wild ungulate carcasses (Gortazar et 
al., 2011b, in press). Wildlife-to-human transmission of M. bovis is hard to prove and no 
single case has been documented in Iberian Peninsula, but it is known to occur elsewhere 
(e.g. USA – Wilkins et al., 2008). Bovine tuberculosis is also one of the main infectious 
diseases affecting the critically endangered Iberian lynx Lynx pardinus, with several free-
ranging and captive lynx killed by this infection (Millán et al., 2009). Iberian lynx is subject to 
an intensive multinational conservation program in Iberian Peninsula, which includes 
releasing captive-bred animals to former range. The persistence of M. bovis on the environment 
and in prey species poses a threat to this conservation action (Millán et al., 2009). 
Iberian Peninsula ecosystems display a high degree of human intervention and have 
experienced some profound changes in the last decades. The most important alterations 
were a shift from domestic ungulate to wild ungulate production for hunting purposes 
(Miguel et al. 1999) and an increasing intensification of the later (Vargas et al. 1995). This 
management of wild ungulate populations aims to increase profits by increasing harvest, 
translating into increased densities of hunted species. This has been accomplished through 
introduction/restocking, provision of food and water (mostly during the summer shortage), 
fencing and sometimes even medication (Miguel et al. 1999, Gortázar et al., 2006). All these 
changes have potential implications on bTB epidemiology (Gortázar et al., 2006). 
In the Iberian Peninsula, ungulates such as the wild boar Sus scrofa and the red deer Cervus 
elaphus have been recognized as the most important maintenance hosts for wildlife 
tuberculosis (Gortázar et al., 2011b). Nevertheless other species have also been identified as 
locally non-negligible hosts, such as the fallow deer Dama dama and the badger Meles meles 
(Gortázar et al., 2011b; Balseiro et al., 2011). Several other species of ungulates and carnivores 
were also found infected (Rodriguez et al., 2010). This situation fits the definition of a multi-
host pathogen within a multi-species ecosystem (Renwick et al., 2007; Gortázar et al., in 
press), in which pathogen persistence and spread is dependent on the density of each 
maintenance host species and also on the effective interspecies contact rate (dependent on 
the ecology of each species).  
Research on host-pathogen interaction usually deals with single-host single-pathogen 
systems, where disease persistence depends solely on the intra-species transmission rate 
(Tompkins et al., 2001). If transmission is density-dependent, then population thresholds for 
disease invasion and persistence are expected and have been described (Swinton et al., 2001). 
By contrast, in multi-host pathogens systems, disease persistence is dependent on both intra 
and inter-species transmission rates and densities of several host species (Renwick et al., 
2007). Moreover, these rates depend on pathological, epidemiological, ecological and 
behavioural factors (Corner, 2006). 
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In such a complex epidemiological setting, it is imperative to determine the precise role of 
each host species in pathogen maintenance before comprehensive control measures are 
undertaken. Much has been investigated in the last decade regarding wildlife tuberculosis 
epidemiology in Iberian Peninsula. In order to contribute to understanding the 
mechanisms underlying wildlife tuberculosis persistence in the multi-host ecosystems of 
this region, under widely different ecological and management pressures, we report a 
systematic bibliographic review on this subject. The aim of this review was to survey the 
peer-reviewed literature for evidence of the: i) epidemiological status of each host species; 
ii) determinants of wildlife tuberculosis occurrence; iii) geographical structuring of 
wildlife tuberculosis in the Iberian Peninsula; iv) time trends in wildlife tuberculosis 
occurrence. 
2. Methods 
We conducted a systematic bibliographic review for epidemiological studies on tuberculosis 
in wildlife in Iberian Peninsula by searching MEDLINE/PubMed, up to the 31st of August 
2011, using MeSH and keywords: “Mycobacterium bovis”, “Mycobacterium caprae”, “wild 
boar”, “deer”, “epidemiology”, “Iberian Peninsula”, “Portugal” and “Spain”. Combinations 
used were: (“Portugal” OR “Spain”) AND ("Mycobacterium bovis" OR “Mycobacterium 
caprae”), ("Mycobacterium bovis" OR “Mycobacterium caprae”) AND “wild boar” AND 
“epidemiology” and ("Mycobacterium bovis" OR “Mycobacterium caprae”) AND “deer” AND 
“epidemiology”. Abstracts were selected according to their relevancy and excluded if 
dealing exclusively with laboratory or pathology investigations, domestic species or humans 
or other geographical regions. Articles were reviewed in full text. 
For each article, information about the type of epidemiological study and study design, 
sample size and sampling methodology, screening and diagnostic tests used, prevalence 
rate, time frame of the study, study areas, characteristics of the populations studied, risk 
factors identified and host epidemiological status was summarized and presented in table 
format for easy comparison. Due to their idiosyncrasies, molecular epidemiology articles 
were characterized differently according to the number of isolates studied, genotyping 
technique, mycobacterial species reported, number of genotypes found, host and 
geographical clustering of genotypes and study areas. Due to differing methodologies and 
sometimes incomplete reporting of results, meta-analysis was not applicable except for a 
small number of studies. 
For the purpose of this review, wildlife tuberculosis was defined according to the OIE 
definition of bovine tuberculosis, but Mycobacterium caprae was also considered etiological 
agent, besides M. bovis.  
3. Results 
The bibliographic search yielded 286 articles. Initially, title and abstracts were reviewed and 
247 articles excluded because they deal only with laboratory/pathology investigations 
(n=74), domestic animals (n=41), humans (n=50), other geographical regions (n=79), or were 
review/model articles (n=3). Full text papers were then reviewed and further 6 papers were 
excluded because they focused exclusively on laboratory/pathology investigations. 
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were a shift from domestic ungulate to wild ungulate production for hunting purposes 
(Miguel et al. 1999) and an increasing intensification of the later (Vargas et al. 1995). This 
management of wild ungulate populations aims to increase profits by increasing harvest, 
translating into increased densities of hunted species. This has been accomplished through 
introduction/restocking, provision of food and water (mostly during the summer shortage), 
fencing and sometimes even medication (Miguel et al. 1999, Gortázar et al., 2006). All these 
changes have potential implications on bTB epidemiology (Gortázar et al., 2006). 
In the Iberian Peninsula, ungulates such as the wild boar Sus scrofa and the red deer Cervus 
elaphus have been recognized as the most important maintenance hosts for wildlife 
tuberculosis (Gortázar et al., 2011b). Nevertheless other species have also been identified as 
locally non-negligible hosts, such as the fallow deer Dama dama and the badger Meles meles 
(Gortázar et al., 2011b; Balseiro et al., 2011). Several other species of ungulates and carnivores 
were also found infected (Rodriguez et al., 2010). This situation fits the definition of a multi-
host pathogen within a multi-species ecosystem (Renwick et al., 2007; Gortázar et al., in 
press), in which pathogen persistence and spread is dependent on the density of each 
maintenance host species and also on the effective interspecies contact rate (dependent on 
the ecology of each species).  
Research on host-pathogen interaction usually deals with single-host single-pathogen 
systems, where disease persistence depends solely on the intra-species transmission rate 
(Tompkins et al., 2001). If transmission is density-dependent, then population thresholds for 
disease invasion and persistence are expected and have been described (Swinton et al., 2001). 
By contrast, in multi-host pathogens systems, disease persistence is dependent on both intra 
and inter-species transmission rates and densities of several host species (Renwick et al., 
2007). Moreover, these rates depend on pathological, epidemiological, ecological and 
behavioural factors (Corner, 2006). 
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In such a complex epidemiological setting, it is imperative to determine the precise role of 
each host species in pathogen maintenance before comprehensive control measures are 
undertaken. Much has been investigated in the last decade regarding wildlife tuberculosis 
epidemiology in Iberian Peninsula. In order to contribute to understanding the 
mechanisms underlying wildlife tuberculosis persistence in the multi-host ecosystems of 
this region, under widely different ecological and management pressures, we report a 
systematic bibliographic review on this subject. The aim of this review was to survey the 
peer-reviewed literature for evidence of the: i) epidemiological status of each host species; 
ii) determinants of wildlife tuberculosis occurrence; iii) geographical structuring of 
wildlife tuberculosis in the Iberian Peninsula; iv) time trends in wildlife tuberculosis 
occurrence. 
2. Methods 
We conducted a systematic bibliographic review for epidemiological studies on tuberculosis 
in wildlife in Iberian Peninsula by searching MEDLINE/PubMed, up to the 31st of August 
2011, using MeSH and keywords: “Mycobacterium bovis”, “Mycobacterium caprae”, “wild 
boar”, “deer”, “epidemiology”, “Iberian Peninsula”, “Portugal” and “Spain”. Combinations 
used were: (“Portugal” OR “Spain”) AND ("Mycobacterium bovis" OR “Mycobacterium 
caprae”), ("Mycobacterium bovis" OR “Mycobacterium caprae”) AND “wild boar” AND 
“epidemiology” and ("Mycobacterium bovis" OR “Mycobacterium caprae”) AND “deer” AND 
“epidemiology”. Abstracts were selected according to their relevancy and excluded if 
dealing exclusively with laboratory or pathology investigations, domestic species or humans 
or other geographical regions. Articles were reviewed in full text. 
For each article, information about the type of epidemiological study and study design, 
sample size and sampling methodology, screening and diagnostic tests used, prevalence 
rate, time frame of the study, study areas, characteristics of the populations studied, risk 
factors identified and host epidemiological status was summarized and presented in table 
format for easy comparison. Due to their idiosyncrasies, molecular epidemiology articles 
were characterized differently according to the number of isolates studied, genotyping 
technique, mycobacterial species reported, number of genotypes found, host and 
geographical clustering of genotypes and study areas. Due to differing methodologies and 
sometimes incomplete reporting of results, meta-analysis was not applicable except for a 
small number of studies. 
For the purpose of this review, wildlife tuberculosis was defined according to the OIE 
definition of bovine tuberculosis, but Mycobacterium caprae was also considered etiological 
agent, besides M. bovis.  
3. Results 
The bibliographic search yielded 286 articles. Initially, title and abstracts were reviewed and 
247 articles excluded because they deal only with laboratory/pathology investigations 
(n=74), domestic animals (n=41), humans (n=50), other geographical regions (n=79), or were 
review/model articles (n=3). Full text papers were then reviewed and further 6 papers were 
excluded because they focused exclusively on laboratory/pathology investigations. 
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Table 1. Studies dealing with wild boar included in the analysis. Classification: SU – survey; 
CS - cross sectional study; CC – case-control study; Screening/diagnostic test: MI – official 
meat inspection scheme; GP – gross pathology; BC – bacteriological culture; SE – serology; 
Fencing: FR – free-ranging populations; FE – fenced populations; MX – mixed free-ranging 
and fenced populations. 
3.1 Characterization of published articles 
Investigation of bTB epidemiology in wild boar and red deer (most often studied hosts) are 
mostly cross-sectional (11/14), the rest being surveys (Tables 1-2). Most studies opt for 
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targeted surveillance on hunted (6/14) or culled (3/14) animals, the rest relying on scanning 
surveillance in routine meat inspection schemes for detection of macroscopic lesions-like 
lesions (Table 1-2). The mean number of animals studied in targeted-design studies is 278 
for wild boar (n=9, range 96-1.060) and 401 for red deer (n=6, range 95-1.368). Thirteen out 
of fourteen studies use bacteriological culture as the diagnostic test. Nevertheless most of 
them (9/14) also include a previous screening test (usually gross pathology or routine meat 
inspection schemes), followed by bacteriological culture when macroscopic lesions were 
observed (Table 1-2). 
As regards studies on other host species (ungulates and carnivores), 5/14 are case reports, 
6/14 surveys while 3/14 are cross sectional studies (Table 3). Five out of twelve studies 
rely on passive surveillance of haphazardly found carcasses and 3/12 on targeted 
surveillance of purposefully trapped animals. Most of these studies deal with carnivore 
species. As expected regarding novel host species, 3/12 studies are case reports (Table 3). 
Mean number of animals studied in survey studies is 105 for fallow deer (n=4, range 89-
134), 63 for badger (n=3, range 2-157) and 15 for Iberian lynx (n=5, range 1-39). Most other 
species (Table 5) are dealt in single studies, usually as case reports. Serologic tests were 
used in 3/9 studies investigating other host species, such as Barbary sheep and carnivores 
(Table 3). 
3.2 Prevalence rates 
For the wild boar populations surveyed by targeted-design studies using bacteriological 
culture as diagnostic test on all animals (n=6), prevalence rates ranged 0,11-0,53, with a meta 
prevalence rate of 0,36 (Table 5). Including all studies, regardless of design, prevalence rates 
ranged 0,18-1 (Table 1). For the red deer populations surveyed by targeted-design studies 
using bacteriological culture as diagnostic test on all animals samples (n=3), prevalence rates 
ranged 0,02-0,27, with a meta prevalence rate of 0,21 (Table 5). Including all studies, 
regardless of design, prevalence rates ranged 0,01-0,44 (Table 2). For the fallow deer 
populations surveyed by targeted-design studies using bacteriological culture as diagnostic 
test on all animals samples (n=4), prevalence rates ranged 0,13-0,67, with a meta prevalence 
rate of 0,28 (Table 5). For other host species, the sample size and/or the study design do not 
allow meta analysis. 
3.3 Trends 
Few studies address or allow addressing the time trend of bTB prevalence rates. In Doñana, 
bTB was not detected in targeted wildlife health surveillance until 1990’s, when the 
population of cattle greatly increased, while in 2000’s high prevalence rates were found in 
all ungulate species (Gortázar et al., 2008). In fact, prevalence rates in this area increased 
from 1998-2003 to 2006-2007 by 100% in wild boar and 50% in red deer (Gortázar et al., 
2011b). In Extremadura region, West-central Spain, prevalence rates detected in routine 
meat inspection schemes steadily raised from 1994-2004, while not detected in 1992-1993 (de 
Mendonza et al., 2006). One study area in South-eastern Portugal showed an increase in M. 
bovis infection rates in wild boar from 0,46 in 2005/06 (Santos et al., 2009) to 0,78 in 2009/11 
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Table 2. Studies dealing with red deer included in the analysis. Classification: SU – survey; 
CS - cross sectional study; CC – case-control study; Screening/diagnostic test: MI – official 
meat inspection scheme; GP – gross pathology; BC – bacteriological culture; SE – serology; 
Fencing: FR – free-ranging populations; FE – fenced populations; MX – mixed free-ranging 
and fenced populations. 
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Fig. 1. Map displaying reported prevalence rates for bTB in the wild boar by administrative 
divisions of Iberian Peninsula (provinces in Spain, districts in Portugal). Bacteriological 
culture data (Aranaz et al., 2004; de Mendoza et al., 2006; Vicente et al., 2006a; Gortázar et al., 
2008; Santos et al., 2009; Pinto et al., 2011) and serology data (Boadella et al., 2011; Santos et 
al., unpublished data) combined. The highest recorded prevalence for each administrative 
division is shown. 
Again, few published articles address or allow addressing the geographical trend in bTB 
prevalence rates. In South-central Spain, an area roughly corresponding to Sierra Morena 
and Montes de Toledo was shown to have high prevalence rates, which declined towards 
the periphery of the area (Vicente et al., 2006a). In Doñana, wild boar and red deer show an 
increasing South-North gradient in prevalence rates (Gortázar et al., 2008). In Portugal, bTB 
was not detected in western regions, while present in the eastern portion of the country 
(Santos et al., 2009). Also in Eastern-central Portugal, wild boar and red deer populations 
show an increasing North-South gradient in prevalence rates (Pinto et al., 2011). In South-
central Spain, lack of geographical autocorrelation in prevalence rates was reported (Vicente 
et al., 2006b). 
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3.4 Determinant factors of disease 
Several risk and protective factors for bTB in both wild boar and red deer have been 
identified (Table 4). Most of the identified risk factors relate to host and other sympatric 
host’s population factors, but also to environmental, management and historical factors. On 
the other hand, protective factors are mainly associated with environmental variables (Table 
4). Notably, only one study has identified fencing, feeding and watering of wild ungulate 
populations as risk factors. 
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Table 4. Determinant factors of bTB occurrence identified in wild boar and red deer 
epidemiological studies in the Iberian Peninsula. 
3.5 Host epidemiological status 
Wild boar and red deer are usually considered maintenance hosts in Iberian Peninsula and 
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characterization of populations maintaining high bTB prevalence rates despite long-term 
lack of contacts with cattle. Fallow deer, Barbary sheep and badger are also discussed as 
possible maintenance hosts, while all other reported hosts are considered spillover. Wild 
boar, red and fallow deer have been suggested as possible reservoirs of infection for 
livestock. 
3.6 Molecular epidemiology 
The most commonly identified causative agent of bTB in Iberian Peninsula has been M. 
bovis, although a small proportion (0,05, n=829) of Mycobacterium caprae was reported in 
6/15 studies. M. caprae is much more frequent among isolates from wild boar (0,08, n=502) 
than from red deer (0,01, n=327). Mycobacterium avium-complex mycobacteria and other 
mycobacteria have also been isolated from wild hosts, but they fall out of the scope of the 
present review. Molecular epidemiology studies rely mostly on spoligotyping (14/15), 
usually coupled with MIRU-VNTR typing (9/15) (Table 6). 
4. Discussion 
4.1 Characterization of published articles 
Most epidemiological studies on wild boar or red deer are cross-sectional, allowing for  
the estimation of prevalence rates and simultaneously the identification of risk or protective 
factors. A few of the earliest studies were surveys; also classified as such were  
some molecular epidemiology articles that allow calculating prevalence rates. As knowledge 
of bTB on other species is more recent, a larger proportion of these studies are case  
reports and surveys. A comparatively large number of studies address molecular 
epidemiology. 
Notably absent from the literature are case-control studies, which could shed light on the 
importance of specific determinants of disease, such as fencing and provision of feed and 
water. The same should be mentioned for experimental studies, were exposure to a certain 
determinant of disease is manipulated and the effect on disease occurrence is then 
measured. This design could be of great help to ascertain the role of each species in the 
persistence of bTB, trough manipulation of host density. The same can be said for 
epidemiological modelling, which could provide a theoretical framework for understanding 
bTB persistence in Iberian Peninsula and test the effect of different control measures 
(Thrushfield et al., 1995) and also to identify key data on host populations and wildlife 
tuberculosis that is missing or that is not feasible or up to date.  
Most articles resort to targeted surveillance of hunted or culled animals, which allows 
prevalence estimation. Culling is expected to be less sex and age-biased than recreational 
hunting, which focuses on specific age (adults) and sex (males) classes. The hunting method 
used for harvesting the animals (drive hunts) is less selective than trophy hunting, allowing 
access also to females and juvenile/subadult animals (Fernández-Llario & Mateos-Quesada, 
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exclusive) 
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2 spoligotypes sheep, pig (none) 
Spain 
Table 6. Molecular biology studies included in the analysis. SP: spoligotyping, MV: MIRU-
VNTR mycobacterial interspersed repetitive units-variable number of tandem repeats. 
On the other hand, studies of wild ungulates relying on routine meat inspection for 
detection of macroscopic tuberculosis-like lesions, do not allow for a reliable estimation of 
prevalence, which is underestimated in this situation (de Mendonza et al., 2006). 
Nevertheless this type of design allows increasing sample size, which makes them suited for 
long-term surveillance rather than detailed epidemiological studies (de Mendonza et al., 
2006) and were mostly used in the first surveys and cross-sectional studies after bTB was 
detected in wildlife in Iberian Peninsula. The investigations on carnivore species, most of 
which are not hunted, tend to rely on passive surveillance schemes based on haphazardly 
found carcasses. This sampling design does not allow to estimate prevalence rates due to 
extensive sampling bias (e.g. Taylor et al., 2002). Targeted sampling in these species has been 
attempted using serological tests but results should be interpreted with caution since these 
techniques have not yet been validated in these species. 
The number of animals studied is usually adequate to determine prevalence rates with 
relatively small confidence intervals, at least in the easily available hunted species. The same 
cannot be said for most studies on protected carnivore species, where the collection of 
biological samples from a large number of animals is inherently difficult. 
Bacteriological culture is the reference test for diagnosing bTB although it is expensive and 
time-consuming (de Lisle et al., 2002). As the financial resources needed to perform 
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long-term surveillance rather than detailed epidemiological studies (de Mendonza et al., 
2006) and were mostly used in the first surveys and cross-sectional studies after bTB was 
detected in wildlife in Iberian Peninsula. The investigations on carnivore species, most of 
which are not hunted, tend to rely on passive surveillance schemes based on haphazardly 
found carcasses. This sampling design does not allow to estimate prevalence rates due to 
extensive sampling bias (e.g. Taylor et al., 2002). Targeted sampling in these species has been 
attempted using serological tests but results should be interpreted with caution since these 
techniques have not yet been validated in these species. 
The number of animals studied is usually adequate to determine prevalence rates with 
relatively small confidence intervals, at least in the easily available hunted species. The same 
cannot be said for most studies on protected carnivore species, where the collection of 
biological samples from a large number of animals is inherently difficult. 
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other methods (usually gross pathology) as screening tests and only perform bacteriological 
culture for lesion-positive animals, sometimes as pooled samples. This introduces a bias and 
it was shown that the sensitivity of gross pathology was 72,2% of that obtained from 
bacteriology in the wild boar (Santos et al., 2010). The same trend has been reported 
elsewhere for deer (Rohonczy et al., 1996; O’Brien et al., 2004). 
4.2 Prevalence rates 
Overall prevalence rates reported for bTB in wild boar, red deer and fallow deer in Iberian 
Peninsula are among the highest recorded for these species worldwide (Corner, 2006; Nishi 
et al.; 2006, Wilson et al., 2008). Interestingly, prevalence rates in wild boar are invariably 
higher than in sympatric red or fallow deer (Gortázar et al., in press). 
Most studies report no sex differences in infection rates, but Santos et al. (2009) reported a 
significantly higher infection rate in female wild boar, presumably linked to more frequent 
social behaviour of females compared to males. Several studies report age differences in 
infection rates in wild boar, but data is conflicting since some authors reported increasing 
prevalence rates with age (e.g. Vicente et al., 2006a,b), while others found higher prevalence 
rate in juveniles (e.g. Gortázar et al., 2008; Santos et al., 2009). Age and sex differences in 
prevalence rates were also reported in red deer (Vicente et al., 2006a), which were higher for 
males and increased with age. This gender difference was already reported for cervids in 
North America (O’Brien et al., 2006). 
4.3 Trends 
The few published data about the temporal dynamics of bTB prevalence rates are 
unanimous in showing an increasing trend across Iberian Peninsula in both wild boar and 
red deer (de Mendonza et al., 2006; Gortázar et al., 2008, 2011b, in press; Santos et al., 2009, 
unpublished data). Gortázar et al., (2011b) recently reported that 11/14 wild ungulate 
populations from central Spain show increasing bTB prevalence rates as assessed by gross 
pathology. This strongly supports previous interpretations that bTB is an emerging disease 
in wildlife in Iberian Peninsula. 
The highest prevalence rates for bTB reported in wild ungulates in Iberian Peninsula lie in 
the central-south-western mountain chains of Montes de Toledo-Sierra Morena-Contenda 
(e.g. Vicente et al., 2006a; Santos et al., 2009) and Doñana (Gortázar et al., 2008). Prevalence 
rates decline to the periphery of this region; the detected limits of this bTB core area are the 
provinces of Cáceres/Ávila to the north, eastern Portugal to the West, the Mediterranean 
coast to the South and Teruel to the East. bTB has not been detected or only sporadically in 
the northern, western and eastern periphery of Iberian Peninsula, despite locally intense 
surveillance (Gortázar et al., 2011b). This pattern, coupled with the abovementioned increase 
in prevalence over time, strongly suggests that the disease is expanding from the central 
core area. 
Interestingly, this core region of high bTB prevalence rates coincides with the main historical 
refuge of the wild boar in Spain (Tellería & Saez-Royuela, 1985) and, to some extent, in 
Portugal (Lopes & Borges, 2004). In the beginning of the XXth century, Iberian populations of 
wild ungulates were at their lowest level due to intense direct persecution and were largely 
restricted to a few mountain regions. Starting in 1960’s, wild boar populations expanded 
from these refuges (Tellería & Saez-Royuela, 1985; Acevedo et al., 2011) to a point they 
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nowadays occupy almost all Iberian Peninsula (Rosell, 2001). Natural expansion of red deer 
also occurred but not to such a great extent as in the wild boar case and was much 
dependent upon translocations (Soriguer, 1998; Acevedo et al., 2011). 
As suggested by Santos et al. (2009) for Portugal, wildlife bTB could be similarly expanding 
from the historical refuges with a lag comparative to its host’s expansion. This lag could be 
explained by the threshold theory for disease persistence, as reported for other bTB hosts 
such as the possum Trichosurus vulpecula in New Zealand – Lloyd-Smith et al., 2005). As wild 
ungulate populations expanded, densities at the front of the expansion wave were too low 
(Holland et al., 2007) to allow for the persistence of bTB, even if presumably some infected 
hosts were involved in that expansion event. As a consequence, wildlife bTB initially 
remained confined to the historical refuges, despite dispersion of infected hosts. As ungulate 
distribution continued to expand, densities increased in a gradient centred at the historical 
refuges and eventually reached the threshold level. At that point, bTB, introduced by 
infected immigrants from the historical refuges, could persist and spread its distribution, a 
process seemingly still taking place. 
This hypothesis could be tested by comprehensive geographical spatial analysis of the 
distribution of bTB in Iberian Peninsula, but the proposed natural expansion pattern has 
probably been much obscured by translocation and intensive management of ungulates 
for hunting purposes (Vargas et al. 1995; Miguel et al. 1999; Castillo et al., 2010). In fact, in 
South-central Spain lack of geographical autocorrelation in prevalence rates was 
suggested to be due to extensive fencing of intensively-managed big game hunting 
estates, which impair animal movements (Vicente et al., 2006b). On the other hand, wild 
ungulate translocations for hunting purposes occur frequently and may spread M. bovis to 
areas where it is absent today. Interestingly, M. bovis was isolated from wild boar in 
Portugal in two areas widely out of the known distribution of the disease (Santos et al., 
2009; Cunha et al., 2012), one of which coincides with the release site of red deer 
originating from a population harbouring the same genotype of M. bovis. This provides 
circumstantial evidence for the role of translocations on bTB geographical spread. 
More spatial data of bTb occurrence in Iberian Peninsula is urgently needed. The advent of 
sensitive, specific, reproducible and cheap serologic tests allows such large-scale research to 
be conducted, at least for wild boar (Boadella et al., 2011). This should improve the 
understanding of bTB occurrence across Iberian Peninsula. 
4.4 Disease determinant factors 
Most risk factors for bTB in wild boar and red deer identified in Iberian Peninsula are host 
population factors, most of them abundance-related. It is interesting to note that in the wild 
boar-red deer system, the abundance of each species influences bTB occurrence in the other 
species, further supporting the multi-host pathogen status of bTB in Iberian Peninsula 
ecosystems. 
The number of risk factors related to management is greater for the red deer (n=5) than 
for the wild boar (n=1). This suggests that bTB occurrence in red deer populations is more 
dependent on management practices, while wild boar is competent to act as maintenance 
host under low-intensity management. This hypothesis could be tested by a case-control 
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areas where it is absent today. Interestingly, M. bovis was isolated from wild boar in 
Portugal in two areas widely out of the known distribution of the disease (Santos et al., 
2009; Cunha et al., 2012), one of which coincides with the release site of red deer 
originating from a population harbouring the same genotype of M. bovis. This provides 
circumstantial evidence for the role of translocations on bTB geographical spread. 
More spatial data of bTb occurrence in Iberian Peninsula is urgently needed. The advent of 
sensitive, specific, reproducible and cheap serologic tests allows such large-scale research to 
be conducted, at least for wild boar (Boadella et al., 2011). This should improve the 
understanding of bTB occurrence across Iberian Peninsula. 
4.4 Disease determinant factors 
Most risk factors for bTB in wild boar and red deer identified in Iberian Peninsula are host 
population factors, most of them abundance-related. It is interesting to note that in the wild 
boar-red deer system, the abundance of each species influences bTB occurrence in the other 
species, further supporting the multi-host pathogen status of bTB in Iberian Peninsula 
ecosystems. 
The number of risk factors related to management is greater for the red deer (n=5) than 
for the wild boar (n=1). This suggests that bTB occurrence in red deer populations is more 
dependent on management practices, while wild boar is competent to act as maintenance 
host under low-intensity management. This hypothesis could be tested by a case-control 





Interestingly, among the protective risk factors described for bTB in Doñana, distance to 
freshwater sources is highlighted. Much remains to be known on the conditions necessary 
for the survival of mycobacteria in the environment, but humidity seems to favour it 
(Humblet et al., 2009), particularly in the arid summer conditions of southern Iberian 
Peninsula. This suggests that environmental contamination with mycobacteria, particularly 
at watering sites, and indirect routes could play a role in disease transmission among wild 
ungulate species. 
4.5 Host status 
Wild boar and red deer are usually referred as maintenance hosts in Iberian Peninsula and 
evidence is available as populations maintaining high prevalence rates for several years, even 
decades, in the absence of domestic cattle which could theoretically serve as reservoirs for 
wildlife (e.g. Vicente et al., 2006a; Gortázar et al., 2008). It seems consensual that high-density 
sympatric populations of wild boar and red deer can maintain bTB at a high prevalence 
independent of the existence of other hosts (e.g. de Mendonza et al., 2006; Vicente et al., 2006a; 
Gortázar et al., in press). This seems also to be independent of intensity of management for 
hunting purposes, favouring high density of animals through habitat management, feeding 
and watering (Miguel et al., 1999), as even non-intensively managed but high-density 
populations of wild boar show high bTB prevalence rates (Santos et al., 2009). 
It should be noted that in most of Iberian Peninsula densities far above the natural carrying 
capacity of wild boar and red deer occur, even in the absence of intensive management, 
because natural predators of these species (essentially wolf Canis lupus) have been 
eliminated during the last 50 years (Rico & Torrente, 2000). Packer et al. (2003) have shown 
through modelling that removal of predators can lead to an increase on pathogens’ 
prevalence. Furthermore, Barber-Meyer et al. (2007) have shown that wolf restoration in 
Yellowstone had significant impacts on the seroprevalence of several pathogens of deer, 
even though those populations were previously subject to predation by other species. 
It could be hypothesized that the current bTB high prevalence rates in wildlife in Iberian 
Peninsula derives from severe changes on the ecosystems caused by intensive management for 
hunting purposes (Gortázar et al., 2006) and eventually also predator eradication (Rico & 
Torrente, 2000). Experimental studies where host density is manipulated through large-scale 
culling are absent from the literature and could help to understand the role of artificialization 
of the ecosystems in the persistence and expansion of bTB. The picture is further complicated 
by the difficulty in separating the effect of each host species, as they usually occur in sympatry 
in the core area. Nevertheless, wild boar populations have been reported to show high bTB 
prevalence rates even in the absence of sympatric deer (Vicente et al., 2006a). 
Fallow deer and badger are most likely local maintenance hosts where they occur at high 
density, notably in scattered populations of fallow deer and in Atlantic Iberian Peninsula for 
the badger. On the other hand, other carnivore and ungulate species infected in Iberian 
Peninsula are most likely spillover hosts, with the possible exception of exotic Barbary sheep. 
4.6 Molecular epidemiology 
Studies reviewed are rather concordant in concluding that genotypes seem to be 
geographically clustered as each location has a few predominant genotypes, responsible for 
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the majority of the infections. Concurrently, there is also a wide variety of locally rare 
genotypes. Local genotypes tend to be the same in different sympatric species, both 
domestic and wild, supporting the local interspecies transmission of M. bovis. 
5. Conclusion 
In summary, published evidence suggests that bTB is a natural pathogen of autochthonous 
wild ungulates in Iberian Peninsula, where wild boar and red deer act as maintenance hosts. 
Bovine tuberculosis is an emergent disease in these hosts, the expansion from the core high 
prevalence area in south-western Iberian Peninsula being fuelled by high densities of these 
species due to intensive management for hunting purposes. Several other species of 
ungulates and carnivores are affected by bTB, most probably as spillover hosts, but fallow 
deer and badger could serve as maintenance host in some locations. Although shown to be 
an important emerging infection, large gaps remain in the knowledge of the epidemiology 
of bTB in wildlife, such as intra and inter-species transmission routes, geographical 
distribution and effectiveness of control methods. Applying different epidemiological study 
designs, such as case-control and experimental studies, spatial analysis and modelling could 
shed light on this subject. 
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1. Introduction  
In Ethiopia, milk production systems can be categorized into urban, peri-urban and rural, 
based on location (Reda, 2001). Located around Addis Ababa and regional towns, urban and 
peri-urban systems are market oriented and make use of the high demand in urban areas. 
The rural system is part of the subsistence farming system and includes pastoralists, agro-
pastoralists, and mixed crop-livestock producers mainly in the highlands. As this system is 
not market oriented, most of the milk produced is retained for home consumption. The 
surplus is mainly processed using traditional technologies into more shelf stable products 
such as Ergo (Ethiopian naturally fermented milk), butter, ghee and Ayib (Ethiopian cottage 
cheese) that are marketed through the informal channel (Reda, 2001). 
In Sub Saharan countries the traditional sector, which is characterized by small herd size 
dominated by indigenous zebu breeds of low milk production with very little or no 
specialized inputs, is the dominant type of production system accounting to 70 - 80% of 
Africa’s cattle population (Ibrahim and Olaloku, 2000). In Ethiopia, around 97% of the 
annual milk production is accounted by the traditional milk production system (Felleke, 
2003), which is likewise dominated by indigenous breeds. Most of the milk produced in the 
country is accordingly processed on-farm using traditional technologies that are generally 
not well understood. Most of the very few enterprises currently operating in and around the 
capital entirely depend on the traditional sector for their milk intake, while others depend 
on it for the majority of their intake. These underscore the importance of understanding the 
traditional sector in order to make improvement interventions. 
Cows contribute to about 95% of the total annual milk produced by cows and camels at 
national level (CSA, 2010). In 2010, the cattle population was estimated at about 50.9 million 
(99.19% indigenous, 0.72% hybrid and 0.09% pure exotic breeds). The female cattle 
population accounted for about 55% of the total. The large livestock population; the 
favorable climate for improved, high-yielding animal breeds; and the relatively animal 
disease-free environment make Ethiopia to hold a substantial potential for dairy 
development. In 2010, a total of 2940 million liters of milk was produced from about 9.6 
million cows at national level. During the same year, dairying has created an estimated 
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588,000 full-time on-farm jobs. However, Ethiopia is a net importer of dairy products with 
import values significantly exceeding export values. In five reference years, for instance, 
export values increased from about 73000 USD in 2005 to 123000 USD in 2009, while import 
values increased from about 5,6 million USD in 2005 to about 10,3 million USD in 2009 (a 4,7 
million USD increment).  
The importance of milk in the Ethiopian diet differs according to the farming system and the 
socio-cultural set-ups. Generally, in the lowlands especially where livestock keeping is the 
main occupation, milk is consumed by all groups of the society. In the highlands, the rural 
people are sedentary farmers raising both livestock and crops. The main part of their diet 
consists of cereals and legumes. Milk is used for rearing calves and children, and the surplus 
is soured for making different fermented milk products. The major ones include: Ergo, Ayib, 
butter (three types of butter can be distinguished namely Lega, Mekakelegna and Besal, which 
refer to fresh, semi-rancid and rancid), Nitir kibie (melted butter or ghee), Arrera (defatted 
sour milk, a by-product of butter-making and a raw material for Ayib-making) and Aguat 
(whey). The demand for milk and milk products is a function of several factors that include: 
population growth, seasonality of demand and supply, low per capita consumption and 
high transaction costs. The per capita milk consumption (about 17kg) for Ethiopia is much 
lower as compared to that for Africa (about 25kg), that recommended by World Health 
Organization (WHO) (200 liters), the 62.5 kg recommended by FAO (1990) as a minimum 
level to be kept for a balanced diet and the world’s per capita average of about 100 
liters/year (FAO, 2010).  
In Ethiopia, milk marketing system is not well developed and for the majority of 
smallholder producers, access to market is limited. In year 2010, for instance, only less that 7 
percent of the annual milk production is estimated to be marketed at national level. In 2009, 
there were 180 cooperatives involved in milk production and marketing in the entire nation, 
accounting for only 2% of the total number of agro-based cooperatives. In most of the cases, 
existing dairy cooperatives are operating in areas that are accessible to transportation and 
market. This means that a substantial amount of milk does not reach the market and a 
number of producers keep on producing at a subsistence level.  
Post harvest losses of up to 40% of milk and its derivatives have been reported from milking 
to consumption (Felleke, 2003). Such loses are mainly attributed to mishandling in the dairy 
value chain from farm to fork. These include: contamination during milking and further 
handling coupled with long storage time at high tropical ambient temperature before 
consumption; deliberate adulteration of milk; substandard handling, transportation and 
distribution systems; inefficient processing technologies; inadequate fresh milk outlet; and 
spillage losses during milking. According to FAO (cited by ENA, 2004), the value of annual 
milk and dairy product losses due mainly to mishandling across five African and the 
Middle East countries (Kenya, Tanzania, Uganda, Ethiopia and Syria) is over 90 million 
USD. Reducing such losses and improving quality are effective ways of making more and 
safer milk available that benefits both producers and consumers.  
Provision of milk and milk products of good hygienic quality is desirable from consumer 
health point of view. This is one reason why milk testing and quality control include 
hygiene as well as microbial qualities in addition to testing for fat content and heat stability 
(Giangiacomo, 2000). The consumption of raw milk and its derivatives is common in 
Ethiopia (Yilma, 2003), which is not safe from consumer health point of view as it may lead 
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to the transmission of various diseases. Prior to the discovery and widespread adoption of 
pasteurization for instance, raw milk and its products were responsible for serious bacterial 
infections such as diphtheria, scarlet fever and tuberculosis (Spreer, 1998). The consumption 
of unpasteurized, incorrectly pasteurized or post pasteurization contaminated milk and its 
derivatives have been reported to cause illnesses (Duffy, Garvey & Sheridan, 2002; 
Desenclos et al., 1996; Cody et al., 1999).  
Consumers all over the world are increasingly concerned about the safety of their food in 
general and milk and milk products in particular. Therefore, quality should not be ignored 
at all stages of the dairy value chain from farm to table. As the bacterial quality of raw milk 
is important to product shelf-life, flavor and product yield, it is important that dairy 
enterprises should strive to obtain the highest quality raw material possible from their own 
farm as well as their suppliers. It is therefore essential to produce best quality raw milk in 
the dairy barn in order to manufacture milk products of not only acceptable quality but of 
high standard premium throughout the year. 
Putting a functional quality control system in place is an important tool to bring about 
improvement in the dairy sector. However, in Ethiopia there is no a properly operational 
formal marketing and grading system that is geared towards relating quality of products to 
market price. Establishing a formal marketing system that relates quality to market price has 
a potential to enhance commercialization of the smallholder dairy sector. Such an approach 
provides an incentive for producers to supply products of good quality from nutritional as 
well as consumer health perspective.  
2. Study approach 
This chapter is essentially based on primary data collection using questionnaire, key informants, 
group discussions, personal observation and review of available literature. Data were generated 
from ten dairy potential areas in the Ethiopian highlands (Addis Ababa, Asella, Debre Birhan, 
Debre Zeit, Holetta, Sululta, Selale, Adama, Sheno, Jimma). A semi-structured questionnaire 
was used to collect information on hygienic practices at different stages of the dairy value chain 
from a total of 765 smallholder producers and 22 primary dairy cooperatives.  
The milk quality assessment includes preliminary quality tests (specific gravity or milk 
density, clot-on-boiling and alcohol tests), while the microbial analysis include Aerobic 
Mesophilic Bacteria, Enterobacteriaceae, Coliform, and Yeast and mould counts.  
3. Hygienic conditions during production, processing, storage and marketing 
of milk and milk products 
3.1 Milk production 
3.1.1 Milking environment 
In Ethiopia, there is no standard hygienic condition followed by producers during milk 
production. The hygienic conditions are different according to the production system, 
adapted practices, level of awareness, and availability of resources. In most of the cases 
under smallholder condition, the common hygienic measures taken during milk 
production especially during milking are limited to letting the calf to suckle for few 
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cleaning purpose (to wash the udder, milk equipment, hands), however, is not secured 
(Yilma, 2003).  
Maintaining the sanitary condition of milking area is important for the production of good 
quality milk. The drainage condition of the milking area, in this regard, is one of the most 
determinant factors. As observed during the current study, about 71% of the respondents had 
well drained and easy to clean barns. This is mainly attributed to the large proportion (80.4%) 
of the respondents from all the study areas that used housed type of barn for their crossbred 
cows. Since housed and well built barns can drain easily, it has positive correlation with 
overall hygienic conditions of a given milking environment rendering the production of better 
quality milk. However, the barns owned by about 29% of the respondents were observed to be 
not well drained and difficult to clean, which leads to poor quality milk production. It is 
therefore important that producers consider appropriate drainage conditions of the milking 
environment as an integral part of production hygiene to ensure the supply of safe and good 
quality milk and its derivatives. It is also essential to implement a regular barn cleaning 
scheme. Although, about 87% of the respondents cleaned their barn on daily basis, about 9% of 
them cleaned only once or twice a week, and the remaining 4% did not clean at all.   
3.1.2 The cow and the milker 
Cleaning the udder of cows before milking is important since it could have direct contact with 
the ground, urine, dung and feed refusals while resting. Not washing udder before milking 
can impart possible contaminants into the milk. Milk is highly nutritious; therefore spoilage as 
well as pathogenic microorganisms present in the dust, urine, dung and feed refusals, once get 
access, can easily multiply and deteriorate the quality of milk making it unsafe for 
consumption and unfit for further processing. As observed during the present study, over 31 
and 14% of the respondents owning local and crossbred dairy cows, respectively, do not wash 
the cow’s udder before milking. They rather let calves to suckle before milking. Such practice, 
however, cannot replace washing. Producers should therefore make udder washing a regular 
practice in order to minimize contamination and produce good quality milk.  
About 39 and 36% of the respondents owning local and crossbred milking cows, 
respectively, reported to not use towel at all, while about 10 and 20% of local and crossbred 
cow owners, respectively, responded to use collective towel to clean the udder of two or 
more milking cows. Such practice, in addition to its effect on milk quality, can lead to cross 
contamination of udder health problems of milking cows and related complications. In the 
current study about 27% of the respondents reported to have encountered udder health 
problems and over 18% of them reported the problem to have occurred more than twice a 
year. To reverse the situation, producers spent 650 birr per crossbred and 242 birr per local 
milking cows per year as treatment cost. The reported milk disposal from infected udders 
was estimated to amount to 1056 birr per crossbred and 560 birr per local cows. The use of 
individual towel and following essential cleaning practices during milking is important for 
the production of good quality milk and need be practiced by all producers. 
Milkers, in addition to keeping good personal hygiene, should be in good health during 
milk operation. In this study, about 94 and 96% of the respondents reported to wash their 
hands before milking their local and crossbred cows, respectively. Covering hair and 
dressing gown during milking and handling of milk and milk products are important 
practices milkers need to obey, which weren’t observed in any of the farms visited.  
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3.1.3 Milking utensils 
About 81 and 3.4% of the respondents used plastic and stainless equipment, respectively, 
while 6.6% of them used clay pot. Equipment used for milking, processing and storage 
determine the quality of milk and milk products. Producers need therefore pay particular 
attention for the type as well as cleanliness of milk equipment. Milking equipment should 
be easy to clean. Aluminum and stainless steel equipment are mostly preferred.   
3.1.4 Source of water used for cleaning  
Although, about 45% of the respondents reported to use tap water for cleaning purpose 
(udder, milk equipment and hand), about 19 and 16% of them reported to use river and 
ground water, respectively, while the remaining about 20% reported to use water from 
either of the aforementioned sources (Fig. 1). Moreover, about 60% of the respondents that 
reported to use water from non tap sources neither boil nor filter it before use (Fig. 2). When 
water from non tap sources is used for cleaning purpose, it is important that producers 
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3.2 Milk processing 
Although various traditional milk processing and storage equipment are used in different 
parts of Ethiopia, clay pot is the most commonly available and used. Though not regularly 
practiced, 74.4% of the producers process milk in to different products. Butter, Ergo and Ayib 
are the major fermented milk products, while clay pot is the most commonly used 
equipment under smallholder condition. Flow diagram of smallholder milk processing is 
presented in Fig. 3 and Fig. 4 depicts utilization of milk and milk products under 
smallholder condition. In Ethiopia, heating milk to sterilization temperature of above 100oC 
for 15 to 40 minutes followed by cooling and inoculation with known bacteria culture 
(starter) to achieve a controlled fermentation (O’Connor, 1994) is not practiced by 
smallholders.  
 













Fermentation: 2-3 days  
Ambient temperature: <20 - >30°C 
pH: 6.7 – 4.3 
Cooking  





Fig. 3. Flow diagram of smallholder milk processing in the highlands of Ethiopia 
Fermented milk is reported to have a storage stability of 15 to 20 days at a temperature of 
about 16 to 18oC (O’Connor, 1994). About 48% of the interviewees use clay pot for milk 
souring and/or churning for butter-making. In smallholder butter-making, microbial 
contamination can come from unclean surfaces, the butter maker and wash water. 
Packaging materials such as cups and leaves can also represent important sources of 
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contamination. Although washing and smoking the churn reduce bacterial numbers, 
traditional equipments are often porous and difficult to clean, therefore can serve as a 
reservoir for many organisms (O’Connor, 1994). Over 61% of the respondents in the study 
areas reported to use clay pot as a churn and for storage. Ayib is made by heating Arera or 
sour skim milk in a clay pot or another material on a low fire to about 40-50oC (FAO, 1990; 
O’Connor, 1993). In the current study, over 59% of the respondents reported to use clay pot 
for Ayib-making and storage.  
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Fig. 4. Flow scheme of smallholder utilization of milk and milk products 
Milk cooperatives sell fresh whole milk directly without further processing as well as 
process into more shelf stable products whenever there is no market for fresh whole milk. 
Unlike smallholder producers, cooperatives use hand operated cream separator and 
therefore, milk makes the basis of processing in cooperative settings (Fig. 5). Although, 
smallholder and cooperative milk processing differs, both produce similar major 
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Fig. 5. Flow diagram of milk processing in cooperative centers in the highlands of Ethiopia 
3.3 Storage  
Milk products are generally more stable than fresh milk because they are more acidic 
and/or contain less moisture. Salt may also be added to milk products to prolong their shelf 
life. Applying principles of acidification, moisture reduction and salting (O'Mahony and 
Peters, 1987) can thus make milk products of good storage stability. All of the smallholder 
producers interviewed and about 82% of cooperatives stored their products at ambient 
temperatures. However, about 9% of the cooperatives have a refrigerator and the rest used 
cold water to store their products in cool conditions. Type of equipment used for different 
milk operations in the cooperative settings is presented in Table 1. 
 
Purpose N Equipment used (frequencies, %) Aluminum/Stainless steel Plastic containers Wooden containers 
Milk collection 22 65.9 34.0 - 
Milk storage 22 76.2 23.8 - 
Cream storage 22 77.5 22.5 - 
Butter storage 22 55.0 15.0 30.0 
Cheese storage 22 88.2 11.8 - 
Table 1. Equipment used for different milk operations in cooperative settings 
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3.4 Marketing of milk and milk products 
There are basically two marketing systems in the central highlands of Ethiopia: formal and 
informal. In the formal system milk is collected at cooperative or private milk collection 
centers and transported to processing plants. In this system, there are somehow milk quality 
tests (alcohol and clot-on-boiling tests and density) up on delivery, and therefore the quality 
of milk is fairly secured. Producers supplying milk in this system pay a due emphasis in the 
production, storage and transportation of milk if their milk has to be accepted. In the 
informal system producers supply their surplus production to their neighbors and/or in 
local markets, either as liquid milk or in the form of butter and/or Ayib (O’Connor, 1992). In 
this system, the quality of milk and milk products is very poor mainly due to the prevailing 
situation where producers have limited knowledge of dairy product handling coupled with 
the inadequacy of dairy infrastructure such as electricity and clean water in the production 
areas.  
In Ethiopia, there is no an operational hygienic regulation set for smallholder marketed 
dairy products. This indicates that the health of the dairy consuming community is not 
secured. This particularly holds true for Ayib, which is consumed with Enjera without 
farther treatment (Duteurtre, 1998). On open markets buyers of milk products practice 
organoleptic tests. The transaction of Ayib is particularly subject to such tests and it is 
uncommon that a buyer of Ayib is not tongue-testing the Ayib before buying it. This type of 
test is only partly associated with the effects of putrefactive microorganisms that can be 
detected by a simple tongue test. The presence of pathogenic microorganisms, however, 
cannot be detected by such tests.  
There are reports that depict experiences of certain cooperatives around the Selale area 
(about 14%) (Yilma, 1999) that had a rewarding mechanism through better payment for 
good quality milk supplied. Such an approach encourages cooperative member and non-
member farmers to be concerned about sanitary conditions during milk production and 
subsequent handling.  
3.5 Major milk quality related constraints   
Milk quality related constraints ranked during group discussions with dairy cooperatives 
are presented in Table 2. The major milk quality related constrains include: limited  
 
Constraints Rank 
Limited awareness on hygienic handling 1st 
Shortage of capital  1st 
Lack of clean water 3rd 
Poor type of barn  3rd 
Hygiene of the milker 5th 
Lack of transport facilities 6th  
Mastitis (udder health problem) 7th 
Inappropriate materials used for milk production and handling 8th 
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awareness on hygienic handling of milk and milk products, which could mainly be 
attributed to inefficient extension services; shortage of capital to purchase recommended 
equipment (milk containers, and processing and packaging materials); lack of clean water 
for sanitation purpose and poor condition of barn or milking area that is directly related to 
shortage of capital and limited awareness of its implication on milk quality.  
4. Quality of milk and milk products 
4.1 Density and freshness of products 
Milk, at its normal state, has unique physico-chemical properties, which are used as quality 
indicators. The density of milk, among others, is commonly used for quality test mainly to 
check for the addition of water to milk or removal of cream. Addition of water to milk 
reduces milk density, while removal of cream increases it (O’Connor, 1994). The solid 
constituents of milk make milk an important food item from nutritional as well as 
processing point of view. Milk fat and protein are most important components of different 
varieties of most shelf stable milk products. All the 22 milk cooperatives used specific 
gravity test as an indicator of milk quality. The average specific gravity of 72 milk samples 
tested was 1.028 and 1.029 for Holetta and Selale areas, respectively (Fig. 6). These values 
fall within the range between 1.028 and 1.032 given to unadulterated milk (O’Connor, 1994). 
About 21% of the same samples checked with alcohol test were positive, while only 14% of 
the samples were positive for clot-on-boiling test. The results indicate that certain farmers 
deliver milk to collectors that has undergone fermentation that occurred either through long 
time elapsed between milking and delivery; mixing evening and morning milk; or use of 
insufficiently cleaned milk containers.  
 
Fig. 6. Specific gravity/density of milk samples in Selale and Holetta areas 
The mean pH values of whole milk ranged from 6.29 for Debre Birhan to 6.66 for Selale 
(data not presented). This variation and low pH may be attributed to the long time elapsed 
between milking and supply to collection centers. Three of the 24 samples of pasteurized 
milk checked with alcohol test were positive, while 5 of the samples were positive for clot-
on-boiling test. These results are consistent with the results of pH values observed for the 
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same samples that ranged from the lowest 5.46 to the highest 6.14 with an overall mean 
value of 5.87. The relatively low pH of Ergo, ranging from 4.3 to 4.5 retards the growth of 
undesirable microorganisms, such as pathogens and spoilage bacteria, and enables its 
further storage (Gonfa et al., 2001).  
4.2 Microbial properties of milk and milk products 
The microbial content of milk indicates the hygienic levels during milking that include 
cleanliness of the milking utensils, proper storage and transport as well as the 
wholesomeness of the udder of the individual cow (Spreer, 1998). The most commonly used 
microbial quality tests for milk and milk products include determination of total bacterial 
count (TBC) or standard plate count (SPC) and colifom count (CC). Estimation of yeast and 
mould counts is also useful for evaluating sanitary practices (O’Connor, 1994). 
Microorganisms can enter milk via the cow, air, feeds, milk handling equipment and the 
milker. Once they get into the milk their numbers increase rapidly. It is therefore more 
effective to exclude microorganisms than trying to control their growth once they get access 
into the milk.  
There are varieties of traditionally fermented dairy products in Ethiopia, for which the exact 
type of desirable lactic acid bacteria responsible for fermentation is unknown due mainly to 
uncontrolled and spontaneous fermentation. Most of these products are produced by 
smallholder producers where access to the required dairy infrastructure is limited. Results 
of the present study and selected reports of relevant earlier research efforts on the microbial 
properties of locally produced milk and milk products that have been carried out in 
different parts of the country are briefly summarized below. 
 
Source No of Obs. TBC Enterobacteriaceae Coliform YMC 
Overall mean 630 8.35 5.10 4.53 8.32 
Whole milk 135 9.10 5.49 4.58 - 
Ergo 105 9.49 4.95 4.51 8.38 
Butter 105 6.67 4.95 4.58 8.32 
Arera 75 9.35 4.94 4.65 - 
Ayib 105 7.01 4.84 4.42 8.26 
Skim milk  105 9.37 5.34 4.44 - 
TBC: Total Bacterial Count; YMC: Yeast and Mould Count 
Table 3. Overall bacterial and yeast and mould counts (log10) per ml/g of milk and milk 
product samples collected from different sources (sites and producer groups) 
Although there are slight variations between sample sources (locations/producer groups) in 
microbial counts, the figures observed in the present study are generally much higher than 
acceptable limits (Table 3). TBC is generally high in samples of whole milk, Ergo and skim 
milk. Counts of Enterobacteriaceae and coliform counts are higher than acceptable limits: 
Enterobacteriaceae <1 and coliform <10 cfu/ml for pasteurized milk, and coliform <100 
cfu/ml for raw milk intended for direct consumption (Council Directives 92/46/EEC, 1992). 
The higher count in milk indicates substandard hygienic conditions practiced during 
production and subsequent handling. The high count in fermented milk products, however, 
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4.2.1 Whole milk  
Mean total bacterial counts ranged from 10.12 log cfu/ml of milk collected from Jimma to 
8.30 log cfu/ml of milk sampled from Debre Zeit and Adama with the average value being 
9.10 log cfu/ml. These values exceed the acceptable value of 105 cfu/ml for milk in most 
European counties (Council Directives 92/46/EEC, 1992; IFCN, 2006). Mean counts of 
Enterobacteriaceae were greater than 5 log cfu/ml and coliform counts greater than 4 log 
cfu/ml of milk sampled from all study sites.   
In Ethiopia, milking animals are kept with the rest of the stock in a shade or enclosure 
during the night. Milking is done in the shade, grazing field in front of the homestead, or 
under a tree. However, as these areas are not generally kept clean enough, milking cows 
usually become soiled with dung and urine. Moreover, cleaning of the udder and hind 
quarters of the cow is not a common practice. This coupled with the unhygienic cleaning 
and handling of milk containers result in microbial contamination of milk (Tola, 2002; Gonfa 
et al., 2001).  
According to an earlier report, milk samples collected form smallholder producers in East 
Wollayta (Southern Ethiopia) had average total microbial count of 7.60 log cfu/ml (Tola, 
2002). A total bacterial count ranging from 6.0 to 8.8 log cfu/ml in which 15% of the samples 
had a count equal or above 7.7 log cfu/ml in raw milk samples in Southern Ethiopia was 
also reported (Beyene, 1994). In another report, milk sampled from most of the dairy 
cooperatives operating in the country had total bacterial count of 108 cfu/ml (Francesconi, 
2006). These values are much higher than the acceptable limits in different countries (104 to 
105 cfu/ml) (IFCN, 2006). This implies that the sanitary conditions in which milk has been 
produced and handled are substandard subjecting the product to microbial contamination 
and multiplication. It is indicated that total bacterial count is a good indicator for 
monitoring the sanitary conditions practiced during production, collection, and handling of 
raw milk (Chambers, 2002). A good instance worth mentioning is a reduced total bacterial 
count observed in milk sampled from farmers who received training on hygienic milk 
production and handling, and who used recommended milk containers as compared to that 
produced by the traditional milk producers (control) (Tola, 2002; Nebiyu, 2008; Sintayehu et 
al., 2008). A similar result was also reported for large-scale producers and research centers 
where there is a better access to dairy facilities as compared to small-scale producers (Yilma 
and Faye, 2006). 
According to a report from Southern Ethiopia, raw cow’s milk sampled from smallholder 
producers contained coliform counts of about 4.46 log cfu/ml (Tola, 2002). Similar counts 
were also observed in raw milk sampled from smallholder producers in the central 
highlands of Ethiopia (Yilma and Faye, 2006; Yilma et al., 2007a). Higher counts of different 
species of Enterobacteriaceae were reported with Escherichia coli being the most abundantly 
isolated species (Yilma et al., 2007a), which is a good indicator of recent fecal contamination 
(Bintsis et al., 2008). 
In a study focused on the identification of major bacterial species found in milk as it comes 
from the udder, it is reported that Micrococci represent the largest proportion followed by 
Streptococci and rods (O’Connor, 1994). In a separate study, Staphylococci and Micrococci are 
reported to be the most common udder-specific bacteria of environmental origin in milk 
samples taken directly from the udder (Godefaye and Molla, 2000).  
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Producer Whole milk Ergo* Butter Arera Ayib Skim milk 
Total bacteria       
Smallholder farmers 8.87 9.48 6.86 9.35 7.16 - 
Cooperatives 9.49 9.54 6.14 - 6.51 9.25 
Overall mean 9.10 9.49 6.67 9.35 7.00 9.25 
Enterobacteria       
Smallholder farmers 5.51 4.94 4.97 4.94 4.85 - 
Cooperatives 5.45 4.98 4.90 - 4.82 5.30 
Overall mean 5.48 4.95 4.95 4.94 4.84 5.30 
Coliforms       
Smallholder farmers 5.59 4.48 4.60 4.65 4.44 - 
Cooperatives 4.54 4.61 4.53 - 4.37 4.37 
Overall mean 4.58 4.51 4.58 4.65 4.42 4.37 
Yeast and mould       
Smallholder farmers - 8.39 8.34 - 8.26 - 
Cooperatives - 8.34 8.27 - 8.27 - 
Overall mean - 8.38 8.32 - 8.26 - 
*Ergo refers to fermented whole milk for smallholder farmers, while it refers to fermented skim milk for 
cooperatives 
Table 4. Microbial count (log10) per ml/g of milk and milk products categorized by sample 
source (producer type) 
Total aerobic plate counts were 1.1 x 105, 4 x 106 and 1.9 x 108 cfu/ml respectively for milk 
samples taken from milking bucket, storage container and processing plant on arrival 
(Godefaye and Molla, 2000).  In the same study, mean coliform counts were reported to range 
from 1.3 x 104 cfu/ml (storage container) to 7.1 x 106 cfu/ml (on arrival at the processing 
plant).  The hygienic quality of the milk from a collection center was poor with a mean total 
bacterial count of 1.3 x 107 cfu/ml. In another study, 4 x 107 and 1 x 109 cfu/ml total microbial 
counts were reported as lowest and highest values, respectively for raw milk samples at a 
processing plant in Addis Ababa. Of the total counts in raw milk, psychrophilic, thermoduric 
and thermophilic organisms made up 98.1, 1.4 and 0.5%, respectively.  
4.2.2 Ergo – Naturally fermented milk  
Ergo is made by natural fermentation of milk under ambient temperature, without the 
addition of starter cultures (Assefa et al., 2008). The use of a portion of ergo from a previous 
batch as a starter in highland areas where ambient temperature is relatively low is reported 
(Kassa, 2008). This practice is technically adapted to overcome the effect of low ambient 
temperature, which slows down the growth of lactic acid bacteria (LAB) in the absence of 
starter culture thus prolongs the fermentation time. The temperature and duration of 
incubation varies from place to place depending on the prevailing environmental 
conditions. According to a previous report, five LAB genera were identified from Ergo that 
include Lactobacillus, Lactococcus, Leuconostoc, Entrococcus and Streptococcus (Assefa et al., 
2008). They also indicated the LAB species identified in Ergo to be Streptococcus thermophilus, 
Strep. acidominus, Enterococcus faecalis var. liquefaciens, Strep. bovis, Strep. mitis, Strep. 
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Producer Whole milk Ergo* Butter Arera Ayib Skim milk 
Total bacteria       
Smallholder farmers 8.87 9.48 6.86 9.35 7.16 - 
Cooperatives 9.49 9.54 6.14 - 6.51 9.25 
Overall mean 9.10 9.49 6.67 9.35 7.00 9.25 
Enterobacteria       
Smallholder farmers 5.51 4.94 4.97 4.94 4.85 - 
Cooperatives 5.45 4.98 4.90 - 4.82 5.30 
Overall mean 5.48 4.95 4.95 4.94 4.84 5.30 
Coliforms       
Smallholder farmers 5.59 4.48 4.60 4.65 4.44 - 
Cooperatives 4.54 4.61 4.53 - 4.37 4.37 
Overall mean 4.58 4.51 4.58 4.65 4.42 4.37 
Yeast and mould       
Smallholder farmers - 8.39 8.34 - 8.26 - 
Cooperatives - 8.34 8.27 - 8.27 - 
Overall mean - 8.38 8.32 - 8.26 - 
*Ergo refers to fermented whole milk for smallholder farmers, while it refers to fermented skim milk for 
cooperatives 
Table 4. Microbial count (log10) per ml/g of milk and milk products categorized by sample 
source (producer type) 
Total aerobic plate counts were 1.1 x 105, 4 x 106 and 1.9 x 108 cfu/ml respectively for milk 
samples taken from milking bucket, storage container and processing plant on arrival 
(Godefaye and Molla, 2000).  In the same study, mean coliform counts were reported to range 
from 1.3 x 104 cfu/ml (storage container) to 7.1 x 106 cfu/ml (on arrival at the processing 
plant).  The hygienic quality of the milk from a collection center was poor with a mean total 
bacterial count of 1.3 x 107 cfu/ml. In another study, 4 x 107 and 1 x 109 cfu/ml total microbial 
counts were reported as lowest and highest values, respectively for raw milk samples at a 
processing plant in Addis Ababa. Of the total counts in raw milk, psychrophilic, thermoduric 
and thermophilic organisms made up 98.1, 1.4 and 0.5%, respectively.  
4.2.2 Ergo – Naturally fermented milk  
Ergo is made by natural fermentation of milk under ambient temperature, without the 
addition of starter cultures (Assefa et al., 2008). The use of a portion of ergo from a previous 
batch as a starter in highland areas where ambient temperature is relatively low is reported 
(Kassa, 2008). This practice is technically adapted to overcome the effect of low ambient 
temperature, which slows down the growth of lactic acid bacteria (LAB) in the absence of 
starter culture thus prolongs the fermentation time. The temperature and duration of 
incubation varies from place to place depending on the prevailing environmental 
conditions. According to a previous report, five LAB genera were identified from Ergo that 
include Lactobacillus, Lactococcus, Leuconostoc, Entrococcus and Streptococcus (Assefa et al., 
2008). They also indicated the LAB species identified in Ergo to be Streptococcus thermophilus, 
Strep. acidominus, Enterococcus faecalis var. liquefaciens, Strep. bovis, Strep. mitis, Strep. 





Lact. lactis. The isolation of similar genera, and Micrococci and coliforms, which are present 
in low numbers was also reported (Gonfa et al., 2001). An average LAB count of 7.68 log 
cfu/ml for Ergo samples collected from different producers in Addis Ababa and major cities 
around Addis Ababa was also reported (Yilma and Faye, 2006).  
LAB are reported to have antimicrobial activities. The use of different LAB species to create 
a stationary phase for Staphylococcus aureus and a higher density of LAB in modeled starter 
culture could result in complete inhibition of the bacterium (Le Marc et al, (2009). Another 
report also indicated that 12 LAB isolates from Ergo that include Lactobacillus plantarum, 
Lactococcus lactic ssp cremoris, Lactococcus lactic ssp lactic, Lactobacillus acidophyilus, Leuconostoc 
lactic, Pediococcus pentosace and Pediococcus sp. have antimicrobial activities against different 
pathogenic microbes including Shigella flexinery, Salmonella typhi, Escherichia coli and 
Staphylococcus aureus (Assefa et al., 2008).  
TBC of Ergo was generally high ranging from 7.71 cfu/ml in samples collected from Sheno 
to about 10 cfu/ml in samples from Jimma. Average Enterobacteriaceae and coliform counts 
were greater than 4 cfu/ml of Ergo sampled from all study sites with differences between 
the lowest and highest counts ranging from 0.25 to 0.37 cfu/ml.  
Mean yeast and mould counts observed in the current study exceeded 8 cfu/ml of Ergo 
sampled from all the sites considered. However, a lower value (2×105 cfu/ml) was reported 
(Gonfa et al., 2001). Yeast and mould count of up to 4.6 log cfu/ml of fermented milk 
sampled from Southern Ethiopia was also reported (Beyene, 1994). These values are much 
higher than the acceptable value (<10 cfu/gm for yoghurt) (Mostert and Jooste, 2002). The 
presence of different species of yeast in milk and its products may result in the spoilage of 
the product or conversely could contribute to the enhancement of the flavor of fermented 
milk, since different yeast species are able to assimilate different milk substrates (Gadaga et 
al., 2000). Bacterial species namely Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter 
cloacae, Citrobacter freundii and Enterobacter sakazakii were isolated from Ergo samples 
collected from smallholder producers in the central Ethiopia (Yilma et al., 2007a). Coliform 
count averaging at 6.57 log cfu/ml was reported for Ergo samples (Yilma and Faye, 2006). 
Lower values were also observed in which 75% of the samples showed coliform count less 
than 4.4 log cfu/ml (Beyene, 1994).  However, the same author also reported TBC of greater 
than 8.6 log cfu/ml for 3/4th of fermented milk samples collected from three villages in 
Southern Ethiopia and coliform counts of higher than 4.4 log cfu/ml in 15% of two 
fermented milk varieties. 
The common traditional milk processing techniques involve smoking of processing utensils 
using embers of Olea africana. This smoking practice is reported to be beneficial to keep 
better quality of Ergo through its inhibitory effect on spoilage and pathogenic organisms. 
For instance, the inhibitory effect of smoking on Listeria monocytogenes was reported 
(Ashenafi, 1994). The effect of lower pH of Ergo in controlling the proliferation of 
undesirable microorganisms is more effective after 24 hours of incubation. However, at this 
time, the ergo is considered to be too sour for direct consumption since ergo coagulates 
within 24 hours and preferably consumed at this time for its good flavor (Ashenafi, 2006). 
Accordingly, the same author recommended that milk should be boiled beforehand and a 
small amount of 3-days-old Ergo that is normally free from pathogens but contains enough 
LAB should be inoculated to initiate fermentation. 
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4.2.3 Kibe – Traditional butter  
Different studies on various aspects of traditional butter-making in Ethiopia have been 
undertaken in different parts of the country. Traditional butter-making is based on sour 
milk that has been accumulated over a few days commonly in a clay pot. Once the amount 
of the accumulated sour milk justifies churning, the sour milk is mixed thoroughly by using 
a wooden stick with 3 to 5 finger-like projections at one end (mesbekia in amahric) then 
churned using different techniques until butter granules are formed.  
Mean total bacterial counts ranged from 6.18 cfu/g in butter samples collected from Selale 
area to 7.25 cfu/g in samples from Sululta. These values are higher than the acceptable limit 
of 5×104 cfu/g (Mostert and Jooste, 2002). Average Enterobacteriaceae and coliform counts 
were greater than 4 cfu/g of butter sampled from all study sites both of which are higher 
than the acceptable value of <10 cfu/g (Mostert and Jooste, 2002). Mean yeast and mould 
counts observed in the current study exceeded 8 cfu/g of butter sampled from all the sites 
considered. 
TBC of 3.15 × 107 and the presence of high variability among samples depending on the 
sources were reported (Mamo, 2007). Samples collected from open markets and rural 
producers, for instance, had higher counts as compared to that obtained from dairy farms 
and urban producers. Coliform counts ranging from 1.92 to 4.5 log cfu/gm of butter are 
reported (Mamo, 2007; Asfaw, 2008; Yilma et al., 2007a). These differences could be 
attributed to the wide variation in hygienic handling during milking, processing, storage 
and transport to market. Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae, 
Citrobacter freundii, and Esherichia coli were isolated from ergo samples collected in the 
central Ethiopia (Yilma et al., 2007ab), and these microbes are considered to be pathogenic 
and spoilage (Walstra et al., 2006). On the other hand, yeast and mould counts ranging 
between 4.3 and 6.86 log cfu/g of butter sampled from Wollayta area are reported (Asfaw, 
2008). Average yeast and mould count of 4.5 × 107 cfu/g of butter was also reported 
(Mamo, 2007). Higher values are observed (Yilma et al., 2005) that varied depending on 
the type of producer where lower counts were observed for butter sampled from research 
centers and small-scale producers than that from large-scale producers. TBC of fresh 
butter sampled from rural and public butter markets in Addis Ababa ranged from 6.2 x 
104 to 1.86 x 108 per gram of butter and coliforms were found in all samples that indicate 
poor hygienic practices (ILCA, 1992). These high deviations from the acceptable value of 
10 cfu/gm (Mostert and Jooste, 2002) indicate substandard handling conditions at all 
stages in the milk chain.  
4.2.4 Arera – Defatted sour milk  
Average counts of total bacteria, Enterobacteriaceae and coliforms were greater than 9, 4.7 and 
4.2 cfu/ml, respectively of Arera sampled from all study sites both of which are higher than 
the acceptable value of <10 cfu/gm (Mostert and Jooste, 2002). Traditionally produced Arera 
sampled from Wollayta area had total bacterial count of about 9 log cfu/ml (Nebiyu, 2008). 
The same author also reported coliform count of 4.86 log cfu/ml. Different species of 
bacteria were identified in Arera samples collected during both dry and wet seasons, which 
include: Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae, Enterobacter sakazakii, 
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4.2.5 Ayib – Ethiopian cottage cheese  
Mean TBC ranged from 6.46 cfu/g in Ayib samples collected from Arsi and Selale area to 
7.87 cfu/g in samples from Sululta with the overall mean being 7.01 cfu/g. Average 
Enterobacteriaceae and coliform counts were greater than 4 cfu/g of Ayib sampled from all 
study sites. Mean yeast and mould counts observed in the current study exceeded 8 cfu/g of 
Ayib sampled from all the sites considered. 
Ayib samples contained high numbers of mesophilic bacteria, Enterococci, and yeasts (Ashenafi, 
2002). The author also reported aerobic mesophilic bacterial counts of over 108 cfu/g for more 
than 90% of the samples collected in Southern Ethiopia. Works undertaken to identify bacterial 
species in ayib samples reported Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae 
(Yilma et al., 2007b), Staphylococcus aureus and Bacillus cereus (Ashenafi, 2002).  
Several earlier works carried out in different parts of the country reported coliform counts of 
ayib samples that ranged between 2 log cfu/gm (Ashenafi, 2002, 2006) and 5.68 log cfu/gm 
(Yilma et al., 2005) with differences being a function of source of samples and handling 
conditions. Coliform counts varied among samples collected from different producers 
where samples from research centers had lower coliform counts (4.85 log cfu/gm) as 
compared to samples from large-scale (5.68 log cfu/gm) and small-scale (5.48 log cfu/gm) 
farms showing variations in the hygienic conditions practiced among the different 
producers (Yilma et al., 2005). However, in all cases values are higher than the acceptable 
level of <10 cfu/gm (Mostert and Jooste, 2002) indicating the poor hygienic conditions 
practiced during processing and handling.  
Ayib samples collected from an open market in Awassa showed high numbers of mesophilic 
bacteria, enterococci and yeasts (Table 19). More than 90% of the samples had aerobic 
mesophilic counts of ≥ 108 cfu/g while more than 75% of the samples had yeast counts of ≥ 
107 cfu/g, and over 85% contained Enterococci in numbers of ≥ 107 cfu/g. The majority of the 
samples had mould and lactic acid bacteria counts of 105 cfu/g or higher, spore-formers of 
about 104 and psychrotrophs of about 106 cfu/g. Over 32% had coliform counts of more than 
102/g and about 27% contained fecal coliform loads of more than 102/g. Bacillus cereus and 
Staphylococcus aureus were isolated in 63% and 23% of the samples, respectively, but at low 
numbers (102 to 103 cfu/g) (Ashenafi, 1990). 
4.2.6 Domestic commercial pasteurized milk 
Mean total bacterial counts ranged from 6.60 to 7.54 log10 cfu/ml of domestic pasteurized milk 
collected from different kiosks and supermarkets in Addis Ababa with the average value being 
7.28 log10 cfu/ml (Table 5). Mean counts of coliform bacteria and Enterobacteriaceae were 2.87 
and 3.69 log10 cfu/ml, respectively. These values are much higher than the acceptable values. 
As presented in microbiological safety limits for major milk products in community legislation 
in force by the European Commission, the maximum limit for total bacterial and coliform 
counts in pasteurized milk intended for drinking is 5x105 and 5 cfu/ml, respectively, while 
Enterobacteriaceae count should be <1 cfu/ml and pathogenic microorganisms should not be 
detected in 25 ml of the product (Council Directives 92/46 EEC, 1992).  
The pasteurized milk samples considered in the present study were between 5 to 2 days 
before the expiry date as indicated on the packaging materials. Although, the high total 
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bacterial count observed in the current study can partly be attributed by lactic acid bacteria, 
which can be explained by the low mean pH value of 5.87, the higher counts of coliform 
bacteria and Enterobacteriaceae imply that there was a problem either in the pasteurization 
process or there occurred post pasteurization contamination during packaging.   Protection 
from post-pasteurization contamination before the milk product is packaged is a critical 
factor in achieving a safe food. Ingredients added after pasteurization of the milk portion of 
the food can be a source of pathogens. The control of potential sources of contamination can 
be addressed by following production practices based on Good Manufacturing Practices. 
Pasteurized milk had mesophilic aerobic counts of 7 x 105 cfu/ml as it left the pasteurizing 
unit (Mahari and Gashe, 1990). According to the same source, psychrophilic, thermoduric 
and thermophilic organisms constituted 53.0, 39.5 and 7.5%, respectively and the isolates 
belonged mostly to the genera Bacillus, Streptococcus, Lactobacillus, Arthrobacter, Alcaligenes, 
Aeromonas and Pseudomonas. Cocci were more predominant than rod-shaped bacteria and of 
the rod-shaped bacteria 73% were gram-negative. As indicated by the same authors, utensils 
holding the raw and pasteurized milk and plastic sheets used for bagging the pasteurized 
milk were reported to contribute for the high bacterial count, which were either thermoduric 
or thermophilic. 
 
Pasteurized milk sample* No. of obs. Count, Log10 cfu/ml 
TBC CC EntC 
A 4 7.28 3.18 3.58 
B 4 6.60 3.28 3.94 
C 4 7.47 3.26 4.26 
D 4 7.37 2.34 3.63 
E 4 7.54 2.77 3.68 
F 4 7.42 2.40 3.05 
Overall mean 24 7.28 2.87 3.69 
*Different letters represent different brands of pasteurized milk marketed in Addis Ababa; 
TBC: Total Bacterial Count; CC: Coliform Count; EntC: Enterobacteriaceae Count; cfu/ml: Colony 
Forming Units per millilitre  
Table 5. Microbial quality of domestic commercial pasteurized milk sampled from different 
kiosks and supermarkets in Addis Ababa 
5. Critical control points in the milk chain 
As with hygiene and food safety, the issue of quality has been growing prominently in recent 
years and the optimum approach to these two areas is remarkably similar. Providing quality 
assured products to the consumer has traditionally relied on quality control of finished 
products, that is, a set of procedures to test and analyze the product to ensure it conforms to 
the required specification. This approach has drawbacks that include incidents of food 
poisoning in spite of quality control procedures, less effective as microorganisms are not 
evenly distributed in products, and high cost of rejected products as the quality control is 
based solely on finished product testing. This is one reason why, developments in quality 
management have focused on the prevention of defects in the first place (through effective 
design and hazard elimination) rather than trying to measure defects once the product has 
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F 4 7.42 2.40 3.05 
Overall mean 24 7.28 2.87 3.69 
*Different letters represent different brands of pasteurized milk marketed in Addis Ababa; 
TBC: Total Bacterial Count; CC: Coliform Count; EntC: Enterobacteriaceae Count; cfu/ml: Colony 
Forming Units per millilitre  
Table 5. Microbial quality of domestic commercial pasteurized milk sampled from different 
kiosks and supermarkets in Addis Ababa 
5. Critical control points in the milk chain 
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the required specification. This approach has drawbacks that include incidents of food 
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evenly distributed in products, and high cost of rejected products as the quality control is 
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Quality Assurance (QA) systems. Hazard Analysis and Critical Control Point (HACCP) in 
particular is employed in the identification of stages in the food chain where spoilage as well 
as pathogenic microorganisms can enter, survive and proliferate in the food and managing 
these as the key control strategy rather than relying on testing end products (IDF, 1994).  
In the Ethiopian smallholder context, six Critical Control Points (CCPs) where milk and milk 
products can be contaminated can be identified (Fig. 7). These include:  
i. During milk production: During milking, contamination can come from the cow, the 
milker, utensils used for milking, storage and filtering the milk, and the barn or the 
milking environment. 
ii. During fermentation: Milk containers used for fermentation, wash water of poor quality 
used, ingredients added with the intention of improving the flavor of the final product 
can represent potential sources of contamination. 
iii. During churning (butter-making):  Churns and warm water added to facilitate the 
churning process (speed-up butter recovery) can be possible sources of contamination. 
iv. During Ayib-making: Low cooking temperatures that may not be enough to kill spoilage 
as well as pathogenic microorganisms can be considered as an important point for the 
poor quality of the final product. Other potential sources of microbial contamination 
include: materials used for Ayib-making, other utensils such as that used for draining 
the whey or ladling out the Ayib, and filtration.  
v. Packaging/storage of butter and Nitir Kibe/ghee: Potential sources of contamination here 
include: product container/packaging, high keeping temperature, and poor personal 
hygiene of people handling the product.  
vi. Packaging/storage of Ayib: Potential sources of contamination here are similar with that 
under v above. 
CCPs at dairy cooperatives are summarized in Fig. 8:   
i. The milk/reception: The raw material milk can be contaminated via the cow; the milker; 
the barn; utensils used for milking, filtering, storage (at farm and cooperative center) 
and transport. 
ii. During cream separation: Contamination at this point can come from the separator, wash 
water, personnel, and environment.  
iii. During fermentation of skim milk: Containers used for fermentation, poor quality wash 
water, personnel and the environment represent potential sources of contamination. 
iv. During churning (butter-making):  Contamination at this point can come from the churn 
(container), personnel, wash water, and environment. 
v. During Ayib-making: Low cooking temperatures that may not be enough to kill spoilage 
as well as pathogenic microorganisms can be considered as an important point for the 
poor quality of the final product. Other potential sources of contamination include: 
materials used for Ayib-making, other utensils such as that used for draining the whey 
or ladling out the Ayib, and filtration.  
vi. Packaging/storage of butter: Potential sources of contamination here include: product 
container/packaging, high keeping temperature, poor personal hygiene of people 
handling the product, and environment.  
vii. Packaging/storage of Ayib: Potential sources of contamination here are similar with that 
under vi above. 
The aforementioned critical points of contaminations can be considered for making 
improvement interventions.  
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6. International quality standards practiced in different countries 
As food safety and quality are a growing concern all over the world, different organizations 
in many countries implement quality control programs and established quality standards 
for all food items including animal products to ensure the health of the consumer. Health 
hazards to the consumer are often grouped into microbiological, physical and chemical 
(FDA, 2004). A microbial criteria stipulate that a type of microorganism, groups of 
microorganisms, toxin produced by a microorganism must either not be present at all, be 
present in only a limited number of samples, or be present at less than a specified number or 
amount in a given quantity of a food ingredient (NRC, 1985).  
Different microbiological tests are used to indicate the hygienic condition of manufacturing of 
a given product. Coliform count provides an indication of unsanitary production practices 
and/or mastitis infection. A count less than 100 Colony Forming Units (CFU)/ml is considered 
acceptable for milk intended to be pasteurized before consumption. Counts of 10 CFU/ml or 
less are achievable and desirable if raw milk will be consumed directly (Jones and Sumner, 
1999; Ruegg, 2003). Estimation of the total bacteria count is the procedure used to measure the 
general sanitary quality of milk. The number of bacteria in aseptically drawn milk varies from 
animal to animal and even from different quarters of the same animal. On average, aseptically 
drawn milk from healthy udders contains between 500 and 1000 bacteria ml-1. High initial 
counts (>105 bacteria ml-1) are evidence of poor production hygiene (O'Connor, 1994). Somatic 
cell count (SCC) is another indirect indicator of the microbial quality of milk. The number of 
somatic cells increases in response to pus-producing bacteria like Staphylococcus aureus, a cause 
of mastitis (Kleinschmit and Gompert, 2007). 
Legal and voluntary bacteriological standards vary widely from country to country and 
there are different standards for different groups and species of microorganisms specific to 
specific products. Standard plate count (SPC) values for raw milk can range from <1000ml-1, 
where contamination during production is minimal, to >1 x 105ml-1. Consequently, high 
initial SPC values (>105ml-1) are evidence of serious hygienic problem during production, 
likewise SPC values of <2x104ml-1 reflect good sanitary practices (IDF, 1994). 
 
Somatic Cell Count/ml Drug residue Country Source 
< 7.5 x 105 Absent USA IFCN, 2006; CDFA, 2008 
< 4.99 x 105 Absent Canada IFCN, 2006; CDFA, 2008 
< 4 x 105 Absent France IFCN, 2006; CDFA, 2008 
< 4 x 105 Absent Sweden IFCN, 2006; CDFA, 2008 
< 106 Absent Russian IFCN, 2006 
< 6 x 105 Absent Israel IFCN, 2006 
< 4 x 105 Absent South Africa IFCN, 2006 
< 7 x 105 Absent Brazil IFCN, 2006 
< 5 x 105 Absent China IFCN, 2006 
< 2.5 x 105 Absent Australia IFCN, 2006 
Table 6. Commonly used safety limits of somatic cell count and drug residue for raw milk 
employed in selected countries 
In many countries, a standard for Grade ‘A’ raw milk is an SPC of <10 ml-1 for milk  
intended for heat treatment before consumption or further processing. For milk that is to be  
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Milk product Microorganism Maximum limit (cfu/ml or g) 
Raw cow’s milk intended  
for processing 
Total bacteria 105 
Staphylococcus aureus 2 x 103 
Raw cow’s milk intended  
for direct human consumption 
Salmonella Absent in 25g 
S. aureus 5 x 102 
Total bacteria 5 x 104 
Pasteurized drinking milk Pathogenic microorganisms Absent in 25g 
Coliforms 5 
Total bacteria 5 x 105 
UHT milk and sterilized milk Total bacteria 100 
Cheese made from raw and  
thermized milk 
Listeria monocytogenes Absent in 1g hard cheese or in 
25g other cheese varieties 
Salmonella Absent in 1g 
S. aureus 104 
E. coli 105 
Soft cheese made from  
heat treated milk 
L. monocytogenes Absent in 25g 
Salmonella Absent in 1g 
S. aureus 103 
E. coli 103 
Coliforms 105 
Fresh cheese L. monocytogenes Absent in 25g 
Salmonella Absent in 1g 
S. aureus 100 
Butter L. monocytogenes Absent in 25g 
Salmonella Absent in 1g 
Coliforms 10 
Powdered milk and  
milk based products 
L. monocytogenes Absent in 1g 
Salmonella Absent in 1g 
S. aureus 100 
Coliforms 10 
Frozen milk based products L. monocytogenes Absent in 1g 
Salmonella Absent in 1g 
S. aureus 100 
Coliforms 100 
Total bacteria 105 
Liquid milk based products L. monocytogenes Absent in 1g 
Salmonella Absent in 1g 
Coliforms 5 
Source: Council Directives 92/46 EEC (1992) 
Table 7. Microbiological safety limits for selected milk products in community legislation in 
force by the European Commission 
consumed raw, a more stringent standard is generally required because consumers of raw 
milk are at a greater risk for contracting a milk-borne illness such as salmonellosis. In 
some countries, standards adopted may depend on whether milk is refrigerated or merely 
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acceptable for manufacturing grade ‘A’ milk. In contrast, in the UK no distinction is made 
between raw milk marketed for further processing and that marketed for fluid 
consumption (Chambers, 2002). Although on-farm testing and independent laboratory 
testing do not guarantee food safety, they are generally accepted means to monitor  
milk quality. In dairy developed countries, buying raw milk from a Grade ‘A’ herd 
assures that the milk is tested for pathogens on a regular basis therefore is fit for further 
processing and consumption (Walstra et al., 2006). Quality related safety limits practiced 
in selected countries are presented in Table 6, while Table 7 depicts microbiological safety 
limits for selected milk products in community legislation in force by the European 
Commission. 
7. Conclusion 
The microbiological properties of marketed milk and milk products in different parts of 
Ethiopia are generally below standards. This is mainly due to unhygienic conditions at one 
or more of the stages in the dairy value chain from farm to table, which in turn might be 
attributed to inadequate dairy infrastructure coupled with limited knowledge on the 
hygienic production and handling of milk and milk products. Based on experiences from a 
number of countries, it is likely that problems with effective translation of knowledge to 
practice, rather than incomplete knowledge per se, are the more important constraints to 
national progress towards improved milk quality. 
Currently, the Ethiopian dairy sector is developing and the involvement of the private sector 
is at the increase. Moreover, consumers are increasingly concerned about the quality of 
products and the production conditions. A concerted effort towards improving the qualities 
of milk and milk products and contributing to the betterment of the Ethiopian formal milk 
business is essential. This benefits both the producer through allowing entering into the 
competitive market and bringing increased income from the sale of quality products, and 
the consumer through creating access to products of acceptable quality. 
From experiences of a number of countries, putting functional quality standards, quality 
control system and payment system based on quality in place resulted not only in improved 
quality of marketed milk but also the volume of milk delivered to collection centers and 
dairies. It is important that quality standards for milk and major milk products for Ethiopia, 
should take into consideration factors such as the prevailing conditions of facilities and 
infrastructures required for dairy development; the existing quality standards currently in 
use in different countries; and the actual qualities of milk and milk products being marketed 
in different parts of Ethiopia. Such an approach will improve the Ethiopian formal milk 
business.  
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1. Introduction 
Lymphoid malignancy is a remarkable disease because of its difference in epidemiology and 
etiology in different areas around the world. Several features of the epidemiology  
of lymphoid malignancy particularly stand out. The overall lymphoid malignancy incidence 
in Asian countries is relatively low. Histopathologic subtypes of lymphoma are different  
in eastern and western countries and generally similar among Asian countries.  
Differences in geographic distribution are striking for follicular lymphoma, which is  
less common in eastern countries than elsewhere. Asians have higher rates of aggressive 
NHL (Non-Hodgkin Lymphoma), T-cell lymphomas, and extra-nodal disease. Hodgkin's 
Lymphoma (HL) is relatively rare in Asian countries, and its subtypes are various in 
comparison with other areas. 
While for most cancers incidence and mortality are decreasing, the incidence rates of all 
subtypes of NHL have increased during the second half of the twentieth century, but the 
reason is poorly understood. This rise has been noted worldwide, in both genders, 
particularly in the elderly, and increase in high-grade NHL is predominant. Increase in NHL 
may be attributed to immunodeficiency, radiation, various infections, blood transfusion, 
familial aggregation, genetic susceptibility to NHL, chemical exposures to pesticides and 
solvents, and diet. Some studies also suggest that association between risk factors and 
specific NHL subtypes may be stronger than association between the same risk factors and 
NHL in aggregate. In addition the mentioned risk factors are different in various areas; 
therefore it may cause different distribution of lymphoid malignancy around the world. 
Geographic variation in lymphoma rate suggests the importance of environmental and gens 
effects. Risks for developing NHL include immunosuppression a causal link between 
infectious agents and lymphomagenesis, which have also been determined, particularly for 
human T-cell leukemia/lymphoma virus type1 (HTLV-1), Epstein– Barr virus (EBV), Helicobacter 
pylori infections and Hepatitis C Viruses (HCV)infection, which are relatively frequent in our 
area. In addition to the incidence of non-Hodgkin’s lymphoma and its histological subtypes 
in Asian migrants to the United States which is lower in first-generation migrants, 
confirmed this suggestion. Other exogenous factors which have been implicated in 
lymphomagenesis, mentioned earlier, are used more without any protection in developing 
countries. They may play an important role in these differences. 
In this chapter we compare our findings with the data from other relevant studies available 
in literature from various parts of Asia, as well as with those of Western countries in an 
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attempt to gain more insights into the differences between the Oriental and Western 
countries. In addition, because most different are related to etiologic factors, we also 
describe some of them. 
2. Non-Hodgkin Lymphoma  
Non-Hodgkin lymphoma is a heterogeneous group of B-cell and T-cell neoplasm that arise 
primarily in the lymph nodes with varied clinical and biologic feature. Current classification 
system include the Revised European-American Lymphoma (REAL) classification and the 
World Health Organization (WHO) classification of hematopoietic and lymphoid neoplasms 
(Alexander, et al., 2007). The distribution of NHL types varies internationally (Anderson, 
Armitage, & Weisenburger, 1998). Epidemiological investigation of the NHL and its etiology 
may result in a better understanding and hence prevention.  
2.1 Descriptive epidemiology  
Based on World Health Organization (WHO) classification,36 subtype of NHL (21 of B-cell 
and 15 of T-cell type) are recognized (Ekström-Smedby, 2006). NHL is the most common in 
the developed world, with the highest incidence in USA, Australia and New Zealand, and 
Europe, and the lowest in eastern and South central Asia (Ekström-Smedby, 2006). The age 
standardized incidence of NHL, around the year 2000, was estimated at approximately 10-
14 per 100000 person-year in western countries, and 3 per 100000 in South central Asia 
(Parkin, Bray, Ferlay, & Pisani, 2005). 
In recent decades, there has been a dramatic increase in NHL incidence worldwide, of about 
2-4% annually (Baris & Zahm, 2000). This increase has been occurred in both males and 
females in all age groups except the very young and in black and whites (Weisenburger, 
1994). Racial differences have not been observed in age-specific incidence curves until the 
age of 45 for males and 35 for females, however over these ages, NHL develops more 
frequently in whites than blacks (Müller, Ihorst, Mertelsmann, & Engelhardt, 2005). The 
highest increase was observed in western countries, but this increase is no limited to these 
countries, and it has been observed in eastern countries such as India, Japan, Singapore 
(Devesa & Fears, 1992). Several reasons including: recategorisation of borderline type of 
lymphoma; less histopathological misdiagnosis of NHL as Hodgkin's disease; greater use of 
immunohistological techniques to examine cancer of uncertain cell type and coding effects, 
may account for part of the increase (A. J. Swerdlow, 2003). The general trends in western 
countries has been a dramatic increase in incidence in young men in areas where AIDS has 
become common (Morton, et al., 2006). 
The median age of NHL in Asian countries is significantly lower, compared to the 
population-based registration in western countries. The Hematological Malignancy 
Research Network reported that the median age of their patients was 68 years old (Smith, et 
al., 2010). However the median age in Asian countries is about 54 years old, in Iranian 
patients was 55 years old (Mozaheb, Aledavood, & Farzad, 2011), in the Korean patients 52 
years (Y.-H. Ko, et al., 1998), in Taiwan 54 years (Lee, Tan, Feng, & Liu, 2005), and in a 
previous study in Japan 54.5 years (Aozasa, et al., 1985), but in a recent study in Japan it was 
66 years (Aoki, et al., 2008). It is notable that the median age of Asian patients at the time of 
presentation was younger than in the western countries and it might be attributable to the 
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lower frequency of lymph node type lymphoma, and higher frequency of T-cell lymphoma, 
which comes as follows. 
Geographically related variation in the incidence of histopathologic distribution and clinical 
feature of NHL are well recognized (Shih & Liang, 1991). T-cell leukemia lymphoma occurs 
more frequently in southwest Japan, and the Caribbean basin (Takatsuki, 1990), northeast of 
Iran (Mashhad) (Abbaszadegan, et al., 2003); follicular lymphoma (FL) occurs less frequently 
in eastern countries (Intragumtornchai, et al., 1996; Mozaheb, et al., 2011; Ohshima, 
Suzumiya, & Kikuchi, 2002), and Immunoproliferative Small Intestinal Disease (IPSID) is the 
most prevalent in the Middle east and Africa (Khojasteh & Haghighi, 1990).  
2.1.1 Immunologic characterization of non-Hodgkin's lymphoma  
Although B-cell lymphomas are constantly more common around the world, T-cell 
lymphomas are proportionally more common in Asia than in western countries (Müller, et 
al., 2005). Despite a higher percentage of T-cell lymphomas in Asians compared with 
westerns, the absolute incidences of T-NHL in HTLV1 non endemic areas, and western 
countries are quite similar when calculated by age-adjusted incidence (Aoki, et al., 2008; Au, 
et al., 2005; Wang, Young, Win, & Taylor, 2005). In a Chinese (non endemic area for HTLV1) 
study T-cell lymphoma proportion was 28.1% (Wang, et al., 2005), and also in Taiwan which 
is not endemic for HTLV1, T/NK lymphoma incidence was 12.4% (Lee, Tsou, Tan, & Lu, 
2005). In an Indian study T-cell lymphomas formed 16.2% of the total NHL (Naresh, 
Srinivas, & Soman, 2000). Previous Japanese studies have reported a higher proportion of T-
cell lymphoma, accounting for approximately 32-38% of non-Hodgkin lymphoma (Kadin, 
Berard, Nanba, & Wakasa, 1983; Pathologists, 2000), but the recent findings in Japan show 
the decreased frequency of T/NK cell lineage (25%) (Aoki, et al., 2008). In endemic area for 
HTLV1 in Japan, T/NK-cell neoplasm accounted for a higher percentage of lymphoid 
neoplasm, in Kyushu (30%) and Okinawa (38%), compared with other areas of Japan (18–
20%) (Aoki, et al., 2008). In one study in 1997 in Korea, in comparison with data reported in 
1992, the proportion of T-lineage lymphoma was markedly decreased (25%). At that time, 
the T-lineage of lymphoma accounted for 35.2% of malignant lymphomas (Y. H. Ko, et al., 
1998). It may be due to an increase in the frequency of B-cell lymphoma and an actual 
decrease in T/NK-cell, but the real reason remains unclear (Y. H. Ko, et al., 1998). 
2.1.2 Histological subtype of non-Hodgkin's lymphoma  
Diffuse Large B Cell Lymphoma. Among B-cell lymphomas, diffuse large B cell lymphoma 
(DLBCL) is the most common non-Hodgkin’s Lymphoma representing approximately one 
third of all Non-Hodgkin’s Lymphomas worldwide. This is one type of Non Hodgkin’s 
Lymphoma in which the relative incidence does not seem to vary geographically (Mozaheb, 
et al., 2011). In almost all parts of the world this is the most frequent occurring non-
Hodgkin’s lymphoma (K. E. Hunt & Reichard, 2008). In some studies like a recent study in 
Mashhad, Iran (Mozaheb, et al., 2011) there was a higher rate of aggressive NHL specially, 
diffuse large B cell lymphoma which occurs more frequent than others. It may be related to 
the etiology of diffuse large B cell lymphoma such as immune deficient conditions and their 
treatments which in most instances caused aggressive non-Hodgkin’s lymphoma, and we 
should consider that a comparative excess of DLBCL resulting in a deficit of follicular 
lymphoma. In addition genetic factors may have an important role in this difference. 
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1994). Racial differences have not been observed in age-specific incidence curves until the 
age of 45 for males and 35 for females, however over these ages, NHL develops more 
frequently in whites than blacks (Müller, Ihorst, Mertelsmann, & Engelhardt, 2005). The 
highest increase was observed in western countries, but this increase is no limited to these 
countries, and it has been observed in eastern countries such as India, Japan, Singapore 
(Devesa & Fears, 1992). Several reasons including: recategorisation of borderline type of 
lymphoma; less histopathological misdiagnosis of NHL as Hodgkin's disease; greater use of 
immunohistological techniques to examine cancer of uncertain cell type and coding effects, 
may account for part of the increase (A. J. Swerdlow, 2003). The general trends in western 
countries has been a dramatic increase in incidence in young men in areas where AIDS has 
become common (Morton, et al., 2006). 
The median age of NHL in Asian countries is significantly lower, compared to the 
population-based registration in western countries. The Hematological Malignancy 
Research Network reported that the median age of their patients was 68 years old (Smith, et 
al., 2010). However the median age in Asian countries is about 54 years old, in Iranian 
patients was 55 years old (Mozaheb, Aledavood, & Farzad, 2011), in the Korean patients 52 
years (Y.-H. Ko, et al., 1998), in Taiwan 54 years (Lee, Tan, Feng, & Liu, 2005), and in a 
previous study in Japan 54.5 years (Aozasa, et al., 1985), but in a recent study in Japan it was 
66 years (Aoki, et al., 2008). It is notable that the median age of Asian patients at the time of 
presentation was younger than in the western countries and it might be attributable to the 
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lower frequency of lymph node type lymphoma, and higher frequency of T-cell lymphoma, 
which comes as follows. 
Geographically related variation in the incidence of histopathologic distribution and clinical 
feature of NHL are well recognized (Shih & Liang, 1991). T-cell leukemia lymphoma occurs 
more frequently in southwest Japan, and the Caribbean basin (Takatsuki, 1990), northeast of 
Iran (Mashhad) (Abbaszadegan, et al., 2003); follicular lymphoma (FL) occurs less frequently 
in eastern countries (Intragumtornchai, et al., 1996; Mozaheb, et al., 2011; Ohshima, 
Suzumiya, & Kikuchi, 2002), and Immunoproliferative Small Intestinal Disease (IPSID) is the 
most prevalent in the Middle east and Africa (Khojasteh & Haghighi, 1990).  
2.1.1 Immunologic characterization of non-Hodgkin's lymphoma  
Although B-cell lymphomas are constantly more common around the world, T-cell 
lymphomas are proportionally more common in Asia than in western countries (Müller, et 
al., 2005). Despite a higher percentage of T-cell lymphomas in Asians compared with 
westerns, the absolute incidences of T-NHL in HTLV1 non endemic areas, and western 
countries are quite similar when calculated by age-adjusted incidence (Aoki, et al., 2008; Au, 
et al., 2005; Wang, Young, Win, & Taylor, 2005). In a Chinese (non endemic area for HTLV1) 
study T-cell lymphoma proportion was 28.1% (Wang, et al., 2005), and also in Taiwan which 
is not endemic for HTLV1, T/NK lymphoma incidence was 12.4% (Lee, Tsou, Tan, & Lu, 
2005). In an Indian study T-cell lymphomas formed 16.2% of the total NHL (Naresh, 
Srinivas, & Soman, 2000). Previous Japanese studies have reported a higher proportion of T-
cell lymphoma, accounting for approximately 32-38% of non-Hodgkin lymphoma (Kadin, 
Berard, Nanba, & Wakasa, 1983; Pathologists, 2000), but the recent findings in Japan show 
the decreased frequency of T/NK cell lineage (25%) (Aoki, et al., 2008). In endemic area for 
HTLV1 in Japan, T/NK-cell neoplasm accounted for a higher percentage of lymphoid 
neoplasm, in Kyushu (30%) and Okinawa (38%), compared with other areas of Japan (18–
20%) (Aoki, et al., 2008). In one study in 1997 in Korea, in comparison with data reported in 
1992, the proportion of T-lineage lymphoma was markedly decreased (25%). At that time, 
the T-lineage of lymphoma accounted for 35.2% of malignant lymphomas (Y. H. Ko, et al., 
1998). It may be due to an increase in the frequency of B-cell lymphoma and an actual 
decrease in T/NK-cell, but the real reason remains unclear (Y. H. Ko, et al., 1998). 
2.1.2 Histological subtype of non-Hodgkin's lymphoma  
Diffuse Large B Cell Lymphoma. Among B-cell lymphomas, diffuse large B cell lymphoma 
(DLBCL) is the most common non-Hodgkin’s Lymphoma representing approximately one 
third of all Non-Hodgkin’s Lymphomas worldwide. This is one type of Non Hodgkin’s 
Lymphoma in which the relative incidence does not seem to vary geographically (Mozaheb, 
et al., 2011). In almost all parts of the world this is the most frequent occurring non-
Hodgkin’s lymphoma (K. E. Hunt & Reichard, 2008). In some studies like a recent study in 
Mashhad, Iran (Mozaheb, et al., 2011) there was a higher rate of aggressive NHL specially, 
diffuse large B cell lymphoma which occurs more frequent than others. It may be related to 
the etiology of diffuse large B cell lymphoma such as immune deficient conditions and their 
treatments which in most instances caused aggressive non-Hodgkin’s lymphoma, and we 
should consider that a comparative excess of DLBCL resulting in a deficit of follicular 
lymphoma. In addition genetic factors may have an important role in this difference. 
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Moreover it can represent the progression/transformation (referred to as secondary) of a 
less aggressive lymphoma, such as follicular lymphoma, marginal zone B-cell lymphoma, or 
nodular lymphocyte–predominant Hodgkin’s lymphoma (K. E. Hunt & Reichard, 2008). All 
lymphoid cancers are more frequent in males than females among all age groups and in our 
study Diffuse large B cell lymphoma occurs about twice among men (Mozaheb, et al., 2011). 
This pattern suggests that the underlying environmental or behavioral factors are also 
important and must be more common in men. The most common subtypes of NHL in 
Various Geographic Locations are showed in table 1. 
Follicular Lymphoma. Incidence rates of follicular lymphoma (FL) inexplicably vary 
markedly between Asian and Western countries (Biagi & Seymour, 2002). Follicular 
lymphoma was found more frequently in North America and Europe compared to other 
geographic sites (Kim, et al., 1992). The lowest rates of follicular lymphoma have been 
reported among Asian population (Anderson, et al., 1998; Mozaheb, et al., 2011). In addition, 
the risk was lower for the first generation of migrants from China and Japan into the US in 
comparison with the subsequent migrant generations, and in Japanese-Americans in Hawaii 
it was reported to be relatively high compared with that for native Japanese and close to the 
rate of North American Caucasians (Yanagihara, Blaisdell, Hayashi, & Lukes, 1989). The 
percentage of follicular lymphoma in our study in Mashhad, IRAN, was the lowest 
observed in any site (1.4%) (Mozaheb, et al., 2011), it was near the incidence rate of NHL in a 
previous study in Korea (1.6) (Y. H. Ko, et al., 1998). Although the exact reason for this 
difference is unknown, the results of several studies suggest differences in genes and 
environmental factors such as diet habits, infections and smoking, which plays an important 
role in follicular lymphoma, are responsible. Some cytogenetic changes such as a higher 
incidence of bcl-2 translocations are seen within follicular lymphoma among individuals in 
the US than for Asian populations (Shih & Liang, 1991). It conclude that a significant 
gradient exists in the bcl-2 frequency between these FL populations, and therefore suggest 
that the relatively low incidence of FL in Asian populations is caused not by a lower 
frequency of bcl-2 rearrangements in healthy populations but by distinct molecular 
pathways developing in different geographic regions that nonetheless culminate in FL, 
which is morphologically similar but molecularly distinct (Biagi & Seymour, 2002). 
In a previous study in Japan the incidence rate of FL was 6.7% (Pathologists, 2000), but in a 
recent study in Japan they found a relatively high rate of FL (19%) similar to that of western 
countries (11-30%) (Aoki, et al., 2008). They suggest the following reasons for the relatively 
high rate of occurrence of follicular lymphomas. First, there have been improvements in the 
recognition and diagnostic accuracy for this subtype due to the development of 
comprehensive diagnostic methods including flow cytometry, immunohistochemistry, 
chromosome testing, gene testing and FISH. Second, the patients in their recent study 
comprised only initial visit cases and did not include consultation cases, because typical 
follicular lymphoma tends to be diagnosed at the initial visit and not during consultation, 
previous studies of patients in large hospitals may not have included initial visit cases and 
thus underestimated the frequency of follicular lymphoma. The third reason is the 
westernization of the Japanese lifestyle that may have contributed to an increase in follicular 
lymphoma (Aoki, et al., 2008). The rate of follicular lymphoma for Japanese– Americans in 
Hawaii was reported to be relatively high compared to that of native Japanese and close to 
the rate of North American Caucasians. A similar trend in completely follicular lymphoma 
has been reported for Korea. In one study in 1997 compared with the data reported in 1991, 
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the increase in the relative frequency of Fl (1.6% vs 6.4%) over time suggests that the 
patterns of malignant lymphoma occurrence in the Republic of Korea might be gradually 
changing, probably due to westernization and other reasons which were mentioned 
previously (Y. H. Ko, et al., 1998). 
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2010 1991/1997 2000/2006 2000 2005 2004 2000/2008 1991 2001 2006 
Total (No) 391 1165/1548 ----/598  447 1983 3025/2260 9567 10580  
NHL % 92 94.7/94.7 ----/93 2831 82.6% 92.1% 94/7/92.7  84.4  
B/T cell %  75/25 81.7/18.3 80.6/19.4 79/15.2 68.6/30.6 75/25 
68/24, 
65.2/25.4 76/24 93/7 90/10 
DLBCL % 37.8 -/43.2 47.2/39 34 35.1 50.5 33/33 41.2 41.3 28 
FL % 1.4 1.6/6.2 8.6/16.4 12.6 8.6 8.4 6.7/18.2 9.2 17 13 
MCL % 2.2 -/1.5 ----/4 3.4 2.6 1.5 2.7/2.7  3.7 2 
MALT 
lymphoma% 2.2 -/0.6 6.1/5.6 8.2 11.7 5.5 8.4/4.2 8.7 3.6 3.7 
SLL/CLL % 23.9 -/2.3  5.6 3.6 3.4 1.4/1.4   20 
NK/T cell 




1.9 -/9.4 19.3/3.8 1.9 12 13.1 6.6/4.5 9.7 5.9 6 
ATLL % 1.4 -/0.1  rare rare  7.4/10  rare rare 
HL % 8 5.3/5.3 ----/7  13.9 7.9 4.4/7.3  15.6 8 
Table 1. The Most Common subtypes of NHL in Various Geographic Locations 
In the analysis of 1983 cases of malignant lymphoma in Thailand shows that Bangkok has a 
significantly high frequency of FL, much higher than that the Central region. They suggest 
that the underlying reason for this observation is not known. Obviously, Metropolitan 
Bangkok has a more diverse population, migrated from various geographical locations, than 
people in the Central region (Sukpanichnant, 2004). A clinicopathological analysis of 598 
Malignant Lymphomas in Taiwan during the period of 1995–2002 was retrieved, and their 
data showed a similar incidence of FL (16.4%) to that in Western countries (Lee, Tan, et  
al., 2005).  
Mantle cell Lymphoma (MCL) in a case series has been between 2 and 10% of all NHL. The 
incidence rate is approximately similar around the world (table 1) and it is about 0.5 cases 
per 100000 person-year, with male to female ratio 2.3-2.5:1, and a median age at diagnosis is 
about 70 years. Relative association of MCL risk with Borrelia burgdorferi infection, family 
history of hematopoietic malignancies, and genetic variation in the interleukin 10 and tumor 
necrosis factor genes have been reported, but finding remain unconfirmed (Smedby & 
Hjalgrim., 2011).  
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Moreover it can represent the progression/transformation (referred to as secondary) of a 
less aggressive lymphoma, such as follicular lymphoma, marginal zone B-cell lymphoma, or 
nodular lymphocyte–predominant Hodgkin’s lymphoma (K. E. Hunt & Reichard, 2008). All 
lymphoid cancers are more frequent in males than females among all age groups and in our 
study Diffuse large B cell lymphoma occurs about twice among men (Mozaheb, et al., 2011). 
This pattern suggests that the underlying environmental or behavioral factors are also 
important and must be more common in men. The most common subtypes of NHL in 
Various Geographic Locations are showed in table 1. 
Follicular Lymphoma. Incidence rates of follicular lymphoma (FL) inexplicably vary 
markedly between Asian and Western countries (Biagi & Seymour, 2002). Follicular 
lymphoma was found more frequently in North America and Europe compared to other 
geographic sites (Kim, et al., 1992). The lowest rates of follicular lymphoma have been 
reported among Asian population (Anderson, et al., 1998; Mozaheb, et al., 2011). In addition, 
the risk was lower for the first generation of migrants from China and Japan into the US in 
comparison with the subsequent migrant generations, and in Japanese-Americans in Hawaii 
it was reported to be relatively high compared with that for native Japanese and close to the 
rate of North American Caucasians (Yanagihara, Blaisdell, Hayashi, & Lukes, 1989). The 
percentage of follicular lymphoma in our study in Mashhad, IRAN, was the lowest 
observed in any site (1.4%) (Mozaheb, et al., 2011), it was near the incidence rate of NHL in a 
previous study in Korea (1.6) (Y. H. Ko, et al., 1998). Although the exact reason for this 
difference is unknown, the results of several studies suggest differences in genes and 
environmental factors such as diet habits, infections and smoking, which plays an important 
role in follicular lymphoma, are responsible. Some cytogenetic changes such as a higher 
incidence of bcl-2 translocations are seen within follicular lymphoma among individuals in 
the US than for Asian populations (Shih & Liang, 1991). It conclude that a significant 
gradient exists in the bcl-2 frequency between these FL populations, and therefore suggest 
that the relatively low incidence of FL in Asian populations is caused not by a lower 
frequency of bcl-2 rearrangements in healthy populations but by distinct molecular 
pathways developing in different geographic regions that nonetheless culminate in FL, 
which is morphologically similar but molecularly distinct (Biagi & Seymour, 2002). 
In a previous study in Japan the incidence rate of FL was 6.7% (Pathologists, 2000), but in a 
recent study in Japan they found a relatively high rate of FL (19%) similar to that of western 
countries (11-30%) (Aoki, et al., 2008). They suggest the following reasons for the relatively 
high rate of occurrence of follicular lymphomas. First, there have been improvements in the 
recognition and diagnostic accuracy for this subtype due to the development of 
comprehensive diagnostic methods including flow cytometry, immunohistochemistry, 
chromosome testing, gene testing and FISH. Second, the patients in their recent study 
comprised only initial visit cases and did not include consultation cases, because typical 
follicular lymphoma tends to be diagnosed at the initial visit and not during consultation, 
previous studies of patients in large hospitals may not have included initial visit cases and 
thus underestimated the frequency of follicular lymphoma. The third reason is the 
westernization of the Japanese lifestyle that may have contributed to an increase in follicular 
lymphoma (Aoki, et al., 2008). The rate of follicular lymphoma for Japanese– Americans in 
Hawaii was reported to be relatively high compared to that of native Japanese and close to 
the rate of North American Caucasians. A similar trend in completely follicular lymphoma 
has been reported for Korea. In one study in 1997 compared with the data reported in 1991, 
 
Epidemiology of Lymphoid Malignancy in Asia 
 
329 
the increase in the relative frequency of Fl (1.6% vs 6.4%) over time suggests that the 
patterns of malignant lymphoma occurrence in the Republic of Korea might be gradually 
changing, probably due to westernization and other reasons which were mentioned 
previously (Y. H. Ko, et al., 1998). 
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Total (No) 391 1165/1548 ----/598  447 1983 3025/2260 9567 10580  
NHL % 92 94.7/94.7 ----/93 2831 82.6% 92.1% 94/7/92.7  84.4  
B/T cell %  75/25 81.7/18.3 80.6/19.4 79/15.2 68.6/30.6 75/25 
68/24, 
65.2/25.4 76/24 93/7 90/10 
DLBCL % 37.8 -/43.2 47.2/39 34 35.1 50.5 33/33 41.2 41.3 28 
FL % 1.4 1.6/6.2 8.6/16.4 12.6 8.6 8.4 6.7/18.2 9.2 17 13 
MCL % 2.2 -/1.5 ----/4 3.4 2.6 1.5 2.7/2.7  3.7 2 
MALT 
lymphoma% 2.2 -/0.6 6.1/5.6 8.2 11.7 5.5 8.4/4.2 8.7 3.6 3.7 
SLL/CLL % 23.9 -/2.3  5.6 3.6 3.4 1.4/1.4   20 
NK/T cell 




1.9 -/9.4 19.3/3.8 1.9 12 13.1 6.6/4.5 9.7 5.9 6 
ATLL % 1.4 -/0.1  rare rare  7.4/10  rare rare 
HL % 8 5.3/5.3 ----/7  13.9 7.9 4.4/7.3  15.6 8 
Table 1. The Most Common subtypes of NHL in Various Geographic Locations 
In the analysis of 1983 cases of malignant lymphoma in Thailand shows that Bangkok has a 
significantly high frequency of FL, much higher than that the Central region. They suggest 
that the underlying reason for this observation is not known. Obviously, Metropolitan 
Bangkok has a more diverse population, migrated from various geographical locations, than 
people in the Central region (Sukpanichnant, 2004). A clinicopathological analysis of 598 
Malignant Lymphomas in Taiwan during the period of 1995–2002 was retrieved, and their 
data showed a similar incidence of FL (16.4%) to that in Western countries (Lee, Tan, et  
al., 2005).  
Mantle cell Lymphoma (MCL) in a case series has been between 2 and 10% of all NHL. The 
incidence rate is approximately similar around the world (table 1) and it is about 0.5 cases 
per 100000 person-year, with male to female ratio 2.3-2.5:1, and a median age at diagnosis is 
about 70 years. Relative association of MCL risk with Borrelia burgdorferi infection, family 
history of hematopoietic malignancies, and genetic variation in the interleukin 10 and tumor 
necrosis factor genes have been reported, but finding remain unconfirmed (Smedby & 
Hjalgrim., 2011).  
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T cell lymphomas are very complicated, based on WHO classification, there are various 
subtypes, and different types of them are different in various area of the world and some are 
extremely rare, occurring in a few patients per year throughout the world. Major T cell NHL 
types were reported in the international study in about 1300 patients 22 sites in different 
countries. Based on this study the most common subtype of T cell lymphoma in North 
American (NA) was PTCL (unspecified), in Europe was Angioimmunoblastic T cell 
lymphoma (AITL), and in Asia was Natural Killer T cell lymphoma (NKTCL) and ATLL 
(Foss, et al., 2011). This variation may reflect exposure or genetic susceptibility to pathogenic 
agents such as EBV and HTLV1 in Asian countries. Table 2 showed the major T cell subtype 
of NHL in different area (Vose, et al., 2008). 
 
% PTCL AITL Anaplastic NKT CL ATLL 
NA 34.4 16 23.8 5.1 2 
Europe 34.3 28.7 15.8 4.3 1 
Asia 22.4 17.9 5.8 22.4 25 
Table 2. Major subtype of T cell lymphoma by region 
Generally speaking an increasing incidence in lymphoma reported from western countries is 
also seen in Asia, albeit at a lower rate (Shih & Liang, 1991).Essential differences in the 
incidence and distribution of major NHL subtypes among different geographic areas were 
seen which seems to be related to host, racial and environmental differences (Atichartakarn, 
et al., 1982), but these differences gradually changes in recent reports, this shows that the 
environmental factors probably are more important than the genes. 
2.1.3 Extra-nodal non-Hodgkin Lymphoma  
Non-Hodgkin lymphoma arises in lymphatic cell in other organs except lymphatic tissues, 
called extra-nodal lymphoma. Some authors believe that, specific local factors may play an 
etiologic role in the development of lymphomas at certain extra-nodal sites e.g., 
Helicobacter pylori infection is associated with primary gastric lymphoma, but not with 
lymphoma at other sites (Parsonnet, et al., 1994b; Wotherspoon, et al., 1993). There are 
geographical and ethnic differences in the incidence of extra-nodal lymphomas (Newton, 
Ferlay, Beral, & Devesa, 1997). 
The frequency of primary extra-nodal NHL in Asia Varied from 28.5 to 45% (Shih & Liang, 
1991), it is similar to Europe, but slightly more common than united states: Denmark 37% 
(d'Amore, et al., 1991), India 22% (Advani, et al., 1990), Hawaii-Japanese 34% (Yanagihara, et 
al., 1989), Lebanon 44% (P. Salem, et al., 1986), Chinese Hong Kong 28% (Ho, Todd, Loke, 
Ng, & Khoo, 1984), USA 25% (Freeman, Berg, & Cutler, 1972), Italy 48%, East Germany 47% 
(Newton, et al., 1997). 
The incidence of extra-nodal NHL in Western countries has increased substantially in the 
last 40 years. This may be due to improved diagnostic procedures (particularly in 
gastrointestinal and brain lymphomas) and changes in classification systems, but the change 
is real and the AIDS epidemic in the 1980s does not completely explain this rise (Groves, 
Linet, Travis, & Devesa, 2000). The etiology of extra-nodal lymphomas appears to be 
multifactorial and includes immune suppression, infections both viral and bacterial, and 
exposure to pesticides and other environmental agents (Zucca, 2008). True geographic 
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differences are, however, present for example, the incidence of Epstein–Barr virus and 
human T-cell lymphotropic virus 1-associated with T-cell lymphomas is higher in Asia than 
in Europe and North America (Zucca, 2008). 
One study, which was done in 39 centers in 14 countries (USA, Europe, Asian) reported the 
most frequent extra-nodal sites of lymphoma are stomach and skin, followed by small 
intestine and tonsil (Newton, et al., 1997). In recent study extra-nodal lymphoma in Japan, 
was seen in 27% of cases, but in previous Japanese series it was 60% (Izumo, 1996). DLBCL 
was the most common type of extra-nodal lymphoma lesion primarily biopsied/resected 
(60%). The ear–nose–throat region (7.2%), gastrointestinal tract (6.0%), soft tissue (2.8%) and 
skin (2.6%) was reported in Japanese study (Aoki, et al., 2008). A clinical analysis in 
Republic Korea revealed that the rate of extra-nodal lymphoma exceeded that of lymph 
node lymphoma (63.3% vs. 36.7%) (Y.-H. Ko, et al., 1998). As in other Far East countries, 
Korea has a relatively high rate of angiocentric lymphomas, which more than 70% of them 
arise in the nose and paranasal sinus. EBV was positive in 80% of nasal and paranasal 
angiocentric lymphomas. (Ko & Lee, 1994, 1996). In a study in Thailand, extra-nodal 
involvement was found in 1072 of 1826 cases (58.7%) of NHL. The frequency of B-cell NHL 
in cases of NHL involving extra-nodal sites was 72.9%, whereas the frequency of nodal B-
cell NHL was 78.0%. Thus, a higher frequency of T-cell NHL involving extra-nodal sites and 
a higher frequency of B-cell NHL involving lymph nodes were significant when compared 
to the overall NHL (P <0.05). In the Thailand study, among the extra-nodal sites involved in 
NHL, the upper aerodigestive tract (including the tonsils, sinonasal region, oral cavity, and 
nasopharynx) was the most common site. The second most common site was the 
gastrointestinal tract, including the stomach and intestine (Sukpanichnant, 2004). These 
studies shows that extra-nodal NK/T cell lymphoma is more prevalent in far east and is 
closely related to EBV infection (Jaffe, 1999; Jaffe, et al., 1996). 
Immunoproliferative small intestinal disease (IPSID) or α heavy chain disease is mostly 
found in young adults of low socioeconomic class in developing countries or in indigent 
immigrant population within western countries. Relatively high incidence rates of small 
intestinal lymphoma have been reported before in the Middle east, Mediterranean region, 
South and central Africa, Mexico, and South America, but is rare in Southeast Asia 
(Pramoolsinsap, Kurathong, Atichartakarn, & Nitiyanand, 1993). 
IPSID was one of the most common small intestinal malignancy in the Middle East (Azar, 
1962). Early infectious stress in infancy and chronic antigenic stimulation along with genetic 
factors are probably important in the pathogenesis of IPSID (Khojasteh, Haghshenass, & 
Haghighi, 1983). It showed that Campylobacter jejune were present in 5/7 cases of IPSID in 
one study and 12/27 (47%) cases in other and 14/87 (16%) cases of other intestinal 
lymphoma. Eradication of the organism with antibiotics lead to complete remission of IPSID 
(Du, 2007). 
In one series of 161 patients with IPSID in Shiraz (Iran), they observed a dramatic decrease 
in the incidence of the disease over the past decade. After the Islamic revolution in Iran, 
improving sanitation in villages was one of the priorities of the many health strategies in 
Iran. Access to sanitary drinking water in rural areas increased from 35% before 1988 to 80% 
a decade later. Vaccination programs increased dramatically after the Islamic revolution, 
reaching more than 90% of children. Local health facilities increased significantly during the 
first two decades after the revolution. They suggest that improvement of health in general 
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T cell lymphomas are very complicated, based on WHO classification, there are various 
subtypes, and different types of them are different in various area of the world and some are 
extremely rare, occurring in a few patients per year throughout the world. Major T cell NHL 
types were reported in the international study in about 1300 patients 22 sites in different 
countries. Based on this study the most common subtype of T cell lymphoma in North 
American (NA) was PTCL (unspecified), in Europe was Angioimmunoblastic T cell 
lymphoma (AITL), and in Asia was Natural Killer T cell lymphoma (NKTCL) and ATLL 
(Foss, et al., 2011). This variation may reflect exposure or genetic susceptibility to pathogenic 
agents such as EBV and HTLV1 in Asian countries. Table 2 showed the major T cell subtype 
of NHL in different area (Vose, et al., 2008). 
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etiologic role in the development of lymphomas at certain extra-nodal sites e.g., 
Helicobacter pylori infection is associated with primary gastric lymphoma, but not with 
lymphoma at other sites (Parsonnet, et al., 1994b; Wotherspoon, et al., 1993). There are 
geographical and ethnic differences in the incidence of extra-nodal lymphomas (Newton, 
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is real and the AIDS epidemic in the 1980s does not completely explain this rise (Groves, 
Linet, Travis, & Devesa, 2000). The etiology of extra-nodal lymphomas appears to be 
multifactorial and includes immune suppression, infections both viral and bacterial, and 
exposure to pesticides and other environmental agents (Zucca, 2008). True geographic 
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differences are, however, present for example, the incidence of Epstein–Barr virus and 
human T-cell lymphotropic virus 1-associated with T-cell lymphomas is higher in Asia than 
in Europe and North America (Zucca, 2008). 
One study, which was done in 39 centers in 14 countries (USA, Europe, Asian) reported the 
most frequent extra-nodal sites of lymphoma are stomach and skin, followed by small 
intestine and tonsil (Newton, et al., 1997). In recent study extra-nodal lymphoma in Japan, 
was seen in 27% of cases, but in previous Japanese series it was 60% (Izumo, 1996). DLBCL 
was the most common type of extra-nodal lymphoma lesion primarily biopsied/resected 
(60%). The ear–nose–throat region (7.2%), gastrointestinal tract (6.0%), soft tissue (2.8%) and 
skin (2.6%) was reported in Japanese study (Aoki, et al., 2008). A clinical analysis in 
Republic Korea revealed that the rate of extra-nodal lymphoma exceeded that of lymph 
node lymphoma (63.3% vs. 36.7%) (Y.-H. Ko, et al., 1998). As in other Far East countries, 
Korea has a relatively high rate of angiocentric lymphomas, which more than 70% of them 
arise in the nose and paranasal sinus. EBV was positive in 80% of nasal and paranasal 
angiocentric lymphomas. (Ko & Lee, 1994, 1996). In a study in Thailand, extra-nodal 
involvement was found in 1072 of 1826 cases (58.7%) of NHL. The frequency of B-cell NHL 
in cases of NHL involving extra-nodal sites was 72.9%, whereas the frequency of nodal B-
cell NHL was 78.0%. Thus, a higher frequency of T-cell NHL involving extra-nodal sites and 
a higher frequency of B-cell NHL involving lymph nodes were significant when compared 
to the overall NHL (P <0.05). In the Thailand study, among the extra-nodal sites involved in 
NHL, the upper aerodigestive tract (including the tonsils, sinonasal region, oral cavity, and 
nasopharynx) was the most common site. The second most common site was the 
gastrointestinal tract, including the stomach and intestine (Sukpanichnant, 2004). These 
studies shows that extra-nodal NK/T cell lymphoma is more prevalent in far east and is 
closely related to EBV infection (Jaffe, 1999; Jaffe, et al., 1996). 
Immunoproliferative small intestinal disease (IPSID) or α heavy chain disease is mostly 
found in young adults of low socioeconomic class in developing countries or in indigent 
immigrant population within western countries. Relatively high incidence rates of small 
intestinal lymphoma have been reported before in the Middle east, Mediterranean region, 
South and central Africa, Mexico, and South America, but is rare in Southeast Asia 
(Pramoolsinsap, Kurathong, Atichartakarn, & Nitiyanand, 1993). 
IPSID was one of the most common small intestinal malignancy in the Middle East (Azar, 
1962). Early infectious stress in infancy and chronic antigenic stimulation along with genetic 
factors are probably important in the pathogenesis of IPSID (Khojasteh, Haghshenass, & 
Haghighi, 1983). It showed that Campylobacter jejune were present in 5/7 cases of IPSID in 
one study and 12/27 (47%) cases in other and 14/87 (16%) cases of other intestinal 
lymphoma. Eradication of the organism with antibiotics lead to complete remission of IPSID 
(Du, 2007). 
In one series of 161 patients with IPSID in Shiraz (Iran), they observed a dramatic decrease 
in the incidence of the disease over the past decade. After the Islamic revolution in Iran, 
improving sanitation in villages was one of the priorities of the many health strategies in 
Iran. Access to sanitary drinking water in rural areas increased from 35% before 1988 to 80% 
a decade later. Vaccination programs increased dramatically after the Islamic revolution, 
reaching more than 90% of children. Local health facilities increased significantly during the 
first two decades after the revolution. They suggest that improvement of health in general 
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and decreasing childhood gastroenteritides in particular has resulted in a decrease in the 
incidence of IPSID. This report highlights the almost complete disappearance of a malignant 
disease from a region where it was once very common. This changes probably related to 
changes in environmental factors, decreasing exposure to infectious agents (Lankarani, et 
al., 2005). Other preliminary recent epidemiological data has also shown a decrease in the 
incidence of this disease in endemic areas; therefore, environmental factors are suspected to 
play an important role in its pathogenesis (P. A. Salem & Estephan, 2005).  
2.2 Epidemiologic etiology  
2.2.1 Immunodeficiency and autoimmune disease  
Immunodeficiency, including acquired conditions and congenital disease, is the strongest 
factor known to increase NHL risk (Chiu & Weisenburger, 2003). About 25% of patients 
with congenital immunodeficiency syndromes such as Wiskott-Aldrich syndrome, ataxia 
telangiectasia and severe combined immunodeficiency, will develop tumors during their 
lifetime, which NHL accounting for 50% of them. It seems that these patients unable to 
promptly eliminate respiratory and gastrointestinal pathogens due to defects in formation of 
specific protective antibodies and are susceptible to chronic antigenic stimulation 
(Filipovich, Mathur, Kamat, & Shapiro, 1992).  
High rate of NHL also have been observed among individual with iatrogenic 
immunosuppression (i.e. organ or blood stem cell transplantation recipients, long term 
survivors of Hodgkin's lymphoma), variety of autoimmune disease, and Acquired 
immunodeficiency syndrome (AIDS). Although immunosuppressive drug use in the 
treatment of these conditions may cause an increase in NHL incidence, evidence suggests 
that the persistent inflammatory activity of the autoimmune process may have a direct 
relation with increase risk of lymphomagenesis. One study showed that these conditions 
may be accompanied by impaired T-cell function, which interferes with an immune 
response to virus and emerging malignant cells. NHL due to secondary immunodeficiency 
is associated with the presence of EBV infection, and tumors are characterized by high grad, 
and proclivity for extra-nodal sites (Fisher & Fisher, 2004). Based on these data 
immunodeficiency may be more common in some area which aggressive lymphoma is more 
common such as Asian countries. 
Autoimmune disorders that are strongly associated with NHL are Sjogren’s syndrome, 
systemic lupus erythematosus (SLE), rheumatoid arthritis, and celiac disease (CD). There is 
no evidence to support excess risk of NHL in other autoimmune disorders. One study 
demonstrated a 25-fold increase in the risk of NHL among persons with highly 
inflammatory RA as compared to a similar group having low inflammatory disease; this risk 
was independent of treatment (Fisher & Fisher, 2004). Finding in the other study suggests 
that the excess risk of NHL in RA patients may be a result of the disease or its treatment, 
rather than shared genetic susceptibility (Ekström, et al., 2003; Kinlen, 1992). 
Celiac disease is an autoimmune digestive disease which is caused by an immune response 
to the protein gluten. Untreated CD is associated with increased risk of lymphoma, mostly 
with origins from gastrointestinal mucosa. The pathogenesis behind this association is not 
fully understood, but greater permeability to environmental carcinogenesis, release of 
proinflammatory cytokines , and chronic antigenic stimulation are among the suggested 
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mechanisms. Also a correlation between the duration of gluten exposure and the incidence 
of lymphoma has been found. The relative risk of lymphoma is reduced by a gluten free diet 
(Jafroodi, Zargari, & Hoda, 2009). In a US cohort study, an increased risk of NHL was 
reported in patients with celiac disease (SMR = 9.1, 95% CI: 4.7-13.0). Similarly, a relative 
risk of 5.8 (95% CI: 1.58-14.86) was observed in a UK cohort (Alexander, et al., 2007).  
The incidence of CD is increasing among certain populations in Africa (Saharawui 
population), Asia (India), and the Middle East (Cummins & Roberts Thomson, 2009). In 
Asian populations, including the Japanese, CD and the associated NHL have been supposed 
to be quite rare, and studies concerning the frequency of CD or its relationship with NHL 
are scarce. A Japanese case report describes a Japanese middle-aged man with intestinal 
diffuse large B-cell lymphoma associated with CD. Following multi-combined 
chemotherapy, the patient's lymphoma has received complete response, and his GI 
symptoms have improved with a gluten free diet (Makishima, et al., 2006). Also an Iranian 
case report describes a child with Hodgkin's disease and sever atopic dermatitis associated 
with CD (Arellano, et al., 2009). These cases suggest that the possibility of CD and its 
association with lymphoid malignancy should be kept in mind, even in Asian populations.  
2.2.2 Infectious agents  
Epidemiological studies pointed towards a viral and bacterial etiology on NHL. In this part 
we discuss about some of them which are more important. 
Epstein-Barr virus (EBV). The Epstein-Barr virus has a worldwide distribution, which 
greater than 80% of people over the age of 30 are infected. Once EBV infection has occurred, 
it remains for the lifetime of the individual (Serraino, et al., 2005). Infection with this virus 
usually occurs in children, but can also occur in adolescence or adulthood. EBV 
asymptomatically establishes persistent infections however, due to effective immune 
control, only a minority of infected carriers develop spontaneous EBV-associated lymphoma 
(Heller, Steinherz, Portlock, & Munz, 2007). Infection by EBV is more common in 
developing countries where sanitation, hygiene, and cooking are not as sterile as nations 
such as the USA (Evans & Kaslow, 1997).  
EBV has a unique set of genes that causes a growth activation of the B-cells that are infected. 
Sometime the growth activating genes may cause the infected B-cell to transform into cancer in 
certain people. The most common type of lymphoma caused by EBV are T-cell lymphoma, 
Post-transplant lymphoma, AIDS associated lymphoma, Burkitt's lymphoma (BL), and 
Hodgkin's lymphoma. These EBV-associated neoplasms are characterized by peculiar 
geographic distributions and distinctive epidemiologic features (Serraino, et al., 2005) . 
In the endemic areas of Africa, BL is the leading childhood cancer, occurring as many as 4-5 
cases per 100000. In areas where EBV infection occurs at a very early age and malaria is 
holoendemic, the incidence of association with BL is highest. In African countries in the 
lymphoma belt there is a very high association between BL and EBV (90%). However, in 
France and the US, the rare cases of BL are only associated with EBV in 10-15% of all 
reported cases (Frimpong-Boateng). 
Induced immunosuppretion, necessary for the transplant to be accepted, leads to a loss of 
control over EBV infection. The lymphoma that is developed contains parts of the latent 
EBV genome. About half of NHL tumors accompanying HIV1 infections are EBV positive. 
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mechanisms. Also a correlation between the duration of gluten exposure and the incidence 
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asymptomatically establishes persistent infections however, due to effective immune 
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Induced immunosuppretion, necessary for the transplant to be accepted, leads to a loss of 
control over EBV infection. The lymphoma that is developed contains parts of the latent 
EBV genome. About half of NHL tumors accompanying HIV1 infections are EBV positive. 
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These lymphoma are grouped into several categories: small non-cleaved-cell lymphoma, 
diffuse large cell lymphoma, anaplastic large cell lymphoma, and body-cavity based 
lymphoma (Gaidano, et al., 1996). 
Several studies showed the association of Asian T cell lymphoma and evidence of EBV 
infections. Asian T-cell lymphomas are different from Western T-cell lymphoma, and are 
also associated with increased levels of cytokine production, including tumor necrosis factor 
(Dutcher, 2003). Aggressive NK-cell LGL leukemia is usually a rapidly progressive disorder 
associated with EBV, with a higher prevalence in Asia and South America (Sokol & 
Loughran, 2006). 
Human T-Cell Lymphotrophic virus-1 (HTLV1). HTLV1, the first human retrovirus to be 
discovered, is estimated to infect 10-20 million people worldwide (De Thé & Bomford, 1993). 
Infection with HTLV1 is strongly related to adult T-cell leukemia/ Lymphoma (Hinuma, et 
al., 1981) and HTLV1 associated myelopathy (Morgan, Mora, Rodgers-Johnson, & Char, 
1989). HTLV1 is primarily transmitted by breast feeding, blood transfusion, Sharing of 
needles and sexual transmission. The predominance of vertical transmission results in 
clustering cases in familial or geographically discrete groups. It is endemic in southern 
Japan, the Caribbean, the Melanesian island, Papua New Guinea, the Middle East, central 
and southern Africa, and South America. In these endemic areas, seroprevalences range are 
different from about one percent in Mashhad in southeast Iran (1-3%) (Abbaszadegan, et al., 
2003; Tarhini, et al., 2009) to 30 percent in rural Miyazaki in southern Japan. In table 3 we 
can see the prevalence rate of HTLV1 in different countries. 
Population HTLV-I seroprevalence increases with age and is twice as high in females. In 
Jamaica 174% of women over 70 and 91% of men over 70 were seropositive. In Japan, 
HTLV-I seroprevalence in persons over 80 was 50% in females and 30% in males. This 
gender difference usually emerges after 30 years of age and may be related to more efficient 
transmission of the virus from males to females in the sexually active years (Yamaguchi, 
1994). Seroprevalence tends to increase with age and women are nearly twice as likely to be 
infected as men (Mueller, Okayama, Stuver, & Tachibana, 1996). 
HTLV1 shows little genomic variability during the course of infection and between patients 
in the same geographic area. Mother/child and spouse pairs from Okinawa (Japan) have 
been shown to be infected with highly conserved viruses upon direct sequencing of viral 
genome (Kakuda, Ikematsu, Chong, Hayashi, & Kashiwagi, 2002). Studies in France 
(Gessain, Gallo, & Franchini, 1992) the Solomon Islands (Nerurkar, Song, Saitou, Melland, & 
Yanagihara, 1993) and Zaire (LIU, et al., 1994) have shown similarly low genomic variability 
based upon the less accurate sequencing of PCR products. Therefore, small strain variation 
is recognized between geographic areas. Risk of infection is higher (fourfold increase) in 
breast fed infants than in those who are bottle fed (HIRATA, et al., 1992). A longer duration 
of breast feeding increase transmission risk (Li, et al., 2004). Another important risk factor is 
provirus load in breast milk. 
The infection is usually asymptomatic in the beginning and the disease typically manifests 
later in life; therefore silent transmission occurs. Since there are no prospects of vaccines and 
screening of blood banks and prenatal care settings are not universal, transmission is active 
in many areas such as parts of Africa, South and Central America, the Caribbean region, 
Asia, and Melanesia (Goncalves, et al., 2010). 
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country Sample size Prevalence of HTLV1 Group 
rural Miyazaki, 
southern Japan  Up to 30% General population 
Iran (Mashhad) 1653 2.1 General population 
Lebanon  3529 0.06 Blood donors 
Taiwan  3700000 0.06 Blood donors 
Korea 9281 0.13 Blood donors 
Jamaica  3-6% General population 
Caribbean  6% General population 
Curacao 2524 1.92% General population 
Papua New Guinea 1221 0-14.6% General population 
Argentina  2082 1.9% General population 
U.S 1700000 0.01 Blood donors 
Italy 14598 0.03 Blood donors 
Germany 100852 0 Blood donors 
U.K 570609 0.001 Blood donors 
Table 3. Prevalence of HTLV1 in different countries 
Adult T-cell lymphoma leukemia (ATL) is an aggressive lymphoproliferative malignancy, 
with short survival in its acute form and an incidence of less than 5% in HTLV-1-infected 
people (Shimoyama, 1991). The cumulative incidence of ATL among Japanese HTLV1 
carrier is about 2.5% (3-5% in male and 1-2% in female). Although women are more infected 
with HTLV1, but ATL is more common in men, it shows that other factors also should be 
responsible. At first ATL was described in Japan and later in the Caribbean region and 
South America (Uchiyama, Yodoi, Sagawa, Takatsuki, & Uchino, 1977). In the United States 
and Europe, ATL was diagnosed in immigrants from regions of endemicity. ATL occurs at 
least 20 to 30 years after the onset of HTLV-1 infection and is more common in adult males. 
Individuals infected in childhood may be at a higher risk of developing ATL (Pawson, et al., 
1998). The occurrence of ATL in the fourth decade predominates in Brazil and in Jamaica 
(Proietti, Carneiro-Proietti, Catalan-Soares, & Murphy, 2005), but in Japan, the fifth decade 
of life is predominant for the occurrence of ATL (Shimoyama, 1991). Possibly, local factors 
play a role in disease pathogenesis. 
Helicobacter pylori (H. pylori). Helicobacter pylori colonizes gastric mucosa, leading to chronic 
Gastric infection, and induce peptic ulcer disease and gastric carcinoma, also may cause B-
cell lymphomas, particularly mucosa-associated lymphoid tissue (MALT) tumors in the 
stomach, with the association being strongest in early lesion (Chiu & Weisenburger, 2003; 
Zucca, et al., 2000). In developing countries, where over 90% of the population may be 
infected, H. pylori infection usually occurs during childhood with chronic infection 
continuing throughout adulthood (Pounder & Ng, 1995). In contrast, although in developed 
countries the overall prevalence generally remains lower than in developing countries, the 
prevalence is low among children and rises with age in adults. H. pylori has been detected in 
more than 90% of patients with low-grade gastric MALT lymphoma, and in 40-75% of high-
grade gastric lymphomas (Boot & Jong, 2002). 
Direct fecal oral transmission is predominant in industrialized countries whereas other 
transmission routes such as contamination of water may be more important in developing 
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countries. The bacteria is transmitted within families in early childhood (Farinha & 
Gascoyne, 2005). Parsonnet et al. (Parsonnet, et al., 1994a) and Vineis et al. (Vineis, et al., 
1999) reported a significant positive association between H. pylori infection and risk of 
gastric NHL but not non-gastric NHL. Greater than 60% of MALT lymphomas regress with 
H. pylori eradication following treatment with antibiotics (R. Hunt, Sumanac, & Huang, 
2001). Because the US prevalence of H. pylori infection is low and declining, H. pylori most 
likely did not play a significant role in the overall rising trend of NHL incidence in the US 
(Alexander, et al., 2007). H. pylori infection is more common in Asian countries, therefore as 
we can see in table 1, MALT lymphoma in most Asian countries are more common than 
western countries. 
Hepatitis C Virus (HCV). Hepatitis C virus infection has been reported to be a prevalent 
disease since the second half of the 20th century (Strickland, 2006). Infection in different parts 
of Asia is similar, with an average seroprevalence of hepatitis C antibody less than 2.5% in 
the general population. The major routes of HCV transmission in Asia have been through 
blood transfusions and intravenous drug use, similar to the other countries. Other possible 
routes of transmission are medical intervention, tattooing, acupuncture, vertical and sexual 
transmission, accidental needle-stick and household contact. It is believed that HCV is still 
spreading in some areas of Asia because of the lack of routine screening of donated blood 
(Kao & Chen, 2000). HCV has been linked to lymphomagenesis in people with and without 
type II mixed cryoglobulinemia (Saadoun, Landau, Calabrese, & Cacoub, 2007). Increasing 
evidence indicates that the association between HCV infection and lymphoma may be due 
to viral infection related chronic antigenic stimulation. The chronic inflammation pathway 
would be consistent with the association between HCV and several types of lymphomas and 
with the regression of some lymphoma after eradicating the HCV infection (Hermine, et al., 
2002; Vallisa, et al., 2005). One study showed that the association between HCV infection 
and risk of NHL subtypes included mostly countries with low background HCV prevalence. 
This study showed increased risks of DLBCL, marginal zone lymphoma and 
lymphoplasmacytic lymphoma associated with HCV infection (De Sanjose, et al., 2008). 
Another study revealed that there is no association between NHL and HCV infection (King, 
Wilkes, & DIAZ ARIAS, 1998). Prevalence of HCV in series of patients with NHL in studies 
from different countries was various, it was more common in Italy and Japan (Armstrong, et 
al., 2006). Based on these studies there are marked regional differences in the prevalence of 
hepatitis C infection in non-Hodgkin lymphoma. It seems that other factors including 
genetics, race, hormonal, and immunologic factors are required for malignant 
transformation. Several studies showed the frequency was higher in older women. 
Lymphoma associated with HCV infection more frequently present as primary extra-nodal 
lymphoma, especially in the liver, spleen and salivary glands (Armstrong, et al., 2006). 
Human Immunodeficiency Virus (HIV). The relationship between human immunodeficiency 
virus/acquired immunodeficiency syndrome (HIV/AIDS) and the risk of developing NHL 
has been observed with strong positive associations in numerous studies. (Hooper, Holman, 
Clarke, & Chorba, 2001; Ragni, et al., 1993). The relative risk of NHL among persons infected 
with HIV has been reported to be over 100, (Coté, et al., 1997; Goedert, et al., 1998) with the 
greatest risk for B-cell lymphomas and high-grade histology (Coté, et al., 1997; A. Swerdlow, 
2003). Chronic antigenic stimulation and immune deficiency may be responsible for the 
increased risk of NHL among HIV-infected persons. HIV may act by inducing 
immunodysregulation, affecting genes responsible for cell regulation and failing to control 
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other viruses, which may result in opportunistic infection and replication of oncogenic 
viruses (Coté, et al., 1997). In AIDS patients NHL has been reported in approximately 2-3% 
of patients with AIDS, but AIDS accounts only for a small fraction of all NHL (Biggar & 
Rabkin, 1992; Rabkin & Yellin, 1994). In an international collaboration on HIV and cancer, 
incidence data from 23 prospective studies were used to compare incidence rates of NHL in 
HIV-infected persons in 1997–1999 with those in 1992–1996 (Coutinho, 2000). The incidence 
rates for NHL declined from 6.2 per 1,000 person-years to 3.6 per 1,000 person-years. 
Grulich et al. (Grulich, et al., 2001) reported a significantly lower relative risk of NHL in 
persons with HIV in the period of highly active antiretroviral therapy (HAART) availability 
than in the period immediately prior (RR = 0.58, 95% CI: 0.36–0.92) (Alexander, et al., 2007). 
In one study in Japan the incidence of AIDS-related lymphoma detected at autopsy was 
higher in Japan (27%) than in the US (12%). However, histological subtypes of AIDS-related 
lymphoma in Japan seem to be similar to those in western countries and DLBCL is also the 
most common subtype of AIDS-related lymphoma in Japan. A large number of AIDS-
related lymphoma cases were categorized into EBV-associated opportunistic lymphoma in 
Japan. The incidences detected by autopsy did not differ statistically between the pre-
HAART era and the HAART era (P = 0.31), and the histological subtype of DLBCL was 
stable in both the pre-HAART era (78%) and the HAART era (77%) . In contrast, they found 
an increase in patients with BL from 2% in the pre-HAART era to13% in the HAART era. 
(Hishima, et al., 2006). Despite the high rate of human immunodeficiency virus infection in 
Thailand, only 5 cases of documented AIDS-associated lymphoma were noted in one study 
(5 of 389 NHL; 1.3%). Similarly, Kaposi's sarcoma is not common in AIDS patients in 
Thailand. The underlying reason for this unique feature of AIDS-related lymphoma in 
Thailand is not known and further investigation is needed (Sukpanichnant, et al., 1998). In 
one study in India the proportional incidence ratio (PIR) for NHL was significantly 
increased in HIV era (PIR in males = 17.1, 95%CI 13.33-21.84, females = 10.3, 95%CI 6.10-
17.41), and their finding was similar to that reported by other studies (Dhir, et al., 2008). In 
one study in Singapore when comparing the age-standardized rates for males and female in 
1998 – 2002 which are 8.2 and 5.0 per 100,000 respectively compared with 7.5 and 4.4 per 
100,000 in 1993-1997 and 3.1 and 1.9 per 100,000 in 1968-1972, this may be partly due to 
HIV/AIDS, changes in pathological classification and improved diagnostic capabilities 
(Seow & Registry, 2004). Except for one study in Thailand, HIV/AIDS lead to increase 
incidence rate of lymphoma in both eastern and western countries. 
Human herpesvirus-8 (HHV-8). Human herpesvirus-8, is endemic in regions of the 
Mediterranean and Africa (Kamiyama, et al., 2004), but the seroprevalence of HHV-8 which 
has been studied in Malaysia, India, Sri Lanka, Thailand, Trinidad, Jamaica and the USA, in 
both healthy individuals and those infected with HIV, was found to be low in these 
countries in both the healthy and the HIV-infected populations (Ablashi, et al., 1999). HHV-8 
is generally accepted to be associated with development of primary effusion lymphoma 
(PEL), a rare B-cell lymphoma that almost exclusively affects HIV-positive patients (Ascoli, 
et al., 2002). However this lymphoma is often associated with both HHV-8 and EBV, limiting 
the understanding of the pathogenic role of HHV-8 (Ascoli, et al., 2002). Within B-cell 
lymphomas, however, HHV-8 infection was associated significantly and positively with risk 
of lymphoplasmacytic lymphoma (OR = 4.47, 95% CI: 1.34–14.85) or low-grade B-cell 
lymphoma and lymphoma not otherwise specified (OR = 5.82, 95% CI: 1.07-31.73) (Feuillard, 
et al., 1997). 
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countries. The bacteria is transmitted within families in early childhood (Farinha & 
Gascoyne, 2005). Parsonnet et al. (Parsonnet, et al., 1994a) and Vineis et al. (Vineis, et al., 
1999) reported a significant positive association between H. pylori infection and risk of 
gastric NHL but not non-gastric NHL. Greater than 60% of MALT lymphomas regress with 
H. pylori eradication following treatment with antibiotics (R. Hunt, Sumanac, & Huang, 
2001). Because the US prevalence of H. pylori infection is low and declining, H. pylori most 
likely did not play a significant role in the overall rising trend of NHL incidence in the US 
(Alexander, et al., 2007). H. pylori infection is more common in Asian countries, therefore as 
we can see in table 1, MALT lymphoma in most Asian countries are more common than 
western countries. 
Hepatitis C Virus (HCV). Hepatitis C virus infection has been reported to be a prevalent 
disease since the second half of the 20th century (Strickland, 2006). Infection in different parts 
of Asia is similar, with an average seroprevalence of hepatitis C antibody less than 2.5% in 
the general population. The major routes of HCV transmission in Asia have been through 
blood transfusions and intravenous drug use, similar to the other countries. Other possible 
routes of transmission are medical intervention, tattooing, acupuncture, vertical and sexual 
transmission, accidental needle-stick and household contact. It is believed that HCV is still 
spreading in some areas of Asia because of the lack of routine screening of donated blood 
(Kao & Chen, 2000). HCV has been linked to lymphomagenesis in people with and without 
type II mixed cryoglobulinemia (Saadoun, Landau, Calabrese, & Cacoub, 2007). Increasing 
evidence indicates that the association between HCV infection and lymphoma may be due 
to viral infection related chronic antigenic stimulation. The chronic inflammation pathway 
would be consistent with the association between HCV and several types of lymphomas and 
with the regression of some lymphoma after eradicating the HCV infection (Hermine, et al., 
2002; Vallisa, et al., 2005). One study showed that the association between HCV infection 
and risk of NHL subtypes included mostly countries with low background HCV prevalence. 
This study showed increased risks of DLBCL, marginal zone lymphoma and 
lymphoplasmacytic lymphoma associated with HCV infection (De Sanjose, et al., 2008). 
Another study revealed that there is no association between NHL and HCV infection (King, 
Wilkes, & DIAZ ARIAS, 1998). Prevalence of HCV in series of patients with NHL in studies 
from different countries was various, it was more common in Italy and Japan (Armstrong, et 
al., 2006). Based on these studies there are marked regional differences in the prevalence of 
hepatitis C infection in non-Hodgkin lymphoma. It seems that other factors including 
genetics, race, hormonal, and immunologic factors are required for malignant 
transformation. Several studies showed the frequency was higher in older women. 
Lymphoma associated with HCV infection more frequently present as primary extra-nodal 
lymphoma, especially in the liver, spleen and salivary glands (Armstrong, et al., 2006). 
Human Immunodeficiency Virus (HIV). The relationship between human immunodeficiency 
virus/acquired immunodeficiency syndrome (HIV/AIDS) and the risk of developing NHL 
has been observed with strong positive associations in numerous studies. (Hooper, Holman, 
Clarke, & Chorba, 2001; Ragni, et al., 1993). The relative risk of NHL among persons infected 
with HIV has been reported to be over 100, (Coté, et al., 1997; Goedert, et al., 1998) with the 
greatest risk for B-cell lymphomas and high-grade histology (Coté, et al., 1997; A. Swerdlow, 
2003). Chronic antigenic stimulation and immune deficiency may be responsible for the 
increased risk of NHL among HIV-infected persons. HIV may act by inducing 
immunodysregulation, affecting genes responsible for cell regulation and failing to control 
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other viruses, which may result in opportunistic infection and replication of oncogenic 
viruses (Coté, et al., 1997). In AIDS patients NHL has been reported in approximately 2-3% 
of patients with AIDS, but AIDS accounts only for a small fraction of all NHL (Biggar & 
Rabkin, 1992; Rabkin & Yellin, 1994). In an international collaboration on HIV and cancer, 
incidence data from 23 prospective studies were used to compare incidence rates of NHL in 
HIV-infected persons in 1997–1999 with those in 1992–1996 (Coutinho, 2000). The incidence 
rates for NHL declined from 6.2 per 1,000 person-years to 3.6 per 1,000 person-years. 
Grulich et al. (Grulich, et al., 2001) reported a significantly lower relative risk of NHL in 
persons with HIV in the period of highly active antiretroviral therapy (HAART) availability 
than in the period immediately prior (RR = 0.58, 95% CI: 0.36–0.92) (Alexander, et al., 2007). 
In one study in Japan the incidence of AIDS-related lymphoma detected at autopsy was 
higher in Japan (27%) than in the US (12%). However, histological subtypes of AIDS-related 
lymphoma in Japan seem to be similar to those in western countries and DLBCL is also the 
most common subtype of AIDS-related lymphoma in Japan. A large number of AIDS-
related lymphoma cases were categorized into EBV-associated opportunistic lymphoma in 
Japan. The incidences detected by autopsy did not differ statistically between the pre-
HAART era and the HAART era (P = 0.31), and the histological subtype of DLBCL was 
stable in both the pre-HAART era (78%) and the HAART era (77%) . In contrast, they found 
an increase in patients with BL from 2% in the pre-HAART era to13% in the HAART era. 
(Hishima, et al., 2006). Despite the high rate of human immunodeficiency virus infection in 
Thailand, only 5 cases of documented AIDS-associated lymphoma were noted in one study 
(5 of 389 NHL; 1.3%). Similarly, Kaposi's sarcoma is not common in AIDS patients in 
Thailand. The underlying reason for this unique feature of AIDS-related lymphoma in 
Thailand is not known and further investigation is needed (Sukpanichnant, et al., 1998). In 
one study in India the proportional incidence ratio (PIR) for NHL was significantly 
increased in HIV era (PIR in males = 17.1, 95%CI 13.33-21.84, females = 10.3, 95%CI 6.10-
17.41), and their finding was similar to that reported by other studies (Dhir, et al., 2008). In 
one study in Singapore when comparing the age-standardized rates for males and female in 
1998 – 2002 which are 8.2 and 5.0 per 100,000 respectively compared with 7.5 and 4.4 per 
100,000 in 1993-1997 and 3.1 and 1.9 per 100,000 in 1968-1972, this may be partly due to 
HIV/AIDS, changes in pathological classification and improved diagnostic capabilities 
(Seow & Registry, 2004). Except for one study in Thailand, HIV/AIDS lead to increase 
incidence rate of lymphoma in both eastern and western countries. 
Human herpesvirus-8 (HHV-8). Human herpesvirus-8, is endemic in regions of the 
Mediterranean and Africa (Kamiyama, et al., 2004), but the seroprevalence of HHV-8 which 
has been studied in Malaysia, India, Sri Lanka, Thailand, Trinidad, Jamaica and the USA, in 
both healthy individuals and those infected with HIV, was found to be low in these 
countries in both the healthy and the HIV-infected populations (Ablashi, et al., 1999). HHV-8 
is generally accepted to be associated with development of primary effusion lymphoma 
(PEL), a rare B-cell lymphoma that almost exclusively affects HIV-positive patients (Ascoli, 
et al., 2002). However this lymphoma is often associated with both HHV-8 and EBV, limiting 
the understanding of the pathogenic role of HHV-8 (Ascoli, et al., 2002). Within B-cell 
lymphomas, however, HHV-8 infection was associated significantly and positively with risk 
of lymphoplasmacytic lymphoma (OR = 4.47, 95% CI: 1.34–14.85) or low-grade B-cell 
lymphoma and lymphoma not otherwise specified (OR = 5.82, 95% CI: 1.07-31.73) (Feuillard, 
et al., 1997). 
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Simian Virus 40 (SV40). Simian Virus 40 is the most well characterized member of the 
Polyomaviridae family, and is closely related to two human polyomaviruses (Poulin & 
DeCaprio, 2006).It induces an inapparent infections in immunocompetent hosts, but can 
produces pathologic effects in immunocompromised individuals through the destruction of 
infected cells (Imperiale, 2000).Simian virus 40, an agent that infects Asian ma- caques, 
contaminated the early poliovirus vaccines used in the United States, Europe, and other 
region during the mass immunization program for poliovirus in the late 1950 and early 1960 
(Strickler, et al., 2003). The Norwegian study shows that between 1953 and 1997, the 
incidence rate of lymphoproliferative diseases increased about 3-fold in both males and 
females (Thu, et al., 2006), and the other study report that polyomavirus SV40 is significantly 
associated with non-Hodgkin lymphoma in HIV-1-infected and HIV-1-uninfected patients 
and might have a role in the development of these hematological malignancies (Vilchez, et 
al., 2002). These observations suggest that polyomavirus SV40 might be causing infections in 
human beings long after the use of the contaminated vaccines. There is no documented 
study around it in Asian countries.  
2.2.3 Genetic factors and family history 
Family history and genetic factors increase risk of NHL in people whose relatives previously 
were diagnosed with NHL, but hereditary factors are hypothesized to account only for a small 
percentage of NHL and are unlikely to explain the increase in NHL incidence. Tumor 
suppressor genes, oncogenes and DNA repair genes may play a role in NHL carcinogenesis, 
and some genes may interact with environmental exposures that affect NHL risk (Fisher & 
Fisher, 2004). In a US multicenter case–control study, Chatterjee et. al showed (Chatterjee, et al., 
2004) the strongest associations were found among siblings (HR = 7.6, 95% CI: 0.98–58.8) and 
male relatives (HR = 6.2, 95% CI: 0.77–50.0) of NHL cases. For a parental history of 
histopathologically concordant lymphoma, the strongest associations with lymphoma risk 
among offspring were found for B-cell lymphoma (SIR = 11.8, 95% CI: 2.2–34.8) and follicular 
lymphoma (SIR = 6.1, 95% CI: 1.1–18.0) (Altieri, Bermejo, & Hemminki, 2005). 
Several genetic polymorphisms associated with the risk of NHL suggest that single 
nucleotide polymorphisms (SNPs) in tumor necrosis factor (TNF) and interleukin-10 (IL10) 
are associated with risk of NHL, especially diffuse large B –cell lymphoma. Relatively few 
studies have examined the potential interaction between germline susceptibility and 
environmental or lifestyle factors in the etiology of NHL (Alexander, et al., 2007). The 
mechanism (s) by which genetic predisposition or gene-environment interactions may 
enhance or reduce the risk of developing NHL remains a largely unexplored area of 
research (Alexander, et al., 2007).  
2.2.4 Lifestyle and personal and environmental factors 
Results from studies that evaluated lifestyle and personal factors are generally inconsistent, 
with few exceptions. Alcohol consumption appears to be inversely associated with NHL, 
based primarily on results from case–control studies (Chiu, et al., 1999; Chiu, et al., 2002). 
Further evidences from cohort studies are needed. Smoking does not appear to play an 
important role in the etiology of NHL overall; however, it has relation with follicular 
lymphoma (Bracci & Holly, 2005). Fish intake has been associated consistently with a 
nonsignificantly decreased risk of NHL in several studies (Zhang, et al., 1999), but intake of 
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omega-3 fatty acids from fish was not associated with reduced risk of NHL in one cohort 
study (Purdue, Bassani, Klar, Sloan, & Kreiger, 2004). Several but not all studies have 
reported positive association with red meat intake. Data are limited, and results have not 
been consistent, for estimates of associations with specific types of red meat or with 
preparation or cooking methods (Chang, et al., 2006; Ward, et al., 1994). Saturated fat intake 
was associated positively (Chang, et al., 2006), however vegetable consumption was 
associated inversely, with NHL risk in most studies (Chang, et al., 2005; Mozaheb & 
Aledawood, 2011). Biological mechanisms for these dietary factors have not been 
established. Neither obesity nor physical activity has been associated consistently with NHL 
(Alexander, et al., 2007). 
Certain workers have a slightly increased risk of developing NHL, including farmers; 
pesticide applicator; miller; meat worker; wood and forestry worker; chemists; painters; 
mechanics; printers; and worker in the petroleum, rubber, plastics, and synthetics industries 
(Alexander, et al., 2007). Some of these occupations are more common in Asian countries 
such as farmers, pesticide applicator, wood worker, worker in petroleum; on the other hand 
exposure is more because of low educational program in these places. Also There is 
significant relationship between hair dye use and NHL risk (Altekruse, Jane Henley, & 
Thun, 1999). 
3. Hodgkin's Lymphoma 
Hodgkin lymphoma is a neoplastic disease of the lymphoid tissue characterized by the present 
of multinucleated giant cell of B-cell origin, known as Red-Stenberg cell, in background of 
numerous reactive lymphocyte (Classical, 2009). HL is less common in Asians, especially at the 
young adult ages. There is incidence variation by age, social class, geographic location in HL. 
Thus, the comparison of HL rates in Asian and western countries could inform the relative 
importance of environmental factors and genetic to disease etiology.  
3.1 Descriptive epidemiology  
The epidemiology of Hodgkin's lymphoma is complex. Hodgkin Lymphoma demonstrates 
different histologic findings, clinical presentation, and outcome. Hodgkin's lymphoma is 
relatively uncommon, but at young adult ages it is one of the most common malignancies. 
Increasingly there is a great difference in incidence between developing and western 
developed countries. In developing countries, the disorder appear predominantly during 
childhood and its incidence decreases with age (Thomas, Re, Zander, Wolf, & Diehl, 2002). 
The annual age adjusted incidence rates of 2.8 and 2.4 per 100,000 in the USA and UK 
respectively (RiesLAG, HankeyBF, & HarrasA, 1994). 
Hodgkin's lymphoma has been reported to be rare in Asians. One study in the US from 2000 
to 2007, 16,710 cases of HL reported that black and Asians had low incidence (black/white 
incidence rate ratio (IRR) 0.86, P<0.01; Asian/White IRR 0.43, P<0.01). The bimodal pattern 
of incidence was less prominent for black males. Asian and black presented at a mean age of 
38 years compared to 42 years for Whites (P<.001) (Pareen, Alison, Neha, & Christopher, 
2010).There are few studies in exploring the relative contributions of environmental and 
hereditary etiology of Hodgkin's lymphoma, and individual risk factors in an Asian 
population. The other study which compared HL incidence rate in Japanese, Chinese, 
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Simian Virus 40 (SV40). Simian Virus 40 is the most well characterized member of the 
Polyomaviridae family, and is closely related to two human polyomaviruses (Poulin & 
DeCaprio, 2006).It induces an inapparent infections in immunocompetent hosts, but can 
produces pathologic effects in immunocompromised individuals through the destruction of 
infected cells (Imperiale, 2000).Simian virus 40, an agent that infects Asian ma- caques, 
contaminated the early poliovirus vaccines used in the United States, Europe, and other 
region during the mass immunization program for poliovirus in the late 1950 and early 1960 
(Strickler, et al., 2003). The Norwegian study shows that between 1953 and 1997, the 
incidence rate of lymphoproliferative diseases increased about 3-fold in both males and 
females (Thu, et al., 2006), and the other study report that polyomavirus SV40 is significantly 
associated with non-Hodgkin lymphoma in HIV-1-infected and HIV-1-uninfected patients 
and might have a role in the development of these hematological malignancies (Vilchez, et 
al., 2002). These observations suggest that polyomavirus SV40 might be causing infections in 
human beings long after the use of the contaminated vaccines. There is no documented 
study around it in Asian countries.  
2.2.3 Genetic factors and family history 
Family history and genetic factors increase risk of NHL in people whose relatives previously 
were diagnosed with NHL, but hereditary factors are hypothesized to account only for a small 
percentage of NHL and are unlikely to explain the increase in NHL incidence. Tumor 
suppressor genes, oncogenes and DNA repair genes may play a role in NHL carcinogenesis, 
and some genes may interact with environmental exposures that affect NHL risk (Fisher & 
Fisher, 2004). In a US multicenter case–control study, Chatterjee et. al showed (Chatterjee, et al., 
2004) the strongest associations were found among siblings (HR = 7.6, 95% CI: 0.98–58.8) and 
male relatives (HR = 6.2, 95% CI: 0.77–50.0) of NHL cases. For a parental history of 
histopathologically concordant lymphoma, the strongest associations with lymphoma risk 
among offspring were found for B-cell lymphoma (SIR = 11.8, 95% CI: 2.2–34.8) and follicular 
lymphoma (SIR = 6.1, 95% CI: 1.1–18.0) (Altieri, Bermejo, & Hemminki, 2005). 
Several genetic polymorphisms associated with the risk of NHL suggest that single 
nucleotide polymorphisms (SNPs) in tumor necrosis factor (TNF) and interleukin-10 (IL10) 
are associated with risk of NHL, especially diffuse large B –cell lymphoma. Relatively few 
studies have examined the potential interaction between germline susceptibility and 
environmental or lifestyle factors in the etiology of NHL (Alexander, et al., 2007). The 
mechanism (s) by which genetic predisposition or gene-environment interactions may 
enhance or reduce the risk of developing NHL remains a largely unexplored area of 
research (Alexander, et al., 2007).  
2.2.4 Lifestyle and personal and environmental factors 
Results from studies that evaluated lifestyle and personal factors are generally inconsistent, 
with few exceptions. Alcohol consumption appears to be inversely associated with NHL, 
based primarily on results from case–control studies (Chiu, et al., 1999; Chiu, et al., 2002). 
Further evidences from cohort studies are needed. Smoking does not appear to play an 
important role in the etiology of NHL overall; however, it has relation with follicular 
lymphoma (Bracci & Holly, 2005). Fish intake has been associated consistently with a 
nonsignificantly decreased risk of NHL in several studies (Zhang, et al., 1999), but intake of 
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omega-3 fatty acids from fish was not associated with reduced risk of NHL in one cohort 
study (Purdue, Bassani, Klar, Sloan, & Kreiger, 2004). Several but not all studies have 
reported positive association with red meat intake. Data are limited, and results have not 
been consistent, for estimates of associations with specific types of red meat or with 
preparation or cooking methods (Chang, et al., 2006; Ward, et al., 1994). Saturated fat intake 
was associated positively (Chang, et al., 2006), however vegetable consumption was 
associated inversely, with NHL risk in most studies (Chang, et al., 2005; Mozaheb & 
Aledawood, 2011). Biological mechanisms for these dietary factors have not been 
established. Neither obesity nor physical activity has been associated consistently with NHL 
(Alexander, et al., 2007). 
Certain workers have a slightly increased risk of developing NHL, including farmers; 
pesticide applicator; miller; meat worker; wood and forestry worker; chemists; painters; 
mechanics; printers; and worker in the petroleum, rubber, plastics, and synthetics industries 
(Alexander, et al., 2007). Some of these occupations are more common in Asian countries 
such as farmers, pesticide applicator, wood worker, worker in petroleum; on the other hand 
exposure is more because of low educational program in these places. Also There is 
significant relationship between hair dye use and NHL risk (Altekruse, Jane Henley, & 
Thun, 1999). 
3. Hodgkin's Lymphoma 
Hodgkin lymphoma is a neoplastic disease of the lymphoid tissue characterized by the present 
of multinucleated giant cell of B-cell origin, known as Red-Stenberg cell, in background of 
numerous reactive lymphocyte (Classical, 2009). HL is less common in Asians, especially at the 
young adult ages. There is incidence variation by age, social class, geographic location in HL. 
Thus, the comparison of HL rates in Asian and western countries could inform the relative 
importance of environmental factors and genetic to disease etiology.  
3.1 Descriptive epidemiology  
The epidemiology of Hodgkin's lymphoma is complex. Hodgkin Lymphoma demonstrates 
different histologic findings, clinical presentation, and outcome. Hodgkin's lymphoma is 
relatively uncommon, but at young adult ages it is one of the most common malignancies. 
Increasingly there is a great difference in incidence between developing and western 
developed countries. In developing countries, the disorder appear predominantly during 
childhood and its incidence decreases with age (Thomas, Re, Zander, Wolf, & Diehl, 2002). 
The annual age adjusted incidence rates of 2.8 and 2.4 per 100,000 in the USA and UK 
respectively (RiesLAG, HankeyBF, & HarrasA, 1994). 
Hodgkin's lymphoma has been reported to be rare in Asians. One study in the US from 2000 
to 2007, 16,710 cases of HL reported that black and Asians had low incidence (black/white 
incidence rate ratio (IRR) 0.86, P<0.01; Asian/White IRR 0.43, P<0.01). The bimodal pattern 
of incidence was less prominent for black males. Asian and black presented at a mean age of 
38 years compared to 42 years for Whites (P<.001) (Pareen, Alison, Neha, & Christopher, 
2010).There are few studies in exploring the relative contributions of environmental and 
hereditary etiology of Hodgkin's lymphoma, and individual risk factors in an Asian 
population. The other study which compared HL incidence rate in Japanese, Chinese, 
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Filipino, and Asian Indian in the US and in Asia reports HL incidence rates were quite low 
in all Asian subgroups but approximately double in US Asian. The consistently low rates of 
HL in Asians suggest genetic resistance to the disease development, possibly associated 
with HLA type. In addition environmental and lifestyle differences between the USA and 
Asia are important. In some study from Eastern Asia and among Chinese immigrants in 
North America indicate increasing incidence trends for HL being associated with 
westernization (Caporaso, Goldin, Anderson, & Landgren, 2009). International and inter-
ethnic differences and risk factor patterns in case-control data, implicate environmental 
influences in the etiology of HL (Glaser & Hsu, 2002). 
Incidence rate of HL are usually grater in male than in female (Correa & O'Conor, 1971). In 
western countries the young adult peak largely consist of nodular sclerosis tumors, whereas 
the rise at older ages are largely mixed cellularity and lymphocytic-depleted histology 
 (Spitz, et al., 1986). Hodgkin's lymphoma tends to be more common in young adult with 
higher socio-economic classes (Correa & O'Conor, 1971). Pattern of low social class 
determinants in children and older adult with HL, the age groups at risk for mixed 
cellularity (MC), support involvement of underling infectious agent given intense exposure, 
and EBV is a likely candidate based on its high prevalence in these groups (Glaser & Jarrett, 
1996). Based on different studies the most common subtype of HL in the most Asian 
countries such as Iran, Korea, Thailand, Japan is mixed cellularity and relative paucity of NS 
subtype, particularly in males (Glaser & Hsu, 2002), which seems to be related to the 
etiologic factors (environment and/or inheritance) of disease. Subtypes of HL in different 
countries are showed in table 4. 
 













NS 10 (31.2) 26 (31.7) 58 (36.9) 29 (69) 70 (42.4) Up to 08 60 
MC 16 (50) 38 (46.3) 64 (40.8) 2 (4.7) 51 (31) <10 15 
LD 3 (9.3) 6 (7.3) 14 (8.9) 0 8 (5) 1 rare 
LP 1 (3.1) 4 (2.6) 18 (11.5) 2 (4.7) 18 (11) 6 10 
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Table 4. Subtypes of Hodgkin's disease in various countries 
A shift from MC-dominant histologic subtype of HL was observed over 20-year period 
within Japan, particularly in young adults (Aozasa, Ueda, Tamai, & Tsujimura, 1986).  
As NS and MC have been shown to have different environmental cofactors, including 
socioeconomic status and degree of EBV tumor-cell presence, geographic variation in HL 
is likely to reflect change in socioeconomically determined exposures whenever possible.  
3.2 Etiologic epidemiology 
The differences in descriptive epidemiology of Hodgkin's lymphoma between children, 
young adults and older adults may reflect differences in etiology between these age groups. 
3.2.1 Environment  
Infections. Systemic analysis of epidemiological data pointed towards an infectious agent as 
a potential cause for Hodgkin's lymphoma. Recognition of an association of infectious 
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mononucleosis with Hodgkin's disease predate the discovery of EBV (Richard F. Ambinder, 
2007). Investigators have reported that EBV infectious mononucleosis is associated with a 
lifelong "immunologic scar" (Sauce, et al., 2007). The statistical analysis suggested that HL 
tended to occur 2.9 years after infectious mononucleosis (R.F. Ambinder, 2007). Remarkably, 
the change in lymphocyte cell population is sustained over years or longer (Richard F. 
Ambinder, 2007). There are new insights into infectious mononucleosis and disturbances in 
cellular immunity, new insight relating to the role that viruses may play in molecular 
pathogenesis of HL, an emerging appreciation of the increased incidence of HL in HIV and 
its relationship to immune suppression (Richard F. Ambinder, 2007). A role for suppression 
T cell suggested in the 1970s, and increasing evidence shows a role for this cells in 
suppressing antitumor immune responses (Hjalgrim, et al., 2007). 
In western countries, about 50% of all cases of classical HL are EBV positive, means the 
virus is carried within the tumor cells. Detection of EBV in tumors in these region are least 
common in young adult disease. In some parts of Latin America, Africa, and Asia, the 
percentage is much higher with the percentage in children approaching 90- 100% (Glaser, 
et al., 1997; Zarate Osorno, Roman, Kingma, Meneses Garcia, & Jaffe, 1995). The MC 
subtype harboring EBV DNA in up to 70% of cases and the NS subtype being positive in 
15-30% of cases (Brousset, et al., 1991). Also detection of EBV in HL in most Asian 
countries are less in young adults and are more detectable in children and older ages. 
Because of these differences infectious cofactors other than EBV have been suggested, but 
no consensus in support of any other particular association have emerge (Wilson, et  
al., 2007). 
As we mentioned EBV induce immune suppression, and in an EBV positive person, MC 
subtype is more common (like HIV positive), therefore in MC subtype of HL, which is more 
common in Asian countries, immunodeficiency has more important role in comparison with 
other subtypes.  
HIV. Hodgkin's lymphoma in the setting of HIV has distinctive features and is usually 
associated with EBV infection (Glaser, et al., 2003). HL in patients with HIV tends to present 
at an advanced stage with associated B symptoms and extra-nodal involvement and is most 
often a mixed cellularity subtype. Model fitting suggested that for persons with AIDS with 
moderate immunosuppretion at the onset of AIDS, HL risk was 15-fold higher than in the 
general population. Lower CD4 counts were associated with less risk, the risk fall as CD4 
count fall (R.F. Ambinder, 2007).  
3.2.2 Inheritance 
The risk of developing HL among family member of patients affected by HL increase  
from three-to nine-fold (Haim, Cohen, & Robinson, 1982). One study showed a significant 
association between HL and parental consanguinity and pointed to the possible  
etiologic role of recessive inheritance (Abramson, Pridan, Sacks, Avitzour, & Peritz,  
1978). 
The relative risk for HL among first degree relatives of cases compared with controls was 
3.1. Relative risks were higher in males compared with females, and in siblings of cases 
compared with parents and offspring. Identifying inherited susceptibility genes is an 
important step towards defining the pathway leading to development of HL and 
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Filipino, and Asian Indian in the US and in Asia reports HL incidence rates were quite low 
in all Asian subgroups but approximately double in US Asian. The consistently low rates of 
HL in Asians suggest genetic resistance to the disease development, possibly associated 
with HLA type. In addition environmental and lifestyle differences between the USA and 
Asia are important. In some study from Eastern Asia and among Chinese immigrants in 
North America indicate increasing incidence trends for HL being associated with 
westernization (Caporaso, Goldin, Anderson, & Landgren, 2009). International and inter-
ethnic differences and risk factor patterns in case-control data, implicate environmental 
influences in the etiology of HL (Glaser & Hsu, 2002). 
Incidence rate of HL are usually grater in male than in female (Correa & O'Conor, 1971). In 
western countries the young adult peak largely consist of nodular sclerosis tumors, whereas 
the rise at older ages are largely mixed cellularity and lymphocytic-depleted histology 
 (Spitz, et al., 1986). Hodgkin's lymphoma tends to be more common in young adult with 
higher socio-economic classes (Correa & O'Conor, 1971). Pattern of low social class 
determinants in children and older adult with HL, the age groups at risk for mixed 
cellularity (MC), support involvement of underling infectious agent given intense exposure, 
and EBV is a likely candidate based on its high prevalence in these groups (Glaser & Jarrett, 
1996). Based on different studies the most common subtype of HL in the most Asian 
countries such as Iran, Korea, Thailand, Japan is mixed cellularity and relative paucity of NS 
subtype, particularly in males (Glaser & Hsu, 2002), which seems to be related to the 
etiologic factors (environment and/or inheritance) of disease. Subtypes of HL in different 
countries are showed in table 4. 
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moderate immunosuppretion at the onset of AIDS, HL risk was 15-fold higher than in the 
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important step towards defining the pathway leading to development of HL and 
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understanding its etiology. There are many studies of somatic mutations in HL tumor cells, 
but although there are associations with HLA types, specific germline genes causing 
susceptibility have not yet been identified. On the other hand it is not known whether or 
how extrinsic risk factors interact with genetic susceptibility (Goldin, et al., 2005). 
Oza et al. in the single study of HL-HLA relationship found that HLA-DPB1*0301 inreased 
risk of HL in all ethnic groups, while HLA-DPB1*0401 was associated with a lowered risk of 
HL in Japanese and Chinese and an elevated risk for US whites and Israelis (Oza, et al., 
1994). Therefore; HLA-DPB1*1401, or factors related to it, could explain some of the lower 
incidence of HL in certain Asian ethnic groups, although environmental factors involves as 
well and indicate that HL etiology is complex. 
4. Conclusion 
There is evidence of etiologic heterogeneity among types of NHL, with different incidence 
patterns according to age, sex, race and specially geography. The extent to which these 
differences reflect differences in etiology needs further study.  
Epidemiologic studies indicate that environmental factors may play an important role in the 
etiology of non-Hodgkin's lymphoma. Given the recognition that transmissible agents, 
especially in the developing world, are a significant cause of some kind of lymphoma, 
focusing on effective strategies to prevent infection altogether will go a long way to 
diminish the lymphoma. Additionally, effective strategies for toxic and occupational 
exposure and changing global lifestyles will yield huge dividends. Future epidemiologic 
research on NHL will be enhanced by analyses of subtypes of NHL, improved reliability 
and validity of exposure assessment tools to evaluate occupational, environmental and 
personal exposures, and evaluation of susceptible subgroups of individuals whose risk of 
NHL may differ from that of the general population. Finding the relation between 
environmental factors and genes in lymphomagenesis also important and it needs more 
investigation. 
Lower rate of HL in Asians suggestive of genetic resistance, in addition international and 
inter-ethnic differences implicate environmental influence. Additional insight into the 
balance of genetic and environment factors on HL risk should be forthcoming. Differences 
in HL risk reported in several studies indicate that such studies of HL risk factors should be 
conducted for specific Asian population.  
Overall in developing countries the most common subtype of lymphoid malignancies both 
HL and NHL are those subtype which immunodeficiency have an important role in their 
pathogenesis. 
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1. Introduction 
Primary immunodeficiencies (PID) are genetic disorders of immunity whose incidence 
varies from 1:250 to 1:1,000,000 depending of disease and study population. Because of 
incomplete records of immunodeficiency in the world, is estimated that the prevalence of 
1:5,000 to 1:100,000 (Geha et al., 2007; Boyle & Buckley, 2007; Notarangelo,et al., 2010). Thus, 
the PID is a important group to public health as other genetic diseases that rely government 
support in a neonatal screening program such phenylketonuria (PKU) with incidence of 
1/15.000 (de Carvalho et al., 2007) and congenital hypothyroidism, with incidence of 1/4.000 
(American Academy of Pediatrics, 1993; Olivieri, 2009). The PID are classified in defective 
immune deficiency prevalent in predominantly antibody; combined immunodeficiencies, 
cellular immunodeficiencies, phagocyte defects, immune deficiencies associated with 
lymphoproliferative diseases, and deficiencies of complement system or secondary 
immunodeficiencies associated with other diseases. This classification is updated 
periodically by the International Union of Immunological Societies (IUIS), associated with 
the World Health Organization (WHO) (Geha et al., 2007; Notarangelo,et al., 2010). 
This classification is progressively adjusting to the rapid evolution of the field. Many new 
phenotypes (e.g. hemophagocytosis, thrombotic purpura, herpes encephalitis, Mendelian 
susceptibility to mycobacterial infection, epidermodysplasia verruciformis, chronic 
mucocutaneous candidiasis, autoinflammatory disorders, and anhidrotic ectodermal 
dysplasia with immunodeficiency) have emerged as reflecting new PID. 
Knowledge of PID is still deficient in many countries and within many countries, since 
doctors and health authorities are often poorly informed about their clinical presentations, 
diagnosis, importance and health impact of these diseases, and geographic factors that 
influence the release of same around the world (Sewell, 2006). Recent estimates of PID made 
by the European Parliament showed that approximately 1 in 800 to 10,000 people have PID 
that significantly affects your health, PID affect at least 10 million people worldwide, the 
true prevalence of PID in some forms of general population is estimated between 1 in 250 
and 1 in 500, data comparable with type I diabetes (1 in 700) and multiple sclerosis (1 in 
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1000), although more than 200 PID have been discovered, some are more common than 
leukemia and lymphoma in children (Banks, 2010). 
Initial efforts in classification of PID left WHO in 1970, where this first meeting was 
identified and classified 14 different entities, and in 2006, more than 100 types (Bonilla & 
Geha, 2006). Currently, they comprise more than 200 different types of genetic diseases that 
predispose the human host to recurrent infections, which may be associated with other 
disorders (Notarangelo et al., 2010), but also to chronic and systemic inflammation, 
hypersensitivity reactions, autoimmunity, and cancer. Advances in biological sciences and 
biotechnology are now making possible for the first time, to systematically assess the actual 
impact of PID in human health, and this promises to revolutionize the way we look at these 
diseases. 
Patients with PID have higher susceptibility to infection often accompanied by 
inflammatory disorders, hypersensitivity reactions, autoimmunity and cancer (Morimoto & 
Routes, 2008; Notarangelo 2010). The clinical presentation of patients is extremely broad, 
with asymptomatic individuals who have fulminating infection, which if not diagnosed and 
treated properly evolution to death (Chapel 2005; Bustamante et al., 2008a). Patients with 
PID have consequence of delay diagnosis and treatment permanent damage of body. This 
involves disabling from attending school and/or work, reducing the number of people with 
productive capacity, increasing the number of people hospitalized with high cost to 
government, increased mortality rate in children and adults of working age 
(Yarmohammadi et al., 2004; Bonilla et al., 2005). The delay in diagnosis leads to pulmonary 
complications such bronchiectasis and irreversible change in the quality of life of patients 
and their families (Kainulainen et al., 2001; Champi, 2002). 
Although this delay in diagnosis of PID is evident in countries or disadvantaged regions, 
also occurs in developed countries after multiple hospitalizations of patients. Thus, is 
recommended research and education in PID, since the prognosis of many patients can be 
improved by early diagnosis and appropriate access to care and treatment (Bonilla et al., 
2005; Turvey & Bonilla, 2009). In medical terms, there are three important reasons for 
understanding the PID, first, a high index of suspicion and early diagnosis may lead to 
treatments that save lives or bring significant improvement in quality of life, secondly the 
discovery of genetic defects in immunity makes possible family counseling and prenatal 
diagnosis, and thirdly, the study of the pathophysiology of genetic and immunological 
defects provides important tools to understanding the regulation of the human immune 
system (Bustamante et al., 2008b; Casanova et al., 2008; Lee & Lau, 2009; Fried & Bonilla, 
2009). In recent decades, no other field of immunology had so much progress in 
understanding how pathophysiology of primary immunodeficiencies. These developments 
have resulted not only in understanding of immunodeficiencies, but understanding of 
immune system in humans (Boufisha et al., 2010). Patients with PID are considered not 
successful experiments of nature that brought many benefits to medicine in the installation 
of diagnostic protocols and rational treatment, location of targets for gene therapy and 
assessment of need for bone marrow transplantation and its benefits (Griffith et al., 2009; 
Neven et al., 2009; Pessach et al., 2009; Kohn 2010). This knowledge was translated  
into association of specific defects of immunity with signs and symptoms that can establish 
correct diagnosis of disease, beyond the description of new immunodeficiency (Cassimos  
et al., 2010). Since the PID diseases are congenital and hereditary character, children are  
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overweight patients, however, a greater number of adults have been diagnosed as children 
grow and become adults (Bustamante et al., 2008a). How healthy children have on average 
6-8 mild respiratory infections, especially upper airway in first year of life and more than six 
episodes of otitis and gastroenteritis per year in the first three years of life, young children 
with high environmental exposure or with siblings who attend schools may exceed these 
averages by one to two years, the diagnosis of PID is often underestimated (Puck, 1997). But 
they may be observed in children with normal development, which may harbor latent PID 
or low impact on the immune system. Pediatrics specialize in PID ensure that half children 
are taken by parents to the doctor with a history of recurrent infections are normal, and 
other 50%, 30% have allergies, 10% other diseases and 10% PID (Grumach et al., 1997). To 
aid diagnosis and reporting of PID, the American Red Cross and Jeffrey Model Foundation 
developed the 10 warning signs suspected for PID. For experts (Modell, 2007a; Modell, 
2007b), these signs are considered extremely important, since the prognosis and therapeutic 
success depends upon prompt diagnosis, and most are performed in referral centers. 
However, some authors consider the 10 warning signs not sensitive or specific, since a third 
of patients do not present single warning sign (Aloi et al., 2007). Once diagnosed with PID, 
the patient is referred to clinical immunologist who directs specific treatment, 
immunizations, and definitive and specific diagnosis. Thus, there is a gain in quality life of 
patients and their families, avoiding sequels, unnecessary suffering and high social cost.  
The therapeutic treatment these patients involve three basic tenets: reduce the exposure  
to the infectious agent, effective or prophylactic antimicrobial therapy, replacement of  
deficient immune functions (Garcia et al., 2007). During the evaluation of PID is essential 
documentation of the patient's clinical history, frequency, duration and complications of 
infections, outbreaks of infection, microorganisms involved and response to treatment, and 
anatomical defects, allergic processes and metabolic disorders (Bonilla et al., 2005). A 
detailed family history should be taken into consideration, since many PID are linked with X 
chromosome and the presence of children in maternal family with recurrent infections, or 
death in childhood due to severe infection indicates the possibility of PID. Initially, 
screening tests are indicated or initial and advanced testing as suspected PID (Sewell et al., 
2006). In general, immune assessment requires specialized laboratory and high financial cost, 
and it comes to pediatric patients, should be chosen methods that can be executed with low 
amount of blood (Oliveira & Fleisher, 2010). The diagnosis of some PID may be removed if 
they are used and selected screening tests such blood test for congenital neutropenia, 
leukocyte adhesion deficiency (LAD), severe combined immunodeficiency (SCID) and 
Wiskott-Aldrich Syndrome (WAS), or immunoglobulin’s quantification in suspected 
predominantly antibody defects (Gill, 2002). The diagnostic criteria are divided into three 
categories, definite, probable and possible. In ensuring inclusion of patients with 
polymorphic variants in genes associated with PID and specific clinical and laboratory 
changes, the patient must meet all criteria characteristic of the disease (Conley et al., 1999). 
The delay in diagnosis is often associated with limited access to specialized resources 
(Lindegren, 2004), is not unique to developing countries (Liang et al., 2008), leading to large 
variation between numbers of cases (Stihem, 2004). In Finland, the common variable 
immunodeficiency (CVID) showed delay time diagnosis of 5 years in 2/3 of patients and 10 
years in 1/3 these (Kainulainen et al., 2001), in United Kingdom this delay was 6.2 years 
during 1989 to 1995, and decreased 3.5 years after implantation of government program to 
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overweight patients, however, a greater number of adults have been diagnosed as children 
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conducted between 1996 to 2002 (Seymour et al., 2005). To be assured diagnostic quality 
indicators should be generated which include patient registration data, which together form 
the field and field set and its variables called record. These cases are based registry designed 
to improve patient care, but are useful for studying diseases. An example is early records of 
368 patients with chronic granulomatous disease (GCD) by American Foundation for 
Immunodeficiencies started in 1993, allowing a calculation of incidence of the disease for 
USA born in 1/200.000 (Winkelstein et al., 2000). In 1997, this study has been expanded to 
Common Variable Immunodeficiency (CVID), Wiskott-Aldrich Syndrome (WAS), Severe 
Combined Immunodeficiency (SCID), Leukocyte Adhesion Deficiency (LAD), DiGeorge 
Syndrome, Hyper-IgM Syndrome (HIGM) (Winkelstein et al., 2003) and X-Linked 
Agammaglobulinemia (XLA) (Winkelstein et al., 2006), showing concern in development 
systems of records, population data for estimating incidence, prevalence and characteristics 
of disease. These data are important to maintain epidemiological studies and research and 
design of new clinical trials, reducing mortality, increasing survival and improved quality of 
life. In Europe, this service is performed by European Society for Immunodeficiency-ESID 
non-governmental organization that aims, to facilitate exchange of information between 
doctors, nurses, researchers, patients and their families, promote research into causes, 
mechanisms and treatment of PID (Sewel et al., 2006; de Vries, 2006; Guzman et al., 2007; 
Gathmann et al., 2009). This group was established in 1993, Society in 1994, and receives data 
from 66 specialized centers in 26 European countries. In 2005 record showed amount of 
10,000 patients from 26 countries with prevalence of 4-47/1.000.000, and the European 
internet-based patient and research database for primary immunodeficiencies results in 
7,047 patients with PID in 30 countries (Knerr et al.,2008) and 7430 patients from 39 countries 
have been documented in the ESID database (Gathmann et al., 2009). 
In Latin America in 1993, was created the Latin American Group for Immunodeficiencies 
(LAGID) to study the prevalence of PID in different regions of Latin America and promote 
awareness of these diseases. There are also databases online with identification of mutations 
locus in specific cases of PID that are established by ESID and extended by others 
researchers. This was initiated in 1995 to collect data in Bruton's tyrosine kinase mutations 
(BTK) in XLA (Lindegren et al., 2004). This occurred in Brazil, through the creation of 
Brazilian Group of Primary Immunodeficiencies (BRAGID), which through information 
campaigns, increased the number of 314 cases in 2000 to 536 cases in 2004 with Southeast 
region responsible for 70% total cases. Another relevant factor in understanding the 
epidemiology of PID is introduction of specialized care networks. In England there is the 
National Specialist Advisory Group Comissionary (NSCAG) of National Health System 
(NHS), which tracks PID complex cases, such the Great Ormond Street Hospital (Jones & 
Gaspar, 2000) and Newcastle General Hospital (Slatter & Gennery, 2010).  
Several international initiatives are currently underway to promote awareness PID and 
increase number of diagnosis and registration of PID (http://www.primaryimmune.org/ 
resources/resources.htm) (Modell, 2007a; Modell, 2007b; Pickett et al., 2008). Considering 
the increasingly frequent recognition of these diseases and their valuable contribution to 
understanding human immune system and mechanisms of defense against infections (more 
frequent medical care in worldwide) (Alcais et al., 2009), it is essential establish the 
frequency and type in population (Casanova & Abel, 2007; Ballow et al., 2009). The lack of 
proper diagnosis and treatment are the main problems in patients with PID in Latin 
America. These are related to lack of proper training of pediatrics, leading to misdiagnosis 
or late diagnosis, lack of proper screening, lack of government resources to implementation 
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of diagnostic centers and disinterest of private institutions in diagnosis of PID, regional 
variability access to educational program and establishment of diagnostic and treatment 
center (Pickett et al., 2008; Condino-Neto et al., 2011; Leiva et al., 2011). 
2. Difficulties in diagnosis, treatment and education of PID in Latin America 
2.1 Argentina 
The main diagnostic centers in Argentina are located in Buenos Aires, and other centers are 
located in La Plata, Rosario, Cordoba and Mendoza. These centers are accessible and 
without cost to the community, provided that patients are referred by doctor. Private 
hospitals in Argentina offer only partial diagnosis, because no they have laboratories and 
professionals specialized in PID. Patients in Paraguay, Bolivia and Uruguay are also 
diagnosed and treated in Buenos Aires since these countries do not have adequate support. 
As their countries do not encourage their costs, or they do not have health insurance, this 
burden financially immunology centers in Argentina (Maceira et al., 2010). Patients with PID 
who need IVIG are usually met in Buenos Aires, and treatment is not automatically 
continued in the pediatric patient who came into adults, it should be transferred from 
pediatric hospital to hospital for adults, interrupting treatment (Krasovec et al., 2007). In 
Argentina, immunologists are not recognized experts by the Ministry of Health, and only 
two hospitals in Buenos Aires offer scholarships programs and post-graduate training  
in immunology funded by government agencies (Galicchio et al., 2010; Condino-Neto  
et al., 2011). 
2.2 Brasil 
It is estimated that Brazil has 2,000 patients on treatment and approximately 20,000 patients 
with PID (Leiva et al., 2007). Immunological diagnosis is supported by numerous centers 
located in São Paulo, Minas Gerais, Paraná, Rio Grande do Sul, Bahia and Rio de Janeiro 
(Grumach et al., 1997; Leiva et al., 2007). Centers located in southeast of country have 
specialized researchers, structure and molecular diagnostics. In Brazil, the federal government 
assists the movement of patients from regions without infrastructure to specialized centers, 
and coverage for certain screening tests of PID (Ocké-Reis & Marmor, 2010; Paim et al., 2011). 
High costs and access to specialized laboratories are considered major problems by doctors for 
the diagnosis of PID (results available http://www.bragid.org.br/download/graphicos.pps), 
with strong educational, whose website presents PID centers throughout Brazil, journals, 
reviews and articles, case discussions, and announcements of meetings. This is supported by 
St. Jude's Hospital children and government agencies FAPESP and CNPq. Activities of this 
group include completion of first and second Summer School of PID by LAGID, 
implementation of Electronic Registration of Latin America Immunodeficiencies 
(http://imuno.unicamp.br:8080/) with installation of hardware in UNICAMP center 
computing support of ESID. The Federal University of São Paulo-UNIFESP, in partnership 
with Jeffrey Modell Foundation and Baxter International, created the first Jeffrey Modell 
Diagnostic Center for PID in Latin America; with goal of enabling physicians perform 
diagnostic, treatment and education of patients and PID cases reported in Brazil and Latin 
America. Patients with PID who need IVIG in Brazil receive government financial support, 
and not institutions or private health insurance, where patients should be initially admitted for 
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programs in allergy and immunology, although only few centers are able to train professionals 
and PID treatment, located in São Paulo (Costa-Carvalho et al., 2011; Condino-Neto et al., 2011). 
2.3 Chile 
The best laboratories for diagnosis of PID in Chile are located in Santiago, Temuco, 
Valparaiso and Concepcion. Initial screening tests for PID can be performed in large 
hospitals, although it does not receive government financial support (Goic & Armas, 2010). 
As in most underdeveloped countries in Latin America, the diagnosis of PID is often 
performed after numerous episodes of infection and treatment, and patient referral to 
specialist in infectious diseases, and finally to immunology center. Patients with PID, who 
need IVIG, are not reimbursed by the public health system for PID, burdening the costs to 
patients, which makes the treatment is not performed or interrupted. Chile has a three-year 
residency in immunology at the University of Santiago of Chile, providing training care of 
adult and pediatric patients (Condino-Neto et al., 2011). 
2.4 Colombia 
Colombia has a national PID referral center located in University of Antioquia in Medellin, 
which has laboratory equipped to perform molecular and immunological diagnosis of PID, 
and other centers and programs are being developed in Bogota, Cali, Cartagena and 
Barranquila. Currently, 80% of cases of PID in Colombia come from Antioquia (Montoya et 
al., 2002; Obando et al., 2005) and neighboring states, which represents less than 20% of 
Colombia population. Most clinical laboratories in Colombia are able to perform initial PID 
screening, but specific tests are only available in Medellin and Bogota (Montoya et al., 2002; 
Diaz et al., 2008). In Colombia, the government Compulsory Health Plan (POS) provides 
basic coverage for PID and additional coverage can be obtained from private insurance 
companies (Gonzáles et al., 1999; Cardona & Segura, 2011). Patients with PID, who need 
IVIG, are not refunded by POS, but IVIG treatments are covered by private insurance 
companies, who refunded through government's national fund FOSYGA. In this country 
there is Foundation for Diana Garcia de Olarte PID, which supports and develops 
educational programs, provides infrastructure for IVIG treatment centers and offers legal 
advice for patients who need IVIG (Montoya & Sorensen, 2001). The University of Antioquia 
in Medellin has immunology program for medical residents, and like Latin American 
countries, this prefer specialize in other areas, since the financial return is greater (Condino-
Neto et al., 2011). 
2.5 Honduras 
Honduras has two PID diagnostic centers, located in Tegucigalpa and San Pedro Sula, 
accessible to entire community, first laboratory support specific PID, and country have 
serious problems in laboratory diagnosis and access costs (Leon, 2003), availability of IVIG 
and cost. Only two hospitals in Tecigalpa, including National Institute of Social Security, 
provide treatment with IVIG. The country has no specific PID program residency, and 
receives training only three months on basic immunology, autoimmunity, allergy and 
immunodeficiency (Condino-Neto et al., 2011). 
 




Mexico has specialized centers diagnosis of PID in Mexico City, Monterrey and Guadalajara, 
and molecular diagnosis of some PID can be performed only in Mexico City. Mexico has 
serious access problems to laboratory tests, cost and medical education in PID (Romero-
Márquez & Romero-Zepeda, 2010; Yavich et al., 2010). The Access to IVIG is extended to 
public health system and is administered in public hospitals and clinics, but doctors do not 
follow specific guidelines for the administration of IVIG. The use of IVIG represents 20% of 
coast in obtaining drugs by National Institute of Pediatrics in Mexico City. In Mexico, there 
are plenty residency programs in allergy and immunology, with emphasis on allergies. Only 
the National Institute of Pediatrics in Mexico City has residency program with emphasis on 
pediatric allergy and immunology (Condino-Neto et al., 2011). 
3. Latin American group of immunodeficiency 
One of major problems of records diseases in underdeveloped countries has been limitation 
of diagnostic and treatment, and send reports of cases by physicians, resulting in 
overestimation in certain clinical centers in collection of samples, since most of these centers 
is reference to some types of PID, and lack of standardized definitions of cases makes it 
impossible to calculate rates of healthy population from this source, by only reporting 
positive cases without reference population data (Condino-Neto et al., 2011). 
The PID diagnosis is performed in immunology centers, usually located in major cities of 
Latin American countries, and the vast majority of pediatricians and general practitioners 
are not prepared to establish PID diagnosis. The medical community educator has a role in 
awareness of population and health professionals in PID. In 1997, the University of São 
Paulo, Brazil, 166 cases of PID were registered with frequency of predominantly humoral 
defects (60.8%), T cell defects (4.9%), combined T-and B-cell deficiencies (9, 6%), phagocyte 
disorders (18.7%) and complement deficiency (6%). During observed period, 13.8% of 
children died, primarily of recurrent infections. In comparison with other reports, was 
higher relative frequency of phagocyte and complement deficiency. This is the first report 
on PID over 15 year’s observation (1981-1996) (Grumach et al., 1997). In 1998, a Colombia 
study with 83 PID patients demonstrated most common disturbance was antibody 
deficiency (74,6%), followed abnormalities of unspecific mechanisms (13,3%), deficiencies of 
cell mediated immunity (9,6%), and mortality ratio was 6% especially in patients with 
cellular deficiency (Núñes, 1988). 
In Antioquia, Colombia, between August of 1994 and July of 2002, 98 patients was 
registered with diagnosis of PID, with most frequent report antibodies deficiency (40,8%), 
followed by combined deficiencies (21,4%)(Montoya et al., 2002). In Latin America, in 
1993, immunologists from four Latin American countries (Argentina, Brazil, Chile, 
Colombia), created the Latin American Group for Immunodeficiencies (LAGID) to study 
the frequency of PID and promote knowledge by general practitioners and specialists in 
allergy and immunology, including Latin American countries, creating a record in each 
participating country. Currently, 14 countries belong to this group, which had record 3321 
patients in 2004.  
LAGID was implemented in 1993 with the mission to include several Latin American 
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promote annual scientific meetings with the participation of well-recognized international 
authorities in the PID field, This environment made possible the intensive interaction among 
Latin American doctors which in turn interacted with North American and European 
investigators resulting in a network, significant scientific development in Latin America, 
and the several resultant publications, starting with the clinical studies based on the LAGID 
registries 
In order to encourage the registration of cases by LAGID, this sets out on its website 
(http://www.lagid.lsuhsc.edu) the objectives: 
1. Knowing the frequency of different PID 
2. Compare the frequency of different PID by region and country 
3. Knowing the time that elapses between the onset of symptoms and diagnosis and 
measure whether this time can be shortened through the dissemination of knowledge 
about PID 
4. Create awareness in importance of PID in primary care physicians, educators from 
basic and clinical science and health authorities to decide how to allocate resources for 
diagnosis and treatment of diseases in diverse groups 
5. Promote research in various aspects of specific PID that would not be possible to settle 
in very small groups of patients 
6. Disseminate the findings in field of Latin American PID to medical and international 
immune community 
7. Facilitate the formation of support groups for parents and sponsors 
The first LAGID published a series of studies in 1998, recording instances of medical 
services totaling 1428 patients of eight countries (Argentina, Brazil, Chile, Colombia, 
Costa Rica, Mexico, Paraguay, Uruguay), concluding that predominantly antibody 
deficiencies were reported in 58% patients, followed by cellular and antibody 
immunodeficiencies associated with others abnormalities in 18%, immunodeficiency 
syndromes associated with granulocyte dysfunction in 8%, phagocytic disorders in 9%, 
combined cellular and antibody immunodeficiencies in 5%, and complement deficiencies 
in 2% of patients (Zelazko et al., 1998). 
In a second step, this same group published a second series of studies in 2007, documenting 
3.321 cases of 12 Latin American countries (Argentina, Bolivia, Brazil, Chile, Colombia, 
Costa Rica, Ecuador, Mexico, Peru, Paraguay, Uruguay and Venezuela). The most common 
form of PID was predominantly antibody deficiency (53,2%), other well-defined PID 
syndromes such ataxia telangiectasia, Hyper IgE and Di George (22,6%), Combined T- and 
B-cell Immunodeficiency (9,5%), phagocytic disorders (8,6%), diseases of immune 
dysregulation (3,3%) and complement deficiencies (2,8%). All countries that participated in 
the first publication in 1998 reported increase in PID register cases, ranging between 10 and 
80% (Leiva et al., 2007). 
In second LAGID record, Argentina recorded 852 cases of predominantly antibody 
deficiency, and Brazil 404 with predominates isothype deficiencies of light chain with 
normal numbers of B cells. Brazil reported 75 cases of Combined T-and B-cell 
Immunodeficiency and Argentina 69 cases. Like other well-defined syndromes, Argentina 
reported 60 cases of Di George Syndrome, 42 of Hyper IgE Syndrome and 40 of Wiskott-
Aldrech Syndrome, Costa Rica 82 cases of DNA repair defects and Brazil 37 cases of Chronic 
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Mucocutaneous Candidiasis. Representing diseases of immune dysregulation, Argentina 
reported 22 cases of Immunodeficiency with Hypopigmentation, followed by 14 cases of 
Brazil. Congenital defects of phagocytic number, function or both, Brazil reported 50 cases 
of cyclic neutropenia and 42 cases of Chronic Granulomatous Disease (CGD), and 
Argentina 46 cases. Brazil reported 50 cases of deficiency complement, followed by 13 
reports of Argentina (Leiva et al., 2007). Like others studies, predominantly antibody 
deficiency was the principal PID observed in Latin America, Australia (Baumgart et al., 
1997; Kirkpatrick et al., 2007), China (Zhao et al., 2006; Wang et al., 2011), Egypt (Reda et 
al., 2009), French (CEREDIH, 2010), Hong Kong (Lam et al., 2005), Iran (Aghamohammadi 
et al., 2002; Farhoudi et al., 2005; Rezaei et al., 2006), Italy (Luzi et al., 1983), Kuwait (Al-
Herz, 2008), Netherland (Zegers et al., 1994), Norway (Stray-Pedersen et al., 2000), Poland 
(Bernatowska et al., 1998), Republic of Ireland (Abuzakouk et al., 2005), Spain (Matamoros 
et al., 1997; Milá et al., 2001), Swiss (Ryser et al., 1998), Taiwan (Lee et al., 2011), Thailand 
(Benjasupattananan et al., 2009), Tunisia (Bejaoui et al., 1997) and USA (Javier et al., 2000; 
Stiehm, 2007), Studies in other countries reveled major number of granulocyte 
dysfunction in India (Verma et al., 2008), and Combined T-and B-cell Immunodeficiency 
in Turk (Shabestari et al., 2007). 
On October 14, 2009, a group of experts from six Latin American countries (Argentina, Brazil, 
Chile, Colombia, Honduras and Mexico) and representatives of LASID meet in Cartagena de 
Indias in Colombia to discuss particular needs of each country about PID. Also this year, was 
created on-line Program Registration in Latin America (Registration of Society for 
Immunodeficiencies Latin American-LASID) in site http://deficiencia.unicamp.br:8080/, to 
provide information of PID epidemiology in Latin America. This meeting was held on 28 and 
29 April in São Paulo, with the participation of 90 participants from Argentina, Brazil, Chile, 
Colombia, Honduras and Mexico, three faculty members from the USA and a faculty member 
of ESID. The online registration for Latin America was adapted from the record set ESID in 
Europe; Latin America is supported by Jeffrey Modell Foundation and National Council for 
Scientific and Technological Development (CNPq) of Brazil. From this date, 24 centers were 
enrolled in diagnosis, treatment and research, with more than 600 registered patients. In others 
countries, the online database network make good results in records of PID (Eades-Perner et 
al., 2007; Guzman et al.,; 2007; Gathmann et al., 2009), 
The LAGID has published four reports and proceedings; the first two papers focused on the 
prevalence and characteristics of PID patients in Latin America (Zelazco et al., 1998; Leiva et 
al., 2007); the third and fourth summarized deficiencies in PID diagnosis and treatment in 
Latin America and described features of educational outreach program, immunology 
fellowship program, and laboratory network aimed at correcting these deficiencies 
(Condino-Neto et al., 2011; Leiva et al., 2011). From July 2009 to September 2010, the LAGID 
recorded 838 cases of PID. 
In April 2011, the registry of Immunodeficiencies completed two years, with more than 1000 
cases reported from 35 centers representing various Latin America countries. Recently, the 
Committee decided to hold LASID collaborative studies with the recorded data to better 
understand profile of prevalent PID, such XLA, HIgM, and CGD, filling out form and 
sending data to protocololasidxla@bragid.org.br or protocololasidhim@bragid.org.br or 
protocololasiddgc@bragid.org.br depending on PID. The group also offers financial 
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Those studies contributed with new insights on clinical presentation and impacted 
positively on the molecular diagnosis of PID. All together the Latin American experience 
shows that BCG complications is prevalent among SCID, T-cell deficiencies, and CGD 
patients; that fungal infections is highly prevalent among X-linked HIGM patients, and that 
ataxia-teleangiectasia is especially frequent in Mexico and Costa Rica. Currently Chile is 
building a new diagnostic center at University La Frontera that will interact with research 
centers in Argentina, Brazil, and Colombia. This strategy will strength even more the 
interaction among the several Latin American research centers. 
Studies by LAGID showed numerous factors responsible for delay in diagnosis and treatment 
of patients with PID. Most pediatricians and family physicians in Latin America are not 
sufficiently trained to carry out the diagnosis of PID, there is a low amount of specialized 
installations for specific immunological tests, there is limited coverage for screening tests given 
by the government or private institutions, regional variability access to health and failure to 
comply with guidelines in certain countries and regions. To improve some of these aspects, 
diagnosis and treatment of patients with PID, experts from Latin America and the USA meet 
to discuss three specific programs, educational program (The L-Project), scholarships program 
and establishing of laboratory network to expand access to data (The Latin América Advisory 
Board on Primary Immunodeficiencies) (Leiva et al., 2011; Condino-Neto et al., 2011). 
3.1 Educational program 
The educational program (L-Project) was established to create increased awareness of 
general public, continuing education network on PID, promote basic and clinical research of 
PID and inform government officials in impact of PID on health published in Latin America. 
This program covers students, residents, pediatricians, nurses and officials involved in 
health system. It also emphasizes encouragement medical students seeking academic 
placement of teaching, research and clinical PID. These programs include summer school, 
containing cases and report on short-term programs associated with PID infection, 
dissemination of information by radio, television, websites, newspapers, magazines and 
educational material for community (Marodi & Casanova, 2009; Leiva et al., 2011). This 
proposal directly contributes to knowledge generation and increase technological capacity 
of Latin America in this field. It is virtuous chain where all the researchers and the 
community involved propagate their knowledge acquired in other centers of reference, 
allowed expansion of existing lines of research in Brazil. 
3.2 Summer school 
Creating of Summer school is considered a viable solution to promote scientific interaction, 
and standardization of PID knowledge in different member countries because educational 
systems and medical residents differ in each country member (Condino-Neto et al., 2011; 
Leiva et al., 2011). In Brazil, São Paulo in 2006 was held the first Summer School, based on 
model proposed by ESID and CIS. This meeting was attended by 12 teachers of LAGID, 
ESID and CIS experts PID and 12 students, where they were focused biochemical and 
molecular diagnosis PID, major PID in Latin America; IVIG therapy guidelines, 
hematopoietic bone marrow transplantation; communication network LAGID. New meeting 
was held in 2008 in Temuco, Chile, and recently in 2010, Bahia, Brazil, with inclusion of 90 
students from different Latin America countries. 
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3.3 Scholarship program offer 
One of great difficulties encountered in developing countries for training professionals in 
PID is to awaken academic and professional interests, without compromising quality of life 
and survival of students and health professionals. Thus, different Latin American countries 
offer scholarships funded by educational institutions and other entities, governmental or 
private, with development of people involved and trained in specific areas of health. One of 
major problems seen in developing countries is the absence of jobs, which means that many 
students, just looking for graduate services that offer post-graduate scholarships, forgetting 
commitment they have with the community. Another problem in Latin America is 
formation of highly trained and qualified for certain areas of education and research, which 
are not absorbed by countries, end migrating to other parts of world. To resolve these 
problems, the Advisory Council LAGID determined availability of scholarships for doctors 
interested in area of clinical PID, as well doctors and teachers interested in immunology. 
The participating institutions were willing to participate in record LAGID, and grant 
applicants to submit personal statement, career development plan, and mentor involved 
with project statement of no conflict of financial interest and letters of recommendation. In 
this agreement, it was established that no country could be assigned more than two grants 
during period of two years, and beneficiaries of scholarship must publish report on its 
activities or clinical results or research (Leiva et al., 2011). 
3.4 Creation of centers of education, diagnosis and treatment 
One of the major problems encountered in developing countries is lack of proper training of 
physicians and pediatric regional variability in access to educational program and 
establishment of diagnostic and treatment center. Thus, education and training are needed 
for specialists, pediatricians, general practitioners from different countries and regions of 
Latin America, ensuring that they are able to recognize warning PID signs. This includes 
creation of Summer School, symposia and conferences of PID. These educational efforts 
should also be understood to medical students, nurses and general public. For that, 
programs are needed government and private funding, and network (Leiva et al., 2011). In 
Brazil, the Jeffrey Modell Foundation, and Baxter pharmaceutical industry, created on April 
29, 2009 at Federal University of São Paulo-UNIFESP, the first Jeffrey Modell Diagnostic 
Center for PID in Latin America, based in field of Immunology pediatric UNIFESP, with 
working points in different parts of the country. The Jeffrey Modell Diagnostic Center 
operates in front of medical education, diagnosis and records of PID and patient education 
(Modell, 2007a; Modell, 2007b). Other diagnostic centers sponsored by the Jeffrey Modell 
will be opened in Mexico, Argentina, Colombia and Chile. Advancing educational model for 
educational outreach in Latin America is observed in the Brazilian Group of Human 
Immunodeficiency (BRAGID) (http://www.bragid.org.br), whose number of registered 
doctors increased from 190 in 2002 to 2.500 in 2009, after creation of local seminars on dating 
PID. The BRAGID provides information on warning PID, different clinical presentation PID 
of and diagnostic laboratories. Offer clinical cases that can be discussed in Internet. This 
model is followed in Colombia, which has specialized site that shows warning PID signs, 
types of PID and use of IVIG. In other Latin American countries, government agencies 
related to areas of health are more concerned with control of infectious diseases, and most 
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The PID are congenital and inherited diseases that affect the immune system, which 
occurrence in population varies by type of study and study group. Recent studies indicate 
that these values in the general population are underestimated and are one of the biggest 
problems and lack of knowledge, both worldwide and Latin America. Many factors 
compromise its knowledge, such as lack of education centers, professional structure, and 
laboratory records. The incidence of PID in Latin America is similar to that observed in 
different parts of the world, with predominantly antibody defects. In Latin America, adds to 
these, the lack of government support and private initiative. To redress this problem was 
created LAGID, which hosts Latin American countries concerned with knowledge of 
incidence, diagnosis, treatment and discovery of new PID. For this, congresses are held, 
online records and establishing laboratory training, diagnosis and treatment of PID, based 
on the model established in Europe. 
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The PID are congenital and inherited diseases that affect the immune system, which 
occurrence in population varies by type of study and study group. Recent studies indicate 
that these values in the general population are underestimated and are one of the biggest 
problems and lack of knowledge, both worldwide and Latin America. Many factors 
compromise its knowledge, such as lack of education centers, professional structure, and 
laboratory records. The incidence of PID in Latin America is similar to that observed in 
different parts of the world, with predominantly antibody defects. In Latin America, adds to 
these, the lack of government support and private initiative. To redress this problem was 
created LAGID, which hosts Latin American countries concerned with knowledge of 
incidence, diagnosis, treatment and discovery of new PID. For this, congresses are held, 
online records and establishing laboratory training, diagnosis and treatment of PID, based 
on the model established in Europe. 
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On Combining Family Data from Different
Study Designs for Estimating Disease Risk
Associated with Mutated Genes
Yun-Hee Choi
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1. Introduction
Genetic disorders caused primarily by abnormalities in genes or chromosomes are rare in the
general population. The associated putative mutations that lead to a high risk of developing
such diseases are even rarer. In order to study disease risks associated with mutated genes,
families sampled under different study designs are commonly used in association studies.
This is because family data recruited via affected individuals (probands) would be expected
to contain more affected individuals and mutation carriers than families randomly sampled
from a general population, thus leading to increased statistical efficiency in estimating the
disease risk. The disease risk associated with a mutated gene can be measured on a relative or
absolute scale. As the event we consider is disease with its age of onset, the relative risk can
be measured as a ratio of two hazards of developing disease between mutation carriers and
non-carriers, and the absolute risk as a function of age, i.e., the cumulative risk of developing
disease by a given age, which is also termed penetrance.
Several family-based study designs have been used for estimating the disease risk associated
with a gene mutation when onset varies with age. Gong & Whittemore (2003) discussed two
basic types of family-based sampling schemes: population-based and clinic-based designs.
For population-based designs, families are ascertained for study inclusion based on affected
family members who are randomly sampled from the disease population. The proband is
usually genotyped to determine if s/he carries the disease risk gene and additional genotype
and phenotype data can then be collected from other family members. A kin-cohort design
described by Wacholder et al. (1998) is an example of the population-based design as
families are sampled through a volunteer (either affected or unaffected) who agrees to be
genotyped and provides the disease history of her or his first-degree relatives through a
questionnaire. Not restricted to including the first degree relatives and genotyping only
probands, a kin-cohort design can be easily extended to case-family studies to include more
extended family members and their genotype information. Case-control family studies have
been widely used to analyse the ages of onset of disease in relation to genetic risk (Li et al.,
1998; Shih & Chatterjee, 2000; Hsu & Gorfine, 2006), where case families are recruited via
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For clinic-based designs, on the other hand, families are ascertained into the study based on
having multiple affected family members in addition to the affected probands. Pedigrees
with many cases are highly informative because they are more likely to carry the disease
gene mutation, but typically have not been ascertained in any population-based manner.
Such families are often identified from high-risk disease clinics and provide substantial
information to estimate the disease risk (for example, Kopciuk et al., 2009). Multistage designs
(Whittemore & Halpern, 1997; Siegmund et al., 1999) provide an alternative way to efficiently
recruit high risk families, often using disease family registries, where families are sampled
from more informative groups via several stages. Studies based on these high-risk families
can be effective for characterizing the prevalence and penetrance of mutated genes, but it is
well known that without proper ascertainment corrections statistical inference would lead
to biased estimations of population attributes such as allele frequency, disease risks, and
penetrance of the mutated genes.
To allow population-based inference for estimating disease risks associated with mutated
genes, family data can be analyzed using various likelihood-based methods (Thomas, 2004).
In particular, ascertainment-corrected likelihood approaches have been developed by several
authors (for example, Choi et al., 2008; Carayol & Bonaïti-Pellié, 2004; Kraft & Thomas, 2000;
Le Bihan et al., 1995). Based on the survival approach, Le Bihan et al. (1995) formulated a
prospective likelihood for modeling phenotypes as the age of onset and disease status given
genotypes, and corrected the likelihood by the probability of families being ascertained for
study. This approach is natural as it models phenotypes as a function of genotype and
covariates, but the ascertainment scheme has to be clearly known and simple enough to
make proper correction. On the other hand, the retrospective likelihood models genotypes
conditioning on the phenotypes of all family members (Carayol & Bonaïti-Pellié, 2004; Kraft
& Thomas, 2000; Schaid et al., 2010). Although this approach provides the most robust
way to obtain consistent estimates of relative risk even with the ascertainment schemes that
are imprecisely defined or complex, it encounters the computational burden of summing
over possible genotypes of all family members and a decreased efficiency resulting from
conditioning. Choi et al. (2008) adapted the retrospective likelihood conditioning only
on phenotypes of individuals who were involved in the ascertainment criteria; for families
sampled from the population-based designs, only probands were used to correct for the
ascertainment, whereas for families from the clinic-based designs, the probands and their
parents and sibs were used for ascertainment correction. Moreover, Schaid et al. (2010)
accommodated the composite likelihood approach to obtaining the retrospective likelihood
based on all possible pairs of individuals in families to reduce the computational burden.
The main objectives of this article are first, to examine the effects of misspecification of study
designs when more appropriate study designs have been ignored or incorrectly specified in
the analysis; second, to provide simple and easy to apply adjustment schemes for estimating
disease risks by combining family data from different study designs; and third, to develop an
Expectation-Maximization algorithm to infer missing genotypes in the estimation of disease
risks. We start with describing ascertainment-corrected likelihood methods to take the study
design into account and propose a likelihood-based approach to estimating the disease risks
for combined family data collected under different study designs. The performance of
these ascertainment-corrected likelihood methods is evaluated in terms of bias and efficiency.
The effect of design misspecification is examined for estimating the disease risks associated
with mutated genes. The bias and efficiency involved in estimating two disease risks are
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compared when only probands for the families from the clinic-based study are adjusted
for, and when the probands and other affected family members for the families from the
population-based design are used for ascertainment correction. For the combined family
data, the two design correction methods (population-based and clinic-based) are applied
and compared respectively with our proposed combined likelihood method in terms of their
accuracies and efficiencies for disease risk estimation.
This chapter includes the following sections. Section 2 introduces two family-based study
designs—the population- and clinic-based study designs and their ascertainment-corrected
likelihood methods for modeling ages at onset for family members in disease risk estimation.
We propose a likelihood-based approach for the combined family data obtained from different
study designs. In Section 3, an Expectation-Maximization (EM) algorithm is incorporated
to account for the missing genotype information, where the missing genetic covariates are
inferred from their conditional expectation given the observed genotypes and phenotypes of
other family members. Moreover, a robust variance estimator is proposed to account for the
dependence of individuals within families. Using simulation studies in Section 4, we examine
the effects of study design misspecification for estimating the disease risks and investigate the
properties of our proposed likelihood approach for combined families from different study
designs. In Section 5, we illustrate our proposed approaches through an application to family
data obtained from the combination of two studies of Lynch Syndrome—first, Newfoundland
data from the clinic-based design and second, Ontario data based on the population-based
design. Final remarks and possible extensions of this work will follow in Section 6.
2. Methods
2.1 Defining disease risks
For diseases caused by mutated genes, the phenotype of interest varies in age at onset, i.e.,
time to an event such as death or disease diagnosis. We denote the age at onset by T, the
affection status at age of examination by δ. Then, the phenotype is given by D = (T, δ).
Under the Cox’s proportional hazards model, the hazard function for individual i conditional
on mutation gene G and other risk factors X is assumed to take the form
h(ti|gi,xi) = ho(t) exp(βgG + βxX),
where ho(t) is a baseline hazard function and βg and βx are unknown regression parameters.
Based on this model, we consider two types of disease risk associated with a mutated
gene—relative risk and absolute risk, the latter is also called penetrance.
(1) the relative risk in survival analysis is defined by the hazards ratio for an individual with
a mutated gene compared to an individual free from the mutation, that is
Relative Risk = exp(βg).
(2) the penetrance function for the disease susceptibility gene is defined as the age-specific
cumulative risk function conditional on the disease susceptibility gene G and other relevant
covariates X,
Penetrance = P(T < t|G, X) .
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way to obtain consistent estimates of relative risk even with the ascertainment schemes that
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The main objectives of this article are first, to examine the effects of misspecification of study
designs when more appropriate study designs have been ignored or incorrectly specified in
the analysis; second, to provide simple and easy to apply adjustment schemes for estimating
disease risks by combining family data from different study designs; and third, to develop an
Expectation-Maximization algorithm to infer missing genotypes in the estimation of disease
risks. We start with describing ascertainment-corrected likelihood methods to take the study
design into account and propose a likelihood-based approach to estimating the disease risks
for combined family data collected under different study designs. The performance of
these ascertainment-corrected likelihood methods is evaluated in terms of bias and efficiency.
The effect of design misspecification is examined for estimating the disease risks associated
with mutated genes. The bias and efficiency involved in estimating two disease risks are
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compared when only probands for the families from the clinic-based study are adjusted
for, and when the probands and other affected family members for the families from the
population-based design are used for ascertainment correction. For the combined family
data, the two design correction methods (population-based and clinic-based) are applied
and compared respectively with our proposed combined likelihood method in terms of their
accuracies and efficiencies for disease risk estimation.
This chapter includes the following sections. Section 2 introduces two family-based study
designs—the population- and clinic-based study designs and their ascertainment-corrected
likelihood methods for modeling ages at onset for family members in disease risk estimation.
We propose a likelihood-based approach for the combined family data obtained from different
study designs. In Section 3, an Expectation-Maximization (EM) algorithm is incorporated
to account for the missing genotype information, where the missing genetic covariates are
inferred from their conditional expectation given the observed genotypes and phenotypes of
other family members. Moreover, a robust variance estimator is proposed to account for the
dependence of individuals within families. Using simulation studies in Section 4, we examine
the effects of study design misspecification for estimating the disease risks and investigate the
properties of our proposed likelihood approach for combined families from different study
designs. In Section 5, we illustrate our proposed approaches through an application to family
data obtained from the combination of two studies of Lynch Syndrome—first, Newfoundland
data from the clinic-based design and second, Ontario data based on the population-based
design. Final remarks and possible extensions of this work will follow in Section 6.
2. Methods
2.1 Defining disease risks
For diseases caused by mutated genes, the phenotype of interest varies in age at onset, i.e.,
time to an event such as death or disease diagnosis. We denote the age at onset by T, the
affection status at age of examination by δ. Then, the phenotype is given by D = (T, δ).
Under the Cox’s proportional hazards model, the hazard function for individual i conditional
on mutation gene G and other risk factors X is assumed to take the form
h(ti|gi,xi) = ho(t) exp(βgG + βxX),
where ho(t) is a baseline hazard function and βg and βx are unknown regression parameters.
Based on this model, we consider two types of disease risk associated with a mutated
gene—relative risk and absolute risk, the latter is also called penetrance.
(1) the relative risk in survival analysis is defined by the hazards ratio for an individual with
a mutated gene compared to an individual free from the mutation, that is
Relative Risk = exp(βg).
(2) the penetrance function for the disease susceptibility gene is defined as the age-specific
cumulative risk function conditional on the disease susceptibility gene G and other relevant
covariates X,
Penetrance = P(T < t|G, X) .
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Design Ascertainment Criteria
POP Proband is affected
POP+ Proband is affected and mutation-carrier
CLI Proband is affected and at least one parent and one sib are affected
CLI+ Proband is affected mutation-carrier and at least one parent and
one sibling are affected
Table 1. Family-based study designs
The disease risks can be estimated by maximizing a likelihood function with proper
ascertainment adjustment of the families. In a crude analysis of family data, their
ascertainments are often corrected by simply excluding the probands from the analysis to
prevent overestimating the risk. However, more prudent approaches such as likelihood
methods would not simply drop out the probands because they include other important
information about the disease risks. Rather they would adjust for the sampling process,
allowing their contributions to the likelihood. To accommodate study designs and the
ascertainment process properly, both the design and the ascertainment criteria should be
known clearly. However, such designs or criteria in many cases are unclear or too complex
to allow adjustment at the analysis stage. Moreover, family data could come from different
sources where families were recruited using different designs or ascertainment criteria.
2.2 Family-based study designs
We consider the two most commonly used family-based study designs—population-based
designs and clinic-based designs. The population-based study design uses the affected
cases (probands) to sample their families while the clinic-based study design is based on
the probands with a high family history of disease risk. Thus, the clinic-based families
likely include more disease cases and mutation carriers compared to the families from
population-based designs.
The ascertainment criteria for the population-based study are based on the affected probands
who are randomly sampled from the diseased population; for example, cancer registries.
To increase the power to study the effect of the mutated gene of interest, one can apply
stringent criteria to recruit the probands to be not only affected but also be a mutation-carrier.
Similarly, the clinic-based study designs can have two variants: one with random probands
with multiple case family members and the other with carrier probands with multiple case
family members. Such families can be recruited from cancer registries or cancer clinics.
Table 1 summarizes the four study designs and their sampling criteria used to ascertain
families. Population-based designs correspond to ascertainment criteria POP and POP+.
They are similar to a kin-cohort design but are more like case-family designs that include
extended family members and their genotype information. Ascertainment criteria CLI and
CLI+ correspond to clinic-based designs which have multiple disease occurrences among
family members. Important to note is that ascertainment criteria for the POP+ and CLI+
designs include families who have at least one member (proband) who carries the mutated
gene of interest.
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2.3 Likelihood approaches for family-based study designs
This section describes the likelihood-based approaches for modeling ages at onset and genetic
covariates using family data via population-based and clinic-based study designs. We propose
a combined likelihood approach for family data arising from the two different study designs.
2.3.1 Ascertainment-corrected retrospective likelihood
The retrospective likelihood corrects for the ascertainment by conditioning on the phenotypes.
Define D = (d1, . . . , dn) as a vector of phenotypes, G = (g1, . . . , gn) as a vector of genotypes,
X = (x1, . . . , xn) a vector of covariates other than genotypes, and A the ascertainment event.
The likelihood contribution L f for a single family f can be written as
L f = P(Gf |Df , X f , A f )
=
P(A f |Df , X f , Gf )P(Df |X f , Gf )P(Gf )
P(Df , A f |X f )
∝
P(Df |X f , Gf )P(Gf )
P(Df , A f |X f )
, (1)
where we assume that P(A f |Df , X f , Gf ) is equal to 1 if the vector Df qualifies for
ascertainment, and 0 otherwise, and so is independent of the parameter of interest.
We further assume that individuals’ phenotypes are independent conditionally given their
genotypes and covariates. Thus, we can express the numerator as











P(gi), if individual i is a founder,
P(gi|gmi , g fi ), if individual i is a nonfounder.
Here P(gi) is based on Hardy-Weinberg Equilibrium (HWE) and depends on the population
allele frequency, P(gi|gmi , g fi ) is the Mendelian transmission probability given parents’
genotypes (gmi , g fi ) of individual i.
The denominator is the correction term used to account for the study designs. In the
population-based study, the ascertainment correction is based on the proband’s phenotype
in that it equals the probability of the proband, p, being affected before his/her age at
examination, ap, i.e.,
P(Df , A f |X f ) = ∑
g
P(Tp < ap|g)P(g),
where the sum is over all possible genotypes of the proband. For POP+ design, the sum takes
place by assuming the proband is a mutation carrier.
In the clinic-based study, the denominator is based on the phenotypes of four individuals,
two parents and two sibs, who involved in their family’s ascertainment process. It can be
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expressed as
P(Df , A f |X f ) = ∑
Gω
P(Tf < a f |x f , gω f )δ f P(Tf ≥ a f |x f , gω f )1−δ f ×
P(Tm < am|xm, gωm )δm P(Tm ≥ am|xm, gωm )1−δm P(gω f , gωm |gωp )×
P(Ts < as|xs, gωs )P(gωs |gωp )P(Tp < ap|xp, gωp )P(gωp ),
where indices f , m, s, p represent father, mother, sib and proband, respectively, δ indicates the
affection status, and Gω = (gω f , gωm , gωp , gωs ) includes all possible genotypes of the four
individuals in the ascertainment set. For CLI+ design, the sum in the denominator is taken
over all possible genotypes, provided that the proband carries a mutated allele of the major
gene. The conditional probabilities P(gω f , gωm |gωp = 1) and P(gωs |gωp = 1) are obtained
based on the HWE and Mendelian transmission probabilities using Bayes theorem.
2.3.2 Combined population- and and clinic-based study designs
Consider a study where the families are sampled via different study designs, say np families
from a population-based design and nc families from a clinic-based design. When their study
designs are known, we can construct the likelihoods based on their study designs. Let Lp and
Lc be the likelihood functions based on the population-based design and clinic-based design,
respectively. We propose the combined likelihood for the families from the two designs as
Lcomb(θ|D, G, X) = Lp(θ|Dp, Gp, Xp)Lc(θ|Dc, Gc, Xc),
where the superscripts p and c denote the population- and clinic-based study designs,
respectively, and the likelihoods Lp and Lc are obtained using the retrospective likelihood
approach in expression (1). Therefore, the combined likelihood using the retrospective
likelihood approach can accommodate both population- and clinic-based designs.
Even when the sampling schemes are not clearly defined, we can still employ this combined
likelihood approach by dividing the families into two groups—high risk and low risk families,
according to the number of cases observed in the family. For example, a family would be
classified as a high risk family if it includes at least three cases among family members,
otherwise it would be classified as a low risk family.
3. Missing genotypes
In practice, family data often include some missing information, particularly, missing
genotypes. In the presence of missing genotype information, we estimate the disease risks
associated with a known gene mutation in the families. Suppose data include genetic
covariates that consist of observed genotypes and missing genotypes and phenotypes as
time-of-onset responses with no missing. To infer the unobserved genotypes in the family, we
implement an expectation-maximazation (EM) algorithm (Dempster et al., 1977) and estimate
the parameters in the likelihood. The EM algorithm is an iterative procedure that computes
the maximum likelihood estimates (MLEs) in the presence of missing data.
3.1 Expectation-maximazation algorithm
Suppose a genetic covariate Gf in family f consists of observed genotypes Gf o and missing
genotypes Gf m and the vector of unknown parameters θ includes both regression parameters
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and baseline hazard parameters. In our situation, the expectation of the complete data
(Df , X f , Gf ), f = 1, . . . , n, is taken with respect to the conditional distribution of missing
genotypes Gf m given observed data (Df , X f , Gf o) and current estimates of θ. Then the
parameter estimates are updated by maximizing the likelihood function using the estimate
of missing data in the expectation step. These two steps iterate until convergence to obtain the
MLEs, where the algorithm is guaranteed to increase the likelihood at each iteration.
The conditional expectation of the log-likelihood function (θ|D, G, X) of the complete data
(D, G, X) given the observed phenotypes Do and genotypes Go, or Q function for the kth
iteration is given by:
Q(θ|θ(k)) = Eθ(k) [(θ|D, G, X)|Do, Go] . (2)
For the ith individual in family f , we can then obtain the conditional expectation of their
missing genotype Gi given their observed phenotype Di, covariates Xi, and the observed
mutation status Go of other family members, especially if the proband’s genotype Gp is
conditioned as:
Eθ(k) [Gi|Di, Xi, Gp = 1] = Pθ(k) (Gi|Di, Xi, Gp = 1)
=
Pθ(k) (Di|Xi, Gi)P(Gi|Gp = 1)
Pθ(k) (Di|Xi, Gi = 1)P(Gi = 1|Gp = 1) + Pθ(k) (Di|Xi, Gi = 0)P(Gi = 0|Gp = 1)
.
Here P(Gi|Gp = 1) is the conditional probability of the mutation carrier status for family
member i, using the family proband’s known mutation status. Based on Mendelian
transmission probabilities, we can express these as simple constants under an assumed genetic
model. Under the model assumptions given above, the phenotype probabilities conditional
on genotype status for the ith individual can be expressed in terms of the hazard function h
and the corresponding survival function S depending on his/her affection status δi as
P(Di|Xi, Gi) = S(ti; Xi, Gi)h(ti; Xi, Gi)δi .
In the M step of the algorithm, we take the partial derivatives of Q with respect to θ and set
to zero, that will maximize Q.
3.2 Robust variance estimator for the EM algorithm
We illustrate the use of robust variance estimators (sandwich estimators) to account for
within-family dependencies for disease risk estimates. In the presence of missing genotypes,
the variance estimators are modified accordingly upon the use of the EM algorithm (Louis,
1982).
Let U(θ) and B(θ) denote the score vector and the negative of the associated matrix of second
derivatives for the complete data, respectively, and U∗(θ) and B∗(θ) be the corresponding
vector and matrix for the incomplete data. Then, the observed information matrix can be
expressed as
Io(θ) = Eθ [B(θ)|go, do]− Eθ [U(θ)U�(θ)|go, do] + U∗(θ)U∗�(θ), (3)
where go and do denote the vectors of observed genotypes and phenotypes from data. At
the maximum likelihood estimate of θ, because of the convergence of the EM algorithm, U∗
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is zero. Thus, the observed information matrix can be obtained as the first two terms on the
right hand side of (3) that arise from the complete data log-likelihood analysis. The first term
is evaluated as








Oakes (1999) explicitly expressed the information matrix in terms of derivatives of the














where  represents the observed data log-likelihood and the second term is viewed as the
‘missing information.’
To account for familial correlation, as our model assumes the independence of the individuals
in the family, we obtain the robust variance estimator for the ascertainment corrected















where U∗f (θ) is the conditional expectation of the complete data score vector for family f
given the observed data. Thus, the robust variance of θ̂ can be estimated by replacing θ by θ̂
in equation (5).
4. Simulation study
We carried out simulation studies to investigate the properties of our proposed likelihood
methods and the effect of design misspecification. The simulation study aims to (1) assess bias
and efficiency in disease risk estimation (relative risk and penetrance) for the retrospective
likelihood-based approaches for family data from different study designs, (2) investigate
potential bias and efficiency loss in risk estimation when the study designs are misspecified,
and (3) evaluate the first two aims using combined data from two different study designs.
4.1 Family data generation
The simulation of family data is based on the method developed by Gauderman (1995) and
further extended by Choi et al. (2008). We generated families of three generations: two parents
and their two offspring, one of whom is the proband (affected individual from whom the
family is selected). Each offspring has a spouse and their children ranged in number from
two to five. At the first stage, all family members’ ages at examination were obtained using a
normal distribution with mean age 65 for the first generation and 45 for the second generation,
with variance fixed at 2.5 years for both generations. It resulted in an average of 20 years
difference between the parents and offspring. At the next stage, the proband’s genotype of a
major gene was determined conditioning on the proband’s affection status by her/his age at
examination, assuming Hardy-Weinberg equilibrium (HWE) with the fixed population allele
frequency. Given the proband’s genotypes, the genotypes of the other family members were
then determined using HWE and Mendelian transmission probabilities calculated with Bayes’
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formula. Once we simulated the age at examination and genotype information for all family
members, then the time-to-onset of individual i was simulated from the proportional hazards
model,
h(ti|gi) = h0(ti) exp(βxi),
where xi indicates a carrier status of disease mutation gene for subject i and the baseline
hazard is assumed to follow the Weibull distribution which has a form, h0(t) = λρ{λ(t −
20)}ρ−1.
The proband’s age at onset was generated conditioning on the fact that the proband was
affected before his(her) age at examination, ap,
Tp ∼ T|T < ap .
For the rest of family members, their times to onset were generated unconditionally. We also
assumed the minimum age at onset was 20 years of age and the maximum age for followup
was 90 years of age. Finally, the affection status δi for the ith individual was determined by
comparing the age at onset Ti and age at examination ai; δi = 1 if Ti < ai and 0 otherwise.
4.2 Simulation study designs
Data were simulated under different configurations. We assumed Weibull baseline hazard
functions with scale (λ) and shape (ρ) parameters equal to 0.01 and 3.2, respectively. This
leads to a cumulative risk of 10% among mutation non-carriers by age 70. Two penetrances
were considered: high and low penetrances corresponding to the log relative risk of a major
gene (β) given by 2.4 and 1.8, respectively. The high penetrance represents a lifetime risk
of 70% by age 70 among carriers of a major gene, which assumes a rare gene with the allele
frequency 0.02 under the dominant model. The low penetrance provides a lifetime risk of 48%
by age 70 among carriers.
We designed the simulation studies, first to investigate the effect of design misspecification,
and second, to examine the properties of our proposed likelihood for combined family data
from different study designs in the estimation of disease risks associated with a mutated gene.
(1) To study the effect of design misspecification, the study designs POP, POP+, CLI, and CLI+
were used to generate family data. For each design, two retrospective likelihood methods
were applied to fit the data—one using correct adjustment of the study design and the other
using a design with misspecified correction; for example, population-based ascertainment
correction was used for the families under CLI+ design and clinic-based ascertainment
correction was used for the families under POP+ design as for the misspecified design. We
simulated 500 random samples of 200 families for each simulation configuration.
(2) To investigate potential bias and efficiency loss in disease risk estimation for the proposed
likelihood approach for combined family data from population-based and clinic-based
designs. We considered the combined families either from POP+ and CLI+ designs or POP
and CLI designs with three mixing ratios between two designs—50-50, 70-30 and 80-20. For
example, with the total 400 families sampled, the ratio 50-50 corresponds to equal numbers
of families from POP+ and CLI+ designs, the 70-30 sampling corresponds to 280 POP+
families and 120 CLI+ families and the ratio 80-20 to 320 POP+ and 80 CLI+ families. The
same numbers were examined for combining POP and CLI families. For each simulation
configuration, 500 random samples were simulated.
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is zero. Thus, the observed information matrix can be obtained as the first two terms on the
right hand side of (3) that arise from the complete data log-likelihood analysis. The first term
is evaluated as
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‘missing information.’
To account for familial correlation, as our model assumes the independence of the individuals
in the family, we obtain the robust variance estimator for the ascertainment corrected















where U∗f (θ) is the conditional expectation of the complete data score vector for family f
given the observed data. Thus, the robust variance of θ̂ can be estimated by replacing θ by θ̂
in equation (5).
4. Simulation study
We carried out simulation studies to investigate the properties of our proposed likelihood
methods and the effect of design misspecification. The simulation study aims to (1) assess bias
and efficiency in disease risk estimation (relative risk and penetrance) for the retrospective
likelihood-based approaches for family data from different study designs, (2) investigate
potential bias and efficiency loss in risk estimation when the study designs are misspecified,
and (3) evaluate the first two aims using combined data from two different study designs.
4.1 Family data generation
The simulation of family data is based on the method developed by Gauderman (1995) and
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family is selected). Each offspring has a spouse and their children ranged in number from
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major gene was determined conditioning on the proband’s affection status by her/his age at
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formula. Once we simulated the age at examination and genotype information for all family
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gene (β) given by 2.4 and 1.8, respectively. The high penetrance represents a lifetime risk
of 70% by age 70 among carriers of a major gene, which assumes a rare gene with the allele
frequency 0.02 under the dominant model. The low penetrance provides a lifetime risk of 48%
by age 70 among carriers.
We designed the simulation studies, first to investigate the effect of design misspecification,
and second, to examine the properties of our proposed likelihood for combined family data
from different study designs in the estimation of disease risks associated with a mutated gene.
(1) To study the effect of design misspecification, the study designs POP, POP+, CLI, and CLI+
were used to generate family data. For each design, two retrospective likelihood methods
were applied to fit the data—one using correct adjustment of the study design and the other
using a design with misspecified correction; for example, population-based ascertainment
correction was used for the families under CLI+ design and clinic-based ascertainment
correction was used for the families under POP+ design as for the misspecified design. We
simulated 500 random samples of 200 families for each simulation configuration.
(2) To investigate potential bias and efficiency loss in disease risk estimation for the proposed
likelihood approach for combined family data from population-based and clinic-based
designs. We considered the combined families either from POP+ and CLI+ designs or POP
and CLI designs with three mixing ratios between two designs—50-50, 70-30 and 80-20. For
example, with the total 400 families sampled, the ratio 50-50 corresponds to equal numbers
of families from POP+ and CLI+ designs, the 70-30 sampling corresponds to 280 POP+
families and 120 CLI+ families and the ratio 80-20 to 320 POP+ and 80 CLI+ families. The
same numbers were examined for combining POP and CLI families. For each simulation
configuration, 500 random samples were simulated.
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4.3 Simulation results
Results of the simulation studies are described based on the empirical summary measures of
bias and standard error obtained from the maximum likelihood estimates.
4.3.1 The effect of design misspecification
We first assessed bias and precision in disease risk estimation (relative risk and penetrance)
for the retrospective likelihood with correct design adjustment for family data from different
study designs. The results are summarized in Table 2.
With the correct design adjustment, the estimates of both the log relative risk and penetrance
appeared unbiased; the absolute values of bias were less than 0.05 under both high and
low penetrance models regardless of the study design. The magnitude of the bias was
much smaller than the standard errors. In the log relative risk estimation, the precision
of clinic-based designs was higher (smaller standard errors) than that of population-based
designs. The population-based designs provided more accurate and precise estimates of the
log relative risk for high penetrance than for low penetrance, whereas the clinic-based designs
performed better for low penetrance. However, in the penetrance estimation, all designs
provided more precise penetrance estimates (smaller standard errors) for high penetrance
than for low penetrance.
We then examined the effect of design misspecification in terms of bias and precision of the
log relative risk and penetrance estimates obtained from the retrospective likelihoods when
the study design was misspecified. The clinic-based ascertainment correction was applied to
the family data under the population-based designs and the population-based ascertainment
correction to the clinic-based study. It is worth noting that the clinic-based design with the
population-based correction provided relatively large bias in both disease risks, however, the
bias in the population-based design with the clinic-based ascertainment correction was not
notably large. Especially, under POP+ design (with affected and mutation carrier probands),
the clinic-based retrospective likelihood yielded estimates at least as accurate as those from
probands-only adjustment (correct design), although their standard errors were larger under
the misspecified design.
4.3.2 The likelihood methods for combined family data from different study designs
We evaluated the accuracy and precision of the disease risk (log relative risk and penetrance)
estimates based on the three retrospective likelihoods for combined data. Simulation results
based on the combined data from CLI+ and POP+ designs are summarized in Table 3, and
those from combining CLI and POP families in Table 4 .
Combined data from POP+ and CLI+ designs
In the log relative risk estimation, as expected, the population-based likelihoods for the
combined data yielded overestimates because the ascertainment correction was based on only
probands, which would not be sufficient for the families from clinic-based designs. However,
the clinic-based retrospective likelihood provided slightly negative but less biased estimates
in log relative risk but slightly larger standard errors. Although the population-based
likelihoods provided smallest standard errors, they were subject to positive bias. Moreover,
the log relative risk estimates for low penetrance performed better (less bias and higher
precision) than for high penetrance. Our proposed likelihood was almost as efficient as the
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Log relative risk (β) estimation
High Penetrance (β = 2.4) Low Penetrance (β = 1.8)
POP POP+ CLI CLI+ POP POP+ CLI CLI+
Correct -0.002 0.010 0.044 -0.015 -0.006 0.017 0.017 -0.003
Design (0.129) (0.236) (0.095) (0.171) (0.153) (0.256) (0.066) (0.136)
Misspecified 0.033 -0.022 1.456 0.444 0.041 0.009 0.665 0.475
Design (0.159) (0.265) (0.201) (0.165) ( 0.185) (0.272) (0.151) (0.144)
Penetrance estimation
High Penetrance (70%) Low Penetrance (48%)
POP POP+ CLI CLI+ POP POP+ CLI CLI+
Correct 0.013 0.015 0.028 0.020 0.008 0.012 0.049 0.037
Design (0.049) (0.033) (0.078) (0.084) (0.057) (0.040) (0.115) (0.103)
Misspecified 0.034 0.009 0.290 0.282 0.056 0.014 0.501 0.480
Design (0.087) (0.098) (0.003) (0.004) (0.140) (0.135) (0.003) (0.006)
Table 2. Effects of the design misspecification: bias and precision in disease risk estimation
based on retrospective likelihoods with correct and incorrect design adjustments; standard
errors are in parenthesis.
population-based likelihood and as accurate as the clinic-based likelihood, regardless of the
mixing rates we considered. Especially, the combined likelihood appeared to perform better
for relative risk estimation when more CLI+ families were included in the sample.
In the penetrance estimation, we observed similar patterns as in the log relative risk
estimation. The population-based likelihood provided substantially large bias with small
standard errors, whereas the clinic-based likelihood yielded less bias with large standard
errors. However, our proposed likelihood method offered the least bias and improved
precision compared to the clinic-based likelihood. In addition, the penetrance was more
precisely estimated with the combined likelihood when fewer CLI+ families were recruited
(20% CLI+ families).
Combined data from POP and CLI designs
The patterns of bias and precision of the three likelihood methods were more clear with the
combined data from POP and CLI designs, as shown in Table 4. In the log relative risk
estimation, our proposed likelihood yielded both the most accurate and precise estimates.
It also provided more precise estimates when 50% CLI families were included. Similarly, in
penetrance estimation, the population-based likelihood provided heavily biased estimates;
however, the combined likelihood performed well in terms of both bias and precision. With
fewer CLI families (20%) in the data, more precise estimates were obtained.
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4.3 Simulation results
Results of the simulation studies are described based on the empirical summary measures of
bias and standard error obtained from the maximum likelihood estimates.
4.3.1 The effect of design misspecification
We first assessed bias and precision in disease risk estimation (relative risk and penetrance)
for the retrospective likelihood with correct design adjustment for family data from different
study designs. The results are summarized in Table 2.
With the correct design adjustment, the estimates of both the log relative risk and penetrance
appeared unbiased; the absolute values of bias were less than 0.05 under both high and
low penetrance models regardless of the study design. The magnitude of the bias was
much smaller than the standard errors. In the log relative risk estimation, the precision
of clinic-based designs was higher (smaller standard errors) than that of population-based
designs. The population-based designs provided more accurate and precise estimates of the
log relative risk for high penetrance than for low penetrance, whereas the clinic-based designs
performed better for low penetrance. However, in the penetrance estimation, all designs
provided more precise penetrance estimates (smaller standard errors) for high penetrance
than for low penetrance.
We then examined the effect of design misspecification in terms of bias and precision of the
log relative risk and penetrance estimates obtained from the retrospective likelihoods when
the study design was misspecified. The clinic-based ascertainment correction was applied to
the family data under the population-based designs and the population-based ascertainment
correction to the clinic-based study. It is worth noting that the clinic-based design with the
population-based correction provided relatively large bias in both disease risks, however, the
bias in the population-based design with the clinic-based ascertainment correction was not
notably large. Especially, under POP+ design (with affected and mutation carrier probands),
the clinic-based retrospective likelihood yielded estimates at least as accurate as those from
probands-only adjustment (correct design), although their standard errors were larger under
the misspecified design.
4.3.2 The likelihood methods for combined family data from different study designs
We evaluated the accuracy and precision of the disease risk (log relative risk and penetrance)
estimates based on the three retrospective likelihoods for combined data. Simulation results
based on the combined data from CLI+ and POP+ designs are summarized in Table 3, and
those from combining CLI and POP families in Table 4 .
Combined data from POP+ and CLI+ designs
In the log relative risk estimation, as expected, the population-based likelihoods for the
combined data yielded overestimates because the ascertainment correction was based on only
probands, which would not be sufficient for the families from clinic-based designs. However,
the clinic-based retrospective likelihood provided slightly negative but less biased estimates
in log relative risk but slightly larger standard errors. Although the population-based
likelihoods provided smallest standard errors, they were subject to positive bias. Moreover,
the log relative risk estimates for low penetrance performed better (less bias and higher
precision) than for high penetrance. Our proposed likelihood was almost as efficient as the
388 Epidemiology Insights On Combining Family Data from Different Study Designs for Estimating Disease Risk Associated with Mutated Genes 11
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Table 2. Effects of the design misspecification: bias and precision in disease risk estimation
based on retrospective likelihoods with correct and incorrect design adjustments; standard
errors are in parenthesis.
population-based likelihood and as accurate as the clinic-based likelihood, regardless of the
mixing rates we considered. Especially, the combined likelihood appeared to perform better
for relative risk estimation when more CLI+ families were included in the sample.
In the penetrance estimation, we observed similar patterns as in the log relative risk
estimation. The population-based likelihood provided substantially large bias with small
standard errors, whereas the clinic-based likelihood yielded less bias with large standard
errors. However, our proposed likelihood method offered the least bias and improved
precision compared to the clinic-based likelihood. In addition, the penetrance was more
precisely estimated with the combined likelihood when fewer CLI+ families were recruited
(20% CLI+ families).
Combined data from POP and CLI designs
The patterns of bias and precision of the three likelihood methods were more clear with the
combined data from POP and CLI designs, as shown in Table 4. In the log relative risk
estimation, our proposed likelihood yielded both the most accurate and precise estimates.
It also provided more precise estimates when 50% CLI families were included. Similarly, in
penetrance estimation, the population-based likelihood provided heavily biased estimates;
however, the combined likelihood performed well in terms of both bias and precision. With
fewer CLI families (20%) in the data, more precise estimates were obtained.
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Log relative risk (β) estimation
High Penetrance (β = 2.4) Low Penetrance (β = 1.8)
POP+ vs. CLI+ 50-50 70-30 80-20 50-50 70-30 80-20
POP+ corrected 0.279 0.196 0.145 0.326 0.240 0.191
likelihood (0.132) (0.142) (0.149) (0.123) (0.139) (0.145)
CLI+ corrected -0.024 -0.024 -0.026 -0.004 -0.010 -0.002
likelihood (0.140) (0.154) (0.163) (0.124) (0.141) (0.150)
Combined -0.025 -0.026 -0.028 -0.005 -0.011 -0.005
likelihood (0.134) (0.143) (0.149) (0.123) (0.140) (0.147)
Penetrance estimation
High Penetrance (70%) Low Penetrance (48%)
POP+ vs. CLI+ 50-50 70-30 80-20 50-50 70-30 80-20
POP+ corrected 0.209 0.151 0.113 0.348 0.247 0.182
likelihood (0.009) (0.015) (0.017) (0.012) (0.017) (0.020)
CLI+ corrected 0.019 0.016 0.015 0.032 0.021 0.024
likelihood (0.060) (0.067) (0.067) (0.079) (0.083) (0.085)
Combined -0.008 -0.011 -0.012 0.002 -0.002 -0.002
likelihood (0.031) (0.029) (0.027) (0.033) (0.030) (0.028)
Table 3. Bias and precision in disease risk estimation based on three retrospective likelihood
approaches for combined data from different family based designs (POP+ and CLI+) with
affected and mutation carrier probands; standard errors are in parenthesis.
5. Application to Lynch Syndrome families
Lynch Syndrome, also referred to as hereditary non-polyposis colorectal cancer is an
autosomal dominant condition which predisposes carriers to colorectal cancer (CRC). Several
DNA mismatch repair (MMR) genes responsible for the majority of Lynch Syndrome cancers
have been identified, predominantly MLH1 and MSH2. For the study of CRC, Lynch
Syndrome families share a founder mutation in an MMR gene sampled from Newfoundland
and Ontario. The Newfoundland data consist of 315 phenotyped individuals (74 affected and
241 not affected) from 12 very large families identified using a high risk criteria. Of them, 261
were genotyped (162 carriers, 99 non-carriers) and 54 were not genotyped. Each family had
a carrier proband and other affected relatives, which corresponds to the study design CLI+.
The Ontario data were identified through the Ontario Familial Colorectal Cancer Registry
(Cotterchio et al., 2000) and consist of 506 phenotyped individuals (126 affected and 380 not
affected) from 32 families with MMR mutation carrier probands, which corresponds to the
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Log relative risk (β) estimation
High Penetrance (β = 2.4) Low Penetrance (β = 1.8)
POP vs. CLI 50-50 70-30 80-20 50-50 70-30 80-20
POP corrected 0.911 0.644 0.485 0.700 0.609 0.506
likelihood (0.089) (0.079) (0.078) (0.094) (0.089) (0.089)
CLI corrected 0.044 0.035 0.038 0.020 0.024 0.029
likelihood (0.079) (0.086) (0.094) (0.063) (0.077) (0.087)
Combined 0.014 -0.009 -0.017 0.003 0.000 -0.002
likelihood (0.072) (0.076) (0.080) (0.058) (0.068) (0.076)
Penetrance estimation
High Penetrance (70%) Low Penetrance (48%)
POP vs. CLI 50-50 70-30 80-20 50-50 70-30 80-20
POP corrected 0.269 0.237 0.203 0.467 0.413 0.353
likelihood (0.005) (0.010) (0.013) (0.007) (0.012) (0.018)
CLI corrected 0.043 0.041 0.042 0.059 0.060 0.062
likelihood (0.055) (0.055) (0.056) (0.081) (0.082) (0.082)
Combined 0.006 -0.002 -0.005 0.015 0.008 0.006
likelihood (0.042) (0.038) (0.036) (0.047) (0.043) (0.042)
Table 4. Bias and precision in disease risk estimation based on three retrospective likelihood
approaches for combined data from different family based designs (POP and CLI) with
random affected probands; standard errors are in parenthesis.
study design POP+. Of them, 154 individuals were genotyped (92 carriers, 62 non-carriers)
and 352 were not genotyped.
The three likelihood methods (POP+ corrected, CLI+ corrected and combined likelihoods)
were applied to combined families with Lynch Syndrome identified from Newfoundland
(CLI+) and Ontario (POP+). A Weibull model was used to assess the effects of MMR
mutation gene and gender on the age at onset of colorectal cancer. The EM algorithm was
implemented to infer missing genotypes. The results of fitting these Lynch Syndrome families
using different likelihood methods are presented in Table 5, and the age-specific penetrance
estimates based on the combined likelihood are graphically illustrated in Figure 1.
In the analysis based on the combined likelihood, the β parameters for the genetic and gender
effects were estimated to be 1.13 with robust standard error (se) = 0.18 and -0.51 with se=0.17,
respectively, which lead to the hazards ratio of the MMR mutation carriers for the colorectal
cancer as 3.10 (se=0.55) and the hazards ratio between female and male as 0.60 (se=0.11).
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Table 3. Bias and precision in disease risk estimation based on three retrospective likelihood
approaches for combined data from different family based designs (POP+ and CLI+) with
affected and mutation carrier probands; standard errors are in parenthesis.
5. Application to Lynch Syndrome families
Lynch Syndrome, also referred to as hereditary non-polyposis colorectal cancer is an
autosomal dominant condition which predisposes carriers to colorectal cancer (CRC). Several
DNA mismatch repair (MMR) genes responsible for the majority of Lynch Syndrome cancers
have been identified, predominantly MLH1 and MSH2. For the study of CRC, Lynch
Syndrome families share a founder mutation in an MMR gene sampled from Newfoundland
and Ontario. The Newfoundland data consist of 315 phenotyped individuals (74 affected and
241 not affected) from 12 very large families identified using a high risk criteria. Of them, 261
were genotyped (162 carriers, 99 non-carriers) and 54 were not genotyped. Each family had
a carrier proband and other affected relatives, which corresponds to the study design CLI+.
The Ontario data were identified through the Ontario Familial Colorectal Cancer Registry
(Cotterchio et al., 2000) and consist of 506 phenotyped individuals (126 affected and 380 not
affected) from 32 families with MMR mutation carrier probands, which corresponds to the
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Combined 0.014 -0.009 -0.017 0.003 0.000 -0.002
likelihood (0.072) (0.076) (0.080) (0.058) (0.068) (0.076)
Penetrance estimation
High Penetrance (70%) Low Penetrance (48%)
POP vs. CLI 50-50 70-30 80-20 50-50 70-30 80-20
POP corrected 0.269 0.237 0.203 0.467 0.413 0.353
likelihood (0.005) (0.010) (0.013) (0.007) (0.012) (0.018)
CLI corrected 0.043 0.041 0.042 0.059 0.060 0.062
likelihood (0.055) (0.055) (0.056) (0.081) (0.082) (0.082)
Combined 0.006 -0.002 -0.005 0.015 0.008 0.006
likelihood (0.042) (0.038) (0.036) (0.047) (0.043) (0.042)
Table 4. Bias and precision in disease risk estimation based on three retrospective likelihood
approaches for combined data from different family based designs (POP and CLI) with
random affected probands; standard errors are in parenthesis.
study design POP+. Of them, 154 individuals were genotyped (92 carriers, 62 non-carriers)
and 352 were not genotyped.
The three likelihood methods (POP+ corrected, CLI+ corrected and combined likelihoods)
were applied to combined families with Lynch Syndrome identified from Newfoundland
(CLI+) and Ontario (POP+). A Weibull model was used to assess the effects of MMR
mutation gene and gender on the age at onset of colorectal cancer. The EM algorithm was
implemented to infer missing genotypes. The results of fitting these Lynch Syndrome families
using different likelihood methods are presented in Table 5, and the age-specific penetrance
estimates based on the combined likelihood are graphically illustrated in Figure 1.
In the analysis based on the combined likelihood, the β parameters for the genetic and gender
effects were estimated to be 1.13 with robust standard error (se) = 0.18 and -0.51 with se=0.17,
respectively, which lead to the hazards ratio of the MMR mutation carriers for the colorectal
cancer as 3.10 (se=0.55) and the hazards ratio between female and male as 0.60 (se=0.11).
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Fig. 1. (a) Estimated cumulative risk of developing colorectal cancer for carriers of any MMR
gene mutation for the Lynch Syndrome families from Newfoundland and Ontario. (b) Same
as (a) for non-carriers.
Log relative risk estimation in terms of hazards ratio
MMR mutation Gender
POP+ corrected likelihood 1.07 (0.17) -0.42 (0.16)
CLI+ corrected likelihood 1.15 (0.18) -0.52 (0.18)
Combined likelihood 1.14 (0.18) -0.51 (0.17)
Age-specific penetrance estimation among mutation carriers
Male Female
POP+ corrected likelihood 62.4% (4.08) 47.5% (4.06)
CLI+ corrected likelihood 58.9% (4.27) 40.9% (4.18)
Combined likelihood 60.7% (4.15) 42.8% (4.10)
Table 5. Disease risk estimates and their corresponding robust standard errors in parenthesis
using different likelihood methods for the Lynch Syndrome families from Newfoundland
and Ontario
These relative risks indicated that the MMR mutation carriers were approximately three times
more likely to develop the colorectal cancers than non-carriers, whereas among males and
females, females showed about one third lower the hazard rate than males. There was very
little difference observed between the relative risk estimates obtained by the CLI+ corrected
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likelihood and the combined likelihood, although their precisions were slightly better with
the combined likelihood.
We obtained that the penetrance of colorectal cancer by age 70 was 61% (se=4.15) among
male carriers and 43% (se=4.1) among female carriers using the combined likelihood.
These estimates were comparable with those obtained using the POP+ and CLI+ corrected
retrospective likelihoods. Penetrances were overestimated (62% for male and 48% for female
carriers) with higher precision (se=4.08 for male, 4.06 for female) under POP+ correction
but slightly underestimated (59% for male carriers and 41% for female carriers) with lower
precision (se=4.27 for male and 4.18 for female) under CLI+ correction, as seen in our
simulation study.
6. Conclusion
In genetic epidemiology, family studies have been widely used for identifying genes
responsible for traits and characterizing their risks in the population and they are often based
on various family-based designs to sample families depending on the objectives of the study
or their budget. To make population-based inferences, the study design should be properly
taken into account, especially when the sampling is not randomly conducted as often is the
case with the sampling of families.
In this study, for estimating disease risks—relative risk and penetrance, we have proposed
the use of a retrospective likelihood to take the sampling process of families into account,
and investigated the effect of sampling design misspecification on disease risk estimation.
Our study showed that the misspecification of study design undoubtedly lead to bias;
overestimation of risks when the study design adjustment was less than it should be
(i.e, the clinic-based designs were analyzed with the correction by probands only), and
underestimation with overcorrection by multiple affected family members. However, the
magnitudes of bias and precision varied depending on the study design and the size of
the penetrance. We found that undercorrection created more bias although it provided
smaller standard error. This implies that conditioning more individuals would be safer
for obtaining accurate estimates at the price of loss of precision if the study design is not
known. The POP+ design with clinic-based correction in fact provided unbiased estimates
of relative risk and penetrance. In general, the population-based designs performed better
for high penetrance for estimating both disease risks but the clinic-based designs performed
differently: penetrance was more efficiently estimated under high penetrance but relative
risk was more efficiently estimated under low penetrance. In addition, we have proposed
the combined likelihood for families sampled under different study designs and the effect of
design misspecification was also investigated for combined data. Our proposed likelihood is
applicable even when the study designs of the combined data are not clearly known since
we can divide families into two categories—high risk families with at least three affected
individuals and low risk families, otherwise. Our proposed combined retrospective likelihood
method yielded accurate and precise estimates of both disease risks. Comparatively, the
clinic-based likelihoods applied to combined data and provided unbiased estimates less
efficiently compared to those from the combined likelihood. It is noteworthy that the EM
algorithm we developed for inferring missing genotypes is a novel way to impute the missing
genotypes using the observed genotypic and phenotypic information from other family
members.
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Fig. 1. (a) Estimated cumulative risk of developing colorectal cancer for carriers of any MMR
gene mutation for the Lynch Syndrome families from Newfoundland and Ontario. (b) Same
as (a) for non-carriers.
Log relative risk estimation in terms of hazards ratio
MMR mutation Gender
POP+ corrected likelihood 1.07 (0.17) -0.42 (0.16)
CLI+ corrected likelihood 1.15 (0.18) -0.52 (0.18)
Combined likelihood 1.14 (0.18) -0.51 (0.17)
Age-specific penetrance estimation among mutation carriers
Male Female
POP+ corrected likelihood 62.4% (4.08) 47.5% (4.06)
CLI+ corrected likelihood 58.9% (4.27) 40.9% (4.18)
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Table 5. Disease risk estimates and their corresponding robust standard errors in parenthesis
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taken into account, especially when the sampling is not randomly conducted as often is the
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the use of a retrospective likelihood to take the sampling process of families into account,
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Our study showed that the misspecification of study design undoubtedly lead to bias;
overestimation of risks when the study design adjustment was less than it should be
(i.e, the clinic-based designs were analyzed with the correction by probands only), and
underestimation with overcorrection by multiple affected family members. However, the
magnitudes of bias and precision varied depending on the study design and the size of
the penetrance. We found that undercorrection created more bias although it provided
smaller standard error. This implies that conditioning more individuals would be safer
for obtaining accurate estimates at the price of loss of precision if the study design is not
known. The POP+ design with clinic-based correction in fact provided unbiased estimates
of relative risk and penetrance. In general, the population-based designs performed better
for high penetrance for estimating both disease risks but the clinic-based designs performed
differently: penetrance was more efficiently estimated under high penetrance but relative
risk was more efficiently estimated under low penetrance. In addition, we have proposed
the combined likelihood for families sampled under different study designs and the effect of
design misspecification was also investigated for combined data. Our proposed likelihood is
applicable even when the study designs of the combined data are not clearly known since
we can divide families into two categories—high risk families with at least three affected
individuals and low risk families, otherwise. Our proposed combined retrospective likelihood
method yielded accurate and precise estimates of both disease risks. Comparatively, the
clinic-based likelihoods applied to combined data and provided unbiased estimates less
efficiently compared to those from the combined likelihood. It is noteworthy that the EM
algorithm we developed for inferring missing genotypes is a novel way to impute the missing
genotypes using the observed genotypic and phenotypic information from other family
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In practice, it might be difficult to collect families with a mutation-carrier proband. However,
with the emergence of large international consortiums such as the Breast and Colon Cancer
Family Registries, the planning of studies using designs POP+ and CLI+ is now quite feasible.
Therefore, the use of 200 families in the CLI+ design, as specified in our simulation study,
seems to provide a reasonable sample size; however, the efficiency gains with more families
would clearly be greater.
There are potential limitations to our study. First, we assumed the Weibull distribution,
chosen to model the penetrance function because of flexible modeling of the baseline hazard
function which includes constant, increasing or decreasing hazard functions. There might
be potential for model misspecification. Kopciuk et al. (2009) employed the generalized
log-Burr model for more flexible modeling as it includes the Weibull model or the log-logistic
model as special cases (Lawless, 2003), where the Weibull model has a monotonic functional
form of the hazard whereas the log-logistic model does not. The baseline hazard can be
also modeled semiparametrically using a step function while assuming proportional hazards.
Second, between-family heterogeneity in allele frequencies and baseline hazards can lead to
bias in parameter estimates based on the homogeneous models. A random effect model would
allow us to take between-family heterogeneity into account while avoiding a great number of
family-specific parameters. Finally, familial correlation is a common feature of family data due
to the unobserved genetic or environmental risk factors shared within families. We did not
explicitly model within-family dependencies, instead, we accommodated a robust variance
estimator. However, ignoring familial correlation can lead to biased estimates of the model
parameters, and so to biased disease risks (Choi et al., 2008). Relating to other work, several
authors have adopted mixed effect models for binary outcomes in family studies (Heagerty,
1999; Pfeiffer et al., 2008; Zheng et al., 2010). Shared frailty models can allow us to model times
to onset data from families while explicitly modeling familial correlation. We are planning to
develop such frailty models in the context of various family designs.
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